{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b-reasoning/e4_page_window_relevance_desc/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T09:14:46.693099"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried a principal balance of **$606 million** in FY 2022 (10‑K p. 101), the same **$606 million** in FY 2023 (10‑K p. 81) and again **$606 million** in FY 2024 (10‑K p. 81).  The flat amount over three years shows the company has chosen to retain this fixed‑rate, long‑dated debt rather than accelerate repayment, using other issuances and term‑loan repayments to manage overall leverage while keeping a stable, low‑cost debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data. According to the ground truth, AVGO's 5.000% notes due April 2030 were $1,086 million in FY 2022, $606 million in FY 2023, and $606 million in FY 2024. The LLM claims the amount was $606 million in FY 2022, which is factually wrong - this represents a $480 million error for the 2022 figure. The LLM correctly identifies the 2023 and 2024 amounts as $606 million each, but the 2022 error is a major quantitative accuracy failure. REASONING FAILURE: The LLM's interpretation of the data is inverted. The ground truth shows a significant debt reduction strategy (from $1,086M to $606M in 2023), indicating active debt management and repayment. The LLM incorrectly characterizes the flat 2023-2024 amounts as evidence the company 'chose to retain' the debt rather than accelerate repayment, missing the crucial $480 million reduction that occurred between 2022-2023. This represents a fundamental misunderstanding of the company's debt management strategy. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year progression. It should have identified the significant 2022-2023 reduction as the key indicator of debt management strategy, not the flat 2023-2024 period. The answer demonstrates incomplete analysis of the temporal evolution requested in the question. The page citations provided cannot be verified but the numerical discrepancy for 2022 is definitive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 404,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for its closed block has stayed essentially unchanged: the 2022 filing notes that the company “reinsured … 59.25 % of the closed block” through a modified‑coinsurance agreement (page 214), the 2023 filing reports the same arrangement at “59 % of the closed block” (page 227), and the 2024 filing again cites “59 % of the closed block” (pages 204 & 206). The near‑identical risk‑transfer proportion over three years shows that MetLife is deliberately maintaining a stable long‑term strategy—off‑loading roughly three‑fifths of the closed‑block exposure while retaining the remainder to manage capital, diversify risk, and preserve flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three key percentages (59.25% in 2022, 59% in 2023, 59% in 2024) and accurately characterizes the consistency of MetLife's modified coinsurance arrangement across the three-year period. The numeric values are precise and match the ground truth. The LLM correctly identifies the strategy as deliberate and stable, maintaining roughly three-fifths of closed-block exposure reinsured. WEAKNESSES: (1) The LLM omits critical context about accounting methodology - the ground truth specifies that MetLife used the 'deposit method of accounting' each year and 'exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable.' This is a material accounting detail that demonstrates how the company operationalized the strategy. (2) The LLM fails to address the significant growth in total net ceded reinsurance recoverables ($6.3B in 2021 to $17.6B in 2024), which is explicitly mentioned in the ground truth as important context for understanding the consistency claim. This growth data is crucial for demonstrating that the stable percentage masked substantial absolute growth in reinsurance activity. (3) The LLM's explanation of the strategy's purpose is somewhat generic ('manage capital, diversify risk, preserve flexibility') compared to the ground truth's more specific framing of 'risk transfer efficiency and capital optimization.' MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern, but incompletely addresses the full scope of the question about what the consistency 'reveals' about long-term strategy. The answer would have been stronger with the accounting methodology details and the absolute dollar growth context. QUANTITATIVE ACCURACY is high (9/10) because all percentages and years are correct. QUALITATIVE ACCURACY is 7/10 because the reasoning is sound but incomplete regarding accounting treatment and contextual financial data. CONTEXTUAL RELEVANCE is 6/10 because while the core answer addresses the main question, it misses important supporting details that would fully answer what the consistency reveals about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 590,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell from $1.5 billion at 12/31/2022 to $0.8 billion at 12/31/2023 and then to $0.49 billion at 12/31/2024. The steep decline signals that the company’s derivative exposure has been shrinking or becoming more efficiently netted, allowing it to reduce the initial‑margin collateral it needs to support those positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1,494M (presented as $1.5B), $800M ($0.8B), and $491M ($0.49B) match the ground truth exactly. The number format variations ($1.5 billion vs $1,494 million) are acceptable and represent the same values. Dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in collateral amounts across the three-year period, and (2) what this trend suggests about derivative exposure management. ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is correctly referenced, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the consistent downward trend across all three years and draws a logical conclusion about derivative exposure reduction and improved netting efficiency. The interpretation that 'steep decline signals shrinking derivative exposure or more efficient netting' is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure or improved offsetting mechanisms.' MINOR OBSERVATION: The LLM uses slightly different terminology ('initial-margin collateral' vs the ground truth's more general 'derivative exposure') but this represents a reasonable elaboration on the mechanism rather than an error. The answer is comprehensive, accurate, and demonstrates proper multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 451,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO still carried the full $5 billion principal of its 3.625 % senior notes due October 2024 in FY 2022 (as disclosed in the FY 2022 filing AVGO_10k_2022.pdf pages 101‑105). By FY 2023 the balance had been cut to $622 million (AVGO_10k_2023.pdf p. 81) and by FY 2024 the notes were completely retired, shown as a zero balance (AVGO_10k_2024.pdf p. 81). This rapid reduction reflects a deliberate strategy to refinance and retire the older, lower‑coupon debt ahead of schedule using proceeds from newer senior‑note issuances and term‑loan repayments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding the FY 2022 balance. The ground truth clearly states that in 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. However, the LLM claims the company 'still carried the full $5 billion principal' in FY 2022. This is a significant quantitative error - the LLM overstates the FY 2022 balance by approximately $4.378 billion (or 704% higher than actual). The LLM then correctly identifies the $622 million balance in FY 2023 and zero balance in FY 2024, but the foundational error in the FY 2022 figure undermines the entire analysis of the 'progression' and 'rapid reduction' claimed. The LLM's narrative of a 'rapid reduction' from $5 billion to $622 million to zero is factually incorrect - the actual progression was $622M (2022) → $622M (2023) → $0 (2024), showing stability in 2022-2023 followed by retirement in 2024. While the LLM correctly identifies the final outcome (complete retirement by 2024) and provides reasonable context about refinancing strategy, the fundamental mischaracterization of the FY 2022 starting point is a critical factual error that invalidates the core analysis of how the exposure 'evolved.' The reasoning about debt management strategy is partially sound but based on incorrect premises. The multi-hop synthesis across three fiscal years is attempted but fails due to the incorrect FY 2022 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 403,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment generated $2.56 billion in surface‑ship revenue in 2022, $2.70 billion in 2023 and $2.82 billion in 2024 – a modest increase each year【page_9】. This steady upward trajectory reflects a growing backlog of destroyer, auxiliary and support‑ship contracts and underscores the company’s strengthening position as a leading U.S. builder of naval surface vessels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct when accounting for format variations: $2,561M (ground truth) = $2.56B (LLM), $2,698M = $2.70B, and $2,819M = $2.82B. The three-year progression is accurately captured with proper chronological ordering (2022→2023→2024). COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) revenue evolution across three years, (2) the trajectory pattern (steady/sustained growth), and (3) positioning implications in naval shipbuilding. ENTITY ACCURACY: Correctly identifies General Dynamics, Marine Systems division/segment, surface ships, and the relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects revenue data points to draw conclusions about company positioning, backlog strength, and market leadership. The mention of destroyer, auxiliary, and support-ship contracts provides appropriate contextual support. SEMANTIC EQUIVALENCE: The LLM's characterization of 'steady upward trajectory' and 'strengthening position as a leading U.S. builder' conveys the same strategic meaning as the ground truth's 'sustained growth and strategic emphasis.' Minor differences in wording (e.g., 'modest increase' vs. ground truth's more neutral 'increased steadily') are stylistic and don't affect factual accuracy. The citation reference [page_9] adds credibility. No calculation errors detected. The answer fully satisfies the multi-hop requirement by synthesizing revenue data across three years and connecting it to strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 444,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "Mastercard’s quarterly cash dividend on its Class A shares rose each year – $2.04 per share in 2022【page_97】, $2.37 in 2023【page_99】 and $2.74 in 2024【page_92】 – while the charter‑defined voting right for each Class A share stayed at one vote per share with no change across the three years (Class A: “One vote per share” in 2022【page_96】, 2023【page_99】 and 2024【page_92】). The rising dividend shows a commitment to increasing cash returns, and the unchanged voting entitlement indicates a stable governance structure for Class A shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer fundamentally misinterprets the question and provides incorrect information. (1) MAJOR FACTUAL ERROR - Dividend Rights Mischaracterization: The ground truth states that A Class shares have 'standard dividend rights' with NO CHANGES across 2022-2024. The LLM claims dividends 'rose each year' ($2.04→$2.37→$2.74), treating this as evidence of evolving dividend rights. However, the question asks about 'dividend rights' (the contractual entitlement structure), not dividend payment amounts. Rising dividend payments do NOT indicate changing dividend rights—they indicate increased cash distributions on unchanged rights. This is a fundamental semantic confusion. (2) QUANTITATIVE ACCURACY ISSUE - The LLM provides specific dividend per-share amounts ($2.04, $2.37, $2.74) with page citations, but these appear to be actual dividend payment amounts rather than evidence of changing 'dividend rights.' The ground truth indicates dividend rights themselves remained constant. Without verification of these specific numbers against the actual filings, and given the conceptual error, these numbers cannot be validated as responsive to the question. (3) VOTING RIGHTS - The LLM correctly identifies that voting rights remained at 'one vote per share' with no changes across all three years, which aligns with ground truth. This is the only element correctly addressed. (4) MULTI-HOP REASONING FAILURE - The question asks about evolution of 'dividend and voting rights' (governance structure elements) and what the 3-year progression indicates about 'shareholder governance structure stability.' The LLM conflates dividend payment increases with dividend rights changes, missing the core insight that STABILITY (no changes to either dividend rights or voting rights) is what the ground truth emphasizes. (5) CONCLUSION MISMATCH - Ground truth concludes with 'stable shareholder structure' due to consistency. The LLM concludes with 'rising dividend shows commitment to increasing cash returns' and 'unchanged voting indicates stable governance'—mixing payment policy with rights structure. The answer demonstrates partial understanding of voting rights but fundamental misunderstanding of what 'dividend rights' means in a governance context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 608,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment posted surface‑ship revenue of $2.56 billion in 2022, $2.70 billion in 2023 and $2.82 billion in 2024 – about a 5% year‑over‑year rise (≈10% growth over the two‑year span)【page_9】. The consistent increase signals a growing backlog of destroyer and auxiliary‑ship contracts and underscores GD’s strengthening position as a primary supplier for U.S. Navy surface‑ship programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All financial figures are correct when accounting for format variations: $2.56B = $2,561M (2022), $2.70B = $2,698M (2023), $2.82B = $2,819M (2024). The stated ~5% year-over-year growth is accurate (2023-2024: ($2,819-$2,698)/$2,698 = 4.5%, rounds to ~5%; 2022-2023: ($2,698-$2,561)/$2,561 = 5.4%, also ~5%). The ~10% two-year growth is correct: ($2,819-$2,561)/$2,561 = 10.1%. ENTITY ACCURACY: Correctly identifies General Dynamics, Marine Systems segment, surface ships, and relevant time periods (2022-2024). MULTI-HOP REASONING: Successfully synthesizes revenue evolution across three years and connects it to broader strategic positioning (destroyer/auxiliary-ship contracts, U.S. Navy programs, supplier positioning). COMPLETENESS: Addresses both parts of the question - the revenue evolution and what it indicates about positioning. MINOR CONSIDERATIONS: The LLM provides slightly more contextual detail (destroyer/auxiliary-ship contracts, backlog references) than the ground truth, which adds value without contradicting the original answer. The citation reference [page_9] suggests proper sourcing. The wording differs from ground truth but conveys identical semantic meaning regarding the consistent upward trend and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 384,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 10‑K filings show that its reliance on long‑term contracts has not changed – each year the company states that “the majority of Linde’s business is conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers” (2022 p. 17; 2023 p. 20; 2024 p. 19). This unchanged emphasis signals a deliberate strategy to lock in predictable revenue and shield cash‑flow from volatile energy prices, using contract structures to maintain stability despite market fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures that Linde's reliance on long-term contracts remained consistent across 2022-2024, with the same core messaging about cash flow stability and cost pass-through appearing in all three years. The specific page references (2022 p. 17; 2023 p. 20; 2024 p. 19) are cited but cannot be independently verified from the provided context; however, the consistency claim is well-supported by the ground truth. (2) QUANTITATIVE ACCURACY: No specific financial metrics, percentages, or dollar amounts are provided in either answer, which is appropriate given the question focuses on strategic consistency rather than numerical data. The answer correctly identifies the three-year period (2022-2024) without error. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop reasoning: it identifies the consistent strategy across years, explains the mechanism (long-term contracts enabling cost pass-through), and connects this to the strategic implication (revenue predictability and cash flow stability amid market volatility). The reasoning is sound and logically structured. (4) ENTITY ACCURACY: Linde is correctly identified, the time period (2022-2024) is accurate, and the relevant metrics (long-term contracts, cash flow stability, energy/feedstock cost pass-through) are all correctly identified. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth: unwavering emphasis on long-term contracts, stability in cash flow, cost pass-through mechanisms, and strategic prioritization of financial resilience. Minor differences in wording ('unwavering emphasis' vs 'unchanged emphasis,' 'lock in predictable revenue' vs 'revenue predictability') are semantically equivalent. The only minor limitation is that the LLM answer doesn't explicitly mention 'inflationary pressures' as a contextual factor, though this is a very minor omission that doesn't affect the core accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 559,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings General Dynamics repeatedly notes that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 p. 47; 2023 p. 49; 2024 p. 49). The unchanged exclusion shows the company’s deliberate, consistent effort to strip out non‑operational accounting items so that ROIC reflects only the core economic returns of its deployed capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies GD (General Dynamics) and the three-year period (2022-2024) with accurate page references; (2) Accurately captures the core finding that non-economic accounting changes were consistently excluded from ROIC calculations across all three years; (3) Provides specific supporting evidence with direct quotes showing the exclusion rationale ('not reflective of company performance'); (4) Correctly synthesizes the multi-hop reasoning: consistent methodology across years → reveals deliberate company approach → indicates how GD defines core performance; (5) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language ('deliberate, consistent effort to strip out non-operational accounting items') that goes slightly beyond the ground truth's more neutral statement about 'institutionalized principle,' though this interpretation is reasonable and supported by the evidence; (2) The ground truth emphasizes that the consistency 'suggests GD views non-economic accounting changes as irrelevant,' while the LLM frames it as a deliberate methodology choice—both are semantically equivalent and logically sound; (3) The LLM provides more specific textual evidence (page numbers and direct quotes) than the ground truth, which enhances credibility without introducing errors. The answer fully addresses the question's multi-part structure: (a) how treatment evolved (answer: it didn't—remained consistent), (b) what this reveals about approach (answer: deliberate focus on core economic returns). No calculation errors, no entity misidentification, and the reasoning chain is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 480,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee commitments did not become material at any point – the 2024 filing states that “none of the amounts accrued, paid or charged to income for service level guarantees were material as of December 31 2024, 2023 or 2022”【page_81】. The fact that the guarantees remained immaterial for three consecutive years indicates that the company’s risk‑management framework and contract‑performance controls have been effective and consistently preventing any material exposure from these guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the key factual finding that service level guarantee amounts were immaterial across all three years (2022, 2023, 2024); (2) Accurately quotes the filing language about amounts being 'immaterial as of December 31 2024, 2023 or 2022'; (3) Properly synthesizes the multi-hop reasoning that consistent immateriality across three years indicates effective risk management and contractual performance; (4) Uses appropriate terminology ('risk-management framework,' 'contract-performance controls') that matches the ground truth's characterization. Quantitative accuracy is perfect - all dates and the three-year period are correct with no calculation errors. The reasoning is sound and logically connects the pattern of immateriality to conclusions about risk management effectiveness. Minor consideration: The LLM answer is slightly more detailed and specific (mentioning 'framework' and 'controls') compared to the ground truth's more general phrasing of 'strong risk management controls and contractual performance,' but this represents appropriate elaboration rather than error. The citation reference【page_81】adds credibility. Overall, the answer demonstrates strong multi-hop synthesis across the three-year period and correctly interprets what the pattern suggests about the company's operational effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 394,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment recorded surface‑ship revenue of **$2.56 billion in 2022**, which rose to **$2.70 billion in 2023** and further to **$2.82 billion in 2024** – an overall increase of roughly 10 % over the two‑year span【page_9】. This consistent upward trend underscores the company’s expanding role in building and supporting surface combatants and auxiliary vessels, reinforcing its strategic positioning as a premier, integrated supplier of naval defense platforms alongside its submarine business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM reports: 2022: $2.56B ($2,560M), 2023: $2.70B ($2,700M), 2024: $2.82B ($2,820M). The 2022 figure is off by $232 million (10% error), the 2023 figure is off by $2 million (negligible), and the 2024 figure is off by $1 million (negligible). The 2022 discrepancy is substantial and represents a material misstatement. The LLM's calculation of '10% growth over two years' is also incorrect based on the ground truth numbers: ($2,819M - $2,328M) / $2,328M = 21.1% growth, not 10%. Even using the LLM's own numbers: ($2,820M - $2,560M) / $2,560M = 10.2%, which happens to be approximately correct for their stated figures, but this is based on the wrong 2022 baseline. QUALITATIVE ASSESSMENT: The reasoning about strategic positioning, naval defense platforms, and the company's role in surface combatants is sound and aligns with the ground truth narrative. The multi-hop synthesis correctly identifies the Marine Systems segment and connects the revenue trend to broader strategic implications. However, the qualitative strength cannot overcome the quantitative failures. COMPLETENESS: The answer addresses both parts of the question (revenue evolution and strategic positioning), but the factual errors in the primary data points significantly compromise the analysis. The citation reference [page_9] appears to be an attempt at source attribution but cannot be verified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 431,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In 2022 Electric Insurance Company (EIC) was still a captive property‑and‑casualty insurer within GE’s run‑off insurance operations, with net claim reserves of roughly $0.2 billion (2021) and $0.3 billion (2020) and no “held‑for‑sale” designation【page_47】. In the fourth quarter of 2022 GE re‑classified EIC as a business held for sale, reporting about $541 million of assets versus $378 million of liabilities and recording a $109 million loss in 2023 as it prepared the transaction【page_50】【page_50】. The sale was completed in the second quarter of 2024, when GE sold EIC to Riverstone International Holdings for $120 million, eliminating the related assets and liabilities from its balance sheet【page_48】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the EIC relationship evolution. Verification of key facts: (1) 2022 status as captive P&C insurer - CORRECT; (2) Net claim reserves of $0.2 billion (2021) - CORRECT; (3) Q4 2022 reclassification as held-for-sale - CORRECT and adds useful temporal specificity; (4) Assets of $541 million and liabilities of $378 million as of Dec 31, 2023 - CORRECT; (5) $109 million loss recorded in 2023 - CORRECT; (6) Sale completion in Q2 2024 to Riverstone International Holdings for $120 million - CORRECT. The LLM answer actually provides slightly more detail than the ground truth by specifying the Q4 2022 reclassification timing and Q2 2024 completion timing, which enhances clarity. The multi-hop synthesis is sound: the answer correctly traces the progression from operational ownership (2022) through held-for-sale classification (Q4 2022/2023) to divestiture completion (Q2 2024). All financial figures are accurate with proper formatting. The answer appropriately addresses all three dimensions of the question: classification evolution, financial exposure, and divestiture. Minor note: The LLM includes additional context about 2020 reserves ($0.3 billion) which, while not in the ground truth, is not contradictory and adds useful historical context. The semantic meaning aligns perfectly with the ground truth regarding the strategic shift from operational ownership to full divestiture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 404,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips began a paced monetization of its CVE stake in 2021 and, in the first quarter of 2022, sold the remaining 91 million CVE common shares, directing the cash to its share‑repurchase program (2023 10‑K p.110). In 2023 the company used those proceeds (and other cash) to buy back 383 million shares for $29 billion, and the board raised the repurchase ceiling from $25 billion to $45 billion (2023 10‑K p.110). By 2024 the ceiling was further expanded to $65 billion and total repurchases rose to 433 million shares at a cost of $34.3 billion through year‑end (2024 10‑K p.110). This progression shows a capital‑allocation strategy focused on returning excess cash to shareholders, using the CVE‑share monetization proceeds to fund an increasingly large buy‑back program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the timing and sequencing of the repurchase program authorization. According to the ground truth, the $45 billion authorization existed at the time of the 2022 CVE share sale, and the board approved an increase to $65 billion in 2024. However, the LLM states that 'the board raised the repurchase ceiling from $25 billion to $45 billion' in 2023, which contradicts the ground truth that indicates the $45 billion authorization was already in place when the CVE shares were sold in 2022. This is a material error in understanding the capital allocation timeline. The LLM correctly identifies: (1) the 91 million CVE shares sold in Q1 2022, (2) the 383 million shares repurchased for $29 billion through 2023, (3) the 433 million total shares repurchased for $34.3 billion through 2024, (4) the $65 billion total authorization by 2024, and (5) the overall strategy of returning cash to shareholders. The multi-hop reasoning is generally sound in connecting CVE monetization to share repurchases and showing program expansion. However, the error regarding when the $45 billion authorization was established (2022 vs. 2023) represents a significant factual inaccuracy that affects the narrative of how the strategy evolved. The answer demonstrates good understanding of the overall capital allocation strategy but fails on a key detail about the authorization timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 395,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance transaction has been essentially unchanged. In the 2022 filing the company said it “reinsured 59.25 % of the closed block…under a modified‑coinsurance agreement” and that it “accounts for this agreement under the deposit method of accounting”【page_214】. The 2023 and 2024 filings each report the same approach – about 59 % of the closed block reinsured and still recorded using the deposit method with the deposit liability offset against the deposit recoverable【page_227】【page_204】. This steady percentage and consistent accounting treatment indicate MetLife is maintaining a long‑term risk‑transfer strategy that permanently shifts roughly three‑fifths of the closed‑block risk to a third‑party reinsurer while using a predictable deposit‑accounting framework to manage the transferred exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% in 2022, ~59% in 2023 and 2024 match the ground truth exactly. The characterization of 'roughly three-fifths' is an accurate semantic representation of 59%. ENTITY ACCURACY: MetLife correctly identified, years 2022-2024 properly referenced, modified coinsurance agreement correctly named, deposit method of accounting correctly identified, and the offset mechanism between deposit liability and deposit recoverable correctly described. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years of filings, comparing percentages and accounting treatments across the period. The logical conclusion about stable long-term risk transfer strategy is sound and well-supported. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution of percentage reinsured (shows consistency), (2) accounting treatment (shows consistency), and (3) what this reveals about strategy (stable, structured risk transfer). MINOR CONSIDERATIONS: The LLM uses slightly more colloquial phrasing ('essentially unchanged,' 'steady percentage') compared to the ground truth's more formal tone, but this represents stylistic variation rather than factual error. The characterization of the reinsurer as 'third-party' and 'unaffiliated' is consistent with the ground truth's reference to 'unaffiliated third-party reinsurer.' The answer provides appropriate context about longevity risk management and the deposit accounting framework. No calculation errors detected. All citations to page numbers appear reasonable for 10-K filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 460,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The RedCard‑penetration metric (which includes the Target MasterCard Credit Card) fell each year – 20.5 % in fiscal 2022, 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024【page_27】. The steady decline signals that a smaller share of guest purchases is being funded with Target’s branded credit cards, suggesting a modest weakening of consumer engagement with Target’s financial products over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three penetration rate percentages are factually correct: 20.5% (2022), 19.8% (2023), 18.6% (2024). (2) The numeric trend is accurately captured - showing consistent year-over-year decline. (3) The LLM correctly identifies this as a RedCard/Target MasterCard metric. (4) The characterization of the trend as 'steady decline' and 'weakening of consumer engagement' is semantically equivalent to the ground truth's 'downward trend' and 'decrease in consumer engagement.' WEAKNESSES: (1) The LLM answer is INCOMPLETE - it fails to address a critical component of the original question about what the trend 'suggests about consumer engagement.' While it mentions 'modest weakening,' it omits the important contextual insight that the 2024 rebranding from RedCards to Target Circle Cards did NOT reverse the decline. (2) The ground truth explicitly notes this rebranding as significant context for understanding the trend's implications, but the LLM answer completely omits this. (3) The LLM answer lacks the nuance that despite 'continued incentives like the 5% discount,' engagement still declined - this is an important qualifier about the strength of the trend. (4) The answer is somewhat superficial in its analysis - it states the decline but doesn't fully explore what this means for Target's financial product strategy. MULTI-HOP REASONING: The LLM successfully synthesizes the penetration rate data across three fiscal years, but fails to integrate the rebranding information that would complete the multi-hop analysis. The question asks what the trend 'suggests' - requiring synthesis of both the numerical trend AND contextual business events (rebranding). The LLM only addresses the numerical trend. CALCULATION VERIFICATION: No calculations required; all percentages are correctly stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 492,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. was listed as a member of PMI’s peer group in the 2022 filing (see 2022 Performance Graph, page 21), and the same company appears in the identical peer‑group list in the 2023 filing (Performance Graph, page 26) and again in the 2024 filing (Performance Graph, page 26). The unchanged inclusion shows that PMI deliberately keeps a stable set of global consumer‑product peers—selected for comparable size, market reach and product focus—to benchmark its performance consistently over time, reflecting a long‑term, continuity‑driven strategic benchmarking approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across 2022, 2023, and 2024; (2) Accurately cites specific filing locations (2022 Performance Graph page 21, 2023 and 2024 Performance Graph page 26); (3) Properly synthesizes the multi-hop information showing consistency across three years; (4) Correctly characterizes the peer group selection criteria (global presence, consumer products, comparable size, market reach); (5) Accurately interprets the strategic implication—that PMI maintains a stable benchmarking methodology with continuity-driven approach. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references are correct. No calculations required, but numeric references are accurate. QUALITATIVE ACCURACY: The reasoning is sound—the answer correctly identifies that unchanged inclusion indicates deliberate strategic choice for stable benchmarking. The characterization of PMI's approach as 'long-term, continuity-driven' is semantically equivalent to the ground truth's 'stable benchmarking methodology.' MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth ('long-term, continuity-driven strategic benchmarking approach' vs. 'stable benchmarking methodology'), but these are semantically equivalent and both accurately convey the same insight. The LLM provides more specific citation details (page numbers) which adds value without introducing errors. The answer fully addresses both parts of the question: (1) how the classification evolved (remained consistent), and (2) what this reveals about PMI's strategic approach (stable, deliberate, continuity-focused).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 477,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s policy for development‑service and IP‑licensing contracts has remained the same from 2022 through 2024. In each filing – 2022 (p. 59) 【page_59】, 2023 (p. 63) 【page_63】 and 2024 (p. 64) 【page_64】 – AMD says it first determines whether the licensing component is distinct; if it is not distinct, the development services and license are combined as a single performance obligation and revenue is recognized over time, whereas a distinct license (or a standalone IP license) is recognized at a point in time when the customer can benefit. The identical language across the three years shows that AMD’s accounting approach for these agreements has been consistent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024, matching the ground truth assertion of 'maintained a consistent revenue recognition policy'; (2) Accurately describes the two-part test for distinctness: (i) capable of being distinct and (ii) distinct in context, though the LLM uses slightly different phrasing ('first determines whether the licensing component is distinct'); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time; (4) Properly cites specific page numbers (59, 63, 64) from the respective filings, demonstrating multi-hop synthesis across three years; (5) Correctly notes the absence of variable consideration issues and the uniform nature of the policy. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly mention 'variable consideration estimates' as the ground truth does, though this is a minor omission that doesn't affect the core accuracy; (2) The phrasing differs slightly from ground truth (e.g., 'first determines whether the licensing component is distinct' vs. the ground truth's more detailed two-part test language), but the semantic meaning is equivalent and accurate; (3) The LLM provides slightly less explicit detail about the 'capable of being distinct' criterion, though it captures the essence of the policy. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; page numbers are cited appropriately. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the consistency pattern. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental information as the ground truth regarding policy consistency and the mechanics of revenue recognition for these arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 517,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. has been a constant member of PMI’s benchmarking peer group – it is listed in the 2022 performance graph (PM_10k_2022 p. 21) and again in the 2023 and 2024 graphs (PM_10k_2023 p. 26; PM_10k_2024 p. 26), with the latter two filings explicitly noting the peer group is unchanged from the prior year. This unchanged inclusion signals that PMI deliberately benchmarks itself against the same set of global consumer‑product leaders, reinforcing its strategic framing as a diversified consumer‑goods competitor rather than a pure tobacco company.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as a consistent member of PM's peer group across 2022-2024; (2) Accurately cites specific document references (PM_10k_2022 p. 21; PM_10k_2023 p. 26; PM_10k_2024 p. 26) showing multi-hop synthesis across three years of filings; (3) Correctly notes that the peer group remained unchanged from prior years in 2023 and 2024 filings; (4) Provides sound strategic interpretation that this consistency reflects deliberate benchmarking methodology and PM's positioning as a diversified consumer-goods competitor. MINOR CONSIDERATIONS: (1) The LLM uses 'PMI' (Philip Morris International) while the question and ground truth use 'PM' - these are equivalent references to the same company, so this is a stylistic variation rather than an error; (2) The LLM adds interpretive insight about PM's 'strategic framing as a diversified consumer‑goods competitor rather than a pure tobacco company,' which goes slightly beyond the ground truth's focus on 'alignment with leading global consumer staples firms,' but this represents complementary analysis rather than contradiction. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page numbers cited are specific and verifiable; the three-year consistency claim is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to establish the consistency pattern and draw conclusions about strategic intent. The logical chain (consistent inclusion → deliberate methodology → strategic positioning) is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 459,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s policy for combined development‑services + IP‑licensing contracts did not change from 2022 through 2024. In each filing the Company says the arrangement may be a single or multiple performance obligations; if the license is distinct, revenue is recognized at the point in time the customer can benefit, and if the license is not distinct it is combined with the development services and recognized over time – the same description appears in the 2022 filing (page 59), the 2023 filing (page 64) and the 2024 filing (page 62).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024. The answer accurately captures the key policy mechanics: (1) assessment of whether licensing is distinct, (2) point-in-time recognition if distinct, and (3) over-time recognition if combined with development services. The page number citations (2022 filing page 59, 2023 filing page 64, 2024 filing page 62) demonstrate proper multi-hop synthesis across three years of filings. Quantitative accuracy is strong with correct year references and no calculation errors. However, the LLM answer has one notable omission compared to the ground truth: it does not mention the explicit statement about 'no variable consideration estimates associated with these arrangements,' which the ground truth identifies as an important indicator of stable accounting treatment. This omission represents a minor but meaningful gap in completeness, as it was specifically highlighted in the original answer as evidence of consistency. The LLM answer is semantically equivalent on the main policy mechanics but misses this supporting detail that reinforces the stability claim. The reasoning is sound and the multi-hop synthesis across three years is properly executed, but the answer would have been stronger with inclusion of the variable consideration detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 396,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips completed the final step of its CVE‑share monetization in early 2022, selling the remaining 91 million CVE common shares and directing the cash to its ongoing buy‑back program 【page_110】.  By the end of 2023 the company had repurchased 383 million shares for about $29 billion, and by December 2024 that total rose to 433 million shares at a cost of $34.3 billion after the board raised the buy‑back ceiling to $65 billion 【page_112】.  The multi‑year pattern—monetizing a non‑core equity stake and steadily scaling share repurchases—signals a capital‑allocation strategy that prioritizes returning excess cash to shareholders through aggressive buy‑backs while using proceeds from asset disposals to fund those returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - 91 million CVE shares sold in early 2022 (Q1 2022), 383 million shares repurchased for $29 billion by end of 2023, 433 million shares repurchased for $34.3 billion by end of 2024, and $65 billion buyback authorization. All dollar amounts and share counts match the ground truth exactly. COMPLETENESS: The answer addresses the core question about CVE monetization evolution from 2022-2024 and capital allocation strategy. It captures the key progression: completion of CVE sale in early 2022 → proceeds directed to buybacks → scaling of repurchases through 2023-2024 → board authorization increase to $65 billion. ENTITY ACCURACY: ConocoPhillips correctly identified, CVE shares properly referenced, fiscal years 2022-2024 correctly specified, financial metrics (share repurchases, dollar amounts) accurately stated. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects the CVE monetization to the buyback program, demonstrating clear causal linkage. The interpretation that CVE proceeds funded share repurchases is accurate and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'prioritizing returning excess cash to shareholders through aggressive buy-backs while using proceeds from asset disposals to fund those returns' accurately captures the ground truth's description of 'consistent and escalating focus on capital discipline and shareholder returns.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information. The phrase 'early 2022' is appropriately specific (Q1 2022 from ground truth). The inclusion of page references adds credibility. The answer effectively conveys the multi-year progression and strategic implications without any factual errors or calculation mistakes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 531,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s risk disclosures show a steady widening of competitive‑landscape exposure across all of its reportable units. In 2022 the company warned that Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability Solutions each faced “changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization” (2022 p.30). By 2023 the same language appears for Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions (2023 p.31), and the 2024 filing adds “new entrants and non‑traditional players” for Aerospace and repeats the competitive‑landscape and commoditization risks for all four segments (2024 p.32), indicating that market pressure has intensified and broadened. In response, Honeywell has reshaped its portfolio – realigning into Industrial Automation and Energy & Sustainability Solutions (2023 p.31), funding repositioning actions (2022‑2024 p.29‑30) and planning a spin‑off of its Advanced Materials business (2024 p.28) – a strategic shift aimed at countering the growing competition with focused automation, sustainability and innovation initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) ENTITY ERRORS: The LLM claims Aerospace Technologies faced competitive landscape risks in 2022 and 2023, but the ground truth specifies only 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, and 'the same segments' in 2023. The LLM incorrectly adds Aerospace, Industrial Automation, and Energy & Sustainability Solutions to 2022 disclosures. (2) SEGMENT NAMING INCONSISTENCIES: The ground truth references 'Building Automation and Industrial Automation' in 2024, while the LLM uses different segment names (Aerospace Technologies, Performance Materials & Technologies) that don't align with the ground truth's identified segments. (3) QUOTE ACCURACY: The LLM provides specific quotes with page numbers (2022 p.30, 2023 p.31, 2024 p.32) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not cite these specific page references or quote the exact language the LLM attributes to them. (4) STRATEGIC RESPONSE DETAILS: While the LLM correctly identifies portfolio restructuring and spin-off activities, it adds specific details (Advanced Materials business spin-off, specific page references for repositioning actions) that go beyond what the ground truth confirms. (5) MULTI-HOP REASONING: The LLM's synthesis across years is flawed because it incorrectly identifies which segments faced competitive pressures in each year. The ground truth shows a narrower, more specific evolution (Building Technologies/Safety & Productivity Solutions → Building Automation/Industrial Automation), while the LLM broadens this to include segments not mentioned in the ground truth. The core insight about intensifying competitive pressure is present, but the factual foundation is compromised by incorrect segment attribution and unverified citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 526,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "The cash dividend paid on Mastercard’s Class A shares rose each year – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024【page_99†L31-L38】【page_92†L31-L38】 – while the voting entitlement stayed fixed at one vote per share for Class A stock throughout the period【page_99†L13-L16】【page_92†L13-L16】. This three‑year pattern shows a governance approach that consistently raises shareholder cash returns but preserves a stable, one‑share‑one‑vote structure, underscoring a focus on rewarding owners without altering voting power.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dividend per-share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth answer. The ground truth explicitly states there were NO CHANGES in the description of dividend rights across 2022-2023-2024, focusing on the CONSISTENCY of rights disclosure, not the actual dividend amounts paid. The LLM has fundamentally misinterpreted the question by: (1) Providing specific dividend payment amounts that cannot be verified against the ground truth and appear to be fabricated or from a different context, (2) Shifting focus from 'dividend rights' (the structural right to receive dividends) to 'cash dividends paid' (actual payment amounts), which are different concepts, (3) Missing the core insight that the ground truth emphasizes: the CONSISTENCY and STABILITY of A Class share rights across the three-year period with NO CHANGES. The LLM's statement about 'consistently raises shareholder cash returns' contradicts the ground truth's emphasis on consistency of RIGHTS, not amounts. While the LLM correctly identifies the one-vote-per-share structure remaining constant, it introduces unverified numerical data and misses the primary point about governance stability. The answer demonstrates a fundamental misunderstanding of what the question asks (evolution of rights structure) versus what the LLM provided (evolution of dividend payment amounts).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 393,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s exposure to total‑return swaps used to hedge deferred‑compensation grew markedly – the notional amount rose from $651 million in FY 2022 to $792 million in FY 2023 and to $985 million in FY 2024【page_92†L31-L38】【page_91†L57-L64】.  At the same time, the accounting impact on operating expense shifted from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024, showing the hedge moved from a negative to a positive contribution as the exposure expanded【page_92†L45-L48】【page_91†L45-L52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million match the ground truth exactly. The answer goes beyond the original answer by providing additional context about the notional amounts of the swaps ($651M in FY2022, $792M in FY2023, $985M in FY2024), which demonstrates deeper synthesis of the filing data and shows how the exposure expanded over the period. The multi-hop reasoning is sound: the LLM correctly synthesizes information about both the notional exposure amounts and the accounting impacts on operating expenses, then logically connects these to show how the hedge moved from negative to positive contribution as exposure expanded. The trajectory analysis is accurate - correctly identifying the shift from a $92M loss to gains of $58M and $91M. The semantic meaning is equivalent to the ground truth, with slightly more detailed explanation. The citation references (page numbers and line numbers) add credibility. Minor: The answer uses 'total‑return swaps' with a special character instead of 'Total Return Swaps', but this is a formatting variation that doesn't affect accuracy. The answer fully addresses all parts of the multi-part question regarding how the financial exposure evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 380,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "In 2022 Johnson & Johnson funded a $2 billion trust and set aside a $2 billion reserve for LTL Management LLC’s talc liabilities while the original LTL Chapter 11 case remained pending; after that case was dismissed, the company filed a second “LTL 2” bankruptcy in 2023 and expanded the reserve to roughly $9 billion (about one‑third recorded as a current liability) to cover all current and future claims【page_113】【page_97】. By 2024 J&J shifted to a pre‑packaged Chapter 11 plan, raised its talc reserve to a present‑value of about $11.6 billion (≈$13.5 billion nominal)【page_102】, secured a multi‑state settlement agreement in principle in January (finalized in June)【page_100】【page_98】, and restructured LTL into three Texas entities—including a Red River Chapter 11 filing—to implement the comprehensive resolution【page_101】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detail than the ground truth but contains several critical discrepancies that reduce accuracy:\n\nCORRECT ELEMENTS:\n- 2022: $2 billion reserve established (correct)\n- LTL Chapter 11 bankruptcy filing in 2022 (correct)\n- 2023: LTL bankruptcy dismissed by Third Circuit, LTL 2 re-filed (correct)\n- 2024: Multi-state settlement with 42 states and DC (correct)\n- Shift from bankruptcy-exclusive to dual strategy of appeals + settlements (correct)\n- General timeline and strategic evolution (correct)\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- LLM claims a \"$2 billion trust\" was funded in 2022 - ground truth only mentions a $2 billion reserve, not a separate trust\n- LLM states reserve \"expanded to roughly $9 billion\" by 2023 - ground truth provides no such figure\n- LLM claims 2024 reserve raised to \"$11.6 billion present-value\" and \"$13.5 billion nominal\" - ground truth does not mention these specific amounts\n- LLM references \"pre-packaged Chapter 11 plan\" in 2024 - ground truth does not mention this\n- LLM describes restructuring into \"three Texas entities\" and \"Red River Chapter 11 filing\" - ground truth does not mention these specific structural details\n- LLM specifies settlement \"in principle in January (finalized in June)\" - ground truth only says \"finalized\" without these specific dates\n\nQUANTITATIVE ACCURACY ISSUES:\nThe LLM introduces multiple reserve figures ($9 billion, $11.6 billion, $13.5 billion) that are not present in the ground truth. While these may be from actual filings, they represent a significant expansion beyond what the ground truth confirms. The citation references (page numbers) suggest the LLM is drawing from source documents, but the ground truth does not validate these specific amounts.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution across years and identifies the strategic shift, but adds substantial detail not confirmed by the ground truth. The reasoning about the shift from bankruptcy to dual strategy is sound and matches the ground truth narrative.\n\nSEMANTIC EQUIVALENCE:\nWhile the core narrative matches, the introduction of unverified financial figures and structural details creates factual discrepancies rather than mere wording differences. The answer goes beyond the ground truth in ways that cannot be confirmed as correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 633,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an unchanged principal balance of **$495 million** in each of the three most recent fiscal years – FY 2022, FY 2023 and FY 2024 (the FY 2023 and FY 2024 figures are shown in the senior‑notes table [page 81] and the FY 2022 filing reports the same amount). This flat balance shows the company has neither retired nor added to this tranche, indicating a deliberate strategy to keep the low‑cost, fixed‑rate debt on the books and let it run to maturity rather than refinance or pre‑pay it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numbers are correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), matching the ground truth exactly. The fiscal years are correctly identified. COMPLETENESS: The answer fully addresses both parts of the question: (1) how the balance evolved (remained constant at $495M across all three years), and (2) what this indicates about debt management strategy. ENTITY ACCURACY: Company name (Broadcom), ticker (AVGO), debt instrument (3.125% notes due January 2025), and fiscal years are all correct. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized that the constant balance across three years indicates no retirements or new issuances. The interpretation that this represents a deliberate strategy to maintain low-cost fixed-rate debt and let it run to maturity is a reasonable inference that goes slightly beyond the ground truth but is logically consistent with the facts presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with enhanced detail about the company's strategic intent (keeping low-cost debt on books, avoiding refinancing/prepayment). The reference to page 81 and specific filing documentation adds credibility. Minor enhancement: The LLM provides slightly more strategic interpretation than the ground truth, characterizing it as a 'deliberate strategy' to maintain the debt - this is a reasonable inference but represents a modest elaboration beyond the stated facts. Overall, this is an excellent answer with accurate numbers, complete coverage, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 467,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note due June 15 2025 carried an effective rate of **3.20 % in FY 2022** (July 30 2022 table)【page_89】. By FY 2023 the same note’s effective rate had risen to **about 6.38 %** (July 29 2023 table)【page_89】, and it climbed further to **≈ 6.66 % in FY 2024** (July 27 2024 table)【page_89】. This upward swing shows that Cisco’s exposure to that fixed‑rate tranche has grown sharply, reflecting higher market borrowing costs and an overall increase in the company’s cost of debt over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three effective interest rates are correct - 3.20% (FY 2022), 6.38% (FY 2023), and 6.66% (FY 2024). The fiscal year dates and note maturity date (June 15, 2025) are accurate. The progression of numbers matches the ground truth exactly. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) identifies the specific note (3.50% June 15, 2025 maturity), (2) traces the evolution across all three fiscal years, (3) provides interpretation of what the progression indicates. ENTITY ACCURACY: Cisco is correctly identified, fiscal years are properly labeled, the specific debt instrument is correctly referenced, and the metric (effective interest rate) is properly understood. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly extracted data from three separate fiscal year tables and synthesized them into a coherent narrative showing the upward trend. The interpretation that this reflects 'higher market borrowing costs' and 'increase in the company's cost of debt' is logically sound and semantically equivalent to the ground truth's explanation about 'deterioration in financing terms' and 'market conditions.' MINOR OBSERVATIONS: The LLM uses slightly different phrasing ('exposure to that fixed-rate tranche has grown sharply' vs. ground truth's 'deterioration in financing terms'), but both convey the same economic meaning. The use of approximate symbols (≈) for 6.66% is reasonable given potential rounding in source documents. Page citations (page_89) add credibility. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 469,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s senior and subordinated notes were $30.8 billion at year‑end 2022, rose to $31.3 billion in 2023, and fell to $30.7 billion in 2024【page_178†L31-L38】【page_179†L31-L38】【page_189†L31-L38】. The modest 2023 increase shows the bank deliberately added fixed‑rate long‑term funding while rates were still relatively low, and the 2024 reduction – together with a higher weighted‑average note rate in 2024 – signals a tightening of the capital structure and selective refinancing to limit exposure to rising interest‑rate costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are central to answering this question. (1) 2022 FIGURE: Ground truth states $27.219 billion; LLM states $30.8 billion - a $3.6 billion discrepancy (13% error). This is a major factual error. (2) 2023 FIGURE: Ground truth states $31.248 billion; LLM states $31.3 billion - this is approximately correct (minor rounding acceptable). (3) 2024 FIGURE: Ground truth states $30.696 billion; LLM states $30.7 billion - this is approximately correct (minor rounding acceptable). (4) INTEREST RATE DATA: The LLM answer mentions 'higher weighted-average note rate in 2024' but provides NO SPECIFIC PERCENTAGES. Ground truth provides critical data: 2.76% (2022), 4.48% (2023), 4.84% (2024). The LLM completely omits these specific interest rate figures, which are essential to answering the question about 'interest rate positioning.' This is a major omission. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the interest rate progression across the three years, which is explicitly requested in the question. The answer mentions rates rose but provides no quantitative support. (6) CAPITAL STRUCTURE ANALYSIS: The LLM's interpretation of the 2023 increase as 'modest' is contradicted by ground truth showing a $4.029 billion increase (14.8% growth), which is substantial, not modest. The LLM also mischaracterizes the strategy - ground truth indicates a 'significant capital raise in 2023' not a 'modest' one. (7) REASONING QUALITY: While the LLM's logic about fixed-rate financing and interest rate management is directionally reasonable, it lacks the quantitative rigor needed to support the claims, particularly regarding the interest rate shift from 2.76% to 4.84%. The answer reads as speculative rather than data-driven. The most critical failure is the incorrect 2022 baseline figure ($30.8B vs $27.219B), which undermines the entire 3-year progression analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 537,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income holdings of Treasury or agency securities fell from roughly **40 % in 2022** to **about 30 % in 2023**, and the **30 % level persisted into 2024**【page_102†L13-L16】【page_100†L13-L16】. This reduction in the most conservative government‑bond slice signals a deliberate tilt toward a broader mix of non‑Treasury government and corporate bonds, suggesting the company is seeking higher yields or greater diversification in its pension‑fund strategy while still maintaining a sizable fixed‑income allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All percentages are correct - 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The numerical progression and year-to-year comparison are accurate. ENTITY ACCURACY: Colgate-Palmolive is correctly identified, the U.S. pension plan is properly specified, and the fixed income portfolio context is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and correctly identifies the trend (reduction from 40% to 30%, then stabilization). The interpretation that this represents a 'deliberate tilt' away from the most conservative securities is sound and matches the ground truth's characterization of 'strategic reallocation.' SEMANTIC EQUIVALENCE: The LLM's description of seeking 'higher yields or greater diversification' aligns well with the ground truth's mention of 'shift in risk tolerance or yield-seeking behavior.' The phrase 'most conservative government-bond slice' effectively conveys the nature of Treasury/agency securities. COMPLETENESS: The answer addresses all parts of the multi-part question - the evolution from 2022 to 2024 and what it suggests about pension fund strategy. Minor note: The LLM includes citation references (page numbers) which add credibility but aren't part of the ground truth evaluation. The answer is comprehensive, accurate, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 416,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "GE first moved its captive industrial insurer, Electric Insurance Company (EIC), into a “held‑for‑sale” disposal group in the fourth quarter of 2022, reporting $541 million of assets and $378 million of liabilities [page 48]. By the end of 2023 the group carried a $124 million valuation allowance (up from $17 million in 2022), indicating a lower fair‑value estimate of the business [page 48], and in the second quarter of 2024 GE completed the sale to Riverstone International Holdings for $120 million, eliminating the assets, liabilities and allowance from the balance sheet [page 48]. This sequence—classification, write‑down, and eventual cash sale—shows GE’s strategic push to divest non‑core insurance operations and generate liquidity while refocusing on its core industrial businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (classification as held-for-sale, write-down, eventual sale to Riverstone for $120M in Q2 2024) and correctly identifies the strategic direction. However, there are significant quantitative discrepancies that undermine accuracy:\n\n(1) QUANTITATIVE ERRORS:\n- LLM states EIC was moved to 'held-for-sale' in Q4 2022, but ground truth indicates this occurred by 2023\n- LLM reports $541M assets and $378M liabilities as of held-for-sale classification, but these figures are not verified in ground truth\n- LLM states a $124M valuation allowance in 2023 (up from $17M in 2022), but ground truth specifies a $109M loss recorded in 2023 in connection with expected sale - these are different metrics and the LLM conflates valuation allowance with loss recognition\n- Ground truth mentions $0.2B net claim reserves as of Dec 31, 2021, which LLM omits entirely\n- The $120M sale price is correctly stated\n\n(2) TIMING DISCREPANCY:\nGround truth clearly indicates the held-for-sale classification occurred by 2023, not Q4 2022 as LLM states. This is a material error in the timeline.\n\n(3) METRIC CONFUSION:\nThe LLM conflates a $124M valuation allowance with the $109M loss mentioned in ground truth. These are different accounting treatments and the LLM's characterization of the allowance increasing from $17M to $124M lacks verification against ground truth.\n\n(4) MULTI-HOP REASONING:\nThe LLM correctly synthesizes the three-stage progression (held-for-sale classification → write-down → sale completion) and properly connects this to GE's strategic direction of divesting non-core assets. The reasoning about liquidity generation and refocus on core industrial businesses is sound and matches ground truth intent.\n\n(5) MISSING ELEMENTS:\nThe LLM fails to mention the $0.2B net claim reserves detail from 2021, which provides context for the insurance subsidiary's scale.\n\nThe answer is directionally correct on strategy but contains multiple quantitative inaccuracies and timing errors that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 563,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 2022 Form 10‑K listed the 4.45 % Notes due 2044 in Exhibit 4.4 of the officer’s certificate [page 55]. The 2023 filing’s excerpts (pages 53‑57) contain no reference to that exhibit, so the note was not newly highlighted that year [page 53]. The 2024 Form 10‑K again includes the same 4.45 % Notes due 2044 in Exhibit 4.4 [page 56], indicating Apple consistently retains this long‑dated, fixed‑rate bond as a core element of its long‑term financing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.45% Notes due 2044 are correctly identified across all three years (2022, 2023, 2024); (2) The percentage rate (4.45%) is accurate; (3) The maturity year (2044) is correct; (4) The general conclusion about stable long-term debt strategy is sound; (5) The reference to Exhibit 4.4 appears consistent with filing structure. PROBLEMATIC ELEMENTS: (1) The claim that '2023 filing's excerpts contain no reference to that exhibit' directly contradicts the ground truth, which states Apple 'repeated the same disclosure' in 2023. The LLM suggests the note was NOT disclosed in 2023, which is factually incorrect; (2) The statement 'the note was not newly highlighted that year' is misleading and contradicts the ground truth's assertion of consistent inclusion across all three years; (3) The LLM provides specific page numbers (55, 53-57, 56) that cannot be verified against the ground truth and may be inaccurate; (4) The reasoning about 2023 is flawed - the ground truth explicitly states the 2023 filing reaffirmed the notes, but the LLM claims they were absent from excerpts. MULTI-HOP SYNTHESIS: The LLM partially addresses the multi-year pattern but introduces a false discontinuity in 2023 that contradicts the ground truth's core finding of consistent disclosure. The final conclusion about Apple's strategy is reasonable but is undermined by the incorrect characterization of the 2023 filing. The answer demonstrates partial understanding but contains a significant factual error regarding 2023 disclosure that affects the credibility of the multi-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 453,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes were $30.8 billion at year‑end 2022, rose modestly to $31.2 billion in 2023, and then fell to $30.7 billion in 2024【COF_10k_2022 p.178】【COF_10k_2023 p.179】【COF_10k_2024 p.188】.  Over the same span the weighted‑average rate on its fixed‑rate senior debt climbed from roughly 4.45 % in 2022 to 4.84 % in 2024, while the floating‑rate senior component was eliminated (0 % in 2024 versus $349 million in 2023)【COF_10k_2022 p.178】【COF_10k_2024 p.188】.  This pattern shows Capital One modestly expanding its long‑term debt in 2023, then trimming it in 2024, and deliberately shifting the debt mix toward higher‑yielding fixed‑rate senior obligations to lock in rising market rates and reduce interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant discrepancies with the ground truth on the primary metric - total senior and subordinated notes carrying value. Ground truth shows: 2022: $27,219M, 2023: $31,248M, 2024: $30,696M. LLM states: 2022: $30.8B (~$30,800M), 2023: $31.2B (~$31,200M), 2024: $30.7B (~$30,700M). The 2022 figure is off by approximately $3.6 billion ($30.8B vs $27.2B), representing a 13% error on the opening year - a material misstatement. The 2023 and 2024 figures are approximately correct. WEIGHTED-AVERAGE RATE ERROR: Ground truth indicates the weighted-average interest rate rose from 2.76% (2022) to 4.84% (2024). The LLM states fixed-rate senior debt climbed from 'roughly 4.45%' in 2022 to 4.84% in 2024. This appears to conflate fixed-rate debt rates with the overall weighted-average rate, which is a different metric. The 4.45% figure does not match the ground truth's 2.76% overall weighted-average rate. FLOATING-RATE DEBT: The LLM correctly identifies the elimination of floating-rate senior debt ($349M in 2023 to $0 in 2024), which aligns with the strategic shift described. MULTI-HOP REASONING: The LLM correctly synthesizes the capital structure strategy (shift toward fixed-rate debt) and interest rate positioning, but the foundational numbers are incorrect, undermining the analysis. The narrative about 'locking in rising market rates' is reasonable but based on flawed data. COMPLETENESS: The answer addresses the evolution question and capital structure strategy, but the quantitative foundation is compromised. The 2022 baseline error is particularly problematic as it affects the entire three-year progression analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 462,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K (see the product‑description sections on pages 95‑99) Adobe makes no mention of Frame.io, indicating that the service was not yet highlighted as part of its core portfolio.  \n- By fiscal 2023, Adobe describes Frame.io as “our cloud‑native creative collaboration platform … directly integrated with Premiere Pro and After Effects” to let video creators request and receive frame‑specific comments within those apps【page_12】.  \n- In the 2024 filing the narrative expands: Frame.io is still a cloud‑native collaboration hub but is now “directly integrated with Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom and Adobe Workfront” and is offered through Adobe GenStudio for large‑scale content production【page_12】.  \n\nThus, Adobe moved Frame.io from an un‑referenced acquisition in 2022 to a video‑focused add‑on in 2023, and then to a broadly integrated collaboration layer across multiple Creative Cloud apps and the GenStudio suite by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year evolution of Frame.io (2022, 2023, 2024) and accurately captures the progression from limited visibility to expanded integration. The 2023 and 2024 descriptions match the ground truth well, including specific integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, plus GenStudio inclusion. The semantic understanding of Frame.io's role as a 'cloud-native creative collaboration platform' is correct.\n\nWEAKNESSES: (1) FACTUAL DISCREPANCY ON 2022: The LLM states Adobe made 'no mention of Frame.io' in the 2022 Form 10-K, claiming it was 'un-referenced.' However, the ground truth explicitly states Frame.io was 'listed as a registered trademark' in 2022, indicating it WAS formally recognized in Adobe's portfolio. This is a material factual error - the LLM contradicts the ground truth on 2022 positioning. (2) INCOMPLETE 2022 CHARACTERIZATION: The ground truth indicates Frame.io had formal trademark status in 2022, suggesting some level of portfolio integration, whereas the LLM dismisses it entirely. (3) MISSING DETAIL: The ground truth mentions 'real-time upload, review, and approval, frame-accurate commenting' as specific 2023 features, which the LLM only partially captures with 'frame-specific comments.'\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and identifies the progression pattern. However, the synthesis is undermined by the incorrect 2022 characterization.\n\nCALCULATIONS/NUMBERS: No calculations required; dates and years are correct (2022, 2023, 2024).\n\nSEMANTIC EQUIVALENCE: The 2023-2024 narrative is semantically equivalent to ground truth. The 2022 characterization is semantically opposite to ground truth.\n\nJUSTIFICATION: The answer demonstrates good understanding of the overall trajectory but contains a significant factual error regarding 2022 that contradicts the ground truth. This prevents a higher score despite otherwise solid reasoning on 2023-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 547,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s 4.550% Notes due April 5 2049 are listed in the exhibit tables of every recent Form 10‑K – Exhibit 4.16 appears in the 2022 filing (see page 76) and the same Exhibit 4.16 is reproduced in the 2023 and 2024 filings (see page 75)【page_76】【page_75】. By keeping this long‑dated, moderate‑coupon bond outstanding, Lowe’s is deliberately anchoring its capital structure with fixed‑rate financing that extends well beyond the next decade, smoothing its debt‑maturity schedule and limiting near‑term refinancing risk while preserving a stable, long‑term funding base.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of information. STRENGTHS: (1) All numeric values are correct - the 4.550% coupon rate and April 5, 2049 maturity date are accurately stated; (2) The exhibit references (Exhibit 4.16 appearing in 2022, 2023, and 2024 filings) are correctly cited with appropriate page numbers; (3) The multi-hop reasoning is sound - the answer correctly synthesizes the consistent presence of these notes across three years to draw conclusions about capital structure strategy; (4) The interpretation aligns with the ground truth: both identify that consistent inclusion without modification indicates deliberate strategic choice to maintain long-dated debt and manage refinancing risk; (5) The language about 'anchoring capital structure,' 'smoothing debt-maturity schedule,' and 'limiting near-term refinancing risk' accurately conveys the strategic implications. MINOR CONSIDERATIONS: (1) The LLM answer is more specific about exhibit locations and page numbers than the ground truth, which adds precision but isn't strictly necessary to answer the question; (2) The ground truth explicitly mentions 'absence of disclosures suggesting modifications, repayments, or restructuring' while the LLM answer implies this through 'keeping outstanding' - both convey the same meaning but the ground truth is slightly more explicit about what the absence of action signifies; (3) The LLM answer could have been slightly more explicit about the 'stability' aspect mentioned in the ground truth, though it is implied through 'stable, long-term funding base.' Overall, the answer correctly addresses the multi-hop question by synthesizing information across three years of filings and drawing appropriate conclusions about Lowe's capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 491,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an outstanding principal of $495 million at the end of fiscal 2023 and the same $495 million at the end of fiscal 2024 (the 2023 and 2024 10‑K tables both list $495 million)【page_81】. Because the balance did not decline from the prior year, it indicates the company has chosen to keep this low‑coupon, fixed‑rate debt on its balance sheet rather than accelerate repayment or refinance it, using other issuances to manage overall leverage while preserving cheap long‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $495 million principal balance for the 3.125% notes due January 2025. (2) The company name (Broadcom/AVGO) and debt instrument details are accurate. (3) The reasoning about debt management strategy is sound and aligns with the ground truth interpretation. (4) The semantic meaning about preserving cheap long-term financing is correct.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM only provides data for fiscal 2023 and 2024, completely missing fiscal 2022. The ground truth explicitly states the balance was consistent across ALL THREE fiscal years (2022, 2023, and 2024). The question specifically asks about evolution \"from fiscal 2022 through 2024,\" requiring all three data points. (2) The LLM states \"Because the balance did not decline from the prior year\" which only covers the 2023-2024 comparison, not the full three-year period. (3) The answer is incomplete in addressing the full temporal scope of the question.\n\nMULTI-HOP REASONING: The LLM demonstrates sound reasoning about debt management strategy and the decision to preserve the liability, but fails to synthesize information across the complete three-year period requested. The reasoning is partially correct but based on incomplete data.\n\nNUMBER VERIFICATION: The $495 million figure is correct where provided, but the answer lacks the fiscal 2022 data point that would complete the picture and fully answer the question.\n\nCOMPLETENESS: The answer addresses only 2 of the 3 required fiscal years, making it materially incomplete despite having correct information for the years it does cover.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 444,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "- In the 2022 Form 10‑K, the 0.950 % Notes due 2025 are not highlighted separately; they are only embedded in the general debt schedule and exhibit list (see the exhibit sections on pages 28‑32).  \n- The 2023 filing makes the treatment explicit by incorporating the instrument that defines the holders’ rights for the 0.950 % Notes due 2025, citing Exhibit 4.1 and 4.2 to a May 22 2017 Form 8‑K (page 20).  \n- The 2024 Form 10‑K moves the notes to the front‑page securities‑registration table under Section 12(b), listing “0.950 % Notes due 2025” with ticker IBM25B (page 1).  \n\nThis progression—from an implicit mention in 2022, to a specific exhibit reference in 2023, to a prominent front‑page listing in 2024—shows IBM’s deliberate use of ultra‑low‑coupon, long‑dated debt as a core financing tool while simultaneously increasing the transparency of that debt to investors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-structured progression of IBM's treatment of the 0.950% Notes due 2025 from 2022-2024. STRENGTHS: (1) All numeric values are correct: 0.950% coupon rate, 2025 maturity date, May 22, 2017 Form 8-K date, ticker IBM25B. (2) The chronological progression is accurately captured: 2022 (embedded in debt schedule), 2023 (explicit exhibit reference to Exhibits 4.1 and 4.2), 2024 (front-page Section 12(b) listing). (3) The multi-hop synthesis correctly identifies the evolution from implicit to explicit to prominent disclosure. (4) Page references (28-32, page 20, page 1) add specificity and credibility. (5) The conclusion about capital structure strategy and transparency aligns with the ground truth's assessment. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM characterizes 2022 treatment as 'not highlighted separately' and 'embedded,' while ground truth states it was 'disclosed as part of long-term debt instruments'—these are semantically equivalent but the LLM's framing is slightly more precise about the disclosure method. (2) The LLM emphasizes 'ultra-low-coupon, long-dated debt as a core financing tool' which adds interpretive context not explicitly in the ground truth, though this is a reasonable inference. (3) The ground truth mentions 'referencing the defining instrument incorporated by reference from a May 2017 Form 8-K' for 2022, while the LLM only explicitly mentions this for 2023—this is a minor omission but doesn't contradict the ground truth. (4) The LLM's characterization of the 2024 shift as moving to 'front-page securities-registration table under Section 12(b)' is more technically precise than the ground truth's 'listed on the New York Stock Exchange.' QUANTITATIVE ACCURACY: All dates, percentages, and ticker symbols are correct. No calculation errors. QUALITATIVE ACCURACY: The reasoning about the progression from implicit to explicit to prominent disclosure is sound and well-articulated. The connection to capital structure strategy and transparency is appropriately drawn. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution, capital structure strategy, and transparency, with appropriate emphasis on each element.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 603,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three Form 10‑K filings – for 2022, 2023 and 2024 – state that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is **185**【page_13】. The same “185” identifier appears in each year’s filing, demonstrating that the PCAOB number has remained unchanged across the three reports【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. (1) CORRECTNESS: The core factual claim is correct - KPMG LLP's PCAOB firm identification number is 185 across all three years (2022, 2023, 2024). The answer correctly identifies the specific number and confirms consistency across the three-year period, matching the ground truth exactly. (2) QUANTITATIVE ACCURACY: The numeric identifier '185' is correct and consistently stated for all three years. No calculations are required for this question, but the number is accurate. (3) QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly synthesizes information across three separate filings and demonstrates understanding that the identifier remained unchanged. The multi-hop synthesis (pulling the same data point from three different annual filings) is executed properly. (4) ENTITY ACCURACY: KPMG LLP is correctly identified, PCAOB is correctly referenced, and all three fiscal years (2022, 2023, 2024) are properly addressed. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, using slightly different wording ('demonstrates that the PCAOB number has remained unchanged' vs 'indicates that the auditor's regulatory identification remained unchanged') but with identical semantic meaning. Minor note: The citation references to 'page_13' and 'page_14' are included in the LLM answer but cannot be verified against the ground truth, though they do not contradict the answer and add helpful sourcing detail. Overall, this is a comprehensive, accurate response that fully answers the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 445,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s Fixed‑rate unsecured senior notes grew from about $24.1 billion at year‑end 2022 to $27.2 billion at year‑end 2023, then slipped slightly to $26.9 billion at year‑end 2024, while the coupon band moved up – the floor rose from 0.80 % to 1.65 % (the ceiling stayed at 7.62 %) and the weighted‑average rate climbed from roughly 4.45 % to 4.84 % and the maturity window shifted out one year (2024‑2034 → 2025‑2035)【page_178】【page_188】. This multi‑year pattern shows Capital One initially adding debt when rates were lower, then in 2024 extending maturities and accepting higher yields as market rates rose, indicating a capital‑structure approach that balances funding needs with a higher‑rate macro environment by locking in longer‑dated financing despite higher costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM reports 2022 balance as $24.1 billion, but ground truth shows $19,975 million ($19.975 billion) - a $4.1 billion overstatement. The LLM reports 2023 as $27.2 billion with no ground truth comparison provided, making verification impossible. The 2024 figure of $26.9 billion ($26,930 million) is correct. (2) INTEREST RATE ERRORS - The LLM claims the weighted-average rate was 'roughly 4.45%' in 2022, but ground truth clearly states 2.91% in 2022 - a massive 1.54 percentage point error. The 2024 rate of 4.84% is correct. This 1.93 percentage point increase from 2.91% to 4.84% is the actual story, not the 0.39 percentage point increase the LLM implies (4.45% to 4.84%). (3) MULTI-HOP REASONING FAILURE - The LLM's narrative about 'initially adding debt when rates were lower' is contradicted by the actual data showing rates were already at 2.91% in 2022 and rose to 4.84% by 2024. The LLM mischaracterizes the timing and magnitude of rate changes. (4) MISSING CONTEXT - The LLM introduces details about coupon bands and maturity windows that, while potentially relevant, are not verified against ground truth and distract from the core quantitative errors. (5) SEMANTIC MISALIGNMENT - The ground truth emphasizes a 'strategic shift toward longer-term fixed-rate financing as interest rates rose,' which the LLM partially captures but undermines with incorrect baseline numbers. The LLM's conclusion about 'locking in longer-dated financing despite higher costs' is directionally reasonable but built on false premises about the starting interest rate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 469,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑service and IP‑licensing deals did not change between the 2022, 2023 and 2024 filings – the company still evaluates whether the licensing component is a distinct performance obligation and, if it is, books revenue at a point in time; if not, it combines the license with development services and recognizes revenue over time, while standalone IP licenses are always recognized at a point in time and no variable consideration is used (2022 p. 59; 2023 p. 64; 2024 p. 63). This consistency signals a deliberate, long‑term strategy to monetize AMD’s IP portfolio in a predictable, GAAP‑aligned way, emphasizing clear performance‑obligation assessment and stable revenue treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that AMD maintained consistent revenue recognition methodology across 2022-2024; (2) Accurately captures the three-part framework: distinct licenses recognized at point in time, non-distinct licenses combined with development services and recognized over time, and standalone IP licenses always recognized at point in time; (3) Correctly notes the absence of variable consideration across all three years; (4) Properly synthesizes the multi-hop reasoning by connecting the consistency finding to strategic implications about IP monetization maturity and deliberate policy framework; (5) Includes specific page references (2022 p. 59; 2023 p. 64; 2024 p. 63) that demonstrate source verification; (6) Uses appropriate financial/accounting terminology (GAAP-aligned, performance obligations, distinct performance obligation). MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'did not change' vs 'maintained consistent') but this is semantically equivalent; (2) The LLM adds interpretive language about 'predictable, GAAP-aligned way' which is reasonable inference but goes slightly beyond the ground truth's more neutral characterization; (3) The phrase 'standalone IP licenses are always recognized at a point in time' is accurate but the ground truth emphasizes the conditional logic more explicitly. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are claimed, so quantitative accuracy is not directly testable, but the three-year consistency claim is correctly stated. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the consistency finding to strategic implications about IP monetization approach. The logic is sound and well-reasoned. COMPLETENESS: All parts of the original question are addressed—the evolution (or lack thereof) is explained, and the strategic implications are discussed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 556,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s senior‑ and subordinated‑note balances were $30.8 billion at year‑end 2022, rose to $31.3 billion at year‑end 2023, and then slipped to $30.7 billion at year‑end 2024【page_178†L31-L34】【page_188†L31-L34】. The 2023 increase reflected modest debt‑raising to fund growth, while the 2024 reduction – coupled with the elimination of floating‑rate senior debt and a rise in the weighted‑average fixed‑rate cost (from roughly 4.45% in 2023 to 4.84% in 2024)【page_178†L23-L27】【page_188†L23-L27】 – indicates a capital‑structure strategy that trims leverage and shifts toward higher‑coupon, fixed‑rate securities to lock in rates and curb interest‑rate risk in a rising‑rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core factual foundation. (1) MAJOR NUMBER DISCREPANCY: The LLM states 2022 balance as '$30.8 billion' when the ground truth clearly shows '$27,219 million' ($27.219 billion). This is a $3.6 billion error - approximately 13% off the actual 2022 figure. This is not a rounding or formatting difference; it's a fundamental factual error. (2) 2023 FIGURE: The LLM states '$31.3 billion' which aligns with ground truth of $31,248 million ($31.248 billion) - this is correct. (3) 2024 FIGURE: The LLM states '$30.7 billion' which matches ground truth of $30,696 million ($30.696 billion) - this is correct. (4) INTEREST RATE DATA: The LLM correctly identifies the 2023 rate as 4.45% and 2024 rate as 4.84%, matching ground truth. However, the LLM OMITS the 2022 weighted-average interest rate of 2.91%, which is a significant omission that weakens the narrative about the rate progression. (5) FLOATING-RATE DEBT: The LLM mentions 'elimination of floating-rate senior debt' but provides no specific numbers. The ground truth shows the decline from $1,709 million (2022) to $349 million (2023) to complete retirement (2024) - these details are missing. (6) REASONING QUALITY: The LLM's interpretation of the capital structure strategy is reasonable and aligns with ground truth conclusions about locking in rates and managing interest-rate risk. However, the reasoning is built on partially incorrect foundational data. (7) MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across years and connect debt levels to interest rate positioning, which is appropriate for the question. The logic connecting the 2024 reduction and floating-rate elimination to rate-locking strategy is sound. SUMMARY: While the LLM demonstrates understanding of the strategic narrative and correctly identifies 2023-2024 figures and interest rates, the 2022 baseline error is a critical flaw that distorts the entire 'evolution' being analyzed. The omission of the 2022 interest rate (2.91%) and specific floating-rate debt figures further weakens completeness. The answer is partially correct but contains material factual errors that would mislead readers about the actual magnitude of changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 613,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from **$24.1 billion at year‑end 2022 to $27.2 billion at year‑end 2023**, then slipped slightly to **$26.9 billion at year‑end 2024**. The weighted‑average interest rate was **4.45 % in both 2022 and 2023**, but rose to **about 4.84 % in 2024** (page_178; page_188). This pattern shows the company expanded its senior unsecured borrowing in 2023, modestly reduced it in 2024, and accepted a higher average cost—suggesting a strategy of maintaining a sizable long‑term funding base while locking in longer‑dated, slightly more expensive debt as market rates increased.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 carrying value. Ground truth states $19,975 million ($19.975 billion) for 2022, but the LLM reports $24.1 billion—a discrepancy of approximately $4.1 billion or 20.5%. This is a major error that undermines the entire analysis. The 2023 and 2024 carrying values are correct ($27.2B and $26.9B respectively). WEIGHTED-AVERAGE INTEREST RATE ERROR: The LLM states the weighted-average interest rate was 4.45% in both 2022 and 2023, but ground truth clearly shows 2.91% in 2022 and 4.45% in 2023. This is a fundamental misstatement of the 2022 rate—off by 1.54 percentage points. The 2024 rate of 4.84% is correct. MULTI-HOP REASONING: The LLM correctly synthesizes the trend narrative (expansion in 2023, slight reduction in 2024, rising rates) and appropriately interprets the strategic implications regarding debt issuance and market rate response. However, this qualitative reasoning cannot compensate for the quantitative errors. COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, weighted-average interest rate evolution, and strategic implications), but the foundational data is incorrect. The interpretation about 'locking in longer-dated debt' is reasonable but is built on flawed premises. ENTITY ACCURACY: Capital One (COF) is correctly identified, years are correct, and the metric terminology is appropriate. The core issue is data accuracy, not entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 417,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed from 2022 through 2024. In each filing (2022 – page 59; 2023 – page 64; 2024 – page 63) the company says it first determines whether the licensing component is distinct. If the license is not distinct it is combined with the development services and revenue is recognized over time; if the license is distinct—or if the arrangement is a standalone IP sale or license—revenue is recognized at a point in time when the customer can benefit, and no variable‑consideration estimates are applied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's policy remained unchanged from 2022-2024, matching the ground truth assertion of 'consistent' and 'no material changes'; (2) Accurately describes the two-part determination process: checking if license is distinct, then applying appropriate revenue recognition timing (over time if combined, at point in time if distinct or standalone); (3) Correctly notes that no variable consideration estimates are applied in either scenario; (4) Provides specific page references (2022-page 59, 2023-page 64, 2024-page 63) that add credibility and demonstrate multi-hop synthesis across three years of filings; (5) Uses precise terminology ('distinct,' 'performance obligations,' 'point in time') consistent with ASC 606 revenue recognition standards. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth, which provides additional context about 'evolving market conditions' and 'ongoing customer arrangements,' but this omission does not constitute an error—it's a stylistic choice that doesn't contradict the ground truth; (2) Both answers convey identical substantive information about policy consistency and the mechanics of revenue recognition. The LLM answer actually enhances clarity by providing specific filing page numbers, demonstrating thorough source verification. No quantitative errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across three fiscal years and multiple filing documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 438,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s short‑term borrowings fell sharply from $883 million at year‑end 2022 to $538 million in 2023 and then rose slightly to $562 million in 2024, while its long‑term debt grew from $47.8 billion in 2022 to $49.3 billion in 2023 before being reduced to $45.0 billion in 2024, leaving total debt of $48.7 billion, $49.9 billion and $45.6 billion respectively【page_178†L13-L19】【page_188†L13-L20】. The three‑year pattern shows COF deliberately cutting reliance on cheap, short‑term funding, initially expanding then actively paying down long‑term obligations, and maintaining a weighted‑average interest rate in the mid‑4% range (e.g., 4.84% on senior notes and 3.48% on securitized debt in 2024) through the use of interest‑rate swaps and other hedges, indicating a proactive debt‑management strategy that limits liquidity risk and moderates interest‑rate exposure【page_188†L25-L33】【page_180†L1-L5】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of COF's debt evolution and provides detailed breakdowns of short-term and long-term debt components. STRENGTHS: (1) Correctly identifies the overall debt trajectory with total debt figures of $48.7B (2022), $49.9B (2023), and $45.6B (2024), which align with ground truth totals of $43.086B, $48.715B, and $45.551B respectively - minor rounding differences acceptable; (2) Accurately captures the weighted-average interest rate progression in the mid-4% range and specifically cites 4.84% for 2024, matching ground truth; (3) Provides superior granular detail on short-term vs. long-term debt components ($883M→$538M→$562M for short-term; $47.8B→$49.3B→$45.0B for long-term), which ground truth does not explicitly break down; (4) Correctly synthesizes the strategic narrative: initial expansion followed by deleveraging, shift toward fixed-rate debt, and use of hedging instruments; (5) Multi-hop reasoning is sound, connecting debt levels to interest rate exposure to strategic intent. WEAKNESSES: (1) Ground truth states total debt was $43.086B in 2022, but LLM's component sum ($883M + $47.8B = $48.683B) doesn't match this figure - this suggests either the LLM's 2022 long-term debt figure is overstated or the ground truth's 2022 total is understated, creating a ~$5.6B discrepancy for 2022; (2) The 2023 total of $49.9B (LLM) vs. $48.715B (ground truth) shows a $1.185B variance; (3) The 2024 total of $45.6B (LLM) vs. $45.551B (ground truth) is very close but still slightly off. These discrepancies suggest either data source differences or calculation errors in the LLM's component breakdown. However, the directional trends and strategic insights are correct. The answer exceeds ground truth in analytical depth and component detail, but the quantitative precision on absolute figures shows minor but consistent overstatement, particularly for 2022-2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 517,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy for development‑services and IP‑licensing arrangements was unchanged from 2022 through 2024. In each filing the company says it evaluates whether the licensing component is distinct; if the license is not distinct it is combined with the development services as a single performance obligation and revenue is recognized over time, while a distinct license (or a standalone IP license) is treated as a separate performance obligation and revenue is recognized at a point in time, with no variable‑consideration estimates (2022 p. 59; 2023 p. 63; 2024 p. 64).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that AMD's policy was unchanged from 2022-2024, matching the ground truth assertion of consistency; (2) Accurately describes the key framework: distinct licenses recognized at a point in time, non-distinct licenses combined with development services and recognized over time; (3) Correctly notes no variable consideration estimates across all three years; (4) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 64) that add credibility; (5) Uses precise accounting terminology ('performance obligation,' 'distinct,' 'variable consideration'). Minor considerations: (1) The LLM answer is more concise than the ground truth, omitting the contextual note about increased Gaming segment emphasis in 2023-2024, though this is not essential to answering the core question about policy evolution; (2) The ground truth emphasizes evaluation 'in capability and context' while the LLM simply states 'distinct,' though these convey the same meaning; (3) The LLM answer doesn't explicitly state 'no material change' as the ground truth does, but the phrase 'unchanged from 2022 through 2024' conveys equivalent meaning. The multi-hop reasoning is sound—the answer correctly synthesizes information across three years and identifies the consistent treatment of performance obligations. No numerical errors or factual inaccuracies detected. The answer directly answers what was asked about policy evolution (or lack thereof) and the distinction between combined arrangements versus standalone licenses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 442,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is listed as an exhibit in Visa’s 2022 filing (see page 114) and again in the 2023 and 2024 filings (see page 109), indicating that the series‑B preferred shares have remained unchanged and continue to be a standing security in Visa’s capital structure. This repeated inclusion signals that the instrument is stable and remains materially relevant to the company’s financing framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general concept that the Series B Convertible Participating Preferred Stock remained stable across the three-year period, but contains significant factual errors that undermine its accuracy. CRITICAL ERRORS: (1) The LLM provides specific page numbers (page 114 for 2022, page 109 for 2023/2024) without verification against the actual filings - these page references are unverified and potentially incorrect. (2) The LLM fails to cite the specific exhibit numbers that are central to the ground truth answer (Exhibit 4.5 for 2022, Exhibit 4.4 for 2023/2024), which are key identifiers in the original answer. (3) The LLM omits the critical filing date of June 21, 2016, which is explicitly mentioned in the ground truth as evidence of the instrument's static nature. CORRECT ELEMENTS: The LLM correctly identifies that the instrument remained unchanged across all three years (2022, 2023, 2024) and correctly concludes that this indicates stability and ongoing relevance. The semantic interpretation that the repeated inclusion signals stability is sound. REASONING ASSESSMENT: The multi-hop synthesis is partially sound - the LLM correctly identifies the pattern of consistency across three years and draws the appropriate conclusion about stability. However, the lack of specific exhibit numbers and filing dates weakens the evidentiary foundation. The answer would benefit from the precise exhibit citations and the June 21, 2016 date to fully match the ground truth's level of specificity. The page number references, while potentially helpful, are not verified and may be incorrect, creating potential factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 452,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "- 2022 – Pratt & Whitney reported a 61 % program‑share interest in IAE and a 49.5 % equity ownership, which after accounting for sub‑collaborator shares left a net 57 % economic interest in the V2500 program【page_110】.  \n- 2023 – The 2023 filing repeats the same figures – 61 % program share, 49.5 % ownership and a net 57 % economic interest after sub‑collaborator adjustments【page_99】.  \n- 2024 – The 2024 filing again shows no change, still showing a 61 % program‑share, 49.5 % ownership and a net 57 % economic exposure to IAE’s V2500 engine【page_101】.  \n\nThis unchanged, majority stake and net‑program‑share over three years signals that Pratt & Whitney (and thus RTX) has maintained its role as the primary beneficiary and dominant partner in the V2500 engine program, underscoring a consistent, long‑term strategic commitment to that engine family.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct - the 61% program-share interest, 49.5% ownership interest, and 57% net program share interest are accurately reported for all three years (2022, 2023, 2024). (2) The multi-hop reasoning is sound: the answer correctly synthesizes information across three separate annual filings to establish the consistency pattern. (3) Entity identification is accurate: RTX, Pratt & Whitney, IAE, and the V2500 engine program are all correctly identified and contextualized. (4) The interpretation of what this consistency means (stable strategic positioning, no alteration of risk profile) aligns with the ground truth's conclusion about strategic commitment. (5) Page citations are provided, adding credibility. MINOR CONSIDERATIONS: (1) The LLM's interpretation adds slightly more emphasis on P&W as 'primary beneficiary and dominant partner' compared to the ground truth's more neutral framing of 'did not alter its strategic positioning,' but this is a reasonable inference from the data rather than a factual error. (2) The ground truth uses the phrase 'did not alter its strategic positioning or risk profile,' while the LLM emphasizes 'maintained its role as primary beneficiary' - these are semantically equivalent conclusions from the same data. (3) The answer could have been slightly more explicit about what 'sub-collaborator participation' means, but this is a minor omission that doesn't affect correctness. Overall, the LLM successfully answered a complex multi-year, multi-entity question with accurate numbers, proper synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 462,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic’s 10‑K for FY 2022 already listed a “Form of Non‑Employee Director Deferred Unit Award Agreement” (Exhibit *10.41 – also cross‑referenced as *10.52) under the 2008 Stock Award and Incentive Plan【page_113】. The FY 2023 filing repeats the same exhibit (again *10.41/*10.52) with no new language or amendment【page_113】, and the FY 2024 filing likewise includes the identical deferred‑unit agreement as Exhibit *10.41/*10.52【page_113】. The unchanged presence of this agreement across three consecutive years indicates that Medtronic relies on a stable, long‑term deferred‑equity component for its non‑employee directors, reflecting a consistent director‑compensation strategy rather than periodic redesigns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core finding that Medtronic maintained a consistent Non-Employee Director Deferred Unit Award Agreement across FY 2022, 2023, and 2024, all tied to the 2008 Stock Award and Incentive Plan. The reasoning about stability and consistency in director compensation strategy is sound and matches the ground truth's conclusion. The semantic meaning is equivalent to the original answer.\n\nCRITICAL ERRORS - EXHIBIT NUMBERING: The LLM contains a significant factual error regarding exhibit numbering. The LLM states the agreement appears as both \"Exhibit *10.41\" and \"*10.52\" across all three years, suggesting they are interchangeable or cross-referenced. However, the ground truth clearly distinguishes: (1) FY 2022 references Exhibit 10.41, and (2) FY 2023 and FY 2024 both reference Exhibit 10.52. This is a material difference in how the exhibits are numbered across years. The LLM's conflation of these exhibit numbers (treating them as equivalent or simultaneously present) is factually incorrect and suggests confusion about the actual filing structure.\n\nMINOR ISSUES: The LLM includes page references (\"page_113\") that appear to be formatting artifacts or placeholder citations rather than actual verification. The ground truth does not include such page references, making it unclear whether these are accurate.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the pattern of consistency. However, the exhibit numbering error undermines confidence in the factual accuracy of the synthesis.\n\nOVERALL ASSESSMENT: While the LLM captures the correct strategic conclusion (stable, consistent director compensation approach), the mishandling of exhibit numbers represents a quantitative/factual error that would be problematic in a compliance or audit context. The answer is directionally correct but contains a material factual inaccuracy in the details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 533,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "LMT’s aggregate notional amount of interest‑rate swaps – the contracts it uses to convert fixed‑rate borrowings to variable‑rate exposure – was $1.3 billion at December 31, 2022 (as disclosed in the 2023 filing) and remained $1.3 billion at both December 31, 2023 (2023 filing) and December 31, 2024 (2024 filing)【page_95†L31-L34】【page_52†L31-L34】. Holding the swap notional steady over three years shows the company has adopted a stable, “set‑and‑maintain” hedge posture, keeping a consistent level of variable‑rate protection rather than expanding or scaling back its interest‑rate risk program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that in 2022, the notional amount was $500 million, which then increased to $1.3 billion by 2023 and remained at $1.3 billion in 2024. However, the LLM answer claims the notional amount was $1.3 billion at December 31, 2022 (citing the 2023 filing), which is incorrect. This is a major quantitative error that undermines the entire analysis. The LLM's statement that the swap notional 'remained steady over three years' is factually wrong—there was a significant 160% increase from 2022 to 2023 ($500M to $1.3B). The LLM completely missed this critical evolution in LMT's interest rate risk management strategy. While the LLM correctly identifies that the amount remained constant from 2023-2024 at $1.3 billion, it fails to capture the most important aspect of the question: the tripling of exposure from 2022 to 2023, which represents a strategic shift toward more active interest rate risk management. The LLM's characterization of a 'stable, set-and-maintain hedge posture' over three years is semantically incorrect given the actual 2022-2023 increase. The answer demonstrates incomplete multi-hop synthesis—it only addresses the 2023-2024 period stability while ignoring the 2022-2023 evolution. The citations provided do not appear to validate the 2022 figure of $1.3 billion claimed in the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 399,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s charter and bylaws have consistently stated that “stockholders may only remove directors for cause” – the same provision appears in the 2022 10‑K (see page 46/47), is repeated unchanged in the 2023 filing (page 27) and again in the 2024 filing (page 27). The three‑year continuity shows that AbbVie has deliberately kept this high‑threshold removal rule unchanged, signalling a steady, proactive stance to deter hostile takeovers by making it difficult for shareholders to replace the board without cause.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information across three years (2022-2024). STRENGTHS: (1) Correctly identifies the core provision: 'stockholders may only remove directors for cause' appearing consistently across all three years; (2) Accurately cites specific page numbers for each filing (pages 46/47 for 2022, page 27 for 2023 and 2024), showing document-level verification; (3) Properly synthesizes the three-year consistency to draw the correct conclusion about deliberate governance strategy; (4) Correctly interprets the strategic implication regarding takeover defenses and shareholder control; (5) Uses appropriate terminology ('high-threshold removal rule,' 'deter hostile takeovers'). MINOR WEAKNESSES: (1) The original answer mentions 'alongside other consistent provisions such as staggered board terms and supermajority voting requirements' as supporting evidence of the broader anti-takeover strategy, but the LLM answer does not reference these additional provisions, making it slightly less comprehensive in demonstrating the full scope of AbbVie's governance posture; (2) The LLM answer could have been slightly more explicit about the 'certificate of incorporation and by-laws' framework mentioned in the ground truth, though this is a minor omission. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the consistency pattern, then appropriately interprets what this consistency signals about corporate strategy. The logic chain (unchanged provision → deliberate strategy → takeover defense) is sound. SEMANTIC EQUIVALENCE: The LLM's phrasing ('steady, proactive stance,' 'high-threshold removal rule') conveys the same meaning as the ground truth's 'stable and deliberate governance strategy' and 'insulating the board from activist pressures.' No numerical errors or calculation issues present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 527,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s short‑term “money‑market funds and time deposits” fell from **$21 million in 2022** to **$10 million in 2023** and stayed at **$10 million in 2024**【page_79†L31-L38】【page_84†L31-L38】.  During the same period cash on hand rose to $12.8 billion in 2023 before dropping to $5.5 billion in 2024【page_79†L23-L30】【page_84†L23-L30】, so the company trimmed and then held steady its allocation to low‑yield short‑term assets, indicating a preference for keeping cash readily available to manage liquidity amid the swing in cash balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers being evaluated. (1) MONEY MARKET FUNDS AND TIME DEPOSITS: Ground truth shows $12M (2022) → $21M (2023) → $10M (2024). LLM states $21M (2022) → $10M (2023) → $10M (2024). This is a complete reversal of the 2022-2023 trend and misplacement of the $21M figure. The LLM incorrectly assigns 2022's value to 2023 and 2023's value to 2022. (2) CASH AND EQUIVALENTS: LLM states $12.8B in 2023 and $5.5B in 2024. Ground truth shows $9,201M ($9.2B) in 2023 and $5,524M ($5.5B) in 2024. The 2023 figure is significantly overstated ($12.8B vs $9.2B—a $3.6B error). The 2024 figure is approximately correct when rounded. (3) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend across the two metrics. The reasoning about 'trimmed and then held steady' is based on incorrect numbers and doesn't match the actual pattern of increase then decrease. (4) SEMANTIC ISSUES: While the LLM correctly identifies the general concept of liquidity strategy and low-yield assets, the factual foundation is so compromised that the conclusions are unreliable. The answer demonstrates poor data extraction and verification, with year-to-year values transposed or misread. This is a case where the reasoning framework is sound but the underlying data accuracy is severely compromised, making the answer fundamentally incorrect despite addressing the right question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 407,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s charter has kept the same anti‑takeover rule in each filing – the 2022 10‑K notes that “stockholders may only remove directors for cause” (page 46), and the 2023 and 2024 10‑Ks repeat that identical provision (page 27 in each) without any amendment. This unchanged language shows that AbbVie deliberately preserves a board‑stability shield, signaling a long‑term strategy to make it difficult for hostile suitors to replace directors and thereby deter coercive takeover attempts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AbbVie's governance evolution. STRENGTHS: (1) Correctly identifies the core provision that 'stockholders may only remove directors for cause' across all three years (2022, 2023, 2024); (2) Accurately notes the consistency/unchanged nature of this provision across filings; (3) Properly synthesizes the multi-hop reasoning connecting governance consistency to anti-takeover strategy; (4) Correctly interprets the strategic implications of maintaining this provision; (5) Provides specific page references (46 for 2022, 27 for 2023 and 2024) that add credibility. MINOR WEAKNESSES: (1) The page number citations, while specific, cannot be independently verified against the ground truth provided, though they appear plausible for 10-K filings; (2) The answer could have been slightly more explicit about the 'broader set of governance mechanisms' mentioned in the ground truth, though it does reference this implicitly through 'anti-takeover rule'; (3) The phrase 'coercive takeover attempts' is semantically equivalent to 'hostile takeovers' but represents a slight variation in terminology. QUANTITATIVE ACCURACY: All numeric references (years 2022, 2023, 2024) are correct. No calculations are required for this question. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly identifies that consistency in governance provisions signals deliberate strategy and board stability. The multi-hop synthesis (connecting unchanged provisions across years to long-term anti-takeover strategy) is logically sound. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: (1) how provisions evolved (they didn't - remained consistent), (2) what this consistency suggests (deliberate anti-takeover strategy). The answer appropriately emphasizes the strategic intent behind maintaining these provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 522,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 filing Intel first introduced PowerVia as a “future” backside‑power technology that would appear on the later‑generation Intel 20A node.  \n- The 2023 filing promoted PowerVia to a headline breakthrough of Intel 20A, saying it would enable up to a 15 % performance‑per‑watt improvement by eliminating front‑side power routing.  \n- By the 2024 filing PowerVia had moved from a planned‑for‑20A feature to a core component of Intel 18A – the first high‑volume node Intel expects to ship (2025) with backside power delivery.  \n\n**Implication:** Intel has accelerated the adoption of backside power delivery, making PowerVia a central pillar of its advanced‑node roadmap to boost signal integrity, reduce front‑side routing complexity, and deliver higher performance‑per‑watt and density scaling in its most advanced process technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate positioning at each stage; (2) Accurately captures the timeline shift from Intel 20A (2023) to Intel 18A (2024); (3) Correctly notes the 2025 high-volume manufacturing target for Intel 18A; (4) Includes the specific 15% performance-per-watt improvement metric mentioned in the 2023 positioning; (5) Properly synthesizes the multi-hop information showing strategic evolution from 'future technology' to 'core component'; (6) The implication statement correctly interprets the strategic pivot toward practical implementation and external foundry offerings. MINOR CONSIDERATIONS: (1) The LLM characterizes the shift as an 'acceleration' while the ground truth describes it as a 'strategic pivot' and 'realignment' - these are semantically similar but the ground truth emphasizes refinement rather than pure acceleration; (2) The LLM's phrasing 'moved from a planned-for-20A feature to a core component of Intel 18A' is accurate but slightly simplifies the nuance that this represents a 'realignment within a more refined roadmap' rather than a simple move. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, 2025), process nodes (20A, 18A), and the 15% metric are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the progression pattern. The reasoning about strategic implications is sound and well-supported by the factual progression. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate technical detail and clear structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 477,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility input rose from 23.04 % for the 2022 grant year, to 24.05 % for 2023, and to 24.29 % for 2024 【page_82】 (the 2022 figure is also shown in the 2022 filing 【page_83】). The modest, year‑over‑year increase—driven by a blend of historical and market‑implied volatility—indicates that the company updates its assumptions to reflect rising perceived stock‑price risk, thereby applying a slightly higher fair‑value estimate to its non‑qualified stock options over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific volatility percentages (23.04%, 24.05%, 24.29%) but fails to address the core question about the EVOLUTION OF METHODOLOGY from 2022-2024. The ground truth emphasizes a critical methodological shift: 2022 used ONLY historical volatility, while 2023-2024 shifted to a BLEND of historical and implied volatility. The LLM answer mentions 'a blend of historical and market-implied volatility' but attributes this to all three years without clearly distinguishing that 2022 was different. The LLM focuses on the numerical progression of volatility percentages rather than the more important methodological evolution that the question asks about. The answer correctly identifies that the company moved toward market-sensitive approaches but fails to clearly articulate that 2022 was purely historical while 2023-2024 incorporated implied volatility. The quantitative figures provided cannot be verified against the ground truth (which does not provide specific percentages), raising concerns about accuracy. The answer partially addresses the multi-hop synthesis by connecting volatility changes to fair-value estimation, but misses the key insight about the shift in METHODOLOGY (historical-only to hybrid approach) that is central to understanding the company's approach to valuing options. The answer is more focused on numerical trends than on the substantive change in valuation methodology that the question seeks to understand.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 404,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first announced PowerVia as a “future process and packaging technology…for Intel 20A” (see page 7).  \n- The 2023 filing then positioned PowerVia as one of two breakthrough features of Intel 20A, expected to deliver up to a 15 % performance‑per‑watt gain by eliminating front‑side power routing (page 14).  \n- The 2024 filing still lists PowerVia as a core element of the Intel 20A node while Intel moves to the next‑generation Intel 18A node that builds on the 20A innovations, showing that PowerVia has become a strategic pillar of Intel’s advanced‑process roadmap to drive power‑efficiency and performance differentiation (page 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies PowerVia's introduction in 2022 as part of Intel 20A, accurately cites the 15% performance-per-watt improvement metric for 2023, and properly recognizes PowerVia's continued strategic importance. The answer appropriately references specific 10-K filing pages and demonstrates understanding that PowerVia remained central to Intel's roadmap evolution. WEAKNESSES: (1) CRITICAL OMISSION - The LLM answer fails to mention the cancellation of Intel 20A productization in 2024, which is a major development explicitly stated in the ground truth. This is a significant gap in the multi-hop synthesis. (2) INCOMPLETE EVOLUTION NARRATIVE - The answer states PowerVia is 'still listed as a core element of the Intel 20A node' in 2024, but doesn't clearly explain that Intel 20A was canceled in favor of Intel 18A. This creates ambiguity about the actual progression. (3) MISSING KEY DETAIL - The answer doesn't mention Panther Lake or the 2025 high-volume manufacturing timeline, which are important indicators of PowerVia's practical implementation timeline. (4) VAGUE SYNTHESIS - While the answer notes Intel 18A 'builds on the 20A innovations,' it doesn't explicitly state that PowerVia was retained in Intel 18A as the replacement node, which is crucial to understanding the strategic continuity. QUANTITATIVE ACCURACY: The 15% performance-per-watt figure is correct. No calculation errors detected. QUALITATIVE ACCURACY: The reasoning about PowerVia's strategic importance is sound, but the multi-hop synthesis across 2022-2024 is incomplete due to the missing Intel 20A cancellation narrative. The answer demonstrates partial understanding but fails to fully capture the evolution from 20A to 18A while maintaining PowerVia. CONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about PowerVia's evolution and strategic role, but the incomplete narrative reduces its overall relevance and usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 529,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "The Black‑Scholes inputs for MDT’s non‑qualified options shifted from a 6‑year expected life, 0.90 % risk‑free rate, 23.04 % volatility and 1.95 % dividend yield in FY 2022 to a 6.1‑year life, 4.16 % risk‑free rate, 24.29 % volatility and 3.18 % dividend yield in FY 2024 (with FY 2023 values in‑between)【page_82】. The modest rise in volatility and dividend yield, together with a higher risk‑free rate and a slightly longer expected life, shows MDT is incorporating higher market‑based expectations and a marginally longer anticipated exercise horizon, indicating a more aggressive view of stock‑price fluctuation and employee option‑holding behavior over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical values (6-year expected life, 0.90% risk-free rate, 23.04% volatility, 1.95% dividend yield for 2022; 6.1-year life, 4.16% risk-free rate, 24.29% volatility, 3.18% dividend yield for 2024) but these cannot be verified against the ground truth, which does not provide these specific quantitative details. The ground truth focuses on the QUALITATIVE evolution: (1) consistent use of Black-Scholes across 2022-2024, and (2) the KEY SHIFT in 2023-2024 toward incorporating implied volatility from market-traded options in addition to historical volatility. The LLM answer completely MISSES this critical methodological evolution - the shift from historical volatility alone to a hybrid approach using both implied and historical volatility. Instead, the LLM provides granular numerical changes without explaining the fundamental change in volatility estimation methodology. The LLM's interpretation that the changes represent 'a more aggressive view' and 'higher market-based expectations' is vague and does not capture the specific methodological shift described in the ground truth. The LLM also fails to address the strategic significance of moving toward market-informed assumptions. While the LLM demonstrates some understanding that assumptions evolved and that this reflects market-based thinking, it fundamentally misses the core insight about the transition to implied volatility methodology. The citation reference [page_82] suggests the LLM may have accessed source material, but the specific numbers provided cannot be cross-verified against the ground truth answer, raising concerns about accuracy. The answer reads as plausible but lacks the methodological insight that defines the actual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 488,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s master‑netting collateral fell dramatically – from **$1.494 billion at 12/31/2022** to **$491 million at 12/31/2024** (a drop of roughly $1 billion)【page_102】. This steep decline, together with the note that the collateral is tied to “Other assets, including intangibles ‑ net,” indicates the firm is netting more of its derivative positions or scaling back exposure, reflecting tighter and more efficient management of its derivative risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the starting value ($1.494 billion in 2022) and ending value ($491 million in 2024), with proper format variation acceptance. (2) The directional trend is correct - a significant decline over the period. (3) The reasoning about derivative exposure management and margin requirements is sound and relevant. (4) The connection to 'Other assets, including intangibles - net' is properly acknowledged. (5) The contextual interpretation about netting efficiency and risk management is reasonable.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM failed to include the intermediate 2023 value ($800 million), which is essential for a complete multi-hop analysis across the three-year period. The ground truth explicitly provides 2022→2023→2024 progression, but the LLM only shows 2022→2024. (2) The calculation of 'roughly $1 billion' drop is approximately correct ($1,494M - $491M = $1,003M), but the LLM should have been more precise or noted the intermediate step. (3) The LLM's interpretation about 'netting more derivative positions' is somewhat speculative compared to the ground truth's more measured explanation about 'strategic reduction in derivative-related exposure or active management of margin requirements.' (4) Missing the nuance that the decline could reflect 'lower volatility in commodity markets or a shift in hedging strategies' - the ground truth provides more specific potential drivers.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis by connecting the collateral amounts to derivative exposure management, but incompletely addresses the full three-year trend analysis required by the question. The omission of 2023 data represents a significant gap in multi-hop completeness.\n\nQUANTITATIVE VERIFICATION: 2022 value correct ($1.494B), 2024 value correct ($491M), but missing 2023 ($800M). The approximate $1B decline calculation is reasonable but lacks precision of the intermediate year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 530,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "At year‑end 2022 the Level‑3 “Options – primarily gas” portfolio was recorded at $356 million of assets versus $347 million of liabilities (net ≈ $9 million) with implied volatilities ranging from 17 % to 295 % (weighted‑average ≈ 36 %)【page_86】. By 2023 the fair‑value had fallen to $100 million of assets and $97 million of liabilities (net ≈ $3 million) and the volatility range narrowed to 20 %–233 % (average ≈ 50 %)【page_85】, and at 2024 it was $100 million of assets against $102 million of liabilities (net ≈ ‑$2 million) with a tighter 15 %–150 % range (average ≈ 52 %)【page_86】. The sharp reduction in the size of the gas‑option position together with higher, more concentrated volatility assumptions shows NextEra has trimmed its gross exposure while still pricing in elevated gas‑price risk, indicating a more focused yet still aggressive risk posture in its gas‑derivative strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding implied volatility trends that directly contradicts the ground truth. According to the original answer, implied volatility DECLINED from 36% in 2022 to 50% in 2023 and 52% in 2024. However, the LLM states the opposite - that volatility 'increased' from 36% to 50% to 52%, and characterizes this as 'higher, more concentrated volatility assumptions.' This is a major semantic and factual error that misrepresents the company's risk positioning. The LLM correctly identifies all dollar amounts ($356M assets/$347M liabilities in 2022; $100M/$97M in 2023; $100M/$102M in 2024) and the volatility percentages themselves (36%, 50%, 52%), but fundamentally misinterprets the directional trend. The statement 'higher, more concentrated volatility assumptions' is incorrect - the volatility percentages increased numerically, but the ground truth indicates this represents a 'reduction in perceived market volatility and risk,' not an increase. Additionally, the LLM's characterization of NextEra's position as 'still aggressive' contradicts the ground truth's implication of reduced risk exposure. The multi-hop reasoning is partially sound in structure but arrives at an inverted conclusion about risk positioning. The quantitative data points are accurate, but the qualitative interpretation of what those numbers mean is reversed, which is a critical failure for a question specifically asking 'what does this reveal about the company's risk positioning.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 424,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "Across the three filings the Unsecured Notes – 35A never changed – it stayed at a $750 million face amount with an annual debt‑service payment of roughly $19.9 million (‑$19,875 k) each year [2022 10‑K p. 50] [2024 10‑K p. 50] [2024 10‑K p. 51].  The unchanged size, low 2.65 % coupon and steady service cost indicate that Simon Property Group is deliberately preserving this low‑cost, long‑dated tranche rather than expanding its long‑term debt, reflecting a strategy of stable, predictable financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental and severe quantitative error. The ground truth states the face amount is $750,000 (seven hundred fifty thousand dollars), but the LLM claims it is $750 million - a 1,000x overstatement. This is not a formatting variation but a catastrophic misreading of the actual financial obligation. The ground truth clearly shows: Face amount: $750,000 (not $750 million); Annual debt service: $19,875 (the LLM correctly identifies this as ~$19.9 million in thousands, but this is inconsistent with claiming a $750 million face amount). The LLM's calculation of a 2.65% coupon ($19,875 / $750,000 = 2.65%) is mathematically correct for the actual numbers, but this coupon calculation is based on the correct $750,000 figure, not the $750 million figure the LLM states. This internal inconsistency reveals the error: if the face amount were truly $750 million, the coupon would be approximately 0.00265% (19,875 / 750,000,000), not 2.65%. The LLM correctly identifies that the figures remained stable across 2022-2024 and correctly interprets this as reflecting a stable debt strategy. However, the magnitude error is so severe that it undermines the entire answer. The LLM also adds interpretive commentary about 'low-cost, long-dated tranche' and 'stable, predictable financing' which are reasonable inferences but cannot compensate for the fundamental numerical error. The answer demonstrates partial understanding of the multi-hop synthesis (comparing across years) but fails catastrophically on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 430,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "- In the 2022 Form 10‑K Texas Instruments explicitly framed its business model around “analog and embedded processing products” and said it would place “additional strategic emphasis” on those products in the industrial and automotive markets (2022 p. 19).  \n- The 2023 filing repeated that same focus, but the segment tables showed embedded‑processing revenue edging up only 3 % year‑over‑year (to $3.37 bn) while operating profit fell 20 % because of higher manufacturing costs (2023 p. 19; 2023 p. 20).  \n- The 2024 filing again underscored analog and embedded processing as the core strategic focus, even as embedded‑processing revenue dropped 25 % to $2.53 bn and operating profit plunged 65 % (2024 p. 19; 2024 p. 20).  \n\nThis three‑year continuity—maintaining a clear strategic priority on embedded processing despite fluctuating revenue and profit—signals TI’s long‑term positioning as a specialist, cash‑flow‑driven player that relies on its analog‑and‑embedded processing expertise and scale to differentiate itself in the broader semiconductor industry.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about TI's consistent strategic emphasis on embedded processing from 2022-2024, which aligns with the ground truth's core finding. However, there are significant quantitative accuracy issues that undermine the response. The LLM provides specific revenue and profit figures ($3.37bn in 2023, $2.53bn in 2024) with year-over-year changes (3% growth in 2023, 25% decline in 2024, 20% profit decline in 2023, 65% profit decline in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific numbers, making it impossible to confirm their accuracy. This is a critical issue because the LLM is presenting precise financial data with page citations as if they are factual, when the ground truth only confirms the strategic narrative without quantifying the revenue/profit figures. The qualitative reasoning is sound—the LLM correctly identifies the three-year continuity of strategic emphasis and draws a logical conclusion about TI's positioning as a specialist, cash-flow-driven player. The answer appropriately addresses both parts of the multi-part question (how the emphasis evolved AND what it indicates about long-term positioning). However, the introduction of unverified specific numbers creates a factual accuracy problem. The LLM should have either (1) provided only the strategic narrative confirmed by ground truth, or (2) clearly indicated uncertainty about the specific financial figures. The semantic equivalence between the LLM's conclusion and the ground truth's conclusion is strong, but the quantitative claims are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 447,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022 CMCSA’s wireless service – including shared‑data plans – was only sold to customers who also subscribed to a qualifying broadband package, and the data‑choice menu was limited to an unlimited plan, a shared‑data pool, or a per‑gigabyte option within that bundle【CMCSA_10k_2022.pdf page_5】. By 2024 the company kept shared‑data plans tied to bundled broadband but broadened its payment menu, adding a prepaid unlimited‑data option under the NOW brand while still offering unlimited, shared‑data and per‑gigabyte choices, giving customers more flexibility in how they pay for data【CMCSA_10k_2024.pdf page_5】. This reflects a shift from a strictly bundled‑only model to a more diversified set of plan and payment options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about CMCSA's shared data plan strategy evolution from 2022 to 2024. STRENGTHS: (1) All factual claims are correct - the answer accurately identifies that in 2022 shared data plans were bundled with broadband and offered alongside unlimited and per-gigabyte options; (2) Correctly identifies the 2024 expansion with NOW brand prepaid unlimited plans while maintaining existing options; (3) Properly synthesizes information across multiple years and documents (CMCSA_10k_2022.pdf and CMCSA_10k_2024.pdf); (4) Accurately characterizes the strategic shift from 'strictly bundled-only model' to 'more diversified set of plan and payment options'; (5) No numeric errors or calculation issues present; (6) All entities (CMCSA, years 2022-2024, plan types) correctly identified. MINOR CONSIDERATIONS: (1) The answer doesn't explicitly mention 2023 as a transition year, though the ground truth notes 2023 maintained the 2022 structure - however, this is a minor omission since the question asks about evolution from 2022 to 2024, and the answer correctly captures the overall trajectory; (2) The phrasing 'shift from strictly bundled-only model' could be slightly misleading since shared data plans remained bundled in 2024, though the answer does clarify this by noting they 'kept shared-data plans tied to bundled broadband' while adding new options. The answer effectively conveys that the evolution was about expanding options rather than abandoning bundling. MULTI-HOP REASONING: The answer successfully synthesizes information across two different years and documents, correctly identifying both continuity (shared data plans maintained) and change (new prepaid options added). The semantic equivalence to the ground truth is strong - both convey the same strategic narrative of maintaining core bundled offerings while expanding flexibility through additional payment/plan options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 532,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew from **$51.4 billion at year‑end 2022** to **$60.4 billion at year‑end 2023** and then to **$71.4 billion at year‑end 2024**【page_73】【page_73】【page_70】.  The steady rise in the treasury‑stock line shows the company has been accelerating share‑repurchase activity, indicating a capital‑allocation focus on returning excess cash to shareholders and enhancing per‑share returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental errors in the treasury stock figures. The ground truth shows negative values (in parentheses, indicating contra-equity accounts): $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM incorrectly reports these as positive values: $51.4 billion (2022), $60.4 billion (2023), and $71.4 billion (2024). While the 2023 and 2024 figures match the absolute values from the ground truth ($60.4B ≈ $60,429M and $71.4B ≈ $71,431M), the 2022 figure is completely wrong ($51.4B vs. $36,658M). More critically, the LLM failed to recognize that treasury stock is recorded as a negative/contra-equity account, fundamentally misrepresenting the accounting treatment. The 2022 number appears to be fabricated or from an incorrect source. REASONING QUALITY: The qualitative interpretation about share buybacks and capital allocation strategy is reasonable and aligns with the ground truth's conclusion about returning value to shareholders. However, this correct reasoning cannot compensate for the severe quantitative errors. MULTI-HOP SYNTHESIS: The answer does synthesize data across three years correctly in structure, but the underlying data accuracy is compromised. The trend direction (increasing buyback activity) is correct, but the starting point is wrong. COMPLETENESS: The answer addresses both parts of the question (evolution and strategic implications), but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 414,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics earned $1.169 billion from Repair and other services in 2022, which slipped to $1.132 billion in 2023 and remained at $1.132 billion in 2024 – a $37 million (about 3 %) drop from 2022 to 2024【page_9】. The figures show a modest decline in 2023 followed by a flat result in 2024, indicating the service business experienced a slight contraction but then stabilized.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) 2022 revenue: $1.169 billion ($1,169 million) - CORRECT; (2) 2023 revenue: $1.132 billion ($1,132 million) - CORRECT; (3) 2024 revenue: $1.132 billion ($1,132 million) - CORRECT; (4) Calculation of decline: $1,169M - $1,132M = $37M - CORRECT; (5) Percentage decline: $37M / $1,169M = 3.16%, rounded to 3% - CORRECT. The LLM properly synthesized the multi-hop information by tracking the revenue across three years and identifying the pattern (decline in 2023, stabilization in 2024). The reasoning is sound: the answer correctly identifies the modest contraction followed by stabilization, which aligns with the ground truth's characterization of stagnation/potential contraction. The only minor distinction is that the LLM uses slightly different language ('slight contraction but then stabilized' vs 'stagnation or potential contraction'), but both convey the same essential insight about the service business trajectory. The answer addresses all parts of the question: the specific revenue figures, the year-over-year changes, and the pattern/trajectory interpretation. Number format variations ($1.169 billion vs $1,169 million) are properly handled as equivalent. The citation reference [page_9] adds credibility though it cannot be verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 376,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- 2022: CVS’s residential‑mortgage‑backed securities (RMBS) carried an amortized cost of $845 m, a fair‑value of $757 m and generated $89 m of gross unrealized losses 【page_147】.  \n- 2023: The RMBS balance rose slightly to $862 m amortized cost, fair‑value increased to $810 m and unrealized losses fell to $60 m (the loss‑position fair‑value was $605 m) 【page_147】【page_150】.  \n- 2024: The only RMBS exposure shown is in the Separate‑Accounts portfolio, with a fair‑value of $71 m and no material unrealized loss disclosed 【page_160】.  \n\nThe trend shows a modest growth in the core RMBS holding from 2022‑23 but a sharp contraction by 2024, with unrealized losses shrinking as the portfolio was largely wound down—indicating CVS has been de‑risking its exposure to residential mortgage‑backed securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022: LLM reports fair value of $757M and unrealized losses of $89M, but ground truth shows fair value of $629M and unrealized losses of $10M. These are dramatically different numbers (20% overstatement on fair value, 790% overstatement on losses).\n   - 2023: LLM reports fair value of $810M and unrealized losses of $60M, but ground truth shows fair value of $614M and unrealized losses of $60M. The unrealized losses match, but fair value is overstated by ~32%.\n   - 2024: LLM correctly identifies $71M fair value, which matches ground truth.\n   - The LLM also introduces amortized cost figures ($845M, $862M) that are not part of the ground truth answer and appear to be from a different data source or misinterpretation.\n\n2. MULTI-HOP SYNTHESIS FAILURE:\n   The LLM failed to correctly synthesize the three-year trajectory. While it correctly identifies the 2024 sharp decline, it mischaracterizes the 2022-2023 period as \"modest growth\" when the ground truth shows a decline from $629M to $614M in fair value.\n\n3. NARRATIVE ACCURACY:\n   - Ground truth: Clear de-risking with fair value declining from $629M (2022) → $614M (2023) → $71M (2024)\n   - LLM narrative: Suggests growth from 2022-23 before sharp contraction, which is factually incorrect\n   - Both reach the correct conclusion about de-risking, but the LLM's supporting data is wrong\n\n4. ENTITY AND METRIC CONFUSION:\n   The LLM introduces \"amortized cost\" as a primary metric when the question specifically asks about \"fair value and unrealized losses.\" While amortized cost may be relevant context, the core metrics requested are misreported.\n\n5. SPECIFIC CALCULATION ERRORS:\n   - 2022 fair value error: $757M vs $629M = $128M discrepancy (20% overstatement)\n   - 2022 unrealized loss error: $89M vs $10M = $79M discrepancy (790% overstatement)\n   - 2023 fair value error: $810M vs $614M = $196M discrepancy (32% overstatement)\n\nThe LLM answer appears to have pulled data from different sections of the filing or confused RMBS data with other securities. Only the 2024 figure ($71M) is correct. The fundamental numbers that drive the analysis are wrong, making this answer unreliable despite reaching a correct directional conclusion about de-risking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 645,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s on‑site contracts for atmospheric gases have remained long‑term “total‑requirement” agreements (typically 10‑20 years) that obligate customers to buy a minimum volume and embed price‑escalation clauses tied to external price indices; any variable‑consideration in those contracts is treated as constrained and recognized only when the uncertainty is resolved【page_87†L1-L9】【page_100†L1-L9】. The 2024 filing still describes the same structure and pricing approach, but it now discloses a larger pool of future minimum‑purchase obligations (≈ $58 bn versus $48 bn in 2023) indicating growth in the scale of on‑site agreements rather than a change in the pricing mechanism【page_102†L1-L9】. The 2022 filing already identified on‑site as one of three distribution methods, implying the same contractual framework was in place at that time【page_94†L1-L7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core contractual structure (10-20 year on-site agreements with minimum purchase requirements and price escalation clauses) and accurately describes the treatment of variable consideration as constrained. However, there are significant issues with quantitative accuracy and completeness:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific future minimum-purchase obligation figures ($58bn vs $48bn in 2023) that cannot be verified against the ground truth, which does not mention these specific dollar amounts\n   - These numbers appear to be fabricated or misattributed, as the ground truth makes no reference to such quantitative comparisons\n   - This is a critical error as it presents unverified financial data as fact\n\n2. COMPLETENESS GAPS:\n   - The ground truth emphasizes a KEY EVOLUTION: In 2023, Linde \"explicitly noted\" that pricing fluctuates with price indices and variable components are present but constrained - this was NOT detailed in 2022\n   - The LLM answer downplays this important distinction, stating the framework \"was in place at that time\" in 2022, which contradicts the ground truth's emphasis on 2023 as the year this clarification emerged\n   - The ground truth highlights growing emphasis on transparency in pricing mechanisms and ASC 606 compliance as a 3-year progression; the LLM answer treats this as static\n\n3. REASONING QUALITY:\n   - The LLM correctly synthesizes the multi-hop information about contract structure across years\n   - However, it misinterprets the evolution narrative by suggesting consistency rather than highlighting the 2023 clarification as a meaningful change\n   - The citation of page numbers and specific figures without ground truth verification is problematic\n\n4. SEMANTIC ISSUES:\n   - The LLM's framing of \"growth in the scale of on-site agreements rather than a change in the pricing mechanism\" is reasonable but misses the ground truth's emphasis on transparency evolution\n   - The answer conflates \"no change in structure\" with \"no meaningful evolution,\" when the ground truth emphasizes evolving disclosure and transparency\n\n5. MISSING ELEMENTS:\n   - No mention of ASC 606 revenue recognition alignment (mentioned in ground truth)\n   - No discussion of the practical expedient for measuring progress toward performance obligations (mentioned in ground truth)\n   - Insufficient emphasis on the 2023 clarification as a turning point in disclosure practices",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 664,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net short position in forward natural‑gas contracts was about 1,307 MMBtu at year‑end 2022, widened to roughly 1,452 MMBtu in 2023, and then contracted to about 1,131 MMBtu by the end of 2024【page_85†L31-L38】【page_84†L31-L38】. The three‑year pattern shows a persistent net‑short stance, with exposure expanding in 2023 and then being trimmed in 2024, suggesting the company moved from a higher‑risk gas‑price position toward a more modest, defensive exposure in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer uses completely different metrics than the ground truth, making it fundamentally incorrect. (1) METRIC MISMATCH: Ground truth reports net exposure in DOLLAR AMOUNTS ($160M, $300M, $250M), while LLM reports PHYSICAL QUANTITIES in MMBtu (1,307, 1,452, 1,131). These are entirely different measurement units and cannot be compared. The question asks about 'net exposure' which in financial context refers to dollar exposure, not physical volume. (2) QUANTITATIVE ACCURACY FAILURE: The LLM numbers (1,307 MMBtu, 1,452 MMBtu, 1,131 MMBtu) are not verified against the ground truth dollar amounts. Even if these MMBtu figures are accurate from the filings, they answer a different question than what was asked. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the correct information. The ground truth clearly shows the calculation methodology: 2022 = $191M assets - $31M liabilities = $160M net; 2023 = $377M assets - $77M liabilities = $300M net; 2024 = $296M assets - $46M liabilities = $250M net. The LLM provided no such asset/liability breakdown and no dollar calculations. (4) SEMANTIC DIVERGENCE: While both answers describe a similar directional trend (expansion then contraction), they do so using incompatible metrics. The LLM's conclusion about 'defensive exposure' may be qualitatively similar, but it's based on wrong quantitative data. (5) MISSING CRITICAL INFORMATION: The LLM completely omits the asset and liability components that are essential to understanding NextEra's actual financial exposure. The ground truth's $300M peak exposure in 2023 is a material financial metric that the LLM fails to capture. This is a fundamental failure to answer the question as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 471,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "In the 2022 and 2023 10‑K filings Broadcom presented industrial fiber optics as a separate bullet‑point in its industrial‑segment product matrix—listed alongside optocouplers, sensors, motion encoders, LEDs and Ethernet ICs and tied to the core markets of factory automation, renewable‑energy and automotive electronics (see tables on pages 5‑7). By the 2024 filing the company had folded the fiber‑optic line into a broader narrative of its industrial portfolio, grouping it with optocouplers, motion encoders and LEDs and expanding the described application markets to include industrial automation, power generation and distribution, medical systems, defense/aerospace and vehicle subsystems such as electric‑vehicle powertrains, infotainment and advanced driver‑assistance systems (see page 10). This shift reflects a move from a discrete product‑line listing to a more integrated positioning within an enlarged set of industrial offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) FACTUAL CONTRADICTIONS: The ground truth states that in 2022-2023, Industrial Fiber Optics was listed among key offerings alongside optocouplers, sensors, motion encoders, and LED devices. However, the LLM claims that in 2022-2023 it was presented as a 'separate bullet-point' and then 'folded into a broader narrative' by 2024. This is backwards—the ground truth indicates consistent positioning across all three years with no significant shift. (2) PRODUCT GROUPING ERRORS: The LLM states that by 2024 the product was 'grouped with optocouplers, motion encoders and LEDs' but omits sensors and Ethernet ICs, which the ground truth explicitly includes in 2024. The LLM also incorrectly suggests this represents a change from 2022-2023 positioning. (3) APPLICATION MARKETS MISCHARACTERIZATION: The LLM claims that expanded application markets (power generation, medical systems, defense/aerospace, vehicle subsystems) were introduced in 2024, but the ground truth clearly states these were already present in 2022. The LLM has reversed the timeline. (4) CORE CONCLUSION ERROR: The LLM concludes there was 'a move from a discrete product-line listing to a more integrated positioning,' but the ground truth explicitly states 'The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role...with no significant expansion or contraction.' This is a fundamental misinterpretation of the evolution. (5) PAGE REFERENCES: The LLM provides specific page numbers (pages 5-7 for 2022-2023, page 10 for 2024) which cannot be verified and appear to be fabricated details. The answer demonstrates poor multi-hop synthesis, inverted chronology of product positioning changes, and contradicts the ground truth's core finding of stability rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 515,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "SPG’s Unsecured Notes – 31B have not changed in size or cost over the three‑year span. In each year the note carries a $750 million face amount and a 3.25 % coupon that translates to roughly $24.4 million of annual debt service (shown as $750,000 and $24,375 in thousands in the 2022, 2023 and 2024 tables)【page_50】【page_51】. The consistency indicates that Simon is maintaining a stable, low‑cost, long‑dated unsecured debt platform rather than adding new long‑term borrowings or refinancing existing notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative facts are correct: the $750 million face amount, 3.25% interest rate, and $24,375,000 annual debt service are accurately stated across all three years (2022-2024). The number format variation ($750,000 in thousands vs $750 million) is properly handled and explained. The multi-hop synthesis is sound—the model correctly tracked the same instrument across three fiscal years and identified the pattern of stability. The reasoning about SPG's debt strategy is logical and well-supported: the consistency of terms demonstrates a stable, low-cost approach without refinancing or restructuring. The answer directly addresses both parts of the question: (1) how the obligations evolved (they didn't—remained constant), and (2) what this reveals about strategy (stability and maintenance of existing debt platform). Minor areas for potential improvement: the answer could have been slightly more explicit about the year-by-year comparison (though the consistency is clearly stated), and the citation format [page_50][page_51] suggests source documentation but doesn't specify which years correspond to which pages. However, these are very minor points that don't affect the factual accuracy or core message. The semantic equivalence is excellent—the LLM's characterization of 'stable, low-cost, long-dated unsecured debt platform' aligns perfectly with the ground truth's assessment of 'stable long-term debt strategy with no refinancing or restructuring.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 421,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024【page_43】. The steady increase over the three‑year period signals a modest but growing commitment by the company to fund employee retirement benefits.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: $70 million (2022), $75 million (2023), and $76 million (2024). The numbers match the ground truth exactly, and the format variation ($70 million vs $70M) is acceptable. The multi-hop synthesis is sound, correctly identifying the trend across the three-year period and drawing appropriate conclusions about the company's commitment to employee retirement benefits. The characterization of the trend as 'steady increase' and 'modest but growing commitment' aligns well with the ground truth's assessment. However, the LLM answer omits the specific percentage calculation (8.6% increase from 2022 to 2024) that was included in the original answer. While this omission is minor and doesn't affect the core correctness of the response, it represents a slight incompleteness in addressing the full analytical depth of the question. The answer appropriately addresses all parts of the multi-part question: the evolution of expenses, the three-year trend, and what it indicates about the company's investment strategy. The reasoning is logical and the entity identification (Texas Instruments, U.S. defined contribution plans) is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 345,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "General Dynamics’ ROIC definition consistently excludes goodwill impairments **and** non‑economic accounting changes in each of its recent filings – the 2022 Form 10‑K notes this exclusion (p. 50), the 2023 filing repeats it (p. 50), and the 2024 filing again states the same (p. 49). The unchanged treatment shows that GD deliberately strips out accounting‑driven items to focus its performance metric on pure operating returns, underscoring a stable evaluation methodology that emphasizes economic returns on capital rather than transient GAAP adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024 - matching the ground truth's core finding. (2) Accurately cites specific page numbers (p. 50 for 2022 and 2023, p. 49 for 2024) which demonstrates proper document referencing. (3) Properly synthesizes the multi-hop information across three years to show consistency. (4) Correctly identifies the company as General Dynamics (GD). (5) The reasoning about 'stable evaluation methodology' and 'disciplined approach' aligns with the ground truth's interpretation. (6) Appropriately emphasizes that the exclusion reflects a focus on 'economic returns on capital rather than transient GAAP adjustments.' MINOR CONSIDERATIONS: (1) The LLM answer adds 'goodwill impairments' to the exclusion list alongside non-economic accounting changes. While the ground truth specifically mentions 'non-economic accounting changes,' the addition of goodwill impairments is not contradicted by the ground truth and represents a reasonable elaboration based on typical ROIC adjustment practices. This is not an error but rather additional context. (2) The LLM uses slightly more elaborate language ('deliberately strips out,' 'pure operating returns') compared to the ground truth's more straightforward phrasing, but this represents semantic equivalence rather than factual divergence. (3) All years (2022, 2023, 2024) are correctly identified and the consistency finding is accurate. The answer fully addresses the question's inquiry into how treatment evolved (or didn't evolve) and what this reveals about methodology. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 480,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS’s Separate‑Accounts assets were $3.313 billion at 12/31/2022, slipped to $3.204 billion in 2023, and then rose to $3.311 billion in 2024 【page_157†L31-L38】【page_108†L31-L38】.  Over the three‑year span the balance was essentially flat – a modest dip in 2023 followed by a rebound in 2024 – indicating that CVS has kept a stable, slightly growing investment base for the assets that back its long‑term insurance (case‑pension) contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. Ground truth shows: 2022: $5,087M, 2023: $3,250M, 2024: $3,311M. LLM reports: 2022: $3,313M, 2023: $3,204M, 2024: $3,311M. The 2022 figure is off by $1,774 million (35% error), and the 2023 figure is off by $46 million. Only the 2024 figure ($3,311M) is correct. The LLM's characterization of the trend as 'essentially flat' with 'modest dip' is completely wrong - the ground truth shows a DRAMATIC 36% decline from 2022 to 2023 ($5,087M to $3,250M), which is a significant strategic shift, not a modest fluctuation. The LLM's conclusion about 'stable, slightly growing investment base' directly contradicts the ground truth's assessment of 'significant decline in 2023 followed by marginal recovery.' The reasoning about long-term insurance products is semantically reasonable but is built on incorrect foundational data. The multi-hop synthesis failed because the underlying numbers are wrong. This is a case where the model appears to have hallucinated or misread the source data, as evidenced by the citation references that don't validate the reported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 345,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. – originally dated October 22 2012 – was amended again in the 2022‑2024 period: a **Third Amendment** was executed on November 1 2022 (listed as Exhibit 10.21.3+ in the 2024 Form 10‑K) and a **Letter Agreement** was entered into on March 8 2023 (Exhibit 10.21.4+) 【page_75】. These amendments, reflected in the 2024 filing, follow the earlier First (Feb 24 2015) and Second (Nov 19 2019) amendments to the same agreement 【page_66】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer introduces significant factual errors not supported by the ground truth. (1) CRITICAL DATE ERROR: The LLM claims a 'Third Amendment' was executed on November 1, 2022, but the ground truth makes no mention of any amendment dated November 1, 2022. The ground truth only references amendments dated February 24, 2015 (First) and November 19, 2019 (Second). (2) UNSUPPORTED CLAIMS: The LLM references a 'Letter Agreement' dated March 8, 2023 (Exhibit 10.21.4), which is not mentioned in the ground truth at all. (3) EXHIBIT CITATIONS: The LLM provides specific exhibit numbers (10.21.3+, 10.21.4+) and page references (page_75, page_66) that cannot be verified against the ground truth and appear to be fabricated. (4) INCOMPLETE ALIGNMENT: While the LLM correctly identifies the original agreement date (October 22, 2012) and the First Amendment (February 24, 2015), it fails to accurately represent what the ground truth actually states about the 2022-2024 period. The ground truth indicates the Second Amendment (November 19, 2019) was 'explicitly listed' in 2024, but does NOT claim any new amendments occurred during 2022-2024. (5) MULTI-HOP REASONING FAILURE: The LLM appears to have hallucinated additional amendments rather than synthesizing the actual information from the filings. The ground truth's narrative about 'formal updates' and 'structured amendments' refers to the historical amendments (2015, 2019), not new ones in 2022-2024. The LLM fundamentally misrepresents the evolution of the agreement by inventing amendments that do not exist in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 444,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In the 2022 filing Linde described rare gases (krypton, neon, xenon) simply as atmospheric‑gas co‑products that are manufactured and sold through the same integrated on‑site, merchant and packaged‑gas distribution network used for its other gases [2022 p.94]. By the 2024 filing the company had turned rare‑gas production into a strategic differentiator, stressing its market‑leadership in non‑cryogenic air‑separation and proprietary VPSA and membrane technologies that create new markets and cost‑saving applications, while still delivering those gases from the same multi‑product plants that serve its broader atmospheric‑ and process‑gas portfolio [2024 p.4].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the core evolution of Linde's rare gases strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the three specific rare gases (krypton, neon, xenon) mentioned in the ground truth; (2) Accurately characterizes the 2022 positioning as treating rare gases as atmospheric-gas co-products distributed through on-site, merchant, and packaged channels; (3) Correctly identifies the 2024 shift toward strategic differentiation with emphasis on non-cryogenic air separation technologies; (4) Accurately names the specific technologies (VPSA and membrane separation) as innovations; (5) Properly synthesizes the multi-hop reasoning showing evolution from product-centric to technology-driven approach; (6) Includes specific page references (2022 p.94, 2024 p.4) that ground the answer in source material. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 intermediate positioning described in the ground truth (emphasis on proprietary technologies, long-term contracts with price escalation clauses, and variable pricing), which represents a slight incompleteness in the three-year progression; (2) Does not explicitly mention the broader market expansion aspect noted in the ground truth. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'from product-centric to technology-driven approach' aligns well with the ground truth's description of 'shift from a product-centric to a technology- and integration-driven approach.' The emphasis on 'market-leadership' and 'cost-saving applications' captures the strategic positioning evolution effectively. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years (2022 and 2024) and correctly identifies the technological differentiation and integration aspects requested in the question. The connection between technologies (VPSA, membrane) and their role in enabling broader market expansion is appropriately made.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 541,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral for master‑netting arrangements fell sharply – it was $1.494 billion at 31 Dec 2022, $800 million at 31 Dec 2023 and $491 million at 31 Dec 2024 (see 2022‑2024 tables in the 10‑K notes)【page_102†L31-L34】【page_99†L31-L34】. The steep reduction in required collateral suggests the firm’s exposure to derivative liabilities tied to its advances and obligations to equity‑company affiliates has been decreasing, reflecting lower netting risk or less reliance on margin for those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and properly handled. The temporal sequence and year-end dates are accurate. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) the evolution of collateral amounts across the three-year period, and (2) what this trend suggests about derivative liability exposure. ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to equity company advances) is precisely stated, and all years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to implications about derivative liability exposure and risk management. The interpretation that this reflects 'de-risking or portfolio optimization' (ground truth) aligns well with the LLM's characterization of 'lower netting risk or less reliance on margin.' SEMANTIC EQUIVALENCE: The LLM's phrasing 'exposure to derivative liabilities tied to its advances and obligations to equity-company affiliates has been decreasing' is semantically equivalent to the ground truth's 'strategic reduction in exposure to derivative liabilities associated with equity company relationships.' Minor differences: The LLM uses slightly different language ('lower netting risk or less reliance on margin') versus the ground truth's 'de-risking or portfolio optimization,' but both convey the same analytical insight. The citation references to page numbers add credibility but cannot be verified against the ground truth. Overall, this is a high-quality response with accurate numbers, proper multi-hop synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 512,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "By the end of 2022 NEER had already locked in roughly 94 % of its net‑generating capacity under long‑term bilateral contracts, and that share stayed essentially unchanged at about 94 % in 2023 【page_18】and again at 94 % in 2024 【page_19】.  This consistently high level of contract coverage shows the company’s deliberate strategy of locking in future electricity sales to hedge price volatility and reduce market‑risk exposure in competitive wholesale markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that contradicts the ground truth. The LLM states NEER had 94% of net generating capacity under long-term bilateral contracts in 2022, but the ground truth clearly indicates it was 92% in 2022, rising to 94% in 2023 and 2024. This is not a minor rounding difference—it's a 2 percentage point discrepancy that misrepresents the actual trend. The ground truth explicitly shows a 'steady increase from 92% in 2022 to 94% in 2023 and 2024,' which is the core finding of the question. The LLM's characterization of the data as 'essentially unchanged at about 94%' across all three years fundamentally misses the evolution/trend that the question specifically asks about. While the LLM correctly identifies the 2023 and 2024 figures (94%), and provides reasonable qualitative analysis about risk mitigation strategy, the incorrect 2022 baseline (94% vs. 92%) undermines the entire answer's credibility. The LLM also fails to explicitly acknowledge the upward trend from 2022-2023, instead suggesting the percentages remained 'essentially unchanged,' which contradicts the ground truth's emphasis on 'steady increase.' The reasoning about hedging and price volatility management is sound and relevant, but it's built on incorrect foundational data. This is a multi-hop question requiring accurate synthesis across three years of data, and the LLM failed on the first data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 402,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 2022 filing (AVGO 10‑K pages 101‑105) contains no line for the 3.125 % senior notes due January 2025, indicating that the instrument was not outstanding at the end of fiscal 2022.  By contrast, the debt tables in the 2023 and 2024 reports show the same $495 million principal balance for those notes as of October 29 2023 and November 3 2024 respectively (page 81).  This pattern – a new $495 million issue after FY 2022 that has been left unchanged – reveals that Broadcom has chosen to keep the note on its balance sheet and let it run to maturity rather than accelerating repayment or refinancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that the 3.125% notes due January 2025 had an outstanding principal balance of $495 million in fiscal 2022, remained at $495 million in fiscal 2023, and was still $495 million in fiscal 2024. However, the LLM claims the instrument 'was not outstanding at the end of fiscal 2022' and that it was a 'new $495 million issue after FY 2022.' This is fundamentally incorrect. The LLM correctly identifies the $495 million balance for fiscal 2023 and 2024, and correctly cites the page numbers (page 81), but the assertion about fiscal 2022 non-existence directly contradicts the ground truth. The LLM's interpretation of the debt management strategy (keeping the note on balance sheet to maturity rather than accelerating repayment) is reasonable and aligns with the ground truth's conclusion, but this cannot overcome the major factual error about the fiscal 2022 status. The LLM also correctly identifies the company as Broadcom (AVGO), the note rate (3.125%), and the maturity date (January 2025). The reasoning about letting the note run to maturity is sound, but it's based on a false premise about when the note was issued. The answer fails to address the core finding that the balance remained 'unchanged' across all three years as stated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 383,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "Simon Property Group’s unsecured notes ‑ 37B have not changed over the last three years: the 2022 10‑K (as of 12/31/2021) shows a 2.25 % coupon, a $700 k face amount and a maturity of 01 Jan 2032【page_50】; the 2023 filing (as of 12/31/2022) lists the same 2.25 % rate, $700 k principal and 01/15/32 maturity, and the 2024 filing (as of 12/31/2023) again reports 2.25 %, $700 k and a 01/15/32 maturity【page_51】. This unchanged profile signals a deliberate long‑term debt strategy that locks in low‑cost financing and preserves a stable, far‑out maturity schedule, minimizing refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. STRENGTHS: (1) All key numeric values are correct - 2.25% interest rate, $700 million face amount (correctly interpreted from '$700 k' notation), and January 15, 2032 maturity date are all accurate across all three years. (2) The answer correctly identifies the consistency of these terms across 2022, 2023, and 2024 filings. (3) The multi-hop synthesis is sound - the model properly tracked the same debt instrument across three separate 10-K filings and confirmed no changes. (4) The strategic interpretation is appropriate and well-reasoned, noting the deliberate strategy to lock in low-cost financing and minimize refinancing risk. (5) Citation references to specific pages add credibility. MINOR ISSUES: (1) The notation '$700 k' is slightly ambiguous (could be interpreted as $700,000 rather than $700 million), though context makes the intent clear and the ground truth confirms $700,000,000 is correct. (2) The LLM uses 'k' notation inconsistently with standard financial reporting conventions (typically would be written as $700 million or $700M). (3) The date format varies slightly between sources (01 Jan 2032 vs 01/15/32 vs January 15, 2032) but all refer to the same date. The answer demonstrates solid understanding of the question's multi-part requirements (interest rate, face amount, maturity date evolution) and provides appropriate strategic context about debt management. The core factual content is accurate and the reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 421,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "- In the 2022 10‑K (Item 2, page 16) Texas Instruments lists “Melaka, Malaysia **” with an X only under **Analog** and a blank under Embedded Processing.  \n- The 2023 10‑K (Item 2, page 16) still shows “Melaka, Malaysia *” marked only for **Analog**.  \n- The 2024 10‑K (Item 2, page 16) again lists “Melaka, Malaysia *” (or †) with an X solely in the **Analog** column.  \n\nAcross the three years the Melaka site’s functional designation never shifted to embedded‑processing – it remained an analog‑focused facility (the lease/ownership status changed, but the product focus did not), indicating TI’s continued emphasis on analog operations at that location.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint evolution from 2022-2024. STRENGTHS: (1) All factual claims are correct - the answer accurately identifies that Melaka was marked with 'X' under Analog in all three years (2022, 2023, 2024) and had no Embedded Processing designation across the period. (2) The multi-hop synthesis is sound - the model correctly synthesized information across three separate 10-K filings to establish the consistent pattern. (3) Entity accuracy is perfect - correct company (Texas Instruments/TXN), correct location (Melaka, Malaysia), correct product categories (Analog vs Embedded Processing), and correct years (2022-2024). (4) The reasoning is logical and well-structured, showing the progression (or lack thereof) and drawing the appropriate conclusion about TI's targeted analog-only strategy. (5) The answer includes helpful contextual detail about lease/ownership status changes while correctly noting the product focus remained constant. (6) Specific document references (Item 2, page 16) add credibility. MINOR CONSIDERATIONS: The LLM uses slightly different notation markers (**, *, †) when referencing the footnotes, which is a minor stylistic variation from the ground truth but does not affect factual accuracy. The semantic meaning is identical to the original answer - both conclude that Melaka maintained an analog-only focus with no expansion into embedded processing. The answer fully addresses both parts of the question: (1) how the footprint evolved (answer: it didn't - it remained stable), and (2) what this reveals about company focus (answer: targeted analog investment without diversification). No calculations were required, and all dates and entities are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "In 2022 Mastercard’s filing described its protection model as a “Payments System Security” program that used a multi‑layered approach—cyber‑ and information‑security controls, third‑party benchmarking, regular testing and technical‑standard work (e.g., EMV)—to safeguard the network while it operated real‑time account‑based payments in 12 markets (as of Dec 31 2021)【page_11】. By the 2024 filing the language had shifted to a broader “Payments Ecosystem Security” framework that added enterprise‑resilience, insurance coverage, public‑private partnership monitoring and expanded technical‑standard development, reflecting the expansion of its real‑time payments infrastructure to 13 markets worldwide (as of Dec 31 2023)【page_11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the evolution from 'Payments System Security' to 'Payments Ecosystem Security' framework, which aligns with the ground truth's description of evolving approach. (2) Numbers are mostly accurate: 12 markets in 2022 (as of Dec 31, 2021) and 13 markets by 2023 (as of Dec 31, 2023) match the ground truth. (3) Key security elements are correctly identified: EMV, multi-layered approach, third-party benchmarking, public-private partnerships. (4) The temporal progression (2022→2024) is properly structured.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to address the 2024 expansion into China through a joint venture, which is explicitly mentioned in the ground truth as a significant evolution requiring security framework scaling. This is a major gap in addressing the 'expanding real-time payment infrastructure across increasing numbers of global markets' aspect of the question. (2) The answer jumps from 2023 data (13 markets) to 2024 without providing 2024-specific market expansion numbers or details about how the security framework evolved to accommodate China's entry. (3) The answer lacks discussion of 'intelligent routing with real-time application of fraud scoring and tokenization services' mentioned in the ground truth for 2023. (4) The connection between market expansion and security framework evolution is stated but not deeply explored—the answer describes what changed but not adequately why or how it responded to the specific market expansions.\n\nQUANTITATIVE VERIFICATION: Market counts are correct (12→13), but the answer provides no 2024 market count or China-specific metrics, leaving the temporal evolution incomplete. The dates cited (Dec 31, 2021 and Dec 31, 2023) are appropriately referenced but the answer doesn't extend to 2024 data.\n\nMULTI-HOP REASONING: The answer demonstrates partial multi-hop synthesis by connecting framework evolution to market expansion, but fails to complete the full 2022-2024 arc by omitting the China expansion and its security implications. The reasoning is sound for what is included but incomplete for the full question scope.\n\nCONTEXTUAL RELEVANCE: While the answer addresses the security evolution and market expansion themes, it incompletely addresses the 'through 2024' timeframe and the specific challenge of expanding into China, which represents a material evolution in the security framework according to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 656,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics’ Land Systems unit said it was building **360 new LAVs** for the Canadian Army in 2022, **449 new LAVs** in 2023, and **399 new LAVs** in 2024 (2022 10‑K p. 11; 2023 10‑K p. 10; 2024 10‑K p. 11). The sharp increase in 2023 shows a purposeful ramp‑up to capture more of the Canadian contract, while the modest cut‑back in 2024 reflects a shift to a steadier, mature production rate—demonstrating that LAV programs remain a core strategic focus for General Dynamics.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the production volumes that directly contradict the ground truth. Specifically: (1) 2022: LLM states 360 units (CORRECT), (2) 2023: LLM states 449 units (INCORRECT - ground truth is 399 units), (3) 2024: LLM states 399 units (INCORRECT - ground truth is 449 units). The LLM has essentially REVERSED the 2023 and 2024 figures. This is a fundamental quantitative error that undermines the entire answer. The ground truth shows a progression of 360→399→449 (steady increase), while the LLM presents 360→449→399 (increase then decrease). This reversal completely changes the narrative about strategic focus and production trends. The LLM's interpretation that 2024 represents a 'modest cut-back' and 'steadier, mature production rate' is factually incorrect given the actual data shows continued growth to 449 units in 2024. While the LLM correctly identifies General Dynamics, the LAV program, the Canadian Army context, and provides appropriate source citations (10-K filings), these contextual elements cannot compensate for the reversed numerical data. The reasoning about strategic focus would be sound IF the numbers were correct, but the transposed figures make the entire analytical conclusion misleading. This is a multi-hop synthesis failure where the model failed to accurately extract and sequence the production volume data across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 402,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s pension plan allocated about $225 million to hedge‑fund limited‑partnership investments in 2022, which rose to roughly $252 million in 2023 and further to about $280 million in 2024 (page 174; page 173; page 169). This steady increase indicates the company is gradually tilting its pension portfolio toward greater alternative‑asset exposure, using hedge‑fund investments to diversify returns and enhance the risk‑adjusted performance of its pension fund.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are essential to answering this question. Ground truth shows: 2022=$214M, 2023=$225M, 2024=$252M. LLM answer states: 2022=$225M, 2023=$252M, 2024=$280M. This represents a systematic shift of all values upward by one year, essentially misaligning the entire dataset. The 2024 figure of $280M is particularly problematic as it exceeds the ground truth by $28M (11% overstatement). CALCULATION ERRORS: The LLM does not calculate the percentage change, but the implied trend is wrong due to incorrect base numbers. The ground truth shows a 17.8% increase over three years; the LLM's numbers would suggest a different (and larger) percentage increase. MULTI-HOP REASONING: While the LLM correctly identifies the general trend (upward allocation to hedge fund investments) and provides reasonable strategic interpretation about diversification and risk-adjusted performance, this reasoning is built on fundamentally incorrect data points. The qualitative analysis about 'gradually tilting toward alternative-asset exposure' is reasonable but cannot be validated against incorrect numbers. ENTITY ACCURACY: CVS is correctly identified, the metric (hedge fund limited partnership investments through pension plan) is correctly understood, and the three-year period is correct. However, the year-to-year values are systematically wrong. COMPLETENESS: The answer addresses the trajectory question and attempts to explain strategic implications, but the foundation is compromised by data errors. The page references provided cannot be verified but appear to be fabricated or misread. SEMANTIC EQUIVALENCE: The interpretation about pension strategy evolution is reasonable in tone, but semantic equivalence cannot be granted when the underlying numbers are incorrect by 11-17% in some cases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 512,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration slipped from 20.5 % of purchases in fiscal 2022 to 19.8 % in fiscal 2023 and further to 18.6 % in fiscal 2024【page_27】. The steady decline indicates that, while the card still enjoys broad use, its adoption and usage are growing more slowly than overall sales, suggesting a modest weakening in consumer engagement with Target’s financial‑card offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM reports the 2024 penetration rate as 18.6%, but the ground truth states it should be 17.8%. This is a material factual error of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. STRENGTHS: The LLM correctly identifies the three-year trend of declining penetration rates and appropriately characterizes this as indicating slower adoption/engagement growth relative to overall sales. The reasoning about RedCard sales growing in dollar terms while total sales grow faster is sound and matches the ground truth interpretation. The LLM correctly notes the modest weakening in consumer engagement. WEAKNESSES: (1) The incorrect 2024 figure (18.6% vs. 17.8%) is a significant quantitative error that undermines accuracy. (2) The LLM provides less comprehensive analysis than the ground truth - it omits discussion of potential causes (shifting consumer preferences, increased competition, reduced sensitivity to discount incentive). (3) The answer is somewhat less detailed in exploring what the trend suggests about consumer behavior. MULTI-HOP REASONING: The LLM successfully synthesizes the multi-year trend and connects it to the broader context of RedCard performance, demonstrating adequate multi-hop reasoning. However, the factual error in the final data point is a critical flaw that prevents a higher score. The semantic equivalence of the decline characterization is good, but the numerical accuracy failure is decisive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 413,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "In 2022 the fair‑value exposure for FPL cost‑recovery clauses was $16 million (the fair‑value of contracts outstanding at year‑end)【page_52】. In 2023 the net exposure fell to $12 million, reflecting a $24 million positive contribution from significant unobservable inputs offset by a $12 million negative contribution from significant other observable inputs【page_53】. By 2024 the exposure rose sharply to $38 million, as other observable inputs turned modestly positive ($4 million) while unobservable inputs grew to $34 million, driving the increase【page_55】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error in the 2022 figure. The ground truth states the 2022 total fair value was $1 million, but the LLM claims it was $16 million. This is a major discrepancy that undermines the entire analysis. Additionally, the LLM's characterization of the 2022 composition is completely absent - it fails to mention the -$5 million from significant other observable inputs and +$6 million from significant unobservable inputs that were present in 2022. For 2023 and 2024, the LLM's numbers align with the ground truth ($12 million and $38 million respectively, with the correct component breakdowns of -$12M/$+24M for 2023 and +$4M/+$34M for 2024). However, the 2022 error is severe and represents a failure in multi-hop synthesis. The LLM correctly identifies the trend of growing reliance on unobservable inputs and the strengthening fair value position, but this insight is undermined by the incorrect baseline year data. The answer demonstrates partial understanding of the 2023-2024 evolution but fails on the complete 2022-2024 trajectory that the question specifically asks about. The citation references suggest the LLM attempted to source the information, but the 2022 figure is demonstrably wrong according to the ground truth knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 367,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "From 2022 through 2024 Nike has kept Anta listed as a primary rival and repeatedly asserted that it remains “competitive” on product quality, innovation and consumer connection. In each filing the company stresses its technical‑innovation focus—highlighting its Air, Zoom, Flyknit, React and related technologies—and its use of market intelligence to launch new product experiences, while also emphasizing digital‑first marketing, social‑media interaction and athlete‑endorsement programs to deepen brand engagement. Thus, Nike’s positioning relative to Anta has stayed consistent, with a steady (and slightly more integrated) emphasis on cutting‑edge product tech and digitally driven brand engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Anta as a named competitor across all three years (2022-2024), matching the ground truth. (2) The LLM accurately captures NKE's emphasis on product innovation and digital engagement strategies across the period. (3) The mention of specific technologies (Air, Zoom, Flyknit, React) demonstrates knowledge of NKE's product portfolio. (4) The characterization of NKE's positioning as 'consistent' with emphasis on innovation and digital engagement is semantically aligned with the ground truth. (5) No quantitative errors in dates or time periods.\n\nWEAKNESSES: (1) The LLM misses the critical EVOLUTION/SHIFT in NKE's strategic positioning from 2022 to 2024. The ground truth explicitly states that in 2023, NKE 'elevated the importance of innovation and development ahead of performance and reliability, signaling a strategic shift.' The LLM characterizes the positioning as 'stayed consistent' rather than capturing this meaningful evolution. (2) The ground truth emphasizes a multi-year strategic effort in response to competitive pressures from Anta and other competitors gaining traction through localized and digitally native strategies. The LLM does not capture this competitive context or the defensive/responsive nature of NKE's strategic shift. (3) The LLM conflates 2022 positioning (quality, performance, reliability) with later years by stating emphasis remained on 'product quality, innovation and consumer connection' throughout—missing the 2023 elevation of innovation ahead of performance/reliability. (4) The LLM's statement that positioning 'stayed consistent' directly contradicts the ground truth's narrative of strategic evolution and shifting emphasis priorities.\n\nMULTI-HOP REASONING: The question requires synthesizing competitive positioning across three years and two companies. The LLM partially succeeds by identifying both companies and the time period, but fails to properly synthesize the TEMPORAL EVOLUTION of NKE's strategy relative to Anta's competitive threat. The ground truth shows a clear progression: 2022 (quality/performance focus) → 2023 (innovation elevated) → 2024 (innovation solidified + digital engagement). The LLM flattens this into a 'consistent' narrative.\n\nSEMANTIC ACCURACY: While the LLM uses different wording than the ground truth, the semantic meaning diverges on a key point: the ground truth emphasizes strategic evolution in response to competition, while the LLM emphasizes consistency. This is a material difference in interpretation of the underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 680,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The 10‑K tables show that the pool of shares available for future issuance – which includes the Texas Instruments 2003 Director Compensation Plan – fell from about **69.8 million shares** at year‑end 2021 (reported in the 2022 filing) to roughly **58.5 million shares** at year‑end 2022 (2023 filing), then rose again to about **65.5 million shares** at year‑end 2023 (2024 filing)【page_63†L1-L4】【page_61†L1-L4】【page_59†L1-L4】.  The drop between 2022 and 2023 reflects the plan’s active use for director equity awards, while the rebound in 2024 – driven by new allocations such as the 2024 LTIP – shows TI continues to maintain and replenish a sizable share pool for director compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the question. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific share pool numbers (69.8M, 58.5M, 65.5M) that appear to reference aggregate share pools across ALL equity plans, not specifically the 2003 Director Compensation Plan. The ground truth indicates the 2003 plan's shares were not separately tracked or reported in later years. (2) MISINTERPRETATION OF TREND: The LLM claims shares 'fell then rose again,' suggesting continued active use of the 2003 plan. However, the ground truth clearly states the 2003 plan was phased out - it was referenced in 2022, no longer listed in 2023, and completely absent from the active compensation structure by 2024. (3) INCOMPLETE SYNTHESIS: The LLM fails to address the core finding that the 2003 plan was being phased out in favor of newer vehicles (2024 LTIP, 2018 Director Plan). While the LLM mentions these newer plans at the end, it contradicts this by claiming the 2003 plan remained actively used. (4) MISSING CONTEXT: The ground truth emphasizes a 'strategic shift toward updated incentive structures' and 'gradual phase-out,' which the LLM's narrative of rising share pools contradicts. The LLM's conclusion that 'TI continues to maintain and replenish' the 2003 plan directly contradicts the ground truth that it was discontinued. (5) CITATION ISSUES: The LLM cites specific page references but the numbers provided appear to be aggregate plan pool data, not 2003-specific data. The answer conflates total available shares across all plans with the specific 2003 Director Compensation Plan's availability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 449,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA first disclosed in its 2022 Form 10‑K that its advertising business began offering “technology, tools, data‑driven services and marketplace solutions” to media‑industry customers to help advertisers reach target audiences (CMCSA_10k_2022.pdf, page 6). In 2023 the company expanded that integration by selling ads on its Sky‑branded networks and on its digital platforms and by representing third‑party advertisers domestically and internationally, thereby extending data‑driven capabilities across more channels (CMCSA_10k_2023.pdf, page 6; CMCSA_10k_2023.pdf, page 8). By 2024 the filing shows the same suite of technology, tools, data‑driven services and marketplace solutions was further refined and deployed across both domestic and international digital platforms, reinforcing enhanced advertiser‑targeting and engagement capabilities (CMCSA_10k_2024.pdf, page 6; CMCSA_10k_2024.pdf, page 8).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of CMCSA's advertising evolution from 2022-2024 and correctly identifies the core narrative: progression from basic offerings in 2022 to expanded integration in 2023 to further refinement in 2024. STRENGTHS: (1) Correctly identifies the consistent suite of 'technology, tools, data-driven services and marketplace solutions' across all three years; (2) Accurately captures the 2023 expansion including Sky-branded networks and third-party representation domestically and internationally; (3) Properly synthesizes multi-hop information across three years of filings; (4) Correctly notes the shift toward integrated, technology-enabled solutions; (5) Provides appropriate source citations. WEAKNESSES: (1) The LLM answer omits some specific enhancements mentioned in the ground truth, particularly the mention of 'cloud-based platforms' and 'integrated search functionality' that were highlighted as 2023 developments; (2) Does not explicitly reference 'cloud infrastructure' and 'data analytics capabilities' as strategic enablers mentioned in the ground truth; (3) The characterization of 2024 as 'the same suite...further refined' is slightly less precise than the ground truth's description of 'enhanced digital advertising tools and strengthened representation agreements'; (4) Missing explicit mention of the strategic shift toward cloud-based infrastructure. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: Successfully synthesizes information across three separate 10-K filings and correctly traces the evolution of offerings. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative accurately, though with less technical specificity regarding cloud platforms and search functionality. The omissions are contextual details rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 509,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "- In 2022 CVS held roughly $1.02 billion of commercial mortgage‑backed securities (CMBS) at fair value, with $155 million of unrealized losses (see 2022 column of the debt‑securities table)【page_147】.  \n- By year‑end 2023 the CMBS fair value had slipped to about $975 million and the unrealized loss position narrowed to $100 million (2023 column)【page_147】.  \n- In the 2024 filing the only CMBS reported are those supporting Separate Accounts, amounting to a mere $3 million of fair‑value assets (no material unrealized loss disclosed)【page_160】.  \n\nThe trend shows CVS sharply reducing its CMBS exposure – from a sizable $1 billion‑plus position with sizable losses in 2022‑23 to a negligible $3 million holding in 2024 – indicating a deliberate de‑risking of this asset class.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer contains substantially incorrect financial figures that directly contradict the ground truth across all three years:\n\n2022: LLM claims $1.02 billion in CMBS fair value with $155 million unrealized losses. Ground truth shows $574 million fair value with $12 million unrealized losses. The LLM's figures are nearly 2x too high for fair value and 13x too high for unrealized losses.\n\n2023: LLM claims $975 million fair value with $100 million unrealized losses. Ground truth shows $675 million fair value with $100 million unrealized losses. The fair value is off by $300 million (44% error), though unrealized losses match.\n\n2024: LLM claims $3 million in CMBS. Ground truth shows $6 million. While closer, still incorrect.\n\nMULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the CMBS data across the three-year period. The trend analysis conclusion (de-risking) is directionally correct but is based on fundamentally wrong numbers. The characterization of 2022-23 as having \"sizable $1 billion-plus position\" is factually incorrect.\n\nCALCULATION IMPACT: The magnitude of errors (especially 2022 and 2023) means the LLM's quantitative foundation is severely compromised. These are not minor rounding differences but substantial misstatements of the company's actual CMBS exposure.\n\nPARTIAL CREDIT: The LLM correctly identified (1) the asset class (CMBS), (2) the company (CVS), (3) the time period (2022-2024), (4) the general trend direction (reduction/de-risking), and (5) the relevant metrics (fair value and unrealized losses). However, the specific numerical values are predominantly wrong, which is critical for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 468,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Across Target’s 2022, 2023 and 2024 Form 10‑K filings, the compensation‑and‑benefits sections each state that team members receive “merchandise and other discounts” (2022 p. 6; 2023 p. 6; 2024 p. 6) but no specific dollar or percentage amount is disclosed. The unchanged, non‑quantified discount over three years indicates that the merchandise discount is treated as a stable, baseline perk rather than a variable or expanding benefit, reflecting a strategy of maintaining consistent non‑cash incentives to bolster total employee compensation and retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer demonstrates a fundamental misunderstanding of the question and provides an incomplete analysis. While the LLM correctly identifies that merchandise discounts are mentioned across all three years (2022, 2023, 2024) without specific dollar amounts disclosed, it fails to address the core question about how the scope and value evolved and what this suggests about employee benefit strategy. The LLM's conclusion that the discount remained 'unchanged' and 'stable' contradicts the ground truth, which documents a clear evolution in how Target framed and positioned employee benefits across these years. The ground truth shows: (1) 2022: merchandise discounts listed among core benefits with $15/hour minimum wage; (2) 2023: wage range expanded to $15-$24/hour with enhanced benefits package emphasizing financial wellness (401k matching, tuition reimbursement); (3) 2024: merchandise discounts within expanded ecosystem including mental health services and virtual healthcare. The LLM completely misses this multi-year progression and the strategic shift toward holistic employee well-being. The LLM's assertion that 'no specific dollar or percentage amount is disclosed' is accurate but irrelevant—the question asks about scope and value evolution in the broader benefits context, not absolute quantification. The LLM fails to synthesize the contextual changes in how benefits were presented and what complementary benefits were added alongside the consistent merchandise discount. The reasoning is overly narrow, focusing only on the discount itself rather than the broader employee benefit strategy evolution. The LLM does correctly identify the page numbers and years, which accounts for partial credit on quantitative accuracy, but the qualitative analysis is severely deficient.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 488,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "- In the 2022 Form 10‑K, Linde mentioned cultural issues only as one line‑item in a long list of integration risks – “cultural challenges associated with integrating employees from the acquired company into the existing organization” (2022 p. 12).  \n- The 2023 filing repeated the same bullet without change (2023 p. 12), but the 2024 filing added a separate paragraph that explicitly calls out “integration of operations across different cultures and languages” as a distinct risk, in addition to the original bullet (2024 p. 11; also reiterated in 2024 p. 12).  \n\nThis shift from a generic bullet to a stand‑alone cultural‑integration risk shows Linde is increasingly foregrounding cross‑border cultural issues, signalling a more proactive strategic focus on managing cultural integration to protect synergies and reduce the uncertainty of multinational acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES BETWEEN LLM AND GROUND TRUTH: The LLM answer fundamentally contradicts the ground truth on the evolution of Linde's cultural challenge messaging. Ground truth states: (1) 2022 - cultural challenges listed among several risks tied to employee integration and cross-border operations; (2) 2023 - EXPANDED discussion with broader regulatory/compliance context; (3) 2024 - SHARPER FOCUS on financial impact and synergy retention. LLM answer claims: (1) 2022 - mentioned as one line-item; (2) 2023 - REPEATED THE SAME BULLET WITHOUT CHANGE; (3) 2024 - ADDED A SEPARATE PARAGRAPH as a distinct risk. These are contradictory narratives about the evolution. Ground truth emphasizes DEEPENING STRATEGIC FRAMING (operational → regulatory context → financial outcomes), while LLM emphasizes STRUCTURAL CHANGES (bullet point → separate paragraph). The LLM's claim that 2023 'repeated the same bullet without change' directly contradicts ground truth's assertion that 2023 'expanded on these concerns.' QUANTITATIVE ACCURACY: Page numbers cited (2022 p. 12, 2023 p. 12, 2024 p. 11-12) cannot be verified against ground truth but appear plausible. However, the substantive characterization of what changed is incorrect. REASONING QUALITY: The LLM's conclusion about 'increasingly foregrounding cross-border cultural issues' is partially aligned with ground truth's conclusion about 'more proactive strategic focus,' but the evidence presented to support this conclusion is factually wrong. The LLM mischaracterizes the nature of the evolution (structural vs. substantive). COMPLETENESS: Both answers address the 2022-2024 timeframe and attempt to identify strategic implications, but they reach different conclusions about HOW the emphasis evolved. The ground truth's multi-hop synthesis (connecting cultural challenges → regulatory complexity → financial outcomes) is more sophisticated than the LLM's structural observation (bullet → paragraph). SEMANTIC EQUIVALENCE: The answers are NOT semantically equivalent - they describe fundamentally different evolutions in Linde's messaging.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 562,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – it was **$1,494 million in 2022** and dropped to **$491 million in 2024**, a net decline of about **$1.0 billion**【page_102】【page_99】.  The reduction signals that the company’s derivative positions (or the margin required to support them) have contracted and that its netting and margin practices are becoming more efficient, indicating tighter control of its overall derivative exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures (2022: $1,494 million and 2024: $491 million) and accurately calculates the net decline of approximately $1.0 billion. The answer demonstrates sound multi-hop reasoning by synthesizing collateral data across the three-year period and connecting it to derivative exposure management insights. However, there is a notable incompleteness: the LLM omits the intermediate 2023 figure ($800 million), which is explicitly mentioned in the ground truth and represents an important data point in the 'consistent decline' trend described in the original answer. The LLM's characterization of the trend as 'sharp' decline is reasonable and semantically equivalent to the ground truth's 'consistent decline,' though the omission of the 2023 data point weakens the completeness of the trend analysis. The reasoning about improved offsetting mechanisms and tighter derivative exposure control is sound and aligns with the ground truth's interpretation. The quantitative accuracy is strong (correct 2022 and 2024 figures, correct calculation), but the omission of the 2023 intermediate value prevents a perfect score. The qualitative reasoning about derivative exposure management is appropriate and well-articulated, though it could have been strengthened by referencing all three years of data to demonstrate the consistent nature of the decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 387,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings Broadcom kept the Security Insights Platform positioned as a mainframe‑focused security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with the output “available for use with in‑house tools for security information and event management.” The description of its remediation process and internal‑tool integration remained essentially unchanged, but by 2024 the platform was more explicitly grouped within Broadcom’s broader Enterprise Security and integrated cyber‑defense portfolio, signalling tighter alignment with the company’s overall cybersecurity strategy while still not adding explicit support for external third‑party tools.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes information across the 2022-2024 period. STRENGTHS: (1) Accurately captures the core platform description with correct quotes about interpreting/assessing mainframe security posture and developing remediation steps; (2) Correctly identifies the SIEM integration capability as unchanged across years; (3) Properly notes the 2024 shift toward broader portfolio integration within Enterprise Security; (4) Correctly identifies the company as Broadcom (AVGO); (5) Accurately reflects that external third-party tool support was not explicitly added. MINOR WEAKNESSES: (1) The LLM answer emphasizes that the description 'remained essentially unchanged' regarding remediation and integration, which is accurate but slightly downplays the evolution narrative present in the ground truth - the ground truth emphasizes a shift from 'standalone risk assessment tool toward a more integrated and strategically aligned component'; (2) The ground truth mentions explicit 2023 positioning tied to 'broader cybersecurity portfolio' and 'modern security practices,' while the LLM focuses primarily on the 2024 grouping within Enterprise Security, missing some of the 2023 intermediate evolution; (3) The ground truth mentions 'Cybersecurity, AIOps, and DevOps' as part of the expanded suite context in 2024, which the LLM doesn't explicitly reference, though it does mention 'integrated cyber-defense portfolio.' MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the key evolution pattern (from standalone to integrated), though it frames this slightly differently than the ground truth. The reasoning is sound and the synthesis is accurate. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically equivalent to the ground truth, just with slightly different emphasis - both convey that the platform maintained core functionality while becoming more strategically integrated over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 543,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "Simon Property Group’s Unsecured Notes – 32B carried a $750 million face amount and a 3.38 % fixed rate in the 2022 filing [page 49], the same $750 million and 3.38 % rate were reported in the 2023 filing [page 50], and again in the 2024 filing [page 51]. The unchanged, low‑cost, long‑dated exposure shows the company is deliberately preserving stable, fixed‑rate debt and limiting interest‑rate risk as part of its long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: face amount of $750 million, interest rate of 3.38%, and the consistent presence across 2022-2024 filings. The multi-hop synthesis is sound—the model correctly tracked the same debt instrument across three fiscal years and identified the pattern of stability. The reasoning about SPG's debt management strategy is logically sound and well-supported by the evidence presented. The answer correctly interprets the unchanged terms as indicating a deliberate strategy to maintain stable, fixed-rate debt and limit interest-rate risk. Minor differences from the ground truth are purely stylistic: the LLM uses 'Simon Property Group' (full name) vs. 'SPG' (ticker), includes page references (which add helpful specificity), and phrases the strategic interpretation slightly differently ('deliberately preserving' vs. 'chosen to maintain'). These are semantic equivalences that enhance rather than detract from the answer. The LLM successfully addresses all parts of the multi-part question: (1) how face value evolved (unchanged), (2) how interest rate exposure evolved (unchanged), and (3) what this reveals about debt management strategy (stable, fixed-rate approach with interest-rate risk mitigation). No calculation errors, no factual inaccuracies, and appropriate contextual framing of the findings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 388,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "Comcast’s 2022‑2024 10‑K filings repeatedly flag Lumen as a wireline rival that is “building and continuing to build fiber‑based network infrastructure … further into their networks, which enables them to provide data‑transmission speeds that exceed … DSL technology” and that “are offering services with these higher speeds in many of our service areas” while also using “bundled services to compete with our broadband services”【page_8】. Across the three years the language is unchanged, indicating that Lumen’s fiber‑to‑the‑premises rollout and its bundling of broadband with other offerings have persisted and remain a steady, if growing, competitive pressure on Comcast’s residential broadband business【page_9】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Lumen as a key competitor to CMCSA (Comcast) and accurate characterization of Lumen's competitive strategies (fiber expansion, bundled services, higher speeds vs. DSL). The answer correctly synthesizes information across the 2022-2024 period and accurately quotes/paraphrases the language from Comcast's 10-K filings regarding Lumen's fiber-to-the-premises deployment and service bundling. Quantitative accuracy is high - no numbers, dates, or metrics are presented, so no calculation errors exist. The multi-hop reasoning is sound: the answer correctly connects Lumen's fiber infrastructure expansion with its competitive impact on CMCSA's broadband services across three years. However, there is a minor weakness in the qualitative assessment: the LLM states 'the language is unchanged' across the three years, which somewhat contradicts the ground truth's characterization of 'escalation in competitive pressure' and 'possibly intensifying' threat. The ground truth suggests evolution/intensification over time, while the LLM emphasizes consistency/steadiness. This is a semantic nuance rather than a factual error - both interpretations are defensible from the same source material, but the ground truth's framing of escalation is slightly more precise to the actual filing language evolution. The answer appropriately addresses all parts of the multi-part question (fiber network expansion, service bundling, evolution from 2022-2024) and maintains strong contextual relevance to the specific question about competitive threat evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 445,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded‑payment‑card usage slipped each year – total RedCard (now Target Circle Card) penetration was 20.5 % in fiscal 2022, 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024【page_27】. The steady decline signals that, although the program still drives a sizable share of transactions, its incremental impact is waning, suggesting the loyalty‑driven payment strategy is becoming less effective over time【page_29】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2024 PENETRATION RATE: The LLM states 18.6% for fiscal 2024, but the ground truth shows 17.8%. This is a material discrepancy of 0.8 percentage points that directly contradicts the factual basis of the answer. CORRECT ELEMENTS: (1) Fiscal 2022 rate of 20.5% is accurate; (2) Fiscal 2023 rate of 19.8% is accurate; (3) The identification of the product as RedCard/Target Circle Card is appropriate contextual information; (4) The overall trend characterization (steady decline) is correct; (5) The reasoning about waning effectiveness is sound and matches the ground truth interpretation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year trend and draws appropriate conclusions about the loyalty strategy's declining effectiveness. The logic connecting declining penetration rates to reduced strategy effectiveness is sound. QUANTITATIVE ACCURACY ISSUE: The 18.6% figure for 2024 is factually incorrect. This is not a formatting variation or rounding difference—it's a specific numerical error that undermines the precision of the answer. The year-over-year decline calculation would also be affected (should be 2.0 percentage points from 2023 to 2024, not 1.2 percentage points). QUALITATIVE STRENGTHS: The answer appropriately contextualizes the data, acknowledges that the program still drives significant transaction share, and correctly interprets the trend as indicating reduced effectiveness. The reasoning is logical and well-articulated. OVERALL ASSESSMENT: While the answer demonstrates good understanding of the question and sound reasoning, the incorrect 2024 figure is a significant factual error that prevents a higher score. The answer is partially correct but contains a material numerical inaccuracy that would be problematic in financial analysis contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 493,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "In 2022 Chevron broadened its Congo footprint by extending deep‑water licences, which added roughly 36 million barrels of oil‑equivalent to its African reserve base and left it holding non‑operated working interests—including a 31.5 % stake in the offshore Haute Mer permit and a 15.75 % stake in the Lianzi area. In 2023 the company kept those assets active, investing about $0.7 billion in offshore development and natural‑gas projects in the Republic of Congo and counting Congo production in its overall output. By 2024, although Congo still supplied about 20 % of Chevron’s net oil‑equivalent production, the firm announced it would sell its Haute Mer and Lianzi interests (effective January 2025), marking a shift from expansion to divestiture in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Chevron's Congo engagement evolution from 2022-2024. STRENGTHS: (1) All key numeric values are correct: 31.5% stake in Haute Mer, 15.75% in Lianzi, $0.7 billion investment in 2023, 20% of net oil-equivalent production in 2024, and 36 million barrels of oil-equivalent added to reserve base. (2) Timeline is accurate: 2022 expansion phase, 2023 active investment, 2024 divestiture announcement with January 2025 effective date. (3) Multi-hop synthesis is sound: correctly connects asset ownership details across years, investment levels, and strategic positioning shift. (4) Entities correctly identified: Republic of Congo, Haute Mer permit, Lianzi area, offshore development. (5) The answer captures the core narrative arc from expansion to divestiture, matching the ground truth's characterization of portfolio realignment. MINOR CONSIDERATIONS: (1) The LLM provides additional context not in the ground truth (36 million barrels added, 20% production contribution, January 2025 effective date) which adds value and demonstrates deeper knowledge without contradicting the original answer. (2) The phrasing 'announced it would sell' vs. 'sold' is semantically equivalent given the January 2025 effective date mentioned. (3) The answer is more detailed and narrative-driven than the ground truth while maintaining complete factual accuracy. No calculation errors detected. All percentages, dollar amounts, and dates align with ground truth information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 422,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "From 2022 to 2024 NEE’s gas‑option exposure fell dramatically—from $356 million of assets and $347 million of liabilities in 2022 (implied volatilities ≈ 17 %/295 %, weighted‑average ≈ 36 %)【page_85】to roughly $100 million on each side in 2023 (≈ 20 %/233 %, weighted‑average ≈ 50 %)【page_84】and a slight net liability of $102 million versus $100 million in 2024 (≈ 15 %/150 %, weighted‑average ≈ 52 %)【page_86】. The sharp cut in gross fair‑value exposure and the decline in the extreme liability‑side volatility, together with a higher overall implied‑volatility profile, indicate the company has trimmed its gas‑option positions while retaining a more targeted, volatility‑sensitive hedge, reflecting a tighter but still market‑exposed risk posture in the gas market.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core trajectory of NextEra Energy's gas-option exposure from 2022-2024 and accurately reports the key financial figures: $356M assets/$347M liabilities in 2022, ~$100M on each side in 2023, and $100M assets/$102M liabilities in 2024. The implied volatility progression (36% → 50% → 52%) is also correct. The multi-hop synthesis across three years is sound, and the interpretation about strategic de-risking and market positioning is appropriate and well-reasoned. However, there are notable issues with the volatility data presentation: the LLM includes specific percentage ranges (17%/295%, 20%/233%, 15%/150%) that appear to reference individual volatility components rather than the stated weighted averages, creating potential confusion. The ground truth simply states 'implied volatilities averaging 36%/50%/52%' without these component breakdowns. While the weighted-average figures match the ground truth, the additional component percentages are unexplained and may represent individual option volatilities rather than summary metrics, introducing ambiguity. The qualitative analysis is strong—correctly identifying the 'sharp reduction' from 2022-2023, stabilization thereafter, and the shift toward 'targeted, volatility-sensitive hedge'—but the presentation of volatility data could mislead readers about what these percentages represent. The answer demonstrates solid multi-hop reasoning and entity accuracy (correct company, years, metrics) but loses points for the potentially confusing volatility component presentation that isn't clearly explained or reconciled with the ground truth's simpler averaging approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 456,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "In Nike’s 2022 Form 10‑K, FlyEase is mentioned as one of a suite of new technologies (“Nike Air, Zoom, Free, Dri‑FIT, Flyknit, **FlyEase**, ZoomX, Air Max, and React”) that illustrate the company’s dedication to innovation (2022 10‑K p. 6). By the 2024 Form 10‑K, FlyEase appears again in the same list of flagship technologies, showing it has moved from a newly‑highlighted innovation to an established, ongoing part of Nike’s product‑development platform (2024 10‑K p. 6). This continuity signals that FlyEase is now a core element of Nike’s broader innovation strategy, reinforcing its role in driving differentiated, inclusive product design.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate information about FlyEase appearing in Nike's 2022 and 2024 10-K filings as part of a suite of technologies, with correct page references (p. 6). However, there are significant gaps in addressing the full scope of the original question. The ground truth indicates a three-year progression (2022→2023→2024) with distinct evolutionary stages: (1) initial introduction in 2022, (2) expansion and scaling in 2023, and (3) full embedding as a core technology in 2024. The LLM answer only addresses 2022 and 2024, completely omitting the 2023 intermediate stage where FlyEase's presence expanded and was emphasized in various product categories. This represents a critical gap in the multi-hop synthesis required by the question. The LLM correctly identifies that FlyEase moved from 'newly-highlighted' to 'established,' but this binary characterization misses the nuanced three-stage progression documented in the ground truth. The LLM's conclusion about FlyEase becoming 'a core element' is directionally correct but lacks the detailed evidence of how this evolution occurred through 2023. The answer demonstrates partial understanding of the innovation strategy implications but fails to fully synthesize the temporal progression across all three years. Quantitative accuracy is solid (correct years, page numbers), but qualitative accuracy suffers from incomplete multi-hop reasoning and missing the 2023 expansion phase that is central to understanding the progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 414,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "SPG’s Unsecured Notes – 35A showed no change over the three‑year span – it carried a $750 000 face amount, a 2.65 % coupon, $19 875 of annual debt service and a July 15, 2030 maturity in 2022, 2023 and again in 2024【page_50】【page_50】【page_51】.  The unchanged terms indicate a deliberate long‑term debt strategy that relies on a stable, low‑cost, long‑dated unsecured note to lock in favorable rates and preserve financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All numerical values are correct - $750,000 face amount, 2.65% interest rate, $19,875 annual debt service, and 07/15/30 maturity date are all accurately stated and consistent across the three-year period (2022-2024). Number formatting variations ($750,000 vs $750 000) are acceptable and do not affect accuracy. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the obligations evolved (showing no change), and (2) what this reveals about debt strategy (stable, low-cost approach). ENTITY ACCURACY: SPG is correctly identified, the specific debt instrument (Unsecured Notes - 35A) is properly named, and all three fiscal years are correctly referenced. MULTI-HOP REASONING: The synthesis is sound - the model correctly identified that consistency across three years indicates a deliberate strategy, and appropriately characterized this as avoiding refinancing/restructuring. The interpretation that unchanged terms reflect a 'stable, low-cost, long-dated' strategy is logically sound and semantically equivalent to the ground truth's characterization of 'steady approach' and 'stable long-term commitment.' MINOR CONSIDERATIONS: The LLM's interpretation adds slightly more strategic context ('lock in favorable rates and preserve financing flexibility') compared to the ground truth's more neutral description, but this represents reasonable inference rather than factual error. The citation references (page_50, page_51) suggest proper source documentation. Overall, the answer is factually correct, complete, well-reasoned, and appropriately addresses the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 473,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments repeatedly stressed that its business model is built around “analog and embedded‑processing products,” noting that this focus generates strong cash‑flow from operations and underpins growth in its industrial and automotive markets (TXN_10k_2022.pdf page 19; TXN_10k_2023.pdf page 19; TXN_10k_2024.pdf page 19). By keeping embedded processing as a core, high‑margin pillar in every MD&A, TI signals a long‑term strategy aimed at continuously expanding free‑cash‑flow‑per‑share – the metric it uses to gauge shareholder value (TXN_10k_2022.pdf page 18; TXN_10k_2023.pdf page 18; TXN_10k_2024.pdf page 18).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about TI's strategic evolution across three years. STRENGTHS: (1) Correctly identifies the consistent emphasis on 'analog and embedded-processing products' across 2022-2024; (2) Accurately notes the connection to free cash flow per share as the key metric for shareholder value; (3) Properly synthesizes information across multiple 10-K filings; (4) Correctly identifies industrial and automotive markets as growth drivers; (5) Appropriately cites specific page numbers from source documents (pages 18-19 across all three years); (6) Captures the strategic intent of maintaining embedded processing as a 'core, high-margin pillar.' MINOR WEAKNESSES: (1) The LLM answer emphasizes 'cash flow from operations' while the ground truth emphasizes 'free cash flow per share' more directly - though both are related and the LLM does mention free-cash-flow-per-share; (2) The ground truth provides slightly more nuanced language about TI viewing embedded processing as 'stable, high-margin, and scalable' and its role in 'capital allocation,' which the LLM touches on but doesn't fully elaborate; (3) The ground truth mentions the 'four competitive advantages' framework from 2022, which the LLM doesn't explicitly reference. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The years (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple documents, correctly linking the strategic emphasis to the ultimate objective of maximizing free cash flow per share. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth - that TI consistently positioned embedded processing as central to its business model and long-term growth strategy focused on free cash flow per share.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 542,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "- In the 2022 Form 10‑K Disney reported Marvel trademarks as part of its “indefinite‑lived intangible assets” (ESPN, Pixar and Marvel trademarks) 【page_110】, showing the brand was already recognized as a high‑value, non‑amortizable asset.  \n- By the 2023 filing Disney was actively leveraging that brand on its streaming service, describing Disney+ as featuring “Disney, Pixar, Marvel, Star Wars and National Geographic” as top‑level selections or “tiles” in the Disney+ interface 【page_7】, which made Marvel a prominent driver of subscriber acquisition.  \n- The 2024 Form 10‑K again lists Marvel among the indefinite‑lived intangible assets 【page_114】, indicating the company continues to treat Marvel as a core IP that fuels Disney+ growth and reflects a financial strategy that monetizes marquee franchises to boost DTC subscriber numbers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about Marvel's strategic evolution across 2022-2024. STRENGTHS: (1) Correctly identifies Marvel as an indefinite-lived intangible asset in 2022, 2023, and 2024 across all three years; (2) Accurately describes the 2023 transition to top-level 'tiles' in Disney+ interface alongside Disney, Pixar, Star Wars, and National Geographic; (3) Properly characterizes the strategic shift from passive asset recognition to active brand utilization; (4) Correctly identifies the financial strategy of monetizing marquee franchises for DTC subscriber growth; (5) Provides appropriate page citations (110, 7, 114) that support the claims. MINOR GAPS: (1) The LLM answer does not mention the specific Disney+ subscriber count of 123 million as of September 28, 2024, which was included in the ground truth and provides concrete evidence of the strategy's impact; (2) Does not reference the ESPN+ tile launch plan for early fiscal 2025, which the ground truth mentions as part of the broader branded content strategy; (3) Does not explicitly discuss the 'retention and growth' impact or the justification for continued asset valuation as thoroughly as the ground truth. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the asset classification to strategic platform implementation to financial strategy. The logic flow is sound and demonstrates understanding of how accounting treatment relates to operational strategy. SEMANTIC EQUIVALENCE: The answer conveys the core message effectively, though with slightly less comprehensive detail than the ground truth regarding specific metrics and forward-looking strategy elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 511,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has consistently covered roughly three‑fifths of the closed block – 59.25 % in 2022 (page 214), about 59 % in 2023 (page 227) and again 59 % in 2024 (page 204).  The reinsurance recoverable balances tied to that arrangement have risen sharply, from $6.1 billion of net ceded recoverables in 2022 (page 227) to $16.7 billion in 2023 (page 227) and $17.6 billion in 2024 (page 204), while the deposit‑account assets fell from $5.1 billion to $4.6 billion and the related deposit liabilities from $1.3 billion to $1.2 billion (page 206).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) PERCENTAGE ACCURACY: The percentages (59.25% in 2022, 59% in 2023, 59% in 2024) are correctly stated in the LLM answer and match the ground truth. This is the only correct quantitative element. (2) REINSURANCE RECOVERABLE BALANCES - CRITICAL ERROR: The ground truth clearly states unsecured reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). The LLM answer reports dramatically different figures: $6.1B (2022), $16.7B (2023), and $17.6B (2024). These numbers are completely wrong and represent a 2-4x overstatement of the actual balances. This is a fundamental factual error that undermines the entire answer. (3) ADDITIONAL INCORRECT INFORMATION: The LLM introduces information about deposit-account assets ($5.1B to $4.6B) and deposit liabilities ($1.3B to $1.2B) that are not mentioned in the ground truth answer and appear to be either fabricated or from a different context entirely. (4) MULTI-HOP REASONING: While the LLM correctly identifies the percentage trend (stable at ~59%), it fails catastrophically on the core metric of reinsurance recoverable balances, which is explicitly requested in the question. The answer does not accurately synthesize the evolution of these balances across the three-year period. (5) SEMANTIC INTERPRETATION: The LLM's characterization of balances as 'rising sharply' is contradicted by the ground truth, which shows relatively stable balances with minor fluctuations ($3.6B → $4.4B → $4.2B). The LLM's narrative is fundamentally misleading. The answer demonstrates a critical failure in quantitative accuracy on the primary metric being evaluated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 477,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) rose modestly from a gross amortized cost of $845 million (fair‑value $757 million) in 2022 to $862 million (fair‑value $810 million) in 2023【page_147】, but the fair‑value of RMBS reported in its Separate Accounts fell sharply to $71 million in 2024 (up from $51 million in 2023)【page_160】—a dramatic contraction compared with the prior year’s corporate holdings. This three‑year trend suggests CVS is deliberately scaling back RMBS exposure, lowering its interest‑rate and credit‑risk sensitivity and repositioning capital toward other fixed‑income assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth clearly states RMBS values of $629M (2022), $614M (2023), and $71M (2024). The LLM reports $845M gross amortized cost and $757M fair value for 2022, $862M and $810M for 2023, and $71M for 2024. These numbers are substantially different from the ground truth figures for 2022-2023, suggesting the LLM may have confused different asset categories or reporting lines. The 2024 figure of $71M matches ground truth, but the prior years are incorrect. (2) UNREALIZED LOSSES OMISSION: The ground truth specifically mentions unrealized losses rising from $10M (2022) to $60M (2023), which is critical context for understanding risk exposure. The LLM completely omits this important metric. (3) MULTI-HOP SYNTHESIS ISSUE: The LLM appears to have mixed data from different reporting sections (possibly confusing 'Separate Accounts' RMBS with consolidated RMBS holdings), creating confusion about which figures represent the actual corporate RMBS portfolio. The reference to 'Separate Accounts' in 2024 ($71M up from $51M in 2023) contradicts the ground truth narrative of a sharp decline from $614M to $71M. (4) REASONING QUALITY: While the LLM correctly identifies a de-risking strategy and reallocation, this conclusion is based on partially incorrect data. The narrative about 'dramatic contraction compared with prior year's corporate holdings' is confusing and doesn't clearly track the actual 3-year trend. (5) SEMANTIC ISSUES: The LLM's framing of 'modest' increases in 2022-2023 contradicts the ground truth's characterization of 'relatively high exposure' during that period. The answer demonstrates partial understanding of the strategic pivot but fails on fundamental numerical accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 513,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance transaction has stayed essentially the same: the 2022 filing disclosed that an unaffiliated reinsurer covered **about 59.25 % of the closed block** (page 214), while the 2023‑2024 filings report a **roughly 59 % coverage** (pages 204 & 227). In all years the arrangement is **accounted for under the deposit method**, with the deposit liability offset against the corresponding deposit recoverable (page 204; also noted in the balance‑sheet discussion on page 206).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% for 2022 and 59% for 2023-2024 match the ground truth exactly. The numbers are presented with appropriate precision and format variations. (2) ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement with an unaffiliated third-party reinsurer is properly characterized, and the closed block is correctly referenced. All three years (2022, 2023, 2024) are properly addressed. (3) ACCOUNTING TREATMENT: The deposit method accounting is correctly identified, and the offset mechanism (deposit liability offset against deposit recoverable) is accurately described. (4) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years, showing the evolution from 59.25% to 59% while demonstrating consistency in accounting treatment. The reasoning that this represents a 'stable strategic and accounting approach' is logically sound and supported by the data. (5) COMPLETENESS: The answer addresses all parts of the question - the percentage evolution, the accounting treatment consistency, and the overall stability of the arrangement. (6) MINOR CONSIDERATIONS: The LLM uses page references (214, 204, 227, 206) which adds credibility but cannot be verified in this evaluation context. The phrasing 'about 59.25%' and 'roughly 59%' appropriately reflects the precision of the original disclosures. The answer is semantically equivalent to the ground truth while using slightly different wording ('stayed essentially the same' vs 'remained unchanged'), which is acceptable and actually enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 459,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra’s net fair‑value position in gas forward contracts rose from a $160 million net asset in 2022 (assets $191 m vs. liabilities $31 m) to roughly $300 million in 2023 (assets $377 m vs. liabilities $77 m) and then eased to about $250 million in 2024 (assets $296 m vs. liabilities $46 m)【page_86】【page_84】【page_86】. The jump through 2023 shows the company built a larger net‑long hedge on natural‑gas prices, while the modest pull‑back in 2024 indicates a rebalancing but still a sizable long exposure, reflecting an ongoing focus on managing gas‑price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - 2022: $160M net ($191M assets - $31M liabilities), 2023: $300M net ($377M assets - $77M liabilities), 2024: $250M net ($296M assets - $46M liabilities). All calculations are accurate. COMPLETENESS: The answer addresses the full evolution from 2022-2024 and provides interpretation of the trend. ENTITY ACCURACY: NextEra Energy correctly identified, years correct, metrics properly labeled as 'net fair-value position in gas forward contracts.' REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the 2023 peak as a 'larger net-long hedge' and the 2024 pullback as 'rebalancing.' The interpretation that this reflects 'managing gas-price risk' aligns with the ground truth's characterization of 'more cautious stance or rebalancing.' SEMANTIC EQUIVALENCE: The LLM's phrasing 'net-long hedge' and 'rebalancing but still a sizable long exposure' conveys essentially the same meaning as the ground truth's 'reduction in net exposure' and 'more cautious stance.' The LLM provides slightly more nuanced interpretation by explicitly noting the 'long exposure' positioning. MINOR DIFFERENCES: The LLM uses 'roughly' and 'about' for the 2023 and 2024 figures, which is appropriate given the context of trend analysis. The ground truth uses 'decreased' while LLM uses 'rose...then eased,' which are semantically equivalent descriptions of the same directional movements. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 426,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings Broadcom consistently placed industrial fiber optics as a core line‑item of its industrial segment, stressing that it serves a wide‑ranging set of markets—including factory automation, renewable‑energy and power‑generation systems, medical equipment, defense/aerospace and vehicle subsystems such as EV power‑train, infotainment and ADAS. In each year the company explicitly grouped industrial fiber optics with motion‑encoders, LEDs and Ethernet ICs, underscoring an integrated portfolio where fiber‑optic links complement motion‑control and Ethernet connectivity for those diverse applications, with little change in positioning over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth, particularly regarding the evolution of AVGO's positioning from 2022 to 2024. CRITICAL ERRORS: (1) The LLM claims 'little change in positioning over the period,' which directly contradicts the ground truth that shows a clear strategic evolution from standalone components (2022) to integrated solutions (2023) to networked/vision-based systems (2024). (2) The LLM states that 'in each year the company explicitly grouped industrial fiber optics with motion-encoders, LEDs and Ethernet ICs,' but the ground truth shows this grouping was specific to 2022, with different groupings in 2023 (sensors, encoders, microcontrollers) and 2024 (Ethernet PHYs, switch ICs, camera microcontrollers). (3) The LLM misses the key evolution: 2023 emphasized 'more integrated industrial solutions' and 2024 showed 'deeper integration into networked and vision-based industrial systems.' CORRECT ELEMENTS: The LLM correctly identifies AVGO/Broadcom, the three-year period (2022-2024), and accurately lists many application areas (factory automation, renewable energy, medical, defense, automotive). The company name variation (AVGO vs Broadcom) is acceptable. MULTI-HOP REASONING FAILURE: The question specifically asks about evolution 'from 2022 to 2024,' requiring synthesis of changes across years. The LLM failed to identify the strategic trajectory and instead claimed consistency where the ground truth shows clear progression. This is a fundamental failure in multi-hop reasoning and understanding the temporal dimension of the question. The answer reads as a static description rather than an analysis of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 461,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock has been unchanged from FY 2022 through FY 2024 – Sojitz America remains the sole holder of the $0.3 million of $1‑par preferred shares, which carry a cumulative dividend of $0.10 per share payable each May 31, and no common‑stock dividends can be declared until that dividend is paid in full【page_79†L1-L7】. The company’s articles of incorporation prohibit any additional preferred‑stock issuances, and the filings state that there have been no changes to the preferred‑stock terms, voting rights or redemption features in any of the three years, indicating a stable capital‑structure relationship【page_79†L8-L14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $0.3 million par value, $0.10 per share annual dividend, $1 par value per share, and May 31 payment date are all accurate and match the ground truth. No calculation errors present. ENTITY ACCURACY: Nike, Sojitz America, and the redeemable preferred stock are correctly identified. Fiscal years 2022-2024 are properly referenced. COMPLETENESS: The answer addresses all key aspects of the question: (1) structural stability across the three-year period, (2) dividend obligations ($0.10 per share annually), (3) stock structure stability ($0.3 million par value unchanged), and (4) the priority of preferred dividends before common stock dividends. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple years and documents, establishing the consistent nature of the relationship and the lack of changes in terms, voting rights, or redemption features. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer provides additional contextual details (May 31 payment date, $1 par value per share, prohibition on additional preferred stock issuances) that enhance understanding but are not explicitly mentioned in the ground truth summary. The LLM also notes that Sojitz America has not sought redemption, which aligns with the ground truth's mention of this point. The answer uses slightly different phrasing (\"cumulative dividend\" vs \"dividend obligation\") but conveys identical meaning. REASONING QUALITY: The logic is sound - the answer correctly identifies the stable nature of the relationship and the consistent financial priority given to preferred shareholders. The citation format suggests proper source documentation. No factual errors or contradictions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 489,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "Across the three most recent filings the terms of the Unsecured Notes – 31B did not change. In the 2022 10‑K the note carried a 3.25 % coupon, a $750 million face amount (shown as $750,000 k), $24.4 million of annual debt service and a maturity of 30 Nov 2026【page_50】; the 2023 filing reports the same 3.25 % rate, $750,000 k face amount, $24,375 k annual service and 11/30/26 maturity【page_50】; and the 2024 filing again shows a 3.25 % rate, $750,000 k face amount, $24,375 k annual service and a 11/30/26 maturity【page_51】.  \n\nThis unchanged profile indicates that SPG is using the 31B note as a stable, long‑term financing tool, locking in low‑cost fixed‑rate funding and maintaining a consistent capital‑structure strategy rather than repeatedly refinancing or altering the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All key numbers are correct - the face amount of $750,000k ($750 million) is consistent across all three years (2022, 2023, 2024); the interest rate of 3.25% is accurate; the maturity date of November 30, 2026 (11/30/26) is correct. The annual debt service figures are provided ($24.4 million in 2022, $24,375k in 2023 and 2024), which are reasonable given the principal and coupon rate. The LLM correctly notes the format variation ($750,000k = $750 million). COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) how the debt evolved (remained unchanged), (2) the specific terms across all three years, and (3) what this indicates about SPG's financing strategy. ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the specific instrument (Unsecured Notes - 31B) is correctly referenced, and all three fiscal years (2022, 2023, 2024) are properly covered. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that despite broader portfolio changes (mentioned in ground truth regarding retirement of certain notes and issuance of new instruments like 41A in 2024), this specific obligation remained stable. The conclusion about SPG's strategy (using it as a stable, long-term financing tool with locked-in low-cost fixed-rate funding) is logically sound and matches the ground truth interpretation. MINOR DIFFERENCES: The LLM provides slightly more granular detail (annual debt service amounts) than the ground truth, which is additive rather than contradictory. The wording differs but conveys the same semantic meaning - both emphasize consistency and strategic stability. The LLM's interpretation of the financing strategy is equivalent to the ground truth's assessment of 'consistent long-term financing approach' and 'preserved structure without refinancing.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 518,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The U.S. defined‑contribution plans held TI stock worth $940 million in 2022 (6 million shares) → $873 million in 2023 (5 million shares) → $852 million in 2024 (5 million shares)【TXN_10k_2023 p.44】【TXN_10k_2024 p.44】. Over the three‑year period the total value fell as the number of shares held dropped and the share price slipped slightly in 2024, indicating that while the stock’s market price has been relatively stable, employees are reducing their exposure to TI stock in retirement plans, likely favoring greater diversification.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct dollar values ($940M in 2022, $873M in 2023, $852M in 2024) and share counts (6 million shares in 2022, 5 million shares in 2023 and 2024). The multi-hop synthesis across years is sound, and the document citations are appropriate. The reasoning about employee behavior (reducing exposure, favoring diversification) is logical and well-supported. However, there are minor differences from the ground truth: (1) The LLM emphasizes 'share price slipped slightly in 2024' and 'market price has been relatively stable,' which adds interpretation not explicitly stated in the ground truth. The ground truth mentions 'potential market valuation shifts' more neutrally. (2) The LLM's explanation focuses primarily on employee behavior (diversification preference) while the ground truth presents multiple possible explanations including 'strategic reduction,' 'freeze on new contributions since 2016,' or 'combination of both.' The LLM doesn't mention the contribution freeze detail, which is a contextual element from the original answer. (3) The LLM's phrasing 'share price slipped slightly in 2024' could be misleading—the decline appears driven more by share count reduction (6M to 5M) than price movement. The quantitative data is accurate, but the qualitative interpretation is slightly narrower than the ground truth's more comprehensive explanation of possible causes. Overall, the answer is substantially correct with strong numerical accuracy but misses some nuance in explaining the underlying drivers of the decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 435,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "In 2022 Disney reported roughly 220,000 employees—about 166,000 in the United States and 54,000 outside the U.S.—with seasonal workers accounting for ≈ 7 % of the workforce and a large share covered by collective‑bargaining agreements and non‑U.S. staff represented by works councils, trade unions or other employee associations【page_5】. By September 2024 the headcount had risen to about 233,000 employees—≈ 171,000 U.S. and 62,000 international—with seasonal employees now about 8 % of the total, while the same pattern of collective‑bargaining coverage and international employee‑association representation persisted【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Disney's workforce evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022 total of 220,000 (166,000 U.S., 54,000 international), 2024 total of 233,000 (171,000 U.S., 62,000 international), seasonal percentages of 7% (2022) and 8% (2024). The calculations are accurate: U.S. growth of 5,000 employees, international growth of 8,000 employees, total growth of 13,000 employees. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple dimensions - temporal (2022 vs 2024), geographic (U.S. vs international), workforce composition (seasonal vs permanent), and labor relations (collective bargaining agreements and employee associations). COMPLETENESS: All parts of the question are addressed: total employees, U.S. vs international distribution, seasonal workforce percentages, and employee association representation. The answer correctly notes the persistence of collective bargaining agreements and international employee association representation throughout the period. MINOR OBSERVATIONS: The LLM uses approximate language ('roughly,' '≈') which is appropriate given the context of workforce reporting. The inclusion of page references adds credibility. The semantic equivalence is maintained throughout - the answer conveys the same information as the ground truth while using slightly different phrasing (e.g., 'outside the U.S.' vs 'internationally'). The only minor point is that the answer could have been slightly more explicit about the 'growing reliance on temporary staffing' aspect mentioned in the ground truth, though the data presentation implicitly conveys this trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 478,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "Both the 2022 and 2023 10‑K disclosures state that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 p. 49; 2023 p. 49‑50). The 2024 filing repeats the same language, again excluding goodwill impairments and non‑economic accounting changes from ROIC (2024 p. 47‑49). This unchanged treatment shows GD consistently strips out non‑operational accounting items to keep ROIC focused on the core operating return of its capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC across all three years (2022, 2023, 2024), matching the ground truth; (2) Accurately cites the specific language from filings ('ROIC excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance'); (3) Properly references page numbers (2022 p. 49; 2023 p. 49-50; 2024 p. 47-49) showing multi-hop synthesis across three years of filings; (4) Correctly interprets the consistency as indicating a stable performance evaluation framework; (5) Accurately characterizes the approach as focusing on core operating return unimpacted by accounting volatility. Minor considerations: (1) The LLM answer uses slightly different phrasing than the ground truth ('strips out non-operational accounting items' vs. 'excluded non-economic accounting changes'), but this is semantically equivalent and actually adds clarity; (2) The answer could have been marginally more explicit about what this consistency 'reveals' about the company's philosophy, though the interpretation provided ('focused on core operating return') is sound and matches the ground truth's characterization. The multi-hop reasoning is sound—the model correctly synthesized information across three separate 10-K filings to demonstrate consistency over time. No numerical errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 409,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "- In the 2022 Form 10‑K Linde simply described rare gases (krypton, neon, xenon) as part of its “atmospheric gases” portfolio – co‑products of its air‑separation plants (see 2022 10‑K p. 94).  \n- By the 2024 filing the company stresses that it is the market‑leader in non‑cryogenic air‑separation technology and is actively developing proprietary, patented processes and applications to produce, store and expand the use of rare gases (see 2024 10‑K p. 4).  \n\nThis evolution from a basic co‑product description to a technology‑driven, innovation‑focused rare‑gas strategy shows Linde is leveraging its advanced separation technology and patents to create differentiated, higher‑margin offerings, reinforcing a durable competitive advantage in the industrial‑gases market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Linde's rare gas strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the three specific rare gases (krypton, neon, xenon) mentioned in both filings; (2) Accurately captures the 2022 positioning as co-products of air-separation plants; (3) Correctly identifies the 2024 evolution toward market leadership in non-cryogenic air-separation technology; (4) Properly synthesizes the strategic shift from basic co-product description to technology-driven innovation; (5) Appropriately cites specific page references (2022 10-K p. 94, 2024 10-K p. 4) showing document verification; (6) Correctly interprets the competitive advantage implications (higher-margin offerings, durable competitive advantage). MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 filing, which the ground truth references as reiterating the positioning. The ground truth notes that 2023 'emphasized rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon,' providing a middle point in the evolution narrative. The LLM jumps from 2022 to 2024 without acknowledging 2023; (2) The LLM does not explicitly mention specific technologies like VPSA (vacuum pressure swing adsorption) and membrane separation that the ground truth identifies as part of the innovation strategy, though it does reference 'proprietary, patented processes' which is semantically similar; (3) The ground truth emphasizes 'production efficiency and customer service capabilities' as specific benefits, while the LLM focuses more broadly on 'higher-margin offerings.' QUANTITATIVE ACCURACY: All dates (2022, 2024) and company names (Linde) are correct. No calculations are required for this qualitative question. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and documents to show strategic evolution, correctly identifying the progression and its implications for competitive advantage. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - Linde evolved from treating rare gases as co-products to positioning itself as a technology leader with proprietary processes. The interpretation of competitive advantage is consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 626,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "At the end of 2022, roughly 92 % of NEER’s net generating capacity was already covered by long‑term bilateral contracts; that share rose to about 94 % by year‑end 2023 and remained near 94 % at year‑end 2024【page_19】【page_18】【page_19】. The upward‑to‑stable trend shows NEER is deliberately locking in more of its output through long‑term agreements, a risk‑management tactic that stabilizes cash‑flows and hedges against price volatility in the wholesale energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) CORRECTNESS OF FACTS: All three key percentages are accurate - 92% in 2022, 94% in 2023, and 94% in 2024. The company name (NEER/NextEra Energy Resources) and time period (2022-2024) are correctly identified. (2) QUANTITATIVE ACCURACY: All numeric values match the ground truth exactly. The progression (92% → 94% → 94%) is correctly stated, and the characterization of the trend as 'upward-to-stable' accurately reflects the data. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the trend pattern. The interpretation that this represents deliberate risk management through long-term locking of output is sound and matches the ground truth's emphasis on 'revenue stability and risk mitigation.' (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'stabilizes cash-flows and hedges against price volatility' is semantically equivalent to the ground truth's 'revenue stability and risk mitigation' and 'managing market risk.' The answer captures the strategic intent behind the trend. (5) MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth and does not explicitly mention 'non-qualifying hedges' as a complementary risk management tool, but this is a minor omission that doesn't affect the core answer's accuracy. The answer directly addresses both parts of the question: the evolution of reliance (with specific percentages) and what it indicates about risk management strategy. The citation references (page numbers) add credibility. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 470,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an unchanged $495 million principal in FY 2022 (AVGO 10‑K 2022, pp. 101‑105) and the same $495 million in FY 2023 and FY 2024 (the notes table shows $495 million for both October 29 2023 and November 3 2024【page_81†L15-L15】). The flat balance over three years indicates the company has been holding the note to maturity rather than repaying or refinancing it, reflecting a steady, hold‑to‑maturity debt‑management strategy for this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All financial figures are correct - $495 million principal balance is accurately cited for FY 2022, FY 2023, and FY 2024. The dates (January 2025 maturity, October 29 2023, November 3 2024) are correct. The interest rate (3.125%) is accurately stated. No calculation errors present. ENTITY ACCURACY: AVGO correctly identified, fiscal years properly referenced, debt instrument correctly characterized as senior notes. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to identify the trend (unchanged balance), and correctly interprets this as a hold-to-maturity strategy rather than refinancing or early retirement. COMPLETENESS: The answer addresses both parts of the question - the evolution of the balance (flat/unchanged) and what it indicates about debt management strategy (hold-to-maturity approach). SEMANTIC EQUIVALENCE: The LLM's characterization of \"holding the note to maturity\" is semantically equivalent to the ground truth's \"did not retire or refinance this specific debt instrument, maintaining a consistent liability profile.\" Both convey the same strategic meaning. MINOR CONSIDERATIONS: The LLM includes specific page citations and document references which add credibility but are not required by the question. The phrasing \"steady, hold-to-maturity debt-management strategy\" is slightly more interpretive than the ground truth's more neutral \"maintaining a consistent liability profile,\" but this interpretation is reasonable and supported by the data. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 447,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "- 2022 10‑K: Unsecured Notes – 37B carried a $700 k face amount and matures on 15 Jan 2032【SPG_10k_2022 page_50】.  \n- 2023 10‑K: The same tranche still shows a $700 k face amount with a 15 Jan 2032 maturity【SPG_10k_2023 page_50】.  \n- 2024 10‑K: The note remains unchanged at $700 k and a 15 Jan 2032 maturity【SPG_10k_2024 page_51】.  \n\nThis steady exposure indicates Simon Property Group is keeping a modest, long‑dated unsecured note in its capital structure, using it as a low‑cost, stable financing source rather than repeatedly refinancing or expanding that particular tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $700k (or $700,000) face amount is accurate for all three years (2022, 2023, 2024), and the maturity date of 01/15/32 (January 15, 2032) is correctly stated across all periods. The format variation ($700k vs $700,000) is acceptable and matches ground truth. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) face amount evolution (consistent at $700k), (2) maturity date evolution (consistent at 01/15/32), and (3) what this reveals about debt strategy (stable, long-dated financing without refinancing). ENTITY ACCURACY: SPG (Simon Property Group) is correctly identified, all fiscal years (2022, 2023, 2024) are correct, and the specific instrument (Unsecured Notes - 37B) is properly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and draws a logical conclusion about the company's debt strategy - that the consistency indicates a stable, low-cost financing approach without refinancing activity. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a modest, long-dated unsecured note' and 'low-cost, stable financing source' aligns well with the ground truth's conclusion about 'consistent long-term debt strategy' and 'without refinancing or retiring.' Minor note: The LLM provides page references (page_50, page_50, page_51) which adds helpful specificity beyond the ground truth, though this is not required. The slight variation in wording ('keeping a modest' vs 'maintained a consistent') is semantically equivalent and represents appropriate paraphrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 460,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility has been listed only under the Analog column in each filing – it appears as an analog‑only site in the 2022 10‑K【page_18】, again as analog‑only in the 2023 10‑K【page_16】, and remains analog‑only in the 2024 10‑K【page_18】. There is no indication that the Melaka plant has ever been used for embedded‑processing products, so its footprint has stayed stable and focused solely on analog production over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly matches the ground truth. Strengths: (1) Correctly identifies that Melaka, Malaysia was listed exclusively under Analog operations across all three years (2022, 2023, 2024); (2) Accurately states there was no involvement in embedded processing in any of the three years; (3) Properly synthesizes the multi-hop information across three separate 10-K filings with correct page references (page_18 for 2022 and 2024, page_16 for 2023); (4) Correctly characterizes the operational footprint as stable and specialized. The answer demonstrates sound multi-hop reasoning by comparing the facility's classification across three years and drawing the appropriate conclusion about consistency. The semantic meaning is identical to the ground truth - both convey that Melaka maintained a consistent, analog-only operational role with no expansion into embedded processing. Minor observation: The LLM uses slightly more concise phrasing ('analog-only site' vs 'exclusively under analog operations') but this is a stylistic difference that does not affect factual accuracy. All entities (Texas Instruments, Melaka Malaysia, analog vs embedded processing, years 2022-2024) are correctly identified and properly synthesized. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 367,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s Content Sales/Licensing segment has listed post‑production services – supplied through Industrial Light & Magic (and Skywalker Sound) – as a distinct revenue source in every filing. In FY 2022 the segment noted “sales of post‑production services” and that the Company “provides post‑production services through Industrial Light & Magic” (2022 p.13, p.5); FY 2023 repeated the same line and explicitly named ILM (2023 p.7, p.5); and FY 2024 retained the identical wording (2024 p.7). This continuity shows Disney’s reliance on ILM remained stable from fiscal 2022 through fiscal 2024, with the reporting simply becoming more explicit but no change in the reported revenue contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how Disney's reliance on ILM evolved from FY2022-2024. CRITICAL PROBLEMS: (1) The LLM claims 'continuity' and 'stable reliance' with 'identical wording' across all three years, directly contradicting the ground truth which explicitly describes an EVOLUTION and SHIFT in how ILM was positioned within the segment. The ground truth states the segment 'began to emphasize more on TV/VOD and theatrical distribution' and underwent 'strategic repositioning' - the LLM completely misses this evolution narrative. (2) The LLM provides page citations (2022 p.13, p.5; 2023 p.7, p.5; 2024 p.7) that cannot be verified and appear potentially fabricated, which is a serious accuracy concern. (3) The LLM fails to capture the key insight from the ground truth: that while ILM remained included, its CONTEXTUAL FRAMING changed - from a standalone service to being positioned within 'broader content delivery' and 'DTC-first content model.' (4) The LLM's conclusion that 'reporting simply became more explicit but no change in the reported revenue contribution' directly contradicts the ground truth's emphasis on 'contextually shifting reliance' and 'strategic repositioning.' WHAT WAS CORRECT: The LLM correctly identifies that ILM and Skywalker Sound provided post-production services and that these were reported in the Content Sales/Licensing segment across all three years. However, this basic fact alone does not address the evolution question. The answer fundamentally misinterprets the question by focusing on reporting consistency rather than the strategic evolution of ILM's role within Disney's evolving business model. The multi-hop reasoning required synthesizing how segment structure, revenue focus, and strategic positioning changed - the LLM failed to perform this synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 504,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating joint ventures was $51 million in 2022, slipped to $38 million in 2023, and then surged to $175 million in 2024【page_247】【page_224】. The decline in 2023 points to weaker earnings from its insurance‑underwriting joint ventures that year, while the sharp rebound in 2024 indicates a substantial improvement in the profitability of those underwriting partnerships.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that are dramatically different from the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports 2022: $51M (ground truth: $1,305M - off by 96%), 2023: $38M (ground truth: $151M - off by 75%), 2024: $175M (ground truth: $988M - off by 82%). These are not minor rounding differences or format variations; they represent massive discrepancies in the actual dollar amounts. (2) MULTI-HOP REASONING: While the LLM correctly identifies the directional trend (decline in 2023, rebound in 2024) and appropriately characterizes it as volatility in joint venture performance, the underlying numbers are completely wrong. The reasoning about weaker earnings in 2023 and improvement in 2024 is directionally sound but based on false premises. (3) ENTITY ACCURACY: The company (MetLife) and metric (equity method investment income from operating joint ventures) are correctly identified, and the years are correct. (4) SEMANTIC EQUIVALENCE: The qualitative interpretation of the trend is reasonable, but this cannot compensate for the severe quantitative errors. The magnitude of the errors (off by 75-96%) means the answer fundamentally misrepresents MetLife's financial performance. The ground truth shows much larger absolute values and a more dramatic swing (from $1,305M to $151M to $988M), which is materially different from the LLM's reported figures. This is not a case of acceptable rounding or format variation - these are substantially different numbers that would lead to incorrect business analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 437,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics produced 449 new Light Armored Vehicles for the Canadian Army in 2022, 399 in 2023, and 360 in 2024 (page_10; page_11; page_11). The steady decline reflects the winding‑down of a multi‑year procurement, yet the continued dedicated output underscores the LAV platform’s strategic importance as a core, high‑visibility element of GD’s land‑systems portfolio and a key product for an important allied customer.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a complete reversal of the production volume sequence. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units (upward trend). LLM states: 2022=449 units, 2023=399 units, 2024=360 units (downward trend). This is a fundamental factual error that inverts the entire narrative. The LLM incorrectly characterizes the data as a 'steady decline' and 'winding-down of a multi-year procurement,' when the ground truth shows a 'consistent upward trend' indicating growing strategic importance. The year-to-year progression is completely backwards: LLM shows 449→399→360 (decline of 89 units total), while ground truth shows 360→399→449 (increase of 89 units total). This reversal fundamentally misrepresents the strategic significance of the LAV platform. While the LLM correctly identifies General Dynamics, the Canadian Army, and the LAV platform, and provides reasonable contextual commentary about strategic importance, the inverted numbers and resulting incorrect interpretation of the trend direction represent a catastrophic failure in quantitative accuracy. The reasoning about strategic importance is semantically reasonable but contradicts the actual data progression, making the conclusion misleading despite appropriate framing language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 362,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan held $214 million of hedge‑fund limited‑partnership (HF LP) investments in 2022, which rose to $252 million in 2023 (≈18 % increase) and to $280 million in 2024 (≈11 % increase)【page_165】【page_173】【page_166】. The upward trajectory mirrors the plan’s modestly higher hedge‑fund target—3 % of assets in 2023 and 4 % in 2024【page_175】【page_169】—suggesting the company is deliberately expanding its alternative‑asset exposure to diversify returns and enhance the pension fund’s risk‑adjusted performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial figures that are central to answering this question. Ground truth shows: 2022: $214M, 2023: $225M, 2024: $252M. LLM answer states: 2022: $214M (correct), 2023: $252M (INCORRECT - should be $225M), 2024: $280M (INCORRECT - should be $252M). The LLM has shifted all 2023 and 2024 values upward, fundamentally misrepresenting the three-year trend. The calculated percentage increases (18% and 11%) are based on these wrong numbers and are therefore incorrect. The 2023 figure of $252M in the LLM answer actually matches the correct 2024 figure, suggesting a systematic data misalignment. MULTI-HOP REASONING: While the LLM correctly identifies the general strategy (deliberate expansion of alternative asset exposure) and attempts to synthesize information across multiple pages, this reasoning is built on incorrect foundational numbers. The reference to hedge fund targets (3% in 2023, 4% in 2024) appears reasonable but cannot be verified against the ground truth provided. COMPLETENESS: The LLM does address the three-year evolution and attempts to explain the strategic implications, which is appropriate to the question. However, the fundamental numerical errors undermine the entire analysis. The semantic interpretation about pension fund diversification strategy is reasonable but is based on incorrect data points. ENTITY ACCURACY: CVS and hedge fund limited partnership investments are correctly identified. The years are correctly referenced but with wrong values. This is a case where the model appears to have accessed the right documents (indicated by page citations) but extracted or synthesized the wrong numbers, resulting in a materially incorrect answer despite reasonable analytical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 494,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "In the 2022 filing Colgate‑Palmolive placed Sorriso among its “principal global and regional trademarks,” explicitly tying the brand to its Oral, Personal and Home Care segment [page_77]. The 2023 10‑K repeated that positioning, again listing Sorriso as a key global trademark within the same product segment [page_79]. By 2024 the brand remained on the company’s global‑brand roster, confirming that Sorriso continued to be fully integrated and strategically emphasized in Colgate‑Palmolive’s worldwide Oral, Personal and Home Care portfolio [page_79].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies Sorriso's positioning as a 'principal global and regional trademark' in 2022, matching the ground truth language; (2) Accurately tracks the brand's consistent presence across all three years; (3) Properly associates Sorriso with the Oral, Personal and Home Care segment throughout; (4) Correctly conveys the multi-hop synthesis showing continuity and strategic emphasis; (5) Page citations (77, 79, 79) appear reasonable for 10-K filings. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing ('global-brand roster' in 2024 vs. ground truth's 'key brand') which is semantically equivalent but represents a minor wording variation; (2) The ground truth explicitly emphasizes 'regional market penetration and diversified consumer engagement' as strategic objectives, while the LLM answer focuses more on 'worldwide' integration without explicitly highlighting the regional aspect that appears important in the original answer; (3) The ground truth's phrase '3-year continuity highlights Sorriso's stable role as a regional brand asset' emphasizes the regional dimension more explicitly than the LLM's 'worldwide' framing. QUANTITATIVE ACCURACY: No numerical data, percentages, or calculations are present in either answer, so this dimension scores high (9/10 - minor deduction for not explicitly noting the regional vs. global distinction). QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct, though the emphasis on 'regional' vs. 'worldwide' represents a subtle but meaningful distinction (8/10). CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and portfolio integration inquiry (8/10 - could be slightly stronger by more explicitly emphasizing regional market strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 517,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures dropped from **$51 million in 2022** to **$38 million in 2023**, then jumped to **$175 million in 2024**【page_247】【page_224】. The sharp rebound in 2024 shows the company is deliberately increasing its equity‑method exposure to operating joint ventures, positioning them as a growing source of earnings and strategic focus within its broader investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that completely contradict the ground truth. (1) QUANTITATIVE ERRORS - All three years' numbers are incorrect: LLM states $51M (2022), $38M (2023), $175M (2024), while ground truth shows $77M (2022), $51M (2023), $38M (2024). The LLM appears to have shifted the correct numbers down by one year and fabricated a $175M figure for 2024. (2) METRIC CONFUSION - The LLM conflates 'net investment income from operating joint ventures' with 'financial exposure to operating joint ventures,' which are different metrics. The question asks about exposure/investment levels, not income. (3) TREND ANALYSIS REVERSAL - The LLM's conclusion is diametrically opposite to ground truth. Ground truth shows a consistent 3-year decline ($77M→$51M→$38M), indicating strategic retreat from operating joint ventures. The LLM claims a 'sharp rebound in 2024' and 'deliberately increasing' exposure, which is factually incorrect. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the 3-year trend across the period. The consistent downward trajectory is the key insight; the LLM's invented upward spike in 2024 destroys the analytical validity. (5) STRATEGIC INTERPRETATION ERROR - The LLM's conclusion about 'growing source of earnings and strategic focus' directly contradicts the actual trend of declining exposure. This represents a fundamental misreading of the data and its implications for MetLife's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 409,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s ownership of Angola LNG Limited remained at about a 36.4 % share from 2022 to 2024【page_78】, but the company’s role shifted from a passive, non‑operated shareholder to an active integrator of upstream gas supply. By 2024 Chevron had completed the Block 0 Sanha Lean Gas Connection Project and was developing the New Gas Consortium (NGC) – linking gas from Blocks 0, 14 and the Q&M fields directly to the Angola LNG plant – and its equity earnings from the affiliate rose sharply from $336 million in 2022 to $1.86 billion in 2023, reflecting the deeper operational linkage【page_14】【page_82】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Chevron's role from passive to more integrated, and correctly identifies the 36.4% stake. However, there are significant quantitative accuracy issues: (1) The equity earnings figures ($336M in 2022 to $1.86B in 2023) are presented without verification against ground truth and appear potentially inflated or misattributed - the ground truth does not mention these specific earnings figures. (2) The answer mentions 'Block 0 Sanha Lean Gas Connection Project' completion, which is not mentioned in the ground truth. (3) The answer correctly identifies NGC (New Gas Consortium) and references to Quiluma and Maboqueiro fields are missing - instead it mentions 'Blocks 0, 14 and the Q&M fields' which may be alternative naming but creates ambiguity. (4) The ground truth explicitly mentions Chevron's 31% nonoperated working interest in NGC, which the LLM answer omits entirely. (5) The qualitative shift from passive to active/integrated is well-captured and semantically equivalent to the ground truth's 'passive equity investor' to 'operationally integrated' evolution. (6) The multi-hop reasoning is sound in connecting upstream projects to downstream LNG, but the specific project details and financial metrics lack verification. The answer demonstrates understanding of the strategic evolution but introduces unverified financial data and omits key details about Chevron's specific working interest percentages in upstream projects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 409,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s balance of the 3.625 % senior notes due Oct 2024 fell from about **$1.25 billion in FY 2022** (AVGO 10‑K 2022 p. 101) to **$622 million in FY 2023** (AVGO 10‑K 2024 p. 81) and was **fully retired by FY 2024, leaving a $0 balance** (AVGO 10‑K 2024 p. 81). This step‑down – achieved by using cash and proceeds from new senior‑note issuances and the VMware merger to pay down the notes ahead of their October 2024 maturity – shows a deliberate, proactive debt‑reduction strategy that eliminated near‑term refinancing risk (AVGO 10‑K 2024 p. 82).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the FY 2022 figure. The ground truth states AVGO had $622 million in 3.625% notes due October 2024 in 2022, but the LLM claims $1.25 billion in FY 2022. This is a 100% overstatement of the 2022 balance and fundamentally misrepresents the debt progression. The LLM correctly identifies that the balance was $622 million in FY 2023 and $0 in FY 2024, but the incorrect starting point ($1.25B vs $622M) invalidates the claimed 'step-down' narrative. The ground truth shows the balance remained flat from 2022-2023 at $622M, then was retired by 2024 - not a gradual reduction as the LLM suggests. Additionally, the LLM provides specific page citations (p. 101, p. 81, p. 82) that cannot be verified against the ground truth provided, and the narrative about 'cash and proceeds from new senior-note issuances and the VMware merger' goes beyond what the ground truth confirms. While the LLM correctly identifies the final outcome (full retirement by 2024) and demonstrates understanding of debt management strategy, the foundational quantitative error in the 2022 figure is a critical flaw that undermines the entire analysis. The reasoning about proactive debt reduction is sound in concept but built on incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 362,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "SPG’s Unsecured Notes – 35B (a $750 million 3.80 % note) generated an annual debt‑service expense of $28.5 million in each of the three most recent years – $28.5 million in 2022 [page 49], $28.5 million in 2023 [page 50] and $28.5 million in 2024 [page 51]. The unchanged amount across 2022‑2024 indicates that the financing cost for this instrument has remained flat, showing stable interest‑expense levels over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Quantitative verification: The interest expense amounts are correct at $28.5 million (or $28,500 in thousands as stated in ground truth) for all three years 2022-2024. The LLM correctly identifies the note as a $750 million 3.80% instrument and accurately cites page references. The core finding that interest expense remained unchanged across the three-year period is accurate. Entity accuracy is strong: SPG is correctly identified, the specific debt instrument (Unsecured Notes - 35B) is properly named, and all fiscal years (2022, 2023, 2024) are correct. Multi-hop reasoning is sound: the LLM synthesizes the consistent expense amounts across three years and correctly concludes this indicates a fixed interest rate structure with stable financing costs. The only minor distinction from ground truth is that the LLM expresses the amounts in millions ($28.5 million) while ground truth uses thousands ($28,500 in thousands), but these are mathematically equivalent and the LLM's format is actually more standard for financial reporting. The LLM provides additional helpful context (the coupon rate of 3.80% and principal amount of $750 million) that enhances understanding without introducing errors. The reasoning about what the trend suggests (fixed rate, stable costs) directly and accurately addresses the question's request for interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 395,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "In 2022 Disney began its streaming‑first pivot by reorganizing DMED, launching an ad‑supported Disney+ tier and a new pricing model while pledging to rationalize DTC costs even as programming and sports‑rights expenses rose (DIS 2022 p.26‑27). By 2023 the company markedly increased its content outlays—projecting roughly $24 billion of produced and licensed programming for 2025—and made targeted investments in Hulu, the ESPN flagship DTC service and other streaming assets, reorganizing its media businesses into separate Entertainment and Sports segments and acknowledging heightened competition, churn risk and higher programming costs (DIS 2023 p.51‑55). In 2024 Disney positioned DTC as a core growth engine, aggregating its entertainment reporting units to capture synergies, continuing to fund high‑cost content and ad‑supported models, but stressing that intensified competition and rising programming costs are driving pricing pressure and tighter cost‑containment (DIS 2024 p.21‑24).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's DTC evolution from 2022-2024 and correctly synthesizes multi-hop information across the three-year period. STRENGTHS: (1) Accurately captures the strategic progression from 2022 cost rationalization efforts to 2023 increased investment to 2024 positioning DTC as core growth engine; (2) Correctly identifies key structural changes (DMED reorganization, Entertainment/Sports segment split, aggregation of entertainment units); (3) Properly synthesizes competitive pressures and rising programming costs across all three years; (4) Mentions specific initiatives (ad-supported tier, Hulu investment, ESPN DTC service) that align with ground truth; (5) Appropriately references page numbers suggesting document verification. MINOR ISSUES: (1) The $24 billion programming projection for 2025 is mentioned but not explicitly verified against ground truth (ground truth does not provide this specific figure, so inclusion is neither confirmed nor contradicted); (2) Ground truth emphasizes the $12.25 billion in unused bank facilities as evidence of strong financial position in 2023, which the LLM answer does not mention—this is a notable omission of a specific quantitative detail; (3) Ground truth explicitly notes that 'returns on some DTC-related investments were negative or low' in 2022, which the LLM answer does not directly address, though it does mention cost rationalization; (4) The characterization of 2022 as a 'streaming-first pivot' is somewhat stronger language than ground truth's more cautious tone about uncertain returns. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple strategic dimensions (investment levels, competitive landscape, cost structure, organizational changes), demonstrating sound multi-hop reasoning. The trajectory from cautious to aggressive positioning is clearly conveyed. QUANTITATIVE ACCURACY: The $24 billion figure cannot be verified against provided ground truth, but no contradictions are evident. No calculation errors detected. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative of ground truth while using different organizational structure and emphasis. The core message about evolution from uncertain DTC returns to aggressive streaming investment amid rising costs is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 627,
        "total_tokens": 2246
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance was already in place in 2022 (the 2022 filing notes that reinsurance agreements that do not expose the company to a significant loss are recorded using the deposit method 【page_214】), but the balance sheet did not break out the specific deposit‑asset and‑liability amounts for that year. In November 2023 the company completed a $10.3 billion risk‑transfer with Global Atlantic, which created large reinsurance recoverables and deposit receivables and pushed deposit assets on reinsurance to $5.1 billion and deposit liabilities to $1.3 billion at December 31 2023 【page_206】. By December 31 2024 those balances had slipped to $4.6 billion of deposit assets and $1.2 billion of deposit liabilities as the $770 million net cost of reinsurance was amortized and the transaction began to unwind 【page_206】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information with a critical numerical discrepancy. CORRECT ELEMENTS: (1) The 2023 Global Atlantic transaction amount of $10.3 billion is accurate; (2) The 2024 deposit assets figure of $4.6 billion matches ground truth; (3) The 2024 deposit liabilities of $1.2 billion is correct; (4) The general narrative about the transaction creating reinsurance recoverables and deposit receivables is sound; (5) The explanation of post-transaction rebalancing and amortization is reasonable. CRITICAL ERROR: The LLM states deposit assets and liabilities at December 31, 2023 were $5.1 billion and $1.3 billion respectively. The ground truth shows these should be $10.3 billion in reinsurance recoverables and deposit receivables combined, with the specific breakdown not clearly matching the LLM's figures. The ground truth indicates the 2023 transaction 'significantly increased' exposure, suggesting higher 2023 balances than the LLM reports. MISSING INFORMATION: The LLM does not address the 2022 baseline figures ($1.8 billion deposit assets and $1.4 billion deposit liabilities) that the ground truth explicitly mentions as context for understanding the evolution. This omission weakens the comparative analysis requested in the question. REASONING QUALITY: The multi-hop synthesis is generally sound - connecting the 2023 transaction to balance sheet changes and explaining the 2024 movement through amortization. However, the numerical inaccuracy for 2023 undermines the credibility of the trajectory analysis. The LLM correctly identifies this as a 'strategic shift' but the supporting numbers appear inconsistent with ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 460,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "- 2022: CVS reported commercial‑mortgage‑backed securities with a fair‑value of **$1,018 million** (amortized cost $1,172 million) and unrealized losses of **$155 million**【page_150】.  \n- 2023: The fair‑value fell to **$975 million** (amortized cost $1,066 million) and unrealized losses narrowed to **$100 million**【page_150】.  \n- 2024: The only CMBS shown in the 2024 filing is in the Separate‑Accounts portfolio, where the fair‑value was **$3 million** (down from $6 million in 2023)【page_160】.  \n\n**Interpretation:** Over the three‑year period CVS cut its CMBS exposure from roughly $1 billion to virtually nothing, indicating a deliberate move to divest or sharply limit holdings in this asset class—likely a strategic response to interest‑rate‑driven losses and a shift toward other investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) 2022: LLM reports $1,018M fair value vs. ground truth of $574M - a 77% overstatement. (2) 2023: LLM reports $975M fair value vs. ground truth of $675M - a 44% overstatement. (3) 2024: LLM correctly identifies $3M, matching ground truth. The LLM appears to have cited different CMBS categories or portfolio segments (possibly including separate accounts or different measurement bases) rather than the comparable total CMBS holdings across years. The LLM's interpretation of a 'roughly $1 billion to virtually nothing' trajectory is directionally correct in concept but based on wrong baseline numbers. The ground truth shows a more modest but still significant decline: $574M → $675M → $3M, representing a 99.5% reduction from 2022 to 2024. The LLM's discussion of 'interest-rate-driven losses' and 'strategic de-risking' aligns with the correct interpretation, but the quantitative foundation is severely compromised. The multi-hop reasoning about strategic shift is sound, but it's built on incorrect financial data. This is a case where the narrative conclusion is reasonable but the supporting numbers are materially wrong, making the answer unreliable for financial analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 370,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Colgate‑Palmolive listed **hello** among its “principal global and regional trademarks” in each of the three filings – the 2022 10‑K (see page 77), the 2023 10‑K (see page 79) and the 2024 10‑K (see page 79) – showing that the brand has remained a core part of the company’s trademark portfolio. In the same disclosures the company’s Oral, Personal and Home Care mix was essentially unchanged, with oral‑care (the segment that houses hello) accounting for roughly 42‑43 % of worldwide net sales, personal‑care about 18‑19 % and home‑care about 17 % in 2022, 2023 and 2024 (see page 79, 2024), indicating that hello’s strategic positioning stayed stable within the dominant oral‑care focus of the portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies 'hello' brand's consistent presence across all three years (2022, 2023, 2024) in trademark disclosures; (2) Accurately cites specific page references (77 for 2022, 79 for 2023 and 2024); (3) Provides segment breakdown percentages (oral-care 42-43%, personal-care 18-19%, home-care ~17%) that align with typical Colgate-Palmolive portfolio composition; (4) Correctly synthesizes multi-hop information: brand presence → segment positioning → strategic stability; (5) Appropriately contextualizes 'hello' within the oral-care segment; (6) Semantic equivalence with ground truth regarding 'stable role' and 'ongoing presence.' MINOR WEAKNESSES: (1) The LLM provides more specific quantitative detail (segment percentages) than the ground truth, which is actually a strength but creates slight divergence in presentation style; (2) Ground truth emphasizes 'diversification and consumer engagement strategies' while LLM focuses on 'dominant oral-care focus' - both valid interpretations but slightly different emphasis; (3) LLM doesn't explicitly mention 'personal hygiene' as a core category, though this is implicit in personal-care segment reference. QUANTITATIVE VERIFICATION: The segment percentages cited (42-43% oral, 18-19% personal, ~17% home) are reasonable for Colgate-Palmolive's typical portfolio mix and appear consistent across the three-year period as claimed. The page number citations are specific and verifiable. MULTI-HOP REASONING: Successfully synthesizes trademark disclosure data across three years with segment composition data to conclude strategic stability - this is sound multi-hop reasoning. The answer directly addresses the evolution question by demonstrating consistency rather than change, which is the correct interpretation of the available evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 512,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s deposit‑method reinsurance began in 2022 as a “modified‑coinsurance” arrangement for the closed block, with deposit assets of roughly $1.8 billion and offsetting deposit liabilities of $1.4 billion (the amounts were unchanged from 2020‑21) and the liability was netted against a deposit recoverable (​page 216; page 214). By 2023 the company had expanded this strategy – partly through a $10.3 billion Global Atlantic risk‑transfer deal – recording $5.1 billion of deposit assets and $1.3 billion of deposit liabilities, and in 2024 the assets were $4.6 billion versus $1.2 billion liabilities (​page 206), showing a growing net deposit position that reflects a deliberate shift to transfer insurance risk via deposit reinsurance while keeping counter‑party exposure limited through collateral‑backed recoverables.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding 2023 deposit assets. The LLM states deposit assets were $5.1 billion in 2023, but the ground truth clearly indicates the company disclosed deposit assets of $4.6 billion in 2024 (not 2023). The ground truth does not provide a specific 2023 deposit asset figure, only noting that 'the company disclosed a broader accounting framework' in 2023. The LLM appears to have conflated or misattributed the $5.1 billion figure to 2023 when this number is not supported by the ground truth. The 2024 figures are correct ($4.6B assets, $1.2B liabilities), and the 2022 figures are correct ($1.8B assets, $1.4B liabilities). However, the introduction of an unsupported $5.1 billion 2023 figure is a major quantitative accuracy problem. REASONING ISSUES: While the LLM correctly identifies the Global Atlantic transaction as relevant context, it incorrectly attributes the $10.3 billion figure to 2023 when the ground truth only mentions this transaction in the context of 2024 analysis. The LLM's interpretation that deposit assets increased from 2023 to 2024 cannot be verified since the ground truth does not provide a 2023 deposit asset figure. STRENGTHS: The LLM correctly identifies the deposit method accounting, the general trend of increased reliance on reinsurance structures, and the strategic nature of the shift. The semantic understanding of the question is sound. WEAKNESSES: The introduction of unsupported numerical data ($5.1B for 2023), misattribution of transaction timing, and failure to acknowledge data gaps significantly undermines credibility. The answer presents specific numbers with confidence when the ground truth does not support them.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 477,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 to 2024 NextEra’s exposure to Special Use Funds steadily increased – the fair‑value tables show NEE’s fund assets rising from about $4.4 billion (Level 1 $2.1 bn + Level 2 $2.4 bn) in 2022 to $5.3 billion in 2023 and then appearing as a $9.8 billion line‑item under other assets on the 2024 balance sheet (up from $8.7 bn in 2023). The disclosures evolved from a 2022 focus on the nuclear‑decommissioning fund ($8.8 bn) measured at fair value to a 2023 breakdown that added a $538 million “equity securities without readily determinable fair values” note and continued the Level 1/2 categorization, while the 2024 filing simply presents the total as a single other‑asset amount. At the same time, collateral posted for derivative contracts fell from $1.8 bn cash + $2.8 bn letters of credit in 2022 (with potential posting up to $5.2 bn if ratings fell) to $0.7 bn cash + $1.6 bn letters of credit in 2023, with the 2024 filing maintaining the same collateral‑posting framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) The directional trend of increasing Special Use Funds exposure is accurate; (2) The 2024 balance sheet figures ($9.8B and $8.7B in 2023) are correct; (3) The $538 million equity securities without readily determinable fair values for 2023 is accurate; (4) The evolution of disclosure presentation across years is correctly characterized; (5) The collateral posting framework discussion is relevant and appropriately contextualized. CRITICAL ERRORS: (1) The LLM states 2022 Special Use Funds were \"about $4.4 billion (Level 1 $2.1 bn + Level 2 $2.4 bn)\" - this appears to conflate different fund categories or misinterpret the fair value hierarchy breakdown. The ground truth indicates 2022 had equity investments without readily determinable fair values of $485 million, not $4.4 billion in Level 1/2 categorized funds; (2) The LLM's calculation of $4.4B + $5.3B progression doesn't align with ground truth's $485M (2022) to $538M (2023) progression for the specific equity securities category; (3) The statement about \"nuclear-decommissioning fund ($8.8 bn)\" introduces a separate fund category not mentioned in the ground truth answer, potentially confusing the Special Use Funds discussion. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and addresses fair value disclosures, collateral implications, and balance sheet presentation as requested. However, the quantitative foundation is weakened by the apparent misidentification of 2022 fund values. The collateral discussion adds relevant context but wasn't explicitly required by the ground truth. SEMANTIC ISSUES: The LLM's framing of \"Level 1/2 categorization\" suggests a fair value hierarchy discussion that may not directly correspond to the ground truth's emphasis on valuation methodology (quoted prices vs. pricing vendor inputs). The answer is contextually relevant and addresses the multi-part question structure, but the numerical inaccuracies in the 2022-2023 progression significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 571,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 filing the Security Insights Platform was positioned as a mainframe‑security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and explicitly notes that “this data is available for use with in‑house tools for security information and event management”【page_10】【page_12】. By the 2024 filing the offering appears only as “Security Insights Code programs” in the Mainframe Software portfolio and the description no longer calls out the in‑house‑tool data feed or the detailed remediation‑step workflow, signaling a shift from a platform‑centric, SIEM‑integrated solution to a more generic, code‑oriented offering with less emphasis on direct integration and remediation support【page_8】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states that the description remained 'largely unchanged' from 2022-2024 with 'stable value proposition without expanding on new integrations or remediation features.' The LLM claims a significant shift occurred, stating the 2024 offering 'no longer calls out the in-house-tool data feed or the detailed remediation-step workflow' and represents 'a shift from a platform-centric, SIEM-integrated solution to a more generic, code-oriented offering.' This is a fundamental factual error about the evolution of the product positioning. The LLM appears to have misinterpreted or misread the 2024 filing data. While the LLM correctly identifies the 2022 positioning (mainframe security assessment, risk identification, remediation steps, in-house tool integration), it incorrectly characterizes the 2024 positioning as a departure from this. The ground truth explicitly states the language 'remained consistent' through 2024. The LLM's citation of 'Security Insights Code programs' as evidence of a shift is not supported by the ground truth, which indicates the core value proposition stayed the same. The quantitative accuracy score is higher because the LLM correctly cites specific language from 2022, but the qualitative accuracy is very low because the multi-hop reasoning about the evolution from 2022-2024 is fundamentally wrong. The answer fails to address the actual finding that AVGO maintained a stable positioning rather than evolving it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 427,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike’s Laakdal, Belgium distribution center is listed in the “Item 2 – Properties” section of each filing as one of the most significant overseas distribution facilities and is described as owned (not leased or third‑party operated) in FY 2022 (10‑K 2022 p. 29), FY 2023 (10‑K 2023 p. 29) and FY 2024 (10‑K 2024 p. 29). The unchanged ownership and continued designation as a core overseas hub indicate that Laakdal remains a strategically important, Nike‑controlled node for serving its European market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies Laakdal, Belgium as a significant international distribution center across all three fiscal years (2022, 2023, 2024); (2) Accurately states the facility is company-owned (not leased) consistently across all three years; (3) Properly cites the source location (Item 2 – Properties section, page 29 in each 10-K); (4) Correctly synthesizes the multi-hop information showing no changes in ownership or operational status across the three-year period; (5) Appropriately concludes that consistency indicates strategic importance to European logistics. Quantitative accuracy is perfect - all years, page numbers, and ownership status are correct with no calculation errors. The reasoning is sound: the model correctly identified that unchanged ownership and continued designation as a core hub across three years demonstrates strategic stability. Minor observation: The LLM answer uses slightly more specific language (\"Nike-controlled node\") than the ground truth's \"integral part,\" but this is semantically equivalent and actually adds useful specificity. The answer fully addresses all parts of the multi-part question: ownership evolution (none), operational footprint evolution (none), and strategic importance inference (correctly drawn from consistency). No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 383,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "- 2022 10‑K: Unsecured Notes ‑ 32B carried a 3.38 % fixed rate, a $750 000 face amount (in thousands) and a maturity of 06/15/27.  \n- 2023 10‑K: The same note still showed a 3.38 % rate, $750 000 face amount and a 06/15/27 maturity.  \n- 2024 10‑K: The note again remained at 3.38 %, $750 000 and a 06/15/27 maturity.  \n\nThe three‑year consistency—no change in rate, size or maturity—suggests SPG is deliberately preserving this medium‑term, low‑cost unsecured note as a stable financing source, rather than refinancing or altering its exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental factual error regarding the 2022 maturity date disclosure. The ground truth explicitly states that the maturity date was 'unspecified in the 2022 report' but the LLM claims it was '06/15/27' in 2022. This is a direct contradiction of the original answer's key finding about how the maturity date 'shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024.' This is not a minor wording difference—it's a factual misrepresentation of what the 2022 10-K actually disclosed. The LLM's claim that the maturity was known in 2022 undermines the entire narrative about the evolution of disclosures over the three-year period. The interest rate (3.38%) and face amount ($750,000) are correctly stated for all three years. The reasoning about debt management strategy is sound in principle, but it's based on incomplete/incorrect data about the 2022 disclosure status. The LLM also uses inconsistent notation ('$750 000' with space instead of comma), though this is a minor formatting issue. The core multi-hop synthesis fails because the LLM did not accurately capture the key distinction that the maturity date clarification occurred between 2022 and 2023, which is central to understanding SPG's disclosure evolution and debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 375,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS’s foreign‑security portfolio shrank modestly from 2022 to 2023 – the fair value fell from $2.55 billion to $2.51 billion and gross unrealized losses were cut roughly in half, from $244 million to $122 million (page 147). By 2024 the fair‑value of foreign securities reported in the separate‑account portfolio had collapsed to only $51 million (down from $202 million a year earlier) (page 160), indicating the company has largely exited its foreign holdings and therefore reduced its exposure to international market risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. (1) 2022-2023 PERIOD: Ground truth shows foreign securities fair value INCREASED from $838M (2022) to $1,650M (2023), but LLM claims it DECREASED from $2.55B to $2.51B - this is completely wrong directionally and numerically. The LLM's $2.55B and $2.51B figures are not supported by the ground truth and appear to be fabricated or from a different portfolio category. For unrealized losses, LLM claims $244M in 2022 declining to $122M in 2023, but ground truth shows $24M in 2022 increasing to $122M in 2023 - the 2022 figure is off by a factor of 10. (2) 2024 DATA: LLM correctly identifies $51M fair value in 2024 and correctly notes the decline from prior year, but the prior year comparison is wrong (LLM says $202M, ground truth implies ~$1,650M from 2023). (3) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend. Ground truth shows: 2022 ($838M) → 2023 ($1,650M) = INCREASE, then 2023 ($1,650M) → 2024 ($51M) = SHARP DECLINE. LLM's narrative of a 'modest shrink' from 2022-2023 is factually incorrect. (4) INTERPRETATION: While the LLM's conclusion about de-risking and reduced international exposure is reasonable given the 2024 collapse, it's based on incorrect intermediate data, making the reasoning path flawed. The LLM appears to have confused different portfolio categories or misread source documents. All three years contain significant quantitative errors that undermine the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 431,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s filings for 2022, 2023 and 2024 all state that an internally‑developed NAIC designation is used only when a newly‑acquired non‑agency RMBS or CMBS has not yet been evaluated by the NAIC, after which a formal NAIC designation is applied (2022 p. 101; 2023 p. 94; 2024 p. 84). In each year the RMBS and CMBS holdings are presented entirely by NAIC designations – $25.5 bn RMBS and $9.8 bn CMBS in 2022 (p. 96), $28.4 bn RMBS and $9.7 bn CMBS in 2023 (p. 95), and $32.9 bn RMBS and $9.1 bn CMBS in 2024 (p. 86) – showing only modest growth and confirming that internal designations are a temporary bridge, while the company’s credit‑quality assessment remains firmly anchored in the NAIC modeling methodology.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific dollar amounts for RMBS and CMBS holdings across the three years (2022-2024) and correctly identifies that internally developed designations serve as a temporary bridge until NAIC designations become available. However, there are significant gaps in addressing the core question about the evolution of MetLife's reliance on internal designations and what the multi-year pattern reveals.\n\nSTRENGTHS:\n1. Quantitative data is presented with specific holdings: $25.5bn/$9.8bn (2022), $28.4bn/$9.7bn (2023), $32.9bn/$9.1bn (2024)\n2. Correctly identifies the transitional nature of internal designations\n3. Accurately states that holdings are presented by NAIC designations\n4. Proper citation format with page numbers\n\nWEAKNESSES:\n1. MISSING KEY METRIC: The ground truth emphasizes Level 3 fixed maturity securities AFS growth ($4.2 billion in 2023, $1.6 billion in 2024 with 14.5% and 4.9% growth rates respectively). The LLM answer completely omits this critical data point that directly addresses the evolution pattern.\n2. INCOMPLETE ANALYSIS: The ground truth reveals a meaningful trend - the SLOWING growth in Level 3 securities (from 14.5% to 4.9%) indicates increasing reliance on NAIC designations over time. The LLM answer notes \"modest growth\" but fails to quantify or analyze this deceleration pattern.\n3. MISSING HISTORICAL CONTEXT: The ground truth references the NAIC's updated modeling methodology refined as of December 31, 2021, providing important context for understanding the 2022 transitional phase. The LLM answer omits this.\n4. INCOMPLETE ANSWER TO MULTI-HOP QUESTION: The question asks what the pattern \"reveals about the company's reliance on NAIC modeling methodology.\" The ground truth provides a clear answer: \"gradual shift away from reliance on internal designations toward standardized NAIC assessments.\" The LLM answer states internal designations are a \"temporary bridge\" but doesn't synthesize the multi-year evolution into a clear conclusion about changing reliance patterns.\n5. REASONING GAP: The LLM answer presents data but doesn't connect the dots across years to show HOW reliance evolved. The ground truth shows this through the Level 3 growth deceleration pattern.\n\nQUANTITATIVE VERIFICATION:\n- RMBS amounts appear reasonable and follow expected trends\n- CMBS amounts show slight decline (expected for mature portfolio)\n- However, the critical missing metrics (Level 3 growth rates and dollar amounts) represent a major omission\n\nMULTI-HOP REASONING:\nThe question requires synthesizing: (1) internal designation usage patterns across 3 years, (2) NAIC methodology adoption timeline, and (3) what this reveals about reliance. The LLM answer addresses #1 partially and #2 implicitly, but fails to synthesize these into a coherent narrative about changing reliance patterns that the ground truth clearly establishes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 766,
        "total_tokens": 2278
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K Chevron still held a 31.5 % non‑operated working interest in the offshore Haute Mer permit and a 15.75 % interest in the Republic‑of‑Congo portion of the Lianzi field (see 2022 10‑K p. 31).  \n- In 2023 the company allocated roughly **$0.7 billion** to offshore development and natural‑gas projects in the Republic of Congo, reflecting continued capital investment in the area (2023 10‑K p. 109).  \n- By 2024 Chevron announced it would **sell both interests**—the 31.5 % stake in Haute Mer and the 15.75 % stake in Lianzi—effectively exiting its operational footprint in the Republic of Congo (2024 10‑K p. 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Chevron's evolution in the Republic of Congo from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - 31.5% nonoperated working interest in Haute Mer, 15.75% interest in Lianzi, and $0.7 billion capital allocation to offshore development and natural gas projects in Africa. The dollar amount matches the ground truth exactly. ENTITY ACCURACY: All entities correctly identified - Chevron, Republic of Congo, Haute Mer permit, Lianzi field, and the specific years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple documents (2022, 2023, and 2024 10-Ks), correctly tracing the evolution from active operation/investment to full divestiture. The logical progression is sound: 2022 (holdings), 2023 (continued investment), 2024 (exit). COMPLETENESS: The answer addresses all aspects of the question - capital allocation, asset ownership changes, and the overall trajectory. The inclusion of specific page references (p. 31, p. 109, p. 43) adds credibility. MINOR OBSERVATION: The LLM states the $0.7 billion was allocated \"to offshore development and natural-gas projects in the Republic of Congo\" while the ground truth indicates this was allocated to \"offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola.\" This is a slight semantic difference - the LLM's phrasing could be interpreted as exclusive to Congo rather than inclusive of multiple African countries. However, the core fact (the $0.7 billion figure and its allocation to African offshore projects) remains accurate. This minor contextual nuance does not significantly impact the overall correctness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 504,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept embedded‑processing products at the heart of its strategy, pairing them with analog as the “core” of the business model. Each 10‑K states that the company’s “great business model … is focused on analog and embedded processing products” and that this focus is embodied in the second of its four sustainable competitive advantages – a **broad portfolio of analog and embedded‑processing products** that creates more opportunity per customer and adds value to its investments (2022 p. 18; 2023 p. 18; 2024 p. 18). Thus, the strategic emphasis on embedded processing has remained steady, serving as a key pillar of the portfolio advantage that underpins TI’s long‑term cash‑flow growth and market reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. STRENGTHS: (1) Correctly identifies embedded processing as a core strategic component across all three years (2022-2024); (2) Accurately cites the specific positioning within TI's four sustainable competitive advantages (the second advantage: broad portfolio of analog and embedded-processing products); (3) Provides consistent page references (p. 18 for all three years) that align with typical 10-K structure; (4) Accurately synthesizes the multi-hop reasoning showing evolution from 2022 through 2024 while noting consistency; (5) Correctly identifies the dual focus on analog AND embedded processing as the 'core' of the business model; (6) Properly connects the strategic emphasis to broader business outcomes (customer opportunity, market reach, long-term cash-flow growth). MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth, explicitly naming the second of four competitive advantages and providing page citations, which adds credibility but goes slightly beyond the ground truth's scope; (2) The ground truth emphasizes 'evolution' and 'narrative reinforcement' across years, while the LLM emphasizes 'steady' consistency - both interpretations are valid and not contradictory, as the ground truth also concludes with 'consistent emphasis indicates a stable...strategic pillar'; (3) No quantitative errors detected - all references to years, company names, and strategic positioning are accurate. The answer successfully addresses the multi-hop requirement by synthesizing information across three separate 10-K filings and connecting embedded processing to the broader competitive advantage framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 478,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s $500 million 3.50 % senior note stayed the same size, but its effective interest rate climbed sharply – about 3.20 % in FY 2022 (see the long‑term debt table on page 89 of the 2022 filing) → 6.38 % in FY 2023 → 6.66 % in FY 2024 (both shown on page 89 of the 2024 filing). The more than‑doubling of the effective rate signals that Cisco’s borrowing cost on this note has risen markedly as market rates have increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the $500 million principal amount, the three effective interest rates (3.20% FY2022, 6.38% FY2023, 6.66% FY2024), and the fiscal year progression. The multi-hop synthesis is sound - the answer correctly traces the evolution of the effective rate across three fiscal years and properly identifies this as a significant increase in borrowing costs. The LLM appropriately characterizes the more-than-doubling of the effective rate and correctly attributes this to market rate increases. The answer includes helpful contextual details (page references to source documents, note maturity date of June 2025) that enhance credibility without being required. The reasoning about what the progression indicates (market rate increases and investor risk perception) aligns with the ground truth interpretation. Minor strengths: the answer uses clear formatting with arrows to show progression, making the trend immediately apparent. The only negligible difference is that the LLM uses slightly more colloquial phrasing ('climbed sharply,' 'more than-doubling') compared to the ground truth's more formal tone, but this is a stylistic choice that doesn't affect factual accuracy. All entities are correctly identified (Cisco, the specific note, fiscal years), and the multi-hop reasoning successfully synthesizes information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 398,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "- In the 2022 Form 10‑K the company warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p. 3).  \n- The same caveat appears unchanged in the 2023 filing (Risk Factors, p. 5) and again in the 2024 filing (Risk Factors, p. 5).  \n\nThis three‑year consistency shows that BNY Mellon’s exposure to U.S. banking‑law limits on capital planning has remained steady, indicating that regulatory constraints are a persistent ceiling on shareholder‑return flexibility and that the firm’s strategic choices must continually accommodate these rules.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year period (2022-2024) and accurately cites the core regulatory constraint language about capital planning and shareholder returns. (2) The page references (2022 p. 3, 2023 Risk Factors p. 5, 2024 Risk Factors p. 5) appear reasonable and specific. (3) The quantitative accuracy is high - no incorrect numbers or dates are present. (4) The LLM correctly identifies BNY Mellon as the subject company.\n\nCRITICAL WEAKNESSES: (1) The LLM fundamentally mischaracterizes the evolution described in the ground truth. The ground truth explicitly states the language 'remained largely consistent with 2023' but notes IMPORTANT CHANGES: 2023 added specific references to Delaware law and preferred stock dividend obligations; 2024 added 'stronger emphasis on liquidity management and potential consequences of failing to meet regulatory standards such as \"well capitalized\" and \"well managed\" status.' (2) The LLM claims 'the same caveat appears unchanged' across all three years, which directly contradicts the ground truth's documentation of evolving language and emphasis. (3) The LLM completely misses the multi-year progression that the question specifically asks about - it treats the three years as static rather than showing how the company's disclosure evolved. (4) The LLM fails to capture the increasing emphasis on liquidity risk, regulatory status consequences, and the interplay between capital planning and liquidity that the ground truth identifies as key to understanding the progression. (5) The conclusion that regulatory constraints 'remained steady' oversimplifies and misses the nuanced evolution in how BNY Mellon framed these constraints over time.\n\nMULTI-HOP REASONING ASSESSMENT: The LLM failed to synthesize the multi-year evolution properly. While it correctly identified the baseline constraint in 2022, it did not trace how the company's emphasis and framing changed in 2023 and 2024. The question explicitly asks 'how did...evolve' and 'what does this progression reveal' - the LLM's answer that nothing changed is factually incorrect based on the ground truth.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation that consistency equals 'unchanged' is semantically incorrect when the ground truth documents specific additions and emphasis shifts in 2023 and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 625,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ “Repair and other services” line fell $37 million, dropping from $1,169 million in 2022 to $1,132 million in 2023 (≈3 % decline) and then held steady at $1,132 million in 2024 【page_9】. The segment’s revenue is tied to ongoing post‑delivery maintenance, modernization and lifecycle‑support contracts for Navy ships—a mature, recurring business that does not fluctuate much year‑to‑year, which explains the flat 2024 result 【page_8】. This pattern signals that the repair‑services business is a stable, strategically important cash‑flow source rather than a high‑growth driver.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures ($1,169M in 2022, $1,132M in 2023 and 2024) and accurate calculation of the decline ($37 million, approximately 3%). The multi-hop synthesis is sound, correctly identifying the revenue trajectory across three years and explaining the pattern. The answer appropriately addresses all parts of the question: the change from 2022 to 2023, the flat performance in 2024, and interpretation of what this pattern suggests. The LLM provides additional context about the nature of the business (post-delivery maintenance, modernization, lifecycle-support contracts for Navy ships) that enriches understanding beyond the ground truth answer. The characterization of the segment as 'stable, strategically important cash-flow source rather than a high-growth driver' aligns well with the ground truth's assessment of 'limited growth or strategic prioritization.' Minor differences exist in framing: the LLM emphasizes stability and recurring revenue nature, while the ground truth mentions possible market saturation or resource reallocation. Both interpretations are reasonable given the data. The LLM's explanation that the business is 'mature, recurring' and 'does not fluctuate much year-to-year' provides a plausible explanation for the flat 2024 result that complements the ground truth's more speculative causes. No calculation errors detected. All numbers verified as correct. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 420,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s venture‑type equity securities grew from about **$3.7 billion in 2022 to $4.9 billion in 2023 and remained at $4.9 billion in 2024**【page_50】, while its **equity‑method stakes in health‑care operating businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then more than doubled to $3.8 billion in 2024**【page_52】.  The rise in unrealized gains on the venture portfolio—from **$211 million in 2022 to $276 million in 2023 and $710 million in 2024**【page_54】—shows the company’s continued and increasingly valuable focus on venture investments, whereas the sharp jump in equity‑method holdings in 2024 signals a strategic shift toward deeper ownership of health‑care operators.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN EQUITY METHOD INVESTMENTS: The LLM states equity-method stakes were '$1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then more than doubled to $3.8 billion in 2024.' However, the ground truth clearly indicates: $1.4 billion in 2022, $1.5 billion in 2023 (not a slip), and $3.8 billion in 2024. The LLM reversed the 2022-2023 values, stating $1.5B in 2022 when it should be $1.4B, and $1.4B in 2023 when it should be $1.5B. This is a significant factual error in a core metric. CORRECT ELEMENTS: (1) Venture-type equity securities figures are accurate: $3.7B (2022), $4.9B (2023), $4.9B (2024). (2) The 2024 equity-method figure of $3.8B is correct. (3) Unrealized gains progression ($211M → $276M → $710M) appears accurate and adds valuable context. (4) Strategic interpretation about the shift toward deeper ownership in 2024 is sound and well-reasoned. (5) Multi-hop synthesis across venture investments, equity method investments, and unrealized gains is logically structured. ASSESSMENT: The answer demonstrates good understanding of the strategic narrative and correctly identifies the 2024 shift toward integrated healthcare business investments. However, the transposition of 2022-2023 equity method values is a material factual error that undermines quantitative accuracy. The inclusion of unrealized gains data (not in ground truth but contextually relevant) shows good analytical depth. The semantic interpretation of 'strategic shift' is appropriate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 418,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. has been listed in PMI’s peer group in every filing – the 2022 10‑K (see page 21) includes it in the peer‑group list, the 2023 10‑K (see page 24) states the peer group is unchanged and again names Colgate‑Palmolive, and the 2024 10‑K (see page 26) repeats the same composition with Colgate‑Palmolive. This three‑year continuity shows that PMI’s benchmarking framework is deliberately stable, applying the same four‑criterion, size‑and‑focus‑based methodology (global presence, consumer‑product focus, comparable net revenues and market cap, plus primary tobacco peers) to a fixed set of peers for consistent performance comparison and strategic assessment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive Co. was consistently included in PMI's peer group across all three years (2022, 2023, 2024); (2) Accurately cites the four criteria for peer group classification (global presence, consumer-product focus, comparable net revenues and market cap); (3) Properly synthesizes the multi-hop information showing year-over-year consistency; (4) Correctly interprets this consistency as evidence of a stable, deliberate benchmarking framework; (5) Appropriately references specific page numbers from the filings (pages 21, 24, 26), demonstrating document-level accuracy. MINOR ISSUES: (1) The LLM adds a phrase about 'primary tobacco peers' in parentheses that is somewhat ambiguous - the ground truth notes PMI 'excluded direct tobacco industry peers from the comparison,' which is slightly different framing. The LLM's phrasing could be misread as suggesting tobacco peers were included in the methodology, though context suggests the LLM meant they were excluded; (2) The ground truth emphasizes that PMI excluded tobacco peers while maintaining consumer products peers, whereas the LLM's phrasing is less explicit about this exclusion strategy. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page references appear reasonable for 10-K filings; no calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and properly connects the consistency of peer group membership to conclusions about PMI's strategic benchmarking framework. The logical flow from observation (consistent inclusion) to interpretation (stable framework) is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis but no material factual divergence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 513,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "In the 2022 filing PayPal warned that “new and continually evolving forms of fraud…in connection with new or expanded product offerings” could raise loss exposure (see page 28). By 2023‑24 the risk discussion had broadened: the company now stresses that “failure to deal effectively with fraud, abusive behaviors…may increase our loss rate” (page 24) and that “measures to detect and reduce the risk of fraud and abusive behavior…may not be effective…especially with new or expanded product offerings” (page 26), while also noting that its “credit products expose us to additional risks” and that it “relies on third‑parties…which creates additional risk” (pages 22, 23, 25). This progression shows PayPal’s exposure to abusive behavior has risen as its credit portfolio and third‑party dependencies have grown, suggesting that its fraud‑mitigation controls are being stretched and may not be keeping pace with the expanding risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's evolving fraud and abuse exposure across 2022-2024, with generally accurate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the progression of PayPal's risk exposure across the three-year period; (2) Accurately captures the shift from general fraud warnings in 2022 to more specific concerns about credit products and third-party dependencies in 2023-24; (3) Properly synthesizes the connection between expanding credit offerings and increased fraud/abuse risks; (4) Correctly notes that mitigation controls appear to be lagging behind risk growth; (5) Page citations (28, 24, 26, 22, 23, 25) suggest proper source documentation. WEAKNESSES: (1) The LLM answer omits the specific €40 billion BNPL receivables sale agreement mentioned in the ground truth as a concrete example of credit expansion - this is a material detail that quantifies the scale of new risk exposure; (2) Does not mention regulatory uncertainty regarding loan receivables post-sale validity, which the ground truth identifies as a specific 2024 concern; (3) The answer is somewhat more general/qualitative than the ground truth, which provides specific examples and figures; (4) Missing the explicit mention of stolen identities and financial instruments as specific abuse vectors noted in 2022. QUANTITATIVE ACCURACY: The answer contains no specific dollar amounts or percentages, relying instead on qualitative descriptions. The €40 billion figure from ground truth is absent, which represents a notable omission of quantitative detail. MULTI-HOP REASONING: The synthesis across years and the connection between credit expansion and fraud risk is sound and logically presented. The answer correctly identifies the causal relationship between product expansion and mitigation effectiveness gaps. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - PayPal's exposure has increased, controls are being stretched, and the company's mitigation effectiveness appears to be lagging. The wording differs but conveys similar meaning. The answer would have scored 8-9 if it had included the €40 billion receivables agreement and regulatory concerns as concrete examples of the risk evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 602,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume grew from roughly 214 mmBtu at 12/31/2022 to a peak of about 339 mmBtu at 12/31/2023, then dropped to roughly 176 mmBtu at 12/31/2024【page_117†L31-L38】【page_114†L31-L38】. The rise in 2023 shows the firm leaned more heavily on options when gas‑price volatility was heightened, while the 2024 decline—accompanied by a shift toward swaps (255 mmBtu in 2024 versus 109 mmBtu in 2023)【page_114†L31-L38】—suggests a flexible risk‑management strategy that adjusts the mix of hedging instruments to changing market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2022 BASELINE: The LLM reports 214 mmBtu for 12/31/2022, but the ground truth states 253 million mmBtu for 2022. This is a significant 15% understatement of the starting point, which affects the entire trend analysis. The 2023 figure of 339 mmBtu matches ground truth correctly. The 2024 figure of 176 mmBtu also matches ground truth. QUANTITATIVE ACCURACY ISSUES: (1) 2022 baseline is incorrect (214 vs 253 mmBtu) - this is a material error; (2) The LLM correctly identifies the 2023 peak and 2024 decline; (3) The swap data (255 mmBtu in 2024 vs 109 mmBtu in 2023) is additional context not in the ground truth but appears to be supplementary information that enhances the answer. QUALITATIVE REASONING: The LLM's interpretation of the trend is sound - it correctly identifies the 2023 increase as a response to heightened volatility and the 2024 decline as a strategic shift. The connection to swap usage is a logical extension showing portfolio rebalancing. However, the incorrect 2022 baseline undermines the accuracy of the 3-year trend characterization. MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three years and connects it to risk management strategy, showing good reasoning. The addition of swap data demonstrates cross-metric synthesis. SEMANTIC EQUIVALENCE: The qualitative interpretation aligns with ground truth (dynamic response, de-risking, market adjustment), but the quantitative foundation is flawed. The 2022 error is not a minor formatting difference but a substantive numerical mistake that affects trend magnitude analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 438,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans grew from **$70 million in 2022** to **$75 million in 2023** and **$76 million in 2024**【page_43】. At the same time, the company notes that its **non‑qualified defined‑benefit pension plans are unfunded and closed to new participants**【page_43】, suggesting a deliberate shift toward expanding and funding defined‑contribution benefits while limiting exposure to legacy, unfunded defined‑benefit obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the three-year progression ($70M in 2022, $75M in 2023, $76M in 2024) matches the ground truth exactly. (2) Numbers are properly formatted and cited with page references. (3) The LLM correctly identifies the trend as a steady increase. (4) The multi-hop synthesis correctly connects the defined contribution plan expenses to the non-qualified defined benefit pension plan status. (5) The reasoning about strategic shift toward defined contribution benefits while limiting defined benefit exposure is sound and well-articulated.\n\nWEAKNESSES: (1) The LLM answer omits important contextual detail from the ground truth - specifically the mention that defined benefit plans were closed to new participants in 1997, which provides historical context for understanding the long-term strategy. (2) The ground truth emphasizes that the trend reflects 'growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan' and mentions 'enhanced defined contribution plan' - the LLM's framing focuses more on limiting defined benefit exposure rather than the positive commitment to defined contribution benefits for employees. (3) The ground truth explicitly connects the trend to 'flexible retirement options' and employees who 'opted out' - the LLM frames it more as a strategic shift away from legacy obligations rather than toward enhanced employee choice.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple data points (three years of expense data + non-qualified plan status) and correctly interprets the relationship between the two. The logic is sound.\n\nCONCLUSION: The answer is factually accurate on all numbers and demonstrates correct multi-hop reasoning, but lacks some of the nuanced contextual framing present in the ground truth regarding the company's long-standing commitment to flexible retirement options and the historical closure of plans to new participants.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 552,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM’s long‑term return assumption for its U.S. defined‑benefit pension plans was 6.3 % in both 2022 and 2023, and the 2024 filing shows the company raised that assumption to about 6.5 % for year‑end 2024【page_87 (2023)】. The upward shift indicates GM is now expecting higher future asset performance and is willing to assume a slightly higher level of investment risk to improve the funded status of its pension plans【page_88 (2024)】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 rate of return assumption. According to the ground truth, GM reported 5.4% in 2022, but the LLM states 6.3% for 2022. The LLM correctly identifies 6.3% for 2023 and 6.5% for 2024, but the missing/incorrect 2022 baseline (5.4%) is essential to answering the question about the evolution 'from 2022 through 2024.' This is a significant quantitative error that undermines the entire multi-hop analysis. The LLM's statement that the rate 'remained unchanged at 6.3%' in 2023 is correct relative to 2022, but only if 2022 were actually 6.3% - which it was not. The reasoning about increased risk tolerance and improved funded status is qualitatively sound and semantically appropriate, but it's built on an incorrect numerical foundation. The LLM does correctly identify the 2024 increase to 6.5% and provides reasonable interpretation of what this trend suggests. However, by missing the 5.4% starting point in 2022, the LLM fails to capture the full magnitude of the upward trend (from 5.4% to 6.5% = 1.1 percentage point increase) and misrepresents the evolution pattern. The answer is incomplete in addressing the full 2022-2024 timeline with accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 352,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation moved from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024, while the notional amount of the swaps grew from $651 million (2022) to $792 million (2023) and $985 million (2024)【page_92】【page_91】. This shift from a loss to increasing gains, together with a larger hedge notional, indicates that Cisco’s use of total‑return swaps to economically hedge deferred‑compensation risk is becoming more effective, reducing compensation‑expense volatility and reflecting a proactive risk‑management and compensation‑strategy approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The notional amounts are also accurate ($651M in 2022, $792M in 2023, $985M in 2024), providing additional context not in the ground truth but consistent with multi-hop synthesis from SEC filings. The answer correctly identifies the three-year progression and the shift from loss to gains. The reasoning about improved market conditions and strategic adjustments is sound and matches the ground truth interpretation. The LLM goes beyond the ground truth by adding the notional amount data and explicitly connecting the growing notional amounts to the effectiveness of the hedging strategy, which represents enhanced analysis rather than error. The multi-hop synthesis across fiscal years is accurate and well-structured. Minor point: The LLM's interpretation about 'becoming more effective' and 'reducing compensation-expense volatility' is a reasonable inference from the data progression, though the ground truth uses slightly more cautious language ('potentially reflecting'). This represents appropriate analytical depth rather than overstatement. All entities (Cisco, total return swaps, deferred compensation, fiscal years) are correctly identified. The answer fully addresses the question's components regarding evolution, realized gains/losses, and implications for risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 411,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s margin‑risk exposure has not changed from 2022 through 2024. In each year the company describes itself as the principal on its payments platform, with full discretion over the fees it charges and therefore full control of pricing, and it “bears full margin risk when completing a payment transaction” while the fees it pays to third‑party processors are recorded as transaction expense (2022 Note 2‑Revenue p. 80; 2023 Note 2‑Revenue p. 75; 2024 Note 2‑Revenue p. 73).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. STRENGTHS: (1) Correctly identifies that PayPal's margin risk exposure remained consistent across 2022-2024 with no structural changes; (2) Accurately states PayPal describes itself as principal with full discretion over fees; (3) Correctly notes that fees paid to third-party processors are recorded as transaction expense; (4) Properly cites specific page numbers from the filings (Note 2-Revenue sections); (5) All factual claims are accurate and verifiable. MINOR WEAKNESSES: (1) The answer is more concise than the ground truth and omits some contextual details - specifically, it doesn't mention the 2023 clarification about tiered pricing not constituting a future material right, which was explicitly noted in the ground truth; (2) Doesn't explicitly reference the 2024 adoption of new segment reporting disclosures mentioned in the original answer, though this is a minor detail; (3) The phrasing 'has not changed from 2022 through 2024' is slightly different from the ground truth's 'consistent exposure...without structural changes,' though semantically equivalent. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the consistent pattern of margin risk exposure and transaction cost recognition. The citation of specific filing locations (page numbers and note references) demonstrates proper source synthesis. QUANTITATIVE ACCURACY: No numerical errors; all references to years (2022, 2023, 2024) are correct. The answer appropriately avoids making unsupported numerical claims. OVERALL ASSESSMENT: This is a strong answer that captures the essential findings with accurate facts and sound reasoning. The omission of the tiered pricing clarification and segment reporting disclosure details prevents a perfect score, but these are relatively minor contextual elements rather than core factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 534,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola LNG natural‑gas output was 49 MMCFD in 2022, fell to 48 MMCFD in 2023, and held steady at 48 MMCFD in 2024【CVX_10k_2023.pdf page 9】【CVX_10k_2024.pdf page 9】. The near‑flat trend indicates Chevron is preserving a steady supply to the Angola LNG project, underscoring a strategic emphasis on maintaining a reliable foothold in the global LNG market rather than aggressively expanding volume.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all quantitative metrics. (1) NUMBERS ARE WRONG: The ground truth states Angola LNG natural gas production was 592 MMCFD (2022), 596 MMCFD (2023), and 609 MMCFD (2024). The LLM claims 49 MMCFD (2022), 48 MMCFD (2023), and 48 MMCFD (2024) - these are off by a factor of approximately 12x. The correct figures are in the 590-610 range, not 48-49 range. (2) TREND ANALYSIS IS INVERTED: Ground truth shows a clear upward trajectory (592→596→609, a +17 MMCFD increase over 3 years). The LLM incorrectly describes a 'near-flat trend' with a decline from 2022 to 2023 (49→48), which contradicts the actual data showing consistent growth. (3) STRATEGIC INTERPRETATION IS BACKWARDS: The ground truth indicates 'growing operational emphasis' and 'strengthening position' based on increasing volumes. The LLM's interpretation of 'preserving steady supply' and 'maintaining a reliable foothold' is inconsistent with the actual upward volume trend and mischaracterizes the strategic positioning. (4) MULTI-HOP SYNTHESIS FAILED: The LLM failed to correctly synthesize the three-year production data to identify the growth pattern and its strategic implications. The answer demonstrates a fundamental misreading or misinterpretation of the source documents cited. This is a complete factual failure on the primary quantitative metrics that form the basis of the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 395,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 10‑K the company only described outdoor‑lighting contracts as short‑term operating leases and explicitly said the cash‑flow impact was immaterial (e.g., “the undiscounted cash flows … at Mississippi Power are immaterial” – p. 268‑270), with scheduled payments merely referenced in a maturity analysis. By the 2023 filing the maturity table for Southern Power now shows a $1 billion “Thereafter” operating‑lease obligation, indicating that the scheduled payments from those contracts had become material (p. 239). The 2024 filing goes further, quantifying the cash flows at $15 million per year through 2028 and $185 million thereafter and separating them from variable lease costs, underscoring the contracts’ growing structural importance to Southern Power’s lease portfolio (p. 241).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($1 billion 'Thereafter' obligation in 2023, $15 million per year through 2028, $185 million thereafter in 2024) with page references (p. 239, p. 241) that cannot be verified against the ground truth. The original answer makes no such specific quantifications for 2023 or 2024, only noting that outdoor lighting contracts were 'immaterial' in 2022 and then 'included in maturity analyses' and 'integrated into lease income reporting' in subsequent years without providing dollar figures. (2) FACTUAL DIVERGENCE: The LLM claims the 2023 maturity table shows a '$1 billion Thereafter operating-lease obligation' - this specific figure is not mentioned in the ground truth, which only states that scheduled payments were 'included in maturity analyses.' The LLM appears to have fabricated or misattributed specific numbers. (3) MULTI-HOP REASONING: While the LLM correctly identifies the three-year progression (2022→2023→2024) and the general trend of increasing materiality, it does so by introducing unsupported quantitative claims rather than synthesizing the actual disclosed information. (4) PAGE REFERENCES: The LLM provides specific page numbers (268-270, 239, 241) that suggest precision but cannot be verified against the ground truth provided, raising concerns about hallucination. (5) SEMANTIC ACCURACY: The LLM's characterization of the evolution is directionally correct (immaterial→material→integrated), but the supporting evidence is fabricated rather than derived from actual filings. The answer would mislead a reader seeking to verify these specific financial figures in the actual 10-K documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 493,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility was listed as serving only the Analog segment in each filing – the 2022 10‑K shows an “X” under Analog and none under Embedded Processing (page 16), the 2023 10‑K repeats the same pattern (page 18), and the 2024 10‑K again shows only an Analog “X” (page 16). Thus, the Melaka footprint did not expand to Embedded Processing; it remained an Analog‑only site throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - the answer accurately states that Melaka served only the Analog segment in all three years (2022, 2023, 2024) with no Embedded Processing involvement. (2) The answer correctly cites specific page references from the 10-K filings (pages 16, 18, 16 respectively), demonstrating proper source documentation. (3) The multi-hop synthesis is sound - the answer successfully synthesizes information across three separate annual filings to establish a consistent pattern. (4) The conclusion is logically derived from the evidence presented - that the footprint remained unchanged and did not expand. (5) Entity identification is correct - Texas Instruments (TXN), Melaka Malaysia, Analog segment, and Embedded Processing segment are all properly identified. (6) The answer uses appropriate notation ('X' marks) consistent with SEC filing conventions. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific detail (page numbers, 'X' notation) than the ground truth, but this adds value rather than detracting from accuracy. The semantic meaning is fully aligned with the ground truth - both convey that Melaka remained an Analog-only operation throughout the period with no expansion to Embedded Processing. No numerical errors, calculation errors, or factual inaccuracies are present. The answer fully addresses all aspects of the question regarding the evolution (or lack thereof) of the operational footprint across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 453,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "- 2022: The 1.600 % senior notes were issued for a $700 million aggregate principal, pay interest semi‑annually on April 15 and October 15, and have a par‑call on March 15 2026【page_48】.  \n- 2023: The same $700 million principal, payment dates and par‑call remain unchanged, with a modest reduction in the unamortized discount/premium (adjustment –$2.6 m versus –$3.7 m the prior year)【page_110】.  \n- 2024: The notes still carry the $700 million principal, the April/October interest schedule and the March 15 2026 par‑call, and the net adjustment further shrinks to –$1.5 m【page_113】.  \n\nThe unchanged size, rate and call date across three years—while the carrying amount gradually declines as discounts/premiums amortize—shows AMT’s strategy of locking in low‑cost, long‑dated financing and steadily winding down its issuance costs rather than refinancing or altering the debt terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question about AMT's 1.600% Notes evolution from 2022-2024. STRENGTHS: (1) All quantitative data is correct: $700.0 million principal amount consistently maintained across all three years, interest payment dates (April 15 and October 15) accurate, par call date (March 15, 2026) correct. (2) Adjustment figures are precisely accurate: -$2.6 million in 2023 (vs -$3.7 million in 2022) and -$1.5 million in 2024, matching ground truth exactly. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across three fiscal years, identifying the key pattern of stable principal and terms while adjustments decreased. (4) Debt management strategy interpretation is insightful and well-reasoned: the LLM correctly identifies that the unchanged terms represent a 'lock-in' strategy for low-cost, long-dated financing, and that the declining adjustments reflect amortization of issuance costs rather than refinancing activity. (5) Entity identification is accurate (AMT, 1.600% Notes, specific dates and amounts). MINOR CONSIDERATIONS: The LLM answer is slightly more interpretive in its final paragraph than the ground truth (which states consistency 'suggests' a stable approach), but this interpretation is logically sound and adds value without contradicting the ground truth. The presentation is clear with year-by-year breakdown that enhances readability. No calculation errors detected. The answer fully addresses all components of the multi-part question: principal amount evolution, interest payment schedule, par call date, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 454,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco kept the 5.90 % senior note unchanged at a $2 billion principal with an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024 (see the senior‑notes table on page 89 for each year).  However, total debt grew from $8.9 billion in FY 2022 to $20.1 billion in FY 2023 and FY 2024 (page 89), so the note’s share fell from roughly 22 % of total debt to about 10 % while its cost stayed the same.  This shows Cisco is retaining the 5.90 % issue as a long‑dated anchor but is expanding its financing mix with larger, lower‑cost senior‑note issuances to diversify maturity and lower the overall weighted‑average cost of debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine its credibility. (1) TOTAL DEBT FIGURES ARE WRONG: Ground truth states total long-term debt was $8,416M in 2022 and $19,621M in 2024. The LLM claims $8.9B in FY2022 and $20.1B in FY2023/2024. While $8.9B is reasonably close to $8.416B (within rounding), the $20.1B figure is notably higher than the ground truth's $19.621B. More problematically, the LLM conflates FY2023 and FY2024 as the same ($20.1B), which obscures the year-by-year evolution the question specifically asks about. (2) PERCENTAGE CALCULATIONS ARE INCORRECT: The LLM calculates the 5.90% Note as 'roughly 22% of total debt' in FY2022 ($2,000M / $8,900M ≈ 22.5%) and 'about 10%' in later years ($2,000M / $20,100M ≈ 9.95%). However, using ground truth figures: FY2022 would be $2,000M / $8,416M ≈ 23.8%, and FY2024 would be $2,000M / $19,621M ≈ 10.2%. The percentages are directionally correct but based on slightly inaccurate base figures. (3) MISSING SHORT-TERM DEBT DATA: The ground truth explicitly mentions short-term debt decreased from $499M to $488M, which is relevant to total debt composition. The LLM focuses only on long-term debt and doesn't address this component. (4) CORRECT ELEMENTS: The LLM correctly identifies the 5.90% Note at $2 billion with 6.11% effective rate held constant across all three years. The strategic interpretation about diversifying the financing mix with lower-cost instruments is reasonable and aligns with the ground truth's conclusion about stabilizing financing costs. (5) MULTI-HOP REASONING: The LLM demonstrates sound reasoning in connecting the stable note amount to changing debt composition and inferring strategic intent, though the numerical foundation is flawed. The answer addresses the evolution question but with imprecise data points that compound across the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 514,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics built 360 new LAVs for the Canadian Army in 2022 (page 11), ramped that up to 449 new LAVs in 2023 (page 10), and then produced 399 new LAVs in 2024 (page 11). The sharp increase in 2023 reflects a deliberate strategic push to expand its LAV manufacturing capacity for the Canadian market, while the modest dip in 2024 suggests a shift toward fulfilling existing orders and fine‑tuning production rather than a retreat from its focus on LAVs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the production volumes and their sequence. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units. LLM answer states: 2022=360 units (correct), 2023=449 units (INCORRECT - should be 399), 2024=399 units (INCORRECT - should be 449). The LLM has reversed the 2023 and 2024 figures. This is a critical error that completely inverts the narrative - the ground truth shows consistent growth through 2024, while the LLM incorrectly describes a 'sharp increase in 2023' followed by a 'modest dip in 2024.' MISSING INFORMATION: The LLM answer fails to mention the LRSS (Light Armoured Vehicle Reconnaissance Surveillance System) program that added 66 specialized LAVs in 2024, which is a key component of the ground truth answer demonstrating GD's strategic expansion. REASONING IMPACT: Because the numbers are reversed, the LLM's interpretation of strategic intent is backwards - it suggests a retreat/consolidation in 2024 when the ground truth indicates accelerating growth and expansion. The multi-hop synthesis is fundamentally compromised by the data errors. PARTIAL CREDIT: The answer correctly identifies General Dynamics, the Canadian Army context, and attempts to address the strategic focus question, but the execution is severely flawed due to transposed production figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 384,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 2022 Form 10‑K warned that CMS could change the way Medicare Advantage risk‑adjustment payments are calculated, exposing the company to possible payment cuts or recoupments (2022 p. 20). The 2023 filing reiterated that risk‑adjustment methodology changes remained a material risk and that UnitedHealth continued to mitigate it by selectively adjusting member benefits and premiums, withdrawing plans from certain counties and tightening both medical and operating cost controls (2023 p. 20‑21). The 2024 filing again highlighted ongoing exposure to CMS risk‑adjustment changes and confirmed the same strategic response—targeted benefit/premium tweaks, plan‑withdrawals and intensified cost‑management efforts—to offset the funding pressure (2024 p. 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of UnitedHealth's exposure to Medicare Advantage risk adjustment payment changes; (2) Accurately captures the consistent pattern of CMS methodology changes and UnitedHealth's strategic responses across all three years; (3) Properly synthesizes multi-hop information by connecting CMS actions to company responses across multiple filings; (4) Correctly identifies specific strategic adjustments: selective benefit/premium adjustments, county withdrawals, and cost management intensification; (5) Appropriately cites page references (p. 20, p. 20-21) showing document-level specificity; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'targeted benefit/premium tweaks' vs 'selective benefit and premium adjustments'). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase about 'beneficiary health status data submissions' mentioned in 2024, though this is a minor detail that doesn't affect the core answer; (2) The ground truth emphasizes 'sustained operational agility' as a meta-conclusion, while the LLM focuses on the specific tactical responses—both are valid interpretations. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, which is appropriate given the question's focus on strategic evolution rather than financial metrics. The three-year period (2022-2024) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the pattern of recurring CMS actions and consistent company responses, demonstrating sound multi-hop reasoning. The answer directly addresses both parts of the multi-part question: (1) how exposure evolved, and (2) what strategic adjustments were made.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 538,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022 and remained exactly $1.5 billion at year‑end 2023 and again at year‑end 2024【page_107】【page_104】.  This flat exposure indicates the company is deliberately keeping a sizable, low‑cost, long‑dated tranche of debt unchanged, reflecting a strategy of locking in inexpensive financing and preserving a stable, predictable long‑term debt profile rather than expanding or retiring that series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - the $1.5 billion carrying value is accurately stated for all three years (2022, 2023, 2024), matching the ground truth exactly. The percentage rate (2.850%) is correct. No calculation errors present. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained constant at $1.5B across all three years), and (2) what this indicates about long-term debt strategy (deliberate preservation of low-cost, long-dated financing). ENTITY ACCURACY: Company correctly identified as PayPal (PYPL), years correctly specified (2022-2024), financial metric correctly identified (fixed-rate notes). REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connected the constant carrying value across years to strategic intent. The interpretation that this reflects a strategy of 'locking in inexpensive financing' and 'preserving a stable, predictable long-term debt profile' is logically consistent with the ground truth's characterization of 'consistent long-term debt strategy' and 'strategic intent to preserve this liability structure.' SEMANTIC EQUIVALENCE: The LLM's phrasing ('deliberately keeping,' 'locking in inexpensive financing,' 'stable, predictable long-term debt profile') conveys essentially the same strategic meaning as the ground truth's 'consistent long-term debt strategy' and 'strategic intent to preserve this liability structure.' Minor difference: The LLM adds slightly more interpretive detail about 'low-cost' and 'long-dated' characteristics, which is reasonable inference from the data but goes marginally beyond the ground truth's more concise statement. This is not an error but rather appropriate elaboration. The citation references (page_107, page_104) suggest proper source documentation. Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 552,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "In 2022 Chevron’s equity stake in Angola LNG Limited was 36.4 % and the carrying value of the investment was $1.96 billion, generating $1.86 billion of equity earnings for the year (Note 15, $1,963 m investment; $1,857 m earnings)【page_82】. By 2023 the ownership percentage was unchanged but the investment value slipped to $1.76 billion and equity earnings fell sharply to $513 million, reflecting a temporary earnings dip while the stake remained intact【page_82】. In the 2024 filing Chevron again emphasizes its 36.4 % shareholding in Angola LNG Limited and shows how it is expanding the gas supply chain—completing the Sanha Lean Gas Connection Project to tie new pipelines from Blocks 0 and 14 to the LNG plant and advancing the New Gas Consortium project to feed additional gas—demonstrating a deliberate, long‑term strategy to monetize Angola’s natural‑gas resources through integrated upstream, mid‑stream and LNG processing assets【page_14】【page_13】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct ownership percentages (36.4% across all three years) and reasonable financial figures ($1.96B in 2022, $1.76B in 2023). The equity earnings numbers ($1.86B in 2022, $513M in 2023) appear plausible and are cited with specific page references. The answer correctly identifies the multi-year consistency of the ownership stake and provides good contextual detail about the strategic evolution. However, there are some notable gaps and discrepancies: (1) The original answer specifically mentions Blocks 49 and 50 exploration acreage and the Quiluma and Maboqueiro (Q&M) gas fields within the New Gas Consortium Project, but the LLM answer instead references the Sanha Lean Gas Connection Project with Blocks 0 and 14, which appears to be different infrastructure. This represents a factual discrepancy in the specific projects mentioned. (2) The LLM answer provides more detailed financial metrics (carrying values and equity earnings) than the original answer, which adds value but wasn't explicitly required. (3) The reasoning about the strategic evolution from standalone facility to integrated hub is present in both answers, but the LLM provides more specific project details (though potentially incorrect ones). (4) The multi-hop synthesis is sound—connecting ownership consistency with strategic evolution—but the specific upstream projects cited differ from the ground truth. The answer demonstrates good understanding of the overall strategic positioning but appears to conflate or misidentify specific upstream development projects, which is a material factual error in a multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 458,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust holdings have risen each year – domestic‑equity investments grew from $829 million in 2022 (page 283) to $973 million in 2023 (page 281) and to $1,099 million in 2024 (page 273), while private‑equity stakes increased from $161 million to $169 million and then to $181 million over the same span. The consistent upward trend, especially the larger boost in domestic equity, shows the company is deliberately expanding long‑term equity exposure and modestly scaling private‑equity positions as part of a capital‑allocation strategy focused on diversified, higher‑return investments for future growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are fundamental to answering this question. Specifically: (1) 2022 Domestic Equity: LLM states $829 million, but ground truth shows $1,016 million - this is a $187 million error (18% understatement). (2) 2023 Domestic Equity: LLM states $973 million, but ground truth shows $829 million - this is a $144 million error (17% overstatement). (3) 2023 Private Equity: LLM states $169 million, but ground truth shows $161 million - a $8 million error. The LLM has essentially reversed or confused the 2022 and 2023 domestic equity figures. (4) The 2024 figures ($1,099 million domestic equity and $181 million private equity) are correct. MULTI-HOP REASONING FAILURE: Because the foundational numbers are wrong, the entire narrative about the progression is incorrect. The ground truth shows domestic equity DECREASED from 2022 to 2023 ($1,016M to $829M), then REBOUNDED in 2024 ($1,099M) - a V-shaped pattern. The LLM incorrectly portrays a consistent upward trend across all three years. This fundamentally mischaracterizes the company's capital allocation strategy. QUALITATIVE ASSESSMENT: While the LLM correctly identifies the strategic themes (diversification, long-term growth, higher-return investments), these conclusions are based on incorrect data patterns. The reasoning about 'consistent upward trend' and 'larger boost in domestic equity' contradicts the actual data. COMPLETENESS: The answer does address the three-year period and both investment types requested, but with wrong numbers. The page citations provided cannot be verified but appear to be fabricated or misread. SEMANTIC EQUIVALENCE: The interpretation of strategy is reasonable but unsupported by the incorrect numbers presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 493,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "GM’s “Eliminations/ Reclassifications” line has grown each year – it reduced total net sales and revenue by **$107 million in 2022**, by **$151 million in 2023**, and by **$296 million in 2024**【page_70†L31-L38】【page_68†L31-L38】. This upward swing shows that GM’s internal adjustments for inter‑segment transactions and reclassifications have become increasingly sizable, reflecting a more complex internal reporting structure across its automotive, Cruise and GM Financial businesses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM reports: 2022=$107M, 2023=$151M, 2024=$296M. The 2022 figure is off by $2M (107 vs 105), the 2023 figure is dramatically incorrect at $151M when it should be $107M (44% error), and only the 2024 figure of $296M is correct. This represents a fundamental failure in multi-hop data synthesis across the three-year period. The LLM correctly identifies the upward trend direction and provides reasonable qualitative interpretation about increasing complexity in internal reporting structures, which aligns with the ground truth's conclusion. However, the quantitative foundation is severely compromised - the trend analysis is based on incorrect intermediate values (2023 should show minimal change from 2022, not a jump to $151M). The reasoning about inter-segment transactions and reclassifications is semantically appropriate and contextually relevant to the question. The citation references suggest the LLM attempted to ground its answer in source material, but the actual numbers extracted are incorrect. This is a case where qualitative reasoning is sound but quantitative accuracy is critically flawed, making the overall answer unreliable for financial analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 376,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In the 2022 and 2023 Form 10‑K filings Netflix only referenced the Performance Bonus Plan as the original 2014 Def 14A filing (listed as “Performance Bonus Plan” in the exhibit schedule).  In the 2024 filing the company added an **Amended and Restated Performance Bonus Plan** (exhibit 10.5) filed as an 8‑K on December 9 2022, and it now appears alongside the updated Executive Severance & Retention Incentive Plan and Director Equity Compensation Plan, indicating that the bonus plan has been formally restated, documented as a current 8‑K exhibit, and integrated into Netflix’s broader compensation framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant structural and logical issues that undermine its accuracy. CORRECT ELEMENTS: (1) The date December 9, 2022 is accurate for the Amended and Restated Performance Bonus Plan filing. (2) The identification of Exhibit 10.5 for the amended plan is correct. (3) The mention of integration with other compensation frameworks (Executive Severance & Retention Incentive Plan, Director Equity Compensation Plan) aligns with the ground truth. (4) The general progression showing formalization in 2023/2024 is directionally correct. CRITICAL ERRORS: (1) The LLM states the amended plan 'now appears' in the 2024 filing, but the ground truth indicates it was filed on December 9, 2022 and appeared in the 2023 10-K (with filing date of December 9, 2022), not newly added in 2024. This is a significant temporal misplacement. (2) The LLM conflates the 8-K filing date (December 9, 2022) with when the plan appeared in 10-K exhibits, creating confusion about the timeline. (3) The LLM states the plan was 'only referenced' in 2022 and 2023 as the original 2014 filing, which contradicts the ground truth that shows the amended version appeared in 2023. (4) The LLM's characterization that the plan was 'newly' added in 2024 is incorrect—it was already present in 2023. MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year evolution. The ground truth shows: 2022 (historical exhibit only), 2023 (amended and restated), 2024 (carried forward unchanged). The LLM presents a two-phase narrative (2022-2023 as original, 2024 as amended) which reverses the actual timeline. QUANTITATIVE ACCURACY: Dates are correct (December 9, 2022; 2024 filing reference), but the temporal sequencing of when documents appeared is wrong. The answer demonstrates partial understanding but significant structural confusion about the evolution timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 514,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 13 contains the same boiler‑plate language: the “Business Relationships and Related Party Transactions Policy” is incorporated by reference to the proxy under **Item 1 – Election of Directors – Corporate Governance and Board Information**, together with the “Director Independence” section and the charters of the **Audit Committee, the Corporate Governance‑Nominating‑Social Responsibility Committee, and the Human Resources & Compensation Committee**. The wording is identical in each year, showing that the company has kept its disclosure of this policy – and the related director‑independence and committee‑structure information – consistently stable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies BK/BNY Mellon as the subject company across all three years (2022, 2023, 2024); (2) Accurately specifies Item 13 as the disclosure location; (3) Correctly names all three committees: Audit Committee, Corporate Governance-Nominating-Social Responsibility Committee, and Human Resources & Compensation Committee; (4) Properly identifies the policy as 'Business Relationships and Related Party Transactions Policy'; (5) Accurately describes the linkage to 'Director Independence' discussions; (6) Correctly characterizes the disclosure as consistent and stable across all three years; (7) Appropriately notes the boilerplate/identical wording across years, which reinforces the consistency finding. MINOR CONSIDERATIONS: (1) The LLM uses 'BNY Mellon' while the ground truth uses 'BK' - both are correct references to the same company (BK is the ticker, BNY Mellon is the full name), so this is not an error but rather a stylistic choice; (2) The LLM adds the detail about 'incorporated by reference to the proxy' which is a reasonable elaboration not contradicted by the ground truth; (3) The LLM explicitly notes 'boilerplate language' and 'identical in each year,' which provides slightly more granular detail than the ground truth's 'consistent placement and linkage,' but this is complementary rather than contradictory. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple disclosure elements (policy, director independence, committee structures) to reach the conclusion about consistency. The reasoning is sound and logically structured. NO QUANTITATIVE ERRORS: There are no numbers, dates, or calculations to verify, and all entity references are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 498,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio shrank each year – the fair‑value balance fell from $679 million in 2022 to $596 million in 2023 and to $508 million in 2024, while the carrying amount fell from $696 million to $603 million to $512 million over the same period【page_53†L31-L38】【page_55†L31-L38】.  The steady decline and the narrowing gap between fair value and amortized cost (‑$17 M in 2022, ‑$7 M in 2023, ‑$4 M in 2024) suggest UnitedHealth is gradually winding down its held‑to‑maturity investments—likely due to maturities or a strategic shift away from these securities—while still valuing them near cost, assuming they will be collected at maturity despite market‑driven price declines.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect fair value figures for 2022. Ground truth shows fair value of $643M in 2022, but LLM states $679M - a $36M discrepancy (5.6% error). For carrying value, ground truth shows $641M in 2022, but LLM states $696M - a $55M error (8.6% error). The 2023 and 2024 figures are correct ($596M and $508M for fair value; $603M and $512M for carrying value). CALCULATION ERRORS: The LLM correctly calculates the fair value/carrying value gaps for 2023 and 2024 (-$7M and -$4M), but the 2022 gap calculation is wrong. Ground truth gap is -$2M ($641M - $643M), not -$17M as stated by LLM. This is a fundamental arithmetic error that undermines the analysis. REASONING QUALITY: The qualitative interpretation about strategic reduction and winding down of investments is reasonable and aligns with the ground truth narrative. The observation about narrowing gaps and reliance on observable pricing is directionally sound. However, the incorrect 2022 baseline numbers distort the trend analysis. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize data across three years and connect it to investment strategy, which is appropriate for the question. However, the factual errors prevent proper trend analysis. MISSING ELEMENTS: The LLM does not explicitly mention the shift away from Level 3 unobservable inputs noted in the ground truth, which is an important strategic indicator. OVERALL ASSESSMENT: While the reasoning framework is sound and 2023-2024 data is accurate, the substantial errors in 2022 baseline figures (both fair value and carrying value) and the resulting miscalculation of the fair value/carrying value gap significantly compromise the credibility of the trend analysis. These are not minor formatting differences but material quantitative errors that affect the interpretation of the 3-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 508,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal warned in its 2022 filing that “failure to deal effectively with fraud, abusive behaviors, bad transactions” could increase loss rates on its credit portfolio, which at that time included its BNPL loan receivables (2022 p. 24). In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables and began transferring those assets in October 2023, shifting the credit‑risk and bad‑transaction exposure to third‑party buyers (2023 p. 23‑25). By the 2024 filing the BNPL‑specific risk is no longer singled out and the discussion of credit‑product risk is broader, reflecting that the bulk of the BNPL portfolio has been off‑loaded and that PayPal’s risk‑mitigation strategy now relies on disposing of receivables and forward‑flow arrangements to reduce exposure to bad transactions (2024 p. 22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE ACCURACY: All numeric values and dates are correct - €40 billion BNPL receivables sale amount, June 2023 agreement date, October 2023 transfer start date. No calculation errors detected. ENTITY ACCURACY: PayPal correctly identified, fiscal years 2022-2024 properly referenced, BNPL and credit products correctly distinguished. MULTI-HOP REASONING: The answer successfully synthesizes information across three years showing the evolution of PayPal's risk exposure: (1) 2022 baseline risk acknowledgment regarding fraud/bad transactions in credit portfolio, (2) 2023 strategic pivot with €40B sale agreement and October 2023 implementation, (3) 2024 shift in risk disclosure reflecting portfolio reduction. The logical progression from exposure acknowledgment → strategic asset sale → reduced BNPL-specific risk is sound. COMPLETENESS: The answer addresses all parts of the multi-part question: evolution of exposure (2022-2024), the June 2023 agreement specifics, and the risk mitigation strategy implications. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly more operational detail (October 2023 transfer timing, page references). The characterization of the strategy as 'disposing of receivables and forward-flow arrangements' aligns with the ground truth's 'asset sales and forward-flow arrangements.' MINOR CONSIDERATIONS: The LLM answer includes specific page references (2022 p. 24, 2023 p. 23-25, 2024 p. 22) which add credibility but weren't in the ground truth. The observation that 'BNPL-specific risk is no longer singled out' in 2024 is a valuable analytical insight that demonstrates deeper understanding of the filing evolution. No factual errors or contradictions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 501,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s net production in Myanmar fell sharply: ≈ 17 k boe / day and 94 MMCFD of gas in 2022, ≈ 15 k boe / day and 87 MMCFD in 2023, and only 4 k boe / day and 22 MMCFD in 2024【page_9】. This steep decline mirrors Chevron’s strategic decision to exit the country – the company announced an orderly withdrawal from Myanmar in April 2024【page_9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with mostly correct information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the production decline trajectory from 2022-2024, (2) Accurately cites the April 2024 complete withdrawal from Myanmar, (3) Properly synthesizes the strategic shift from declining volumes to full exit, (4) Includes additional detail on gas production (MMCFD) not in ground truth but consistent with filing data, (5) Appropriately characterizes this as portfolio optimization/risk management. QUANTITATIVE VERIFICATION: Oil production figures (17 MBD → 15 MBD → 4 MBD) align with ground truth directional movement and approximate magnitudes. Gas production data (94 MMCFD → 87 MMCFD → 22 MMCFD) shows consistent proportional decline. The 2024 figure of 4 k boe/day represents a ~73% reduction from 2023, reflecting the orderly withdrawal process. MINOR CONSIDERATIONS: (1) Ground truth states 'completely withdrew' while LLM shows 4 k boe/day in 2024 - this likely reflects partial operations during the April 2024 exit period (withdrawal was orderly, not instantaneous), (2) LLM provides more granular data (gas volumes) than ground truth, which adds value without contradicting the core answer. MULTI-HOP REASONING: Successfully synthesizes production volume changes across three years with the strategic decision to exit, correctly linking operational metrics to business strategy. The answer properly addresses both the 'how did it evolve' and 'what strategic shift' components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 424,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "The 2022 filing lists PC & Notebooks as the fourth‑largest sub‑segment of the Personal‑electronics market (after Body electronics & lighting, Mobile phones and Portable electronics)【page_7】, while the 2024 filing moves it up to the third‑largest position, just behind Body electronics & lighting and Mobile phones【page_5】. This rise in ranking indicates that TI’s PC‑and‑notebook business is gaining a larger slice of the Personal‑electronics segment, signaling a strategic push to strengthen its foothold in the consumer‑computing market even as the overall Personal‑electronics share of total revenue has modestly slipped.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The ground truth provides specific revenue percentages (Personal Electronics: 24% in 2022, 15% in 2023, 20% in 2024), but the LLM answer provides NO quantitative data whatsoever. Instead, it focuses on ranking positions of PC & Notebooks within the segment. (2) FACTUAL CONTRADICTION: The ground truth indicates PC & Notebooks declined in priority (moving lower in the list of priorities from 2022 to 2024), while the LLM claims it moved UP from fourth-largest to third-largest position. This is a direct contradiction of the ground truth's conclusion. (3) STRATEGIC INTERPRETATION ERROR: The ground truth concludes TI shifted AWAY from PC & Notebooks toward higher-growth Automotive and Industrial markets. The LLM concludes the opposite—that TI is strengthening its foothold in consumer computing. This is a fundamental misinterpretation of the strategic trend. (4) INCOMPLETE ANALYSIS: The LLM fails to address the overall Personal Electronics segment decline (24%→15%→20%) which is central to understanding the strategic positioning. The ranking of subcategories within a declining segment is less meaningful than the segment's overall trajectory. (5) MISSING CONTEXT: The LLM does not synthesize the multi-hop information required: segment-level trends + subcategory positioning + strategic implications. The answer cherry-picks ranking data while ignoring the more important revenue contribution percentages that define the actual strategic shift. The LLM's conclusion that this represents a 'strategic push to strengthen its foothold' directly contradicts the ground truth's assessment of strategic de-emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 476,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "From the 2017 sale of the Opel/Vauxhall business, GM has repeatedly said that its indemnification to Stellantis is immaterial and no material accrual has been recorded. In the 2022 filing GM noted that “we are unable to estimate any reasonably possible material loss…certain of these indemnification obligations are subject to time‑limitations, thresholds and/or caps” and that it “indemnified Stellantis for an immaterial amount for certain recalls…Takata inflator recalls…any further indemnification is remote” 【page_89】 【page_92】. The 2023 note contains the same language – no material loss can be estimated, obligations remain subject to caps and thresholds, and only an immaterial amount has been indemnified for Takata‑related recalls 【page_90】 【page_92】. The 2024 filing again states the obligations are immaterial, no material accruals are recorded, and any additional future indemnification (including for Takata recalls or emissions‑related lawsuits in Europe) is considered remote 【page_91】 【page_92】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how indemnification obligations EVOLVED from 2022-2024. Key problems: (1) INCOMPLETE EVOLUTION NARRATIVE: The LLM states that 2022, 2023, and 2024 all contain essentially the same language about immateriality and inability to estimate losses. This contradicts the ground truth, which shows clear evolution: 2022 had NO specific indemnification accruals disclosed, 2023 introduced specific categories (pre-sale representations, emissions, product liabilities, recalls), and 2024 added NEW accruals for European Commission/UK CMA investigation into end-of-life vehicle practices. The LLM completely missed this progression of emerging regulatory risk exposure. (2) MISSING KEY 2024 DEVELOPMENT: The ground truth explicitly states that 2024 disclosed 'accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era.' The LLM mentions 'emissions-related lawsuits in Europe' as 'remote' but fails to capture the actual accrual that was recorded for the regulatory investigation. (3) MISCHARACTERIZATION OF 2023: The ground truth indicates 2023 was when GM first disclosed specific indemnification categories (pre-sale representations, emissions claims, product liabilities, recalls). The LLM treats 2023 as identical to 2022, missing this important disclosure expansion. (4) QUANTITATIVE ACCURACY: While the LLM correctly identifies amounts as 'immaterial,' it fails to distinguish between 'no accrual' (2022), 'immaterial accrual' (2023-2024), and the emergence of specific regulatory accruals (2024). (5) REASONING FAILURE: The question explicitly asks about evolution 'particularly in terms of known liabilities, accruals, and potential future exposures.' The LLM's answer suggests static consistency across years rather than the dynamic evolution the ground truth documents. The LLM does correctly identify that obligations are immaterial and subject to caps/thresholds, and correctly notes Takata-related matters, but fundamentally fails to capture the temporal evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 580,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower’s 1.450 % senior notes due 2026 were issued through Supplemental Indenture No. 10 on September 27 2021 and are shown as Exhibit 4.22 in the 2022 10‑K filing【page_70】. The same exhibit appears unchanged in the 2023 10‑K【page_70】 and again in the 2024 10‑K【page_70】, indicating the notes remain outstanding. This continuity reflects a debt‑management approach that locks in low‑cost, medium‑term financing and preserves a stable, long‑dated debt profile rather than repeatedly refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding exhibit numbering that undermines accuracy. CORRECT ELEMENTS: (1) The 1.450% Senior Notes due 2026 were issued via Supplemental Indenture No. 10 on September 27, 2021 - CORRECT. (2) The notes remained outstanding and unchanged across 2022-2024 - CORRECT. (3) The interpretation of debt management strategy (low-cost, medium-term financing, stable profile) is reasonable and semantically equivalent to the ground truth. (4) The multi-hop synthesis across three years is sound. CRITICAL ERROR: The LLM states the exhibit appears as 'Exhibit 4.22 in the 2022 10-K filing' but the ground truth indicates it was 'Exhibit 4.25' in 2022, then 'Exhibit 4.22' in 2023, and 'Exhibit 4.21' in 2024. This is a quantitative accuracy failure - the exhibit numbering progression is factually incorrect for 2022. The LLM appears to have conflated the 2023 exhibit number with 2022. PARTIAL CREDIT: The answer correctly identifies the core pattern (consistent presence across years, no refinancing/modification) and provides reasonable strategic interpretation. However, the exhibit number error for 2022 is a material factual mistake that would mislead readers about the specific documentation trail. The answer also lacks the detail about the exhibit number evolution (4.25→4.22→4.21) which was part of the ground truth's documentation continuity narrative. The reasoning about debt management strategy is sound but somewhat generic compared to the ground truth's more specific observation about 'deliberate and stable' positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 433,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan (Exhibit 10.13) remained the governing framework in each filing, and the company’s Deferred Stock Unit Agreement for Directors (Exhibit 10.8) continued to be referenced (page 18). Starting in 2022 the firm added a new 2022 Performance Share Unit Agreement (Exhibit 10.21) and a 2022 Restricted Stock Unit (deferred stock) Agreement (Exhibit 10.22) (page 19); in 2023 it filed a 2023 Performance Share Unit Agreement (Exhibit 10.26) and a 2023 Restricted Stock Unit Agreement (Exhibit 10.27) (page 19); and in 2024 it introduced a 2024 Performance Share Unit Agreement (Exhibit 10.28) and a 2024 Restricted Stock Unit Agreement (Exhibit 10.29) (page 20). These successive filings show the 2019 LTIP being used to issue fresh deferred‑stock and performance‑share awards each year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CHRONOLOGICAL ERRORS: The LLM claims 2022, 2023, and 2024 forms were introduced in those respective years (e.g., '2022 Performance Share Unit Agreement' in 2022, '2023 Performance Share Unit Agreement' in 2023, '2024 Performance Share Unit Agreement' in 2024). However, the ground truth indicates that in 2022, the company referenced 2019 forms (2019 Form of Performance Share Unit Agreement and 2019 Form of Restricted Stock Unit Agreement), not 2022 forms. The LLM appears to have confused the form dates with the filing years. (2) MISSING KEY INFORMATION: The ground truth specifically mentions the introduction of the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' in 2023, which the LLM does not clearly distinguish or highlight as a new introduction in that year. (3) FORM NAMING DISCREPANCIES: The ground truth references '2019 Form of Performance Share Unit Agreement' and '2019 Form of Restricted Stock Unit Agreement' in 2022, but the LLM references '2022 Performance Share Unit Agreement' and '2022 Restricted Stock Unit Agreement' for the same year. This is a fundamental factual error. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the 2019 LTIP remained the governing framework, it fails to accurately capture the evolution described in the ground truth—which shows early implementation with 2019 forms in 2022, extension to directors in 2023, and incorporation of newer forms (2022 forms) by 2024. The LLM's narrative suggests annual updates with year-matching forms, which contradicts the actual progression. (5) EXHIBIT REFERENCES: The LLM provides specific exhibit numbers (10.21, 10.22, 10.26, 10.27, 10.28, 10.29) and page numbers, but these cannot be verified against the ground truth and appear to be fabricated details that don't align with the actual filing structure described in the original answer. The core narrative of the LLM answer is fundamentally misaligned with the ground truth regarding which forms were introduced in which years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 568,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics’ Combat Systems filings repeatedly stress that its Ordnance & Tactical Systems business “provides missile subsystems … with critical aerostructures” for both legacy and next‑generation missiles – first noted as a market‑leading position in 2022 (p. 12), reiterated in 2023 (p. 13), and again highlighted in the 2024 filing (p. 12). The unchanged, explicit focus over three years shows GD is deliberately cementing its role as a key supplier of aerostructure technology for next‑generation, including hypersonic, missile subsystems.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The LLM answer completely omits the specific revenue percentages that are central to the ground truth - Combat Systems was 20% of consolidated revenue in 2023 and 19% in 2024. These percentages are essential to answering the question about 'what this 3-year trend reveals' and represent a significant decline that the LLM fails to capture. (2) UNVERIFIABLE PAGE REFERENCES: The LLM cites specific page numbers (p. 12, p. 13, p. 12) without providing actual evidence these pages exist or contain the stated information. This is a red flag for potential hallucination. (3) INCOMPLETE TEMPORAL COVERAGE: While the ground truth explicitly addresses 2022, 2023, and 2024 with specific data points, the LLM provides only general statements about 'three years' without year-by-year breakdown or quantitative evolution. (4) UNSUPPORTED CLAIMS: The LLM introduces 'hypersonic' missile subsystems without any mention in the ground truth, suggesting potential extrapolation beyond available data. (5) MISSING STRATEGIC INSIGHT: The ground truth emphasizes 'slight revenue share fluctuations' and 'sustained positioning' - a nuanced finding that the LLM's answer fails to convey. The LLM states the focus is 'unchanged' but doesn't address the actual revenue percentage changes that occurred. STRENGTHS: The LLM correctly identifies General Dynamics, the Combat Systems segment, aerostructures, and next-generation missiles as relevant entities. The general strategic positioning narrative aligns with the ground truth's conclusion about sustained focus. However, the absence of quantitative data (20% to 19% decline) and year-by-year analysis significantly undermines the answer's ability to address the core question about 3-year trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 483,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three filings, PMI repeatedly lists Jackpot as one of its “important local cigarette brands” in the Philippines – the 2022 10‑K first notes Fortune and Jackpot among its local portfolio, the 2023 filing again highlights Jackpot as a core Philippine brand, and the 2024 filing continues to feature Jackpot alongside the premium Marlboro line as a key low‑price/mid‑price offering. This uninterrupted presence shows that Jackpot is treated as a stable pillar of PMI’s South‑and‑Southeast Asia strategy, providing volume and market‑share strength in the Philippines while complementing the company’s broader mix of international premium brands and local brands across price tiers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-year information about Jackpot's positioning. STRENGTHS: (1) Correctly identifies Jackpot as a key local cigarette brand mentioned consistently across 2022-2024 filings; (2) Accurately captures the three-year progression showing stable strategic positioning; (3) Properly contextualizes Jackpot within PMI's broader portfolio strategy (low-price/mid-price tier); (4) Correctly notes the relationship to premium brands like Marlboro; (5) Appropriately emphasizes the brand's role in regional market share and volume despite PMI's smoke-free future vision. MINOR ISSUES: (1) The LLM answer adds interpretive detail about Jackpot being positioned 'alongside the premium Marlboro line' which, while reasonable, is not explicitly stated in the ground truth and represents slight inference beyond what was documented; (2) The phrase 'stable pillar of PMI's South-and-Southeast Asia strategy' is slightly more assertive than the ground truth's 'strategically relevant in key regional markets like the Philippines' - the LLM broadens geographic scope slightly; (3) The ground truth explicitly mentions Swedish Match integration context in 2023, which the LLM omits, though this is a minor contextual detail. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of consistent strategic emphasis. The logic connecting Jackpot's repeated mentions to its role in PMI's portfolio strategy is sound. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The answer correctly references the three-year timeframe (2022-2024) and maintains chronological accuracy. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth - that Jackpot remained strategically important across the three-year period despite PMI's broader smoke-free product expansion. The slight differences in framing (regional strategy emphasis vs. key regional markets) are minor variations in expression rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 577,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "- In 2022 Chevron’s activity in the Republic of Congo was an investment‑stage move – it extended deep‑water licences there, which added about 36 million barrels to its African reserves 【page_111】.  \n- In 2023 the company continued to put capital into the country, spending roughly $0.7 billion on offshore development and natural‑gas projects in the Republic of Congo 【page_109】.  \n- By 2024 the focus had shifted to divestiture: Chevron announced the sale of its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Lianzi area (effective January 2025), moving from capital deployment to asset disposition 【page_43】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Chevron's evolution in the Republic of Congo from 2022-2024, with a clear progression from investment to divestiture. STRENGTHS: (1) Correctly identifies the 2023 capital deployment of approximately $0.7 billion in offshore development and natural gas projects in Africa/Republic of Congo; (2) Accurately captures the 2024 divestiture details: 31.5% nonoperated working interest in Haute Mer permit and 15.75% interest in Lianzi, with January 2025 effective date; (3) Properly synthesizes the multi-hop information across three years showing strategic shift; (4) Correctly identifies the transition from operational continuity to asset disposition. MINOR ISSUES: (1) The 2022 description differs from ground truth - LLM states Chevron 'extended deep-water licences' and added '36 million barrels to African reserves,' while ground truth simply notes it was 'listed as one of its key operational areas, signaling ongoing presence and strategic importance.' The LLM provides more specific operational detail (license extension, reserve addition) that isn't contradicted by ground truth but represents additional specificity not explicitly confirmed in the provided ground truth statement; (2) The LLM's characterization of 2022 as 'investment-stage move' is reasonable but slightly more specific than the ground truth's more general 'ongoing presence.' QUANTITATIVE VERIFICATION: The $0.7 billion figure for 2023 matches exactly; the 31.5% and 15.75% percentages match exactly; the January 2025 date matches. The 36 million barrels figure for 2022 cannot be verified against the provided ground truth but is not contradicted. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the strategic evolution. The logic connecting capital deployment to divestiture is sound. Overall, the answer is substantially correct with minor variations in 2022 characterization that add detail rather than contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 555,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company kept the outdoor‑lighting agreements in the operating‑lease category, but the lease horizon was lengthened – the 2022 filing describes the contracts as having “initial terms of up to seven years” (p. 268), while the 2024 filing says the initial terms are now “up to 10 years” (p. 240). The cash‑flow impact remained immaterial, but the disclosure broadened: 2022 notes the undiscounted cash flows for Mississippi Power’s lighting contracts are immaterial (p. 270), whereas 2024 adds that the same contracts at both Georgia Power and Mississippi Power are immaterial (p. 241). Revenue from these leases continues to be embedded in each subsidiary’s operating‑lease income (shown in the lease‑income tables) and the payment schedule is presented in the maturity analyses, with contracts renewing month‑to‑month after the initial term.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) INCORRECT LEASE TERM CHANGES: The LLM claims lease terms changed from 'up to seven years' in 2022 to 'up to 10 years' in 2024, citing specific page numbers (p. 268 and p. 240). The ground truth makes no mention of such a change in initial lease terms - it only notes that 2024 expanded disclosure to 'include the initial terms of outdoor lighting contracts.' This appears to be a fabrication with false citations. (2) MATERIALITY MISCHARACTERIZATION: The LLM states 'The cash-flow impact remained immaterial' and references page 270 for 2022 and page 241 for 2024, but the ground truth indicates that in 2022 the contracts were 'considered immaterial, with no significant value disclosed,' while by 2024 the company was expanding disclosure and emphasizing 'transparency and standardization' - suggesting a shift toward greater materiality recognition, not continued immateriality. (3) INCOMPLETE SUBSIDIARY COVERAGE: The LLM mentions Mississippi Power and Georgia Power but fails to adequately address Alabama Power and Southern Power, which the ground truth explicitly identifies as part of the 2024 expansion showing 'lease income from PPAs was included in wholesale revenues.' (4) REVENUE ALLOCATION MISUNDERSTANDING: The LLM states revenue 'continues to be embedded in each subsidiary's operating-lease income' but the ground truth specifically clarifies that by 2024, lease income from PPAs was 'included in wholesale revenues' - a different accounting treatment than simple embedding in operating-lease income. (5) MONTH-TO-MONTH RENEWAL CLAIM: The LLM adds detail about 'contracts renewing month-to-month after the initial term' which is not mentioned in the ground truth and appears to be unsupported inference. (6) MISSING KEY EVOLUTION: The LLM fails to capture the important 2023 transition point where 'the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses,' which represents a key step in the evolution from 2022 to 2024. The answer demonstrates poor multi-hop synthesis, contains apparent citation fabrications, and misrepresents the direction and nature of changes in Southern Company's treatment of these contracts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 616,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco’s 3.50 % senior note has kept the same $500 million principal in each of the three years – $500 million was reported in FY 2022, FY 2023 and FY 2024 – but its effective interest rate has risen sharply, from about 3.20 % in FY 2022 to roughly 6.38 % in FY 2023 and to about 6.66 % in FY 2024【page_89】.  The unchanged carrying amount alongside a more than‑doubling of the effective rate shows that the note is being valued at higher market yields, reflecting rising interest‑rate conditions (and related issuance/hedging costs) over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $500 million carrying amount for all three years (FY 2022, 2023, 2024), effective interest rates of 3.20% (FY 2022), 6.38% (FY 2023), and 6.66% (FY 2024) match the ground truth exactly. The characterization of the rate increase as 'more than doubling' is accurate (3.20% to 6.66% represents approximately a 108% increase). (2) COMPLETENESS: The answer addresses all required elements - the carrying amount evolution, effective interest rate progression across all three fiscal years, and the implications for debt valuation and market conditions. (3) ENTITY ACCURACY: Cisco is correctly identified, the 3.50% Note is properly specified, and all fiscal years are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the stable carrying amount with rising effective rates to conclude that market yields have increased, reflecting changing interest rate conditions. The interpretation that this reflects 'rising interest-rate conditions (and related issuance/hedging costs)' is a reasonable inference from the data pattern. (5) SEMANTIC EQUIVALENCE: The LLM's explanation of what the progression 'indicates' (higher market yields, rising interest rates) aligns well with the ground truth's statement about 'shift in market conditions or internal risk assessments.' Minor note: The LLM includes a citation reference [page_89] which adds credibility but wasn't in the original answer - this is a minor enhancement. The only very minor consideration is that the ground truth uses 'carrying amount' terminology consistently while the LLM uses both 'carrying amount' and 'principal' interchangeably, though this is semantically appropriate and not an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 494,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s outstanding face amount of Unsecured Notes – 35A was $750 million in the 2022 filing and stayed at $750 million in the 2023 filing and again in the 2024 filing【page_50】【page_51】【page_50】. The unchanged exposure over three consecutive years shows the company is maintaining this tranche as a stable, medium‑term component of its capital structure, reflecting a disciplined long‑term debt strategy that avoids frequent refinancing or large swings in leverage.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the core quantitative facts - $750 million face value maintained consistently across 2022, 2023, and 2024 with proper citation references. The number format and consistency across years are accurate. The basic characterization of this as a 'stable, medium-term component' is semantically sound. WEAKNESSES: The LLM answer is incomplete relative to the ground truth. It omits several key contextual details that were explicitly in the original answer: (1) The specific 2.65% interest rate is not mentioned, (2) The July 15, 2030 maturity date is not provided, (3) The broader context of Simon's debt management strategy (new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities) is completely absent. The ground truth emphasizes that the stability of 35A 'contrasts with broader changes' in their unsecured debt portfolio, which provides important strategic context that the LLM answer fails to capture. The LLM's reasoning about 'disciplined long-term debt strategy' is reasonable but generic and doesn't leverage the comparative analysis that the ground truth provides. The answer addresses the 'how did it evolve' part (answer: it didn't change) but inadequately addresses 'what does this reveal about their long-term debt management strategy' by missing the comparative context of selective refinancing and new issuances. This is a multi-hop question requiring synthesis across multiple debt instruments and years, and the LLM only partially synthesizes this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 427,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept embedded‑processing at the heart of its strategy throughout the 2022‑2024 period. Each filing (2022 p.18‑19, 2023 p.18‑19, 2024 p.18‑19) says the company’s “great business model … is focused on analog and embedded‑processing products” and that this focus fuels the four sustainable competitive advantages – most directly the “broad portfolio of analog and embedded‑processing products” (advantage b) and, by extension, the reach, diversity and longevity of its market channels (advantages c and d). While the emphasis has not shifted, the embedded‑processing segment’s contribution has varied (e.g., revenue fell 25 % in 2024 versus 2023), but TI continues to present it as a core cash‑flow driver within its four‑advantage framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Embedded Processing Products remained a core strategic component across 2022-2024, accurately notes the consistent framing across filings, and properly contextualizes the product portfolio within TI's four sustainable competitive advantages framework. The answer demonstrates sound multi-hop reasoning by synthesizing information about strategic positioning, competitive advantages, and business model consistency. The page references (p.18-19 for each year) appear plausible and the semantic understanding of the strategic emphasis is accurate.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM claims 'revenue fell 25% in 2024 versus 2023' for the embedded-processing segment. This specific percentage is not verified in the ground truth and represents an unsubstantiated quantitative claim that could be factually incorrect. This is a significant issue because the evaluation criteria emphasize strict accuracy on numbers. (2) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - The ground truth emphasizes the specific repeated phrase 'more opportunity per customer and more value for our investments' as consistent language across all three years. The LLM answer mentions 'great business model...focused on analog and embedded-processing products' but does not capture or verify the specific quoted language that the ground truth identifies as the consistent framing. (3) ADDED INFORMATION NOT IN GROUND TRUTH - The LLM introduces segment revenue decline data that, while potentially accurate, is not part of the ground truth answer and represents information synthesis beyond what was verified in the knowledge graph.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between embedded processing products and the four sustainable competitive advantages, properly identifying advantage (b) as the direct connection and advantages (c) and (d) as indirect extensions. This demonstrates sound multi-hop reasoning across the strategic framework.\n\nCORE ISSUE: The primary concern is the unverified 25% revenue decline claim. While the qualitative analysis of strategic consistency is sound, introducing specific quantitative claims not in the ground truth violates the strict accuracy requirement for numbers. The answer would score higher if it either: (1) verified this percentage against source documents, or (2) omitted the specific percentage claim and focused on the qualitative strategic consistency that is well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 662,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "- In the 2022 filing, Comcast’s wireless service was provided only through an MVNO partnership with Verizon (and its Wi‑Fi‑hotspot network) and was sold exclusively as part of a broadband bundle, with no separate shared‑data options mentioned (2022 10‑K p. 7).  \n- By 2023, the company introduced a menu of domestic unlimited, shared‑data and per‑gigabyte plans and also began offering gigabyte‑based plans to international customers, giving customers more flexibility (2023 10‑K p. 5).  \n- In 2024, Comcast added prepaid unlimited‑data plans under the NOW brand and extended unlimited‑data options to international customers, further expanding plan flexibility and its international wireless footprint (2024 10‑K p. 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 baseline - MVNO partnership with Verizon, exclusive bundled broadband offering, no separate shared-data options; (2) Accurately captures 2023 evolution - introduction of menu of domestic unlimited, shared-data, and per-gigabyte plans, plus gigabyte-based plans for international customers; (3) Properly describes 2024 expansion - prepaid unlimited-data plans under NOW brand and extended unlimited-data to international customers; (4) Correctly synthesizes the multi-hop progression showing increasing flexibility and geographic diversification across all three years; (5) Appropriately cites specific 10-K page references for each year. MINOR CONSIDERATIONS: The LLM answer provides slightly more technical detail about the MVNO partnership structure (mentioning Wi-Fi hotspot network) compared to the ground truth, but this is supplementary and accurate. The answer uses consistent terminology (shared-data, per-gigabyte, unlimited-data) that aligns with ground truth language. The chronological progression is clear and logically structured. No quantitative errors detected - all years, plan types, and geographic scope claims are accurate. The answer fully addresses both sub-questions (plan flexibility evolution and international expansion) with proper synthesis across the three-year period. The semantic meaning matches the ground truth's conclusion about increasing flexibility and geographic diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 428,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "PayPal’s risk disclosures show a steady widening of its exposure to abusive behavior. In the 2022 filing the company warned that “measures to detect and reduce the risk of fraud and abusive behavior are complex” and that its credit products “expose us to additional risks,” while also noting its reliance on third‑party lenders and partners (pages 24‑27). By 2023 the language had sharpened, stressing that “abusive behavior…continues to evolve” and that third‑party fraud schemes—such as synthetic‑identity accounts and stolen instruments—are “difficult to detect and may be deployed at scale,” with credit‑product risk still tied to model accuracy and partner funding (pages 23‑26). The 2024 filing further cautions that failures to manage “fraud, abusive behaviors…could increase our loss rate” and that credit‑product risk now hinges on “risk‑model inaccuracies, defaults and third‑party funding constraints,” while third‑party fraud is described as “continually evolving” and harder to detect (pages 21‑23). Together, these updates illustrate a growing complexity in PayPal’s risk management, requiring ever‑more sophisticated detection tools, tighter oversight of credit‑risk models, and stronger governance of third‑party relationships across its digital payments ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of PayPal's evolving exposure to abusive behaviors across 2022-2024, captures the progression from basic fraud concerns to more sophisticated threats (account takeovers, synthetic identity fraud), and appropriately emphasizes the growing complexity of risk management. The qualitative reasoning about third-party fraud schemes, credit product risks, and detection challenges is sound and well-articulated. The answer demonstrates good multi-hop synthesis across three years of filings.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to include the specific €40 billion BNPL loan receivables agreement mentioned in the ground truth as a key 2023 development. This is a significant omission because it represents a concrete, quantifiable expansion of PayPal's exposure to third-party fraud in large-scale loan portfolios. The ground truth explicitly cites this as evidence of how PayPal's risk exposure evolved materially from 2022 to 2023. The LLM answer mentions 'partner funding' and 'third-party lenders' generically but misses this specific, material transaction.\n\nWEAKNESSES - ENTITY/DETAIL: The LLM answer also omits the 2024 detail about 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks,' which is an important evolution showing regulatory/legal complexity added to the fraud risk narrative.\n\nWEAKNESSES - PAGE CITATIONS: While the LLM provides page numbers (24-27, 23-26, 21-23), these cannot be verified against the ground truth, which does not provide page citations. This is a minor concern but suggests the LLM may be generating plausible-sounding citations.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression pattern. However, the synthesis is incomplete because it misses the €40 billion transaction, which is a key quantitative anchor point for understanding the scope of PayPal's exposure expansion.\n\nSEMANTIC EQUIVALENCE: The LLM's general characterization of risk evolution is semantically aligned with the ground truth, but the omission of specific quantitative details (€40 billion) and regulatory details (FDIC-insured banks) represents a material gap in completeness rather than just wording differences.\n\nJUSTIFICATION: Correctness score of 6 reflects that while the LLM captures the overall narrative and reasoning quality is good, the omission of the €40 billion BNPL transaction is a significant factual gap that undermines the quantitative accuracy and completeness of the answer. A score of 7-8 would require inclusion of this key metric and the FDIC-related legal uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 711,
        "total_tokens": 2333
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K, El Segundo was listed only as one of Gilead’s “principal manufacturing facilities” in California (Item 2 – Properties, page 33).  \n- By the 2023 filing, the company described the El Segundo site as the location “we utilize … for clinical and commercial manufacturing and processing of our cell‑therapy products” and noted that Gilead is “continuing to develop additional manufacturing capabilities and establish additional third‑party suppliers” (Manufacturing Facilities, page 11).  \n- The 2024 filing repeats that El Segundo is used for “clinical and commercial manufacturing and processing of our cell‑therapy products” and reiterates that Gilead’s capital resources are sufficient to purchase, lease or construct additional facilities to meet long‑term growth needs (Facilities list, page 12).  \n\nTogether, these disclosures show the El Segundo plant evolving from a generic manufacturing site in 2022 to a dedicated hub for both clinical and commercial cell‑therapy production by 2023‑2024, reflecting Gilead’s strategic investment in expanding its internal cell‑therapy manufacturing capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year timeline (2022-2024) and accurately characterizes the evolution of El Segundo's role from a generic 'principal manufacturing facility' in 2022 to a dedicated cell therapy manufacturing hub by 2023-2024. (2) Properly cites specific filing locations and page numbers (Item 2 Properties page 33 for 2022; Manufacturing Facilities page 11 for 2023; Facilities list page 12 for 2024), demonstrating document-level accuracy. (3) Accurately quotes or paraphrases key language about 'clinical and commercial manufacturing and processing of cell-therapy products' across the three years. (4) Correctly synthesizes the multi-hop information showing continuity and strategic focus on cell therapy production scaling. (5) Appropriately contextualizes the facility investments within Gilead's broader supply chain strategy and capital resource planning. (6) No quantitative errors - all dates, years, and facility references are correct. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes page numbers and filing item references), which adds value rather than detracting. The characterization of the evolution from 'generic' to 'dedicated' is a reasonable interpretation supported by the filing language changes, though the ground truth uses slightly different framing ('identified' vs 'evolved from generic'). The LLM's conclusion about 'strategic investment in expanding internal cell-therapy manufacturing capacity' is well-supported by the evidence presented and aligns with the ground truth's emphasis on 'strategic focus on scaling.' No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 490,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Costco’s 2.750 % Senior Notes were presented in the same way in each of the three reports – as “Form of 2.750 % Senior Notes due May 18 2024” (Exhibit 4.6) appears in the exhibit list of the 2022, 2023 and 2024 Form 10‑K filings【page_66】. The unchanged maturity date across the three years shows that Costco has kept this tranche on a fixed, long‑term schedule, reflecting a disciplined debt‑management strategy that relies on stable, fixed‑rate senior notes and plans to hold them to maturity rather than repeatedly refinancing or altering the maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the specific debt instrument (2.750% Senior Notes) and its consistent maturity date of May 18, 2024 across all three filing years (2022, 2023, 2024). (2) Accurately cites the exhibit reference (Exhibit 4.6) and filing locations. (3) Properly synthesizes the multi-hop information showing consistency across three years of filings. (4) Correctly interprets the strategic implication - that the unchanged maturity structure reflects a disciplined debt management approach with plans to hold to maturity rather than refinance. (5) All numeric values and dates are correct with no calculation errors. Minor considerations: (1) The LLM answer uses slightly different phrasing than ground truth ('fixed, long-term schedule' vs 'static approach') but conveys semantically equivalent meaning. (2) The answer could have been marginally more explicit about what the consistency 'reveals' about strategy, though the interpretation provided is sound and matches the ground truth's conclusion. (3) The citation format with page reference adds credibility. Overall, the answer demonstrates strong multi-hop reasoning by connecting the consistent maturity date across three years to broader strategic implications about debt management, which is exactly what the question requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 383,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s Angola LNG gas output (oil‑equivalent natural gas, MMCFD) was 49 MMCFD in 2022, slipped to 48 MMCFD in 2023, and remained at 48 MMCFD in 2024 【page_9】. This flat‑to‑slightly‑declining trajectory shows the asset is a mature, steady‑state producer, indicating Chevron is maintaining stable supply from Angola rather than aggressively expanding its African gas output.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS - The numbers provided are completely wrong. Ground truth shows Angola LNG production at 7,107 MMCFD (2022), 7,148 MMCFD (2023), and 7,569 MMCFD (2024). The LLM claims 49 MMCFD (2022), 48 MMCFD (2023), and 48 MMCFD (2024) - these are off by approximately 145x. The LLM appears to have confused the metric or misread the data entirely. (2) METRIC CONFUSION - The LLM references 'oil-equivalent natural gas' which is not the correct metric. The ground truth uses standard MMCFD (million cubic feet per day) for natural gas production volumes. (3) DIRECTIONAL ERROR - The LLM describes a 'flat-to-slightly-declining trajectory' when the actual data shows a clear upward trend: 7,107 → 7,148 → 7,569 MMCFD represents increases of 41 MMCFD (2022-2023) and 421 MMCFD (2023-2024). (4) STRATEGIC INTERPRETATION ERROR - The LLM concludes Chevron is 'maintaining stable supply' and 'not aggressively expanding,' which directly contradicts the ground truth interpretation of a 'steady upward trend' indicating 'strengthening production output' and 'maintained or expanded operational focus.' (5) MULTI-HOP REASONING - The LLM failed to correctly synthesize the three-year data trajectory and draw appropriate conclusions about Chevron's African gas strategy. The answer demonstrates a fundamental misunderstanding or misreading of the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 396,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge deferred‑compensation obligations rose from $651 million in FY 2022 (page 92) to $792 million in FY 2023 and $985 million in FY 2024 (page 91).  The related accounting impact moved from a $92 million gain (negative expense) in FY 2022 (page 91) to $58 million and $91 million of operating expense in FY 2023 and FY 2024 (page 91), indicating that Cisco is expanding its swap‑based hedge to cover larger deferred‑compensation liabilities while market‑linked equity‑price volatility is now turning the hedge into a cost rather than a gain.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth on the core financial metrics. (1) SIGN ERROR ON GAINS/LOSSES: The ground truth clearly states FY 2022 was a LOSS of $92 million, but the LLM incorrectly reports this as a '$92 million gain (negative expense)' - this is a direct contradiction. The LLM then compounds this by stating FY 2023 and FY 2024 were 'operating expense' when the ground truth indicates these were GAINS of $58 million and $91 million respectively. This represents a complete reversal of the financial direction. (2) NOTIONAL EXPOSURE NUMBERS: The LLM introduces notional exposure figures ($651M, $792M, $985M) that are not mentioned in the ground truth answer. While these may be accurate supplementary details from the filings, they are not part of the core answer being evaluated and their inclusion alongside the incorrect gain/loss characterization creates confusion. (3) DIRECTIONAL MISINTERPRETATION: The ground truth explicitly states the trajectory shows 'transformation from a net liability to a net benefit' (loss to gains), but the LLM characterizes it as 'market-linked equity-price volatility is now turning the hedge into a cost rather than a gain' - which is backwards. The LLM's interpretation suggests deteriorating conditions when the ground truth indicates improving conditions. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year progression of the P&L impact from the swaps. The core answer requires understanding that 2022 was negative, 2023-2024 were positive and increasing - the LLM got this fundamentally wrong. The only partially correct element is the identification of Cisco and the fiscal years, but the financial metrics and their interpretation are substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 496,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "In its 2022 filing Lowe’s described a human‑rights policy (updated in FY 21) and a Vendor Code of Conduct with enhanced environmental standards, a wood‑sourcing policy that required all wood products to come from well‑managed, non‑endangered forests, and a growing portfolio of independently certified products [page_10]. By 2023 the company revised the wood‑sourcing policy to add country‑specific risk levels, stronger monitoring and a new forestry‑grievance process, began requiring suppliers to report emissions to CDP, and secured external verification of Scope 1‑2 emissions and SmartWay certification for its transportation providers [page_9][page_10]. The 2024 report further deepened the risk‑based wood‑sourcing approach with improved monitoring, continued expanding independently certified product offerings, and maintained third‑party verification of GHG data while pursuing 100 % SmartWay certification for its logistics partners [page_9][page_10].",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022-2024 with accurate year-by-year progression; (2) Accurately captures 2022 baseline: human rights policy (updated FY21), Vendor Code of Conduct, enhanced environmental standards, wood sourcing policy for well-managed non-endangered forests, and independently certified products; (3) Correctly details 2023 enhancements: revised wood sourcing policy with country-specific risk levels, stronger monitoring, new forestry grievance process, CDP emissions reporting requirement, external verification of Scope 1-2 emissions, and SmartWay certification for transportation; (4) Accurately describes 2024 deepening: risk-based wood sourcing approach, improved monitoring, expanded certified product offerings, third-party GHG verification, and pursuit of 100% SmartWay certification; (5) Properly synthesizes multi-hop information across three years and multiple policy domains (environmental standards, human rights, wood sourcing, emissions monitoring, third-party certifications); (6) Includes specific details like CDP reporting, SmartWay certification, and Scope 1-2 emissions verification that demonstrate comprehensive understanding. MINOR CONSIDERATIONS: The LLM answer includes slightly more specific details (CDP reporting, SmartWay certification percentages) than the ground truth summary, but these additions are factually accurate enhancements rather than errors. The page references [page_9][page_10] add credibility and traceability. The answer directly addresses all three components of the question: policy updates, monitoring enhancements, and third-party certifications. No quantitative errors detected. The semantic meaning and factual content align precisely with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 502,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "In the 2022 filing Comcast warned that wireless‑telecom firms were beginning to erode its broadband market by offering 4G and 5G wireless broadband and by bundling those services with attractive pricing, but it did not name any specific rivals [page_28]. By the 2023 filing the threat had sharpened: competitors were now using 5G fixed‑wireless as well as 4G/5G broadband, and Comcast explicitly identified AT&T, T‑Mobile and Verizon (and UK wireless providers) as the firms bundling wireless with other services [page_8]. The 2024 filing still highlights 4G/5G and 5G fixed‑wireless competition and adds that rivals are pairing unlimited‑data plans with free or low‑cost DTC streaming bundles, again referring to wireless telecom companies generically rather than naming particular companies [page_21].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of CMCSA filings. STRENGTHS: (1) Correctly identifies the evolution of competitive threats from 2022-2024 with appropriate technological progression (4G/5G → 5G fixed wireless → bundling with DTC streaming); (2) Accurately names the three major competitors (AT&T, T-Mobile, Verizon) as appearing in 2023 filings; (3) Properly captures the shift in bundling strategies, from basic wireless bundling in 2022 to integration with DTC streaming services by 2024; (4) Correctly notes that 2022 filings did not name specific competitors while 2023 and 2024 did; (5) Page references provided add credibility and specificity. MINOR WEAKNESSES: (1) The answer states that 2024 filings refer to wireless companies 'generically rather than naming particular companies' - while this may be accurate, the ground truth doesn't explicitly confirm whether specific names were or weren't mentioned in 2024, creating slight ambiguity; (2) The mention of 'UK wireless providers' in 2023 is not addressed in the ground truth, though this appears to be an accurate detail from the filing that adds context rather than contradicting the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and filing documents, correctly identifying the progression of competitive threats and the evolution of bundling strategies. The temporal evolution is clearly articulated. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate wording variations. Numbers and dates are accurate (2022, 2023, 2024). No calculation errors present. The core narrative of intensifying competitive pressure through technological advancement and strategic bundling is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 502,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "Across all three filings – 2022 (​Note 2‑Revenue, p. 80​), 2023 (​Note 2‑Revenue, p. 76​) and 2024 (​Note 2‑Revenue, p. 77​) – PayPal repeatedly states that it “recognizes fees … on a gross basis” and “has full discretion in determining the fee charged … independent of the costs we incur when we use payment processors or other financial institutions,” so it “bears full margin risk when completing a payment transaction.” The company also notes that any merchant‑ or consumer‑incentives are recorded as reductions of revenue (2022 p. 78, 2023 p. 76, 2024 p. 77), and its tiered, volume‑based pricing is treated as a normal pricing adjustment rather than a material right. Thus, from 2022 through 2024 PayPal’s margin‑risk exposure has remained stable, reflecting a consistent strategy that gives it strong control over pricing and cost management despite reliance on external processors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that PayPal's margin risk exposure remained stable from 2022-2024, with consistent language about 'full discretion' and 'full margin risk.' (2) Accurately cites specific page numbers from all three years' filings (2022 p. 80, 2023 p. 76, 2024 p. 77 for revenue recognition; p. 78, 76, 77 for incentives), demonstrating proper multi-hop synthesis across documents. (3) Correctly characterizes merchant/consumer incentives as revenue reductions across all three years. (4) Properly identifies the key strategic insight: PayPal's consistent control over pricing independent of processor costs. (5) Accurately notes that tiered, volume-based pricing is treated as a normal pricing adjustment. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention the 2024 addition of contractual compensation from sellers violating terms (fraud/counterfeiting) as a new revenue stream. However, this omission is minor since the ground truth itself notes this 'potentially affecting margin dynamics' without quantifying its impact, and the LLM's core conclusion about stable margin risk remains accurate. (2) The LLM answer emphasizes 'tiered, volume-based pricing' treatment, which is a valid detail not explicitly mentioned in the ground truth but is consistent with PayPal's pricing strategy discussion. QUANTITATIVE ACCURACY: No numerical errors detected. All page citations are consistent with typical SEC filing structures. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and properly identifies the multi-hop connection between pricing discretion, processor costs, incentive treatment, and margin risk. The conclusion about 'strong control over pricing and cost management' is well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all components of the multi-part question: evolution of margin risk exposure, transaction pricing strategy, use of payment processors, revenue incentives, and what the trend reveals about pricing control and cost management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 591,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease policy was unchanged from FY 2022 through FY 2024: free‑rent periods (and step‑rent provisions) are recognized on a straight‑line basis over the lease’s original term plus any extension options that are “reasonably certain” to be exercised, and the lease term is defined as the non‑cancelable period plus those certain extensions (see the lease disclosures on pages 45‑46 of each filing). The right‑of‑use asset is measured at the present value of the minimum lease payments over that term—so the zero‑payment free‑rent months are included in the term but reduce the present‑value calculation—and the only evolution was the addition of a $391 impairment charge to certain leased assets disclosed in FY 2023 (and reiterated in FY 2024), while the free‑rent accounting and lease‑term assumptions remained the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core accounting policy (straight-line recognition over lease term including reasonably certain extensions, using incremental borrowing rate) and accurately states that the policy remained unchanged from FY 2022-2024. However, there are significant issues: (1) The LLM introduces a specific $391 impairment charge claim with no corroboration in the ground truth, which is a factual error that cannot be verified and appears to be hallucinated. (2) The LLM provides specific page references (pages 45-46) that cannot be verified against the ground truth and may be inaccurate. (3) The LLM's explanation of how free-rent periods reduce the present-value calculation is technically sound but adds detail not present in the ground truth. (4) The ground truth emphasizes variable lease payments (indexed to price/sales) as a key disclosure evolution in FY 2023, which the LLM completely omits—this is a material omission of a key disclosure element. (5) The ground truth notes that FY 2024 reaffirmed no material residual value guarantees or restrictive covenants, which the LLM also omits. The LLM correctly captures the stability/consistency theme but fails to address the variable lease payment disclosure emphasis and introduces unverified quantitative claims. The answer is partially correct on the core policy but incomplete on disclosure evolution and contains potential hallucinations regarding the impairment charge.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 403,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across 2022‑2024 PayPal repeatedly stated that it acts as the principal on every payment, setting fees (a fixed‑plus‑percentage component known at processing) at its discretion and therefore “bear[s] full margin risk when completing a payment transaction,” with the fees it pays to payment processors recorded as transaction expense. Its contracts remained open‑ended, transaction‑level and tiered by volume, a structure the company says does not create a future material right, so the exposure to margin risk stayed essentially unchanged over the three years【page_80†L14-L22】【page_75†L14-L22】【page_77†L14-L22】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies PayPal's core margin risk exposure (bearing full margin risk as principal, setting fees at discretion, paying processors as transaction expense) and accurately notes that the fundamental pricing model remained unchanged across 2022-2024. The statement about open-ended, transaction-level, tiered contracts without material rights is factually accurate. No numeric errors detected.\n\nWEAKNESSES: The LLM answer is significantly incomplete relative to the ground truth. Specifically:\n\n1. MISSING KEY 2023 DEVELOPMENT: The ground truth explicitly states that in 2023, PayPal added clarifying language about how incentives to users were recognized as revenue reductions based on performance targets or amortized over contractual terms. This represents an important evolution in margin structure variability that the LLM completely omits. This is a material omission for a question asking how exposure \"evolved.\"\n\n2. MISSING 2024 SEGMENT REPORTING CHANGE: The ground truth notes that in 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses and potentially affected margin risk analysis across business units. The LLM provides no mention of this structural change.\n\n3. INCOMPLETE CHARACTERIZATION OF EVOLUTION: The ground truth describes the evolution as \"structurally stable but operationally nuanced,\" capturing both continuity and change. The LLM only emphasizes stability (\"exposure to margin risk stayed essentially unchanged\") without acknowledging the operational nuances and specific changes in 2023-2024.\n\n4. MISSING CONTEXT ON INCENTIVE RECOGNITION: The ground truth's discussion of how incentive recognition introduced \"more variability into its margin structure\" is absent from the LLM answer, which is a significant gap for understanding how margin risk exposure actually evolved.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of the core pricing model across years but fails to synthesize the temporal evolution of disclosure practices and incentive recognition changes that occurred between 2022-2024.\n\nSEMANTIC EQUIVALENCE: While the LLM's statements about the fundamental model are semantically equivalent to ground truth, the answer is incomplete in addressing the full scope of how exposure evolved, particularly regarding the 2023 and 2024 changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 643,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90 % senior note has stayed essentially unchanged over the three most recent fiscal years.  In FY 2022 the note carried a $2 billion balance with an effective interest rate of 6.11 % 【page_89】; the same $2 billion balance and 6.11 % effective rate were reported in FY 2023 【page_89】 and again in FY 2024 【page_89】.  \n\nThe unchanged utilization and steady 6.11 % effective cost indicate that Cisco has deliberately kept this tranche of long‑term debt in place, using it as a stable source of financing while its overall financing cost for the note has not risen, reflecting a disciplined debt‑management strategy that locks in rates and avoids cost volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $2 billion (or $2,000 million) outstanding balance consistently reported across FY 2022, 2023, and 2024; effective interest rate of 6.11% constant across all three years; coupon rate of 5.90% correctly identified. The format variation ($2 billion vs $2,000 million) is appropriately handled. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) utilization evolution (unchanged), (2) effective interest rate evolution (unchanged at 6.11%), (3) implications for long-term debt strategy (stable, disciplined approach), and (4) financing costs (locked in, no volatility). ENTITY ACCURACY: Cisco correctly identified, fiscal years 2022-2024 properly referenced, the 5.90% Note correctly characterized with February 2039 maturity implied through context. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly draws logical conclusions about Cisco's debt management strategy - that the consistency indicates deliberate maintenance of this debt tranche without refinancing. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents a 'disciplined debt-management strategy that locks in rates' is semantically equivalent to the ground truth's characterization of 'consistent approach to managing this portion of its capital structure.' Minor note: The LLM adds interpretive language about 'deliberately kept this tranche' and 'locks in rates' which, while reasonable inferences, go slightly beyond the ground truth's more neutral statement of 'maintained without modification.' However, this represents appropriate analytical interpretation rather than factual error. The citation references to page_89 add credibility though cannot be independently verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 508,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Across all three filings, Lowe’s treats “Kobalt” the same way – it is repeatedly listed as a key private‑brand trademark owned by its subsidiaries. In the fiscal‑2022 IP section the company notes that its subsidiary “owns … private brand product names, such as, ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’” 【page_7】 (and again in the later IP paragraph 【page_9】). The fiscal‑2023 filing contains an identical statement, again naming Kobalt alongside the other private brands 【page_7】. The fiscal‑2024 IP disclosure likewise repeats the same language, positioning Kobalt as a core private‑brand name 【page_7】. Thus, from FY 2022 through FY 2024 the intellectual‑property disclosures show a consistent, steady emphasis on Kobalt as an integral part of Lowe’s trademark portfolio, with no notable shift in positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that Kobalt's positioning remained consistent across fiscal 2022-2024, matching the ground truth's conclusion of 'stable strategic role rather than an expanding one.' (2) Accurately cites the specific trademark language showing Kobalt listed alongside 'STAINMASTER' and 'allen+roth' across all three years. (3) Properly synthesizes the multi-hop requirement by examining IP disclosures across three fiscal years and drawing the correct conclusion about consistency. (4) The reasoning is sound: the LLM correctly notes that identical language across filings indicates no shift in positioning. (5) All entities are correct (Lowe's, Kobalt, the three fiscal years, the other private brands mentioned). (6) No quantitative errors or calculation issues. MINOR CONSIDERATIONS: The LLM answer includes page references (【page_7】, 【page_9】) which add specificity but cannot be verified against the ground truth provided. However, these do not contradict the ground truth and actually enhance credibility by showing source documentation. The semantic meaning is fully equivalent to the ground truth - both conclude that Kobalt maintained a consistent, stable strategic role with no notable increase or decrease in prominence. The LLM answer is slightly more detailed in showing the repetition of language across filings, which strengthens rather than weakens the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 408,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Simon Property Group’s Unsecured Notes ‑ 37B have been unchanged from 2022 through 2024 – each filing shows a 2.25 % coupon, a $700 million face amount (shown as $ 700,000 thousand) and a maturity of January 15, 2032 (annual debt service $15,750 thousand)【SPG_10k_2022.pdf page_50】【SPG_10k_2023.pdf page_51】【SPG_10k_2024.pdf page_51】.  The consistency of the rate, size and long‑dated maturity indicates that Simon is deliberately preserving a stable, low‑cost tranche of unsecured debt, locking in cheap financing for the long term and maintaining predictable cash‑flow obligations to support its capital‑intensive portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - 2.25% interest rate, $700 million face amount (correctly noted as $700,000 thousand in filing format), maturity date of January 15, 2032, and annual debt service of $15,750 thousand. The format variations are properly handled and explained. COMPLETENESS: The answer addresses all three sub-components of the question: interest rate evolution (unchanged at 2.25%), face amount evolution (unchanged at $700M), and maturity date evolution (unchanged at 01/15/32). MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three years (2022, 2023, 2024) and three separate 10-K filings, demonstrating proper multi-hop reasoning. ENTITY ACCURACY: Simon Property Group correctly identified, Unsecured Notes - 37B correctly specified, all years and metrics properly referenced. REASONING QUALITY: The interpretation that consistency indicates deliberate preservation of stable, low-cost debt and long-term financing strategy is sound and well-supported. The mention of 'cheap financing' and 'predictable cash-flow obligations' appropriately contextualizes the strategic implications. MINOR CONSIDERATIONS: The LLM provides slightly more detailed strategic interpretation than the ground truth (mentioning 'capital-intensive portfolio'), which adds value without contradicting the original answer. The citation of specific page numbers from source documents enhances credibility. The answer is semantically equivalent to the ground truth while being more detailed and better supported with evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 441,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site was listed only under the Analog segment in each filing – it shows an “X” for Analog and no mark for Embedded Processing in 2022 (TXN_10k_2022 p. 16), again in 2023 (TXN_10k_2023 p. 16), and once more in 2024 (TXN_10k_2024 p. 16). Thus, across the three years the Melaka facility’s role did not change; it remained dedicated to Analog products and was never identified as part of the Embedded Processing segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - Melaka was exclusively dedicated to Analog segment across all three years with no Embedded Processing involvement; (2) Specific document references are accurate (TXN_10k filings for 2022, 2023, 2024, all citing page 16); (3) The marking system ('X' for Analog, no mark for Embedded Processing) is correctly described; (4) Multi-hop synthesis is sound - the answer properly compares the three years and identifies the consistency pattern; (5) Entity identification is perfect (Texas Instruments/TXN, Melaka Malaysia, Analog and Embedded Processing segments, correct fiscal years). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but conveys identical information. The ground truth uses phrases like 'stable, specialized role' and 'centered exclusively on Analog product development and manufacturing' while the LLM uses 'remained dedicated to Analog products' - these are semantically equivalent. Both answers correctly conclude that there was no change across the three-year period. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all aspects of the multi-part question regarding evolution (or lack thereof) across the three years and both business segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 404,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on its fixed‑rate 2.850 % notes was $1.5 billion in 2022, stayed at $1.5 billion in 2023, and remained $1.5 billion in 2024【page_107】【page_104】. Holding this tranche steady for three consecutive years indicates the company is preserving a stable, moderate‑cost fixed‑rate debt base as a long‑term financing anchor while managing overall leverage through other issuances and repayments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: PYPL's fixed-rate 2.850% notes remained constant at $1.5 billion across 2022, 2023, and 2024. The numbers are accurate and properly formatted. The answer demonstrates sound multi-hop reasoning by synthesizing the three-year progression and drawing a logical conclusion about debt management strategy. The interpretation that this represents a 'stable, moderate-cost fixed-rate debt base as a long-term financing anchor' is reasonable and aligns with the ground truth's characterization of 'consistent long-term liability with no principal repayments or retirements.' However, the LLM answer is somewhat less comprehensive than the ground truth in one key aspect: it does not explicitly mention the contrast with PYPL's active debt management in other areas (specifically the retirement of 1.350% notes by 2023 and introduction of new high-interest notes in 2024). This contextual comparison in the ground truth provides important nuance about the overall debt management strategy. The LLM answer focuses primarily on what happened with this specific tranche rather than situating it within the broader debt portfolio evolution. The reasoning is sound and the core message is correct, but the answer lacks the fuller strategic context that would elevate it to a 9-10 score. The citation references (page_107, page_104) suggest proper sourcing, though these cannot be independently verified in this evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 407,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "In Gilead’s 2022 10‑K the Hoofddorp, Netherlands site was only listed as one of the company’s principal manufacturing facilities (2022 p. 34), with no specific function noted. By the 2023 filing the company said it “utilizes the facility for commercial manufacturing and processing of our cell‑therapy products” (2023 p. 11), and the 2024 filing repeats that same description (2024 p. 10), showing that Hoofddorp has evolved from a generic manufacturing site to a dedicated hub for commercial cell‑therapy production within Gilead’s global manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) All factual claims are correct - the progression from 2022 (principal manufacturing facility with no specific function noted) to 2023-2024 (commercial manufacturing and processing of cell therapy products) is accurately captured. (2) Specific page references are provided (2022 p. 34, 2023 p. 11, 2024 p. 10) which adds credibility and verifiability. (3) The multi-hop synthesis across three years is sound - the answer correctly identifies the evolution from generic to specialized facility role. (4) The characterization of the facility's evolution from 'generic manufacturing site to dedicated hub for commercial cell-therapy production' accurately reflects the ground truth's description of 'consistent and growing emphasis.' (5) All entities are correctly identified (Gilead, Hoofddorp Netherlands, cell therapy products, years 2022-2023-2024). Minor observation: The LLM answer uses slightly more concise language than the ground truth but conveys identical semantic meaning. The phrase 'evolved from a generic manufacturing site to a dedicated hub' is semantically equivalent to the ground truth's 'progression indicates a consistent and growing emphasis.' No calculation errors, no factual inaccuracies, and the answer fully addresses all aspects of the multi-part question regarding the facility's role evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 394,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were carried at a constant $1.25 billion in each filing, but the amount treated as a current liability shifted dramatically. In the 2022 10‑K the notes were part of long‑term debt with only $73 million classified as current (Long‑term debt excl. current $6,484 m)【page_52】; in the 2023 filing the current portion jumped to $1,081 million (Long‑term debt excl. current $5,377 m) indicating most of the notes were re‑classified as current【page_52】; and by the 2024 filing the current portion fell back to $103 million (Long‑term debt excl. current $5,794 m), moving the bulk of the notes back into the long‑term category【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All key numbers match the ground truth exactly: (1) Principal amount: $1,250 million ($1.25 billion) consistently across 2022-2024 ✓; (2) 2022 current portion: $73 million ✓; (3) 2023 current portion: $1,081 million ✓; (4) 2024 current portion: $103 million ✓. The long-term debt exclusions cited ($6,484M in 2022, $5,377M in 2023, $5,794M in 2024) provide supporting context. MULTI-HOP REASONING: The answer correctly synthesizes the evolution across three years, identifying the key pattern: stable principal with dramatic classification shifts. The 2023 spike to $1,081M (nearly the full principal) and subsequent drop to $103M in 2024 demonstrates proper understanding of debt maturity reclassification mechanics. COMPLETENESS: The answer addresses all aspects of the question: (1) principal amount consistency, (2) current portion classification changes, (3) long-term debt composition shifts, (4) temporal evolution 2022-2024. ENTITY ACCURACY: Correct company (Costco), correct security (1.375% Senior Notes due June 2027), correct years (2022, 2023, 2024), correct metrics (principal, current portion, long-term debt). SEMANTIC EQUIVALENCE: The phrasing \"carried at a constant $1.25 billion\" and \"constant principal amount of $1,250 million\" are semantically equivalent. The description of the classification shifts as \"dramatic\" and \"re-classified\" accurately conveys the magnitude of change. MINOR CONSIDERATIONS: The answer includes page references (【page_52】) which add credibility but are not essential to correctness. The supporting long-term debt figures enhance the answer's quality without introducing errors. No calculation errors detected. The narrative flow clearly explains the \"why\" (shifting debt maturity profiles) behind the \"what\" (classification changes).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 508,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s outstanding principal on its Fixed‑rate 2.850 % notes remained unchanged at $1.5 billion at each year‑end – $1.5 bn as of Dec 31 2022 and again $1.5 bn in 2023 (PYPL 2023 10‑K)【page_107】, and $1.5 bn in 2024 (PYPL 2024 10‑K)【page_104】, carrying an effective rate of about 2.96 % and a 2029 maturity. Keeping this tranche flat while the total term‑debt portfolio grew shows PayPal is preserving a stable, low‑cost long‑term financing base and managing its overall debt mix through other issuances and repurchases rather than expanding this specific liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics: the $1.5 billion principal amount across 2022-2024, the 2.96% effective interest rate, and the October 1, 2029 maturity date. The quantitative data is precisely accurate with proper formatting and citation references to the 10-K filings. The multi-hop synthesis is sound, correctly connecting the stable debt obligation across three years to PayPal's broader debt management strategy. The answer appropriately interprets the lack of change in this specific tranche as evidence of strategic capital structure preservation while the company managed other debt instruments. One minor limitation is that the LLM answer does not explicitly mention the original September 2019 issuance context or the $5.0 billion total issuance amount that provided background in the ground truth answer. However, this omission does not materially affect the core answer's accuracy or the validity of the strategic conclusions drawn. The reasoning about preserving a 'stable, low-cost long-term financing base' while 'managing its overall debt mix through other issuances and repurchases' directly parallels the ground truth's assessment of PayPal's debt management strategy. The answer successfully addresses all parts of the multi-part question regarding how obligations evolved and what this reveals about long-term debt strategy. The semantic equivalence is strong, with the LLM's phrasing conveying the same substantive insights as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 424,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s net exposure to gas‑related options expanded from a modest $170 million net Level‑3 fair‑value position in 2022 (the reconciliation of net derivatives shows a $170 million fair‑value at 12/31/2022) 【page_85】to a roughly balanced $100 million of gas‑option assets versus $102 million of liabilities in 2023, with implied‑volatility assumptions weighted at about 52 % 【page_84】and remaining at a similar $100 million/$102 million balance in 2024 while implied‑correlation rose sharply to 99 % (volatility still ~52 %) 【page_86】. The upward shift in both the fair‑value size and the volatility/correlation assumptions indicates that NEE is maintaining a sizable gas‑option position and is increasingly comfortable with higher gas‑price volatility, reflecting a more aggressive risk posture in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. VOLATILITY ASSUMPTIONS - MAJOR ERROR: The LLM states implied volatility was \"about 52%\" in 2023 and \"still ~52%\" in 2024. The ground truth clearly shows volatility DECLINED from 36% in 2022 to 50% in 2023, then increased slightly to 52% in 2024. The LLM completely misses the 2023 volatility figure (50%) and incorrectly characterizes the trend.\n\n2. FAIR VALUE PROGRESSION - PARTIAL ERROR: The LLM correctly identifies the 2023-2024 balance ($100M assets/$102M liabilities) but mischaracterizes the 2022 position. The LLM states a \"$170 million net Level-3 fair-value position in 2022\" which appears to be a net calculation, but the ground truth specifies separate asset and liability values: $356M (assets) and $347M (liabilities) in 2022. The LLM fails to properly present the 2022 baseline figures.\n\n3. TREND INTERPRETATION - FUNDAMENTALLY WRONG: The LLM concludes NEE is \"increasingly comfortable with higher gas-price volatility, reflecting a more aggressive risk posture.\" This directly contradicts the ground truth interpretation that the declining fair values and volatility changes indicate \"strategic de-risking in gas market exposure.\" The LLM's conclusion is the opposite of what the data shows.\n\n4. MISSING KEY DATA: The LLM completely omits the 2022 volatility assumption (36%), which is critical to understanding the multi-year trend. Without this baseline, the trend analysis is incomplete.\n\n5. CORRELATION MENTION: The LLM introduces implied-correlation rising to 99% in 2024, which is not mentioned in the ground truth answer. While this may be factually present in the filings, it's not part of the established ground truth and represents an addition rather than synthesis of the required information.\n\n6. MULTI-HOP REASONING: The LLM fails to properly synthesize the three-year trend. It should show: 2022 ($356M/$347M assets/liabilities, 36% volatility) → 2023 ($100M/$97M, 50% volatility) → 2024 ($100M/$102M, 52% volatility), demonstrating a clear de-risking pattern. Instead, it presents a confused narrative that leads to an incorrect conclusion.\n\nThe answer demonstrates poor quantitative accuracy (wrong volatility figures, incomplete 2022 data), weak qualitative reasoning (inverted interpretation of risk posture), and fails to correctly synthesize the multi-year trend that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 655,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments posted a **$9 million gain** to other income (loss), net in FY 2022, then a **$21 million loss** in FY 2023, and a **$67 million loss** in FY 2024【page_46】. The shift from a modest gain to increasingly larger losses shows that the fair‑value movements of its AFS debt portfolio were volatile, with market and credit‑risk pressures turning the investment line from positive to sharply negative over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data that directly addresses the question about AFS debt investment performance across FY 2022-2024. Strengths: (1) Provides exact dollar amounts ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) that align with the ground truth narrative of a shift from gains to losses; (2) Correctly identifies the three-year period and fiscal years; (3) Accurately characterizes the trend as volatile with 'fair-value movements' and 'market and credit-risk pressures'; (4) Properly synthesizes the multi-hop information showing the progression from positive to negative impact on other income (loss), net; (5) Includes source citation [page_46]. The answer is more specific and quantitatively detailed than the ground truth, which only describes the trend qualitatively. The LLM's statement that AFS debt investments moved from a $9M gain to $21M and $67M losses directly supports the ground truth's assertion of 'recurring negative impact from AFS debt investments over two consecutive years' and 'increasing volatility.' Minor consideration: The ground truth mentions 'offsetting gains from equity and private investments' in FY2024, which the LLM answer doesn't explicitly address, but this doesn't contradict the LLM's answer—it simply focuses on the AFS debt component specifically. The LLM answer is more precise and data-driven while maintaining semantic alignment with the ground truth's core findings about volatility and negative trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 412,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe’s first issued the 4.550 % senior notes in the Fifteenth Supplemental Indenture on April 5 2019 (due April 5 2049).  The same notes are listed as Exhibit 4.16 in the 2022 Form 10‑K (see page 82) and are again shown as Exhibit 4.16 in both the 2023 (page 75) and 2024 (page 75) filings, indicating that the issuance has not changed and the notes remain outstanding and disclosed each year.  This repeated, multi‑year inclusion signals that Lowe’s relies on long‑dated, fixed‑rate bonds as a core component of its capital structure, using them to lock in financing costs and support a stable, long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All numbers and dates are correct - 4.550% interest rate, April 5, 2019 issuance date, April 5, 2049 maturity date, and exhibit references (Exhibit 4.16) across 2022 (page 82), 2023 (page 75), and 2024 (page 75) filings all match the ground truth. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) how the notes evolved from 2022-2024 (consistent documentation), (2) the documentation pattern (same exhibit across three years), and (3) what this indicates about debt strategy (stable, long-term financing approach). MULTI-HOP REASONING: The LLM correctly synthesized information across three years of filings and drew appropriate conclusions about the company's capital structure strategy. The logic is sound - repeated inclusion across years indicates no changes and reflects a deliberate long-term financing strategy. ENTITY ACCURACY: Company name (Lowe's Companies, Inc.), note characteristics (4.550% senior notes), indenture details (Fifteenth Supplemental Indenture), and all dates are correct. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Lowe's maintained consistent documentation of these notes across 2022-2024, indicating a stable debt strategy. The LLM adds slightly more detail about the specific exhibit locations and provides additional context about the strategic purpose (locking in financing costs, supporting stable capital structure), which enhances rather than contradicts the ground truth. Minor note: The LLM uses slightly different formatting for the date (April 5 2019 vs April 5, 2019) but this is inconsequential. The answer is comprehensive, accurate, and demonstrates strong multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 492,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 to 2024 Simon Property Group’s Unsecured Notes – 35B always showed a $750 million face amount (recorded as $750,000 in thousands) and a fixed 3.80 % coupon, with a maturity of July 15 2050【page_50】【page_50】【page_51】.  The unchanged size and rate over three years signals that SPG is deliberately keeping this long‑dated, moderate‑cost debt on its balance sheet to lock in stable financing and limit interest‑rate risk as part of a long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - $750 million face value (properly noted as $750,000 in thousands format), 3.80% interest rate, and July 15, 2050 maturity date all match the ground truth. The format variation ($750 million vs $750,000 in thousands) is correctly handled and shows understanding of financial statement conventions. COMPLETENESS: The answer addresses all key components of the question: (1) face value evolution (consistent at $750M), (2) interest rate exposure (unchanged at 3.80%), (3) time period coverage (2022-2024), and (4) strategic implications. ENTITY ACCURACY: Simon Property Group (SPG) correctly identified, Unsecured Notes - 35B properly referenced, and fiscal years 2022-2024 correctly covered. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that stability across three years (unchanged principal, rate, and maturity) indicates deliberate strategy rather than coincidence. The interpretation that this reflects 'confidence in managing long-dated liabilities' and 'locking in stable financing' aligns with the ground truth's assessment of SPG's long-term debt strategy. MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'moderate-cost debt' for a 3.80% coupon is reasonable contextual interpretation. Citation references (page_50, page_51) add credibility. The answer could have been marginally enhanced by explicitly noting the maturity date remained unchanged (as the ground truth does), but this is a very minor omission given the overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 469,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s bad‑transaction exposure has widened and become more granular over the three‑year period. In 2022 the risk factor was framed mainly as fraud and erroneous payments that could generate “substantial losses” (see page_28), the 2023 filing added explicit concerns about the company’s reliance on unaffiliated lenders, payment processors and the volatility of cross‑border trade (see page_23), and the 2024 filing deepens that narrative by stressing higher default risk on its consumer‑ and merchant‑credit products, rising cross‑border cost pressures and a concentrated dependence on a small set of partner banks and processors (see pages 22‑25). This progression shows PayPal moving from a broad fraud‑risk warning to a more detailed, multi‑dimensional risk‑management approach that diversifies third‑party relationships and tightens credit‑risk controls, indicating a stronger focus on operational resilience.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer cites specific page numbers (page_28, page_23, pages 22-25) without verification against actual filings, which is problematic for a financial evaluation task. More critically, the LLM answer completely OMITS the €40 billion BNPL loan receivable sale agreement mentioned in the ground truth as a key 2023 strategic development - this is a major factual omission for a multi-year trend analysis. (2) ENTITY/FACT ACCURACY - The ground truth specifically identifies Synchrony Bank as PayPal's U.S. consumer credit partner in 2022, which the LLM answer does not mention. The ground truth also identifies the 'valid-when-made' doctrine legal uncertainty in 2024, which the LLM answer completely misses. (3) REASONING QUALITY - While the LLM answer correctly identifies a progression from fraud-focused risks to more granular, multi-dimensional risks, it frames this as 'diversifying third-party relationships and tightening credit-risk controls' when the ground truth shows a more strategic shift toward EXTERNAL RISK MITIGATION through asset sales (the €40B sale). This is a fundamental mischaracterization of PayPal's risk management strategy. (4) COMPLETENESS - The LLM answer addresses fraud, cross-border trade, and third-party dependencies (matching question requirements), but fails to capture the strategic asset sale as a core risk mitigation tactic, which is central to understanding the company's operational resilience strategy. (5) SEMANTIC ISSUES - The LLM's conclusion about 'diversifying third-party relationships' contradicts the ground truth's emphasis on reducing balance sheet exposure through external sales. The answer shows partial understanding but misses critical strategic elements that define the actual risk management evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 493,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "- In the 2022 filing Costco identified BJ & Sons Wholesale Club as a direct warehouse‑club competitor and stressed that its private‑label Kirkland Signature “are high quality, offered at prices that are generally lower than national brands, help lower costs, differentiate our merchandise offerings, and generally earn higher margins” (COST_10k_2022.pdf p.7).  \n- The 2023 and 2024 10‑Ks repeat the same competitive set—again naming BJ’s Wholesale Club—and continue to highlight Kirkland Signature as a key differentiator, noting an ongoing strategy to “increase the sales penetration of our private‑label items” (COST_10k_2023.pdf p.8; COST_10k_2024.pdf p.8).  \n\nThus, from 2022 through 2024 Costco’s positioning relative to BJ’s remained stable, while its emphasis on Kirkland Signature as a cost‑effective, margin‑enhancing differentiator was consistently reinforced and even deepened.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies BJ's Wholesale Club as the competitive reference point across all three years (2022-2024); (2) Accurately captures the core Kirkland Signature positioning language, including the specific quote about products being 'high quality, offered at prices that are generally lower than national brands, help lower costs, differentiate our merchandise offerings, and generally earn higher margins'; (3) Properly synthesizes the multi-hop requirement by tracking the evolution (or lack thereof) across three fiscal years; (4) Correctly identifies the stable/consistent nature of the competitive positioning strategy; (5) Appropriately cites specific document pages (p.7 for 2022, p.8 for 2023 and 2024); (6) Accurately notes the strategic emphasis on 'increase the sales penetration of our private-label items' as reinforcement of the differentiation strategy. MINOR CONSIDERATIONS: (1) The LLM uses 'BJ & Sons Wholesale Club' in the first reference while the ground truth and subsequent references use 'BJ's Wholesale Club'—this appears to be a minor naming variation that doesn't affect factual accuracy; (2) The LLM characterizes the strategy as 'even deepened' in the final sentence, which is a slight interpretive enhancement beyond the ground truth's 'remained stable,' though this is a reasonable inference from the data presented and doesn't contradict the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, correctly identifying the consistent competitive positioning and the stable emphasis on Kirkland Signature as a differentiator. The reasoning chain is sound and logically presented. ENTITY ACCURACY: All entities are correctly identified (Costco/COST, BJ's Wholesale Club, Kirkland Signature, fiscal years 2022-2024). No calculation errors or date inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 531,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra’s gas‑forward portfolio grew in 2023 and then was trimmed in 2024. In 2022 the fair‑value of gas‑forward assets was about **$191 million** with liabilities of **$31 million**【page_86†L31-L34】; in 2023 those balances rose to roughly **$377 million** of assets and **$77 million** of liabilities【page_84†L31-L34】; by 2024 they had fallen back to about **$296 million** of assets and **$46 million** of liabilities【page_86†L31-L34】. This three‑year swing shows NextEra expanded its natural‑gas hedge in 2023 (likely to lock in prices amid higher gas demand or price expectations) and then reduced exposure in 2024, indicating a shift from a more aggressive risk‑taking stance to a more cautious positioning in the volatile gas market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correctly stated: 2022 assets $191M/liabilities $31M, 2023 assets $377M/liabilities $77M, and 2024 assets $296M/liabilities $46M. All numbers match the ground truth exactly. The multi-hop synthesis across three years is sound, correctly identifying the progression pattern and the 2023 spike followed by 2024 reduction. The reasoning about strategic expansion in 2023 and shift to cautious positioning in 2024 is logically sound and well-supported by the data. One minor discrepancy: the ground truth states 2023 liabilities as $77M, but the original answer summary only mentions the 2024 liability figure of $46M without explicitly noting the 2023 spike in liabilities. The LLM answer actually provides MORE complete information by including the 2023 liability figure ($77M) that the ground truth summary omitted. The LLM's interpretation of the trend as reflecting 'a shift from a more aggressive risk-taking stance to a more cautious positioning' is a reasonable inference from the data pattern, though slightly more interpretive than the ground truth's more neutral 'increasingly balanced exposure.' The answer effectively addresses all parts of the question: the evolution of both assets and liabilities across the 3-year period, and what this indicates about risk positioning. The contextual framing about locking in prices and market volatility is appropriate and adds useful context. Minor deduction only for the slightly more interpretive tone compared to the ground truth's more measured language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 436,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "- In the 2022 filing Lowe’s disclosed a **$2.56 billion notional amount of forward interest‑rate‑swap agreements** used as cash‑flow hedges for anticipated debt issuances【page_62】.  \n- The 2023 filing still shows forward swaps on the books, but only a **fair‑value of $251 million** is reported (no notional is given), indicating the exposure had been sharply reduced【page_46】【page_54】.  \n- By the 2024 filing the forward‑swap line is blank—no fair‑value or notional is reported—showing the company had essentially unwound the program【page_54】.  \n\n**Interpretation:** Lowe’s moved from a large forward‑swap hedge in 2022 to a much smaller position in 2023 and then eliminated it by 2024, reflecting a strategic shift in its interest‑rate risk management as market conditions and its financing plans changed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Lowe's forward interest rate swap evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the $2.56 billion notional amount in 2022 as a key data point showing the scale of hedging activity; (2) Accurately reports the $251 million fair value in 2023, matching the ground truth exactly; (3) Correctly notes the absence of forward swaps in 2024, indicating complete unwinding; (4) Provides clear progression narrative showing the three-year trajectory; (5) Offers sound interpretation that the shift reflects strategic response to changing market conditions and financing plans. MINOR WEAKNESSES: (1) The LLM answer provides more granular detail (notional amounts, specific page references) than the ground truth, which could be seen as either more comprehensive or potentially introducing information not explicitly verified in the ground truth; (2) The ground truth mentions 'other current assets' classification in 2023, which the LLM answer omits; (3) The ground truth references the 2019-2021 impact period for cash flow hedges in 2022 disclosure, which the LLM answer doesn't capture; (4) The ground truth suggests 'possibly in response to stabilized interest rates or refinancing activities' as potential drivers, while the LLM answer more broadly states 'market conditions and financing plans changed.' QUANTITATIVE VERIFICATION: The $2.56 billion notional (2022) and $251 million fair value (2023) figures are accurate. The progression from large position → smaller position → zero position is correctly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the strategic shift in risk management approach. The logic connecting the numerical changes to strategic intent is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth regarding the evolution and strategic implications, though with slightly different emphasis and detail level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 560,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "In the 2022 filing Comcast already flagged Lumen as a “wireline telecommunications company… that has built and is continuing to build fiber‑based network infrastructure… and is offering higher‑speed services in many of our service areas” (see 2022 Competition discussion – page 8). By the 2023 filing Comcast reported that, under its multiyear network‑transformation plan, it had begun rolling out 2 Gbps downstream speeds to residential customers and was deploying DOCSIS 4.0 in select markets, covering roughly one‑third of its HFC footprint (see Network & Technology – page 7). The 2024 filing shows that the same rollout now reaches about 50 % of the footprint and that Comcast is expanding fiber‑to‑the‑premises with symmetric speeds up to 10 Gbps for residential customers and up to 100 Gbps for business customers (see Network & Technology – page 7; Broadband service description – page 6). This accelerated fiber deployment has narrowed the gap with Lumen’s fiber expansion, allowing Comcast to offer comparable or higher symmetric speeds in overlapping markets and thereby strengthening its competitive position.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed, nuanced response than the ground truth. STRENGTHS: (1) Correctly identifies Lumen as a key competitor across 2022-2024 with accurate characterization from 2022 filing ('wireline telecommunications company...building fiber-based network infrastructure'); (2) Accurately cites specific technical metrics: 2 Gbps downstream speeds (2023), DOCSIS 4.0 deployment, coverage progression from ~1/3 to ~50% of HFC footprint, and 10 Gbps symmetric residential/100 Gbps business speeds (2024); (3) Demonstrates superior multi-hop synthesis by connecting Lumen's fiber expansion to CMCSA's competitive response strategy, showing how CMCSA narrowed the competitive gap through accelerated fiber deployment; (4) Provides specific page references and filing sections, enhancing credibility; (5) Correctly interprets the evolution of competitive positioning from 2022-2024. MINOR WEAKNESSES: (1) The ground truth emphasizes Lumen's 'growing influence' and 'intensifying competition' more broadly, while the LLM answer focuses more heavily on CMCSA's response strategy rather than equally balancing both competitors' positioning; (2) The LLM answer could have more explicitly stated that Lumen continued expanding through 2024 (though this is implied); (3) Does not explicitly mention 'bundled offerings' that the ground truth references for 2023. QUANTITATIVE VERIFICATION: All numeric values (2 Gbps, 10 Gbps, 100 Gbps, 1/3 footprint, 50% footprint) appear consistent with typical 10-K disclosures and are presented without contradiction. The progression of coverage percentages (1/3 to 50%) is logically sound. MULTI-HOP REASONING: Excellent synthesis connecting Lumen's competitive actions (2022-2024 fiber expansion) with CMCSA's strategic responses (network transformation, speed upgrades, fiber-to-premises expansion), demonstrating how competitive dynamics evolved. The answer goes beyond the ground truth by explaining the strategic implications and competitive narrowing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 550,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "In 2022 PayPal’s 10‑K stressed that its core goal was “the simplest checkout experience possible for consumers online or offline” and that the PayPal‑ and Venmo‑branded checkout could be funded with its consumer‑credit products, while a “seamless, omnichannel solution” let merchants accept payments in roughly 200 markets and 150 currencies (page_8, page_10). By 2024 the focus had deepened: buy‑now‑pay‑later and new PayPal‑ and Venmo‑branded credit cards are embedded directly into the branded checkout (including expanded BNPL in the U.S., U.K., Europe and Japan via Paidy) (page_6), the platform now supports payments in >200 markets, >150 currencies, withdrawals in 56 currencies and balances in 24‑25 currencies (page_10), and merchants can sell online, mobile and in‑store through Zettle, card readers and point‑of‑sale systems (page_8).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth, particularly regarding currency support metrics. CRITICAL ERRORS: (1) The LLM claims 2022 supported '150 currencies' when ground truth states 'over 100 currencies' in 2022. (2) The LLM claims 2022 supported payments in '200 markets' when ground truth makes no such claim for 2022. (3) The LLM states 2024 supports '>150 currencies' which matches ground truth, but the progression narrative is broken by the incorrect 2022 baseline. (4) The LLM introduces specific details about '56 currencies for withdrawals' and '24-25 currencies for balances' that are not mentioned in the ground truth, raising questions about accuracy. CORRECT ELEMENTS: The LLM correctly identifies BNPL integration in 2024, PayPal/Venmo branded cards, Zettle omnichannel solutions, and the general evolution toward financial services integration. The semantic understanding of the strategic shift is reasonable. MULTI-HOP REASONING: The LLM attempts to synthesize across years and product categories, but the foundational numbers are wrong, undermining the comparative analysis. The answer conflates or misrepresents the 2022 baseline metrics, making the 'evolution' narrative factually incorrect. The inclusion of page references suggests document-based sourcing, but the numbers don't align with stated ground truth. The answer is partially responsive to the question's three components (consumer credit, currency support, omnichannel) but with compromised accuracy on the quantitative evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 428,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The Target Debit Card’s penetration slipped from roughly 20.5 % in fiscal 2022 to 19.8 % in fiscal 2023 and then to 18.6 % in fiscal 2024 【page_27】. The downward trend indicates that, although the card still drives incremental purchases, its share of total sales is gradually diminishing, suggesting a waning incremental‑sales contribution over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM reports: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is wrong (19.8% vs 18.6%) and the 2024 figure is wrong (18.6% vs 17.8%). These are not minor rounding differences but represent material misstatements of the actual data. The LLM essentially shifted all figures upward by approximately 1.2 percentage points for 2023-2024. QUALITATIVE ASSESSMENT: The LLM correctly identifies the downward trend and appropriately characterizes it as indicating a 'waning incremental-sales contribution,' which aligns with the ground truth interpretation. The reasoning about diminishing card penetration and its implications is sound. However, the reasoning is built on incorrect numbers, which undermines the credibility of the analysis. COMPLETENESS: The LLM addresses the core question about trend evolution and implications, though it could have been more explicit about the magnitude of decline (3.2 percentage points over three years per ground truth vs. 1.9 percentage points per LLM's incorrect figures). MULTI-HOP SYNTHESIS: The answer appropriately synthesizes the penetration rate data with its implications for incremental sales, demonstrating understanding of the relationship between card adoption and sales contribution. The fundamental issue is the accuracy of the underlying data points, not the reasoning framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 417,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑and‑IP licensing contracts did not change between the 2022, 2023 and 2024 filings. In each filing (2022 p. 59; 2023 p. 63; 2024 p. 64) the company says it first assesses whether the licensing component is distinct – if it is not distinct, the license is combined with the development services as a single performance obligation and revenue is recognized over time; if it is distinct, or when the arrangement is a standalone IP license, revenue is recognized at a point in time, and no variable consideration is estimated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024, matching the ground truth assertion of 'maintained a consistent revenue recognition framework'; (2) Accurately describes the dual-path approach: distinct licenses recognized at point in time vs. non-distinct licenses combined with development services and recognized over time; (3) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 64) that add credibility and verifiability; (4) Correctly notes that no variable consideration is estimated for these arrangements; (5) Properly synthesizes the multi-hop requirement by comparing the approach across three fiscal years. The answer is more specific and detailed than the ground truth in some respects (e.g., explicitly mentioning page numbers and the variable consideration detail), which demonstrates thorough research. Minor considerations: (1) The ground truth mentions 'Despite no explicit quantitative metrics being disclosed' while the LLM answer doesn't explicitly address this absence of quantitative metrics, though this is a minor omission that doesn't affect the core accuracy; (2) The LLM answer is slightly more technical/precise in its language ('non-distinct licenses combined with development services as a single performance obligation') which is semantically equivalent to the ground truth's description. The answer fully addresses the question's focus on how the approach evolved (or didn't evolve) from 2022-2024 and the distinction between combined arrangements and standalone licensing deals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 445,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "In Nike’s 2022 Form 10‑K, FlyEase was highlighted alongside Air, Zoom, Flyknit, Free, Dri‑FIT, ZoomX, Air Max and React as part of the “proliferation” of its breakthrough technologies, signaling its role as a core innovation in the product pipeline (Item 1 – Product Research, Design & Development, p. 6). The 2024 Form 10‑K repeats the same language, again listing FlyEase among those flagship technologies, showing that the company has kept FlyEase firmly positioned as a central, ongoing element of its innovation portfolio with no major shift in strategic emphasis from fiscal 2022 through fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim of the question. Ground truth establishes a clear three-year evolution: FlyEase moved from newly introduced (FY2022) → growing strategic importance alongside established technologies (FY2023) → mature/core technology (FY2024). The LLM claims there was 'no major shift in strategic emphasis from fiscal 2022 through fiscal 2024,' which directly contradicts the documented progression. Specific errors: (1) The LLM states FlyEase was listed among 'flagship technologies' in 2022 alongside Air, Zoom, etc., but ground truth indicates it was 'newly introduced' and 'emerging' in 2022, not yet at flagship status. (2) The LLM claims the 2024 10-K 'repeats the same language' as 2022, but ground truth shows FY2024 positioned FlyEase among 'mature technologies' like React and Air Max—a different categorization than FY2022. (3) The LLM misses the critical FY2023 transition point where FlyEase gained 'growing strategic importance.' (4) The LLM's conclusion that there was 'no major shift' is the opposite of what the ground truth documents—there was a clear three-stage evolution from emerging to established to mature. The LLM appears to have conflated or misread the 10-K data, failing to capture the temporal progression that is central to answering this multi-hop question about evolution over time. The answer demonstrates poor multi-hop reasoning by not synthesizing the three fiscal years' data to show the progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 417,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250 % senior notes have been shrinking each year – $609.1 million in 2022【page_48†L...】, $551.9 million in 2023 (down $57 million)【page_111†L...】, and $517.7 million in 2024 (down another $34 million)【page_114†L...】. This steady decline shows American Tower is actively repaying or retiring this low‑coupon series, using cash or proceeds from newer financings to reduce overall debt and tighten its leverage profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All principal amounts are correct - $609.1M (2022), $551.9M (2023), $517.7M (2024). The year-over-year decreases are accurately calculated: $57.2M decline from 2022-2023 (LLM states ~$57M, acceptable rounding) and $34.2M decline from 2023-2024 (LLM states ~$34M, acceptable rounding). The interest rate (1.250%) and maturity date (February 2033) are correctly identified. COMPLETENESS: The answer addresses the core question about debt management strategy trends across all three years. ENTITY ACCURACY: American Tower (AMT) is correctly identified, years are correct, and the financial metric (principal amount of notes) is properly tracked. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) identifying the consistent downward trend across three years, (2) interpreting this as an active debt reduction strategy, (3) connecting the pattern to debt management objectives (reducing leverage, managing long-term obligations). The conclusion about 'repaying or retiring' and 'tighten its leverage profile' aligns well with the ground truth's characterization of 'managed amortization or repurchase strategy.' MINOR DIFFERENCES: The LLM provides slightly more specific interpretation (mentioning 'cash or proceeds from newer financings') which adds reasonable context without contradicting the ground truth. The ground truth mentions 'consistent interest payment schedules' which the LLM doesn't explicitly state, but this is a minor omission that doesn't affect the core answer about the debt management trend. Overall, the LLM answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 477,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA has kept the 3.50 % Notes Due 2040 on its balance sheet at the original issuance amount (net of un‑amortized discount and issuance costs) and classified them as Level 2 liabilities throughout FY 2022‑FY 2024 (Note 9, p. 67).  The disclosed fair‑value estimate fell modestly from $870 million as of Jan 29 2023 to $851 million as of Jan 28 2024 (p. 67), while the net carrying amount remained around $1.0 billion in FY 2024 (p. 72).  This steady accounting treatment and only slight fair‑value decline indicate that NVIDIA’s long‑term debt strategy is to issue low‑coupon, long‑dated notes and retain them as a stable, low‑cost source of financing rather than frequently refinancing or retiring the securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM reports fair value of $870M as of Jan 29, 2023, but the ground truth states $851M for FY2023. The LLM also reports $851M as of Jan 28, 2024, but ground truth shows $1,000M for FY2024. The LLM completely omits the FY2022 fair value of $1,066M, which is critical to understanding the multi-year trajectory. The carrying amount of ~$1.0B in FY2024 aligns with ground truth ($1,000M), but the fair value progression is fundamentally misrepresented. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The question explicitly asks about evolution from FY2022 through FY2024. The LLM only addresses FY2023-FY2024 data, missing the crucial starting point ($1,066M in FY2022) that would show the full trajectory of decline from $1,066M → $851M → $1,000M. This omission undermines the core analytical requirement. (3) FACTUAL ACCURACY ON CLASSIFICATION - The LLM correctly identifies Level 2 classification and the accounting treatment (original issuance amount net of unamortized discount/costs), which aligns with ground truth context. (4) REASONING QUALITY - While the LLM's conclusion about NVIDIA's debt strategy (low-coupon, long-dated, stable financing) is reasonable and somewhat supported, it's based on incomplete data. The ground truth explicitly notes 'stabilization in valuation' in FY2024, whereas the LLM characterizes only a 'modest' and 'slight' decline without capturing the full volatility pattern. (5) SEMANTIC ISSUES - The LLM's statement about 'only slight fair-value decline' from $870M to $851M ($19M decline) misses the larger context of the $1,066M → $851M decline in the prior year, which represents a 20% drop. This selective framing obscures the actual trajectory. The answer demonstrates partial understanding of debt accounting but fails on the critical multi-year comparative analysis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 510,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "Netflix’s 2022 filing first disclosed a new lower‑priced ad‑supported subscription tier and the rollout of games, and warned that “if our efforts to attract and retain members are not successful…adjustments … may not be well‑received…our ability to attract and retain members may be negatively impacted” (2022 10‑K p. 6) and that scaling “introducing games and advertising on our service, as well as offering live programming” could also affect growth (2022 10‑K p. 7). The 2023 filing showed the plan maturing – it kept expanding games, the ad‑supported tier and added live programming, while again stressing that “if our efforts to develop and offer games…or pricing adjustments are not valued…our ability to attract and retain members may be negatively impacted” (2023 10‑K p. 6‑7). By 2024 Netflix was scaling those same initiatives—further growing games, advertising and live content and tweaking pricing – and reiterated that “if we do not continuously provide value…or adjust pricing…these adjustments may not be well‑received…our ability to attract and retain members could be adversely affected” (2024 10‑K p. 6‑7).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND FACTS: The LLM answer contains a fundamental factual error that undermines the entire response. According to the ground truth, Netflix introduced games in 2022 and the ad-supported tier in 2023, but the LLM claims both were disclosed in the 2022 filing ('Netflix's 2022 filing first disclosed a new lower‑priced ad‑supported subscription tier and the rollout of games'). This is incorrect - the ad-supported tier was introduced in 2023, not 2022. The LLM also incorrectly attributes live programming to 2022 ('introducing games and advertising on our service, as well as offering live programming' in 2022), when the ground truth clearly states live programming was added by 2024. TIMELINE ERRORS: (1) 2022: LLM incorrectly includes ad-supported tier and live programming; should only mention games introduction. (2) 2023: LLM correctly identifies ad-supported tier expansion and games continuation, but the sequencing is wrong given the 2022 error. (3) 2024: LLM correctly identifies live programming, but this is presented as continuation rather than new addition. REASONING ISSUES: While the LLM correctly identifies the general risk narrative (that new features/pricing changes could impact member acquisition and retention), the multi-hop synthesis across years is compromised by the incorrect timeline. The LLM appears to have conflated information from different years, suggesting it did not properly synthesize the evolution across the three-year period. POSITIVE ASPECTS: The LLM does capture the core risk messaging about member acquisition and retention, and correctly identifies that risks were consistently highlighted across years. The quoted language about 'if our efforts...may not be well-received' aligns with the ground truth's characterization of stated risks. However, these positives cannot overcome the fundamental factual errors about when each service expansion occurred. The answer demonstrates partial understanding of the risk narrative but fails on the critical factual accuracy required for a multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 560,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑equity holdings grew modestly, rising from $3.7 billion of equity securities in 2022 to $4.9 billion in 2023 and staying at $4.9 billion in 2024 (UNH 10‑K 2023 p. 50; UNH 10‑K 2024 p. 52).  By contrast, its equity‑method stakes in health‑care operating businesses slipped slightly from $1.5 billion in 2022 to $1.4 billion in 2023, then jumped to $3.8 billion in 2024 (UNH 10‑K 2023 p. 50; UNH 10‑K 2024 p. 52).  This pattern shows the company keeping a stable, sizable venture portfolio while dramatically expanding direct ownership in health‑care businesses, underscoring a strategic push to deepen its integrated position in the health‑care sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a critical factual error in the 2022 equity method investments figure. The ground truth states $1.3 billion in 2022, but the LLM claims $1.5 billion. This is a material discrepancy of $200 million (15% difference). All other numbers are correct: equity securities at $3.7B (2022), $4.9B (2023-2024), and equity method investments at $1.4B (2023) and $3.8B (2024). COMPLETENESS: The LLM answer addresses all required components - equity securities holdings, equity method investments, the 2022-2024 timeframe, and strategic implications. ENTITY ACCURACY: Company (UnitedHealth/UNH), metrics (equity securities, equity method investments), and years are correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the stable equity securities trend versus the dramatic jump in equity method investments in 2024, and appropriately characterizes this as a strategic shift toward deeper healthcare business ownership. The interpretation aligns with the ground truth's conclusion about integrated health services positioning. SEMANTIC EQUIVALENCE: The LLM's characterization of the pattern ('keeping a stable, sizable venture portfolio while dramatically expanding direct ownership') effectively conveys the same strategic insight as the ground truth. The reasoning about strategic positioning is well-articulated. CRITICAL ERROR: The $1.5B vs $1.3B discrepancy for 2022 is a factual error that cannot be overlooked, as it misrepresents the baseline for the equity method investment trend analysis. This error prevents a higher score despite otherwise sound reasoning and correct synthesis of the remaining data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 467,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America has been essentially unchanged from FY 2022 through FY 2024.  Sojitz America continued to be the sole owner of Nike’s $0.3 million of redeemable preferred stock, which carries a $0.10‑per‑share cumulative dividend payable each May 31 and prevents any common‑stock dividend until that preferred dividend is paid; the preferred shares have the same limited voting rights (only on asset‑sale, merger, liquidation or U.S. trademark matters) and no additional preferred stock has been issued during this period【page_79†L1-L9】【page_8†L1-L9】.  At the same time, Sojitz America remains Nike’s long‑standing import‑export financing partner, providing financing services that support Nike’s international operations【page_7†L1-L4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all quantitative facts: Sojitz America as sole holder of Nike's redeemable preferred stock with $0.3 million par value, $0.10 per share cumulative dividend payable May 31, voting rights limitations, and the long-standing import-export financing relationship since 1972. Numbers and dates are accurate. CRITICAL WEAKNESSES: (1) The LLM answer fails to capture the key evolution highlighted in the ground truth - that Nike explicitly emphasized Sojitz America's strategic operational role in FY 2024 specifically, particularly in the context of rising global trade risks and supply chain volatility. The ground truth explicitly states this represents 'a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024.' The LLM answer presents the relationship as 'essentially unchanged' and 'long-standing,' missing this important temporal evolution. (2) The LLM answer does not address the strategic context of why Nike highlighted this relationship in 2024 - the rising trade protectionism and supply chain volatility that made the import-export financing services more strategically important. (3) The question specifically asks about how the relationship 'evolved' - the ground truth identifies a meaningful evolution in emphasis and strategic positioning by 2024, while the LLM answer characterizes it as unchanged. This is a significant gap in addressing the core question about evolution. The LLM answer is factually accurate on static details but misses the dynamic, temporal dimension of the relationship's evolution that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 452,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 have been carried on the balance sheet at their original issuance amount of **$2 billion** throughout the period – the net‑carrying‑amount column in the 2024 filing shows $2,000 million for the note (Jan 28 2024) and the same amount is listed for Jan 26 2025, and the footnote in the 2023 filing confirms that these liabilities are recorded at original issuance value, net of any un‑amortized discount (​【page_72†L13-L20】​;​【page_67†L31-L38】​). Because the carrying amount has not changed from FY 2022 through FY 2024, NVIDIA’s long‑term debt profile for this instrument has remained stable, indicating the company has neither retired nor added to this senior debt tranche and is maintaining a consistent financing structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. Ground truth shows the carrying value evolved as: FY2022: $2,147 million → FY2023: $1,604 million → FY2024: $2,000 million. The LLM claims the carrying amount 'has not changed from FY 2022 through FY 2024' and remained at '$2 billion throughout the period,' which directly contradicts the documented fluctuations. Specific errors: (1) FY2022 value was $2,147M, not $2,000M - the LLM missed the initial higher amount; (2) FY2023 value was $1,604M, not $2,000M - the LLM completely omitted the significant 2023 decline; (3) The claim of 'stable' carrying amount is factually wrong - there was a $543M decrease from 2022-2023 and a $396M increase from 2023-2024; (4) The conclusion that 'the carrying amount has not changed' is demonstrably false given the documented $543M swing. The LLM's reasoning about 'original issuance value, net of unamortized discount' may be technically accurate regarding accounting treatment, but this does not explain why the carrying value fluctuated if the instrument remained unchanged. The LLM failed to synthesize the multi-hop requirement of tracking the evolution across three fiscal years and identifying the trend. The answer shows a fundamental misreading or misinterpretation of the source data, presenting a static picture when the ground truth clearly shows dynamic changes in carrying value. This is a critical failure on a quantitative question where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 410,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s 2022 filing stressed that its liquidity comes from a broad set of global funding sources—including commercial‑paper programs, credit and committed facilities, long‑term debt and equity—which “enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds” (page 127).  Short‑term debt (largely commercial paper) fell from $175 million in 2022 to $119 million in 2023 (page 111) but then rose sharply to $465 million in 2024 (page 101), indicating a greater use of short‑term funding while the company continues to rely on a diversified global funding mix to keep financing costs low (page 101).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific quantitative data and multi-hop synthesis. STRENGTHS: (1) Correctly identifies MetLife's diversified funding strategy across 2022-2024; (2) Accurately cites specific short-term debt figures: $175M (2022), $119M (2023), $465M (2024) with proper page references; (3) Properly synthesizes the evolution showing a decline from 2022-2023 then sharp increase in 2024; (4) Correctly quotes the company's stated rationale about enhancing flexibility, limiting market dependence, and lowering cost of capital; (5) Appropriately identifies commercial paper as the primary short-term debt instrument; (6) Demonstrates sound multi-hop reasoning by connecting quantitative trends to strategic intent. MINOR WEAKNESSES: (1) The original answer emphasizes 'consistent mention' and 'stable reliance' across all three years, while the LLM answer highlights volatility (the sharp rise in 2024), which is technically more precise but slightly shifts emphasis from the ground truth's focus on consistency; (2) The LLM answer provides more granular quantitative detail than the original answer, which is generally positive but represents a different level of specificity; (3) Could have more explicitly stated that despite the 2024 increase, the diversified funding approach remained the core strategy. VERIFICATION: The specific dollar amounts ($175M, $119M, $465M) and page citations appear credible and internally consistent with the narrative of declining short-term debt followed by an increase. The quote about funding flexibility and cost reduction aligns with typical corporate messaging. The answer fully addresses the question's multi-part requirements: evolution over time (2022-2024), short-term debt usage, and reliance on diverse funding sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 490,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s service‑level guarantees have been immaterial in every year – the filing notes that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022”【page_81】. At the same time, the company’s notes payable to subsidiaries shifted dramatically: short‑term, on‑demand notes fell from $8.7 billion in 2022 to $9.9 billion in 2023 and then collapsed to $2.0 billion in 2024, while a new long‑term note balance of $14.4 billion appeared in 2024 (none was reported in 2022 or 2023)【page_78】【page_78】【page_78】. This evolution shows UnitedHealth moving liquidity commitments from large, potentially volatile short‑term debt toward a more stable long‑term financing structure, while its contractual risk from service‑level guarantees remains minimal.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that service level guarantees were immaterial across all three years (2022-2024), matching the ground truth. (2) The qualitative reasoning about the shift from short-term to long-term financing structure is sound and insightful. (3) The answer appropriately synthesizes information across multiple data points to address the multi-hop question. (4) The contextual framing about liquidity strategy evolution is relevant and well-reasoned.\n\nCRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states short-term notes payable were $8.7 billion in 2022, but the ground truth specifies $8.1 billion. This is a material error of $600 million (7.4% difference). (2) The LLM correctly identifies the 2023 figure as $9.9 billion and 2024 short-term as $2.0 billion, which match ground truth. (3) The introduction of the $14.4 billion long-term note in 2024 is a significant detail not mentioned in the ground truth answer, though it may be factually correct from the filing - this represents additional information rather than an error.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and two distinct financial metrics (service level guarantees + notes payable), correctly identifying the inverse relationship and strategic implications. The reasoning that the company shifted from volatile short-term to stable long-term debt is logically sound.\n\nCOMPLETENESS: The answer addresses both components of the question (service level guarantees AND notes payable evolution) and provides temporal analysis across the full 2022-2024 period. However, the ground truth emphasizes that the volatility in notes payable suggests 'shifting liquidity strategies or contractual obligations,' while the LLM frames this more definitively as a deliberate move toward stability.\n\nJUSTIFICATION: The primary issue is the $8.7B vs $8.1B discrepancy for 2022, which is a factual error in a key quantitative metric. This prevents a higher score despite otherwise sound reasoning and mostly correct information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 557,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "- In the 2022 and 2023 filings American Express described its global card network as the fourth‑largest general‑purpose network worldwide—behind China UnionPay, Visa and Mastercard—and highlighted intense competition from those networks and from emerging payment platforms, noting that regulatory scrutiny of card‑network operations (including interchange‑fee rules) was a material risk factor (see 2022/23 page 12‑13).  \n\n- By the 2024 filing the company said regulatory pressure had intensified: it was re‑classified as a Category III firm subject to stricter U.S. banking oversight, it exited its network‑licensing businesses in the EU and Australia because of local regulations, and it is confronting possible interchange‑fee caps and a proposed Visa/Mastercard settlement that could further compress merchant‑discount revenue (see 2024 page 34‑35).  \n\n- Together, these disclosures show that while Amex’s competitive rank has remained stable, its reliance on card‑network regulations has grown, prompting strategic actions such as bolstering compliance programs, withdrawing from regulated licensing activities, and preparing to adjust pricing and network‑related offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024 filings. STRENGTHS: (1) Correctly identifies Amex as fourth-largest general-purpose network behind China UnionPay, Visa, and Mastercard across 2022-2023; (2) Accurately captures the shift to Category III regulatory classification in 2024; (3) Correctly notes exits from EU and Australia network-licensing businesses due to regulatory pressure; (4) Properly identifies key regulatory concerns (interchange fees, network routing, cobrand arrangements); (5) Accurately references specific filing pages (2022/23 pages 12-13, 2024 pages 34-35); (6) Sound multi-hop reasoning connecting competitive positioning to regulatory dependency evolution. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth, omitting some contextual details about alternative payment platforms (Alipay, PayPal, Venmo, NPCI) that were highlighted in 2023 filings—though this is a matter of comprehensiveness rather than factual error; (2) Does not explicitly characterize the 'tone shift' or strategic posture transformation as clearly as the ground truth (from 'market-driven competition' to 'regulatory navigation'), though the substance is captured; (3) The phrase 'proposed Visa/Mastercard settlement' is mentioned but not elaborated, though this appears accurate to 2024 filing disclosures. QUANTITATIVE VERIFICATION: All numeric references (fourth-largest ranking, Category III classification, specific page numbers) are accurate. No calculation errors detected. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years of filings, properly connecting competitive landscape evolution to regulatory constraints and strategic responses. The logical flow from 2022 competitive positioning through 2023 intensification to 2024 regulatory transformation is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the core message of the ground truth—that Amex's competitive independence has been increasingly constrained by regulatory forces—though with slightly less narrative depth regarding the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1716,
        "completion_tokens": 584,
        "total_tokens": 2300
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips kept its cash‑settled PSU design the same – for performance periods that begin in 2018 or later the awards provide an **accrued reinvested dividend equivalent** that is charged to compensation expense and paid only at settlement (instead of cash dividends during the period) (2022 10‑K p. 136; 2023 10‑K p. 123; 2024 10‑K p. 124). Maintaining this structure shows the company’s deliberate effort to align long‑term executive incentives with shareholder returns by tying cash‑settled awards to the firm’s stock performance and total shareholder return.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key dividend equivalent structure for performance periods beginning in 2018 or later (accrued reinvested dividends paid at settlement) and accurately cites the relevant 10-K pages. However, the answer has significant gaps in completeness and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the accrued reinvested dividend equivalent structure for 2018+ periods; (2) Accurately cites page numbers from 2022, 2023, and 2024 10-Ks; (3) Correctly notes the structure remained consistent across the three-year period; (4) Appropriately connects the structure to long-term incentive alignment. WEAKNESSES: (1) INCOMPLETE COMPARISON: The ground truth explicitly contrasts the dividend equivalent structure for pre-2018 periods (no payments during performance period, began after conclusion) versus 2018+ periods (accrued reinvested dividends paid at settlement). The LLM answer only describes the 2018+ structure and fails to highlight this evolution/shift, which is central to the question about how the strategy 'evolved'; (2) MISSING VESTING DETAILS: Ground truth mentions vesting tied to either five years or retirement eligibility—the LLM omits this; (3) INCOMPLETE BALANCE SHEET CONTEXT: Ground truth notes the consistent classification as liabilities across all three years, which underscores commitment to cash-based structures. The LLM doesn't mention this; (4) WEAK MULTI-HOP SYNTHESIS: The question asks what the evolution 'reveals' about long-term incentive alignment approach. The ground truth provides deeper insight (shift from deferred to accrued reinvestment suggests strategic move toward stronger alignment by deferring rewards until performance outcomes realized). The LLM's explanation is more superficial; (5) MISSING HISTORICAL CONTEXT: The ground truth references the 2012 downstream separation context, which the LLM omits. The answer addresses only the 2018+ structure without the comparative analysis that demonstrates actual evolution. The LLM essentially answers 'what is the current structure' rather than 'how did it evolve.' This is a significant gap for a question specifically asking about evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 586,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "Special Use Funds fell from roughly $11 billion in 2022 (the combined NEE and FPL equity, government, corporate, asset‑backed and other securities shown in the 2022 note) to $8.7 billion in 2023, then rose to $9.8 billion in 2024 [84, 64]. During the same span, the cash and letter‑of‑credit collateral posted for derivatives dropped from $1.8 billion cash and $2.8 billion letters of credit in 2022 to $0.7 billion cash and $1.6 billion letters of credit in 2023, and the worst‑case collateral requirement under a rating‑downgrade scenario fell from $5.2 billion to $2.4 billion [86]. Consequently, NextEra’s Special Use Funds have consistently exceeded both the collateral actually posted and the maximum potential collateral it could be required to post, indicating a robust liquidity buffer throughout the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the entire response. (1) SPECIAL USE FUNDS TRAJECTORY: The LLM claims Special Use Funds were 'roughly $11 billion in 2022' but the ground truth shows $8,698 million in 2023 and $9,800 million in 2024 with no 2022 figure provided in the ground truth. The LLM's $11 billion 2022 figure cannot be verified and appears to be fabricated or misinterpreted. The LLM correctly identifies the 2023 ($8.7B) and 2024 ($9.8B) figures. (2) COLLATERAL POSTED FIGURES: The LLM states '$1.8 billion cash and $2.8 billion letters of credit in 2022' but the ground truth explicitly shows '$84 million in 2022' for actual collateral posted in cash, increasing to '$691 million in 2023.' This is a massive discrepancy (1,800% error on 2022 cash collateral). The LLM's figures for 2023 ($0.7 billion cash, $1.6 billion LOC) also don't match the ground truth's $691 million cash figure. (3) DOWNGRADE SCENARIO COLLATERAL: The LLM correctly identifies the worst-case collateral requirement falling from $5.2 billion to $2.4 billion, which matches ground truth. However, the ground truth also mentions a potential $2.7 billion figure for 2024 that the LLM omits. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the relationship between Special Use Funds and collateral obligations, the foundation is built on incorrect numbers, making the conclusion unreliable. The LLM's conclusion about 'robust liquidity buffer' is reasonable in structure but based on flawed data. (5) MISSING CONTEXT: The LLM fails to highlight the significant reduction in collateral posting requirements from 2022 to 2023 (from $5.2B to $2.4B potential exposure), which is a key insight in the ground truth about strategic risk management improvement. The answer demonstrates poor data accuracy despite reasonable analytical framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 516,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s $700 million 1.600 % senior notes were amortized by $3.7 million in 2022, $2.6 million in 2023 and $1.5 million in 2024, leaving roughly $696.3 million, $693.7 million and $692.2 million of principal outstanding respectively 【page_110†L1-L7】【page_113†L1-L7】【page_48†L1-L5】.  The year‑over‑year decline in amortization (‑$1 million‑plus each year) shows a deliberately slowing repayment pace, preserving cash while still modestly reducing the debt – a pattern that signals a strategy of extending the amortization schedule and keeping flexibility for this instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) PRINCIPAL AMOUNT ERROR: The ground truth explicitly states the outstanding principal remained constant at $700.0 million across 2022-2024. The LLM incorrectly claims the principal declined to $696.3M, $693.7M, and $692.2M respectively. This is a major factual error. (2) AMORTIZATION INTERPRETATION ERROR: The ground truth indicates adjustments to principal (likely amortization/accrued interest) were (3.7)M in 2022 and (2.6)M in 2024, with no 2023 figure provided in the ground truth. The LLM claims amortization was $3.7M in 2022, $2.6M in 2023, and $1.5M in 2024 - introducing a 2023 figure and a 2024 figure ($1.5M) not mentioned in the ground truth. (3) CALCULATION ERROR: The LLM's remaining principal calculations ($696.3M, $693.7M, $692.2M) are mathematically inconsistent with a constant $700M principal. These appear to be cumulative subtractions of the amortization figures, which misrepresents how the debt was actually structured. (4) STRATEGY INTERPRETATION: While the LLM's interpretation of a 'deliberately slowing repayment pace' is plausible reasoning, it is built on incorrect numerical foundations. The ground truth suggests stable debt management with predictable patterns, not a deliberate slowing strategy. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year pattern - it misread whether principal remained constant or declined. This is a fundamental synthesis failure. The answer demonstrates misunderstanding of the debt instrument's structure and provides materially incorrect financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 455,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth first disclosed in its 2022 Form 10‑K that CMS could change the way Medicare Advantage risk‑adjustment payments are calculated and that RADV audits could produce retroactive payment cuts, so it began “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” to blunt the funding pressure【page_25】【page_26】. The 2023 filing reiterated that CMS continued to modify risk‑adjustment methodology (and even freeze benchmarks), prompting the company to double‑down on those same selective benefit‑premium tweaks and cost‑control measures【page_20】. By 2024 the risk‑adjustment exposure remained, with CMS still making changes and RADV audit risk highlighted, and UnitedHealth again emphasized targeted benefit and premium adjustments, plan‑offering reductions and heightened medical‑and‑operating cost‑management and compliance efforts to mitigate the funding pressures【page_20】【page_21】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of UnitedHealth's exposure to Medicare Advantage risk adjustment payment changes; (2) Accurately captures the specific strategic responses: selective benefit/premium adjustments, county exits, and intensified cost management across all three years; (3) Properly synthesizes multi-hop information by connecting CMS regulatory changes to UnitedHealth's corresponding strategic adjustments year-by-year; (4) Correctly identifies key regulatory mechanisms (RADV audits, risk adjustment methodology changes, benchmark freezes); (5) Uses appropriate page citations suggesting document verification; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'double-down' vs 'continuing to adapt'). MINOR CONSIDERATIONS: (1) The LLM answer includes additional detail about RADV audits and retroactive payment cuts that, while accurate and relevant, goes slightly beyond the ground truth's focus on the core risk adjustment methodology changes - this is actually a strength as it provides more comprehensive context; (2) The phrasing 'blunt the funding pressure' and 'mitigate the funding pressures' effectively conveys the motivation behind the strategic adjustments, matching the ground truth's implication that these were responsive measures. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages were required in either answer, so quantitative accuracy is not a limiting factor. The answer correctly identifies all three fiscal years (2022, 2023, 2024) and maintains chronological accuracy. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, correctly linking regulatory changes to strategic responses in each year and showing the evolution of the company's approach. The consistent theme of ongoing adaptation to CMS recalibrations is clearly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 550,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023 and 2024 all describe employee merchandise discounts in the same way – as a generic “merchandise and other discounts” benefit that is part of the overall compensation and benefits package, with eligibility based on full‑time/part‑time status, work location, pay level and tenure (2022 p.5; 2023 p.5; 2024 p.5). The unchanged scope and structure signal that Target views the discount as a stable, core perk rather than a variable program, underscoring a consistent strategy to support team‑member financial well‑being through an ongoing, inclusive benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misrepresents the ground truth in several critical ways: (1) FACTUAL ERRORS: The LLM claims merchandise discounts were described 'in the same way' across all three years with 'unchanged scope and structure,' directly contradicting the ground truth which explicitly documents significant evolution. The ground truth shows starting wages expanded from '$15 per hour' (2022) to '$15-$24 per hour' (2023), and new benefits were added (sick pay, tuition-free education, free virtual healthcare, expanded mental health services). The LLM completely omits these documented changes. (2) MISSING CRITICAL CONTEXT: The ground truth emphasizes a 3-year progression showing Target 'increasingly positioned' discounts within a 'holistic financial and well-being strategy' with evolving framing from basic benefits to 'equitable pay and belonging.' The LLM misses this entire narrative arc. (3) CONTRADICTORY CONCLUSION: The LLM concludes the 'unchanged' nature signals stability, when the ground truth explicitly documents changes in the broader compensation and benefits ecosystem. The LLM's characterization of the discount as 'unchanged' is factually incorrect based on the ground truth's documentation of wage expansion and new benefit additions. (4) INCOMPLETE SYNTHESIS: The question asks about evolution 'from 2022 through 2024' - the LLM fails to synthesize the documented progression across these years. (5) PAGE CITATIONS: The LLM cites page 5 for all three years without substantiating the claim of identical language, and this citation pattern itself appears generic rather than evidence-based. The answer demonstrates a fundamental failure to identify and synthesize the documented evolution in Target's employee financial well-being strategy across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 489,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio was modest – $630 million at year‑end 2021 – and was almost entirely short‑dated, with $628 million (≈99 %) due within one year and only $2 million in longer‑dated buckets; the weighted‑average yields for those buckets were about 1.74 % for the ≤1‑year portion, 2.42 % for 1‑5 years and 5.46 % for 5‑10 years【page_120】【page_121】. In the 2023 and 2024 10‑K filings the company no longer reports a separate foreign‑government‑bond line, implying the exposure has not expanded and is now folded into broader investment‑security categories, which signals a continued low‑risk, short‑duration allocation and a conservative risk‑appetite in its asset‑allocation strategy【page_176】【page_179】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer contains multiple critical errors that fundamentally misalign with the ground truth:\n\n1. TEMPORAL MISALIGNMENT: The LLM references 2021 data ('$630 million at year-end 2021') when the question explicitly asks about 2022-2024. The ground truth clearly states the $630 million figure is from 2022, not 2021. This is a fundamental error in understanding the time period being analyzed.\n\n2. MISSING CORE DATA: The LLM completely fails to provide the 2023 and 2024 yield data that are central to the question. The ground truth shows:\n   - 2023: 6.45% yield (≤1 year), 4.48% yield (1-5 years)\n   - 2024: 5.86% yield (≤1 year), 2.03% yield (1-5 years)\n   The LLM provides none of this critical information.\n\n3. INCORRECT INTERPRETATION: The LLM claims that in 2023 and 2024 'the company no longer reports a separate foreign-government-bond line,' suggesting the data is unavailable. However, the ground truth demonstrates that specific yield and maturity data exists for all three years (2022-2024), contradicting the LLM's assertion.\n\n4. FLAWED REASONING: The LLM's conclusion about 'conservative risk-appetite' contradicts the ground truth's finding of 'more aggressive short-term investments in 2023.' The yield progression (1.74% → 6.45% → 5.86% for short-term bonds) clearly indicates increased risk appetite in 2023, not conservatism.\n\n5. INCOMPLETE ANALYSIS: The LLM fails to address the 3-year pattern evolution that is the core of the question. It provides no comparison across the three years and no analysis of the strategic shift indicated by the yield changes.\n\n6. QUANTITATIVE ERRORS: While the $630 million figure is correct, the context (year) is wrong, and the yield figures provided (1.74%, 2.42%, 5.46%) appear to be only from 2022, not the full 2022-2024 evolution requested.\n\nThe answer demonstrates a fundamental failure to synthesize multi-hop information across the three-year period and misses the entire analytical thrust of the question regarding the evolution of yields and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 551,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s un‑offset collateral tied to master‑netting arrangements (which is recorded against the “Other assets, including intangibles – net” line) fell sharply: $1.494 billion at 12/31/2022, $0.800 billion at 12/31/2023, and $0.491 billion at 12/31/2024【page_102】【page_99】.  The downward trend shows the company is reducing the amount of margin‑related collateral it must hold, indicating tighter control and possibly lower net derivative exposure through more efficient netting and risk‑management practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The LLM properly converted these to billions ($1.494B, $0.800B, $0.491B) which is an acceptable format variation. All dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it identifies the collateral amounts across all three years and explains the trend's implications for derivative exposure management. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the specific balance sheet line item 'Other assets, including intangibles - net' is correctly referenced, and the master netting arrangements concept is properly contextualized. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified the downward trend across three years and provided logical interpretation about what this suggests regarding risk management (reduction in margin collateral, tighter control, more efficient netting). The reasoning that lower collateral requirements suggest improved risk management practices is appropriate and well-supported. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('tighter control and possibly lower net derivative exposure through more efficient netting') is semantically equivalent to and slightly more detailed than the ground truth's 'strategic reduction in derivative-related exposure or a shift in risk management practices.' The only minor distinction is that the LLM provides slightly more specific interpretation about the mechanism (margin collateral, netting efficiency) while the ground truth is more general. This represents a minor enhancement rather than a deviation. The inclusion of page references adds credibility without affecting accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 514,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 filing the 2.700 % senior notes were shown as a $700 million issue dated March 29 2021, carrying a fixed 2.700 % coupon, semi‑annual interest (April 15 and October 15) and a maturity of April 15 2031 with a par‑call on January 15 2031 【page_48】.  \n- The 2023 filing still lists the same notes as outstanding with the unchanged 2.700 % rate and only a modest principal adjustment (‑$5 million) – no new issuance or rate change 【page_111】.  \n- By the 2024 filing the company had not issued any additional 2.700 % notes; instead it raised new senior debt at much higher coupons (e.g., 5.200 % and 5.450 % notes due 2029/2034) 【page_113】, showing that AMT locked in low‑cost, long‑dated fixed‑rate financing early and, as market rates rose, turned to higher‑coupon issuances for new funding.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about AMT's financing strategy but contains several factual discrepancies with the ground truth that affect accuracy:\n\nQUANTITATIVE ACCURACY ISSUES:\n1. MATURITY DATE DISCREPANCY: The LLM states maturity as 'April 15, 2031' in 2022, but the ground truth clearly states 'April 15, 2031' in 2022 filing. However, the ground truth also mentions 'January 15, 2031' as the maturity date in 2023 and 2024. The LLM's 2022 date of April 15, 2031 conflicts with the ground truth's January 15, 2031 stated for 2023-2024. This is a critical discrepancy in a key financial term.\n2. PRINCIPAL ADJUSTMENT: The LLM mentions a '-$5 million' adjustment in 2023, which is not mentioned in the ground truth. This appears to be an unsupported detail.\n3. INTEREST RATE SPREAD: The ground truth explicitly mentions the interest rate spread decreased from (5.0) to (4.4) by 2024, which the LLM completely omits. This is a significant omission of a key metric showing the evolution of financing costs.\n4. INTEREST PAYMENT DATES: The LLM states 'April 15 and October 15' while the ground truth states 'April and October' without specific dates. Minor formatting difference but the LLM is more specific.\n\nQUALITATIVE ACCURACY:\n1. The LLM correctly identifies the $700 million principal amount across all three years.\n2. The LLM correctly identifies the 2.700% coupon rate.\n3. The LLM correctly identifies the March 29, 2021 issuance date.\n4. The LLM correctly identifies the par call date of January 15, 2031.\n5. The LLM provides good contextual reasoning about market conditions and financing strategy evolution, noting that AMT locked in low-cost financing early and turned to higher coupons later.\n6. However, the LLM fails to mention the interest rate spread reduction (5.0 to 4.4), which is explicitly stated in the ground truth as revealing about the company's financing strategy.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates sound multi-hop reasoning by synthesizing information across three years and connecting it to broader market conditions and financing strategy. The conclusion about locking in low-cost debt early and issuing higher-coupon debt later is logically sound and well-supported. However, the reasoning is incomplete because it misses the interest rate spread reduction metric.\n\nCRITICAL ERRORS:\n1. The maturity date inconsistency (April 15, 2031 vs. January 15, 2031) is problematic and suggests potential confusion about which date applies in which year.\n2. The omission of the interest rate spread change (5.0 to 4.4) is a significant gap, as this metric directly addresses the question about how terms 'evolved' and what this reveals about financing strategy.\n3. The unsupported '-$5 million' principal adjustment in 2023 appears to be fabricated or misread.\n\nSTRENGTHS:\n- Clear year-by-year progression\n- Good narrative about market conditions and strategy\n- Correct identification of principal amount and coupon rate\n- Appropriate contextual analysis about higher-coupon issuances in later years\n\nThe answer is partially correct with good reasoning but contains factual errors and significant omissions that prevent it from fully matching the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 847,
        "total_tokens": 2251
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA carried roughly $1.04 billion of its 2.00 % senior unsecured notes due 2031 in 2022, the same $1.04 billion in 2023, and the balance rose modestly to $1.057 billion in 2024【page_78】【page_67】.  The near‑flat level—only a slight increase—shows the company’s preference for a stable, low‑cost long‑term debt base, using inexpensive, long‑dated notes to support growth while keeping overall leverage essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states '~$1.04 billion' for 2022, but ground truth shows $1.2 billion - a $160 million discrepancy (13% error). For 2023, LLM claims '$1.04 billion' but ground truth indicates $1.044 billion at beginning and $1.057 billion at end - the LLM conflates these and misses the progression. For 2024, LLM states '$1.057 billion' but ground truth shows $1.25 billion - another major error ($193 million difference, 15% error). (2) CHRONOLOGICAL CONFUSION: The LLM reverses the 2023-2024 progression, stating 2024 was $1.057B when it should be $1.25B. This is a critical factual error. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the actual evolution - the ground truth shows a dip in 2023 ($1.044B-$1.057B range) followed by a significant increase to $1.25B in 2024, suggesting a strategic adjustment. The LLM's narrative of 'near-flat level' and 'only a slight increase' is factually incorrect given the actual $1.2B→$1.25B movement and the 2023 dip. (4) REASONING QUALITY: While the LLM's interpretation about 'stable, low-cost long-term debt' is reasonable in tone, it's built on incorrect numbers, making the conclusion unreliable. The actual data shows more complexity than 'near-flat.' (5) MISSING CONTEXT: The ground truth explicitly notes 'no short-term portion' in 2024, which the LLM omits. The ground truth also provides more nuanced analysis of the 2023 beginning vs. end values, which the LLM conflates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 429,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances were still modest before 2023 – the most recent pre‑2023 figures disclosed were about $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (the 2021 amounts shown in the 2022 filing 【page_216】). After the November 2023 Global Atlantic risk‑transfer transaction, the balances jumped to $5.1 billion of deposit assets and $1.3 billion of deposit liabilities at year‑end 2023, then eased slightly to $4.6 billion of assets and $1.2 billion of liabilities at year‑end 2024 (as reported in the 2024 filing 【page_206】). The surge in 2023 shows MetLife deliberately expanded its use of the deposit method to support large, non‑risk‑bearing reinsurance agreements, while the modest decline in 2024 suggests it is now fine‑tuning or scaling back those arrangements as the strategy matures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "MAJOR DISCREPANCY IDENTIFIED: The LLM answer reports 2024 deposit assets as $4.6 billion, but the ground truth states $5.1 billion for year-end 2024. This is a significant factual error ($400 million difference). The LLM also characterizes the 2024 change as a 'modest decline' from 2023's $5.1 billion to $4.6 billion, which contradicts the ground truth showing an increase to $5.1 billion in 2024. CORRECT ELEMENTS: (1) 2022 deposit assets of $1.8 billion - correct; (2) 2022 deposit liabilities of $1.4 billion - correct; (3) 2023 deposit assets of $5.1 billion - correct; (4) 2023 deposit liabilities of $1.3 billion - correct; (5) 2024 deposit liabilities of $1.2 billion - correct; (6) Reference to Global Atlantic transaction in November 2023 with $10.3 billion in reinsurance recoverables - correct; (7) Overall narrative about strategic shift toward deposit method accounting - correct. REASONING QUALITY: The LLM demonstrates sound multi-hop synthesis across multiple years and correctly identifies the Global Atlantic transaction as a key driver. The interpretation of the trend as reflecting a strategic shift is reasonable. However, the fundamental error in the 2024 asset figure undermines the conclusion about 'scaling back' in 2024. The ground truth indicates continued growth to $5.1 billion in 2024, not a decline to $4.6 billion. This is a critical quantitative error that affects the validity of the trend analysis and strategic interpretation. The LLM's characterization of 2024 as showing a 'modest decline' is factually incorrect based on the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 435,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "- 2022: carrying (amortized‑cost) $696 million; fair‑value $679 million.  \n- 2023: carrying $603 million; fair‑value $596 million.  \n- 2024: carrying $512 million; fair‑value $508 million【page_53】【page_55】.  \n\nThe held‑to‑maturity portfolio has been shrinking each year and its market price has fallen, but the discount between fair value and carrying amount has narrowed (‑$17 M in 2022 → ‑$7 M in 2023 → ‑$4 M in 2024), indicating UnitedHealth is gradually reducing this low‑risk bond position while accepting temporary valuation declines—reflecting a strategy of maintaining a modest, stable held‑to‑maturity investment that aligns more closely with market prices over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and provides superior analysis compared to the ground truth. QUANTITATIVE VERIFICATION: All numbers are precisely correct - 2022: carrying $696M, fair value $679M; 2023: carrying $603M, fair value $596M; 2024: carrying $512M, fair value $508M. The discount calculations are also accurate: -$17M (2022), -$7M (2023), -$4M (2024). COMPLETENESS: The answer fully addresses the multi-part question by providing the 3-year progression for both fair value and carrying value, and offering strategic interpretation. ENTITY ACCURACY: UnitedHealth Group (UNH) correctly identified, fiscal years 2022-2024 correct, Debt Securities - Held-to-Maturity metric correctly specified. REASONING QUALITY: The LLM provides superior multi-hop synthesis compared to ground truth. While the ground truth simply states 'downward trend indicates strategic reduction or repositioning,' the LLM goes further by: (1) calculating and tracking the narrowing discount between fair value and carrying value, (2) interpreting this narrowing as evidence of gradual market price alignment, (3) providing more nuanced strategic insight about maintaining a 'modest, stable' position while accepting temporary valuation declines. This demonstrates sophisticated understanding of the relationship between fair value and carrying value dynamics. MINOR CONSIDERATION: The LLM's interpretation about 'gradually reducing this low-risk bond position while accepting temporary valuation declines' is a reasonable inference from the data, though slightly more interpretive than the ground truth's more cautious language. However, this represents enhanced analysis rather than error. The inclusion of page references (page_53, page_55) adds credibility. Overall, the LLM answer is factually perfect and provides more insightful analysis than the ground truth baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 506,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s credit‑card usage share has been slipping. The company reported that RedCard (now Target Circle) penetration fell from 20.5 percent in FY 2022 to 19.8 percent in FY 2023 and to 18.6 percent in FY 2024 【page_27】. Because Target tracks this metric as a proxy for incremental purchases, the steady decline suggests the card program’s ability to generate extra sales is waning, even though the firm still views the cards as a driver of incremental revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match ground truth exactly. (2) The downward trend is accurately identified and characterized. (3) The LLM correctly notes that Target views the metric as a proxy for incremental purchases. (4) The conclusion that the declining trend suggests weakening effectiveness is sound. (5) The acknowledgment that Target still views cards as drivers of incremental revenue is present. WEAKNESSES: (1) The LLM introduces 'RedCard (now Target Circle)' terminology which conflates two different loyalty programs - RedCard is the credit card product, while Target Circle is a separate loyalty program. This is a minor entity accuracy issue but could create confusion about what metric is being discussed. (2) The answer is slightly less nuanced than the ground truth - it states the trend 'suggests the card program's ability to generate extra sales is waning' more definitively, whereas the ground truth more carefully notes this 'may indicate' weakening engagement while still acknowledging 'meaningful portion of incremental purchases.' (3) The phrase 'even though the firm still views the cards as a driver of incremental revenue' is present but less detailed than the ground truth's 'Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales.' MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend data and connects it to the strategic implication about incremental sales effectiveness. The logic is sound. CALCULATION VERIFICATION: No calculations required; all percentages are stated correctly. OVERALL: The answer is substantially correct on the core facts and reasoning, with minor issues in terminology precision and nuance of interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 502,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike owned its Laakdal, Belgium distribution center in FY 2022 (Item 2, 2022 10‑K, p. 27) and the 2023 filing still lists Laakdal as an owned, key overseas distribution facility (Item 2, 2023 10‑K, pp. 27‑31). The FY 2024 10‑K again includes Laakdal among the most significant distribution sites outside the United States and notes that it is owned by Nike (Item 2, 2024 10‑K, p. 29). The unchanged ownership and its repeated designation as a major European hub show Nike’s strategic focus on retaining direct control of its European logistics infrastructure to support growth in the Europe, Middle‑East & Africa market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Nike's Laakdal facility evolution. STRENGTHS: (1) Correctly identifies Nike's ownership status across all three fiscal years (2022, 2023, 2024) with proper citation to Item 2 in each 10-K filing. (2) Accurately characterizes the facility as a 'significant' or 'most significant' distribution center consistently across the period, matching the ground truth. (3) Properly synthesizes the multi-hop information by tracking ownership continuity and operational role across three years. (4) Correctly interprets the strategic implication - that unchanged ownership indicates Nike's commitment to direct control of European logistics infrastructure. (5) Adds relevant context about the EMEA market focus, which is a logical extension of the data and aligns with Nike's strategic priorities. (6) Provides specific page references (p. 27 for 2022, pp. 27-31 for 2023, p. 29 for 2024) that demonstrate source verification. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and interpretive than the ground truth (mentioning EMEA market support), but this represents appropriate elaboration rather than error. The ground truth uses 'significant' while LLM uses 'most significant' for 2024 - both are accurate characterizations from the filings. No quantitative errors, calculation errors, or factual inaccuracies detected. The reasoning chain is sound: ownership consistency → strategic focus on direct control. All entities (Nike, Laakdal, Belgium, fiscal years) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 438,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings is listed in NVIDIA’s “Competition” section in every filing – as a rival in the networking‑switch, optical‑module and interconnect space in FY 2022 (see page 9), FY 2023 (see page 15) and again in FY 2024 (see page 15) – showing a stable competitive presence. At the same time, NVIDIA’s disclosures increasingly stress expanding its supplier base and building redundancy in its Asia‑Pacific supply chain (manufacturing discussion in FY 2022 page 8 and FY 2023 page 8) and tightening IP‑protection through licensing and enforcement (IP discussion in FY 2022 page 8 and FY 2023 page 8). Thus, while Lumentum’s role as a named competitor has remained unchanged, NVIDIA’s growing supply‑chain resilience and stronger IP strategy suggest a more aggressive ecosystem that could heighten competitive pressure on Lumentum.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Lumentum's competitive positioning relative to NVIDIA's supply chain and IP strategies across FY 2022-2024.\n\nSTRENGTHS:\n1. Correctly identifies Lumentum as consistently named competitor across all three fiscal years (2022, 2023, 2024)\n2. Accurately characterizes Lumentum's competitive domain: networking, switches, optical modules, and interconnect solutions\n3. Properly synthesizes the multi-hop relationship: Lumentum's stable competitive presence + NVIDIA's expanding supply chain resilience + IP protection strategies = heightened competitive pressure\n4. Correctly notes NVIDIA's strategic moves (supplier base expansion, Asia-Pacific supply chain redundancy, IP licensing/enforcement)\n5. Page references are reasonable and consistent with typical 10-K structure\n6. Semantic equivalence maintained with ground truth regarding patent portfolio expansion (implied through IP discussion)\n\nMINOR WEAKNESSES:\n1. Page numbers cited (page 9, 15, 8) cannot be verified against the ground truth, which doesn't specify exact page locations. However, this is a minor issue as the substantive content is correct.\n2. The answer doesn't explicitly mention specific patent expiration date ranges (2022 to 2045) that appear in the ground truth, though it does reference IP protection expansion\n3. Doesn't explicitly name TSMC and Samsung as manufacturing partners, though it references \"expanding supplier base\"\n\nMULTI-HOP REASONING ASSESSMENT:\nThe answer successfully synthesizes information across three fiscal years and connects Lumentum's competitive positioning to NVIDIA's strategic initiatives. The logic is sound: despite NVIDIA's strengthening position through supply chain and IP strategies, Lumentum maintains competitive relevance, suggesting persistent competitive pressure.\n\nQUANTITATIVE ACCURACY:\nNo specific financial metrics or calculations are required for this question. The temporal references (FY 2022, 2023, 2024) are all correct.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys the same core message as the ground truth: Lumentum's consistent competitive presence across three years, NVIDIA's strategic strengthening, and the implication that competitive pressure persists despite NVIDIA's advantages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 622,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s filings show that its reliance on external studios and other rights‑holders has remained essential, but the risk narrative has grown sharper. In the 2022 10‑K the company warned that studios launching their own streaming services could refuse or raise the price of licences (Risk Factors, p. 11), while the 2023 and 2024 reports stress that “our ability to provide our members with content … depends on studios, content providers and other rights‑holders licensing rights” (Intellectual Property, p. 4) and now also confronts new regulatory pressures such as content‑quota rules, levies and ownership restrictions (Regulation, p. 4). This evolution reveals that Netflix is increasingly leaning on exclusive licences and expanding original‑content production to offset rising competition from rights‑holders‑turned‑competitors and tighter government controls.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and accurately characterizes the evolution of Netflix's content licensing risk narrative; (2) Accurately captures the 2022 risk factor regarding studios launching competing services and raising licensing costs; (3) Correctly identifies the consistent emphasis in 2023-2024 on dependence on rights holders for content licensing; (4) Properly synthesizes the regulatory dimension introduced in 2024 (content quotas, levies, ownership restrictions); (5) Correctly concludes that Netflix is shifting toward exclusive licenses and original content production as a strategic response; (6) Multi-hop reasoning is sound—the answer successfully connects information across three years and multiple risk/strategic dimensions. MINOR CONSIDERATIONS: (1) The LLM provides specific page references (Risk Factors p. 11, Intellectual Property p. 4, Regulation p. 4) which add credibility but cannot be verified against the ground truth provided; these appear plausible but represent added detail beyond the ground truth; (2) The phrasing 'rights‑holders‑turned‑competitors' is a reasonable characterization but slightly more interpretive than the ground truth's 'studios launched their own streaming services'; (3) The term 'levies' is mentioned as a regulatory constraint, which aligns with the ground truth's 'investment obligations' concept but uses slightly different terminology. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth—a progression from content availability risks to a more complex landscape involving competition and regulation, with Netflix responding through exclusive content and original production. The core narrative arc matches perfectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 553,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "Southern Company has consistently accounted for the scheduled payments under its outdoor‑lighting contracts as operating‑lease obligations, showing the cash‑flow schedules in the operating‑lease maturity‑analysis tables and reporting the related income in the “lease‑income – operating leases” line item rather than as revenue (see the lease‑income tables)【page_269】. The contracts were described as having initial terms of up to seven years in the 2022 filing【page_268】, but the description was updated to up‑to‑ten‑year terms in the 2023 and 2024 filings【page_240】; the immateriality footnote also changed—from noting only Mississippi Power’s outdoor‑lighting cash flows as immaterial in 2022 and 2023【page_270】【page_241】—to stating that both Georgia Power and Mississippi Power’s outdoor‑lighting cash flows are immaterial in 2024【page_233】. Throughout the three years the presentation in the maturity‑analysis tables remained unchanged (e.g., 2023 table【page_239】 and 2024 table【page_231】), while lease income from PPAs is included in wholesale revenue for some subsidiaries, the outdoor‑lighting lease income continues to be classified separately as lease income.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific details about Southern Company's treatment of outdoor lighting contracts but has significant issues with alignment to the ground truth and question focus:\n\nSTRENGTHS:\n1. Correctly identifies that outdoor lighting contracts are accounted for as operating leases\n2. Accurately notes the shift in contract term descriptions (7 years in 2022 to up to 10 years in 2023-2024)\n3. Correctly identifies the immateriality footnote evolution (Mississippi Power only in 2022-2023, then both Georgia Power and Mississippi Power in 2024)\n4. Properly notes that lease income is classified separately rather than as revenue\n5. Provides specific page references supporting claims\n6. Correctly identifies that maturity analysis tables remained unchanged across years\n\nWEAKNESSES:\n1. MAJOR: The LLM answer focuses heavily on accounting classification details (operating lease treatment, income line items) rather than the evolution of disclosure and materiality treatment that the question emphasizes\n2. The ground truth emphasizes a PROGRESSION: immaterial in 2022 → included in maturity analyses in 2023 → explicitly stated inclusion in 2024. The LLM answer states the presentation \"remained unchanged\" which contradicts the ground truth's narrative of evolution\n3. The LLM answer doesn't clearly articulate the shift from considering payments immaterial to including them in maturity analyses as a meaningful evolution\n4. The answer is more technical/accounting-focused rather than addressing the evolution of disclosure practices and transparency\n5. The LLM answer suggests consistency throughout (\"consistently accounted for\") when the ground truth emphasizes change and progression\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across multiple years and identifies the immateriality footnote changes, but fails to properly synthesize the broader narrative of evolving disclosure practices that the question asks about. The answer treats the topic as static accounting treatment rather than dynamic disclosure evolution.\n\nSEMANTIC ALIGNMENT:\nWhile the LLM provides accurate technical details, it misses the core narrative arc of the ground truth answer: the progression from immateriality disclosure → structured reporting inclusion → explicit transparency. The LLM's emphasis on \"unchanged presentation\" directly contradicts the ground truth's emphasis on evolution and increasing transparency.\n\nNUMERIC/FACTUAL VERIFICATION:\nAll specific facts mentioned (7-year vs 10-year terms, Mississippi Power vs Georgia Power and Mississippi Power, page references) appear consistent with typical SEC filing patterns, though the page numbers cannot be independently verified. The factual claims about accounting treatment are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 736,
        "total_tokens": 2259
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million in fiscal 2022**, and that same **$606 million balance was reported in fiscal 2023 and again in fiscal 2024**【page_101】【page_81】【page_81】. The flat balance over three years shows the company has chosen to retain this low‑cost, fixed‑rate note rather than accelerate repayment, reflecting a debt‑management approach that preserves liquidity and focuses repayment effort on other, higher‑cost or more flexible borrowings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states the outstanding principal was $606 million in fiscal 2022, 2023, and 2024 (flat across all three years). However, the ground truth clearly shows: FY2022: $1,086 million, FY2023: $606 million, FY2024: $606 million. This is a major quantitative error - the LLM missed the $480 million reduction that occurred between FY2022 and FY2023 ($1,086M - $606M = $480M decrease). The LLM's characterization of a 'flat balance over three years' is factually incorrect. Additionally, the LLM's interpretation that the company 'chose to retain this low-cost, fixed-rate note rather than accelerate repayment' contradicts the actual debt management strategy evidenced by the significant $480 million principal reduction in 2023. The ground truth indicates a deliberate debt reduction strategy in 2023, not a retention strategy. The LLM failed to capture the key evolution of the debt balance and mischaracterized the company's debt management approach. While the LLM correctly identified the note type (5.000% senior notes due April 2030) and the final balance ($606 million in FY2024), it fundamentally failed on the core multi-hop requirement: tracking the evolution across three fiscal years and correctly interpreting what that progression indicates about debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 383,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM kept its weighted‑average long‑term return assumption for U.S. pension assets at 6.3 % for both 2022 and 2023, then lifted it to 6.5 % for 2024 [GM_10k_2023.pdf: page_87; GM_10k_2024.pdf: page_88]. This uptick follows a re‑allocation that raised equity exposure from 8 % in 2022 to 11 % and expanded “other” assets (private‑equity, real‑estate, hedge‑funds) from 23 % to 29 % while cutting debt from 69 % to 60 % [GM_10k_2022.pdf: page_87; GM_10k_2023.pdf: page_87; GM_10k_2024.pdf: page_88], indicating GM is shifting its pension portfolio toward higher‑return, higher‑risk assets to improve funded status and respond to more favorable market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 rate of return assumption. The ground truth clearly states that in 2022, GM reported 5.4%, which then remained at 6.3% in 2023 (a 0.9 percentage point increase from 2022 to 2023, not unchanged). The LLM incorrectly claims the rate was 6.3% in both 2022 and 2023, which contradicts the ground truth. This is a major quantitative error that undermines the entire answer. The 2024 figure of 6.5% is correct, but the LLM's characterization of the trend is wrong - it should show a 1.1 percentage point increase over two years (5.4% to 6.5%), not a 0.2 percentage point increase (6.3% to 6.5%). The asset allocation percentages provided (equity 8% to 11%, other assets 23% to 29%, debt 69% to 60%) appear reasonable and support the narrative of shifting toward higher-risk assets, but these cannot be verified against the ground truth provided. The LLM's reasoning about strategic asset mix adjustments is sound in principle, but it is built on an incorrect foundation regarding the rate of return assumptions. The multi-hop synthesis attempted (connecting rate changes to asset allocation changes) is conceptually appropriate but is compromised by the factual error in the primary metric. The answer demonstrates effort in providing supporting detail with asset allocation data, but the core quantitative accuracy failure is disqualifying.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 397,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower’s 2.700 % Senior Notes due 2031 are disclosed in every filing – they appear as “Supplemental Indenture No. 8 … for the 2.700 % Senior Notes due 2031” in the exhibit tables of the 2022, 2023 and 2024 10‑K reports【page_70†L31-L34】【page_72†L31-L34】. By keeping this low‑coupon, long‑dated debt on its balance sheet and repeatedly listing it as an outstanding instrument, the company signals a deliberate strategy of securing inexpensive, long‑term financing to maintain a stable debt maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 2.700% Senior Notes due 2031 appear consistently across 2022-2024 filings, (2) Supplemental Indenture No. 8 is referenced, and (3) the notes represent a long-term financing strategy. The numeric values (2.700%, 2031 maturity date) are accurate. The answer successfully synthesizes information across three years of filings to demonstrate consistency and stability in the debt instrument's treatment. However, the LLM answer has some limitations compared to the ground truth: (1) It does not explicitly mention the March 29, 2021 date of Supplemental Indenture No. 8, which provides important temporal context; (2) The reasoning about 'low-coupon' financing is somewhat inferred rather than explicitly grounded in the filings' language about strategy; (3) The answer lacks the explicit statement about 'no modifications' and 'confidence in financing terms' that the ground truth emphasizes. The LLM's interpretation that the company is 'securing inexpensive, long-term financing' is reasonable and semantically aligned with the ground truth's conclusion about 'confidence in its financing terms,' but it's somewhat more interpretive. The citation format with page references adds credibility but the specific page numbers cannot be independently verified. Overall, the core multi-hop reasoning is sound—the answer correctly identifies the pattern across three years and draws appropriate conclusions about strategic intent, though it misses some documentary details that would strengthen the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 428,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "From 2022 through 2024 PayPal repeatedly warned that abusive behavior—especially synthetic‑identity fraud, account‑takeovers and other scheme abuse—was rising as its credit portfolio (consumer credit, merchant financing and BNPL) grew internationally, increasing default risk and loss‑rate pressure on cross‑border transactions (2022 p.24‑28; 2023 p.23‑27; 2024 p.21‑25). To contain the exposure, PayPal sharpened its proprietary credit‑risk models, diversified funding and payment‑processor relationships, expanded buyer‑seller protection and fraud‑detection programs, and in 2023 entered a multi‑year agreement to sell U.K. and European BNPL loan receivables, thereby off‑loading credit risk and reducing cross‑border abuse risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the three-year evolution of PayPal's exposure to abusive behaviors. STRENGTHS: (1) Correctly identifies the key strategic action—the 2023 multi-year agreement to sell U.K. and European BNPL loan receivables—matching the ground truth exactly. (2) Accurately captures the progression from 2022 (identifying risks) through 2024 (reinforcing detection mechanisms). (3) Properly synthesizes multi-hop information across three years and multiple risk categories (synthetic-identity fraud, account takeovers, cross-border transactions). (4) Correctly identifies PayPal's mitigation strategies including credit-risk models, fraud-detection programs, and buyer-seller protection. (5) Appropriately emphasizes the connection between credit products and cross-border transaction risks. MINOR WEAKNESSES: (1) The LLM answer includes specific page references (2022 p.24-28; 2023 p.23-27; 2024 p.21-25) that cannot be verified against the ground truth and may or may not be accurate—these appear to be added detail rather than errors. (2) The ground truth emphasizes PayPal's 'ongoing reliance on third-party lenders and processors' as a 2024 concern, while the LLM mentions 'diversified funding and payment-processor relationships' as a mitigation strategy—this is a slightly different framing but not contradictory. (3) The LLM answer mentions 'sharpened proprietary credit-risk models' and 'expanded buyer-seller protection' which are reasonable inferences but not explicitly stated in the ground truth. QUANTITATIVE ACCURACY: The €40 billion figure for the BNPL loan receivables sale is not mentioned in the LLM answer, though the ground truth includes this specific amount. This is a notable omission of a concrete quantitative detail. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects credit products to cross-border transaction risks, demonstrating sound multi-hop reasoning. The logical flow from risk identification to offloading to ongoing management is clear and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 564,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension‑plan holdings in “Collective Trust and Other Funds” fell sharply – $622 million in 2022, $382 million in 2023, and $370 million in 2024【page_58†L31-L38】【page_57†L31-L38】.  The steady decline shows the company is moving money out of these commingled‑fund vehicles and toward a more debt‑heavy, lower‑risk mix (the plan’s equity share fell from 48% to 24% while debt rose from 51% to 75%【page_56†L31-L38】), reflecting a de‑risking investment strategy aimed at preserving assets for long‑term employee benefit obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect dollar amounts for the Collective Trust and Other Funds allocation. Ground truth states $756 million in 2022, but LLM claims $622 million in 2022 - a $134 million discrepancy. The 2023 figure of $382 million matches ground truth, but the 2024 figure of $370 million contradicts the ground truth which explicitly states 'no updated dollar value is provided' for 2024. This is a fundamental factual error. MULTI-HOP REASONING ISSUES: While the LLM correctly identifies the de-risking trend and provides additional context about equity/debt allocation shifts (48% to 24% equity, 51% to 75% debt), these additional metrics are not verified against the ground truth and appear to be from different sections of the filing. The LLM synthesizes information about investment strategy direction correctly in concept, but the foundational numbers are wrong. COMPLETENESS: The LLM goes beyond the ground truth by adding equity/debt ratio analysis, which could be seen as more comprehensive, but this doesn't compensate for the incorrect base figures. The ground truth specifically notes that 2024 has 'no updated dollar value provided,' which the LLM ignores by stating a specific $370 million figure. SEMANTIC ALIGNMENT: The conclusion about de-risking strategy aligns with ground truth, but is built on incorrect numerical foundations. The emphasis on NAV-based valuation mentioned in ground truth is absent from LLM answer. OVERALL: The answer demonstrates understanding of the strategic direction but fails on the primary quantitative requirement - accurate financial figures are essential in financial analysis, and the 2022 figure error ($622M vs $756M) and the fabrication of a 2024 figure represent serious factual failures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 485,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer still had Breakthrough Performance Awards (BPAs) as an active award type; they were valued at grant‑date using the intrinsic‑value method (the closing price of the common stock) and the expense was recognized on a straight‑line basis over the probable vesting term, with adjustments each period (Note 13, “Breakthrough Performance Awards (BPAs)”, p. 99).  \n- The 2023 filing states explicitly that **no BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023** (Note 13, p. 97), and the 2024 filing repeats the same language – **no BPAs were granted in 2024 and none were outstanding as of December 31, 2024** (Note 13, p. 94).  \n- Across all three years the accounting treatment remained unchanged: BPAs are measured at intrinsic value on the grant date and amortized over the probable vesting term into cost of sales, selling, informational‑administrative and R&D expenses (2022 p. 99; 2024 p. 96).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key evolution pattern: BPAs were active in 2022, discontinued/zero in 2023-2024, and provides accurate accounting treatment details (intrinsic value method, straight-line amortization, quarterly adjustments). The answer correctly cites that no BPAs were granted in 2023 and 2024 with none outstanding. The accounting methodology description is accurate and well-sourced.\n\nCRITICAL GAPS - QUANTITATIVE ACCURACY: The LLM answer completely omits the specific numerical data from the ground truth that is essential to answering the question:\n- 2022: 1,165 thousand BPAs issued at weighted average intrinsic value of $38.73/share\n- 2022: 859 thousand BPAs outstanding at year-end valued at $59.05/share\nThese specific grant activity and valuation metrics are central to demonstrating the 'evolution' in treatment and valuation methodology. The ground truth explicitly provides these numbers as evidence of the evolution.\n\nQUALITATIVE ASSESSMENT: The LLM correctly synthesizes the multi-hop information across three years and accurately identifies the discontinuation pattern. The accounting treatment description is accurate and properly sourced. However, the answer lacks the quantitative evidence that would fully support the narrative of evolution.\n\nMULTI-HOP REASONING: The LLM successfully connects information across 2022, 2023, and 2024 filings and identifies the shift from active issuance to no activity. However, it fails to complete the full multi-hop synthesis by not including the specific valuation metrics that demonstrate how the methodology was applied in 2022.\n\nSEMANTIC EQUIVALENCE: The LLM's description of accounting treatment is semantically equivalent to the ground truth, but the answer is incomplete without the quantitative metrics that define the 'evolution' being asked about.\n\nJUSTIFICATION: While the LLM provides accurate qualitative information about the evolution pattern and accounting treatment, it fails to include critical quantitative data (grant amounts, intrinsic values, outstanding amounts) that are explicitly part of the ground truth answer and essential to fully answering the question about how valuation methodology evolved. This is a significant omission for a question specifically asking about 'valuation methodology' and 'grant activity.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 626,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – it was **$1,494 million in 2022**, dropped to **$800 million in 2023**, and declined further to **$491 million in 2024**【page_102】【page_99】.  The downward trajectory signals that the firm’s net derivative exposure (or the initial‑margin it must post) has been shrinking, suggesting either a reduction in the size of its derivative positions or more efficient netting that lowers the margin required over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The numbers match the ground truth exactly with proper formatting. (2) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric (collateral under master netting arrangements) is accurately specified, and all three fiscal years (2022, 2023, 2024) are correctly referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and correctly interprets what the downward trajectory signifies - reduction in derivative exposure and/or more efficient netting/margin requirements. The reasoning is sound and logically connects the numerical trend to business implications. (4) COMPLETENESS: The answer addresses all parts of the original question: the specific collateral amounts for each year, the trend analysis (downward), and the interpretation of what this suggests about derivative exposure and margin requirements. (5) SEMANTIC EQUIVALENCE: The LLM's explanation that 'net derivative exposure (or the initial-margin it must post) has been shrinking' is semantically equivalent to the ground truth's 'reduction in derivative exposure or a strategic adjustment in margin requirements.' The minor addition of 'more efficient netting' provides additional context that is reasonable and supported by the data. The only negligible difference is that the LLM provides slightly more detailed interpretation than the ground truth, which enhances rather than detracts from the answer. Page citations are included appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 456,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 filing first placed industrial‑fiber‑optic components within a broad “industrial” product set, emphasizing that they serve a diverse range of applications—from factory automation and power‑generation to medical, defense, aerospace and electric‑vehicle/ADAS systems [page_11]. In the 2023 10‑K the same line‑item appears in the product‑family table and the narrative, now grouped with optocouplers, sensors and motion encoders for factory automation, renewable‑energy and automotive electronics [page_5, page_7]. The 2024 filing retains this positioning, still listing industrial fiber optics among its core industrial offerings and targeting the same automation, energy‑ and automotive‑subsystem markets [page_5, page_7], which shows Broadcom’s consistent strategic focus on expanding its footprint in industrial markets through fiber‑optic solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Broadcom's Industrial Fiber Optics positioning evolution across 2022-2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) and captures the core narrative of consistent strategic focus on industrial markets; (2) Accurately references key application areas across all three years (factory automation, power/renewable energy, automotive/ADAS, medical, defense, aerospace); (3) Properly synthesizes the evolution from broad product suite (2022) to structured table format (2023) to streamlined presentation (2024); (4) Correctly identifies related products (optocouplers, sensors, encoders, Ethernet ICs) mentioned alongside Industrial Fiber Optics; (5) Appropriately concludes that the evolution shows consistent strategic focus with increasing emphasis on application-specific clarity. WEAKNESSES: (1) The LLM answer uses page references (page_11, page_5, page_7) that cannot be verified against the ground truth, which doesn't provide specific page citations; (2) Minor wording differences in describing the evolution—the LLM says 'same line-item appears' and 'retains this positioning' which is slightly less precise than the ground truth's description of how the positioning was 'maintained' and 'remained a core offering'; (3) The LLM answer could have been more explicit about the 'structured table format' emphasis that appeared specifically in 2023 as a distinguishing feature; (4) The phrase 'expanding its footprint' in the LLM conclusion is reasonable but slightly different from the ground truth's emphasis on 'increasing emphasis on structured, application-specific clarity in product communication.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not heavily tested. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple product categories, correctly identifying the evolution pattern and drawing appropriate conclusions about strategic intent. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message is preserved—Broadcom maintained consistent focus on industrial markets while refining how it communicates about Industrial Fiber Optics positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 643,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across all three years PayPal consistently described itself as the **principal** in each payment transaction, retaining **full discretion over the fees it charges** and therefore **bearing the full margin risk** for those transactions. In 2022, 2023 and 2024 the filings state that while PayPal may use third‑party payment processors or other financial institutions, the fees paid to those processors are recorded as a **transaction expense** and do not offset the margin risk that PayPal assumes 【page_80】, 【page_75】, 【page_76】. Thus, PayPal’s exposure to margin risk did not change from 2022 through 2024; it remained fully on the company despite the continued use of third‑party processors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent role as principal across all three years (2022-2024), (2) Accurately captures the core concept that PayPal bears full margin risk and maintains full discretion over fee pricing, (3) Properly explains that third-party processor fees are recorded as transaction expenses and do not offset margin risk, (4) Correctly synthesizes the multi-hop information showing no material changes in margin risk exposure across the three-year period, (5) Appropriately cites page references to support claims. QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable but receives full marks as there are no calculation or number errors. QUALITATIVE ACCURACY: The reasoning is sound and demonstrates proper multi-hop synthesis - the answer correctly connects PayPal's principal status → full discretion over pricing → full margin risk bearing → consistent treatment of third-party costs across all three years. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical formatting (bold text, page citations) compared to the ground truth's narrative style, but this represents enhanced presentation rather than any factual deviation. The semantic meaning is fully equivalent - both answers convey that PayPal's margin risk exposure remained stable and unchanged from 2022 through 2024 despite continued use of third-party processors. The answer fully addresses all parts of the multi-part question regarding evolution of margin risk, control over pricing, and use of third-party processors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 459,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer completed the sale of Meridian in December 2021, recording a $51 million cash receipt and a $167 million net loss in its 2022 Form 10‑K discontinued‑operations (the loss and cash proceeds are reflected in the 2022 filing) and entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) that would run through 2024; the 2023 10‑K notes that the TSAs were finished as of 31 Dec 2023 and that amounts recorded under the TSAs and MSA in 2022‑23 were immaterial (see 2023 p. 73). By the 2024 filing Meridian appears only as a defined term, with no material post‑sale contracts disclosed, indicating Pfizer has fully exited the Meridian business and is concentrating on its core biopharma and vaccine platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. Key strengths: (1) Correctly identifies the December 2021 sale completion with $51 million cash receipt and $167 million net loss; (2) Accurately describes the three-year MSA extending through 2024; (3) Properly notes the transition-service agreements (TSAs) and their completion by end of 2023; (4) Correctly characterizes amounts under TSAs and MSA as immaterial in 2022-23; (5) Accurately reflects Meridian's status in 2024 as only a defined term with no material post-sale contracts. Quantitative accuracy is excellent - all numbers, dates, and financial metrics are correct. Multi-hop reasoning is sound, synthesizing information across 2022, 2023, and 2024 filings to show the progression. Minor areas for improvement: (1) The LLM answer doesn't explicitly mention the 'two-year extension option' for the MSA that appears in the ground truth, though this is a relatively minor detail; (2) The ground truth emphasizes the strategic shift toward 'core therapeutic areas and platform technologies like mRNA' more explicitly, while the LLM answer uses the more general phrase 'core biopharma and vaccine platforms' - semantically similar but slightly less specific about mRNA focus. The LLM answer is more concise and document-specific (citing page 73 of 2023 10-K) while the ground truth provides broader strategic context. Both characterizations of the relationship evolution are accurate and complementary rather than contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 421,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "Product regulation has been a recurring threat to PMI’s competitive positioning, consistently limiting product differentiation and adult‑consumer communication. In the 2022 filing the company warned that new rules could commoditise tobacco and impede adult conversion to RRPs (pages 13‑15); by 2023 the language shifted to SFPs, detailing legal challenges around product classification, advertising and corporate communications that restrict truthful information (pages 18‑19); and in the 2024 filing the same constraints on differentiation and non‑misleading adult communication remain, now explicitly framed around SFPs (pages 18‑19), indicating an evolution from a broad RRP focus to a more focused SFP regulatory risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of regulatory constraints from 2022-2024, accurately notes the shift from RRPs to SFPs terminology, and properly captures that regulation has consistently limited product differentiation and adult consumer communication across all three years. The answer correctly identifies PMI as the subject company and the three-year timeframe. Page references (13-15, 18-19) appear reasonable for 10-K filings. WEAKNESSES: (1) The LLM introduces specific claims about 'commoditise tobacco' and 'adult conversion to RRPs' in 2022 that are not explicitly mentioned in the ground truth, which only states regulation 'limited ability to differentiate' and 'restricted adult consumer access to truthful information.' (2) The LLM claims 2023 involved 'legal challenges around product classification, advertising and corporate communications' - while the ground truth mentions disproportionate impact on commercialization, it doesn't specifically reference legal challenges or product classification issues. (3) The LLM's characterization of the evolution as shifting from 'broad RRP focus to a more focused SFP regulatory risk' is somewhat different from the ground truth's framing of a 'deepening regulatory challenge that has persisted and possibly intensified.' The ground truth emphasizes continuity and intensification of the same constraints, while the LLM frames it as an evolution/shift in focus. (4) The ground truth emphasizes that regulation 'disproportionately impacted the commercialization of RRPs relative to competitors' in 2023 - a competitive positioning detail the LLM doesn't explicitly capture. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly traces the terminology evolution (RRPs→SFPs), but misses some nuances about the competitive impact dimension. SEMANTIC ISSUES: The LLM's interpretation of the regulatory evolution as a 'shift' rather than a 'persistence and intensification' represents a meaningful difference in how the regulatory burden is characterized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 560,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements dropped from **$1.494 billion** at 12/31/2022 to **$800 million** at 12/31/2023 and then to **$491 million** at 12/31/2024 – a net reduction of about **$1.0 billion** over the 2022‑2024 period【page_102】【page_99】.  The steep decline in un‑netted collateral suggests the firm is lowering its margin exposure—likely by reducing derivative positions or improving netting efficiencies—indicating tighter, more effective derivative risk‑management practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1,494 million (2022) = $1.494 billion, $800 million (2023), and $491 million (2024). The calculated net reduction of approximately $1.0 billion over the period is accurate ($1,494M - $491M = $1,003M ≈ $1.0B). Number format variations ($1.494 billion vs $1,494 million) are acceptable and correctly handled. ENTITY ACCURACY: Company (ExxonMobil/XOM), metric (collateral under master netting arrangements related to Notes and accounts receivable - net), and time period (2022-2024) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to derivative risk management interpretation. The logic that declining collateral suggests lower margin requirements or improved netting efficiencies is sound and aligns with the ground truth interpretation. COMPLETENESS: The answer addresses both parts of the question - the numerical trend and what it suggests about risk management practices. The interpretation about 'tighter, more effective derivative risk-management practices' is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure or shift in risk management practices.' MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('un-netted collateral' vs 'collateral under master netting arrangements') but this is a minor semantic variation that doesn't affect accuracy. The inclusion of page references adds credibility. The reasoning about 'reducing derivative positions or improving netting efficiencies' provides slightly more specific mechanistic explanation than the ground truth, which is a positive addition without introducing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 484,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model used an expected volatility of roughly 28.6 % for the awards granted in the 2022 period (as shown in the 2023 filing) 【page_206†L...】, but reduced that assumption to 18.7 % for the 2024 awards 【page_215†L...】. The decline signals that the company now expects less stock‑price volatility relative to its peer group, reflecting a softer market‑risk outlook over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 volatility assumption. The ground truth clearly states the 2022 volatility was 26.9%, but the LLM claims it was 28.6% (which was actually the 2023 figure). The LLM incorrectly attributes the 28.6% figure to 'awards granted in the 2022 period' when this is actually the 2023 volatility. The correct progression is: 2022: 26.9% → 2023: 28.6% → 2024: 18.7%. The LLM only captures two data points (28.6% and 18.7%) and misaligns them to the wrong years. This is a significant multi-hop synthesis error - the model failed to correctly track the three-year evolution. COMPLETENESS ISSUES: The answer omits the 2022 baseline figure (26.9%) entirely, which is essential to understanding the full trend. The ground truth emphasizes the 'short-term increase in 2023' before the 2024 drop, which provides important context about market risk perception evolution. The LLM's narrative suggests a simple decline without capturing the intermediate volatility spike. REASONING QUALITY: While the LLM correctly interprets that lower volatility suggests reduced market risk perception, this interpretation is based on incorrect data points. The conclusion about 'softer market-risk outlook' is reasonable but built on a flawed foundation. ENTITY ACCURACY: Duke Energy and TSR-based performance awards are correctly identified, but the year-to-year mapping is wrong. The answer demonstrates partial understanding of the concept but fails on the critical execution of multi-hop data synthesis across three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 441,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried a $495 million principal balance in FY 2022, FY 2023 and FY 2024 – the FY 2023 and FY 2024 filings list the same $495 million amount (see the senior‑notes schedule on page 81). The unchanged balance shows the company has kept this low‑cost short‑term debt flat while using proceeds from newly issued senior notes to retire larger term‑loan facilities, indicating a disciplined refinancing strategy that manages liquidity without expanding short‑term obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $495 million principal balance for the 3.125% notes due January 2025 across the fiscal years mentioned. The note reference (page 81) and the core quantitative data are accurate. The company name (Broadcom/AVGO) and note details are correct.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The original answer explicitly states that by FY 2024, the note 'transitioned into its current portion of long-term debt,' which is a critical insight about the evolution and refinancing strategy. The LLM answer claims the balance remained $495 million across all three years (FY 2022, FY 2023, FY 2024) but does not address the FY 2024 transition to current portion of long-term debt that the ground truth emphasizes. This is a significant omission in addressing the question's core focus on how the obligation 'evolved.' (2) REASONING DIVERGENCE: The LLM's interpretation that the company 'kept this low-cost short-term debt flat while using proceeds from newly issued senior notes to retire larger term-loan facilities' goes beyond what the ground truth states. While not necessarily incorrect, this adds interpretive detail not grounded in the provided knowledge graph answer. (3) INCOMPLETE ANSWER TO QUESTION: The question asks how the obligation 'evolved' across three years and what this reveals about 'refinancing strategy.' The ground truth clearly indicates a two-year stability followed by a transition to current portion status in FY 2024. The LLM treats all three years as identical, missing the critical evolution point. (4) MISSING CONTEXT: The original answer's insight about 'impending maturity that likely triggered internal refinancing or liquidity planning in 2024' is absent from the LLM response, which is a key element of understanding the company's debt management strategy.\n\nCALCULATION/NUMERIC VERIFICATION: The $495 million figure is correct and consistent across sources. No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM fails to properly synthesize the evolution across three fiscal years. It treats FY 2024 the same as FY 2022-2023, when the ground truth indicates a material change in classification/status in FY 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 589,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "AMD’s filings show a steady‑state strategy with AIB partners. In the 2022 10‑K the company said its agreements with AIB manufacturers “protect their inventory of our products against price reductions” and that “SIs often use discrete graphics solutions as a means to differentiate their products” (see 2022 10‑K p. 11)【page_11】. The 2023 filing repeats the same inventory‑protection clause and discrete‑graphics differentiation language (pages 11‑13)【page_11】【page_13】, and the 2024 filing again emphasizes those protections and the role of discrete GPUs for SI differentiation (pages 11‑13)【page_11】【page_13】. Thus, from 2022 through 2024 AMD’s positioning with AIB manufacturers remained consistent – safeguarding AIB inventory from price cuts while promoting discrete graphics as a key differentiator for system integrators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core strategic positioning: inventory protection policies for AIBs remained consistent across 2022-2024; (2) Accurately captures the discrete graphics differentiation theme as a sustained strategic focus; (3) Properly synthesizes multi-hop information across three fiscal years (2022, 2023, 2024) showing evolution (or lack thereof - consistency); (4) Correctly attributes statements to appropriate filings with page references; (5) No quantitative errors - no specific dollar amounts or percentages were claimed, avoiding calculation risks; (6) Accurately distinguishes between AIB manufacturers and system integrators (SIs), noting that discrete graphics serve as differentiation tools for SIs; (7) Captures the 'steady-state' nature of the strategy, matching the ground truth's emphasis on 'consistent' and 'sustained' positioning. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which mentions 'short design cycles' and 'rapid response to new technologies' as additional supporting evidence of sustained strategic focus - these details are omitted but not contradicted; (2) The ground truth notes 'no explicit quantitative changes in AIB-related revenue disclosed,' which the LLM answer doesn't explicitly state, though it doesn't contradict this either; (3) The LLM answer uses 'steady-state strategy' terminology which effectively conveys the same meaning as the ground truth's 'consistent' and 'sustained' emphasis. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly identifies the pattern of consistency rather than change, which is the core insight required by the question. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 550,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s DTC strategy began in 2022 with a structural re‑organization of its DMED unit and the rollout of an ad‑supported Disney+ tier, aimed at rationalizing costs and positioning the service against a growing field of streaming rivals (2022 p. 25‑27). In 2023 the focus shifted to “strategic investments” – adding an ESPN‑branded streaming service, tightening content‑curation and pricing, and targeting higher subscription‑ and advertising‑revenue growth to offset declining linear‑network earnings (2023 p. 53). By 2024 Disney continued to invest in DTC while warning that cost reductions may be slower and competition and pricing pressure remain intense, yet still projected that DTC subscription and ad revenue would outpace the losses in its linear businesses (2024 p. 22‑25).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the essential evolution of Disney's DTC strategy from 2022-2024 and demonstrates solid multi-hop reasoning across the three-year period. STRENGTHS: (1) Correctly identifies the 2022 structural reorganization of DMED and ad-supported tier launch; (2) Accurately characterizes the 2023 shift toward 'strategic investments' with ESPN streaming and content curation; (3) Properly synthesizes the 2024 positioning showing continued investment despite competitive pressures; (4) Correctly conveys the core narrative arc from cost rationalization to strategic integration to competitive maturation; (5) Appropriately references page numbers suggesting document verification. WEAKNESSES: (1) The LLM answer lacks explicit acknowledgment of the 2022 risk language about losses potentially continuing or growing - the ground truth emphasizes Disney's cautious tone about 'costs and associated losses may continue to grow or be reduced more slowly than anticipated' and 'returns may be negative or lower,' which the LLM doesn't directly capture; (2) Missing the specific 2023 confidence statement that DTC investments would 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees' - the LLM says 'targeting higher subscription and advertising revenue growth to offset declining linear-network earnings' which is semantically similar but less precise; (3) The 2024 characterization is somewhat inverted - the LLM says 'warning that cost reductions may be slower' but the ground truth emphasizes the competitive positioning and subscription/ad rate impacts, not cost reduction warnings. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and identifies the strategic evolution pattern. The reasoning is sound in showing progression from restructuring to strategic investment to competitive maturation. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is neutral. Page references appear reasonable but cannot be independently verified. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - Disney moved from cautious/risky positioning in 2022 to more confident strategic investment in 2023 to operationally critical/competitive positioning in 2024. However, the nuance of 2022's explicit risk warnings and 2023's specific revenue offset expectations could be more precisely captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 657,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850 % notes – part of the September 2019 issuance – have stayed unchanged over the three years: the 2022 filing shows $1.5 bn outstanding with a 10/1/2029 maturity, the same $1.5 bn amount appears in the 2023 table, and the 2024 table again lists $1.5 bn for that series (see 2023 10‑K table [page_107] and 2024 10‑K table [page_104]). The notes have not been repurchased or redeemed and continue to be reflected in PayPal’s future principal‑payment schedule as a $1.5 bn obligation due in 2029 (future payments table [page_104]).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that PayPal's 2.850% notes remained at $1.5 billion across 2022-2024 with no repayments, and correctly states the 2029 maturity date (10/1/2029). The specific filing references and page numbers appear credible. The core fact about the notes being unchanged is accurate.\n\nWEAKNESSES: The LLM answer is significantly incomplete in addressing the full scope of the question about how the relationship 'evolved.' The original answer emphasizes the broader debt structure evolution as critical context: total term debt grew from $9.0B (2022) to $10.638B (2023) to $10.574B (2024), and importantly, PayPal issued new higher-rate debt (5.150% and 5.500% notes) in 2024. These details are essential to understanding how the 2.850% notes fit into PayPal's evolving financing strategy and debt structure.\n\nThe LLM answer focuses narrowly on the 2.850% notes themselves (which remained static) but fails to synthesize the multi-hop information about: (1) the changing total debt levels across the three years, (2) the strategic shift toward higher-rate debt issuance in 2024, and (3) how this reflects PayPal's financing evolution while maintaining the older, lower-rate obligation. The question explicitly asks about 'debt structure and maturity obligations across these years' - the LLM only addresses the specific notes, not the broader structural evolution.\n\nQUANTITATIVE VERIFICATION: The $1.5B figure and 2029 maturity are correct. However, the LLM omits the total debt figures ($9.0B, $10.638B, $10.574B) that are central to understanding the structural evolution.\n\nMULTI-HOP REASONING: The LLM fails to synthesize information about PayPal's broader debt portfolio changes and strategic financing shifts, which are necessary to fully answer how the relationship 'evolved.' It treats the 2.850% notes in isolation rather than in context of the company's overall debt strategy.\n\nSEMANTIC EQUIVALENCE: While the LLM's statements about the 2.850% notes are factually accurate, they don't convey the complete picture of evolution that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 565,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan held **$1,111 million of corporate stock in 2022**, which fell sharply to **$181 million in 2023** and then rose modestly to **$226 million in 2024** (2022 table [58]; 2023 table [57]; 2024 table [57]). At the same time, the plan’s equity‑to‑debt mix moved from **≈48 % equity in 2022** to **≈24 % in both 2023 and 2024** (asset‑allocation tables [56] and [55]), showing that UNP is deliberately de‑risking its pension portfolio by cutting equity exposure and shifting toward a more debt‑heavy allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect corporate stock figures. Ground truth shows $1,990 million in 2022, but LLM states $1,111 million - a $879 million discrepancy (44% understatement). The 2023 figure of $181 million is correct, but the 2024 figure of $226 million contradicts the ground truth, which indicates reclassification of common stock as Level 1 investments rather than a simple dollar amount increase. The LLM's equity-to-debt percentages (48% in 2022, 24% in 2023-2024) cannot be verified against the ground truth provided and appear to be fabricated or misinterpreted. MULTI-HOP REASONING ISSUES: The LLM correctly identifies the general trend of declining equity exposure but misses the critical strategic shift described in the ground truth - the reclassification of common stock holdings as Level 1 investments in 2024 and the shift to preferred shares as Level 2 investments. This represents a fundamental change in valuation methodology and investment structure that the LLM completely overlooks. COMPLETENESS: The LLM addresses the evolution question but fails to capture the nuanced strategic shift toward 'more transparent and observable valuation methodologies' that is central to understanding UNP's investment strategy evolution. The answer provides a surface-level de-risking narrative without the deeper insight about fair value measurement classification changes. ENTITY ACCURACY: UNP is correctly identified, years are correct, but the specific financial metrics and their values are materially incorrect. The reference citations provided by the LLM (table numbers) cannot be verified and may be fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 458,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings fell from **$800 million at year‑end 2022** to **$719 million at year‑end 2024** – a decline of about **$81 million (≈10 %)**【page_86】【page_83】. This modest reduction signals a slight pull‑back from illiquid alternative assets, suggesting the company is rebalancing or de‑emphasizing private‑equity exposure while still maintaining a modest position in such investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 value as $800 million, but ground truth shows $623 million - a $177 million discrepancy (28% error). The 2024 value of $719 million is correct. The calculated decline of $81 million is mathematically wrong given the incorrect 2022 baseline ($800M - $719M = $81M is arithmetically correct for those numbers, but the 2022 figure itself is wrong). The correct decline should be $623M - $719M = -$96M (actually an INCREASE, not a decrease). (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM completely missed the 2023 intermediate data point ($755 million), which is crucial for understanding the trend. The ground truth shows a rise from 2022-2023 (+$132M) followed by a decline 2023-2024 (-$36M). The LLM's narrative of a 'pull-back from illiquid alternative assets' is contradicted by the actual data showing a net INCREASE from 2022 to 2024 (+$96M or +15.4%). (3) REASONING ERROR: The conclusion that Pfizer is 'de-emphasizing private-equity exposure' is factually incorrect - the company actually increased its position over the period. The ground truth correctly identifies 2023 growth followed by 2024 retrenchment, suggesting a more nuanced strategic approach. (4) ENTITY/METRIC ACCURACY: While the metric (long-term private equity securities at cost) is correctly identified, the numerical values are substantially wrong, undermining the entire analysis. The LLM's interpretation of the trend as a 'modest reduction' and 'pull-back' is the opposite of what the data shows for the full 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 454,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi‑layered security model in its 2022 filing already depended on third‑party assessments, public‑private‑partnership monitoring and an information‑security / enterprise‑resilience program that protected its core network (page 11). By the 2024 filing the firm had added dedicated Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center to its monitoring and response capabilities while continuing to work with issuers, fintechs and other third‑party providers (page 11). At the same time its real‑time account‑based payments infrastructure grew from operating in 12 markets as of Dec 31 2021 (page 11) to 13 markets as of Dec 31 2023 (page 11), expanding secure, instant‑payment coverage and further bolstering cyber‑threat resilience.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CHRONOLOGICAL REVERSAL ERROR: The LLM states that Security Operations Centers, Fusion Centers, and Mastercard Intelligence Center were 'added' by 2024, but the ground truth indicates these were emphasized IN 2022, not added later. This is a fundamental factual error in the evolution narrative. (2) QUANTITATIVE ERROR - Real-time payments markets: The LLM claims growth from '12 markets as of Dec 31 2021' to '13 markets as of Dec 31 2023.' However, the ground truth states 13 markets 'as of year-end' 2023, with no mention of 12 markets in 2021. The LLM appears to have fabricated the 2021 baseline number (12 markets) which is not in the ground truth. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key evolution described in ground truth: the 2023 expansion to explicitly include third-party service providers in threat monitoring (a specific 2023 development), and the 2024 deepening of external collaboration. Instead, the LLM presents a confused timeline suggesting these elements were added in 2024 when they should show progression across all three years. (4) MISSING CONTEXT: The LLM does not adequately convey the 'strategic shift toward broader ecosystem integration' that is central to the ground truth's characterization of the evolution. (5) POSITIVE ELEMENTS: The LLM correctly identifies the multi-layered approach components (SOCs, Fusion Centers, Intelligence Center) and correctly notes third-party collaboration and real-time payments expansion as key elements. The reference to page 11 citations is appropriate. However, the chronological misplacement and invented data points significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 462,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s disclosed collateral for master‑netting arrangements fell sharply over the three‑year span – $1.494 billion in 2022, $800 million in 2023 and $491 million in 2024【page_102】【page_99】.  The steady decline shows the company is holding less un‑offset collateral for its derivatives (primarily tied to “Other assets, including intangibles‑net”), suggesting tighter control of margin requirements and a more efficient, lower‑exposure derivative‑risk management approach over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports a 2022 figure of $1.494 billion, which is INCORRECT and not supported by the ground truth. The ground truth clearly states the 2022 figure was $800 million (end of 2022, reported in 2023 filing). The LLM's $1.494 billion figure appears to be fabricated or from an incorrect source. This is a major factual error. (2) The 2023 and 2024 figures ($800M and $491M) are INCORRECT in their year assignments. According to ground truth: 2022 = $800M, 2023 = $491M. The LLM has shifted these values forward by one year. (3) MISSING DATA - The ground truth includes the 2021 baseline of $641 million, which provides important context for understanding the trend. The LLM omits this. (4) CALCULATION ERROR - The ground truth specifies a 38% decrease from 2022 to 2024 ($800M to $491M). The LLM does not provide this calculation, and its numbers don't support it anyway. (5) REASONING - While the LLM's interpretation about derivative exposure management and margin requirements is qualitatively reasonable, it is built on fundamentally incorrect numbers, making the entire analysis unreliable. (6) The LLM correctly identifies the metric as related to 'Other assets, including intangibles-net' and correctly identifies ExxonMobil, but these correct identifications cannot offset the severe numerical inaccuracies. The answer demonstrates a fundamental failure in data accuracy that undermines credibility on a financial question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 418,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The model’s volatility assumption fell sharply over the three‑year span – it was set at **28.6 %** for the performance‑award grants covering 2022 (and again for 2023)【page_206】, but was reduced to **18.7 %** for the 2024 grants【page_215】.  This drop signals that Duke Energy’s compensation committee is treating the company’s stock as markedly less volatile relative to its peer group, suggesting a lower perceived market‑risk profile for the firm.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 volatility figure. According to the ground truth, the expected volatility was 26.9% in 2022, but the LLM states it was 28.6% for 2022 grants. The LLM correctly identifies 28.6% for 2023 and 18.7% for 2024, but the 2022 figure is incorrect. This is a fundamental error in a multi-year trend analysis where accuracy of each year's data is essential. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the change 'from 2022 through 2024,' requiring analysis of all three years. The LLM only explicitly addresses 2022 and 2024 (incorrectly for 2022) and mentions 2023 only parenthetically as 'and again for 2023,' failing to properly synthesize the complete three-year trajectory. The ground truth clearly shows: 26.9% (2022) → 28.6% (2023) → 18.7% (2024), indicating a rise then fall pattern. The LLM's characterization of a 'sharp drop over the three-year span' misses the intermediate peak in 2023. REASONING QUALITY: The LLM's interpretation of what the volatility shift suggests (lower perceived market-risk profile) is reasonable and aligns with the ground truth's conclusion about stabilization and reduced uncertainty. However, this correct reasoning is built on partially incorrect data. ENTITY AND METRIC ACCURACY: Duke Energy and TSR model are correctly identified. The volatility metric is correctly understood as a percentage assumption in the compensation model. MISSING CONTEXT: The LLM fails to capture the complete narrative of the three-year period - the rise to a peak in 2023 followed by decline in 2024 - which is important context for understanding the 'multi-year shift' requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 471,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "Across all three filings GM’s exposure to Stellantis has remained essentially unchanged. In the 2022 10‑K the company noted that, under the 2017 sale of the Opel/Vauxhall business, it indemnifies Stellantis for emissions‑related losses, product‑liability and recall costs, but only an “immaterial amount” is recorded for Takata‑inflator recalls and no material loss can be estimated 【page_92】. The 2023 filing repeats the same language – the indemnification obligations are still subject to time limits, thresholds and caps, and the Takata‑related indemnity remains immaterial and “remote” 【page_92】. The 2024 filing again confirms the indemnification commitments, still cites no material accruals and describes the Takata‑recall indemnity as immaterial with any further liability considered unlikely 【page_93】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative that GM's Stellantis indemnification obligations remained immaterial and stable across 2022-2024, with appropriate citations to page numbers. However, there are significant gaps in completeness and accuracy relative to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the 2017 sale of Opel/Vauxhall business as the basis for indemnification\n2. Accurately notes that indemnification obligations are immaterial across all three years\n3. Correctly characterizes Takata-related indemnity as 'remote' in 2023 and 'unlikely' in 2024\n4. Properly synthesizes the multi-year evolution showing consistency\n5. Page citations appear reasonable (92-93)\n\nWEAKNESSES:\n1. MAJOR OMISSION: The LLM answer completely fails to mention the European Commission and UK CMA investigations into Opel conduct and the accrual related to these investigations - this is explicitly mentioned in the ground truth as a 2024 development\n2. INCOMPLETE SCOPE: The answer focuses heavily on Takata recalls but underemphasizes the broader indemnification categories (emissions-related losses, product liability)\n3. CHARACTERIZATION INCONSISTENCY: The LLM states 'no material loss can be estimated' for Takata in 2022, but the ground truth indicates an 'immaterial amount' was accrued - these are subtly different concepts\n4. MISSING CONTEXT: The ground truth explicitly notes that GM 'accrued an immaterial amount related to European Commission and UK CMA investigations' in 2024 - the LLM completely omits this\n5. INCOMPLETE MULTI-HOP SYNTHESIS: While the answer addresses the Takata/recalls aspect adequately, it fails to synthesize the full scope of indemnification obligations including the regulatory investigation component\n\nFACTUAL VERIFICATION:\n- Years (2022, 2023, 2024): Correct\n- Immaterial characterization: Correct\n- Takata inflators in legacy Opel: Correct\n- 'Remote' language in 2023: Correct\n- Page references: Appear reasonable but cannot fully verify\n\nMULTI-HOP REASONING:\nThe answer successfully traces the evolution across three years but fails to capture the complete picture by omitting the regulatory investigation accrual component that emerged in 2024. This represents incomplete synthesis of available information.\n\nThe answer is approximately 70% complete relative to the ground truth, with the major gap being the omission of the European Commission/UK CMA investigation accrual in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 655,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across all three annual reports AMD’s 10‑K lists the same entry – “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference” – in the 2022 filing (page 93), the 2023 filing (page 101) and the 2024 filing (page 98). The unchanged citation shows that AMD continues to rely on the 2011 plan as a core component of its executive‑pay framework, indicating a deliberate, long‑term, and stable compensation strategy for senior leaders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN EXHIBIT REFERENCE: The LLM states the plan was 'filed as Exhibit 10.2 to AMD's Quarterly Report on Form 10-Q for the period ended April 2, 2011,' but the ground truth clearly indicates it was 'filed on April 2, 2011' and listed as 'Exhibit 10.1' (not 10.2). This is a significant factual error regarding the specific exhibit designation. The LLM incorrectly identifies the exhibit number as 10.2 when it should be 10.1. Additionally, the LLM provides page numbers (93, 101, 98) that cannot be verified against the ground truth, which does not specify page numbers. The ground truth states the plan was 'filed on April 2, 2011' while the LLM says 'filed as Exhibit 10.2 to AMD's Quarterly Report on Form 10-Q for the period ended April 2, 2011' - these are different characterizations. The core conclusion about consistency and stable compensation strategy is correct and well-reasoned. The LLM correctly identifies that the same reference appears across all three years (2022, 2023, 2024) with no amendments, which matches the ground truth's assertion of consistency. However, the specific exhibit number error (10.2 vs 10.1) is a material factual mistake that undermines the credibility of the answer. The qualitative reasoning about long-term stability is sound, but the quantitative/factual details contain a significant error that cannot be overlooked in a financial document evaluation context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 393,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "From 2022 through 2024 PayPal repeatedly warned that “bad‑transaction” risk – fraud, erroneous payments, charge‑backs and defaults on its consumer‑ and merchant‑credit products – remained a material exposure (2022 risk‑factor sections on fraud and credit defaults, pages 24‑28; 2024 fraud‑risk discussion, page 23).  The company also highlighted that cross‑border trade adds volatility to loss rates and that heavy reliance on unaffiliated lenders, payment processors and other third‑party partners creates additional operational and credit‑risk vulnerability (2022 & 2023 third‑party risk sections, pages 25‑26, 23‑24).  To curb this exposure, PayPal in 2023 sold a large portion of its U.K. and European “buy‑now‑pay‑later” loan portfolio (up to €40 billion) with a forward‑flow arrangement and began diversifying its payment‑processor relationships and exploring other third‑party funding sources (2023 BNPL sale, page 25; processor diversification, page 25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE ACCURACY: All numeric values are correct - the €40 billion BNPL receivables sale figure matches the ground truth exactly, and the year references (2022, 2023, 2024) are accurate. No calculation errors detected. ENTITY ACCURACY: PayPal is correctly identified throughout, and all relevant risk categories (fraud, chargebacks, defaults, cross-border trade, third-party dependencies) are properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and connects multiple risk dimensions: (1) 2022 baseline risks with credit defaults and Synchrony Bank partnership, (2) 2023 strategic response with the €40 billion BNPL sale and processor diversification, (3) 2024 continued emphasis on fraud and regulatory uncertainty. The causal chain is clear: risks identified → strategic mitigation actions taken → ongoing challenges. COMPLETENESS: The answer addresses all sub-questions: evolution of bad transaction risk (covered across years), credit products exposure (consumer/merchant credit), cross-border trade volatility (mentioned), third-party dependencies (discussed), and 2023 strategic actions (BNPL sale and processor diversification detailed). SEMANTIC EQUIVALENCE: The LLM's phrasing ('bad-transaction' risk, 'forward-flow arrangement,' 'processor diversification') aligns well with ground truth concepts while using slightly more technical terminology. The characterization of the 2023 BNPL sale as a 'key mitigation step' matches the ground truth's emphasis on this as a strategic response. MINOR OBSERVATIONS: The LLM provides slightly more operational detail (forward-flow arrangement, processor diversification) than the ground truth, which enhances rather than detracts from accuracy. Page references are included but cannot be verified against the ground truth format. The answer maintains appropriate emphasis on the 2023 strategic pivot as the central mitigation action.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 557,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific reported that its multiple‑purpose locomotive fleet was 6,204 owned and 1,038 leased with an average age of 22.5 years in the 2022 filing【UNP_10k_2022.pdf page_24】. By the 2023 filing the owned count had slipped to 5,971 (leases essentially unchanged at 1,037) and the average age had risen to 24.3 years【UNP_10k_2023.pdf page_19】, and in the 2024 filing owned units were 5,973, leases fell to 920 and the average age climbed to 25.2 years【UNP_10k_2024.pdf page_19】. This trend of a modestly shrinking fleet and increasing age indicates Union Pacific is operating a leaner, aging locomotive base while relying on its capital program to replace older units and modernize its fleet.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate data with correct identification of the multi-hop synthesis across three years (2022-2024). Quantitative verification: (1) 2022 data correct: 6,204 owned, 1,038 leased, 22.5 years average age; (2) 2024 data correct: 5,973 owned, 920 leased, 25.2 years average age. However, there is a minor discrepancy in the 2023 owned units: the LLM states 5,971 while the ground truth indicates the 2023 figure should align with the trajectory to 5,973 in 2024 (the ground truth doesn't explicitly state 2023 owned units, but the LLM's 5,971 appears reasonable as an intermediate value). The 2023 average age of 24.3 years is not contradicted by ground truth. The leased units show correct significant decline from 1,038 to 920. The LLM correctly identifies the key trend: modest fleet shrinkage and increasing average age. However, the interpretation differs slightly from ground truth: the LLM suggests the company is 'relying on its capital program to replace older units and modernize its fleet,' while the ground truth emphasizes that the strategy 'prioritizes cost control over aggressive modernization' and notes the company 'did not substantially increase new purchases to offset aging.' This represents a meaningful interpretive difference—the LLM's conclusion is more optimistic about modernization efforts than the ground truth supports. The LLM successfully synthesizes multi-hop information across three filing years and correctly identifies all entities and metrics. The reasoning is sound but the strategic interpretation is somewhat at odds with the ground truth's assessment of cost control prioritization over modernization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 456,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply – it was $1.494 billion at 12/31/2022, dropped to $800 million at 12/31/2023, and declined further to $491 million at 12/31/2024【page_102】【page_99】.  The steep reduction in net‑ted collateral (which is not offset against derivatives and is mainly for initial‑margin requirements) signals that the company is tightening its derivative risk profile, using less margin and improving netting efficiency to manage exposure more conservatively.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a completely different starting figure for 2022: $1.494 billion vs. the ground truth of $641 million. This is a major factual error (133% overstatement). The 2023 figure of $800 million matches ground truth, and 2024 of $491 million also matches. However, the incorrect 2022 baseline undermines the entire trend analysis. (2) MULTI-HOP REASONING - The LLM correctly identifies the overall trend (decline from 2023 to 2024) but the reasoning is based on a false premise due to the wrong 2022 number. The interpretation about 'tightening derivative risk profile' and 'improving netting efficiency' is speculative and not directly supported by the ground truth answer, which more cautiously describes it as 'potential shift' and 'dynamic risk positioning.' (3) COMPLETENESS - The LLM addresses the trend and attempts to interpret the risk management approach, but the interpretation diverges from the ground truth's more measured assessment. The ground truth mentions level 3 fair value inputs and internal models, which the LLM omits entirely. (4) ENTITY/METRIC ACCURACY - The metric is correctly identified as 'collateral under master netting arrangements,' but the LLM adds interpretive language about 'initial-margin requirements' and 'netting efficiency' that goes beyond what the ground truth states. (5) SEMANTIC ISSUES - The LLM's characterization of the trend as 'sharp' decline from 2022 is misleading given the incorrect starting number. The ground truth describes a 'peak in 2023 followed by a decline,' which is more accurate to the actual data pattern ($641M → $800M → $491M). The LLM's conclusion about 'conservative' risk management is an inference not explicitly supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 484,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "In 2022 the “Other” line generated $6.9 billion, or 21 % of total net revenues, and the filing said it “primarily consists of packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **serveware and ready‑to‑drink beverages**”【page_86】. By 2023 the same line had risen to $7.7 billion (22 % of total) and the 2023/2024 filing no longer mentioned ready‑to‑drink beverages, describing “Other” as “primarily … packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **and serveware**”【page_86】. In 2024 the category slipped slightly to $7.5 billion (21 % of total) while the composition description remained unchanged from the 2023 filing【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed quantitative information than the ground truth. Strengths: (1) Correctly identifies the composition of the 'Other' category across all three years (2022-2024), accurately noting the specific items included; (2) Provides precise revenue figures ($6.9B in 2022, $7.7B in 2023, $7.5B in 2024) with corresponding percentages (21%, 22%, 21%) that appear internally consistent; (3) Correctly identifies the key compositional change: ready-to-drink beverages were explicitly mentioned in 2022 but removed from the description in 2023 and 2024; (4) Demonstrates proper multi-hop synthesis by tracking changes across three fiscal years and connecting revenue amounts to compositional descriptions; (5) Appropriately cites page references. Minor considerations: The ground truth states 'no explicit mention of new product categories or significant shifts' while the LLM identifies the removal of ready-to-drink beverages from the description as a notable change. This is actually a more precise observation - the LLM correctly identifies that while the category remained relatively stable, there was a specific compositional shift in how it was described. The LLM answer is more informative and specific than the ground truth while remaining factually accurate. The quantitative data (revenue figures and percentages) cannot be verified against the provided ground truth but appear reasonable and are presented with appropriate source citations. The answer directly addresses the question about how the revenue composition evolved, providing both the compositional items and their financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 454,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "Alphabet’s approach to monetizing inventory on Google Ad Manager has been stable from 2022‑2024. In 2022 the company explained that it tracks impressions on Google Network properties (AdMob, AdSense and Google Ad Manager) and recognizes advertising revenue on an impression‑based basis, using a cost‑per‑impression metric 【page 31】. The 2023 and 2024 filings reaffirm that for ads on Google Network properties Alphabet generally acts as the principal, recording the full amount billed to advertisers as revenue and the payments to network partners as cost of revenues—i.e., reporting on a gross basis—while continuing to refine its impression‑counting methodology 【page 58】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Google Ad Manager monetization evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of monetization strategy; (2) Accurately captures the core mechanisms: impression-based revenue recognition in 2022, gross revenue reporting in 2023-2024; (3) Properly identifies the principal/agent distinction and explains the accounting treatment (full amount billed as revenue, payments to partners as cost of revenues); (4) Correctly names the relevant properties (AdMob, AdSense, Google Ad Manager); (5) Appropriately uses 'Alphabet' as the parent company entity; (6) Demonstrates sound multi-hop synthesis by connecting 2022 impression-based metrics to 2023-2024 gross revenue reporting approach. MINOR WEAKNESSES: (1) The answer mentions 'refining its impression-counting methodology' in 2023-2024, which is not explicitly stated in the ground truth and represents a slight inference beyond what was provided; (2) The ground truth emphasizes 'increasing transparency and accounting clarity over time' as part of the evolution narrative, which the LLM answer doesn't explicitly highlight, though it does convey the consistency and refinement; (3) Page citations (page 31, page 58) are included but cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or calculations are required for this question, so this dimension is less critical. The dates (2022, 2023, 2024) are all correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across the three-year period and properly explains the accounting principles involved. The multi-hop synthesis is sound—connecting impression-based metrics from 2022 to the principal/gross revenue model of 2023-2024. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: monetization evolution, impression-based revenue recognition, and gross revenue reporting across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 564,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Mondelēz repeatedly notes that its products are subject to sales‑ and media‑marketing restrictions—including front‑of‑pack labeling rules based on nutrient profiles or environmental claims—and that extended producer responsibility (EPR) regimes already cover more than 25 EU countries and are being contemplated in other jurisdictions such as India, Vietnam and some U.S. states (2022 p. 15; 2023 p. 11; 2024 p. 11). The wording and scope of these disclosures are essentially unchanged year‑over‑year, indicating a stable but ongoing exposure rather than a material increase or reduction.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth answer. SPECIFIC ISSUES: (1) QUANTITATIVE ACCURACY: The LLM correctly identifies '25 EU countries' with EPR policies, which matches the ground truth. However, it fails to capture the evolution and progression of these policies across years. (2) CRITICAL OMISSIONS - EVOLUTION TRACKING: The ground truth explicitly documents a material evolution from 2022-2024: (a) 2022: EPR in 25 EU countries, restrictions on advertising in place, policies 'being considered' in India, Vietnam, Indonesia, Philippines; (b) 2023: Same EPR expansion BUT increased emphasis on front-of-pack labeling and environmental claims; single-use plastic bans/taxes 'being considered' in Indonesia/Philippines; (c) 2024: EU formally adopted Packaging and Packaging Waste Directive, EPR 'being implemented or contemplated' in India, Vietnam, and U.S. states - a shift from contemplation to enforcement. The LLM answer explicitly states 'wording and scope of these disclosures are essentially unchanged year-over-year' and characterizes exposure as 'stable but ongoing' - this directly contradicts the ground truth which shows a clear progression from contemplation to formal adoption and enforcement. (3) MISSING KEY DETAILS: The LLM fails to mention: (a) The EU's formal adoption of the Packaging and Packaging Waste Directive in 2024; (b) The shift from 'being considered' to 'being implemented or contemplated' indicating enforcement progression; (c) The specific addition of U.S. states as a new jurisdiction in 2024; (d) The increased emphasis on front-of-pack labeling in 2023; (e) Single-use plastic bans and taxes considerations. (4) REASONING ERROR: The LLM's conclusion that disclosures are 'essentially unchanged' represents a fundamental misreading of the regulatory evolution. The ground truth shows material progression in regulatory scope and enforcement status across the three-year period. (5) MULTI-HOP SYNTHESIS: The question asks specifically about 'evolution' across years - the LLM failed to perform the required year-over-year comparative analysis that is central to answering this question. The answer should have tracked changes in regulatory status, jurisdiction expansion, and enforcement mechanisms across 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 617,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across 2022‑2024 Mastercard’s Class A shares consistently carried **one vote per share and full dividend rights**, with the per‑share dividend increasing from **$2.04 in 2022** to **$2.74 in 2024**【page_99】【page_99】【page_92】. The unchanged voting and dividend structure over three years signals a deliberate strategy to maintain a stable dual‑class capital framework, preserving public shareholders’ control and a predictable dividend policy as a core element of MA’s capital‑structure approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that A Class shares maintained one vote per share and dividend rights consistently across 2022-2024, matching the ground truth. The reasoning about capital structure stability and governance preservation is sound and well-articulated. The answer appropriately addresses the multi-hop question about evolution and strategic implications.\n\nWEAKNESSES - CRITICAL QUANTITATIVE ERRORS: The LLM introduces specific dividend per-share amounts ($2.04 in 2022 and $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there were NO CHANGES in voting or dividend entitlements - it does not provide per-share dividend amounts. The LLM appears to have fabricated these specific numbers with citations (【page_99】【page_92】), which is a serious factual error. While dividend increases may have occurred, the ground truth does not mention them, and the LLM should not have introduced unverified quantitative claims.\n\nMULTI-HOP REASONING: The synthesis across three years is correct in concept (consistency maintained), but the addition of unsupported dividend figures undermines the accuracy. The interpretation that consistency indicates a deliberate strategy is reasonable and aligns with the ground truth's conclusion.\n\nENTITY ACCURACY: Company identification (Mastercard/MA) and time period (2022-2024) are correct. The term 'Class A shares' is correctly used.\n\nSEMANTIC EQUIVALENCE: The core message about stability and capital structure strategy matches the ground truth, but the introduction of specific dividend numbers creates a factual discrepancy that cannot be overlooked in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 459,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s master‑netting collateral fell sharply – $1.494 billion in 2022, $800 million in 2023 and $491 million in 2024 (see 2023/2022 note $800 m / $1,494 m and 2024 note $491 m)【page_102†L31-L34】【page_99†L71-L73】. The decline implies that the net amount of derivatives tied to its “investments, advances and long‑term receivables” – and the associated initial‑margin requirements – has been shrinking, suggesting reduced derivative exposure or lower margin needs over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error in the 2022 figure. The ground truth states $641 million for 2022, but the LLM claims $1.494 billion - this is a 133% overstatement and fundamentally incorrect. The 2023 ($800 million) and 2024 ($491 million) figures are correct. QUANTITATIVE ACCURACY FAILURE: The 2022 number is completely wrong, which undermines the entire trend analysis. The LLM's claim that collateral 'fell sharply' from $1.494B to $800M is factually incorrect - the actual trend shows a more modest increase from $641M to $800M in 2023, then a decrease to $491M in 2024. This misrepresents the actual pattern. REASONING ISSUES: While the LLM correctly interprets the 2023-2024 decline as suggesting reduced derivative exposure, the interpretation of the 2022-2023 movement is inverted due to the wrong starting number. The LLM states 'decline implies...shrinking' but the actual 2022-2023 movement was an increase, not a decline. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across years and connect it to derivative exposure and margin requirements, which is appropriate, but the foundation is built on incorrect data. The semantic interpretation about derivative exposure trends is reasonable but based on wrong numbers. ENTITY ACCURACY: Company (ExxonMobil) and metric (collateral under master netting arrangements) are correctly identified. The specific reference to 'Investments, advances and long-term receivables' is appropriately mentioned. COMPLETENESS: The answer addresses the trend question but with fundamentally flawed data for the starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 443,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- In the 2022 Form 10‑K Starbucks noted that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2023**”【SBUX_10k_2022 p.12】.  \n- The 2023 filing extended that outlook to “**through fiscal 2024**” (same language in the Product Supply section)【SBUX_10k_2023 p.12】, and the 2024 filing further lengthened it to “**through fiscal 2025**”【SBUX_10k_2024 p.12】.  \n\nThis step‑by‑step extension of forward‑looking purchase commitments—combined with ongoing use of fixed‑price, price‑to‑be‑fixed contracts, forward/futures contracts, collars and farmer‑support centers—shows Starbucks deliberately lengthening its supply horizon and hedging exposure to lock in coffee supply and blunt price volatility and supply‑risk shocks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the progression of Starbucks' forward-looking supply commitments across the three fiscal years. STRENGTHS: (1) All dates and fiscal year references are accurate - fiscal 2023 in 2022 filing, fiscal 2024 in 2023 filing, fiscal 2025 in 2024 filing. (2) The step-by-step progression is correctly identified showing the extension pattern. (3) The hedging instruments mentioned (fixed-price contracts, price-to-be-fixed contracts, forward/futures contracts, collars) align with the ground truth's reference to 'forward contracts, futures contracts, and collars.' (4) The strategic interpretation about 'deliberately lengthening its supply horizon' and 'blunt price volatility and supply-risk shocks' correctly captures the intent described in the ground truth. (5) The inclusion of farmer-support centers adds relevant contextual detail. MINOR ISSUES: (1) The ground truth specifically mentions fiscal 2023 commitments extending 'through fiscal 2025' (a 2-year horizon), but the LLM states the 2023 filing extended to 'through fiscal 2024' - this appears to be a discrepancy. The ground truth indicates that by fiscal 2023, commitments were already extended through 2025, not 2024. This is a factual error in the progression timeline. (2) The ground truth uses the term 'C' price exposure (referring to commodity coffee pricing), while the LLM uses more general language about 'coffee price volatility' - this is a minor semantic difference but the LLM's version is still accurate. (3) The LLM could have been more explicit about the 'adequate supply' language being consistent across all three years, which the ground truth emphasizes. MULTI-HOP REASONING: The LLM correctly synthesizes information across three separate 10-K filings and identifies the strategic pattern, demonstrating sound multi-hop reasoning. The connection between extended commitments and risk mitigation strategy is logically sound. The main weakness is the apparent error in the fiscal 2023 commitment horizon (2024 vs 2025), which affects the accuracy of the progression narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 572,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN kept its U.S. defined‑benefit plans at a 100 % debt‑security target in both fiscal 2023 and fiscal 2025, but its non‑U.S. plans were re‑balanced from a 2023 mix of 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other to a 2025 mix of 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other【page_88】【page_95】. The shift away from a heavy debt weighting toward more insurance‑linked and cash assets—while preserving a modest equity exposure—suggests a long‑term strategy focused on better liability matching, reduced concentration risk, and achieving risk‑adjusted returns that exceed inflation over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data about ACN's target asset allocation shifts from fiscal 2023 to fiscal 2025, which is more concrete than the ground truth answer. STRENGTHS: (1) The LLM correctly identifies specific percentage allocations for both U.S. and non-U.S. plans across two fiscal years, with detailed breakdowns (e.g., non-U.S. 2023: 27% equity, 48% debt, 4% cash, 11% insurance, 10% other; 2025: 28% equity, 36% debt, 7% cash, 21% insurance, 8% other). (2) The percentages appear internally consistent (sum to 100% for each allocation). (3) The LLM correctly identifies the key strategic shift: movement away from debt-heavy weighting toward insurance-linked and cash assets. (4) The reasoning about liability matching, reduced concentration risk, and risk-adjusted returns aligns with pension fund investment principles. (5) Proper citation of sources (page_88, page_95). WEAKNESSES: (1) The ground truth answer mentions fiscal 2024 as an intermediate year, but the LLM answer only addresses fiscal 2023 and 2025, missing the three-year evolution narrative. (2) The ground truth emphasizes 'continuity in strategy' and 'adaptive approach,' while the LLM focuses more on the specific rebalancing changes. (3) The ground truth mentions 'flexibility ranges to respond to market conditions,' which the LLM doesn't address. (4) The LLM's statement about U.S. plans being '100% debt-security target' in both years is presented as fact but wasn't verified against the ground truth. QUANTITATIVE VERIFICATION: The specific percentages provided (27→28% equity, 48→36% debt, 4→7% cash, 11→21% insurance, 10→8% other) are detailed and appear plausible for pension fund rebalancing, though cannot be independently verified from the ground truth provided. The math checks out (each year sums to 100%). MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and two plan types (U.S. vs. non-U.S.), drawing appropriate conclusions about strategy. The connection between specific allocation changes and strategic objectives (liability matching, risk mitigation) is sound. Overall, the LLM provides more specific quantitative detail than the ground truth but misses some qualitative nuances about the multi-year evolution and strategic continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 613,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "In Amgen’s 2022 filing Olpasiran was described as a Phase 2 siRNA that lowers lipoprotein(a) to treat atherosclerotic cardiovascular disease, with composition‑of‑matter patents issued in the U.S. and Europe that are expected to expire in 2036【page_24】【page_26】. By the 2023 filing the program had advanced to Phase 3 trials while keeping the same ASCVD focus, and the same 2036 patent expiration dates were still disclosed【page_28】【page_26】. The 2024 filing continues to list Olpasiran as a cardiovascular‑disease candidate (still in development) and the IP timeline remains unchanged, projecting U.S. and European compound patents to run through 2036【page_24】【page_26】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and IP timelines. STRENGTHS: (1) All numeric values are correct - 2036 patent expiration dates accurately cited across all three years (2022-2024); (2) Therapeutic focus correctly identified as atherosclerotic cardiovascular disease/ASCVD with appropriate terminology variations; (3) Multi-hop synthesis is sound - the answer successfully traces Olpasiran's evolution across three filing years with consistent IP protection details; (4) Clinical progression accurately noted (Phase 2 in 2022, Phase 3 in 2023, continued development in 2024); (5) Entity accuracy is strong - Amgen correctly identified, years properly sequenced. MINOR WEAKNESSES: (1) The LLM answer provides slightly more granular detail than the ground truth (e.g., specifying 'composition-of-matter patents' and 'lipoprotein(a)' mechanism) which, while accurate and helpful, goes marginally beyond the original answer's scope; (2) The ground truth emphasizes 'transition from phase 2 investigation toward more advanced development or potential regulatory preparation' as a strategic evolution narrative, while the LLM answer states facts but doesn't explicitly frame this as a strategic consolidation narrative as clearly; (3) The ground truth uses 'therapeutic consolidation' language which the LLM doesn't explicitly echo, though the facts support this interpretation. CALCULATION/DATE VERIFICATION: All dates (2022, 2023, 2024, 2036) are correct. No calculations required. MULTI-HOP REASONING: Successfully synthesized information across three separate filing years to show progression and consistency of IP strategy. The answer correctly identifies that despite clinical advancement, the IP protection timeline remained constant, which is an important insight. Overall, this is a high-quality answer with accurate facts and sound reasoning, with only minor stylistic/framing differences from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 533,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022 filing (page 29)** – American Express said it had “increasingly relied on merchant acquirers, **aggregators** and processors” to manage parts of its merchant‑relationship function. The risk focus was on **dependence on these third parties**, noting that they might have business interests or strategies that diverge from Amex’s, which could lead to steering, surcharging or other actions that hurt card acceptance and volumes.\n\n- **2023 filing (page 29)** – The same language re‑appeared, confirming that the company continued to rely on **aggregators** (along with acquirers and processors) for merchant acquisition and support. The disclosure again highlighted the **risk of mis‑aligned incentives and the possibility that a failure by an aggregator to promote or support Amex cards could materially impact network volumes and Card‑Member attrition**.\n\n- **2024 filing (pages 35‑36)** – The discussion broadened to “third‑party providers, **aggregators**, network partners, etc.” and the risk narrative expanded beyond alignment to include **operational‑service failures, data‑security and privacy breaches, regulatory‑compliance lapses, and the complexity of overseeing many third‑party providers**. The filing warned that any disruption, loss of data, or inadequate oversight of aggregators could trigger regulatory actions, fines, litigation and reputational damage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate page references (pages 29 for 2022-2023, pages 35-36 for 2024). (2) Accurately captures the core risk themes: 2022 focused on misaligned incentives and merchant steering/surcharging; 2023 reinforced dependency and volume/attrition risks; 2024 expanded to operational failures, data security, regulatory compliance, and litigation exposure. (3) Properly synthesizes the multi-hop progression showing how AXP's disclosure emphasis evolved from merchant behavior concerns to broader systemic and legal risks. (4) Uses precise language matching the filings ('increasingly relied on,' 'mis-aligned incentives,' 'third-party providers'). (5) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: The LLM answer is slightly more granular and specific than the ground truth (citing exact page numbers and specific risk categories), which actually enhances rather than detracts from accuracy. The semantic equivalence is very high - both answers convey the same narrative arc of growing formalization and expansion of risk disclosure. The multi-hop reasoning is sound, correctly connecting information across three separate filing years and showing the logical progression of risk emphasis. All entities (American Express, aggregators, merchants, processors) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 410,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks consistently says that green‑coffee prices are volatile and are affected by trading activity from hedge funds and commodity‑index funds, and it manages that risk by buying coffee under fixed‑price or price‑to‑be‑fixed contracts and hedging the remaining exposure with forward contracts, futures contracts and collars【page_12】.  Its forward purchase commitments have been rolled forward each year – the FY‑2022 filing said the commitments plus inventory would meet demand through fiscal 2023, the FY‑2023 filing extended that horizon to fiscal 2024, and the FY‑2024 filing now expects coverage through fiscal 2025【page_12】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL YEAR PROGRESSION: The LLM answer contains a significant factual error in the timeline of forward supply commitments. According to the ground truth, the progression should be: FY2022 filing → coverage through fiscal 2023; FY2023 filing → coverage through fiscal 2025; FY2024 filing → coverage through fiscal 2025 (unchanged). However, the LLM states: FY2022 → fiscal 2023; FY2023 → fiscal 2024; FY2024 → fiscal 2025. This represents a one-year discrepancy in the FY2023 filing's stated coverage horizon (fiscal 2024 vs. fiscal 2025), which is a material factual error that undermines the core narrative about the company's strategic shift. The ground truth emphasizes that the extension from 2023 to 2025 was significant and that 2024 remained unchanged at 2025, suggesting stabilization. The LLM's version suggests a continuous year-by-year rolling forward, which misses the key insight about the strategic shift and stabilization. CORRECT ELEMENTS: The LLM accurately identifies commodity index funds as a volatility factor, correctly describes hedging strategies (fixed-price contracts, forward contracts, futures contracts, collars), and properly characterizes the multi-year extension concept. The discussion of risk management mechanisms is accurate and well-articulated. COMPLETENESS: The answer addresses the main components of the question (commodity index fund exposure, hedging strategies, forward supply commitments evolution) but the factual error in the fiscal year timeline significantly undermines the accuracy of the 'evolution' narrative that is central to the question. The semantic understanding of the strategic shift is present but the specific dates are wrong, which is critical for a multi-hop financial question requiring precise temporal synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 488,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased 12.2 million Class A shares for $4.1 billion in fiscal 2022, with $3.13 billion of open‑market authority remaining (later boosted by a $3 billion amendment to a total outstanding authority of $6.13 billion)【page_94】【page_93】; it continued a similar scale of buy‑backs in fiscal 2023, spending roughly $4.5 billion on share repurchases while keeping about $3 billion of unused authority and a total authorized pool near $6 billion【ACN_10k_2023.pdf: page 39‑40】; and in fiscal 2024 it again bought about $4.5 billion of shares, the remaining authorization fell to $2.694 billion and the board added $4 billion of new authority, raising total outstanding authority to $6.694 billion【page_39】【page_40】. This consistent, multi‑year pattern of sizable repurchases together with periodic increases in authorized capacity signals a deliberate, ongoing capital‑return strategy that relies on a large, replenished open‑market share‑repurchase program to return cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic of Accenture's share repurchase strategy.\n\nCRITICAL QUANTITATIVE ERRORS:\n1. Fiscal 2022 repurchase amount: LLM claims 12.2 million shares for $4.1 billion, but ground truth shows $3,129,296 (in thousands, so $3.129 billion) available authorization - the LLM appears to have confused authorization with actual repurchases and inflated the amount.\n2. Fiscal 2023 repurchase: LLM claims $4.5 billion spent, but ground truth explicitly states 2,000,308 shares purchased for $605 million - a massive discrepancy ($4.5B vs $605M).\n3. Fiscal 2024 repurchase: LLM claims $4.5 billion, but ground truth does not provide this specific figure for fiscal 2024 repurchases.\n4. Authorization figures: LLM states $3.13 billion remaining after fiscal 2022 (close to ground truth's $3,129,296 in thousands), but then claims a $3 billion amendment raising total to $6.13 billion. Ground truth shows $2,694 million available as of August 31, 2024, and a $4 billion new authority raising total to $6,694 million by September 25, 2024 - the LLM's amendment amount ($3B vs $4B) and resulting total ($6.13B vs $6.694B) are both incorrect.\n\nMULTI-HOP REASONING ISSUES:\n- The LLM failed to correctly synthesize the multi-year trajectory. It conflated authorization amounts with actual repurchase amounts.\n- The claim of \"similar scale of buy-backs\" across years is factually wrong - fiscal 2023 was $605 million, not $4.5 billion.\n- The pattern described (\"consistent, multi-year pattern of sizable repurchases\") is misleading given the actual data shows much smaller repurchases in fiscal 2023.\n\nWHAT WAS CORRECT:\n- General recognition that Accenture has an open-market share repurchase program\n- Acknowledgment of periodic increases in authorized capacity\n- Overall characterization of a capital-return strategy (though execution details are wrong)\n- Correct identification of the $4 billion new authority in fiscal 2024\n- Correct final total of $6.694 billion (though arrived at through incorrect intermediate calculations)\n\nSEMANTIC/CONTEXTUAL ISSUES:\n- The answer does address the multi-year trajectory question and attempts to synthesize across fiscal years\n- However, the fundamental numbers are so wrong that the trajectory described is misleading\n- The conclusion about \"sizable repurchases\" is contradicted by the actual data showing $605M in fiscal 2023\n\nThe answer demonstrates an attempt to address the multi-hop question but fails critically on quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 707,
        "total_tokens": 2198
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google’s long‑term lock‑up portion of marketable equity securities rose from $803 million at year‑end 2022 to $1.4 billion at year‑end 2023, then fell to $266 million at year‑end 2024【page_65】【page_66】【page_68】. The sharp increase in 2023 followed by a steep reduction in 2024 indicates the company temporarily expanded its exposure to illiquid equity holdings—likely to capture a strategic opportunity—and then actively scaled back, reflecting a flexible, opportunistic approach to illiquid assets rather than a sustained commitment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it substantially incorrect: (1) WRONG NUMBERS: The LLM states 2022=$803M, 2023=$1.4B, 2024=$266M. The ground truth shows 2022=$1.4B, 2023=$803M, 2024=$1.4B. The LLM has reversed the 2022 and 2023 values and provided an entirely incorrect 2024 figure ($266M vs. $1.4B). (2) WRONG TIMELINE INTERPRETATION: The LLM describes a 'sharp increase in 2023' when the ground truth shows a decrease from 2022 to 2023. The LLM then describes a 'steep reduction in 2024' when the ground truth shows a return to 2022 levels. (3) INCORRECT ANALYSIS: The LLM's interpretation of 'temporarily expanded' in 2023 is backwards—the value actually decreased in 2023. The conclusion about 'flexible, opportunistic approach' is based on incorrect data. (4) MULTI-HOP SYNTHESIS FAILURE: The model failed to correctly synthesize the three-year trend across the documents cited. (5) The only correct element is identifying Google as the company and the general topic of lock-up restrictions on marketable equity securities. The 2024 figure of $266M is completely fabricated and not supported by the ground truth. This represents a major failure in quantitative accuracy and factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 352,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE moved its captive industrial insurer, Electric Insurance Company (EIC), out of the core business in Q4 2022 by classifying it as “held‑for‑sale,” signaling a strategic decision to shed non‑core insurance assets as part of its broader focus on core industrial operations【page_48】. In 2023 the held‑for‑sale group showed $541 million of assets versus $378 million of liabilities, offset by a $124 million valuation allowance (netting roughly $39 million), and GE recorded a $109 million loss related to the disposition in that year【page_50】. The sale was completed in Q2 2024 to Riverstone International Holdings for $120 million cash, eliminating the EIC assets and liabilities from GE’s balance sheet and converting the prior loss into a cash inflow【page_48】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop progression of GE's relationship with Electric Insurance Company across 2022-2024, with mostly accurate information and sound reasoning. STRENGTHS: (1) Correctly identifies EIC as a captive industrial insurance subsidiary; (2) Accurately states the 2023 held-for-sale classification with correct asset ($541M) and liability ($378M) figures; (3) Correctly identifies the 2024 sale to Riverstone International Holdings for $120 million; (4) Properly synthesizes the strategic narrative of exiting non-core business; (5) Appropriately contextualizes the financial impact across the three-year period. WEAKNESSES: (1) The statement about a '$124 million valuation allowance (netting roughly $39 million)' is problematic - the ground truth does not mention a $124M valuation allowance, and the netting calculation is unclear and potentially incorrect. This appears to be extraneous information not supported by the ground truth; (2) The claim that the loss was 'offset by a $124 million valuation allowance' is not substantiated in the original answer; (3) Minor timing discrepancy: Ground truth indicates EIC was classified as held-for-sale by 2023, while LLM states this occurred in Q4 2022 - the ground truth is less specific about exact timing. QUANTITATIVE VERIFICATION: The core numbers are correct ($541M assets, $378M liabilities, $109M loss in 2023, $120M sale price in 2024), but the introduction of the $124M valuation allowance figure without ground truth support is a significant concern. The 2022 net claim reserves of $0.2 billion mentioned in ground truth are not addressed by the LLM, though this is a minor omission. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly traces the progression from 2022 classification through 2023 valuation to 2024 sale completion. The logical flow is sound and the strategic narrative is well-articulated. The score is reduced from 8-9 range to 7 due to the unexplained and potentially incorrect valuation allowance reference, which introduces factual uncertainty despite otherwise strong performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 579,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported 13 Phase‑3 programs in its 2022 filing (the “Phase 3 Product Candidate Program Changes” table notes 13 programs as of Feb 8 2022)【page_25】. By the 2023 filing the count had risen to 18 programs at the start of 2023 and to 24 programs as of Jan 31 2024【page_26】. The 2024 filing shows 24 programs at the start of 2024 and 25 programs by early 2025【page_25】. The jump from 13 to 25 Phase‑3 candidates—nearly a doubling—illustrates Amgen’s aggressive pipeline expansion through new study initiations, acquisitions (e.g., Horizon biosimilars) and a broadened therapeutic focus across oncology, cardiovascular, immunology and rare‑disease areas.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the Phase 3 program progression: 13 programs in 2022, 18 in 2023, 24 in early 2024, and 25 by early 2025. The quantitative data matches the ground truth precisely. The answer correctly identifies key drivers of growth including the Horizon acquisition and new study initiations. However, there is a minor discrepancy in the ground truth statement which claims '24 programs in 2024' while also stating '25' by 2024—the LLM clarifies this as 24 at start of 2024 and 25 by early 2025, which appears more accurate based on the filing dates cited. The LLM provides additional context about therapeutic focus areas (oncology, cardiovascular, immunology, rare-disease) that adds valuable detail beyond the ground truth. The multi-hop reasoning is sound: the answer synthesizes data across multiple years and filing periods, correctly attributes growth to specific strategic actions (acquisitions, new initiations), and draws appropriate conclusions about pipeline expansion strategy. The characterization of the growth as 'nearly a doubling' is accurate (13 to 25 = 92% increase). Minor weakness: the ground truth mentions 'regulatory approvals in both the U.S. and Japan' which the LLM does not explicitly address, though this is a relatively minor omission given the focus of the question on portfolio evolution. Overall, the answer effectively addresses the multi-part question about how the portfolio evolved and what this reveals about R&D strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 421,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In 2022 American Express portrayed its global card network as the fourth‑largest general‑purpose network, competing head‑to‑head with Visa, Mastercard, China UnionPay and other issuers (2022 p.12). By 2024, heightened regulatory scrutiny of interchange fees, network routing and merchant‑surcharge rules forced Amex to exit its network‑licensing businesses in the EU and Australia and to confront proposed Visa/Mastercard settlement agreements that would cap fees and reshape merchant discount rates (2024 p.34‑35). Thus, the relationship shifted from a primarily competitive stance to one increasingly driven by regulatory constraints and strategic adjustments to its network partnerships.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of AXP's relationship with global card networks from 2022-2024, correctly identifying the shift from competitive positioning to regulatory constraint-driven strategy. Key strengths: (1) Accurately identifies AXP as fourth-largest general-purpose network in 2022; (2) Correctly cites exits from EU and Australia network-licensing businesses in 2024; (3) Properly identifies regulatory pressures around interchange fees, network routing, and merchant-surcharge rules; (4) Accurately references Visa/Mastercard settlement agreements affecting fee structures; (5) Correctly synthesizes the multi-hop reasoning showing trajectory from competition to regulatory constraints. Minor weaknesses: (1) The answer omits some contextual details present in ground truth, such as specific mention of cobrand partnership challenges and uncertainty regarding cobrand arrangements in EU; (2) Does not explicitly mention alternative payment platforms (Alipay, PayPal) as competitive pressures that emerged in 2023; (3) Less comprehensive on the 2023 intermediate period showing growing emphasis on alternative payment platform competition; (4) Page citations (2022 p.12, 2024 p.34-35) cannot be verified against ground truth but appear reasonable. The answer demonstrates sound multi-hop reasoning by connecting 2022 competitive positioning to 2024 regulatory constraints, though it could have been more complete in addressing the full 2022-2024 evolution including the 2023 transition period. The semantic meaning aligns well with ground truth despite some omissions of supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 442,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE stake in the first quarter of 2022 by selling the remaining 91 million CVE common shares and used the cash to repurchase 87.7 million of its own shares that year 【page_110】. The buy‑back continued with 48.6 million shares repurchased in 2023 and 49.1 million shares in 2024, taking total repurchases to 433 million shares at a cumulative cost of $34.3 billion (up from $29 billion for 383 million shares through 2023, implying roughly $5.3 billion of additional spend in 2024) 【page_110】【page_112】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) Correctly identifies the completion of CVE monetization in Q1 2022 with 91 million shares sold; (2) Accurately states cumulative repurchase totals of 433 million shares at $34.3 billion through 2024; (3) Provides specific annual repurchase volumes (87.7M in 2022, 48.6M in 2023, 49.1M in 2024); (4) Correctly calculates the implied 2024 spend of ~$5.3 billion ($34.3B - $29B); (5) Properly synthesizes multi-hop information across years and documents. Minor weaknesses: (1) The answer does not mention the October 2024 authorization increase to $65 billion, which was included in the ground truth; (2) The 2022 repurchase volume stated (87.7M shares) appears to be a subset of the total 383M shares repurchased through 2023, but the ground truth indicates 383M total through 2023, not just 2022 - this creates slight ambiguity about whether the LLM is correctly parsing annual vs. cumulative figures; (3) Does not explicitly state the $29 billion cost for 383M shares through 2023 as clearly as ground truth. Calculation verification: The implied 2024 calculation ($34.3B - $29B = $5.3B) is mathematically sound. The annual share volumes (87.7M + 48.6M + 49.1M = 185.4M) represent a portion of the 433M cumulative total, which is logically consistent. Overall, the answer successfully addresses the core question about monetization evolution and provides specific dollar amounts and share volumes across the three-year period with strong accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 434,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "Home Depot’s Omnibus Stock Incentive Plans had about 117 million shares available for future grants in early 2022 under the 2005 Omnibus Plan, which fell to roughly 77 million shares at the close of fiscal 2023 under the new Omnibus Plan, and further declined to about 70 million shares by the end of fiscal 2024 [page_67][page_66][page_69]. The steady drop in the share pool shows the company has been actively issuing stock‑based awards, consuming its authorized shares while still retaining a sizable reserve for future compensation grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key numbers are correct - 117 million shares in 2022, 77 million shares in 2023, and 70 million shares in 2024. The numerical progression and decline amounts match the ground truth exactly. ENTITY ACCURACY: Correctly identifies Home Depot, the 2005 Omnibus Plan (2022), the new Omnibus Plan (2023), and the fiscal years 2022-2024. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, showing the evolution of share availability and correctly interpreting the trend as indicating active utilization of equity awards. COMPLETENESS: Addresses both parts of the question - the evolution of shares (with specific numbers) and what this indicates about stock-based compensation capacity and utilization. The answer notes the 'steady drop' and 'actively issuing stock-based awards,' which aligns with the ground truth's characterization of 'consistent drawdown' and 'steady utilization.' MINOR DIFFERENCES: The LLM answer uses slightly different phrasing ('roughly 77 million' vs. 'approximately 77 million' in ground truth, and 'about 70 million' vs. exact '70 million'), but these are acceptable format variations. The LLM adds the phrase 'retaining a sizable reserve for future compensation grants,' which is a reasonable inference not contradicted by the ground truth. The inclusion of page references adds credibility. Overall, the answer is factually accurate, logically sound, and appropriately addresses the multi-hop question about share availability trends and their implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 446,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Accenture plc Class A ordinary shares for awards in the 2022 filing (and the 2023 filing still referenced that same 127 million‑share ceiling)【page_91】【page_81】, and the ceiling was raised to 141 million shares in the 2024 filing【page_98】. This upward adjustment shows Accenture is expanding its equity‑based compensation pool, underscoring a strategic emphasis on using share awards to attract, retain and motivate talent.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numeric progression: 127 million shares in 2022, maintained at 127 million in 2023, and increased to 141 million in 2024. All numbers match the ground truth exactly. The answer properly synthesizes the multi-hop information across three fiscal years and correctly identifies the Amended 2010 SIP as the relevant plan. The strategic interpretation about expanding equity-based compensation for talent attraction, retention, and motivation is sound and aligns with the ground truth's characterization of the increase as indicating 'growing emphasis on equity-based incentives.' However, there is a minor discrepancy in how the 2023 data is presented. The LLM states '2023 filing still referenced that same 127 million-share ceiling,' which could be interpreted as the ceiling remaining unchanged in 2023. The ground truth indicates the number 'had increased to 141,000,000' by both 2023 and 2024, suggesting the increase occurred between 2022 and 2023, not between 2023 and 2024. This represents a slight mischaracterization of the timing of the increase, though the final 2024 number is correctly stated as 141 million. The qualitative reasoning about strategic emphasis on share-based compensation is appropriate and well-articulated. The answer demonstrates solid multi-hop synthesis across the three-year period and correctly interprets the business implications of the authorization increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 398,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio saw its weighted‑average yield climb from roughly 2.1 % in 2022 (the 2.08 % total yield shown for foreign government bonds and obligations) to about 6.1 % in 2024 (the non‑U.S. taxable‑investment‑securities yield, which includes those bonds)【page_120】【page_176】. The jump signals that yields on its foreign‑government‑debt holdings have risen sharply, indicating a growing exposure to higher international interest‑rate environments – boosting potential interest income but also making the company more sensitive to global rate moves.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. CRITICAL ERRORS: (1) The LLM cites 2.1% (2.08%) as the 2022 yield, which is completely incorrect - the ground truth clearly states 5.86% for 2022. (2) The LLM cites 6.1% as the 2024 yield, which is also incorrect - the ground truth states 5.86% for 2024. (3) The LLM conflates 'foreign government bonds and obligations' with 'non-U.S. taxable investment securities,' which are different categories. The LLM appears to have confused or misidentified the relevant financial metrics. MISSING CRITICAL INFORMATION: (1) The LLM completely omits the 2023 data point (6.45%), which is essential to understanding the trend described in the question. (2) The ground truth shows a clear three-year trajectory (5.86% → 6.45% → 5.86%), but the LLM presents a monotonic increase (2.08% → 6.1%), fundamentally mischaracterizing the trend. REASONING ISSUES: (1) The LLM's conclusion about 'sharp rise' and 'growing exposure to higher international interest-rate environments' is based on incorrect numbers and misses the actual story: a spike in 2023 followed by a return to baseline in 2024. (2) The multi-hop synthesis failed - the LLM did not correctly identify and combine the relevant data points across the three-year period. SEMANTIC ISSUES: While the LLM correctly identifies that the question concerns international interest rate exposure, it fundamentally misrepresents the actual yield movements and trend direction. The answer would mislead readers about American Express's actual foreign bond portfolio performance and exposure patterns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 447,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "In 2022 the foreign‑government‑bond portfolio was almost entirely short‑dated – $628 million of the $630 million held was due within one year – which kept its effective yield at the low short‑term level (≈1.7 %)【page_121】. By 2023 the weighted‑average yield on that segment had risen sharply to about 6.45 % and then eased to roughly 5.85 % in 2024, showing Amex deliberately shifted into longer‑dated, higher‑yielding sovereign debt as global rates climbed and then trimmed exposure as yields moderated, reflecting a tactical move to capture higher returns while managing duration risk in a changing interest‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key portfolio composition in 2022 ($630M total, $628M short-dated), accurately cites the 2023 yield of 6.45% and 2024 yield of 5.85%, and provides reasonable interpretation of the strategic shift and market conditions. The multi-hop synthesis across years is sound, and the reasoning about tactical positioning in response to interest rate changes is logical and relevant. CRITICAL ERRORS: The LLM introduces a specific 2022 yield figure of approximately 1.7% that is NOT present in the ground truth answer. The ground truth explicitly states '2022 fair value distribution' without providing a specific yield percentage for that year. This is a significant factual error - the LLM appears to have fabricated or inferred a number not supported by the source material. QUANTITATIVE ISSUES: While the dollar amounts ($630M, $628M) and the 2023-2024 yields (6.45%, 5.85%) are correct, the introduction of the 1.7% 2022 yield is problematic and reduces quantitative accuracy. The ground truth does not provide a comparable 2022 yield figure, making this addition either unsupported or incorrect. QUALITATIVE ASSESSMENT: The interpretation of the yield progression and strategic implications is sound and well-reasoned. The explanation of the shift from short-duration to longer-dated instruments and the response to interest rate movements aligns with the ground truth's assessment. However, the fabricated 2022 yield undermines the overall credibility. MULTI-HOP REASONING: The synthesis across 2022-2023-2024 is logically structured, though the unsupported 2022 yield figure creates a false comparison point. The reasoning about market conditions and portfolio strategy is appropriate but built partially on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 480,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In the 2022 Form 10‑K the debentures were shown together with the common‑stock line as a single entry – “Common Stock, $.01 Par Value 7 % Debentures due 2029” (COP_10k_2022.pdf page_1). The 2023 filing broke this out, listing a separate row for “7 % Debentures due 2029” with its own CUSIP and exchange (COP_10k_2023.pdf page_1). By the 2024 filing the company reverted to the combined wording “Common Stock, $.01 Par Value 7 % Debentures due 2029” (COP_10k_2024.pdf page_1). This progression shows ConocoPhillips consistently discloses the debenture issue under Section 12(b) but adjusts the table’s formatting—experimenting with a clearer, separate listing in 2023 before returning to a more concise combined entry—reflecting a pragmatic, compliance‑driven approach that balances regulatory requirements with readability.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth states that in 2024, COP 'maintained this structured disclosure' with the debentures in a separate row (as they were in 2023), indicating consistency from 2023-2024. However, the LLM claims that by 2024 the company 'reverted to the combined wording' of 'Common Stock, $.01 Par Value 7% Debentures due 2029,' suggesting a return to the 2022 format. This is a fundamental mischaracterization of the multi-year progression. The ground truth progression is: (1) 2022: combined entry, (2) 2023: separated into own row with distinct CUSIP, (3) 2024: maintained separate row format. The LLM progression is: (1) 2022: combined, (2) 2023: separated, (3) 2024: reverted to combined. This represents a significant factual error in describing the 2024 disclosure status. Additionally, while the LLM correctly identifies the CUSIP (718507BK1) and the separation that occurred in 2023, it misinterprets the 2024 filing as a reversion rather than a continuation of the 2023 approach. The LLM's conclusion about 'pragmatic, compliance-driven approach' and 'experimenting' with formatting is contradicted by the ground truth's characterization of 'consistent and more transparent treatment' and 'growing emphasis on clarity.' The multi-hop reasoning fails because the LLM incorrectly synthesizes the three-year progression, fundamentally altering the narrative about the company's disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 412,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 have risen only slightly over the last three fiscal years – the net carrying amount was about **$1.03 billion in FY 2022** (NVDA 10‑K 2022, p. 78), **$1.044 billion in FY 2023** and **$1.057 billion in FY 2024** (NVDA 10‑K 2023, p. 67).  The note’s low 2.09 % effective interest rate and long 2031 maturity (NVDA 10‑K 2024, p. 72) show that NVIDIA is deliberately keeping a modest, low‑cost, long‑dated debt tranche on its balance sheet, allowing the discount to amortize rather than aggressively repaying it, which reflects a disciplined strategy of locking in cheap financing to support growth while preserving liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) FY 2022: LLM states $1.03 billion, but ground truth is $1.2 billion - a $170M discrepancy (14% error). (2) FY 2023: LLM states $1.044 billion, but ground truth is $1.057 billion - close but still incorrect. (3) FY 2024: LLM states $1.057 billion, but ground truth is $1.25 billion - a $193M discrepancy (15% error). The LLM appears to have confused or transposed the 2023 and 2024 figures. (4) The LLM also cites a 2.09% effective interest rate, which differs from the stated 2.00% coupon rate and is not verified against ground truth. MULTI-HOP REASONING: While the LLM correctly identifies the three-year progression and attempts to synthesize debt management strategy, the fundamental numerical errors undermine the entire analysis. The conclusion about 'modest, low-cost, long-dated debt' is contradicted by the actual trend in ground truth (which shows an increase from $1.2B to $1.25B, not the flat trajectory the LLM's numbers suggest). ENTITY ACCURACY: Company (NVIDIA/NVDA) and instrument (2.00% Notes Due 2031) are correctly identified, but the fiscal years and corresponding values are materially wrong. The semantic interpretation of debt strategy is reasonable but built on incorrect data. COMPLETENESS: The LLM addresses the evolution question and attempts to explain strategy, but the incorrect numbers make the answer fundamentally unreliable for decision-making or analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 422,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has consistently treated Marvel as a high‑value, indefinite‑lived intangible – the 2022 balance sheet lists “Marvel trademarks” with ESPN and Pixar (page 110), and the same classification appears in the 2023 and 2024 filings (page 114). In 2023 Disney explicitly elevated Marvel to a marquee brand on its streaming platform, describing it as a top‑level “tile” on Disney+ alongside Pixar, Star Wars and National Geographic (page 7); the 2024 filing continues to include Marvel among the indefinite‑lived intangibles, indicating the brand remains a core strategic asset even as the specific streaming‑service branding language is not restated.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the three fiscal years. STRENGTHS: (1) Correctly identifies Marvel's classification as indefinite-lived intangible assets across 2022, 2023, and 2024; (2) Accurately references the grouping with ESPN and Pixar in 2022; (3) Correctly identifies Marvel's elevation to a top-level 'tile' on Disney+ in 2023 alongside Pixar, Star Wars, and National Geographic; (4) Properly synthesizes the dual strategic positioning (financial asset classification + streaming branding); (5) Page references (110, 114, 7) appear reasonable for 10-K filings. MINOR WEAKNESSES: (1) The LLM states 'the same classification appears in the 2023 and 2024 filings' but the ground truth only explicitly confirms 2022 and 2024 for indefinite-lived intangible assets listing - the 2023 mention is less clear in the original answer; (2) The LLM notes that '2024 filing continues to include Marvel among the indefinite‑lived intangibles' but adds 'the specific streaming‑service branding language is not restated' - this is a reasonable inference but slightly goes beyond what the ground truth explicitly states about 2024. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and two distinct dimensions (balance sheet classification and streaming platform branding), demonstrating sound multi-hop reasoning. The conclusion that Marvel remains 'a core strategic asset' logically follows from the evidence presented. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly more specific detail about page numbers and additional context about other branded tiles on Disney+. No numerical errors detected. The answer is comprehensive and directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 503,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "- 2022 10‑K – Discount revenue is recognized at the moment a Card‑Member transaction occurs; when a third‑party merchant acquirer is used (e.g., the OptBlue program or a GNS partner) the “network‑rate fee” that Amex negotiates with that acquirer is also recorded as discount revenue at transaction time【page_104】.  \n- 2023 10‑K – The same recognition model is retained, but the filing adds that contracts with large merchants are usually fixed‑term (3‑7 years, often with auto‑renewal) while small‑ and mid‑size merchants have no set duration, and the network‑rate fee remains an individually‑negotiated component of discount revenue【page_103】.  \n- 2024 10‑K – The discussion shifts to strategy: Amex emphasizes expanding merchant coverage globally—targeting low‑to‑plastic merchants, priority international cities and new industry verticals—and using its network‑rate negotiations and continued network investments to grow acceptance and mitigate pressure on merchant discount rates【page_93】【page_94】【page_91】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the core revenue recognition mechanism for discount revenue at transaction time across all three years; (2) Accurately captures the network-rate fee negotiation structure with third-party acquirers (OptBlue, GNS partners); (3) Properly notes the shift in 2023 to clarify contract terms (3-7 years for large merchants, no set duration for SMBs); (4) Correctly identifies the 2024 strategic pivot toward merchant coverage expansion, international growth, and vertical diversification; (5) Multi-hop reasoning is sound—synthesizing evolution across years and connecting revenue recognition mechanisms to strategic initiatives. MINOR GAPS: (1) The LLM answer does not explicitly mention 'processed revenue from network partnership agreements, including royalties and fees' introduced in 2023, which the ground truth specifically highlights as a new revenue stream distinct from discount revenue; (2) The answer could have been more explicit about the distinction between discount revenue and processed revenue as separate revenue categories emerging in 2023; (3) The phrase 'mitigate pressure on merchant discount rates' in 2024 is a reasonable inference but not explicitly stated in the ground truth. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were provided in either answer, so this dimension is not directly testable. Page citations appear reasonable and support the narrative. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential evolution of American Express's merchant acquirer relationships and revenue structure, with appropriate emphasis on the progression from transaction-based recognition to strategic expansion. The omission of processed revenue as a distinct category is the primary substantive gap, reducing the completeness of the answer relative to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 533,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "In the 2022 10‑K Amgen only flagged that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks” and that reliance on third‑party suppliers for those devices could affect product development (2022 p.34). The 2023 filing expanded the disclosure, linking device approval to clinical‑trial execution and product labeling, describing post‑marketing obligations (e.g., a confirmatory study for LUMAKRAS and a five‑year observational requirement for EVENITY) and detailing FDA safety reviews and ongoing monitoring of device complaints and adverse events such as the Neulasta Onpro kit (2023 p.52‑55). By 2024 the risk narrative further stressed that delays or loss of device clearance can directly stall clinical trials and product launches, that contemporaneous regulatory approval of the device and drug may be required, and reiterated continuous device‑safety oversight, adverse‑event reporting and the possibility of product removal if device approval is withdrawn (2024 p.52‑54).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core 2022 disclosure about drug delivery/companion diagnostic devices and third-party supplier risks; (2) Accurately captures the 2023 expansion with specific examples (LUMAKRAS confirmatory study, EVENITY five-year observational requirement, Neulasta Onpro kit monitoring); (3) Properly synthesizes the 2024 evolution emphasizing device clearance delays, concurrent regulatory approval requirements, and withdrawal risks; (4) Provides specific page references (2022 p.34, 2023 p.52-55, 2024 p.52-54) that add credibility; (5) Correctly identifies the progression from general dependencies to specific post-marketing and safety compliance challenges, matching the ground truth narrative arc. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer is more detailed and specific than the ground truth in some respects (e.g., naming specific products and requirements), which is actually beneficial but slightly exceeds the ground truth scope; (2) The ground truth mentions 'Complete Response Letter from the FDA' for LUMAKRAS, while the LLM answer references 'confirmatory study' - these are related but the CRL context is slightly underemphasized; (3) The LLM answer could have been slightly more explicit about the shift from 'general dependencies' framing to 'specific compliance challenges' framing, though this is implied. QUANTITATIVE VERIFICATION: No specific numbers, percentages, or dollar amounts are present in either answer, so quantitative accuracy is assessed on dates (2022, 2023, 2024 - all correct) and product/requirement specificity (all verified as accurate). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, connecting device regulatory oversight to clinical trial execution, post-marketing obligations, and enforcement consequences. The logical progression is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while providing more granular detail and specific examples, which enhances rather than detracts from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 592,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has remained focused on auditing both business‑unit operations and staff groups, but the 2024 filing renames the process “Corporate HSE audits” and explicitly ties it to annually‑set objectives, targets and deadlines 【2024 page 18】. All three years note that any improvement actions identified are “tracked to completion,” yet the 2024 report adds that audit progress is formally reported to both the Executive Leadership Team and the Board of Directors, tightening governance oversight 【2022 page 18】【2023 page 18】【2024 page 18】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misrepresentations compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2024 terminology shift to 'Corporate HSE audits'; (2) Accurately notes that improvement actions are 'tracked to completion' across all three years; (3) Correctly identifies governance reporting to ELT and Board; (4) Proper citation format with page references. CRITICAL WEAKNESSES: (1) The LLM claims 2024 'explicitly ties it to annually-set objectives, targets and deadlines' - this specific detail is not mentioned in the ground truth and appears to be an unsupported addition; (2) The LLM states that 2024 'adds that audit progress is formally reported to both the Executive Leadership Team and the Board' - this misrepresents the ground truth, which indicates governance reporting to ELT and Board was already established in 2022, not newly added in 2024; (3) The LLM completely omits the 2023 expansion context regarding Life Saving Rules, Process Safety Fundamentals, and stop work policy - these are explicitly mentioned in the ground truth as part of the evolution; (4) The LLM fails to capture the strategic narrative of evolution from 'localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024)' - this represents a fundamental gap in understanding the multi-year progression; (5) The LLM's characterization of 'tightening governance oversight' in 2024 is misleading since governance reporting existed in 2022. MULTI-HOP REASONING: The answer inadequately synthesizes the three-year evolution. It treats the years more as isolated snapshots rather than showing how the program matured from conformance-focused (2022) to integrated systems (2023) to standardized corporate approach (2024). The answer misses the broader human capital management framework integration mentioned for 2023. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, but the temporal claims about when governance reporting was introduced are factually incorrect relative to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 566,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022 filing warned that AI, cloud‑and‑as‑a‑service shifts were displacing legacy services and that the firm must create new pricing or commercial models to capture the value of those technologies (2022 p. 18, 22). By the 2023‑2024 reports the company framed that need as part of a broader, continuous strategy to develop AI‑driven and cloud‑based solutions, invest in innovation and adjust pricing to reflect the evolving value proposition (2023/2024 p. 21). Across all three years Accenture consistently highlighted the risk that it may be unable to roll out these new pricing models quickly enough—leading to client spending delays and revenue shortfalls—while also noting ongoing cyber‑security and AI‑regulatory risks tied to the same technology changes (2022 p. 18, 22; 2023/2024 p. 21).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Accenture's evolving pricing model strategy across 2022-2024 and correctly identifies the core risks. Strengths: (1) Accurately captures the progression from 2022 acknowledgment of need for new pricing models to 2023-2024 strategic implementation; (2) Correctly identifies AI, cloud, and as-a-service solutions as key technological drivers; (3) Properly synthesizes the consistent risk theme across all three years regarding inability to deploy pricing models quickly enough and resulting revenue shortfalls; (4) Appropriately mentions client adoption/spending delays as a key concern. Minor weaknesses: (1) The answer introduces 'cyber-security and AI-regulatory risks' as consistently highlighted across all three years, which is not explicitly mentioned in the ground truth as a consistent theme—this appears to be an addition not fully supported by the original answer; (2) Page citations (p. 18, 22, p. 21) are provided but cannot be verified against the ground truth, which doesn't include specific page references; (3) The answer could have been more explicit about the 2023 specific focus on 'delays in client spending due to evaluation of new technologies' as a distinct evolution point. The core multi-hop reasoning is sound—the answer successfully synthesizes information across three years and identifies the evolution pattern. The semantic equivalence is strong, with the LLM capturing the essential meaning of the ground truth despite different wording. The introduction of additional risk factors (cyber-security, AI-regulatory) slightly detracts from strict accuracy, though these may be present in the actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 460,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior note grew from $900 million at 12/31/2022 to $944 million at 12/31/2023 and then to $982 million at 12/31/2024 (see the fair‑value tables for 2022‑2024)【page_74†L1-L4】【page_70†L1-L4】.  By selling all of its AerCap equity and expanding the debt holding, GE is moving from an equity stake to a larger, lower‑risk interest‑bearing position, suggesting a strategic shift to maintain a foothold in AerCap while preferring a more stable, income‑focused investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the AerCap note grew from $900M (12/31/2022) to $944M (12/31/2023) to $982M (12/31/2024). The ground truth states the holdings DECREASED from $993M (end of 2021, reported in 2022 disclosure) to $944M (end of 2023, reported in 2024 disclosure). The LLM's numbers for 2024 ($982M) are not supported by the ground truth, which only provides data through 2023. The LLM invents a 2024 figure that contradicts the documented decline pattern. (2) DIRECTIONAL ERROR: The LLM describes an INCREASE in holdings (900M→944M→982M), while the ground truth shows a DECREASE (993M→944M). This is a fundamental mischaracterization of the investment trajectory. (3) MULTI-HOP REASONING FAILURE: The LLM correctly identifies a strategic shift from equity to debt, but this reasoning is built on incorrect numerical foundations. The claim about 'expanding the debt holding' is contradicted by the actual data showing a decline from $993M to $944M. (4) TEMPORAL SCOPE ISSUE: The question asks about evolution 'from 2022 through 2024,' but the ground truth only provides data through end of 2023. The LLM fabricates 2024 data ($982M) without acknowledging this limitation. (5) SEMANTIC CONTRADICTION: The LLM's interpretation of 'expanding' the debt position contradicts both the numerical decline and the ground truth's characterization of 'consistent decline' and 'strategic reduction.' The answer demonstrates poor data synthesis and introduces unsupported figures that fundamentally alter the investment narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 452,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "In Amgen’s 2022 filing Bemarituzumab was listed as a Phase 3 candidate for gastro‑esophageal‑junction adenocarcinoma (and also in Phase 2 for other tumors and Phase 1 for NSCLC) with composition‑of‑matter patents projected to expire in 2029 in both the U.S. and Europe (see the Phase‑3/2/1 tables and the patent table). By the 2023 and 2024 filings the molecule is shown only as a Phase 3 program for the same GEJ indication, and the patent expiration dates remain unchanged at 2029 for both territories, reflecting a consolidated clinical focus while its IP timeline stayed constant.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key numeric facts: (1) Bemarituzumab was in Phase 3 for GEJ adenocarcinoma in 2022, (2) Patent expiration dates of 2029 for both U.S. and Europe are accurate, (3) The mention of Phase 2 and Phase 1 programs in 2022 adds detail. The quantitative accuracy is solid on dates and patent timelines.\n\nWEAKNESSES - CRITICAL ISSUES: (1) The LLM's characterization of evolution is CONTRADICTORY to the ground truth. The ground truth states there was a SHIFT from clinical development focus to 'broader therapeutic positioning' with 'expanded investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC' by 2024. The LLM instead claims the molecule is 'shown only as a Phase 3 program' with 'consolidated clinical focus' - this directly contradicts the ground truth's statement about expansion. (2) The LLM fails to capture the key evolution narrative: the ground truth emphasizes a progression from narrow (GEJ adenocarcinoma) to broader therapeutic scope by 2024. The LLM presents this as consolidation rather than expansion. (3) The LLM mentions Phase 2 and Phase 1 programs in 2022 but doesn't explain what happened to these programs or how the portfolio evolved - missing the narrative arc of the question.\n\nMULTI-HOP REASONING: The question asks about evolution 'from 2022 to 2024' with two dimensions: (a) clinical phase progression and (b) patent expiration timelines. The LLM addresses patent timelines adequately but fails on the clinical progression narrative. It correctly notes phases existed in 2022 but mischaracterizes the 2024 positioning as 'consolidated' when the ground truth indicates 'expanded' scope.\n\nSEMANTIC ACCURACY: While individual facts are mostly correct, the overall interpretation and synthesis is flawed. The LLM's conclusion that IP timeline 'stayed constant' is correct, but the clinical positioning characterization is inverted from the ground truth's intended meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 538,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "American Express’s 2022 filing already warned that “alternative mechanisms, systems and products that leverage new technologies” were reshaping the payments landscape and that “the speed of innovation and investment in systems, technologies and product and service offerings” would be a key competitive factor【page_12】. By the 2024 filing the company describes “continued intense competitive pressure” from lower‑cost rivals and large tech firms that are building their own payment and financing solutions, and it now commits to “substantial…investment in technology…including AI, machine‑learning, open‑banking, tokenization, real‑time settlement and other alternative‑payment and financing mechanisms” to protect merchant discount rates and network volume【page_29】【page_31】. Together, these disclosures show a shift from merely acknowledging fintech threats to a proactive, technology‑focused strategy designed to preserve its brand and merchant relationships as fintech disruption accelerates.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's strategic evolution from 2022-2024 and correctly identifies the core shift from defensive acknowledgment to proactive investment. However, there are notable gaps in completeness when compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies 2022 positioning: acknowledges alternative payment mechanisms as competitive threats and emphasizes speed of innovation\n2. Accurately captures 2024 positioning: describes shift to proactive investment in technologies (AI, machine learning, open banking, tokenization, real-time settlement)\n3. Correctly synthesizes the multi-hop evolution: defensive → proactive strategic shift\n4. Appropriately cites specific technologies and competitive pressures\n5. Reasoning is sound and logically connects the temporal evolution\n\nWEAKNESSES:\n1. INCOMPLETE COVERAGE OF 2023: The ground truth explicitly mentions that by 2023, American Express \"expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption.\" The LLM answer completely omits the 2023 filing analysis, jumping from 2022 to 2024. This is a significant gap in the three-year evolution narrative.\n2. MISSING NUANCE ON DEPENDENCY POSTURE: The ground truth emphasizes a shift to a \"dependency posture\" where alternative payment mechanisms are framed as \"necessary to integrate...into core offerings.\" The LLM answer frames this as investment/protection strategy but doesn't capture the semantic shift from threat to necessity/dependency.\n3. INCOMPLETE THREAT CHARACTERIZATION: The ground truth specifically mentions digital wallets (Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems in 2022. The LLM answer is more generic about \"alternative mechanisms\" without these specific examples.\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The LLM appropriately avoids inventing metrics.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods (2022 and 2024) to show strategic evolution. However, the omission of 2023 weakens the completeness of the multi-hop analysis across the full 2022-2024 period requested.\n\nSEMANTIC EQUIVALENCE: The core message is conveyed correctly, but the ground truth's distinction between \"competitive threat\" (2022), \"expanded awareness\" (2023), and \"dependency/necessity\" (2024) is more nuanced than the LLM's simpler \"acknowledgment → proactive investment\" framing.\n\nJUSTIFICATION: The answer is substantially correct on the main thesis but incomplete in addressing the full three-year evolution. The omission of 2023 analysis and the less precise characterization of the strategic shift (missing the \"dependency posture\" concept) prevent this from being a 9-10 score, though the core facts and reasoning are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 800,
        "total_tokens": 2362
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of the cash‑settled performance‑share units rose from **$91.58 per unit for the 2022 grants**【page_124】, jumped to **$112.50 per unit for the 2023 grants**【page_124】, and was **$110.39 per unit for the 2024 grants**【page_126】.  This upward trend – with a modest dip after the 2023 peak – shows ConocoPhillips is increasing the monetary value of its cash‑settled PSUs, reflecting a strategy of strengthening long‑term incentive compensation to better align senior‑management rewards with shareholder performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IDENTIFIED: The LLM answer provides THREE data points (2022: $91.58, 2023: $112.50, 2024: $110.39), but the ground truth only mentions TWO data points (2022: $91.58, 2024: $112.50). The ground truth does NOT include a 2023 value of $112.50 or a 2024 value of $110.39. This is a significant factual error that undermines the core answer. The LLM appears to have fabricated or misattributed the 2023 and 2024 values. QUANTITATIVE ACCURACY: The 2022 figure ($91.58) and the 2024 figure ($112.50) match the ground truth, but the introduction of an intermediate 2023 value ($112.50) that contradicts the ground truth's statement that the value increased 'from 2022 through 2024' (implying a single endpoint in 2024) is problematic. The LLM's claim of a 'modest dip' from 2023 to 2024 cannot be verified against the ground truth and appears to be an unsupported inference. QUALITATIVE ACCURACY: The reasoning about strategic alignment with shareholder performance is sound and consistent with the ground truth's interpretation. The LLM correctly identifies this as reflecting a shift toward higher-value incentive compensation. However, the multi-hop synthesis is compromised by the incorrect intermediate data point. COMPLETENESS: The LLM addresses the evolution question and provides strategic interpretation, but does so with inaccurate data. The ground truth indicates a simpler two-point comparison (2022 to 2024), not a three-point trajectory. ENTITY ACCURACY: ConocoPhillips and cash-settled PSUs are correctly identified. The page citations (124, 126) appear plausible but cannot be verified against the ground truth. OVERALL ASSESSMENT: While the LLM demonstrates good reasoning about compensation strategy and correctly identifies the 2022 and 2024 endpoints, the introduction of an unsupported 2023 intermediate value and the resulting narrative of a 'peak and dip' pattern represents a material factual error that significantly reduces the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 536,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s 2022 filing warned that its fraud‑detection controls are complex and that “numerous and evolving fraud schemes” could hurt its credit products, noting that “measures to detect and reduce the risk of fraud and abusive behavior… may not be effective” (page_24). By 2023 the company added that “failure to deal effectively with fraud, abusive behaviors… may increase our loss rate” and explicitly said it expects “third parties … to continue to attempt to abuse access to and misuse our payments services to commit fraud,” linking those schemes to its credit‑product exposure (page_23). The 2024 filing repeats and expands this language, stressing continued third‑party abuse attempts and the ongoing risk to its credit products (pages_22‑23). This steady, increasingly explicit focus on abusive behavior suggests PayPal is sharpening its risk‑management awareness, but the persistent and growing emphasis indicates that fully mitigating these evolving fraud threats remains a significant challenge.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year evolution of PayPal's fraud and abuse concerns from 2022-2024, accurately captures the progression from general fraud warnings to explicit third-party abuse language, and appropriately synthesizes the connection between fraud risks and credit products across the three-year period. The reasoning about PayPal's risk management awareness is sound and well-articulated. The answer demonstrates good understanding of the multi-hop nature of the question.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to mention the €40 billion multi-year agreement to sell BNPL receivables in 2023, which is a key quantitative fact and strategic risk mitigation action explicitly stated in the ground truth. This is a significant omission for a financial question requiring synthesis of specific data points. (2) INCOMPLETE CONTEXT: The answer does not address the 'valid-when-made doctrine' regulatory uncertainty mentioned in the ground truth as impacting U.S. credit products in 2024. (3) VAGUE SOURCING: While the LLM provides page references, it doesn't specify which filing year each page reference corresponds to, creating ambiguity about the multi-hop synthesis. (4) MISSING STRATEGIC DIMENSION: The ground truth emphasizes PayPal's strategic shift toward third-party risk mitigation (the €40B receivables sale), whereas the LLM focuses primarily on awareness/acknowledgment rather than concrete mitigation actions.\n\nQUANTITATIVE ACCURACY: The answer contains no specific dollar amounts or quantitative metrics, missing the €40 billion figure that is central to understanding PayPal's 2023 risk management strategy. This represents a material gap in financial specificity.\n\nQUALITATIVE ACCURACY: The reasoning about the evolution of language and risk awareness is sound, but the synthesis is incomplete due to missing key strategic actions and regulatory context.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question's core inquiry about evolution and risk management effectiveness, but the missing €40B transaction and regulatory factors limit its completeness in assessing effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 586,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "From 2022 (see page 5) through 2024 (see page 6), Cyramza was consistently positioned as a second‑line therapy for advanced or metastatic gastric cancer, NSCLC, colorectal cancer and hepatocellular carcinoma and as a first‑line option for EGFR‑mutated metastatic NSCLC. The 2023 IP table (see page 11) shows its compound patents expire in the U.S. and Japan in 2026 and in Europe in 2028, with U.S. biologics data protection through 2026 and data‑protection in Europe and Japan already ending in 2024 and 2023. Together, the stable, multi‑indication positioning and the narrowing exclusivity horizon suggest Lilly is leveraging Cyramza’s broad therapeutic scope while preparing for patent cliffs, indicating a long‑term oncology strategy that relies on expanding indications, combination regimens and a diversified pipeline rather than on a single product’s IP protection.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Cyramza's therapeutic positioning across multiple cancer indications (gastric, NSCLC, colorectal, hepatocellular carcinoma) and accurate patent/data protection timelines. Quantitative accuracy is high: patent expiry dates (2026 U.S./Japan, 2028 Europe) and data protection dates (2023 Japan, 2024 Europe, 2026 U.S.) are all correct. The answer correctly synthesizes multi-hop information about therapeutic positioning evolution and IP protection across 2022-2024. The reasoning about Eli Lilly's strategy—leveraging broad therapeutic scope while preparing for patent cliffs through pipeline diversification—is sound and well-supported. Minor differences from ground truth: (1) The LLM provides more granular detail about first-line vs. second-line positioning and EGFR-mutated NSCLC specificity, which adds nuance beyond the ground truth but is not contradictory. (2) The LLM explicitly mentions European patent data (2028) which the ground truth does not address, representing additional accurate information rather than error. (3) The ground truth emphasizes 'no new indications added' in 2024, while the LLM focuses on stable positioning—semantically equivalent but with slightly different emphasis. The LLM's conclusion about strategy (expanding indications, combination regimens, diversified pipeline) aligns well with the ground truth's implication about preparing next-generation products. All numeric values are accurate, multi-hop synthesis is correct, and the answer comprehensively addresses the question's components about therapeutic positioning evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 458,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022 to 2024 PMI moved from a debt profile dominated by short‑term notes (e.g., 2.375%‑2.500% due 2022, 2.625%‑3.600% due 2023 and 2.875%‑3.250% due 2024)【page_1】to a more staggered and longer‑dated program that added new series maturing through 2026‑2028 in 2023【page_1】and further extended the schedule to 2029‑2044 in 2024【page_2】. Throughout this evolution the 3.875% Notes due 2042 remained on the balance sheet, serving as a stable, low‑cost anchor while the company actively issued, refinanced and diversified the rest of its debt instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core elements of the ground truth answer. MAJOR ISSUES: (1) The LLM focuses on short-term notes (2.375%-3.600% due 2022-2024) which are not mentioned in the ground truth answer at all. The ground truth specifically discusses long-term debt instruments like the 3.875% Notes due 2042, 4.125% Notes due 2043, and 4.875% Notes due 2043. (2) The LLM claims new series were added maturing through 2026-2028 in 2023 and 2029-2044 in 2024, but the ground truth indicates the opposite pattern: the 4.125% Notes due 2043 and 4.875% Notes due 2043 that existed in 2022 were NO LONGER listed in 2024, suggesting retirement/refinancing rather than extension. (3) The LLM mentions a 4.250% Notes due 2044 appearing in 2023, which the ground truth does mention, but then fails to note that this instrument also appears to have been retired by 2024. (4) The LLM's characterization of the strategy as 'extending the schedule to 2029-2044' contradicts the ground truth's finding that 'no new long-dated notes beyond 2042 were introduced' by 2024. (5) While the LLM correctly identifies the 3.875% Notes due 2042 as a stable component, it misses the key insight that the company was actually RETIRING/REFINANCING older instruments rather than continuously extending maturity dates. The LLM appears to have confused or inverted the actual capital structure evolution. The answer demonstrates poor multi-hop synthesis and factual inaccuracy on the core narrative of the capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 424,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "In its 2022 filing PayPal warned that its credit‑product portfolio heightened exposure to defaults and fraud and that “measures to detect and reduce the risk of fraud and abusive behavior are complex, require continuous improvement” (pages 24‑26). In 2023 the company cut that exposure by entering a multi‑year €40 bn agreement to sell U.K. and European BNPL loan receivables and beginning those sales (page 25) and by launching a diversification‑and‑migration program to reduce reliance on a single U.S. payment‑processor and add additional processors (page 25). In 2024 it continued the processor diversification (page 25) and further bolstered its fraud‑detection, abusive‑behavior monitoring and compliance policies to manage third‑party and credit‑product risk (page 24).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about PayPal's evolving exposure to abusive behaviors from 2022-2024. STRENGTHS: (1) All key numeric values are correct: €40 billion BNPL receivables sale agreement, correct years (2022, 2023, 2024). (2) The multi-hop synthesis is sound - the answer correctly traces the progression from problem identification (2022) through strategic mitigation (2023) to infrastructure enhancement (2024). (3) Specific actions are accurately identified: the €40bn BNPL receivables sale, processor diversification program, and fraud detection improvements. (4) The answer includes relevant supporting details like page references and specific policy areas (compliance, third-party risk management). (5) Semantic equivalence is maintained - the LLM's description of 'cutting exposure' and 'bolstering fraud-detection' aligns with the ground truth's characterization of 'offloading risk' and 'enhancing fraud prevention infrastructure.' MINOR WEAKNESSES: (1) The LLM mentions processor diversification as a 2023 action, which is not explicitly mentioned in the ground truth answer, though this appears to be additional accurate information from the filings rather than an error. (2) The answer could have been slightly more explicit about the shift from 'identifying the problem' to 'actively mitigating' as a narrative arc, though this progression is clearly implied. (3) The mention of 'synthetic identities, stolen financial instruments' from the ground truth is not explicitly repeated, though the LLM's broader characterization of fraud and abusive behavior encompasses these concepts. QUANTITATIVE VERIFICATION: The €40 billion figure is correct and properly formatted. All years are accurate. No calculation errors detected. REASONING QUALITY: The answer successfully synthesizes information across three fiscal years and multiple risk management strategies, demonstrating clear understanding of the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 545,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "- In the 2022 filing (page 37) AMD listed “loss or modification of exemptions for taxes and tariffs” as one of many political‑legal‑economic risks affecting its foreign operations.  \n- The 2023 filing (page 41) repeats the same exposure, now coupling it with “changes in tax laws, trade protection measures and import or export licensing requirements,” signaling a broader regulatory focus.  \n- The 2024 filing (page 41) again highlights the risk of losing or altering tax‑ and tariff‑exemptions, but adds explicit references to recent sanctions, export‑control revisions and heightened China‑Taiwan and Ukraine‑Russia tensions, indicating that AMD perceives growing regulatory uncertainty in its global supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of AMD's risk exposure regarding tax and tariff exemptions; (2) Accurately captures the evolution from general listing of risks to more explicit linkage with geopolitical factors; (3) Provides specific page references (37, 41, 41) which adds credibility; (4) Correctly synthesizes the multi-hop information showing how regulatory concerns became more prominent and specific over time; (5) Accurately identifies the shift from generic 'political-legal-economic risks' to explicit mentions of sanctions, export controls, and specific geopolitical tensions (China-Taiwan, Ukraine-Russia). MINOR WEAKNESSES: (1) The LLM answer is slightly more detailed and specific than the ground truth (mentioning specific page numbers and specific geopolitical conflicts), which could be seen as either enhancement or potential over-specification; (2) The ground truth uses more general language ('geopolitical conflicts') while LLM specifies particular conflicts, though this is factually consistent with typical 10-K disclosures; (3) The LLM answer emphasizes 'supply chain' implications more explicitly than the ground truth, though this is a reasonable inference. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are involved in this question, so quantitative accuracy is assessed on date/year accuracy (all correct: 2022, 2023, 2024) and page reference accuracy (cannot fully verify without access to actual filings, but references appear reasonable). QUALITATIVE ACCURACY: The reasoning about regulatory uncertainty evolution is sound and logically structured. The multi-hop synthesis correctly connects: (a) initial risk identification, (b) expanded regulatory focus, (c) explicit geopolitical linkage. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how exposure evolved and what the trend suggests about regulatory uncertainty, providing appropriate context about global operations impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 563,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred‑compensation moved from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and then to a **$91 million gain in FY 2024**【page_91†L31-L38】.  The notional amount of these swaps also grew (≈$651 m in FY 2022 → $792 m in FY 2023 → $985 m in FY 2024)【page_91†L45-L48】, indicating that Cisco has expanded and is now more effectively using these derivatives to offset the variability of its deferred‑compensation expense, reducing its net exposure to that risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million match the ground truth exactly. The notional amounts cited ($651M, $792M, $985M) are also accurate and provide additional supporting detail not in the ground truth. COMPLETENESS: The answer addresses the core question about the evolution of gains/losses across the three-year period and provides interpretation of what this progression indicates. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metric (total return swaps tied to deferred compensation) is properly characterized. MULTI-HOP REASONING: The answer correctly synthesizes the progression across three fiscal years and draws a logical conclusion about the company's strategy - that the expansion of notional amounts combined with the shift from losses to gains indicates more effective use of derivatives to offset deferred compensation expense variability. This reasoning is sound and goes slightly beyond the ground truth by connecting the notional amount growth to the strategic implication. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'improved market conditions or a strategic shift' (ground truth) is conveyed through the phrase 'more effectively using these derivatives to offset the variability' (LLM answer), which is semantically equivalent and arguably more specific. MINOR CONSIDERATIONS: The LLM provides additional context (notional amounts) that enhances understanding without contradicting the ground truth. The citation format with page references adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 487,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "Beginning in FY 2022 Disney rolled out an ad‑supported Disney+ tier, raised subscription prices and reorganized its DMED unit to rationalize DTC costs, while warning that its streaming services now compete with an expanding set of SVOD rivals and face pricing pressure (pages 26‑28). In FY 2023 the company escalated strategic investments—spending billions on Hulu, taking a 20 % stake in its sports‑streaming business and expecting subscription‑ and ad‑revenue growth to offset linear‑network declines—yet noted flat subscriber growth, rising content‑costs and goodwill impairments (pages 53‑55, 52). By FY 2024 Disney deepened those investments with new pricing, bundling, the launch of an ESPN flagship service and an aggregated entertainment reporting unit, but emphasized heightened competition, macro‑economic headwinds, higher debt‑service costs and the risk of further impairments as it scales its streaming platform (pages 22‑24, 25). This trajectory shows Disney moving from early DTC experiments to heavy capital commitment, while the scaling of its streaming services exposes it to significant financial risks from large cash outlays, debt‑service pressure, content‑cost inflation and subscriber churn.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and provides more detailed, specific information than the ground truth answer. Key strengths: (1) Correctly identifies the three-year progression (FY 2022-2024) with accurate strategic shifts; (2) Accurately captures specific initiatives: ad-supported tier launch, price increases, 20% sports-streaming stake, ESPN flagship service launch, bundling strategies; (3) Correctly identifies financial risks: rising content costs, goodwill impairments, debt-service costs, subscriber churn, macro-economic headwinds; (4) Properly synthesizes multi-hop information across fiscal years showing evolution from experimentation to heavy capital commitment. Quantitative elements verified: The 20% stake figure is specific and appears accurate based on Disney's sports streaming investments; fiscal year references are correct. Minor considerations: (1) The answer includes page references (26-28, 53-55, etc.) which cannot be verified against the ground truth but add specificity; (2) The answer is more granular than the ground truth, providing specific examples (ESPN flagship service, bundling, DMED reorganization) that align with and expand upon the ground truth's core narrative; (3) The characterization of financial risks (debt-service pressure, content-cost inflation, subscriber churn) directly supports the ground truth's assertion about 'financial risks and market pressures.' The LLM answer successfully addresses all components of the multi-part question: strategic investment evolution, competitive positioning, financial risks, and market pressures. The reasoning is sound and the synthesis across three fiscal years is logically coherent. No significant factual errors detected; the answer appears to be a more detailed and specific version of the ground truth rather than contradicting it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 501,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s margin‑risk exposure has been essentially unchanged over the three years. In its 2022 filing the company said it “has full discretion in determining the fee charged to our customers… we therefore bear full margin risk… fees paid to payment processors … are recognized as transaction expense” (2022 Note 2‑Revenue, p. 80). The same disclosure appears in the 2023 filing (2023 Note 2‑Revenue, p. 77) and again in the 2024 filing (2024 Note 2‑Revenue, p. 76), showing that PayPal continues to set fees independently of processor costs and thus continues to assume full margin risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the core finding that PayPal's margin risk exposure remained stable/unchanged across 2022-2023-2024; (2) Accurately cites specific filing locations (Note 2-Revenue with correct page numbers: p. 80 for 2022, p. 77 for 2023, p. 76 for 2024); (3) Properly synthesizes the multi-hop relationship between fee-setting discretion, processor costs, and margin risk across three years; (4) Correctly quotes PayPal's language about bearing 'full margin risk' and recognizing processor fees as 'transaction expense'; (5) Accurately conveys that PayPal sets fees independently of processor costs. Minor considerations: (1) The answer is slightly more concise than the ground truth, which provides marginally more contextual detail about ASU 2023-07 adoption in 2024, though this is not material to the core answer; (2) The LLM answer focuses on the consistency of the disclosure rather than explicitly mentioning 'no material changes' or 'no indication of structural changes,' but this is a semantic difference rather than a factual error. The quantitative elements (page numbers, years, filing references) are all correct. The multi-hop reasoning correctly synthesizes information across three separate annual filings to demonstrate consistency. The answer directly addresses all parts of the question regarding how exposure evolved (answer: it didn't materially change), the role of fee discretion, and the treatment of processor costs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 418,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor sections show the same wording each year – 2022 warned that a “downturn in the global demand for air travel… may impact new aircraft production or result in the delay or cancellation of new aircraft orders” (2022 10‑K p. 30); the 2023 filing repeats this language (2023 10‑K p. 31); and the 2024 filing again lists the same risk (2024 10‑K p. 32). The fact that the concern remains but is not amplified or newly highlighted suggests the risk of order cancellations has become a steady, monitored background issue rather than an acute threat, indicating that commercial aviation is gradually recovering and its stability is improving.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims the risk language is 'the same wording each year' and remained 'steady, monitored background issue' - this directly contradicts the ground truth which explicitly states the language 'expanded' from 2022 to 2023 to include 'broader external events such as regional conflicts and environmental issues' and shifted from 'pandemic-specific concerns to more generalized macroeconomic and geopolitical risks.' (2) The LLM's interpretation that unchanged wording indicates 'improving stability' is logically flawed - the ground truth indicates the opposite: the persistence and evolution of the risk language shows the sector 'remained fragile and susceptible to both external shocks and evolving market dynamics.' (3) The LLM failed to synthesize the multi-hop evolution across the three years. The ground truth shows a clear progression: 2022 (COVID-specific) → 2023 (expanded to geopolitical/macro factors) → 2024 (structural/competitive shifts). The LLM missed this entirely. QUANTITATIVE ACCURACY: The page numbers cited (p. 30, 31, 32) appear reasonable and are not contradicted, though they cannot be verified as exact. The years (2022, 2023, 2024) are correct. However, the LLM's claim about 'same wording' is factually incorrect based on the ground truth. QUALITATIVE ACCURACY: The reasoning is fundamentally flawed. The LLM inverted the correct interpretation - it concluded that consistent risk language indicates improving stability, when the ground truth indicates it reflects ongoing fragility. The LLM also failed to identify the key evolution in risk characterization across the three-year period. CONTEXTUAL RELEVANCE: The answer addresses the question's structure but arrives at the wrong conclusion about what the risk progression indicates about sector recovery.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 516,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 to 2024 PMI’s risk disclosures show a clear escalation of regulatory pressure on its non‑combustible portfolio. In 2022 the company warned that “requirements that lead to a commoditisation of tobacco products or impede adult consumers’ ability to convert to our RRPs” and “regulation that limits branding, communication and product differentiation” could erode its competitive position (2022 p.13‑16). By 2023 and again in 2024 the filings repeatedly cite “administrative and legal challenges” – including product‑classification, advertising, corporate‑communication and scientific‑substantiation allegations – for both RRPs and Smoke‑Free Products, stating that “product regulation … diminishes the ability to differentiate … and restricts adult consumer access to truthful and non‑misleading information” (2023 p.18‑21; 2024 p.18‑21). This progression reveals that regulatory constraints on product differentiation and adult‑consumer communication have intensified, increasingly threatening PMI’s competitive positioning for its reduced‑risk and smoke‑free offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the evolution of regulatory constraints on PMI's competitive positioning. (2) Accurately captures the shift from RRPs focus in 2022-2023 to inclusion of Smoke-Free Products (SFPs) in 2024, matching the ground truth's 'strategic shift in product focus.' (3) Properly synthesizes multi-hop information showing how regulatory pressure intensified across years, with specific citations to page numbers (2022 p.13-16; 2023 p.18-21; 2024 p.18-21) that demonstrate document-level verification. (4) Correctly identifies key regulatory themes: commoditization, branding/communication restrictions, product differentiation limitations, and adult consumer access to truthful information. (5) The semantic meaning aligns well with ground truth regarding 'intensifying regulatory constraints' and 'unfair competition/regulatory asymmetries.' MINOR GAPS: (1) The LLM answer mentions 'administrative and legal challenges' and 'product-classification, advertising, corporate-communication and scientific-substantiation allegations' which are not explicitly mentioned in the ground truth summary, though these appear to be accurate elaborations from the actual filings. (2) The ground truth specifically mentions 'digital media in spreading misleading information about RRPs' in 2023, which the LLM answer does not capture. (3) The ground truth emphasizes 'disproportionate impact relative to competitors' in 2023, which the LLM answer addresses more implicitly through 'unfair competition' language. QUANTITATIVE ACCURACY: No specific financial metrics, percentages, or dollar amounts are required for this qualitative question, so this dimension scores high based on correct year citations and page number references. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly traces the evolution across three years and connects regulatory changes to competitive positioning impacts. The synthesis of RRP-to-SFP transition is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses all components of the complex question: the evolution from 2022-2024, the relationship to RRPs and SFPs, and what this reveals about regulatory constraints on differentiation and communication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 629,
        "total_tokens": 2240
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "Across 2022‑2024 PayPal repeatedly describes itself as the **principal** in every payment, so it “bears full margin risk when completing a payment transaction” and records the fees it pays to payment processors as a **transaction expense** (2022 Note 2‑Revenue p. 80; 2023 Note 2‑Revenue p. 75; 2024 Note 2‑Revenue p. 76).  In each year the company’s pricing model still consists of a fixed‑plus‑variable fee that is **tiered/volume‑based** (fees can be adjusted up or down based on processed volume) and it continues to **reduce transaction revenue by customer incentives** (discounts, rebates, rewards) that are recorded as revenue reductions (same pages).  Consequently, PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024 – it continues to carry the full margin risk despite the same pricing structure, processor‑cost pass‑through, and incentive‑related revenue offsets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024. STRENGTHS: (1) Correctly identifies PayPal as 'principal' in transactions and confirms full margin risk exposure across all three years; (2) Accurately cites specific page numbers from Note 2-Revenue sections (2022 p.80, 2023 p.75, 2024 p.76) showing proper document sourcing; (3) Correctly describes transaction expenses for processor fees and revenue reduction treatment of customer incentives; (4) Accurately characterizes pricing model as fixed-plus-variable, tiered/volume-based structure; (5) Sound multi-hop reasoning synthesizing pricing models, processor relationships, and incentive structures across three years. MINOR WEAKNESSES: (1) The LLM answer emphasizes that margin risk 'remained essentially unchanged' which is slightly more definitive than the ground truth's 'stable strategic approach with increasing detail around incentives' - the ground truth suggests evolution in disclosure detail even if the underlying risk exposure remained constant; (2) The LLM answer could have been slightly more explicit about the 'increasing detail' and 'more nuanced disclosure' aspect mentioned in ground truth, though it does reference the same underlying mechanisms; (3) The phrase 'processor-cost pass-through' in the LLM answer is slightly imprecise - PayPal doesn't pass through costs but rather bears the margin risk independently of what it charges customers. QUANTITATIVE VERIFICATION: All page numbers and year references are accurate. No calculations required. SEMANTIC EQUIVALENCE: The LLM answer conveys the core factual content correctly - PayPal bears full margin risk, records processor fees as transaction expenses, uses tiered pricing, and reduces revenue for incentives. The conclusion about stability is reasonable though slightly different in emphasis from ground truth's focus on 'increasing detail' in disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 529,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings AMD’s AIB strategy was essentially unchanged. In each filing AMD says its agreements with add‑in‑board (AIB) manufacturers “protect their inventory of our products against price reductions” and that it also sells directly to some system‑integrator (SI) customers, while noting that “SIs often use discrete graphics solutions as a means to differentiate their products and add value to their customers” (2022 p. 11; 2023 p. 13; 2024 p. 13). Thus the inventory‑protection policy and the emphasis on discrete‑graphics‑driven differentiation for SIs remained consistent from 2022 through 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core inventory protection policy and discrete graphics differentiation messaging that remained consistent across 2022-2024. The page citations (2022 p. 11; 2023 p. 13; 2024 p. 13) appear reasonable and the quoted language about inventory protection and discrete graphics differentiation is accurate. However, the answer significantly misses a critical evolution that the ground truth emphasizes: the 2024 shift in strategic emphasis and language. The ground truth explicitly states that by 2024, AMD 'placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies' and that there was 'a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition.' The LLM answer dismisses this as 'essentially unchanged' and 'remained consistent,' which directly contradicts the ground truth's characterization of a meaningful evolution in strategy and emphasis. The LLM correctly captures the static elements (inventory protection, discrete graphics importance) but fails to recognize and articulate the dynamic shift in strategic positioning and language that occurred in 2024. This represents a failure in multi-hop reasoning to synthesize the temporal evolution across the three-year period. The answer is partially correct on the baseline facts but incomplete in addressing the nuanced strategic evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 428,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s investment‑credit policy has been consistent: it only transacts with counterparties that have a credit rating of A‑ or better and requires collateral if a rating falls below A‑ or if aggregate exposures exceed limits set in the contracts, and it caps any single institution’s exposure at roughly 10 % of total cash and cash equivalents (see Note 17, p. 119 of the 2024 filing). In fiscal 2023 the company reported that no institution exceeded the 10 % cap (p. 120), but by fiscal 2024 it disclosed that 24 % of cash and cash equivalents were with institutions that individually exceeded the 10 % threshold (p. 119), indicating a higher concentration while the rating‑and‑collateral criteria remained unchanged since fiscal 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported with specific filing references. Strengths: (1) All key numeric values are accurate - the A- credit rating threshold, the 24% concentration figure for fiscal 2024, the 10% cap threshold, and the fiscal 2023 statement that no institution exceeded the cap are all correct. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution from fiscal 2022 (no concentration) through fiscal 2023 (compliance with 10% cap) to fiscal 2024 (24% concentration), demonstrating the shift in liquidity strategy. (3) Entity identification is precise - correctly identifies Disney, the specific policy criteria (counterparty ratings, collateral requirements, concentration limits), and the fiscal years. (4) The answer provides specific page references (Note 17, p. 119 and p. 120) that enhance credibility. (5) The reasoning about the policy remaining unchanged while concentration increased is logically sound. Minor considerations: (1) The LLM answer adds detail about the '10% cap' that, while accurate and helpful, goes slightly beyond what the ground truth explicitly states, though this represents appropriate elaboration rather than error. (2) The ground truth mentions 'no such concentration in fiscal 2022' while the LLM answer implies this through the fiscal 2023 reference, which is semantically equivalent. (3) Both answers correctly convey that the rating and collateral criteria remained consistent while concentration exposure increased significantly. The answer demonstrates strong multi-hop reasoning by synthesizing information across three fiscal years and multiple policy dimensions (ratings, collateral, concentration).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 464,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s outstanding principal on the 10 Oct 2029 Fixed‑rate 2.850 % notes was $1.5 billion in 2022, stayed at $1.5 billion in 2023, and remained $1.5 billion in 2024【page_107】【page_104】. Holding the same $1.5 billion tranche across three years shows the company is deliberately keeping this low‑cost, long‑dated debt on its balance sheet, locking in a stable interest rate and smoothing its maturity profile rather than aggressively refinancing or retiring the issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metric: PayPal's 2029-maturing Fixed-rate 2.850% notes remained at $1.5 billion across all three years (2022, 2023, 2024). The quantitative data is accurate and properly formatted ($1.5 billion is equivalent to $1,500 million in the ground truth). The multi-hop synthesis is sound—the answer correctly identifies the consistent principal amount across the three-year period and appropriately contextualizes this within PayPal's broader debt management strategy. The reasoning about deliberate retention of low-cost, long-dated debt and interest rate locking is logically sound and aligns with the ground truth's interpretation. One minor limitation: the LLM answer does not explicitly mention the contrast with newer, higher-interest debt issued in 2023-2024 (5.150% and 5.500% notes), which the ground truth specifically highlights as evidence of strategic selectivity in debt management. This omission represents a slight incompleteness in addressing the full context of the company's debt strategy, though the core answer about the 2029 notes themselves is accurate. The answer appropriately addresses the multi-year pattern and provides reasonable strategic interpretation. The citation references (page_107, page_104) suggest proper sourcing from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 380,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "In the 2022 and 2023 10‑K filings Honeywell singled out “raw material demand and supply” as a distinct risk for its Performance Materials and Technologies segment (2022 RISK FACTORS, p. 32; 2023 RISK FACTORS, p. 31). By the 2024 filing—after the segment was re‑named Energy and Sustainability Solutions—the language shifted to broader operational‑risk wording and the company noted that a majority of the raw‑material supply base is now under contract, though price fluctuations remain a concern (2024 RISK FACTORS, p. 31; operational risks, p. 33). This evolution suggests Honeywell is trying to mitigate exposure through contracts, but it still remains vulnerable to commodity‑market volatility that could affect costs and margins.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and introduces information not supported by the ground truth. CORRECT ELEMENTS: (1) The identification of 2022 and 2023 as years when raw material demand and supply were highlighted as distinct risks for the Performance Materials and Technologies segment is accurate. (2) The recognition that the segment was rebranded to Energy and Sustainability Solutions by 2024 is correct. (3) The general conclusion that Honeywell remains vulnerable to commodity market volatility is sound. (4) Page references (p. 31-33) appear reasonable for 10-K filings. SIGNIFICANT GAPS AND ERRORS: (1) The LLM answer introduces a new claim about 'a majority of the raw-material supply base is now under contract' which is NOT mentioned in the ground truth. This is a factual addition that cannot be verified against the original answer and represents potential fabrication or hallucination. (2) The ground truth explicitly mentions 2022 risks including 'product commoditization and illegal imports of hydrofluorocarbons into Europe' - the LLM answer omits these specific risk factors entirely. (3) The ground truth emphasizes the 2023 focus on 'volatility in oil and natural gas prices on customer investment and product demand' - the LLM answer does not capture this specific evolution. (4) The ground truth notes the 2024 framing linked 'more explicitly to the company's ability to maximize production capacity and minimize downtime' - the LLM answer does not capture this specific contextual shift. (5) The LLM answer's characterization of 2024 language as 'broader operational-risk wording' is vague and doesn't match the ground truth's more specific description of the reframing. MULTI-HOP REASONING: The LLM answer attempts to synthesize across three years but does so incompletely, missing key evolutions in how the risks were framed. The reasoning about mitigation through contracts is introduced without ground truth support. SEMANTIC EQUIVALENCE: While the overall conclusion about vulnerability to commodity volatility is semantically equivalent to the ground truth, the path to that conclusion is incomplete and partially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 587,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC appears in PMI’s peer‑group list in all three filings – it is listed among the peers in the 2022 filing (see page 21), again in the 2023 filing (see page 26), and once more in the 2024 filing (see page 26). The unchanged inclusion of Imperial Brands over 2022‑2024 shows that PMI maintains a stable, consistent set of global tobacco and consumer‑product companies for benchmarking, emphasizing a deliberate strategy to compare its performance against a fixed group of peers with similar scale and market presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Imperial Brands PLC as consistently included in PM's peer group across all three years (2022, 2023, 2024), matching the ground truth assertion of stable inclusion. (2) Accurately cites specific page references (page 21 for 2022, page 26 for 2023 and 2024), providing verifiable sourcing. (3) Correctly interprets the strategic implication: that unchanged inclusion reflects a stable, deliberate benchmarking strategy focused on comparable global tobacco and consumer product companies. (4) Uses appropriate terminology ('PMI' as alternative reference to 'PM', which is semantically equivalent). (5) Multi-hop reasoning is sound - synthesizes information across three years to draw a conclusion about strategic consistency. MINOR CONSIDERATIONS: (1) The LLM uses 'PMI' while the question uses 'PM' - these are equivalent references to Philip Morris International, so this is not an error but a minor stylistic variation. (2) The answer provides slightly more specific detail (page numbers) than the ground truth, which adds value without contradicting the original answer. (3) Both answers convey identical core findings: Imperial Brands remained consistently in the peer group, indicating stable benchmarking strategy. The LLM answer is marginally more detailed and evidence-based while maintaining complete factual accuracy with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 408,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on its fixed‑rate 2.850 % notes was $1.5 billion in 2022, remained $1.5 billion in 2023, and stayed at $1.5 billion in 2024 【page_107】 【page_104】. The unchanged exposure to this long‑dated, low‑cost tranche shows that PayPal is deliberately keeping a stable fixed‑rate component in its capital structure, locking in favorable rates and preserving predictability rather than expanding or reducing that specific series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. (1) CORRECTNESS: All quantitative facts are accurate - the $1.5 billion principal balance is correctly stated for all three years (2022, 2023, 2024), and the fixed rate of 2.850% is correctly identified. The answer correctly conveys that there were no changes to the exposure across the three-year period. (2) QUANTITATIVE ACCURACY: All numbers are precise and correctly formatted. The dollar amounts ($1.5 billion) match the ground truth exactly, and the percentage (2.850%) is accurate. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM provides sound reasoning about PYPL's debt management strategy, correctly identifying that the stable balance indicates deliberate maintenance of a fixed-rate component rather than repayment or refinancing. The interpretation aligns with the ground truth's assessment that this reflects strategic capital structure management. The answer appropriately notes the company is 'locking in favorable rates and preserving predictability.' (4) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and connects the factual progression to strategic implications about debt management. (5) MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions 'possibly prioritizing other debt maturities' as an additional contextual point, which the LLM answer doesn't explicitly state, but this is a minor omission that doesn't affect the core correctness. The LLM's framing of 'deliberately keeping a stable fixed-rate component' and 'locking in favorable rates' conveys equivalent strategic insight. Overall, the answer is factually sound, well-reasoned, and appropriately addresses the multi-part question about both the evolution of exposure and what it indicates about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 531,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "In the 2022 10‑K ConocoPhillips said that corporate HSE audits were performed on business‑unit and staff‑group level to verify conformance with its HSE policies, standards and practices, and that any improvement actions “were tracked to completion” (2022 page 18). By the 2024 filing the audit program had been broadened to a formal, enterprise‑wide scope, with systematic conformance tracking and a new requirement that audit progress be reported to the Executive Leadership Team and the Board of Directors (2024 page 18), showing a shift from a compliance‑only focus to one that is fully integrated into corporate governance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of ConocoPhillips' HSE audit approach from 2022 to 2024 with generally accurate information. STRENGTHS: (1) Correctly identifies the 2022 baseline of business-unit and staff-group level audits with tracking to completion; (2) Accurately notes the shift toward enterprise-wide scope and governance integration by 2024; (3) Properly identifies reporting to Executive Leadership Team and Board of Directors; (4) Correctly cites page 18 for both 2022 and 2024 filings; (5) Appropriately characterizes the evolution as moving from compliance-only to governance-integrated. WEAKNESSES: (1) The LLM answer states audits were 'broadened to a formal, enterprise-wide scope' by 2024, but the ground truth indicates they were 'conducted at the corporate level' - these are subtly different concepts. The ground truth emphasizes 'centralized oversight' while the LLM emphasizes 'enterprise-wide' which could imply broader distribution rather than centralization; (2) Missing the explicit 2023 intermediate step where audit outcomes were linked to annual objectives, targets, and deadlines - the LLM jumps from 2022 to 2024 without acknowledging this important 2023 development; (3) The characterization of 'compliance-only focus' in 2022 is not explicitly supported by the ground truth, which describes 2022 as already having 'conformance checks' and 'improvement actions' - this is a minor interpretive overreach. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects audit scope changes to governance integration, though it misses the 2023 intermediate evolution. The reasoning linking audit evolution to strategic performance tracking is sound but not fully developed. NUMERIC/DATE ACCURACY: Years (2022, 2024) and page references (page 18) are correct. No calculations required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 504,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across all three years AMD kept the 2011 Executive Incentive Plan on the exhibit list, incorporating it by reference as Exhibit 10.1 (2022 *10.1 on p. 93, 2023 *10.1 on p. 101, 2024 *10.1 on p. 98). Even as each filing added the current year’s proxy‑statement executive‑compensation disclosures (2022 Item 11 on p. 91, 2023 Item 11 on p. 99, 2024 Item 11 on p. 96), the 2011 plan remained cited, showing that AMD continues to treat it as a foundational governance document while expanding its broader compensation disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's reliance on the 2011 Executive Incentive Plan across 2022-2024. STRENGTHS: (1) Correctly identifies the 2011 plan as Exhibit 10.1 across all three years, matching the ground truth; (2) Provides specific page references (2022 p. 93, 2023 p. 101, 2024 p. 98) that add granular detail beyond the ground truth; (3) Accurately synthesizes the multi-hop information showing consistency across years; (4) Correctly identifies the relationship between the foundational 2011 plan and newer proxy statement disclosures (Item 11); (5) Properly characterizes the plan's role as foundational despite broader compensation framework evolution. MINOR CONSIDERATIONS: (1) The LLM answer includes page numbers not present in the ground truth - while these appear plausible and add specificity, they cannot be verified against the provided ground truth and represent additional claims; (2) The ground truth emphasizes 'no material changes or replacements' more explicitly, while the LLM focuses on the plan's continued presence and foundational role; (3) The LLM's mention of 'expanding its broader compensation disclosures' is a reasonable inference but goes slightly beyond the ground truth's scope. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) correctly identified; Exhibit designation (10.1) consistently correct across all three years; page numbers provided are specific but unverifiable. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the relationship between the foundational 2011 plan and evolving compensation mechanisms. The logic that the plan's consistent citation indicates it remains foundational is sound and matches the ground truth's conclusion. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - AMD's consistent reliance on the 2011 plan as a foundational document across all three years with no material changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 549,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- 2022 10‑K – GM said its wholly‑owned seller would indemnify Stellantis for any inaccuracy of the sale representations and for “certain emissions and product liabilities,” but it could not estimate any loss and gave no detail on recall‑related payments (2022 p. 90).  \n- 2023 10‑K – the disclosure was broadened to note that GM had already paid an **immaterial** amount to cover specific recalls, including Takata‑inflator recalls on legacy Opel vehicles, and that any further indemnification was deemed remote (2023 p. 92).  \n- 2024 10‑K – the same language persists: only an immaterial recall indemnity is recorded and GM still cannot estimate a material loss, reaffirming that further exposure is considered remote (2024 p. 93).  \n\n**Interpretation:** Over the three years GM’s indemnification obligation shifted from a vague, unquantified emissions‑liability exposure to a concrete, but immaterial, recall payment (Takata) and a statement that any additional post‑sale liability is unlikely, indicating that GM’s exposure to legacy Opel/Vauxhall liabilities remains limited and not material.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant omissions and misrepresentations compared to the ground truth. CORRECT ELEMENTS: (1) The identification of immaterial Takata-inflator recall payments in 2023 is accurate; (2) The general progression from unquantified to immaterial amounts is directionally correct; (3) The statement that further indemnification was deemed remote is accurate. CRITICAL OMISSIONS AND ERRORS: (1) The LLM completely fails to mention the geographic expansion of legal exposure (Germany, UK, Netherlands in 2023, and Austria added in 2024), which is a key part of the ground truth narrative about 'widening legal exposure'; (2) The LLM omits the European Commission and UK CMA regulatory investigation related to end-of-life vehicle practices at Opel mentioned in 2024, which represents a material escalation in regulatory scope; (3) The LLM mischaracterizes the progression as showing 'limited and not material' exposure, when the ground truth indicates 'growing complexity and persistence' with expanding jurisdictions and new regulatory actions; (4) The LLM's interpretation that exposure 'remains limited' contradicts the ground truth's conclusion that the 'increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities.' REASONING ISSUES: The LLM's multi-hop synthesis is incomplete—it focuses narrowly on the financial accrual amounts (immaterial) while missing the substantive expansion of legal and regulatory scope across years and jurisdictions. The question specifically asks what the progression 'indicates about GM's exposure,' and the ground truth indicates growing exposure complexity, while the LLM indicates stable/limited exposure. This is a fundamental misinterpretation of the trend. The LLM provides page citations (p. 90, 92, 93) which adds credibility but doesn't compensate for the missing jurisdictional and regulatory details that are central to answering the question about how obligations 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 547,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 bamlanivimab generated roughly $2 billion of net product revenue (U.S. $2,008.9 m + $14.7 m outside) and triggered tiered royalties to AbCellera of mid‑teens to mid‑twenties percent of sales, creating a material cost of sales (page 68; royalty rates page 72). By 2023 and 2024 the revenue line shows $0 for the antibody, eliminating any royalty payments, which shows that Lilly’s financial exposure – and thus the strategic weight – of bamlanivimab was largely confined to the pandemic surge and has now essentially disappeared, indicating limited long‑term importance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) Correctly identifies 2022 U.S. revenue of $2,008.9 million for COVID-19 antibodies/bamlanivimab; (2) Accurately notes the $14.7 million international component, totaling approximately $2 billion; (3) Correctly states tiered royalty rates to AbCellera in mid-teens to mid-twenties percent range; (4) Accurately reports zero revenue in 2023 and 2024; (5) Properly synthesizes the multi-hop reasoning showing the decline in financial exposure and elimination of royalty obligations. Minor weaknesses: (1) The LLM answer includes a parenthetical reference to 'page 68' and 'page 72' which adds specificity but cannot be verified against the ground truth provided; (2) The ground truth mentions the product was 'no longer mentioned in revenue tables' in 2024, while the LLM simply states '$0' revenue - both convey the same information but the ground truth provides slightly more context about complete portfolio exit; (3) The LLM answer could have been more explicit about the strategic shift to 'cardiometabolic health' mentioned in the ground truth, though this is a minor omission. The core multi-hop synthesis is sound: tracking the product from significant pandemic-era contributor ($2B+ revenue with material royalty obligations) through complete phase-out (zero revenue, no royalties) to demonstrate loss of strategic importance. The reasoning correctly connects financial metrics to strategic conclusions. Overall, the answer is substantially correct with accurate numbers, proper entity identification, and sound multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 464,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, PMI repeatedly lists Jackpot as one of its “important local cigarette brands” in the Philippines (2022 p.5; 2023 p.6; 2024 p.5), showing no change in how the brand is positioned. This three‑year consistency signals that, even as PMI expands its smoke‑free portfolio and reshapes its global footprint, it continues to rely on local brands like Jackpot to anchor its presence in key markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Jackpot was consistently listed as an important local cigarette brand in the Philippines across 2022-2024, matching the ground truth's main conclusion. The answer accurately cites page numbers from the 10-K filings (2022 p.5; 2023 p.6; 2024 p.5) and correctly characterizes the positioning as showing 'no change' across the three-year period. The synthesis of the multi-hop information (tracking a single brand across three years) is sound and logically presented. However, the LLM answer is notably more concise and omits several contextual details present in the ground truth: (1) it doesn't mention Fortune as a companion local brand in the Philippines, (2) it doesn't explicitly note PMI's 'dual strategy' of maintaining local brands while transitioning to smoke-free products, and (3) it doesn't emphasize the role of local brands in 'complementing international brands' or their function in 'sustaining market share.' The ground truth provides richer context about the strategic rationale behind maintaining Jackpot. The LLM's statement that PMI 'continues to rely on local brands like Jackpot to anchor its presence' is semantically equivalent to the ground truth's characterization of their importance, though less detailed. The answer demonstrates correct multi-hop reasoning by synthesizing information across three separate 10-K filings and drawing a valid conclusion about strategic consistency. No factual errors are present, but the answer lacks the depth and contextual richness of the ground truth response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 434,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In the 2022 filing PayPal warned that its credit and BNPL offerings left it highly exposed to “bad transactions” – credit‑product defaults, sizable fraud‑related losses and heavy reliance on third‑party processors (2022 pp. 24‑28). In 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, a step meant to off‑load much of that BNPL‑related risk, but it stressed that the sale was contingent and that fraud and third‑party processing disruptions remained material concerns (2023 pp. 23‑27). By the 2024 filing the sale had begun (receivables started being sold in October 2023), reducing BNPL exposure, yet PayPal still highlighted ongoing credit‑default risk, fraud losses and the same third‑party processing vulnerabilities (2024 pp. 21‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE ACCURACY: All key numbers are correct - the €40 billion BNPL receivables sale amount is accurate, the June 2023 timing of the agreement is correct, and the October 2023 start of actual sales is accurate. No calculation errors detected. ENTITY ACCURACY: PayPal correctly identified, years 2022-2024 properly sequenced, BNPL and credit products correctly named, U.K. and European markets properly specified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk dimensions: (1) 2022 baseline risks (fraud, synthetic identities, third-party dependencies), (2) 2023 risk mitigation strategy (€40B sale agreement), and (3) 2024 ongoing exposure despite partial offloading. The logical progression showing evolution from growing exposure → partial risk transfer → residual risk is sound. COMPLETENESS: The answer addresses all major components of the question: bad transaction exposure evolution, the specific €40B sale, fraud risks, and third-party processing disruptions. The mention of contingency conditions on the sale and the October 2023 execution date adds appropriate nuance. SEMANTIC EQUIVALENCE: The LLM's phrasing (\"off‑load much of that BNPL‑related risk\") aligns with the ground truth's \"partially offloading that risk.\" The characterization of risks as \"material concerns\" and \"ongoing\" matches the ground truth's assessment of persistent threats. MINOR CONSIDERATIONS: The LLM provides specific page references (2022 pp. 24-28, etc.) which adds credibility but cannot be verified against the ground truth. The answer is slightly more concise than the ground truth but captures all essential information without loss of accuracy. The framing of the sale as \"contingent\" appropriately reflects execution risks mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 518,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "Honeywell warned in its 2022 filing that fluctuations in retail markets could hurt the Safety and Productivity Solutions segment by lowering market share, selling prices and margins (Risk Factors, p. 30). The same exposure is carried forward to the 2024 filing for the newly created Industrial Automation segment and was highlighted in the 2023 filing as a key element of the company’s overall macro‑economic risk posture (Risk Factors, p. 30; overall risk posture, p. 32), showing that retail‑demand volatility remains a material sensitivity across Honeywell’s industrial portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) 2022 Safety and Productivity Solutions segment identified retail market fluctuations as a risk factor, (2) 2023 reiterated this risk as part of macroeconomic concerns, (3) 2024 tied the risk to the Industrial Automation segment. The answer accurately captures the three-year progression and the company's persistent sensitivity to retail demand volatility. However, there are some notable differences from the ground truth: (1) The LLM answer mentions 'lowering market share, selling prices and margins' as specific impacts, while the ground truth states these could result from reduced investments in safety monitoring and process automation leading to reduced demand. The LLM's framing is slightly different but not necessarily incorrect—it describes consequences rather than mechanisms. (2) The LLM answer cites specific page numbers (p. 30, p. 32) which adds credibility but cannot be verified against the ground truth provided. (3) The LLM answer is more concise and direct, while the ground truth provides more detailed explanation of the causal chain (fluctuations → reduced investments → reduced demand). (4) Both answers correctly identify the multi-hop synthesis across three years and two/three business segments. The core narrative about persistent sensitivity to retail volatility is present in both. Minor weakness: The LLM answer could have been more explicit about the mechanism (reduced customer investment behavior) that the ground truth emphasizes, and could have elaborated slightly more on what the evolution suggests about the company's sensitivity profile. Overall, the answer is substantially correct with minor omissions in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 469,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "In 2022 the worldwide license with Incyte gave Eli Lilly tiered double‑digit royalties (up to ~20 %) on Olumiant sales and an extra low‑teen royalty on COVID‑19 sales, and required LLY to record development, success‑based regulatory and sales‑based milestone payments as intangible assets that are amortized (net milestones were not material)【page_71】. By 2024 the royalty structure remained the same, milestone payments were still capitalized and amortized (the 2023 filing disclosed up to $100 million of additional sales‑based milestones)【page_72】, and Olumiant’s contribution to LLY’s top line grew from $830.5 million in 2022 to $957.4 million in 2024, showing a stronger strategic focus on the product【page_73】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the tiered royalty structure (up to ~20% on general sales, low-teen royalty on COVID-19 sales), accurately notes that milestone payments were capitalized and amortized, and provides correct revenue figures for Olumiant ($830.5M in 2022 and $957.4M in 2024). The answer appropriately synthesizes the evolution from 2022 to 2024 and captures the strategic shift toward revenue recognition and product expansion. CRITICAL ERRORS: (1) The LLM states 'up to $100 million of additional sales-based milestones' in 2023, but the ground truth specifies Incyte was eligible for 'up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones)' - this is a significant understatement of the milestone obligations. (2) The LLM mentions 'net milestones were not material' but provides no context about the $260.0 million in capitalized milestone payments from 2022, which is a material omission of key financial data. (3) The answer lacks discussion of the specific regulatory approval milestones (U.S., Europe, Japan) and the strategic positioning of Olumiant under EUA and follow-on compounds mentioned in the ground truth. QUANTITATIVE ISSUES: The $100M vs $200M milestone discrepancy is a 50% error on a key financial metric. The revenue figures appear correct but lack the context of how they demonstrate the evolution of the partnership's financial structure. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 and connects financial obligations to strategic focus, but incompletely captures the full scope of milestone obligations and their evolution. The reasoning about maturity and expansion is sound but underdeveloped compared to the ground truth's more comprehensive analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 490,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Al Rita’s relationship with UST has remained unchanged – UST LLC (through its wholly‑owned subsidiary USSTC) has been a 100 % owned subsidiary in every filing from 2022 through 2024 (see the subsidiary list in 2023 Note 1 – page 60 and the 2024 Business description – page 4).  The MST and snus trademarks acquired in the 2009 UST purchase were recorded as $8.8 billion of indefinite‑life intangible assets (plus roughly $5 billion of goodwill) in 2022 (Note 4 – page 66) and, because the 2023 and 2024 filings report no goodwill or indefinite‑life intangible‑asset impairments, those values have been carried forward unchanged.  UST’s oral‑tobacco products are classified in Al Rita’s oral‑tobacco segment and are explicitly referenced as a key component of the company’s “smoke‑free future” vision and its “Moving Beyond Smoking” strategy (2024 Business description – page 4; oral‑tobacco segment description – page 5).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and structural relationships. Strengths: (1) Correctly identifies $8.8 billion in indefinite-lived intangible assets for MST and snus trademarks from 2009 UST acquisition; (2) Accurately states UST remains 100% wholly-owned subsidiary through USSTC across 2022-2024; (3) Correctly notes no impairments reported in 2023-2024 filings, meaning values carried forward unchanged; (4) Properly cites goodwill (~$5 billion) alongside intangible assets; (5) Accurately references oral-tobacco segment classification and 'Moving Beyond Smoking' strategy. Minor weaknesses: (1) The answer focuses heavily on structural continuity ('relationship has remained unchanged') but somewhat underemphasizes the strategic evolution aspect of the original question - the ground truth explicitly notes 'strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer...alternatives' (Helix oral nicotine pouches, NJOY e-vapor); (2) While the LLM mentions UST is 'explicitly referenced as a key component' of smoke-free strategy, it doesn't fully capture the nuance that this represents a shift from UST being the primary focus to being one component among diversifying alternatives; (3) The answer doesn't explicitly address how the portfolio strategy 'shifted toward oral nicotine pouches via Helix and e-vapor via NJOY' as the ground truth does. Quantitative accuracy is excellent - all dollar amounts ($8.8B, ~$5B), ownership percentages (100%), and years (2022-2024) are correct. The multi-hop reasoning correctly synthesizes information across multiple years and filing sections. The semantic meaning aligns well with ground truth, though the answer emphasizes continuity over strategic evolution more than the original answer does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 508,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note showed a rising effective cost: about 3.2 % in FY 2022, roughly 6.4 % in FY 2023, and about 6.7 % in FY 2024【page_89】. The more‑than‑doubling of the effective rate indicates that borrowing costs on this fixed‑rate debt climbed sharply as market rates and issuance discounts widened, reflecting tighter capital‑market conditions and higher prevailing interest rates over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key percentages are correct - FY2022: 3.2% (matches ground truth 3.20%), FY2023: 6.4% (matches 6.38%, acceptable rounding), FY2024: 6.7% (matches 6.66%, acceptable rounding). The characterization of 'more-than-doubling' is mathematically sound (3.2% to 6.66% represents approximately 108% increase). ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Senior Note, and all three fiscal years (2022-2024). MULTI-HOP REASONING: Successfully synthesizes the trend across three years and correctly interprets what the rising effective rates indicate about capital market conditions and borrowing costs. COMPLETENESS: Addresses both parts of the question - the evolution of interest rate exposure AND what it indicates about borrowing costs and capital market conditions. SEMANTIC EQUIVALENCE: The explanation that 'borrowing costs on this fixed-rate debt climbed sharply as market rates and issuance discounts widened' is semantically equivalent to the ground truth's reference to 'tightening capital market conditions and potentially higher perceived risk or changing interest rate environments.' Minor note: The LLM uses slightly rounded percentages (6.4% vs 6.38%, 6.7% vs 6.66%), which is acceptable and standard practice in financial reporting. The inclusion of a page reference adds credibility. No material errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 399,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 senior‑note balance fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023 and further to $13 billion at 12/31/2024【page_58】【page_57】. This steady decline shows the company is actively retiring a portion of its 2017 issuance, reflecting a disciplined debt‑reduction strategy that uses cash generation (and possibly refinancing) to lower long‑term leverage while preserving financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - the 2017 Notes balances are correctly stated as $16.0B (2022), $15.0B (2023), and $13.0B (2024). (2) The LLM correctly identifies the trajectory of decline and characterizes it as a 'steady decline' and 'active retiring' of debt. (3) The reasoning about debt management strategy is sound and logically connects the specific note reduction to broader financial discipline. (4) Multi-hop synthesis is present - the answer connects the specific 2017 Notes behavior to the company's overall debt reduction strategy. (5) Number formatting is consistent and clear.\n\nWEAKNESSES: (1) The LLM answer omits the broader context provided in the ground truth about Amazon's total long-term debt reduction from $67.2B (2022) to $52.6B (2024). While the question asks about the 2017 Notes specifically, the ground truth answer includes this contextual information to demonstrate how the 2017 Notes reduction fits into the overall debt management picture. The LLM mentions 'broader trend' but doesn't quantify it. (2) The LLM speculates about 'possibly refinancing' as a mechanism, which is reasonable inference but goes slightly beyond what the ground truth explicitly states. (3) The answer could have been more comprehensive by including the specific total debt figures to fully address the 'broader trend' aspect of the question.\n\nCALCULATION VERIFICATION: The year-over-year reductions are: 2022-2023: $1.0B reduction; 2023-2024: $2.0B reduction. These are implicit in the stated balances and the LLM correctly characterizes this as a 'steady decline.' The total reduction from 2022-2024 is $3.0B (16.0 - 13.0), representing an 18.75% reduction in this specific issuance.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the specific 2017 Notes with broader debt management strategy, though it could have been more explicit with the total debt figures. The connection between the specific note reduction and overall financial strategy is appropriately made.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 546,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 have shown virtually no change over the three‑year period.  In the 2022 Form 10‑K the note was reported with an outstanding principal of **$606 million** and an effective interest rate of **5.18 %**【page_101】.  The same figures appear in the 2023‑2024 filing – the 2024 10‑K lists $606 million outstanding at a 5.18 % effective rate for both the 2024 and 2023 columns【page_81】.  \n\nThe unchanged balance and rate indicate that Broadcom has deliberately kept this fixed‑rate, long‑dated debt on its balance sheet, neither repaying nor refinancing it, which reflects a disciplined strategy of preserving low‑cost, stable financing capacity over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - $606 million principal balance for all three years (2022, 2023, 2024) and 5.18% effective interest rate consistently reported. The answer correctly identifies that these figures remained unchanged across the three-year period. ENTITY ACCURACY: Correctly identifies AVGO/Broadcom (note: the answer uses both names, which is acceptable as Broadcom is AVGO's full name), the specific debt instrument (5.000% senior notes due April 2030), and all relevant fiscal years. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the pattern of consistency. The citation references (page_101 for 2022, page_81 for 2024) add credibility. REASONING QUALITY: The interpretation that the unchanged balance and rate indicate a 'disciplined strategy of preserving low-cost, stable financing capacity' is a reasonable inference from the static data, though slightly more interpretive than the ground truth's more neutral 'static approach.' Both characterizations are semantically equivalent and appropriate. MINOR CONSIDERATIONS: The ground truth uses 'AVGO' terminology while the LLM answer uses 'Broadcom' - both are correct as they refer to the same company. The LLM answer is slightly more detailed in explaining the strategic implications (mentioning 'neither repaying nor refinancing') which adds value without introducing errors. The answer fully addresses all parts of the multi-part question regarding principal balance evolution, interest rate consistency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 464,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "In the 2022 filing the company only referenced a legacy “Performance Bonus Plan” as Exhibit 10.6† under a Def 14A proxy filing dated April 28 2014 【page_66】.  By the 2023 10‑K the plan had been formally revised and restated – it appears as “Amended and Restated Performance Bonus Plan” (Exhibit 10.5†, an 8‑K filed December 9 2022) 【page_68】.  The 2024 10‑K continues to list the same amended‑and‑restated plan (Exhibit 10.5†) and places it alongside other executive‑compensation documents such as the Executive Severance and Retention Incentive Plan and the Executive Officer Severance Plan, showing that the bonus plan is now fully integrated into Netflix’s broader executive compensation framework 【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the foundational 2022 reference to the Performance Bonus Plan with accurate exhibit citation (Exhibit 10.6†, Def 14A proxy dated April 28, 2014); (2) Accurately captures the 2023 formal restatement through the 'Amended and Restated Performance Bonus Plan' with correct filing details (Exhibit 10.5†, 8-K filed December 9, 2022); (3) Properly traces the 2024 continuation and integration of the amended plan alongside other executive compensation documents (Executive Severance and Retention Incentive Plan, Executive Officer Severance Plan); (4) Demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and showing the evolution from legacy plan to formalized/restated plan to integrated framework; (5) Provides specific exhibit numbers and filing dates that enhance credibility. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes exhibit numbers, specific filing dates, and page references), but this represents added value rather than inaccuracy. The semantic meaning aligns perfectly with the ground truth's narrative of evolution from foundational role → strategic update → integrated mature compensation strategy. All dates are correct (April 28, 2014 for original; December 9, 2022 for restatement; 2024 continuation). The answer fully addresses all three components of the multi-part question: formalization, restatement, and integration. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 451,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In the 2022 filing (the 2023 Form 10‑K), AIG said it “actively monitors terrorism risk and manages exposures…using a third‑party vendor model…adjusted for model gaps” and quantified a five‑ton bomb scenario at roughly **$1.3 billion net of TRIPRA and reinsurance recoveries**【page_121】; U.S. exposure was capped by the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and limited private reinsurance, while international risk was covered through **targeted reinsurance purchases and participation in government‑sponsored terrorism pools**【page_121】. By the 2024 filing, the same modeling approach and reliance on TRIPRA, targeted reinsurance and pool participation remain, but the company no longer discloses a specific loss figure and instead highlights broader **property‑per‑risk covers and continued use of government‑arranged terrorism reinsurance programs** for non‑U.S. jurisdictions【page_88】—showing a modest refinement rather than a fundamental shift in its international terrorism exposure management.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $1.3 billion five-ton bomb scenario figure for 2022 and accurately notes it is net of TRIPRA and reinsurance. (2) The LLM correctly identifies that AIG uses third-party vendor models and monitors terrorism exposure. (3) The LLM appropriately notes the shift from specific loss disclosure in 2022 to broader strategic descriptions in 2024. (4) The mention of TRIPRA, targeted reinsurance, and government-sponsored pools is accurate. (5) The overall characterization of 'modest refinement rather than fundamental shift' is reasonable.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the specific 2024 attachment points ($200 million for Japan, $125 million for rest of world) that are explicitly stated in the ground truth as key evolution metrics. This is a significant factual gap in addressing the 'reinsurance protections' component of the question. (2) CRITICAL OMISSION: The LLM does not mention the $20.1 billion in collateral held to support reinsurance recoverable assets, which is a concrete quantitative metric showing evolution in risk mitigation strategy. (3) The LLM mentions 'property-per-risk covers' but the ground truth specifies these are for 'non-critical and critical catastrophe events outside North America'—the LLM's description is less precise. (4) The LLM's characterization of 2023 activities is vague ('routine monitoring') compared to the ground truth's more specific mention of 'targeted reinsurance purchases for certain lines of business.' (5) The LLM does not adequately synthesize the three-year progression as a 'strategic deepening' but rather frames it as continuity with modest refinement.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across 2022, 2023, and 2024 filings but incompletely. It correctly identifies the modeling consistency but fails to capture the quantitative evolution in attachment points and collateral management that demonstrate strategic deepening.\n\nNUMERIC VERIFICATION: The $1.3 billion figure is correct. However, the absence of the $200M, $125M, and $20.1B figures represents incomplete quantitative coverage of the answer.\n\nJUSTIFICATION: While the LLM provides a coherent narrative with some correct facts, it omits multiple specific quantitative metrics that are central to answering how AIG's international terrorism exposure management 'evolved' from 2022 to 2024. The answer reads as partially correct but significantly incomplete in addressing the reinsurance protections and risk mitigation strategies components of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 688,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio grew substantially.  Total equity‑security holdings rose from $3.7 billion at year‑end 2022 to $4.9 billion in both 2023 and 2024, while equity‑method investments in health‑care operating businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then surged to $3.8 billion by the end of 2024, showing a shift toward larger direct health‑care stakes【page_50】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. SPECIFIC ERRORS: (1) Equity securities 2022: LLM states $3.7 billion vs. ground truth $3.5 billion - a $200 million discrepancy (5.7% error). (2) Equity method investments 2022: LLM states $1.5 billion vs. ground truth $1.3 billion - a $200 million error (15.4% error). The 2023 and 2024 figures for both metrics are correct ($4.9B equity securities both years; $1.4B and $3.8B for equity method investments respectively). MULTI-HOP REASONING: The LLM correctly synthesizes the evolution narrative across three years and identifies the strategic pivot toward deeper healthcare involvement, which is sound reasoning. However, the foundational numbers are wrong, which undermines the entire analysis. COMPLETENESS: The answer addresses all required elements (equity securities holdings and equity method investments across 2022-2024) and captures the strategic shift narrative. SEMANTIC EQUIVALENCE: The interpretation of the trend (growth then stabilization in equity securities, decline then surge in equity method investments) is semantically correct. The characterization of the shift toward 'larger direct health-care stakes' appropriately captures the strategic pivot. CRITICAL ISSUE: The 2022 baseline numbers are materially incorrect, which is particularly problematic for a multi-year trend analysis where accuracy compounds. The errors appear to be data retrieval mistakes rather than calculation errors, as the 2023-2024 figures are accurate. This suggests inconsistent data sourcing or verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 438,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 1.700 % Notes due 2025 are listed in the “Securities registered pursuant to Section 12(b)” of each filing – the 2022 Form 10‑K (page 1), the 2023 Form 10‑K (page 1) and the 2024 Form 10‑K (page 1) all show the same 1.700 % Notes due 2025 as an outstanding security【MO_10k_2022.pdf page_1】【MO_10k_2023.pdf page_1】【MO_10k_2024.pdf page_1】.  \n\nMaintaining this low‑coupon, long‑dated bond across three consecutive years indicates that Altria deliberately preserves a stable, inexpensive source of debt, locking in fixed‑rate financing through 2025 rather than repeatedly issuing or retiring the notes. This reflects a debt‑management strategy focused on long‑term cost certainty and reduced refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 1.700% 2025 Notes as present across all three years (2022, 2023, 2024) with accurate percentage and maturity date. (2) Numeric accuracy is strong - the coupon rate (1.700%) and year (2025) are correct throughout. (3) The LLM properly cites the source documents (Form 10-K filings for 2022, 2023, 2024) and correctly notes these appear on page 1 of each filing. (4) The debt management strategy interpretation is sound - the LLM correctly identifies that maintaining the same notes across three years indicates deliberate preservation of stable, low-cost financing. (5) The reasoning about 'locking in fixed-rate financing' and 'reduced refinancing risk' aligns with the ground truth's characterization of 'stable element' and 'mid-term capital strategy.' WEAKNESSES: (1) The LLM answer is less comprehensive than the ground truth - it does not mention the other debt instruments (1.000% 2023 Notes, 2.200% 2027 Notes, 3.125% 2031 Notes) that provide important context for understanding Altria's broader capital structure evolution. (2) The ground truth specifically notes that the 1.000% 2023 Notes matured and were no longer listed by 2023, which is a key detail about active debt management that the LLM omits. This omission weakens the multi-hop synthesis aspect. (3) While the LLM's characterization of the strategy is accurate, it misses the important detail about how Altria actively managed short-term debt obligations (the matured 2023 Notes) while retaining mid-term instruments. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression of the 1.700% 2025 Notes. However, it fails to complete the full multi-hop analysis by not comparing the evolution of the entire debt portfolio across the three years. The ground truth requires understanding not just what remained constant (the 2025 Notes) but also what changed (the matured 2023 Notes), which provides fuller insight into debt management strategy. SEMANTIC EQUIVALENCE: The LLM's interpretation of the strategy as focused on 'long-term cost certainty' and 'reduced refinancing risk' is semantically equivalent to the ground truth's 'stable element' and 'mid-term capital strategy.' The core insight about deliberate preservation of low-cost debt is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 623,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s treasury‑stock balance grew each year – it held about **$51.4 billion of Class A treasury stock at the end of 2022**, rose to **$60.4 billion by year‑end 2023**, and reached **$71.4 billion at the end of 2024**【page_73†L31-L38】【page_70†L31-L38】.  This steady, accelerating increase shows the company is using excess cash to repurchase shares, signaling confidence in its valuation and a capital‑allocation focus on returning cash to shareholders through buybacks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental misinterpretation of the treasury stock figures. The ground truth shows treasury stock values as negative numbers: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. These negative values represent accumulated treasury stock (a contra-equity account on the balance sheet). The LLM incorrectly converted these to positive values ($51.4B, $60.4B, $71.4B), which is factually wrong. The 2022 figure is particularly egregious - the LLM states $51.4 billion when the ground truth shows $(36,658) million or approximately $(36.7) billion. The 2023 and 2024 figures happen to align numerically with the ground truth ($60.4B ≈ $60,429M and $71.4B ≈ $71,431M), but the sign convention is incorrect throughout. REASONING QUALITY: The LLM's interpretation of the trend is qualitatively sound - it correctly identifies that the increasing magnitude of treasury stock repurchases reflects confidence in valuation and shareholder return focus. However, this correct reasoning is built on incorrect numerical foundations. MULTI-HOP SYNTHESIS: The answer does synthesize information across years (2022-2024) and correctly identifies the pattern of growth, but the fundamental misrepresentation of the data as positive values rather than negative (accumulated) values is a material error that undermines the entire answer. The semantic interpretation of capital allocation strategy is reasonable, but the quantitative foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 422,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return‑swap exposure swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and then to a $91 million gain in FY 2024, showing a clear turnaround to positive earnings impact (page 91).  At the same time the notional amount of these swaps expanded—from $651 million in FY 2022 (page 92) to $792 million in FY 2023 and $985 million in FY 2024 (page 91)—indicating a larger, but increasingly profitable, exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core financial evolution of Cisco's Total Return Swaps-Deferred Compensation: $92M loss in FY2022 → $58M gain in FY2023 → $91M gain in FY2024. The qualitative assessment of the 'turnaround to positive earnings impact' is accurate and well-reasoned. However, there are significant issues with the quantitative expansion data provided: The LLM states notional amounts of $651M (FY2022), $792M (FY2023), and $985M (FY2024), but these specific figures cannot be verified against the ground truth knowledge graph. The ground truth answer does not mention these notional amounts at all, and the LLM provides page references (pages 91-92) that cannot be cross-checked. This represents unverified quantitative claims that go beyond the ground truth. The core answer about the P&L evolution is correct and the reasoning about 'larger, but increasingly profitable, exposure' is logical, but the introduction of unverified notional amount figures introduces factual uncertainty. The answer demonstrates good multi-hop synthesis by connecting the P&L changes to the notional exposure expansion, but the lack of verification for the specific notional figures prevents a higher score. The semantic equivalence to the ground truth is maintained for the verified portion (the three-year P&L progression), but the additional quantitative claims create a factual accuracy concern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 389,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s reliance on external rights‑holders has grown more precarious over the three years. The 2022 filing already warned that studios or other rights‑holders could refuse or abruptly withdraw licenses and that competition for exclusive titles was intensifying (Risk Factors – “if studios, content providers…refuse to license…as content providers develop their own streaming services” – page 11); the 2023 filing stressed that rising competition for exclusive rights and higher programming costs now make short‑notice content loss a material risk (Risk Factors – page 11) and that securing exclusive rights is critical to stay competitive (Competition discussion – page 3); by 2024 the company highlighted expanding regulatory pressures—new cultural‑support laws, content‑quota rules, levies and ownership‑restriction requirements in many countries—that further constrain its ability to obtain and retain licensed content (Intellectual Property & Regulation sections – pages 4 and 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the intensification of Netflix's dependency on rights holders; (2) Accurately captures the key risk factors: content providers launching competing services (2022), rising competition for exclusive rights and higher costs (2023), and regulatory pressures including content quotas and investment obligations (2024); (3) Properly synthesizes multi-hop information across years and risk categories; (4) Correctly identifies specific regulatory constraints (cultural-support laws, content-quota rules, levies, ownership restrictions) mentioned in 2024 filings; (5) Uses appropriate semantic language ('precarious,' 'material risk,' 'constrain') that conveys the escalating nature of the challenge. MINOR WEAKNESSES: (1) The LLM answer includes specific page references (e.g., 'page 11,' 'page 3,' 'page 4,' 'page 10') that cannot be verified against the ground truth and may or may not be accurate—while these add specificity, they introduce unverifiable detail; (2) The answer could have been slightly more explicit about the 'cost-effectiveness' angle mentioned in the ground truth ('cost-effective content library'), though the reference to 'higher programming costs' captures this concept; (3) Minor stylistic differences in phrasing ('precarious' vs. 'intensified,' 'material risk' vs. 'growing risks') are semantically equivalent but represent slight variations in emphasis. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal progression (2022→2023→2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk categories (competition, licensing, regulation), demonstrating sound multi-hop reasoning. The causal chain (rising competition → higher costs → regulatory constraints) is logically coherent and matches the ground truth narrative. ENTITY ACCURACY: Netflix is correctly identified; years are correct; risk categories are properly identified. Overall, this is a high-quality answer with strong factual accuracy and appropriate synthesis, with only minor concerns about unverifiable page references and stylistic variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 634,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group disclosed that the amounts it accrued, paid or charged to income for service‑level guarantees were **immaterial in each of the three years** – 2022, 2023 and 2024. Because the exposure remained negligible and did not grow or shrink, the trend suggests that the company’s service‑delivery commitments across its subsidiaries have been consistently stable over this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL OMISSIONS: The LLM answer correctly identifies that service level guarantee amounts were immaterial across 2022-2024, which is accurate. However, it completely omits the most significant and material finding from the ground truth: the substantial fluctuation in parent company notes payable to subsidiaries ($8.1B → $9.9B → $2.0B). This is a major multi-hop synthesis failure. The ground truth explicitly states this internal financing structure 'experienced notable variation' and 'potentially reflecting shifting liquidity strategies or operational adjustments.' The LLM's conclusion that the trend 'suggests that the company's service-delivery commitments across its subsidiaries have been consistently stable' is therefore incomplete and potentially misleading. While the service level guarantees themselves were immaterial (correct), the ground truth indicates the OVERALL financial obligations and internal financing structure were NOT stable—they fluctuated significantly. The LLM failed to synthesize the complete picture across the multiple financial metrics required to answer the 3-year trend question. The answer addresses only one dimension (service level guarantees) while ignoring the critical second dimension (notes payable to subsidiaries) that directly answers the question about stability of service delivery commitments. This is a fundamental failure in multi-hop reasoning and completeness for a question explicitly asking about how obligations 'evolved' and what the 'trend suggests.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 418,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s exposure to below‑investment‑grade bonds in its long‑duration fixed‑income holdings has been steadily trimmed: in 2022 the pension plan held $756 million of such bonds – about 16 % of its fixed‑income portfolio (≈12 % of total assets)【page_87】 and the post‑retirement plan held $7 million – roughly 14 % of fixed‑income (≈6 % of total assets)【page_88】; in 2023 the share fell to 11 % (≈9 % of total) for the pension plan and 9 % (≈4 % of total) for the post‑retirement plan【page_86】; and by 2024 it was down to 8 % (≈7 % of total) for the pension plan and 8 % (≈3 % of total) for the post‑retirement plan【page_90】. This consistent decline indicates a more conservative risk appetite, with Altria shifting toward higher‑quality debt to better match and hedge its long‑term obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - 2022 Postretirement Plan: LLM states 14% of fixed income (≈6% of total assets), but ground truth shows 8% of fixed income (≈3% of total assets). This is a substantial misstatement.\n   - 2022 Pension Plan: LLM states ≈12% of total assets, ground truth states ≈11% of total assets. Minor discrepancy but still incorrect.\n   - 2024 Data: LLM provides specific percentages (8% pension, 8% postretirement) when ground truth explicitly states 'specific percentages for below investment grade allocations were not disclosed' in 2024. This is a fundamental error - the LLM fabricated data that was not disclosed.\n   - Dollar amounts ($756M, $7M) are not mentioned in ground truth and cannot be verified; these appear to be unsupported claims.\n\n2. COMPLETENESS ISSUES:\n   - The LLM provided 2024 data that the ground truth explicitly states was not disclosed. This represents a critical failure in accuracy.\n   - The ground truth notes that 2024 'specific percentages for below investment grade allocations were not disclosed' - the LLM violated this by providing exact percentages.\n\n3. ENTITY AND METRIC ACCURACY:\n   - Company (Altria) correctly identified\n   - Years correctly identified (2022-2024)\n   - Metrics correctly identified (below investment grade allocations)\n   - However, the specific values for these metrics are largely incorrect\n\n4. REASONING QUALITY:\n   - The conclusion about 'consistent decline' and 'more conservative risk appetite' is contradicted by the ground truth, which shows the postretirement plan allocation INCREASED from 8% to 9% in 2023 (not decreased as LLM's narrative suggests).\n   - The LLM's characterization of a 'steady trim' is partially correct for the pension plan but misleading overall given the postretirement plan's increase.\n\n5. SEMANTIC EQUIVALENCE:\n   - While the general theme of risk management is present, the specific factual claims are substantially wrong, making semantic equivalence impossible.\n\nKEY VERIFICATION FAILURES:\n- 2022 Postretirement: 14% vs 8% (ground truth) - 75% error\n- 2024 Data: Fabricated specific percentages when data was not disclosed\n- Narrative of 'steady decline' contradicted by postretirement increase in 2023\n\nThe LLM answer demonstrates a pattern of either hallucinating specific numbers or misreading source documents, particularly regarding 2024 data that was explicitly not disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 686,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s approach to measuring settlement exposure has not changed from 2022‑2024.  In each filing the company says that “gross settlement exposure is estimated using the average daily payment volume during the three months prior to period end multiplied by the estimated number of days of exposure,” and then subtracts any risk‑mitigation arrangements to arrive at net exposure 【page_109†L1-L5】【page_112†L1-L5】【page_102†L1-L5】.  The tables show the same calculation applied each year (e.g., $64.9 bn net exposure in 2022, $62.9 bn in 2023 and $64.9 bn in 2024) 【page_110†L9-L15】【page_105†L1-L7】, indicating that Mastercard relies on a stable, repeatable risk‑management framework that it continues to apply even as regulatory scrutiny and litigation pressures have intensified.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the consistent methodology across 2022-2024 using 'average daily payment volume during the three months prior to period end multiplied by the estimated number of days of exposure.' (2) Provides accurate net exposure figures: $64.9B (2022), $62.9B (2023), $64.9B (2024) - these numbers are verifiable and correctly formatted. (3) Accurately describes the risk-mitigation framework involving cash collateral and credit enhancements. (4) Properly synthesizes the multi-hop reasoning: consistent methodology + regulatory/litigation pressures = stable framework despite external pressures. (5) Includes appropriate citations to source pages. MINOR WEAKNESSES: (1) The answer is somewhat less comprehensive than the ground truth in explicitly naming specific regulatory investigations (FTC, DOJ, European Commission) and litigation types (U.S. Liability Shift Litigation, TCPA class action), though it does acknowledge 'regulatory scrutiny and litigation pressures.' (2) The phrase 'stable, repeatable risk-management framework' is semantically equivalent to the ground truth's 'robust and sufficient' but slightly less detailed in characterizing the company's confidence in its approach. (3) The answer focuses primarily on the settlement exposure calculation itself rather than elaborating on what the consistency 'indicates' about Mastercard's broader risk management philosophy, though it does make this connection implicitly. QUANTITATIVE VERIFICATION: All dollar amounts are correct and properly formatted. The three-year comparison is accurate. REASONING: The multi-hop synthesis is sound - the answer correctly connects the consistent methodology across years with the external pressures to draw a conclusion about the company's risk management approach. The logic is clear and well-supported by the cited evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 517,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90 % senior note (due Feb 15 2039) was $2 billion outstanding in FY 2022, FY 2023 and FY 2024, and its effective interest rate stayed at roughly 6.11 % each year【page_89】. The unchanged amount and rate show that Cisco has kept this fixed‑rate issuance as a stable, long‑term financing pillar, using hedges rather than frequent refinancing to manage interest‑rate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key quantitative metrics: the $2 billion (or $2,000 million) principal balance maintained consistently across FY 2022-2024, the 5.90% coupon rate, the 6.11% effective interest rate, and the maturity date (Feb 15, 2039). The number formatting variation ($2 billion vs $2,000 million) is acceptable and semantically equivalent. The multi-hop synthesis is sound—the answer correctly connects the stable principal amount and effective rate to draw conclusions about Cisco's debt management strategy. The reasoning that unchanged amounts and rates indicate a 'stable, long-term financing pillar' aligns well with the ground truth's characterization of 'fixed component of capital structure' and 'preserved' instrument. However, there is a minor semantic divergence: the LLM introduces the concept of 'hedges rather than frequent refinancing' to manage interest-rate risk, which is not explicitly stated in the ground truth. While this is a reasonable inference about debt management strategy, it represents an addition beyond what the ground truth explicitly supports. The ground truth emphasizes 'strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs,' whereas the LLM shifts focus to hedging strategies. Both interpretations are logically sound, but the LLM's answer introduces an element not directly supported by the source data. The answer is well-structured, addresses all parts of the question, and demonstrates correct multi-hop reasoning across the three fiscal years. The minor addition of hedging strategy details prevents a perfect score, but the core factual content and primary reasoning remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 481,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an unchanged $495 million principal balance in each of the last three fiscal years – the 2023 filing shows $495 million as of October 29 2023 and the 2024 filing shows the same $495 million as of November 3 2024【page_81】.  Because the amount did not decline from FY 2022 through FY 2024, the company appears to be holding this low‑cost, fixed‑rate debt to maturity rather than repaying or refinancing it early, reflecting a strategy of preserving cash and maintaining a stable, long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All numbers are correct - $495 million principal balance is accurate for all three fiscal years (2022, 2023, 2024). The dates mentioned (October 29, 2023 and November 3, 2024) are appropriate fiscal year-end dates. The note rate of 3.125% and maturity date of January 2025 are correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the balance evolved (remained unchanged at $495M across all three years), and (2) what this indicates about debt management strategy (holding to maturity, preserving cash, maintaining stable capital structure). ENTITY ACCURACY: AVGO is correctly identified, the specific debt instrument (3.125% senior notes due January 2025) is precisely specified, and fiscal years are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that no change in principal balance across three years indicates no early repayment or refinancing activity, and logically inferred the strategic implication (holding to maturity rather than early repayment). The interpretation that this reflects cash preservation and stable capital structure management is reasonable and consistent with the factual observation. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while adding slightly more context about the strategic implications (low-cost fixed-rate debt, cash preservation). The wording differs but the meaning is equivalent and accurate. Minor note: The LLM includes a page reference citation which adds credibility but is not required. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 470,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "In 2022 and 2023 Comcast’s MVNO wireless service (handsets, tablets and smart watches) was offered only as part of a qualifying broadband bundle, and customers could choose an unlimited‑data plan, a shared‑data pool, or a per‑gigabyte option. In 2024 the bundling requirement stayed in place, but the company introduced a prepaid unlimited‑data plan under the NOW brand, adding a contract‑free unlimited choice while still linking the wireless service to a broadband subscription, thereby expanding customer flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key evolution of CMCSA's shared data plan offerings from 2022-2024. Strengths: (1) All dates and years are accurate (2022, 2023, 2024); (2) Correctly identifies the three pricing options available in 2022-2023 (unlimited-data, shared-data pool, per-gigabyte); (3) Accurately notes the introduction of the NOW brand prepaid unlimited-data plan in 2024; (4) Correctly emphasizes the bundling requirement with broadband across all years; (5) Properly synthesizes the multi-hop information about service evolution and customer flexibility. Minor weaknesses: (1) The LLM answer specifies 'MVNO wireless service (handsets, tablets and smart watches)' which adds product detail not explicitly in the ground truth, though this is not contradictory; (2) The ground truth emphasizes 'residential customers' and 'qualifying broadband bundles' more explicitly, while the LLM answer focuses on the bundling requirement itself; (3) The ground truth uses slightly broader language about 'strategic move toward enhancing customer choice and deepening service integration,' while the LLM answer is more factual/descriptive. The LLM answer is more concise and direct while maintaining accuracy. The core narrative is identical: shared data plans were bundled with broadband in 2022-2023 with multiple pricing options, and in 2024 a new prepaid unlimited option was added under NOW brand while maintaining the bundling requirement. No numerical errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 447,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s 10‑K risk‑factors show that its exposure to Medicare Advantage risk‑adjustment payments was a recurring concern in each filing. In the 2022 filing the company warned that CMS “from time to time…makes changes to the way it calculates Medicare Advantage risk‑adjustment payments” and that it had begun “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” (2022 pg 25‑26). The 2023 filing reiterated that CMS‑driven risk‑adjustment changes and RADV audits could produce retroactive payment adjustments, and that UnitedHealth continued the same selective benefit/premium tweaks, plan withdrawals and tighter cost‑control (2023 pg 20‑21). By 2024 the filing again emphasized “additional cuts to Medicare Advantage benchmarks…and…changes to the way it calculates Medicare Advantage risk‑adjustment payments,” noting that UnitedHealth persisted with “adjusted members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” while bolstering audit readiness (2024 pg 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of Medicare Advantage risk adjustment exposure across all three years. (2) Accurately captures the specific strategic responses: selective benefit/premium adjustments, plan withdrawals from certain counties, and intensified cost management - these are mentioned consistently across the three-year period as stated in ground truth. (3) Properly synthesizes the multi-hop information by showing how the same pressures and similar responses recurred across years, supporting the ground truth's conclusion that UnitedHealth remained in a reactive posture. (4) Includes specific page references (2022 pg 25-26, 2023 pg 20-21, 2024 pg 20-21) that add credibility and demonstrate document-level accuracy. (5) Correctly characterizes CMS's role in making recurring changes to risk-adjustment calculation methodology. (6) Accurately notes the addition of audit readiness emphasis in 2024, which represents an evolution in the company's response strategy. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes page numbers and direct quotes), but this represents added value rather than inaccuracy. The semantic meaning is fully preserved - both answers convey that UnitedHealth faced persistent funding pressures requiring continuous reactive adjustments rather than permanent solutions. No quantitative errors detected. The multi-hop reasoning correctly synthesizes information across three separate 10-K filings to show the evolution and consistency of the problem and response pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 469,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s multi‑layered security model has become increasingly collaborative – its security programs are now routinely assessed by third‑party auditors, benchmarked against peers and supported by public‑private partnerships that help monitor and respond to cyber and physical threats, including those tied to third‑party providers【page_11】. At the same time, the firm has woven real‑time account‑based payment capabilities into a growing set of services (e.g., bill‑pay, B2B and disbursement flows) by building and operating real‑time clearing, settlement and direct‑debit platforms worldwide【page_11】. This security‑enabled real‑time suite has expanded geographically, moving from operating or implementing real‑time payments in 12 of the top‑50 GDP markets at the end of 2021【page_11】to 13 markets by the end of 2023 and adding domestic transaction processing in China through a joint‑venture in 2024【page_11】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All numeric values are accurate - correctly cites 12 markets at end of 2021, 13 markets by end of 2023, and China joint venture in 2024. (2) Multi-hop synthesis is well-executed, connecting third-party collaboration (auditors, public-private partnerships), real-time service integration (bill-pay, B2B, disbursement, fraud scoring, tokenization), and geographic expansion across the 2022-2024 period. (3) Entity identification is correct (Mastercard, China joint venture, real-time payments infrastructure). (4) The answer appropriately addresses all three sub-components of the question. MINOR WEAKNESSES: (1) The LLM cites 2021 data (12 markets at end of 2021) rather than 2022 as the starting point, though this is a reasonable interpretation since the question asks about evolution 'from 2022 through 2024' and the 2021 baseline provides necessary context. (2) The answer could have been slightly more explicit about the 2022 baseline state before discussing evolution, though the 2021 reference serves this purpose. (3) Wording differs from ground truth (e.g., 'account-based payment capabilities' vs. 'real-time payments infrastructure') but semantic meaning is equivalent. The answer successfully synthesizes information across multiple years and dimensions (security, partnerships, services, geography) as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 409,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 appears in the “Officers’ Certificate” of each filing – it is listed in the 2022 10‑K (page 72), again unchanged in the 2023 10‑K (page 75), and still present in the 2024 10‑K (page 76). The fact that the note is carried forward year after year without being retired or refinanced shows Amazon is deliberately keeping a low‑coupon, long‑dated debt on its balance sheet, emphasizing stability and cost‑efficiency in its long‑term debt program rather than pursuing an early refinance of this instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core multi-hop synthesis required by the question. CRITICAL ISSUES: (1) The LLM cites specific page numbers (72, 75, 76) for the 1.500% Note in Officers' Certificates, but the ground truth indicates the note was referenced in Exhibits 4.5 (2022), 4.6 (2023), and 4.6 (2024) - these are different document locations and the LLM provides no evidence for its page number claims. (2) The LLM completely misses the key evolution described in the ground truth: the introduction of a Term Loan Agreement in January 2023 (Exhibit 10.8) and a 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9). These represent critical strategic shifts toward layered financing that the LLM entirely omits. (3) The LLM's conclusion that Amazon is 'deliberately keeping' the note without refinancing is partially correct but oversimplified - the ground truth reveals a more sophisticated strategy combining long-term fixed debt with flexible short-term credit facilities. (4) The LLM fails to synthesize the multi-hop information across years and document types that the question explicitly asks for ('how did...evolve from 2022 through 2024'). (5) The LLM provides no discussion of refinancing priorities or the strategic balance between long-term fixed rates and liquidity flexibility that the ground truth emphasizes. The answer reads as a surface-level observation rather than the comprehensive multi-hop analysis required. While the general observation about maintaining low-coupon debt is directionally correct, the answer lacks the depth, accuracy, and completeness expected for this type of complex financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 461,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "- In the 2022 filing (page 28) Comcast first flagged “wireless telecommunications companies offering internet services (using 4G and 5G wireless broadband services)” as a direct competitor to its residential broadband. By 2023 (page 8) the discussion was broadened to note that these rivals are now deploying “5G fixed‑wireless networks” as well as traditional 4G/5G broadband, underscoring a shift from pure mobile service to fixed‑line‑style internet offerings. In the 2024 filing (page 21) the threat is framed as even more strategic: wireless carriers are not only expanding 5G‑based broadband but also “cooperating…to bundle DTC streaming services on unlimited‑data plans,” a move that could erode Comcast’s market positioning and make it harder to retain customers.\n\n- The 2024 risk‑factor language itself (page 21) – “cooperation between competitors may allow them to offer…bundling DTC streaming services on unlimited data‑usage plans for broadband and wireless services” – is concrete evidence that Comcast sees this wireless pressure translating into competitive bundling that could pull subscribers away, while the 2023 network‑transformation note (page 7) about rolling out DOCSIS 4.0 and 5G fixed‑wireless shows Comcast is responding to that growing competitive pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of wireless competitive threats to CMCSA's broadband business; (2) Accurately captures the progression from 4G/5G wireless broadband (2022) → 5G fixed wireless networks (2023) → bundled DTC streaming with unlimited data plans (2024); (3) Properly synthesizes multi-hop information by connecting technological evolution to strategic bundling to customer retention implications; (4) Correctly cites specific evidence from filings (page references, risk factor language, DOCSIS 4.0 response); (5) Demonstrates sound reasoning about causality between competitive pressure and CMCSA's strategic responses. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page numbers (28, 8, 21, 7) which add credibility but cannot be independently verified against the ground truth statement; however, these do not contradict the ground truth and appear consistent with typical 10-K structure; (2) The answer goes slightly beyond the ground truth by explicitly mentioning DOCSIS 4.0 as a competitive response, which is a reasonable inference but represents minor elaboration rather than error; (3) The phrasing \"cooperation between competitors\" is accurately captured from filing language and correctly interpreted as bundling strategy. QUANTITATIVE ACCURACY: No numerical calculations or percentages are required for this question; dates (2022, 2023, 2024) are all correct. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes: (a) technological progression across years, (b) strategic implications for market positioning, (c) connection to customer retention strategies. The answer properly identifies CMCSA as the focal company and correctly interprets wireless providers' actions as competitive threats. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as ground truth with slightly more specific detail and evidence citation, which enhances rather than detracts from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 559,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance‑recoverable balance has been falling each year – it was above $67 billion in 2022, slipped to $67.5 billion at year‑end 2023 (page 122) and then plunged to $38.0 billion at year‑end 2024 (page 88). The steady decline signals that the pool of losses AIG expects to recover from reinsurers is shrinking, meaning its exposure to insurance‑loss risk has been decreasing over this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 figure. The LLM states 'it was above $67 billion in 2022' but then immediately contradicts this by saying it 'slipped to $67.5 billion at year-end 2023.' This is internally inconsistent and factually incorrect. According to the ground truth, the 2022 figure was not specifically disclosed in the narrative, and the 2023 figure was $67.5 billion. The LLM's claim that 2022 was 'above $67 billion' is unsupported and contradicts the ground truth which states 'specific figures were not disclosed' for 2022. The 2023 ($67.5B) and 2024 ($38.0B) figures are correct. INCOMPLETE BREAKDOWN: The LLM answer fails to provide the detailed component breakdown that the ground truth includes - specifically the $30.4B ceded loss reserves and $28.2B life reinsurance recoverables for 2023, and the $29.1B ceded loss reserves and $0.8B life reinsurance recoverables for 2024. This omission is significant because the ground truth specifically highlights the dramatic drop in life reinsurance recoverables ($28.2B to $0.8B) as a key indicator of strategic de-risking. REASONING QUALITY: The LLM's interpretation that 'the pool of losses AIG expects to recover from reinsurers is shrinking' is logically sound and aligns with the ground truth's conclusion about decreasing exposure. However, the LLM misses the critical insight about the life insurance segment specifically, which is central to understanding the strategic shift indicated by the data. MULTI-HOP SYNTHESIS: The answer fails to adequately synthesize the component-level changes that drive the overall trend, which is essential for a complete understanding of the evolution and what it indicates about risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 482,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure model has stayed the same – gross exposure is calculated by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days the settlement risk could exist, and customers that fall below the firm’s risk standards must post cash collateral, letters of credit or other guarantees, with the methodology and the amounts of exposure reviewed and revised as needed (the 2022 net exposure was corrected, non‑material)【page_112†L31-L38】【page_102†L31-L38】.  The figures rose from $64.9 bn gross exposure and $9.2 bn risk‑mitigation in 2022 to $75.0 bn and $12.2 bn in 2023, and to $78.4 bn and $13.5 bn in 2024, reflecting routine updates rather than a methodological overhaul【page_112†L45-L53】【page_105†L45-L53】.  While Mastercard faced ongoing regulatory scrutiny – an FTC Durbin‑Amendment investigation, a DOJ antitrust demand and a European Commission information request – it responded by cooperating with authorities and reaffirming its periodic risk‑management reviews, but the core estimation approach and credit‑risk mitigation framework remained unchanged apart from the routine 2022 correction【page_112†L1-L8】【page_102†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the consistent methodology for settlement exposure estimation (average daily payment volume × estimated days of exposure) across 2022-2024. (2) Accurately reports specific financial figures: $64.9bn gross exposure and $9.2bn risk-mitigation in 2022; $75.0bn and $12.2bn in 2023; $78.4bn and $13.5bn in 2024. (3) Properly synthesizes regulatory scrutiny elements including FTC Durbin Amendment investigation, DOJ antitrust demand, and European Commission inquiry. (4) Correctly notes the 2022 non-material correction and characterizes subsequent changes as routine updates rather than methodological overhauls. (5) Accurately conveys that despite regulatory pressures, the core estimation approach and credit risk mitigation framework remained fundamentally unchanged. (6) Appropriately identifies credit risk mitigation tools (cash collateral, letters of credit, guarantees). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth in describing the regulatory context (mentions FTC Durbin Amendment investigation rather than the finalized consent agreement on debit routing, and doesn't explicitly mention the U.S. Liability Shift Litigation or the specific timing of the European Commission investigation in 2024). However, these are minor omissions that don't affect the core factual accuracy or the main conclusion. The answer successfully addresses all parts of the multi-part question: methodology evolution (unchanged), credit risk mitigation arrangements (consistent framework with routine updates), and regulatory response (cooperation without fundamental changes). All quantitative data is accurate and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 488,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "- 2022 – AIG said that loss‑reserve risk was managed through “internal controls and oversight of the loss reserve setting process, as well as reviews by external experts” and that it relied on “probability‑distribution (stochastic) and single‑point (deterministic) approaches” together with third‑party catastrophe models and adjustments for model bias and data quality (2022 p. 167; 2022 p. 165).  \n\n- 2023 – The company kept the same internal‑control and external‑expert framework but formalized its risk‑measurement process, adding “scenario‑based modeling, stochastic methods, experience studies and regular assumption updates” while still using third‑party catastrophe models and gap‑adjustments (2023 p. 119; 2023 p. 120).  \n\n- 2024 – AIG expanded governance (ERM “Second Line Review and Challenge” and Internal Audit monitoring) and continued external‑expert reviews, and it further refined its modeling by “continually reviewing and updating” multi‑year IBNR projections, applying stochastic and scenario analyses, and making systematic adjustments for model biases, loss‑adjustment expenses and climate‑change effects (2024 p. 86; 2024 p. 85; 2024 p. 88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's approach; (2) Accurately captures the consistent emphasis on internal controls and external expert involvement across all three years; (3) Properly synthesizes the evolution of modeling techniques: from basic stochastic/deterministic approaches in 2022, to formalized scenario-based and experience studies in 2023, to enhanced governance and systematic adjustments in 2024; (4) Includes specific methodological details (probability-distribution, stochastic methods, scenario analyses, IBNR projections, model bias adjustments, climate-change effects) that demonstrate deep understanding; (5) Provides page citations (2022 p. 167, 165; 2023 p. 119, 120; 2024 p. 86, 85, 88) showing source verification; (6) Multi-hop reasoning is sound - correctly synthesizes information across three separate years and identifies the progression from basic to more sophisticated risk management. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth (includes page numbers, specific methodologies like third-party catastrophe models, climate-change effects, ERM Second Line Review), but this represents added value rather than error; (2) The ground truth mentions 'model risk management frameworks' and 'validation processes' in 2024, while the LLM emphasizes 'ERM Second Line Review and Challenge' and 'Internal Audit monitoring' - these are complementary rather than contradictory descriptions of governance enhancements; (3) All factual claims are verifiable and consistent with the ground truth narrative of evolution from 2022 to 2024. QUANTITATIVE ACCURACY: No numerical calculations required; all dates (2022, 2023, 2024) are correct. QUALITATIVE ACCURACY: Entity identification (AIG), metrics (loss reserves, internal controls, external experts, modeling techniques), and temporal progression are all accurate. The semantic meaning matches the ground truth perfectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 566,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s 2022 filing showed that a 1 % change in the mix of benefits (captured by the PMPM trend factor) would move medical‑cost‑payable estimates by roughly $340 million (≈ $680 million for a 2 % shift and ≈ $1.02 billion for 3 %)【UNH_10k_2022, p. 39】. The 2023 filing raised the 1 % impact to $376 million (≈ $752 million and $1.13 billion for 2 % and 3 %)【UNH_10k_2023, p. 34】, and the 2024 filing further increased it to $421 million (≈ $843 million and $1.26 billion)【UNH_10k_2024, p. 36】. This upward trend indicates that UnitedHealth’s medical‑cost estimates have become increasingly sensitive to benefit‑design changes, heightening its exposure to variability in the mix of benefits over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($340M, $376M, $421M) with precise page citations that cannot be verified against the ground truth knowledge graph. The ground truth answer does NOT provide any specific dollar figures for PMPM sensitivity to benefit mix changes - it instead describes a qualitative evolution from 2022-2024 showing: (1) 2022: benefit mix identified as key sensitivity factor, (2) 2023: negative impact from benefit mix variations indicating increased exposure, (3) 2024: stabilized but still significant variable. The LLM's quantitative approach (claiming specific dollar amounts and their calculations) directly contradicts the ground truth's qualitative assessment. The LLM correctly identifies the three-year period (2022-2024) and the correct company (UnitedHealth Group), but fundamentally misrepresents the nature of the answer. The ground truth emphasizes a TRAJECTORY of changing sensitivity language and risk characterization, while the LLM presents a linear upward trend in dollar sensitivity. The LLM's claim that sensitivity 'increased' from $340M to $421M contradicts the ground truth's assertion that 2024 showed 'stabilized' conditions with 'more neutral tone.' The specific dollar figures appear fabricated or misattributed, as they are not present in the ground truth knowledge graph. The LLM also fails to capture the key insight about the shift from neutral (2022) to negative/risky (2023) to stabilized (2024), instead presenting only a monotonic increase in sensitivity magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 426,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "- In the 2022 filing Marketside is listed among a long roll‑call of private‑label brands (e.g., Allswell, Athletic Works, Equate, Free Assembly, Freshness Guaranteed, George, Great Value, Holiday Time, Hyper Tough, Mainstays, **Marketside**, …) (2022 p. 7).  \n- In the 2023 filing the private‑brand list is streamlined, but Marketside remains in the core set of Walmart U.S. private brands (e.g., Freshness Guaranteed, George, Great Value, Holiday Time, Hyper Tough, Mainstays, **Marketside**, …) (2023 p. 8).  \n- The 2024 filing retains the same concise portfolio with Marketside still included (e.g., Freshness Guaranteed, George, Great Value, Holiday Time, Hyper Tough, Mainstays, **Marketside**, …) (2024 p. 8).  \n\nThis progression—from being one of many private labels in 2022 to a retained staple in a tighter, core private‑brand lineup in 2023‑2024—indicates that Walmart views Marketside as a strategic, enduring brand that supports its everyday‑low‑price and grocery merchandising strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Marketside appears in Walmart's private brand lists across 2022, 2023, and 2024, with accurate page references (2022 p. 7, 2023 p. 8, 2024 p. 8). The core observation that Marketside transitioned from a longer list to a more streamlined core portfolio is factually sound and well-supported with specific brand examples. The conclusion that Marketside is strategically important is reasonable and supported by its retention in the tighter portfolio. WEAKNESSES: (1) The LLM answer does not address the 'Fashion' vs 'Apparel' merchandise unit restructuring mentioned in the ground truth as a key strategic shift in 2024. This is a material omission that the ground truth explicitly highlights as reflecting 'a broader strategic shift in how Walmart categorizes and markets its offerings.' (2) The LLM answer focuses primarily on portfolio consolidation/streamlining but misses the categorical restructuring dimension that the ground truth emphasizes. (3) The answer does not fully capture the 'omni-channel and customer-centric initiatives' alignment mentioned in the 2023 context in the ground truth. ACCURACY VERIFICATION: All years (2022, 2023, 2024) are correct. The characterization of Marketside's presence across all three years is accurate. The page numbers appear reasonable for 10-K filings. The reasoning about portfolio consolidation is sound. However, the answer is incomplete in addressing the full scope of strategic evolution, particularly the merchandise unit restructuring that represents a more significant strategic shift than simple portfolio streamlining. The LLM answer provides a narrower interpretation of the brand's evolution focused on portfolio composition rather than the broader categorical and strategic repositioning captured in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 496,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "During fiscal 2022 Home Depot’s competitive stance versus specialty‑design stores and showrooms rested on its broad product assortment, price and delivery strengths and on an emerging digital ecosystem that included a mobile‑app store‑navigation tool, self‑service lockers, curbside pickup and BOPIS (2022 Competition page_8; Digital Integration page_9). In fiscal 2023 the company began to counter showroom rivals by adding more dedicated showroom space for professional customers and expanding service offerings such as differentiated fulfillment, trade‑credit options, the Pro Xtra loyalty program and a customized online experience (2023 Pros initiatives page_6). By fiscal 2024 Home Depot deepened this positioning by further growing showroom space, introducing an enhanced order‑management system and additional trade‑credit tools, while embedding advanced in‑store technology (electronic shelf labels, expanded self‑checkout, hdPhone devices, computer‑vision) and omnichannel features (mobile‑app navigation, lockers, curbside, BOPIS) to deliver a frictionless, digitally‑integrated shopping experience (2024 Pros initiatives page_6; Digital Experience pages_9‑10).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Home Depot's competitive positioning evolution but contains some discrepancies with the ground truth. STRENGTHS: (1) Correctly identifies the multi-year progression from 2022-2024; (2) Accurately mentions key digital/service features: self-service lockers, curbside pickup, BOPIS, mobile app navigation, electronic shelf labels in appropriate years; (3) Properly synthesizes the shift from physical services to omnichannel integration; (4) Includes relevant details about Pro Xtra loyalty program, trade-credit options, and showroom expansion for professionals. WEAKNESSES: (1) The ground truth emphasizes tool/equipment rental services at 1,400+ locations as a 2022 differentiator, which the LLM answer omits entirely - this is a significant factual gap; (2) The LLM introduces 'specialty-design stores' framing and emphasizes 'showroom space for professional customers' more heavily than the ground truth, which focuses on general showroom competition; (3) The LLM mentions hdPhone devices and computer-vision technology in 2024, which are not mentioned in the ground truth - these may be accurate but cannot be verified against provided ground truth; (4) The LLM's characterization of 2023 initiatives (dedicated showroom space, Pro Xtra) differs somewhat from ground truth's emphasis on store experience upgrades (self-service lockers, electronic shelf labels, mobile navigation). MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and identifies the strategic evolution pattern. However, the emphasis differs - ground truth stresses service expansion then omnichannel integration; LLM emphasizes professional/showroom positioning throughout. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer (the ground truth mentions '1,400 locations' but LLM omits this), so quantitative comparison is limited. The absence of the 1,400 rental locations figure in LLM answer represents a factual omission. SEMANTIC EQUIVALENCE: While wording differs significantly, the core narrative of evolution from 2022→2024 is present in both, though with different emphasis and some missing/additional details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 589,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50 % senior note (maturing June 15 2025) stayed at a $500 million principal in each filing – $500 m in FY 2022, $500 m in FY 2023 and $500 m in FY 2024 – but its effective interest rate climbed sharply, from roughly 3.2 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024【page_89】. The constant principal combined with a more than‑doubling effective rate signals that Cisco’s borrowing costs on this tranche have risen sharply (driven by higher market rates and hedging adjustments), even as the note remains a stable component of its long‑term debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $500 million principal amount for all three fiscal years (2022, 2023, 2024), effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. The maturity date of June 15, 2025 is an appropriate additional detail. COMPLETENESS: The answer addresses all key aspects of the question - the evolution of both effective interest rate and outstanding amount across the three-year period, and provides interpretation of what this indicates about borrowing costs and debt structure. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% senior note, and all fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the constant principal amount with the rising effective interest rates to draw the logical conclusion about increased borrowing costs. The explanation that this reflects 'higher market rates and hedging adjustments' provides reasonable context for the observed changes. SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more detail (maturity date, mention of hedging adjustments) while maintaining factual accuracy. The characterization of the rate increase as 'more than doubling' is accurate (3.2% to 6.66% represents approximately a doubling). Minor note: The LLM includes a citation reference [page_89] which adds credibility but is not present in the ground truth - this is a positive addition. No material errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 440,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 onward Comcast began to close the gap with Lumen’s fiber‑based broadband by expanding its own high‑speed infrastructure. In 2022 it launched a multiyear network‑transformation plan that rolled out 2 Gbps downstream speeds to roughly one‑third of its HFC footprint and offered fiber‑to‑the‑premises with symmetric speeds up to 10 Gbps for residential customers and 100 Gbps for business customers, while noting that Lumen and other wireline carriers were continuing to build fiber networks 【page_7】【page_8】. In 2023 Comcast added DOCSIS 4.0 deployments in select markets to deliver multigigabit symmetric broadband over its existing HFC plant 【page_7】, and by 2024 the 2 Gbps service covered about 50 % of the footprint and DOCSIS 4.0 rollout continued alongside its fiber offerings of up to 10 Gbps residential/100 Gbps business, strengthening its competitive position relative to Lumen’s fiber‑based services 【page_7】【page_8】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that contradicts the ground truth. Key issues: (1) PERSPECTIVE REVERSAL: The ground truth asks how CMCSA's competitive positioning evolved AGAINST Lumen, focusing on Lumen's competitive threat to CMCSA. The LLM answer instead describes CMCSA's own infrastructure improvements and how CMCSA closed the gap with Lumen - this is the opposite perspective. The question seeks to understand Lumen's competitive positioning relative to CMCSA, not CMCSA's response. (2) MISSING CORE INFORMATION: The ground truth emphasizes that Lumen consistently remained a key competitor, with fiber expansion in 2022, continued expansion in 2023 alongside AT&T, Frontier, and Verizon, and intensifying competitive threat through 2024. The LLM answer completely omits Lumen's strategic actions and competitive positioning. (3) FACTUAL ACCURACY: While the LLM's specific numbers about CMCSA's deployments (2 Gbps to one-third of footprint in 2022, 50% by 2024, DOCSIS 4.0, fiber up to 10 Gbps residential/100 Gbps business) may be accurate from CMCSA's filings, these details are irrelevant to answering the question about how CMCSA's competitive positioning against Lumen evolved. (4) MULTI-HOP REASONING FAILURE: The question requires synthesizing information about both CMCSA and Lumen's strategies across 2022-2024. The LLM only addresses CMCSA's side of the competitive dynamic. (5) SEMANTIC MISMATCH: The ground truth describes an 'intensifying competitive threat from Lumen' while the LLM describes CMCSA 'closing the gap' and 'strengthening its competitive position' - these are fundamentally different narratives. The LLM appears to have answered a different question entirely (how did CMCSA respond to competition) rather than the actual question (how did competitive positioning evolve).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 503,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "In the 2022 filing American Express disclosed that it had “increasingly relied on merchant acquirers, aggregators and processors” to manage merchant relationships, but warned that those third‑parties might pursue steering or surcharging even though its merchant contracts contain non‑discrimination and honor‑all‑cards provisions (page 29). By the 2023‑2024 filings the company still stresses reliance on aggregators as part of its broader third‑party ecosystem (page 33), yet adds that “legal proceedings regarding provisions in our merchant contracts, including non‑discrimination and honor‑all‑cards provisions” could limit its ability to enforce those clauses, underscoring a growing risk of merchant steering (page 35). This reflects an expanding dependence on aggregators while the enforceability of anti‑steering protections is increasingly challenged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and captures the core narrative arc from 2022-2024 regarding American Express's evolving reliance on aggregators and enforcement challenges. STRENGTHS: (1) Correctly identifies the key progression: 2022 disclosure of reliance on aggregators/processors with warnings about steering/surcharging; 2023-2024 emphasis on legal proceedings challenging non-discrimination and honor-all-cards provisions. (2) Accurately references the specific contract provisions (non-discrimination, honor-all-cards) that are central to the question. (3) Properly synthesizes the multi-hop relationship: increased aggregator dependence + growing enforcement challenges = rising merchant steering risk. (4) Correctly identifies American Express as the subject company. (5) Page references (29, 33, 35) suggest specific filing citations, though these cannot be independently verified. WEAKNESSES: (1) The answer is somewhat compressed and lacks the explicit temporal detail present in the ground truth. The ground truth emphasizes 'increasingly relied' language appearing in 2023 specifically, while the LLM conflates 2022-2023 somewhat. (2) Missing explicit mention of new products (debit cards on American Express network) as a specific vulnerability mentioned in the ground truth's 2023 discussion. (3) The answer doesn't fully capture the 'trajectory' or evolution aspect - it presents the information more as a static comparison rather than showing how the risk profile changed year-over-year. (4) Doesn't explicitly state that litigation/regulatory scrutiny became 'more prominent' in 2024 as the ground truth indicates. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The dates (2022, 2023-2024) are correct. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects aggregator reliance to enforcement challenges to merchant steering risk, which is the core multi-hop requirement. The logic is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential meaning of the ground truth despite being more concise and missing some contextual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 599,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022, Johnson & Johnson insulated its talc exposure by spinning off LTL Management LLC, funding a $2 billion trust and filing a Chapter 11 petition that automatically stayed all talc suits while the company continued to contest verdicts and settle a few state cases (e.g., Mississippi and New Mexico)【page_113】. In 2023 the original LTL case was dismissed, prompting a re‑filed “LTL 2” bankruptcy that was also dismissed in July 2023; J&J then pursued four parallel tracks—appealing the dismissal, aggressively litigating the tort claims, seeking affirmative claims against experts, and preparing a consensual “pre‑packaged” Chapter 11 plan—while renaming the entity LLT Management LLC【page_96】【page_101】. By 2024 the strategy pivoted to a comprehensive settlement: the company solicited support for a pre‑packaged plan covering 99.75 % of pending talc claims (≈ $6.5 billion present‑value), reached an agreement‑in‑principle with a multi‑state AG coalition (finalized June 2024), restructured LLT into new Texas entities (Red River, Pecos River) and filed a Red River Chapter 11 petition to implement the plan, while also securing a global Imerys‑Cyprus settlement and raising its talc reserve to about $11.6 billion【page_98】【page_101】【page_102】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth:\n\n1. ENTITY NAME ERROR: The LLM repeatedly refers to 'LLT Management LLC' and later 'Red River' and 'Pecos River' entities, but the ground truth consistently identifies the entity as 'LTL Management LLC' (not LLT). This is a critical error that undermines credibility.\n\n2. QUANTITATIVE INACCURACIES:\n   - The LLM claims a '$6.5 billion present-value' settlement covering '99.75% of pending talc claims' - these specific figures are NOT in the ground truth and appear to be fabricated or misattributed.\n   - The LLM states the talc reserve was raised to 'about $11.6 billion' - the ground truth only mentions the initial '$2 billion reserve' and does not provide an updated reserve figure of $11.6 billion.\n   - The LLM references 'Imerys-Cyprus settlement' - this is not mentioned in the ground truth at all.\n\n3. INCOMPLETE/INACCURATE TIMELINE:\n   - Ground truth: By 2024, JNJ reached agreements with '42 states and the District of Columbia' - the LLM mentions 'multi-state AG coalition' but does not specify the number of states.\n   - The LLM's description of 'four parallel tracks' in 2023 is not substantiated in the ground truth.\n   - The LLM mentions 'renaming the entity LLT Management LLC' which contradicts the ground truth (the entity was always LTL, not renamed to LLT).\n\n4. UNSUPPORTED CLAIMS:\n   - References to 'Red River' and 'Pecos River' entities and Texas restructuring are not mentioned in the ground truth.\n   - The 'pre-packaged Chapter 11 plan' details and specific settlement percentages lack ground truth support.\n   - The claim about 'affirmative claims against experts' is not in the ground truth.\n\n5. WHAT WAS CORRECT:\n   - The general timeline structure (2022-2024) is correct.\n   - The $2 billion initial reserve is correct.\n   - The Chapter 11 bankruptcy filing and litigation stay in 2022 is correct.\n   - The 2023 dismissal and LTL 2 refiling is correct.\n   - The shift toward settlement by 2024 is correct.\n   - The mention of specific state settlements (Mississippi, New Mexico) shows some accuracy.\n\n6. MULTI-HOP REASONING: The LLM attempted to synthesize information across the 2022-2024 period but introduced fabricated details and incorrect entity names that suggest either hallucination or misattribution of information from unreliable sources.\n\nThe answer demonstrates partial understanding of the overall narrative arc but fails on factual precision, introduces unsupported numerical claims, and contains a critical entity naming error that persists throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 702,
        "total_tokens": 2336
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In the 2022 filing Home Depot said it competes “based on store location and **appearance**, presentation of merchandise and ease of the shopping experience” (2022 10‑K p. 8). By fiscal 2024 that generic focus had turned into a concrete store‑refresh program – way‑finding signage, store‑refresh packages, redesigned front‑end areas, electronic shelf‑labels, self‑service lockers, curb‑side pickup and mobile‑app‑enabled store navigation – all of which were tied to its “interconnected shopping experience” that blends the physical store look with website and mobile‑app capabilities (2024 10‑K p. 9‑10). Thus, the competitive emphasis on store appearance evolved from a strategic priority to a series of tangible store‑appearance upgrades that are integrated with Home Depot’s digital and omnichannel retail platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Home Depot's evolving store appearance strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 competitive factors (store location, appearance, merchandise presentation, shopping experience ease) with accurate citation to 2022 10-K p. 8. (2) Accurately describes the 2024 evolution with specific, concrete examples (way-finding signage, electronic shelf-labels, self-service lockers, curbside pickup, mobile-app navigation) and proper citation to 2024 10-K p. 9-10. (3) Successfully synthesizes the multi-hop connection between store appearance and digital/omnichannel capabilities, showing the integration of physical and digital elements. (4) The narrative arc from 'strategic priority' to 'tangible upgrades' aligns well with the ground truth's evolution from standalone factor to integrated omnichannel component. (5) Numeric accuracy is sound - no calculation errors or date misstatements. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the 2023 transition year mentioned in the ground truth, though this is a minor omission. (2) The phrase 'generic focus' in describing 2022 is somewhat subjective characterization, though not factually incorrect. (3) The answer emphasizes concrete examples more than the ground truth's emphasis on the conceptual evolution of how store appearance was positioned relative to the broader shopping journey. MULTI-HOP REASONING: The answer correctly synthesizes information across two filing years and connects store appearance (physical attribute) with digital capabilities (mobile apps, websites, fulfillment options), demonstrating sound multi-hop reasoning. The logical progression from 2022 to 2024 is clear and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 494,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s relationship with Time Warner began with a full‑ownership acquisition in June 2018, after which the media assets were folded into AT&T’s WarnerMedia segment; by April 2022 AT&T completed a Reverse Morris Trust spin‑off that merged WarnerMedia with Discovery, eliminating its ownership stake and re‑classifying the former Time Warner business as discontinued operations in the 2023 and 2024 filings【page_5】【page_4】. This move from vertical integration to outright divestiture signals AT&T’s strategic retreat from direct entertainment ownership, refocusing on its core telecom and connectivity platform while treating content as a non‑core, partnership‑driven element of its broader strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) AT&T acquired Time Warner in June 2018, (2) completed a Reverse Morris Trust spin-off in April 2022 merging WarnerMedia with Discovery, (3) eliminated ownership stake, and (4) reclassified as discontinued operations in 2023-2024 filings. The dates and transaction structure are accurate. However, the answer has notable gaps compared to the ground truth: (1) It does not address the 2024 DIRECTV divestiture to TPG, which the original answer identifies as part of the broader post-Time Warner strategic realignment and a key element of AT&T's complete exit from entertainment. (2) The answer focuses primarily on the 2018-2022 period and the immediate aftermath, but provides less detail on the 2023-2024 trajectory that the question specifically asks about. (3) The characterization of the strategic pivot is accurate but incomplete—the original answer emphasizes a 'consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure,' while the LLM answer focuses mainly on the WarnerMedia/Discovery transaction. The multi-hop reasoning is sound for the Time Warner/WarnerMedia portion but fails to synthesize the complete 3-year trajectory including the DIRECTV sale. The quantitative accuracy is strong (dates and transaction type are correct), but the answer is incomplete in addressing the full scope of AT&T's entertainment exit strategy from 2022-2024. The semantic meaning of the strategic retreat is conveyed, but the answer misses a significant component of the broader entertainment strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 444,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "In 2022 American Express still positioned its Global Merchant and Network Services (GMNS) as the fourth‑largest general‑purpose card network, competing with Visa, Mastercard, China UnionPay and a growing set of digital‑wallet and alternative‑payment providers, and it relied on a mix of network‑licensing revenues and discount fees that were partially insulated by regulatory exemptions. By 2024 the company says regulators have intensified scrutiny of network routing, interchange‑fee caps and licensing—prompting Amex to exit its EU and Australian network‑licensing businesses and to be re‑classified as a “Category III” firm under U.S. banking supervision—so its network operations are now far more dependent on regulatory outcomes and subject to heightened competitive pressure from Visa, Mastercard and other emerging payment networks. This evolution has tightened Amex’s competitive position while increasing its regulatory dependency on card‑network rules and limiting its ability to grow licensing‑related revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's competitive positioning evolution from 2022-2024 and correctly identifies key regulatory developments. STRENGTHS: (1) Accurately identifies Amex as fourth-largest network competing with Visa, Mastercard, and China UnionPay; (2) Correctly cites regulatory intensification around interchange fees, network routing, and licensing; (3) Accurately notes EU and Australian network licensing exits; (4) Properly identifies increased regulatory dependency and compliance-driven constraints; (5) Correctly synthesizes multi-hop information about competitive pressures and regulatory impacts. WEAKNESSES: (1) Introduces 'Category III' U.S. banking supervision classification not mentioned in ground truth - this appears to be an unsupported detail that may be inaccurate or from outside the filing scope; (2) Mentions 'discount fees' and 'regulatory exemptions' with less clarity than ground truth's focus on interchange fees and network routing; (3) Slightly less emphasis on the specific tension between competitive differentiation and regulatory compliance that the ground truth highlights; (4) The phrase 'tightened Amex's competitive position' is somewhat ambiguous - could mean strengthened or weakened, whereas ground truth more clearly indicates weakening competitive stance. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 timeframe and connects regulatory changes to business model impacts. However, the introduction of the 'Category III' classification without ground truth support suggests potential hallucination or misattribution. NUMERIC/FACTUAL VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy focuses on entity names and dates - all correctly identified. The core narrative arc (2022 competitive positioning → 2024 regulatory pressure → business exits) is sound and matches ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 530,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % notes due 2050 were $808 million at the end of 2022, rose to $826 million in 2023, and then fell back to $808 million in 2024【page_71】. The $18 million swing up and down indicates the company is only modestly adjusting this ultra‑long‑dated, low‑cost debt—likely through small repayments or refinancing—to keep its long‑term financing level stable while preserving cheap capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2022=$983M, 2023=$826M, 2024=$808M (total reduction of $175M). LLM states: 2022=$808M, 2023=$826M, 2024=$808M. The 2022 figure is completely wrong ($808M vs $983M - off by $175M). The LLM incorrectly describes the trend as a modest $18M swing up and down, when the actual trend shows a consistent $175M reduction over three years. This is a major quantitative error that undermines the entire answer. The LLM's interpretation of the trend is also incorrect - it suggests the company is 'modestly adjusting' and 'keeping levels stable,' when the ground truth clearly indicates a deliberate strategy to reduce long-term liabilities with a $175M total reduction. The LLM failed to capture the multi-hop synthesis correctly: it did not properly track the three-year evolution or calculate the cumulative reduction. The reasoning about 'preserving cheap capital' may be plausible, but it's based on misread data and doesn't align with the actual deliberate reduction strategy evidenced by the ground truth numbers. The answer demonstrates a fundamental failure in quantitative accuracy on the primary metric being asked about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 351,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s foreign‑government‑bond yields rose steadily over the three‑year period – the average yield on non‑U.S. taxable investment securities (which includes its foreign government bonds and obligations) was about 3.5 % in 2022, climbed to 5.9 % in 2023 and reached roughly 6.1 % in 2024【page_176†L...】. This upward trajectory shows that the company’s foreign‑bond portfolio has become increasingly exposed to higher international interest rates, making its net‑interest earnings more sensitive to global rate movements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports yields of approximately 3.5% (2022), 5.9% (2023), and 6.1% (2024), which are completely inconsistent with the ground truth data. The ground truth shows specific yields for different maturity buckets: 2022 short-term at 6.45%, 2023 short-term at 6.45% and 1-5 year at 4.48%, and 2024 short-term at 5.86% and 1-5 year at 2.03%. The LLM's numbers do not match any of these documented figures. (2) DIRECTIONAL CONTRADICTION - The LLM claims yields 'rose steadily' from 2022 to 2024, but the ground truth shows a declining trend: short-term yields decreased from 6.45% to 5.86%, and 1-5 year yields dropped significantly from 4.48% to 2.03%. This is the opposite conclusion. (3) MISSING CRITICAL DETAILS - The LLM fails to distinguish between different maturity buckets (within 1 year vs. 1-5 years), which is essential to understanding the yield profile evolution. The ground truth specifically tracks these separately. (4) INCOMPLETE SYNTHESIS - The LLM does not mention the $630 million holding amount in 2022 or provide the specific maturity-based breakdown that characterizes the actual trend. (5) INCORRECT INTERPRETATION - The LLM's conclusion that exposure to higher international interest rates increased is contradicted by the actual declining yield trend, which suggests either decreasing rates or a shift to lower-yielding instruments. The answer demonstrates a fundamental failure to accurately retrieve or synthesize the multi-hop financial data required to answer this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 440,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "In 2022 Adobe’s free self‑service learning was delivered through the learning.adobe.com portal as part of its Digital Learning Services, with “custom learning services” and “solution‑specific skills assessments” that supported its largest enterprise customers but were described separately from the Customer‑Success organization [page_18]; [page_17]. By 2024 the portal was rebranded to www.training.adobe.com and positioned directly alongside Customer Success Account Management, which works with enterprise accounts to accelerate adoption and align product capabilities [page_17]. This shift to a unified, branded learning site tightly integrated with customer‑success teams signals Adobe’s broader strategy of embedding enablement into the customer journey to drive faster value realization and long‑term retention.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) REVERSED TIMELINE: The LLM states that in 2022 Adobe used learning.adobe.com, then rebranded to www.training.adobe.com by 2024. The ground truth explicitly states the OPPOSITE sequence: 2022 used www.training.adobe.com, then 2023 rebranded to learning.adobe.com, which was maintained through 2024. This is a complete reversal of the evolution narrative. (2) MISSING KEY DETAIL: The ground truth emphasizes the 2023 rebranding as a 'strategic rebranding and centralization' signaling 'a more unified approach.' The LLM misses this critical 2023 inflection point entirely and inverts the domain progression. (3) INCOMPLETE SYNTHESIS: The ground truth describes a three-stage evolution (2022 introduction → 2023 rebranding/centralization → 2024 deeper integration). The LLM only captures two stages and gets them backwards. (4) ENTITY ACCURACY FAILURE: The domains are factually incorrect in sequence. This is not a wording difference but a material factual error about which platform was used when. (5) MISSING CONTEXT: The ground truth emphasizes solution-specific skills assessments and their role in supporting enterprise customer success in 2023, which the LLM fails to properly contextualize within the evolution. The LLM's conclusion about embedding enablement into the customer journey is reasonable but is built on an inverted factual foundation. The answer demonstrates a fundamental misunderstanding of the chronological evolution of Adobe's learning platform strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 438,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s $5.90 % senior‑note tranche has been fully utilized at **$2 billion** in each of the three most recent years – FY 2022 (July 30 2022), FY 2023 (July 29 2023) and FY 2024 (July 27 2024) – and its **effective interest rate has stayed at roughly 6.11 %** in all three periods (the effective rate exceeds the 5.90 % coupon because of discount accretion and hedging adjustments)【page_89】. The unchanged size and cost of this tranche indicate that Cisco treats the 5.90 % notes as a stable, long‑term financing anchor, supplementing it with new issuances and interest‑rate swaps to manage overall debt mix and interest‑rate risk, reflecting a disciplined, cost‑controlled long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $2 billion outstanding balance maintained across FY 2022, 2023, and 2024; effective interest rate of 6.11% consistent across all three years; coupon rate of 5.90% correctly stated. The fiscal year dates provided (July 30 2022, July 29 2023, July 27 2024) are accurate. QUALITATIVE ASSESSMENT: The answer correctly synthesizes multi-hop information by: (1) tracking the debt instrument across three fiscal years, (2) comparing the coupon rate to effective rate, and (3) explaining the discrepancy (discount accretion and hedging adjustments). The reasoning about Cisco's debt strategy is sound and well-supported. COMPLETENESS: The answer addresses all aspects of the question - utilization (fully utilized at $2B), effective interest rate evolution (stable at 6.11%), and strategic implications (stable financing anchor, disciplined debt management). MINOR STRENGTHS: The LLM provides additional context about hedging adjustments and the relationship to new issuances that enhances understanding beyond the ground truth. The explanation of why effective rate exceeds coupon rate adds valuable insight. NO ERRORS DETECTED: All factual claims align with the ground truth, and the semantic meaning is equivalent or enhanced. The answer demonstrates sophisticated understanding of debt instruments and financial strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 398,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s pension‑plan allocation to private‑equity – the asset class that houses its leveraged‑buyout, venture‑capital, growth **and special‑situation** strategies – was 8 % of total assets in both 2022 and 2023 (the 2023 filing shows 8 % for each year) and rose to 9 % in 2024【page_92†L31-L38】【page_99†L31-L38】. The flat‑then‑slight‑upward trend indicates that Boeing is gradually increasing its exposure to private‑equity, signaling a modest but growing emphasis on higher‑return, illiquid special‑situation opportunities within its long‑term investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific quantitative claims (8% in 2022-2023, 9% in 2024) that directly contradict the ground truth, which explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year.' The ground truth indicates that while Special Situation Strategies were mentioned as a category, no separate allocation percentages were disclosed. The LLM appears to have cited pension plan allocation percentages for the entire private equity asset class (which may be accurate), but incorrectly attributed these to Special Situation Strategies specifically. This is a fundamental misunderstanding of the question and the available data. The LLM conflates overall private equity allocation with Special Situation Strategies allocation, which are different metrics. The ground truth emphasizes 'strategic continuity' and 'consistent inclusion' without quantitative disclosure, whereas the LLM provides specific percentages suggesting a trend analysis that the ground truth explicitly says 'limits trend analysis.' The reasoning about 'gradually increasing exposure' and 'modest but growing emphasis' is speculative and unsupported by the disclosed data. While the LLM correctly identifies Special Situation Strategies as part of BA's private equity portfolio, it fundamentally misrepresents the availability and nature of allocation data. The citation format suggests the LLM may have referenced actual filing pages, but the interpretation of those pages appears incorrect relative to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 428,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "- Interventional Solutions worldwide sales jumped from **$4.3 billion in 2022** to **$6.35 billion in 2023** (a 47.7 % increase)【page_90】, and the franchise’s momentum carried into 2024, helping lift the MedTech segment’s total worldwide sales to **$31.86 billion in 2024** (up 4.8 % versus 2023)【page_93】.  \n\n- This rapid growth—especially after the December 2022 acquisition (and a further acquisition in May 2024) noted in the footnotes【page_93】—shows that Interventional Solutions has become a key growth engine for J&J’s MedTech business, underscoring its strategic importance post‑acquisition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) YEAR MISALIGNMENT: The LLM states '$4.3 billion in 2022' and '$6.35 billion in 2023', but the ground truth clearly shows 2022=$3,971M, 2023=$4,300M, 2024=$6,350M. The LLM has shifted all years forward by one position, making 2023 data appear as 2022 and 2024 data appear as 2023. (2) MISSING 2024 DATA: The ground truth explicitly provides 2024 sales of $6,350 million, but the LLM fails to report this critical data point. Instead, it only mentions MedTech segment total sales of $31.86B in 2024, which is a different metric entirely and does not answer the specific question about Interventional Solutions' 2024 performance. (3) CALCULATION ERROR: The LLM calculates a 47.7% increase from $4.3B to $6.35B, which is mathematically correct for those numbers, but those numbers are assigned to the wrong years. The actual progression should show: 2022-2023 increase of 8.3% ($3,971M to $4,300M) and 2023-2024 increase of 47.7% ($4,300M to $6,350M). (4) INCOMPLETE ANSWER: The question asks about evolution 'from 2022 through 2024' - requiring all three data points. The LLM only provides two years of Interventional Solutions data (albeit mislabeled). (5) MULTI-HOP REASONING: While the LLM correctly identifies the strategic importance and acquisition context, this qualitative reasoning cannot compensate for the fundamental quantitative errors. The answer demonstrates understanding of the question's intent but fails catastrophically on factual accuracy. The reference to a May 2024 acquisition is additional context not in the ground truth, suggesting potential hallucination or confusion with other acquisitions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 477,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Walmart kept “No Boundaries” in the same spot – as a private‑brand line within its **general‑merchandise** unit of Walmart U.S. – in each of the three filings. The brand appears in the private‑brand list for fiscal 2022 (see page 7), again in the 2023 filing (page 7) and is unchanged in the 2024 filing (page 7). This three‑year continuity shows Walmart’s deliberate strategy to maintain a stable, value‑focused private‑label portfolio in its core general‑merchandise categories, reinforcing its everyday‑low‑price model and long‑term commitment to private‑label growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: 'No Boundaries' remained a consistent private brand across 2022-2024 within general merchandise. The answer accurately captures the three-year continuity and correctly notes the brand's positioning in Walmart U.S.'s general merchandise unit. However, there are notable gaps compared to the ground truth: (1) The LLM mentions page references (page 7) without verification that these are accurate citations, which could be problematic if incorrect. (2) The LLM misses the important detail about the merchandise unit reorganization in 2024 where 'Apparel' shifted to a new 'Fashion' category - this is a significant structural change that the ground truth explicitly mentions as context for understanding the brand's evolution. (3) The LLM's explanation of the strategy focuses on 'everyday-low-price model' and 'value-focused' positioning, which is reasonable inference but differs from the ground truth's emphasis on 'margin expansion in competitive categories' and 'differentiate offerings.' (4) The LLM correctly synthesizes the multi-hop information (tracking the brand across three years and merchandise units) but doesn't fully address how the reorganization affected the brand's positioning. The core factual claim about consistency is correct, but the answer lacks the nuanced understanding of the organizational changes that provide fuller context for the strategic positioning evolution. The answer is fundamentally sound but incomplete in addressing the full scope of how the brand's positioning 'evolved' - it emphasizes consistency but underplays the structural reorganization that occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 452,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023, and the loss widened further to $67 million in fiscal 2024, dragging down other income (loss), net each year【page_46】. This progression shows the investments shifting from a small positive contribution to an increasingly negative impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data that directly addresses the question about Cisco's available-for-sale debt investments across fiscal 2022-2024. STRENGTHS: (1) Provides concrete numbers ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) that show the evolution requested; (2) Correctly identifies the progression from positive to negative impact; (3) Clearly explains the impact on other income (loss), net; (4) Demonstrates proper multi-hop synthesis by connecting investment performance to financial statement impacts across three fiscal years; (5) Uses appropriate financial terminology. VERIFICATION: The specific dollar amounts and directional changes (gain to losses, widening losses) align with the ground truth's description of 'higher losses' in 2023 and 2024, and the characterization of fiscal 2022 as having a different (positive) impact. The numbers show a clear quantifiable trajectory that supports the ground truth's narrative of 'consistent negative impact' in the latter years. MINOR CONSIDERATIONS: (1) The ground truth uses more general language ('higher losses') while the LLM provides specific figures - this is actually a strength as it's more precise; (2) The LLM answer is more concrete and data-driven than the ground truth, which is appropriate for a financial analysis question; (3) The citation reference [page_46] adds credibility. The answer fully addresses all parts of the multi-hop question: the evolution from FY2022 to FY2024, the specific impacts on other income (loss), net, and the year-over-year comparison. No calculation errors detected. The semantic meaning aligns perfectly with the ground truth's conclusion about negative trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 466,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In the 2022 filing the company noted that discount‑revenue is earned both from merchants that sign direct acceptance agreements and from “other third‑party merchant acquirers (e.g., under our OptBlue program or certain GNS partners)” that settle a network‑rate fee on each transaction 【page_104】. The 2023 filing repeats this description, showing that third‑party acquirers continue to support the bulk of small‑ and mid‑size merchant activity while large merchants are covered by longer‑term contracts 【page_103】. By 2024, the discussion shifts to a strategic view, stating that the success of “third‑party merchant acquirers, aggregators and processors” is a key driver of expanding merchant coverage worldwide and of growing transaction volume across small, mid‑sized and large merchants 【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about American Express's evolving reliance on third-party merchant acquirers from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with accurate characterization of each period's focus; (2) Accurately cites specific programs (OptBlue, GNS) and correctly describes the network-rate fee structure; (3) Properly synthesizes the evolution from transactional description (2022-2023) to strategic dependency (2024); (4) Correctly identifies the merchant segments (small, mid-sized, large) and their coverage patterns; (5) Appropriately notes the shift in strategic importance across the three-year period; (6) Includes page references that ground the answer in source material. MINOR CONSIDERATIONS: (1) The LLM answer is more concise than the ground truth, focusing on the key evolution narrative rather than elaborating on the 'financial integration' aspect mentioned in the original answer regarding how discount revenue is recorded; (2) The phrase 'shift to a strategic view' in 2024 captures the essence of the ground truth's 'deeper strategic dependency' but uses slightly different framing; (3) The answer could have been slightly more explicit about the 'shift from supplementary to essential' characterization, though this is clearly implied. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filing years, correctly identifying the progression and evolution of American Express's relationship with third-party acquirers. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while maintaining appropriate brevity and clarity. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 494,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a **multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for human resources, information technology, procurement, supply‑chain and finance** – a program designed to grow its financial shared‑service capabilities and to standardize its financial systems【page_117】. The 2023 filing repeats the same description, confirming the effort is still underway and that the company is **continuing to align and streamline the design and operation of its financial control environment** as the integration matures【page_118】, and the 2024 filing again reiterates the initiative and its ongoing alignment with enterprise‑wide process‑standardization across those functions【page_119】. Together, the three years show a consistent, evolving rollout that remains focused on expanding shared‑service capacity while embedding standardized HR, IT, procurement, supply‑chain and finance processes throughout the enterprise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative spanning 2022-2024; (2) Accurately lists all five functional areas (HR, IT, procurement, supply chain, finance); (3) Properly synthesizes the evolution across three years showing consistency and continuity; (4) Correctly captures the key narrative elements: growth of financial shared service capabilities, standardization of financial systems, alignment and streamlining of financial control environment; (5) Appropriately notes this was a proactive effort not prompted by identified deficiencies/weaknesses; (6) Uses proper semantic equivalence (e.g., 'continuing to align and streamline' matches ground truth language). MINOR CONSIDERATIONS: (1) The LLM answer includes page references (page_117, page_118, page_119) which add specificity but are not present in the ground truth - however, this is supplementary detail that enhances rather than detracts from accuracy; (2) The phrasing 'evolving rollout' and 'embedding standardized processes' conveys the same meaning as ground truth's 'consistent, multi-year approach' and 'long-term strategic commitment'; (3) All three years (2022, 2023, 2024) are correctly referenced with appropriate progression of the narrative. QUANTITATIVE ACCURACY: No numerical data, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, correctly identifying the consistent thread while noting the evolution and maturation of the initiative. The logical flow from initial launch through continuation to reiteration is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth with appropriate flexibility in wording while maintaining factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 539,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "In the 2022 and 2023 10‑K filings (see the “Competition” sections on pages 12‑13 of each report) American Express already warned of “intense competition” and the emergence of “alternative payment mechanisms” that could erode its merchant‑discount revenue. By the 2024 filing, that pressure is described as coming from large tech firms that are building proprietary digital wallets and real‑time settlement platforms (page 29), and the company now says it is actively investing in open‑banking interfaces, tokenization, real‑time settlement and related technologies to preserve its network relevance (page 31). This marks a shift from merely acknowledging the threat to explicitly adapting its strategy to the new open‑banking, digital‑wallet and real‑time‑settlement landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core narrative arc and strategic evolution of American Express's positioning from 2022-2024, correctly identifying the shift from viewing alternative payment mechanisms as threats to adopting them strategically. The qualitative reasoning is sound and well-structured.\n\nSTRENGTHS:\n1. Correctly identifies the three-year evolution (2022→2023→2024)\n2. Accurately names specific technologies: digital wallets, open banking, real-time settlement, tokenization\n3. Properly synthesizes the strategic shift from defensive acknowledgment to proactive investment\n4. Correctly identifies competitive threats from tech firms and payment aggregators\n5. Appropriately cites specific filing sections (Competition sections, pages referenced)\n6. Semantic equivalence is strong - conveys the same transformation narrative as ground truth\n\nWEAKNESSES:\n1. QUANTITATIVE ACCURACY ISSUE: The LLM cites specific page numbers (pages 12-13, page 29, page 31) without verification. The ground truth does not provide these page citations, making it impossible to verify their accuracy. This is a significant concern for factual precision.\n2. MISSING DETAIL: The ground truth explicitly mentions \"dynamic and rapid growth\" as language from 2022 filings - the LLM uses \"intense competition\" instead, which is semantically similar but not the exact characterization from the source.\n3. INCOMPLETE SYNTHESIS: The ground truth notes that by 2024 the company shifted to \"strategic dependence\" on these technologies - the LLM captures this as \"actively investing\" but doesn't fully convey the dependency aspect.\n4. MISSING CONTEXT: The ground truth mentions the scope of alternative mechanisms expanded in 2023 to include \"more integrated financial services offerings from competitors\" - the LLM doesn't explicitly address this 2023 expansion.\n\nMULTI-HOP REASONING: The multi-hop synthesis is generally sound - the model correctly connects information across three years and identifies the progression. However, the unverified page citations create uncertainty about whether the synthesis is based on actual filing content.\n\nOVERALL ASSESSMENT: The answer captures the essential narrative and demonstrates good understanding of American Express's strategic evolution. The core claim about the shift from threat acknowledgment to strategic adoption is correct. However, the specific page citations without verification and some missing nuances prevent a higher score. The answer would be stronger with verified citations or without specific page numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 689,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In Adobe’s 2022 10‑K (pages 95‑99) Frame.io is not discussed, indicating it was not yet a prominent part of the company’s product narrative【page_95】. By the 2023 10‑K (page 12) Adobe describes Frame.io as a cloud‑native creative‑collaboration platform tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and offered through GenStudio, and the 2024 10‑K (page 12) repeats this expanded integration【page_12】. This shift from omission to deep, cross‑app integration shows Adobe’s strategy of turning Frame.io into a core, cloud‑based collaboration layer across Creative Cloud, making collaborative workflows a central pillar of its offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the progression from 2022 (Frame.io not prominently discussed) to 2023-2024 (expanded integration). (2) The core narrative about Frame.io becoming a cross-app collaboration platform is accurate. (3) The identification of integrated apps (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) is correct. (4) The conclusion about Adobe's strategy to make Frame.io a central collaboration layer is sound.\n\nWEAKNESSES: (1) The LLM states Frame.io was 'not discussed' in 2022, but the ground truth indicates it was 'listed among Adobe's trademarks,' suggesting some presence/recognition in 2022. The LLM's characterization of complete omission is slightly inaccurate. (2) The LLM mentions GenStudio in the 2023 context, which is not mentioned in the ground truth answer and may represent additional information not directly relevant to Frame.io's evolution. (3) The LLM misses important 2024 expansion details: the ground truth specifically mentions Frame.io's expansion into 'casting, location scouting, and marketing campaign management' - broader video workflows beyond post-production. This is a significant omission as it demonstrates the scope of Frame.io's evolution. (4) The ground truth emphasizes Frame.io becoming 'a central hub for multi-app, cross-functional workflows at scale' with specific workflow examples, while the LLM provides a more generic characterization.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022-2024) and correctly identifies the progression pattern. However, it fails to capture the full depth of the 2024 expansion into new use cases beyond post-production.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are involved in this question. Page references are provided but cannot be independently verified. The factual claims about product integrations and positioning are largely accurate but incomplete regarding 2024 capabilities.\n\nOVERALL ASSESSMENT: The answer captures the main narrative arc correctly but omits important details about Frame.io's 2024 expansion into new workflow categories (casting, location scouting, marketing). The characterization of 2022 as complete omission is slightly inaccurate. The answer is directionally correct but lacks the specificity and completeness of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 629,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from $16 billion at the end of 2022 to $15 billion at the end of 2023 and then to $13 billion at the end of 2024【page_58】【page_57】. This steady decline shows Amazon is actively repurchasing or retiring this tranche, using cash flow to reduce its long‑term debt and improve its balance‑sheet leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $16 billion (2022), $15 billion (2023), and $13 billion (2024). The progression and year-end dates match the ground truth exactly. (2) ENTITY ACCURACY: Amazon and the 2017 Notes are correctly identified. The fiscal years (2022-2024) are accurate. (3) MULTI-HOP REASONING: The answer correctly synthesizes the three-year progression and draws appropriate conclusions about debt management strategy. The interpretation that Amazon is 'actively repurchasing or retiring this tranche' and 'using cash flow to reduce its long-term debt' aligns with the ground truth's characterization of 'deliberate debt management strategy to gradually pay down this liability.' (4) COMPLETENESS: The answer addresses both parts of the question - the evolution of the balance AND what it indicates about debt management strategy. (5) MINOR DIFFERENCES: The LLM uses slightly different phrasing ('actively repurchasing or retiring' vs. 'gradually pay down') and adds the detail about 'improve its balance-sheet leverage,' which is a reasonable inference from debt reduction but not explicitly stated in the ground truth. The citation references (page_58, page_57) suggest proper sourcing. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate interpretation of the debt management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 401,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s Business description lists “upgrades and conversions” as a core element of Global Services in each filing – it appears in the 2022 description (Item 1, page 3), again in the 2023 description (Item 1, page 5), and is unchanged in the 2024 description (Item 1, page 5). The steady presence of this service over the three‑year span shows Boeing is keeping aftermarket modernization and conversion work central to its strategy for sustaining and extending the life of its aerospace platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies 'Upgrades and Conversions' as a consistent element across all three years (2022, 2023, 2024); (2) Accurately cites specific filing locations (Item 1, pages 3 and 5); (3) Properly synthesizes the multi-hop concept that consistency across years indicates strategic focus; (4) Uses appropriate terminology ('aftermarket modernization,' 'lifecycle management') that aligns with the ground truth's characterization; (5) Correctly interprets the trajectory as 'unchanged' and 'steady presence,' matching the ground truth's 'sustained' and 'remained unchanged' language. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual details about 'supply chain management and maintenance' being listed alongside Upgrades and Conversions in 2022, though this omission doesn't affect the core answer's accuracy; (2) The phrase 'unchanged in the 2024 description' could be more explicitly comparative to 2023, though the meaning is clear; (3) Doesn't explicitly mention 'defense and commercial needs' as context, though this is a minor detail. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page references appear accurate based on standard 10-K formatting; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings to establish a pattern and draw a strategic conclusion, which is the core requirement of the question. The reasoning that 'steady presence = strategic commitment' is sound and matches the ground truth's logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 469,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "From the 2022 filing onward, Johnson & Johnson repeatedly restated the amendment it announced in January 2021: effective January 1 2026 all eligible U.S. non‑union employees – regardless of whether they were hired before or after January 1 2015 – will earn pension benefits under the Retirement Value formula, and the change will not affect benefits already accrued under the Final Average Pay formula for service before that date. The 2023 and 2024 10‑K reports simply reaffirmed this same eligibility expansion and the 2026 implementation date, indicating that the company’s pension strategy remained consistent across the three years. (Sources: 2022 10‑K p. 73; 2023 10‑K p. 77; 2024 10‑K p. 77)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across three years of SEC filings. STRENGTHS: (1) All dates are correct - January 2021 announcement, January 1 2026 implementation date, and the three-year period (2022-2024) are all accurate. (2) Numeric/quantitative elements are precise: correctly identifies the 2015 hire date threshold and the consistent messaging across all three years. (3) Multi-hop reasoning is sound - the answer successfully synthesizes information from 2022, 2023, and 2024 10-K filings to show consistency in strategy and messaging. (4) Entity accuracy is perfect - Johnson & Johnson, U.S. non-union employees, Retirement Value formula, and Final Average Pay formula are all correctly identified and contextualized. (5) The answer correctly captures the key evolution (or lack thereof): the strategy remained consistent with no changes to plan or timeline across the three years. (6) Eligibility criteria are accurately stated - all U.S. non-union employees regardless of hire date, with pre-2015 hires retaining Final Average Pay for pre-2026 service. (7) Page citations (2022 10-K p. 73; 2023 10-K p. 77; 2024 10-K p. 77) add credibility and specificity. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth, but this represents added clarity rather than inaccuracy. The semantic meaning is fully aligned with the original answer - both convey that the strategy remained unchanged from 2022-2024, with consistent communication of the 2026 implementation date and unchanged eligibility criteria. The answer fully addresses all parts of the multi-part question regarding evolution, eligibility, and communication around the 2026 date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 480,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million** at the end of fiscal 2022 (AVGO 2022 10‑K, p. 101), and the same $606 million was reported at the end of fiscal 2023 and fiscal 2024 (AVGO 2023/2024 10‑K, p. 81). The balance remained unchanged, showing that the company has been maintaining this low‑cost, long‑dated debt rather than repurchasing or issuing more of it—i.e., it is using the notes as a stable, long‑term financing tool.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. According to the original answer (from the knowledge graph), AVGO's 5.000% notes due April 2030 had an outstanding principal of $1,086 million in fiscal 2022, which decreased to $606 million in fiscal 2023, and remained at $606 million in fiscal 2024. However, the LLM claims the balance was $606 million at the end of fiscal 2022, which is incorrect. The LLM has essentially skipped the first year of the progression and misrepresented the evolution of the debt. This is a major quantitative error that undermines the entire answer. The question specifically asks about the evolution 'from fiscal year 2022 through 2024,' requiring all three data points. The LLM only provides two distinct values and misplaces them chronologically. Additionally, while the LLM's interpretation about debt management strategy (maintaining stable long-term financing) is reasonable, it fails to capture the significant $480 million reduction that occurred between FY2022 and FY2023, which is the most important indicator of the company's debt management strategy for this instrument. The LLM's conclusion that the company is 'maintaining this low-cost, long-dated debt' misses the deliberate reduction strategy that the ground truth emphasizes. The multi-hop reasoning is incomplete and the synthesis across the three fiscal years is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 401,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s relationship with Time Warner shifted dramatically after 2022. In April 2022 the company completed a Reverse‑Morris‑Trust spin‑off that moved its WarnerMedia business – built around the 2018 Time Warner acquisition – into discontinued operations, ending AT&T’s direct ownership of the content assets 【page_4】. The 2023 filing shows how WarnerMedia was restructured beforehand, first agreeing to combine it with Discovery (May 2021) and then selling the Xandr marketplace to Microsoft (Dec 2021), reflecting the operational break‑up of the former Time Warner assets 【page_6】. By the 2024 report the WarnerMedia segment no longer appears as a reportable unit, but AT&T still highlights HBO Max as a strategic focus area, indicating that its involvement now rests on its equity stake in the spun‑off Warner Bros. Discovery entity rather than on operating the business 【page_7】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AT&T's strategic evolution regarding Time Warner/WarnerMedia from 2022-2024, with mostly accurate facts and dates. STRENGTHS: (1) Correctly identifies April 2022 as the Reverse Morris Trust completion date; (2) Accurately notes the May 2021 agreement to combine WarnerMedia with Discovery; (3) Correctly mentions the December 2021 sale of Xandr to Microsoft; (4) Properly explains the shift from direct ownership to equity stake in Warner Bros. Discovery; (5) Accurately states WarnerMedia no longer appears as a reportable segment by 2024; (6) Good multi-hop synthesis connecting the 2018 acquisition through the 2022 spin-off to 2024 positioning. WEAKNESSES: (1) The LLM answer contains a temporal inconsistency - it states the Reverse Morris Trust was completed in April 2022 (correct) but then says 'By 2023, the company had already separated' in the ground truth, yet the LLM presents this as happening before 2023, which is accurate but could be clearer; (2) The ground truth mentions 'finalized the divestiture of its remaining interest in DIRECTV' in 2024, but the LLM answer does not address DIRECTV at all - this is a notable omission as DIRECTV was explicitly mentioned in the ground truth as 'the last major asset tied to the entertainment strategy'; (3) The LLM mentions HBO Max as a 'strategic focus area' in 2024, which is not explicitly confirmed in the ground truth provided; (4) Minor: The LLM uses page citations that cannot be verified against the ground truth. QUANTITATIVE ACCURACY: All dates are correct (April 2022, May 2021, December 2021). No calculations required. QUALITATIVE ACCURACY: The reasoning about the strategic pivot is sound and well-synthesized across the three-year period. However, the omission of DIRECTV divestiture represents incomplete synthesis of the multi-hop question about 'broader WarnerMedia segment' evolution. CONTEXTUAL RELEVANCE: Highly relevant to the question about integration, restructuring, and divestiture, though incomplete regarding the DIRECTV component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 556,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 to 2024 AIG has consistently relied on a third‑party vendor model to simulate terrorism loss scenarios—initially spelling out specific attacks such as conventional bombs, anthrax and nuclear events in 2022 [page_169] and then referring more generally to scenario‑based modeling in 2023 [page_121] and 2024 [page_88]. Throughout the period the firm kept targeted reinsurance purchases and dependence on TRIPRA, limited private reinsurance and government‑sponsored terrorism pools for both U.S. and international exposures [page_169, page_121, page_88], and in 2024 it explicitly retained core attachment points of $200 million for Japan and $125 million for the rest of the world [page_88], showing a stable geographic attachment‑point framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All quantitative data is correct - the $200 million Japan attachment point and $125 million rest-of-world attachment point are accurately cited for 2024, matching the ground truth exactly. (2) The multi-hop synthesis across three years (2022-2024) is sound, correctly identifying the evolution from specific attack scenarios (conventional bombs, anthrax, nuclear) in 2022 to more general scenario-based modeling in 2023-2024. (3) The answer correctly identifies key components: third-party vendor modeling, TRIPRA reliance, private reinsurance, and government-sponsored terrorism pools. (4) The geographic attachment point framework is accurately characterized as stable and region-specific. (5) Page citations add credibility and traceability. MINOR WEAKNESSES: (1) The ground truth explicitly mentions a '$1.3 billion loss' estimate for a five-ton bomb attack in New York City in 2022, which the LLM answer does not include. While the LLM references specific attack types (conventional bombs, anthrax, nuclear), it doesn't quantify the modeled loss scenario. (2) The characterization of the evolution differs slightly - the ground truth emphasizes a 'strategic shift from reactive modeling to proactive geographic risk segmentation,' while the LLM describes it more as 'stable' and 'consistent,' which is somewhat less dynamic in tone but not factually incorrect. (3) The LLM could have been more explicit about the 2023 'participation in international terrorism pools' mentioned in the ground truth, though this is implied in the broader reinsurance discussion. CALCULATION/VERIFICATION: No calculations required; all cited figures are accurate. ENTITY ACCURACY: AIG correctly identified throughout; years 2022-2024 correctly referenced; metrics (attachment points, TRIPRA, reinsurance) correctly identified. SEMANTIC EQUIVALENCE: The answer conveys the core information effectively, with the main omission being the specific $1.3 billion loss figure rather than a fundamental misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 566,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "In 2022 Emerson’s Tools & Home Products segment described its pipe‑working tools as “pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, drain cleaners, tubing tools and diagnostic systems, including closed‑circuit‑television pipe inspection and locating equipment”【page_9】. By 2023‑24 the Safety & Productivity segment’s description had been refreshed to list “pipe wrenches and cutters, pipe threading and roll‑grooving equipment, battery‑hydraulic tools for press connections, drain cleaners and diagnostic systems, including sewer inspection cameras and locating equipment”【page_73】, while segment sales stayed flat at roughly $1.4 billion each year【page_74】. This evolution shows Emerson is augmenting its core wrench offering with newer battery‑powered hydraulic tools and updated diagnostics, signaling a strategic push to modernize and capture higher‑margin, technology‑focused opportunities in the professional tools market while preserving its traditional product base.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions: (1) FACTUAL ACCURACY: The product portfolio evolution is correctly traced from 2022 to 2023-24, with accurate product listings including pipe wrenches, cutters, threading equipment, drain cleaners, and diagnostic systems. The introduction of battery-hydraulic tools for press connections and sewer inspection cameras is correctly identified as a 2023-24 addition. (2) QUANTITATIVE ACCURACY: The segment sales figure of approximately $1.4 billion for both years is accurate and appropriately contextualized. The LLM correctly notes sales remained flat, which is a meaningful observation about the segment's performance during this period. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple years and segments (Tools & Home Products in 2022 transitioning to Safety & Productivity in 2023-24), correctly identifying the segment name change and product evolution. (4) STRATEGIC POSITIONING: The LLM correctly interprets the evolution as a strategic modernization effort, emphasizing the shift toward battery-powered and diagnostic technologies while maintaining traditional products. The conclusion about capturing higher-margin, technology-focused opportunities aligns with the ground truth's assessment of strategic positioning. (5) MINOR CONSIDERATIONS: The LLM provides more specific product details and segment sales data than the ground truth, which adds value without contradicting it. The citation references (page numbers) enhance credibility. The answer is comprehensive, addressing both the portfolio evolution and its strategic implications. No factual errors, calculation mistakes, or entity misidentifications were detected. The semantic meaning and conclusions match the ground truth effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 499,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "In the 2022 filing Costco’s lease note only described the lease options (renewal, purchase, right‑of‑first‑refusal) and did not mention free‑rent periods at all (COST_10k_2022.pdf p.44). Beginning with the 2023 Form 10‑K – and repeated in the 2024 filing – the company added that “some leases include free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise” (COST_10k_2023.pdf p.45; COST_10k_2024.pdf p.45). This straight‑line recognition spreads the rent expense evenly and, because the right‑of‑use (ROU) asset is measured at the present value of lease payments, the zero‑payment free‑rent periods reduce the total lease payments and therefore lower the initial ROU‑asset valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims that in 2022, Costco's lease note 'did not mention free-rent periods at all,' but the ground truth explicitly states that Costco 'consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024).' This is a fundamental contradiction. (2) REVERSED TIMELINE: The LLM suggests free-rent period disclosure was ADDED in 2023-2024, when the ground truth indicates the methodology was consistent across all three years with disclosure details actually DECREASING in 2023-2024. (3) MISSING KEY INFORMATION: The LLM completely omits the critical 2022 disclosure about discounted future minimum lease payments, incremental borrowing rates, and ARO treatment—details that were explicitly mentioned in 2022 but not repeated in later years. This is the core of the evolution story. (4) INCOMPLETE ANALYSIS: The LLM fails to address the 'shift toward more standardized ASC 842 compliance language' and the 'maturation of lease accounting practices post-adoption period' that characterizes the actual evolution. (5) LOGICAL ERROR: The LLM's explanation of how free-rent periods 'reduce the total lease payments and therefore lower the initial ROU-asset valuation' is mechanically correct but misses the broader point about disclosure depth changes. The answer demonstrates a fundamental misreading of the source documents and provides an inverted narrative of how Costco's disclosures actually evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 439,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "- In the 2022 filing the only 2.000 % series shown is in **Exhibit 4.13 (Tenth Supplemental Indenture)** – “2.000 % Notes due 2020” 【page_105】.  \n- In the 2023 filing a new 2.000 % series appears in **Exhibit 4.14 (Eleventh Supplemental Indenture)** – “2.000 % Notes due 2023” 【page_105】, shifting the maturity three years later.  \n- By the 2024 filing the 2.000 % series is no longer listed among the outstanding notes, indicating the 2023 maturity has been reached and no additional 2.000 % issuance is documented.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - 2022 Filing: LLM claims \"2.000% Notes due 2020\" under Tenth Supplemental Indenture. Ground truth states the 2.000% Notes were due 2023 under the Eleventh Supplemental Indenture (dated August 8, 2016). This is a fundamental error - the maturity date is wrong (2020 vs 2023) and the indenture is wrong (Tenth vs Eleventh).\n   - 2023 Filing: LLM claims this is a \"new\" 2.000% series appearing for the first time under Eleventh Supplemental Indenture with 2023 maturity. Ground truth indicates this was the SAME note referenced in 2022, not a new issuance. The LLM incorrectly characterizes this as a shift in maturity \"three years later\" when it was already due 2023 in 2022.\n   - 2024 Filing: LLM states the 2.000% series is \"no longer listed among the outstanding notes.\" Ground truth indicates the notes were \"still present in the exhibit list\" in 2024, suggesting they remained part of historical indenture documentation even after maturity.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - Wrong maturity dates (2020 vs 2023 in 2022 filing)\n   - Incorrect characterization of timeline evolution (claims a 3-year shift when there was no shift)\n   - Misidentifies which supplemental indenture applies in 2022\n\n3. MULTI-HOP REASONING FAILURE:\n   - Failed to correctly synthesize the consistent nature of the debt instrument across three years\n   - Incorrectly interpreted the data as showing multiple different issuances rather than one stable instrument\n   - Misunderstood the relationship between the indentures and the notes\n\n4. SEMANTIC MISALIGNMENT:\n   - Ground truth emphasizes \"stable inclusion\" and \"no modifications\" - LLM describes it as evolving with new issuances and maturity shifts\n   - Ground truth notes the documentation remained in exhibits post-maturity - LLM claims it's no longer listed\n\nThe LLM answer fundamentally misrepresents the evolution of Microsoft's 2.000% Notes, getting the core facts wrong about which indenture applied in each year, the maturity dates, and whether these represented new issuances or a single stable instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 593,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "- 2022 10‑K – Amazon described its seller‑service revenue as “fixed fees, a percentage of sales, per‑unit activity fees, interest, or some combination thereof” and said the revenue is recognized when the services are performed 【page_3】.  \n- 2023 10‑K – The company clarified that “commissions and any related fulfillment and shipping fees we earn from these arrangements are recognized when the services are rendered, which generally occurs upon delivery of the related products to a third‑party carrier or, in the case of an Amazon delivery, to the customer” 【page_43】.  \n- 2024 10‑K – The same language on recognizing commissions and fulfillment fees at delivery was retained, indicating no change in timing or composition from the 2023 filing 【page_3】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amazon's revenue recognition evolution from 2022-2024. STRENGTHS: (1) All factual information is correct - the 2022 description of 'fixed fees, a percentage of sales, per-unit activity fees, interest, or some combination thereof' matches the ground truth; (2) The 2023 clarification about commissions and fulfillment/shipping fees being recognized 'when services are rendered, which generally occurs upon delivery of the related products to a third-party carrier or, in the case of an Amazon delivery, to the customer' is accurately captured; (3) The 2024 finding that language was retained with no changes is correct; (4) The multi-hop synthesis across three years is sound, showing the evolution from general description to specific timing clarification to consistency; (5) Page references are provided, adding credibility; (6) The answer directly addresses both timing and composition aspects of the question. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth in some areas - it doesn't explicitly state 'increasing clarity in disclosures over time' as a meta-observation, though this is implied; (2) The ground truth mentions 'reinforcing its commitment to enabling sellers to grow through its platform' for 2024, which the LLM answer omits, though this is contextual rather than substantive to the revenue recognition question. QUANTITATIVE ACCURACY: No calculations or specific dollar amounts were required; all dates (2022, 2023, 2024) and descriptive metrics are correct. REASONING: The multi-hop reasoning correctly synthesizes information across three separate 10-K filings and identifies the progression from general to specific disclosure, then consistency. The answer properly distinguishes between what changed (disclosure clarity) and what remained consistent (recognition timing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 523,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T still lists a “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” (Exhibit 4‑c) in its recent 10‑K exhibit schedules, showing that the company continues to back‑stop the debt of those legacy subsidiaries in 2022, 2023 and 2024【page_103】. By keeping these guarantees in place, AT&T signals a long‑term liability‑management strategy that retains responsibility for historic telecom entities—using corporate guarantees to preserve credit quality, contain legacy risk and maintain control over the obligations of its predecessor businesses【page_98】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its accuracy. The ground truth specifies that AT&T guaranteed Southwestern Bell Telephone Co.'s obligations, but the LLM answer incorrectly includes Pacific Bell Telephone Co. as a co-guaranteed entity (Exhibit 4-c vs. Exhibit 4-b). This is a material error in entity identification. The LLM correctly identifies the three-year period (2022, 2023, 2024) and the core concept that AT&T maintained these guarantees consistently. However, the inclusion of Pacific Bell alongside Southwestern Bell is factually incorrect according to the ground truth. The LLM's interpretation of the strategy—that AT&T uses guarantees to preserve credit quality and maintain control—is reasonable and adds some analytical depth beyond the ground truth, but this interpretive value is offset by the entity error. The answer demonstrates partial understanding of the multi-hop synthesis (connecting guarantee persistence across years to strategy implications), but the wrong company name and exhibit reference represent a clear factual mistake. The dates and years are correct, and the general reasoning about liability management strategy is sound, but the specific entity error prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 351,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s outstanding balance of its 2.250 % Notes due 2050 fell from $983 million in 2022 (​page 67​) to $826 million in 2023 (​page 71​) and to $808 million in 2024 (​page 72​). This steady decline shows the company is gradually retiring or refinancing this long‑dated, low‑coupon debt, reflecting a deliberate strategy to streamline its long‑term capital structure while preserving low‑cost financing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all three key financial figures correct: $983 million (2022), $826 million (2023), and $808 million (2024). The year-over-year progression is accurately captured, and the characterization of the trend as a 'steady decline' is appropriate. The answer correctly identifies the debt instrument (2.250% Notes due 2050) and properly synthesizes the multi-year data. However, there are notable omissions compared to the ground truth: (1) The LLM does not mention the fixed effective rate of 2.29% that remained constant throughout the period, which is a specific detail provided in the original answer; (2) The LLM's interpretation focuses on 'retiring or refinancing' the debt, while the ground truth emphasizes a 'cautious approach to managing long-dated liabilities while maintaining a stable cost of capital' - these are subtly different strategic characterizations. The LLM's framing of 'streamlining' the capital structure is reasonable but slightly different from the ground truth's emphasis on stability and deliberate strategy. The answer is well-structured with page references and addresses the core question about how the investment evolved and what it indicates about strategy, but misses some nuanced details about the company's approach to maintaining low-cost financing. The reasoning is sound and the multi-hop synthesis across three years is correct, but the strategic interpretation could be more complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 409,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were carried at a constant $1.25 billion in 2022 (COST_10k_2022.pdf page 52) and remained unchanged in the 2023 and 2024 balance‑sheet presentations (COST_10k_2024.pdf page 52). At the same time the company retired its higher‑cost 2.750 % notes in 2024, shrinking the current‑portion of debt from $1,081 million in 2023 to $103 million in 2024 (COST_10k_2024.pdf page 52), which shows a capital‑management strategy of preserving low‑cost, long‑dated financing while using cash to pay down higher‑interest obligations and extend the overall debt maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 1.375% Senior Notes at $1.25 billion ($1,250 million) as constant across 2022-2024, matching ground truth exactly. (2) The format variation ($1.25 billion vs $1,250 million) is acceptable. (3) The LLM correctly identifies the strategic insight about preserving low-cost, long-dated financing while retiring higher-cost debt. (4) The specific mention of retiring 2.750% notes in 2024 and the current-portion debt reduction from $1,081M to $103M adds relevant detail. WEAKNESSES: (1) The LLM answer OMITS critical total long-term debt figures that are central to the ground truth: $6,590M (2022), $6,484M (2023), and $5,919M (2024). The ground truth explicitly states these numbers as evidence of 'gradual reduction in overall debt burden.' (2) The LLM does not provide the complete three-year trend analysis of total long-term debt that the ground truth emphasizes. (3) While the LLM's reasoning about capital management strategy is sound and partially overlaps with ground truth, it focuses narrowly on current-portion reduction and specific debt retirement rather than the broader debt structure evolution across all three years. (4) The answer lacks the comprehensive multi-hop synthesis required - it should have connected: (a) the constant 1.375% notes, (b) the declining total debt levels, and (c) the strategic implications of this combination. CALCULATION VERIFICATION: The numbers provided ($1.25B, $1,081M, $103M) appear accurate based on context, but without verification against actual filings, these cannot be fully confirmed. The reasoning about debt reduction strategy is logically sound but incomplete relative to ground truth. The answer addresses the question partially but misses the quantitative evidence of overall debt reduction that is fundamental to understanding Costco's capital management strategy over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 513,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s filings show that its multi‑layered security program – a “robust … program designed to protect our network from cyber and information‑security threats” that now includes third‑party benchmarking, enterprise‑resilience, insurance coverage and dedicated security‑operations centers – was already in place in 2022 (2022 10‑K p. 11) and was further reinforced in 2024 (2024 10‑K p. 11). At the same time, the company’s real‑time account‑based payments infrastructure grew from operating or being implemented in 12 of the top‑50 markets as of Dec 31 2021 (2022 10‑K p. 11) to 13 markets by Dec 31 2023 (2024 10‑K p. 11). The parallel expansion of a more comprehensive, layered security framework with a broader real‑time payments footprint indicates a deliberate strategy to manage processing risk by coupling global scaling of payment flows with increasingly resilient, multi‑layered protection of the network.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All key numbers are correct: 12 markets as of Dec 31, 2021 (2022 10-K), 13 markets by Dec 31, 2023 (2024 10-K), and the progression is accurately captured. (2) The security framework components are correctly identified (third-party benchmarking, enterprise-resilience, insurance coverage, security operations centers) and properly attributed to 2022 and 2024 filings. (3) Multi-hop reasoning is sound: the answer successfully synthesizes the parallel evolution of security capabilities and real-time payments infrastructure across three years (2022-2024), drawing the logical conclusion about deliberate risk management strategy. (4) The answer correctly interprets the qualitative shift from specific market counts to 'several countries around the world' in 2024, though it doesn't explicitly mention this shift. (5) Proper citation format with page numbers enhances credibility. MINOR CONSIDERATIONS: (1) The LLM answer doesn't explicitly mention the 2023 intermediate state (13 markets) as a distinct data point in the progression, though it does reference the 2024 10-K which would contain this information. (2) The phrase 'qualitative shift toward broader global deployment' from the ground truth is not explicitly stated in the LLM answer, though the concept is implied through 'broader real-time payments footprint.' (3) The ground truth notes 'filings do not explicitly state that security measures directly enabled infrastructure expansion' - the LLM answer states the strategy is to 'couple' these elements, which is a reasonable interpretation but slightly stronger than the ground truth's cautious framing. Overall, the LLM answer is factually accurate, well-reasoned, and appropriately addresses the complex multi-hop question about the relationship between security evolution and infrastructure expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 519,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 appear only in the “Third Supplemental Indenture” that was dated Feb 8 2011 and is listed as an exhibit in the 10‑K filings for FY 2022, FY 2023 and FY 2024, with no new issuance or amendment of that series in any of those years【page_104】. The fact that the same historical note is simply carried forward and not re‑issued shows that Microsoft issues debt in discrete tranches, lets each tranche mature (the 2021 notes matured in 2021) and then moves on to new issuances, reflecting a disciplined, stagger‑maturity approach to long‑term debt management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The answer correctly identifies that the 4.000% Notes due 2021 appear in the Third Supplemental Indenture across FY 2022, 2023, and 2024; (2) The reasoning about disciplined, staggered-maturity debt management is sound and aligns with the ground truth interpretation; (3) The answer correctly notes that the same historical note is carried forward without new issuance or amendment. PROBLEMATIC ASPECTS: (1) DATE ERROR - The LLM states the Third Supplemental Indenture was 'dated Feb 8 2011' but the ground truth specifies the base Indenture was 'dated May 18, 2009.' The LLM appears to have confused or misidentified the date of the Third Supplemental Indenture itself; (2) INCOMPLETE CONTEXT - The ground truth emphasizes that despite the note being 'past its maturity date' by 2024, Microsoft continued disclosure, suggesting 'delayed settlement, rollover, or ongoing disclosure requirement.' The LLM mentions the notes 'matured in 2021' but doesn't adequately address the significance of continued disclosure post-maturity in 2024, which is a key insight about debt management strategy; (3) EXHIBIT NUMBER OMISSION - The ground truth specifically references Exhibit 4.6, which the LLM does not mention; (4) MISSING TRANSPARENCY ANGLE - The ground truth emphasizes 'consistent and transparent approach to debt disclosure, even post-maturity,' which the LLM's answer doesn't fully capture. The LLM's interpretation of the pattern is reasonable but less nuanced than the ground truth regarding what post-maturity disclosure indicates about Microsoft's practices. The answer demonstrates adequate understanding of the multi-hop synthesis (tracking the same instrument across three years) but lacks precision on dates and misses important contextual details about post-maturity disclosure implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 510,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s 10‑K filings for 2022, 2023 and 2024 each list an “Officers’ Certificate … containing a Form of 1.500 % Note due 2030” (see pages 72, 75 and 76). By repeatedly keeping this low‑coupon, long‑dated note in its debt portfolio, Amazon signals that it uses the 1.500 % Note as a cornerstone of its capital structure to lock in cheap, stable financing for the next decade, while the other notes it issues carry higher rates and staggered maturities, reflecting a layered strategy that blends low‑cost long‑term debt with higher‑cost, shorter‑term borrowings.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 1.500% Note due 2030 as a consistent element across Amazon's 2022, 2023, and 2024 filings and accurately characterizes it as a low-coupon, long-dated debt instrument. The numeric values (1.500%, 2030 maturity date) and years cited are all correct. The answer appropriately synthesizes the multi-hop concept that Amazon uses this note as a cornerstone of its capital structure strategy.\n\nHowever, the LLM answer is less comprehensive than the ground truth in several ways: (1) It does not mention specific comparable instruments like the 4.700% Note due 2024 or 4.700% Note due 2032, which the ground truth uses to illustrate the contrast between low-cost legacy debt and higher-yielding new issuances. (2) It does not reference the broader 2022 issuance context that included instruments maturing as far as 2060, which provides important context for understanding Amazon's long-term capital strategy. (3) The answer lacks the explicit discussion of how Amazon manages near-term obligations (2024 maturity) alongside long-term debt, which is a key insight in the ground truth. (4) The phrase 'higher-cost, shorter-term borrowings' is somewhat vague compared to the ground truth's specific examples.\n\nThe reasoning is sound and the semantic meaning aligns with the ground truth—both convey that Amazon uses the 1.500% Note as part of a layered debt strategy. The answer correctly identifies the strategic intent (locking in cheap, stable financing) and the comparative approach (blending low-cost long-term with higher-cost shorter-term debt). The citation of specific page numbers (72, 75, 76) adds credibility, though these cannot be independently verified in this evaluation.\n\nThe answer is contextually relevant and addresses the core question about capital structure strategy, but lacks the depth and specific comparative examples that would make it fully equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 523,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "- 2022: AT&T still owned **41.3 % of SKY Mexico** and treated the investment under the **equity‑method** (the 2022 filing notes that “We continue to hold a 41.3 % interest in SKY Mexico, a leading pay‑TV provider in Mexico” 【page_93】).  \n- 2023: The stake remained unchanged; SKY Mexico was listed among AT&T’s **equity‑method affiliates** (“Our investments in equity affiliates at December 31, 2023, primarily included our interests in DIRECTV, Gigapower and SKY Mexico”) 【page_66】.  \n- 2024: In **June 2024 AT&T sold its 41.3 % interest** and removed SKY Mexico from the equity‑method schedule (“In June 2024, we sold our 41.3 % interest in SKY Mexico… Does not include SKY Mexico after disposition in June 2024”) 【page_66】.  \n\n**Implication:** Over the three‑year period AT&T moved from holding a strategic minority stake in an international pay‑TV operator to a complete exit, reflecting a broader divestiture pattern of shedding non‑core media assets (e.g., Vrio, WarnerMedia, Hulu) to focus on its core telecommunications business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All quantitative data is correct - the 41.3% ownership stake is accurately cited for 2022 and 2024, the June 2024 sale date is precise, and the equity method accounting treatment is properly identified for 2022-2023. (2) Multi-hop synthesis is sound - the answer correctly traces the evolution across three years, connecting ownership stake changes to accounting treatment changes to the final exit. (3) Entity identification is accurate - AT&T, SKY Mexico, DIRECTV, Gigapower, and related divestitures (Vrio, WarnerMedia, Hulu) are all correctly named and contextualized. (4) The reasoning about AT&T's broader divestiture strategy is well-supported and logically connects the SKY Mexico exit to the larger pattern of shedding non-core international media assets. (5) Page citations (page_93, page_66) are provided, enhancing credibility. (6) The answer addresses all components of the complex question: ownership stake evolution, accounting treatment, exit details, and strategic implications. MINOR CONSIDERATIONS: The answer could have been slightly more explicit about the 2022 equity method accounting treatment (the ground truth notes it was accounted for under equity method in 2023, and the LLM states 2022 used equity method, which appears consistent with standard practice but could have been more explicitly sourced). However, this is a very minor point as the overall treatment is correct. The semantic equivalence between the LLM answer and ground truth is very high - both convey the same strategic narrative of phased divestiture aligned with core business refocusing. No calculation errors detected. All dates, percentages, and company names are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 487,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path method ties the “return‑seeking” slice of the U.S. qualified pension plan to the plan’s funded ratio – as the ratio rises, the mix is shifted from growth assets toward liability‑hedging assets. The target mix fell from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 (page 250) to an intermediate step in 2023 (where the plan was actually holding about 8 % equity, 77 % fixed‑maturity and 15 % other, reflecting the next glide‑path adjustment, page 252) and to 9 % equity, 80 % fixed‑maturity and 11 % other by 2024 (page 252). The steady reduction in equity exposure and increase in fixed‑income assets shows AIG progressively de‑risking the pension plan as its funded status improves.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable allocation percentages across the three-year period. STRENGTHS: (1) Provides concrete target allocations for each year (2022: 15% equity/75% fixed-maturity/10% other; 2023: 8% equity/77% fixed-maturity/15% other; 2024: 9% equity/80% fixed-maturity/11% other) that show clear de-risking progression; (2) Correctly identifies the glide path mechanism tied to funded ratio; (3) Accurately traces the evolution showing consistent reduction in equity exposure (15%→8%→9%) and increase in fixed-income assets (75%→77%→80%); (4) Properly synthesizes multi-hop information across three years; (5) Includes page references (250, 252) suggesting source verification. MINOR WEAKNESSES: (1) The ground truth emphasizes that allocations are based on funded status at specific year-end dates (Dec 31, 2021 for 2022 target; Dec 31, 2023 for 2024 target; Dec 31, 2024 for 2025 target), which the LLM answer doesn't explicitly state - this is a contextual detail about the timing mechanism; (2) The LLM mentions 2023 as an 'intermediate step' with actual holdings (8%/77%/15%) versus target, which adds nuance but differs slightly from the ground truth's focus on target allocations; (3) Doesn't explicitly mention the 2025 target allocation that would complete the narrative. QUANTITATIVE VERIFICATION: All percentages sum correctly (15+75+10=100, 8+77+15=100, 9+80+11=100). The directional trends are accurate: equity declining, fixed-maturity increasing. The answer successfully demonstrates the de-risking strategy through concrete data. The semantic meaning aligns well with the ground truth's emphasis on liability-driven investing principles and methodical adjustment as funded status improves.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 479,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024 Mastercard moved away from a modest $589 million cash‑settlement fund (2022) to larger, year‑over‑year accruals and more extensive credit‑risk safeguards – risk‑mitigation arrangements rose from $9.2 billion in 2022 to $12.2 billion in 2023 and $13.5 billion in 2024, while accrued MDL liabilities grew to $559 million (2024) (pages 110‑112, 105, 102).  The company also tightened its policy of requiring cash collateral, letters of credit and guarantees for customers that do not meet risk standards and increased monitoring of its credit‑risk portfolio (page 112).  This escalation of mitigation tools demonstrates Mastercard’s ability to adapt its risk‑management framework to heightened regulatory scrutiny and mounting litigation exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported numerical claims not present in the ground truth. CRITICAL ISSUES: (1) FABRICATED NUMBERS: The LLM cites specific dollar amounts ($589 million cash-settlement fund in 2022, risk-mitigation arrangements of $9.2B/$12.2B/$13.5B, and $559M accrued MDL liabilities in 2024) that do not appear in the ground truth. These appear to be hallucinated figures without verification. (2) MISSING REGULATORY CONTEXT: The ground truth explicitly mentions the FTC's finalized consent agreement (2023), DOJ antitrust investigation into U.S. debit program (2023), U.S. Liability Shift Litigation (2024), and European Commission investigation (2024). The LLM answer completely omits these specific regulatory and litigation events, which are central to understanding how Mastercard's risk management evolved in response to external pressures. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Mastercard maintained consistent credit risk mitigation tools (cash collateral, letters of credit, guarantees), it fails to synthesize the temporal evolution of regulatory pressures across the three-year period. The ground truth shows a progression from routine monitoring (2022) → regulatory response (2023) → ongoing refinement amid multiple investigations (2024). (4) UNSUPPORTED CLAIMS: The statement about 'moving away from a modest $589 million cash-settlement fund' lacks grounding in the provided ground truth and appears to misinterpret or fabricate financial data. (5) PARTIAL CREDIT: The LLM correctly identifies that Mastercard tightened policies and increased monitoring, and correctly notes the company's ability to adapt its framework. However, these correct elements are undermined by the fabricated numbers and missing regulatory context. The answer demonstrates some understanding of the general concept but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 529,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Home Depot 10‑K shows that the share pool for future grants fell sharply – about 117 million shares were available under the Omnibus (2005) plan on January 30 2022【page_67】, the pool was down to roughly 77 million shares by January 28 2024【page_66】, and further contracted to about 70 million shares by February 2 2025【page_69】. This steady decline indicates the company has been drawing down its authorized equity for stock‑based awards, reflecting a strong reliance on equity compensation while gradually depleting the pool to manage future dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key numbers are correct - 117 million shares (Jan 30, 2022), 77 million shares (Jan 28, 2024), and 70 million shares (Feb 2, 2025). The dates are accurate and properly formatted. The trend calculation is implicit but correct (117→77 is a 34% decline, 77→70 is a 9% decline, showing consistent reduction). ENTITY ACCURACY: Correctly identifies The Home Depot, the Omnibus Stock Incentive Plan (2005), and the proper fiscal year dates. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the trend as indicating active stock-based compensation issuance. SEMANTIC EQUIVALENCE: The LLM's interpretation that the decline 'reflects a strong reliance on equity compensation while gradually depleting the pool to manage future dilution' is semantically equivalent to the ground truth's statement about 'increased reliance on equity incentives to retain and motivate associates and directors.' Both convey the same strategic insight. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('drawing down authorized equity' vs 'actively issuing stock-based compensation') but both capture the same underlying phenomenon. The LLM adds the nuance about 'managing future dilution' which is a reasonable inference from the data. The answer is complete, addresses all parts of the question (evolution of shares AND strategic implications), and provides accurate page references. No calculation errors detected. The reasoning is sound and the conclusion logically follows from the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 453,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom reported $622 million of 3.625 % senior notes due October 2024 on its balance sheet in FY 2022 and the same $622 million remained outstanding in FY 2023 (AVGO_10k_2023.pdf page 81). By the end of FY 2024 the notes had matured and the balance was $0 (AVGO_10k_2024.pdf page 81). This shows Broadcom kept the notes on its books until their scheduled maturity and then retired them, reflecting a hold‑to‑maturity, non‑refinancing approach to managing this debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $622 million for FY 2022 and FY 2023, and $0 for FY 2024. The dates (October 2024 maturity) and note characteristics (3.625% senior notes) are accurately stated. COMPLETENESS: The answer addresses all three fiscal years requested and traces the evolution of the obligation across the period. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, fiscal years are properly sequenced, and the specific debt instrument is accurately characterized. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings to show the progression of this liability from $622M to $0, demonstrating proper cross-year analysis. SEMANTIC EQUIVALENCE: The LLM's characterization of the debt management strategy as 'hold-to-maturity, non-refinancing approach' is semantically equivalent to the ground truth's 'deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.' Both convey that the company allowed the notes to mature and then retired them rather than refinancing. MINOR CONSIDERATIONS: The LLM provides slightly more specific interpretation ('hold-to-maturity, non-refinancing approach') compared to the ground truth's 'deliberate debt management strategy,' but this represents a reasonable analytical inference rather than an error. The inclusion of document citations (AVGO_10k_2023.pdf page 81, AVGO_10k_2024.pdf page 81) adds credibility and transparency. No calculation errors, no factual inaccuracies, and proper synthesis of multi-year data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 464,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "In the 2022 Form 10‑K AT&T still listed its Time Warner investment as the bulk of its WarnerMedia segment but said the company would spin it off; the separation was completed in April 2022 through a Reverse Morris Trust transaction and the former Time Warner assets were thereafter treated as discontinued operations【page_4】. By the 2024 filing the company no longer discusses Time Warner, instead framing its strategy around 5G, fiber and HBO Max as its three core focus areas, showing that AT&T has fully exited the content‑ownership business and is now concentrating on telecom infrastructure and a streaming platform【page_7】. This evolution reflects a shift from an integrated telecom‑media model to a pure telecommunications and connectivity focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR DATE ERROR: LLM states the WarnerMedia separation was completed in April 2022, but the ground truth indicates it was completed in 2023. This is a fundamental factual error that undermines the entire timeline. (2) INCOMPLETE ANSWER: The LLM completely omits the 2024 DIRECTV divestiture to TPG, which is explicitly mentioned in the ground truth as the final exit strategy and a key part of the multi-year progression. The question specifically asks about evolution through 2024, and this major transaction is missing. (3) PARTIAL ACCURACY: The LLM correctly identifies that AT&T moved away from entertainment/media focus and back toward telecommunications, and correctly notes the Reverse Morris Trust transaction structure. However, the timing is wrong. (4) MISSING CONTEXT: The LLM does not adequately explain the full three-step progression: (a) 2022 - holding Time Warner/WarnerMedia, (b) 2023 - separation via RMT with Discovery, (c) 2024 - DIRECTV sale to TPG. Instead, it conflates 2022 and 2023 events. (5) SEMANTIC ISSUES: While the LLM correctly identifies the strategic shift from integrated telecom-media to pure telecom focus, it fails to capture the complete narrative arc that the question asks for. The mention of HBO Max as a 'core focus area' in 2024 is also somewhat contradictory to the claim of 'full exit from content-ownership business' and is not substantiated in the ground truth. QUANTITATIVE ACCURACY: The date error (April 2022 vs. 2023) is a critical quantitative/temporal error. QUALITATIVE ACCURACY: The reasoning about strategic shift is sound but incomplete due to missing the DIRECTV transaction. CONTEXTUAL RELEVANCE: The answer addresses the general strategic evolution but fails to fully answer the specific question about the progression through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 495,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In the 2022 filing Emerson listed pipe cutters simply as part of its “pipe‑working tools” within the Safety & Productivity segment, treating them as a conventional mechanical tool (EMR_10k_2022.pdf p.11). By the 2024 filing the company’s description of the same segment now groups pipe cutters with battery‑hydraulic tools for press connections and with diagnostic systems such as sewer‑inspection cameras, signalling a strategic shift to embed the cutters in a battery‑powered, diagnostics‑enabled tool portfolio that enhances safety and productivity (EMR_10k_2024.pdf p.73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the evolution of Emerson's Pipe Cutters positioning from 2022 to 2024, capturing the three-year progression accurately. (2) Properly synthesizes multi-hop information across multiple 10-K filings (2022, 2024) and correctly identifies the Safety & Productivity segment context. (3) Accurately characterizes the strategic shift from 'standalone tools' (2022) to integration with 'battery-hydraulic tools' and 'diagnostic systems like sewer-inspection cameras' (2024). (4) Correctly identifies the company (Emerson/EMR) and segment. (5) Uses appropriate terminology ('battery-powered technologies,' 'diagnostic integration,' 'smart, integrated tooling solutions'). (6) Provides specific document references (EMR_10k_2022.pdf p.11, EMR_10k_2024.pdf p.73) that enhance credibility. MINOR CONSIDERATIONS: (1) The LLM answer omits explicit mention of 2023 as an intermediate year with 'battery hydraulic tools for press connections' mentioned in the ground truth, though this is a minor omission that doesn't significantly impact the overall narrative of evolution. (2) The LLM answer uses slightly different phrasing ('battery‑powered, diagnostics‑enabled tool portfolio') versus ground truth's 'smart, integrated tooling solutions,' but these are semantically equivalent. (3) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not applicable but receives full marks as no errors exist. The multi-hop reasoning is sound, correctly synthesizing information across years and documents to demonstrate strategic evolution. The answer directly addresses all aspects of the question regarding integration with battery-powered technologies and diagnostic systems.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 501,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it was launching a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes in order to grow its financial shared‑service capabilities and harmonize financial systems (2022 p. 118). The 2023 filing reiterated that the same multi‑year effort remained underway, with continued alignment and streamlining of the financial control environment (2023 p. 119), and the 2024 filing again highlighted the ongoing initiative, confirming it is still a strategic priority and not driven by any identified control deficiency (2024 p. 119). This repeated emphasis shows that J&J is strategically committed to standardizing its financial processes and expanding a shared‑service model as a core driver of operational efficiency and control.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about J&J's financial shared services initiative evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative across all three years (2022, 2023, 2024); (2) Accurately captures the core components: integration, simplification, standardization of processes and systems; (3) Properly synthesizes the consistent messaging across years showing strategic commitment; (4) Correctly notes the initiative is NOT driven by control deficiencies; (5) Appropriately cites page numbers (118-119) showing document-level precision; (6) Effectively conveys the strategic focus on process standardization and operational efficiency. MINOR WEAKNESSES: (1) The LLM answer includes additional functions (HR, IT, procurement, supply-chain) beyond what the ground truth explicitly emphasizes - while not incorrect, this adds scope not directly addressed in the original answer; (2) The ground truth emphasizes 'financial control environment' alignment more explicitly, while the LLM answer focuses more on the shared-service model expansion; (3) The ground truth's phrase about 'foundational to operational efficiency and control framework' is semantically similar but not explicitly stated in the LLM answer. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the evolution pattern (launch → reiteration → continuation). The logical conclusion about strategic commitment is sound. QUANTITATIVE ELEMENTS: Page numbers cited (118-119) appear reasonable for 10-K filings and add credibility, though cannot be independently verified. No calculations required. Overall, the answer is substantively correct and addresses the question comprehensively with only minor variations in emphasis from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 519,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco’s 10‑K exhibits list the Executive Health Plan as Exhibit 10.1 and show it filed as part of the Form 10‑K (Period Ended 9/2/2012; Filing Date 10/19/2012) in each of the FY 2022, FY 2023 and FY 2024 reports [COST_10k_2022.pdf p.66; COST_10k_2023.pdf p.66; COST_10k_2024.pdf p.66]. The filing status never changed, indicating that the Executive Health Plan is treated as a stable, ongoing benefit and reflects Costco’s long‑term commitment to providing consistent health coverage for its executives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All key dates are correct - Period Ended 9/2/2012 and Filing Date 10/19/2012 are accurately stated; (2) All fiscal years are correctly identified (FY 2022, FY 2023, FY 2024); (3) The exhibit designation (Exhibit 10.1) is correct; (4) The core finding is accurate - the filing status remained unchanged across all three years; (5) The multi-hop synthesis is sound, correctly identifying that consistency across three years indicates stability in executive benefit strategy; (6) The interpretation about long-term commitment and stable benefits is logically sound and matches the ground truth's conclusion about 'stable long-term executive benefit strategy without structural changes.' MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references (p.66) which, while helpful for verification, are not present in the ground truth but do not contradict it; (2) The wording 'treated as a stable, ongoing benefit' and 'long-term commitment to providing consistent health coverage' is semantically equivalent to the ground truth's 'maintained a stable long-term executive benefit strategy' - both convey the same meaning about consistency and stability; (3) The answer could have been slightly more explicit about 'no material updates or amendments' but the phrase 'filing status never changed' effectively conveys this same concept. QUANTITATIVE VERIFICATION: All dates and years are factually correct with no calculation errors. REASONING QUALITY: The multi-hop reasoning correctly synthesizes information across three fiscal years and draws appropriate conclusions about strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 462,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "The cash dividend on Mastercard’s Class A shares rose each year – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024【page_99†L1-L8】【page_92†L1-L8】 – while the voting entitlement for Class A stock never changed, remaining “one vote per share” in every filing【page_99†L1-L8】【page_92†L1-L8】. This steady‑voting structure together with steadily higher payouts shows a governance strategy that preserves equal voting power for public shareholders and reinforces a shareholder‑friendly focus on returning cash to owners.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core question. The ground truth explicitly states that MA's A Class Shares maintained IDENTICAL dividend and voting rights across 2022-2024 with NO CHANGES. However, the LLM answer claims dividend amounts ROSE each year ($2.04→$2.37→$2.74), which directly contradicts the ground truth assertion of consistency. This is a major factual error that misrepresents the company's shareholder governance strategy. The LLM correctly identifies that voting rights remained constant at 'one vote per share,' which aligns with ground truth. However, the introduction of specific dividend dollar amounts that show year-over-year increases fundamentally mischaracterizes the answer to the question about 'evolution' and 'consistency.' The question asks about how rights 'evolved' and what consistency 'reveals' about governance strategy. The ground truth answer emphasizes STABILITY and UNCHANGING governance. The LLM answer, by introducing rising dividend amounts, suggests CHANGE and EVOLUTION in dividend policy, which is the opposite interpretation. The LLM's conclusion about 'shareholder-friendly focus on returning cash to owners' may be accurate commentary on dividend increases, but it contradicts the core finding that dividend rights remained consistent/identical across the three years. The LLM appears to have confused or conflated dividend AMOUNTS (which may have increased) with dividend RIGHTS (which remained constant per share). This is a fundamental misunderstanding of what the question is asking about governance structure versus actual payout levels.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 449,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Broadcom’s Security Insights Platform was described in essentially the same way – a mainframe‑security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that “makes this data available for use with in‑house tools for security information and event management” (e.g., FY 2022 p. 12; FY 2023 p. 10; FY 2024 p. 10). The 10‑K filings show no new features or expanded integration; the platform’s risk‑identification and SIEM‑integration capabilities remained consistent over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the three fiscal years (2022, 2023, 2024) and accurately characterizes the platform's evolution as essentially stable with no new features or expanded integration across the period. (2) Provides specific, accurate quotes from the 10-K filings describing the platform's core functionality: mainframe security posture assessment, risk identification, remediation planning (ongoing and ad-hoc), and SIEM integration with in-house tools. (3) Correctly cites page references (FY 2022 p. 12; FY 2023 p. 10; FY 2024 p. 10), demonstrating multi-hop synthesis across three years of filings. (4) The reasoning is sound - the answer correctly synthesizes information across multiple fiscal years to show consistency and maturity of the offering. (5) Semantic equivalence is strong: the LLM answer conveys the same core message as the ground truth (stable functionality, consistent integration, mature offering) while providing more specific textual evidence. Minor consideration: The LLM answer is slightly more detailed and evidence-based than the ground truth, providing direct quotes and page citations, which actually strengthens rather than weakens the response. The answer fully addresses the multi-part question about evolution across three fiscal years and integration capabilities. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 388,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "In the 2022 filing AIG described loss‑reserve risk as “the potential inadequacy of the liabilities we establish for unpaid losses and loss‑adjustment expenses” and said it was managed through internal controls, oversight of the reserve‑setting process, and periodic reviews by external experts (2022 p. 167). The 2023 filing reiterated the same framework—internal controls and external‑expert reviews continued to be the primary safeguards for reserve adequacy (2023 p. 119). By the 2024 filing, AIG added that its IBNR and ultimate‑loss estimates are now based on multi‑year frequency‑and‑severity projections that management “continually reviews and updates,” while still relying on external experts to validate the reserves (2024 p. 88 & 86).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some accurate details but has significant gaps in completeness compared to the ground truth. STRENGTHS: (1) Correctly identifies the core framework of internal controls and external expert reviews across all three years (2022-2024); (2) Accurately captures the 2024 evolution toward multi-year frequency-and-severity projections; (3) Page citations appear reasonable and specific; (4) Correctly identifies the definition of loss-reserve risk from 2022. WEAKNESSES: (1) MAJOR OMISSION - The answer completely fails to mention the 2023 expansion of methodologies, specifically the introduction of 'detailed modeling techniques (both stochastic and deterministic)' and 'formalized actuarial profitability and reserve reviews' that are explicitly highlighted in the ground truth as a key evolution point; (2) INCOMPLETE SYNTHESIS - The answer presents a linear progression (2022→2023→2024) but misses the substantive methodological changes in 2023, making it appear that only 2024 saw meaningful evolution; (3) MISSING CONTEXT - No mention of ERM second-line reviews or enhanced budget/expense assumption monitoring introduced in 2024, which the ground truth identifies as part of the 'multi-tiered risk oversight'; (4) The claim that 2023 'reiterated the same framework' is contradicted by the ground truth, which shows 2023 introduced expanded risk management frameworks. The answer captures the beginning and end points of the evolution but misses the critical middle evolution in 2023, which represents a substantial gap in addressing the multi-hop synthesis required by the question. The answer is partially correct on the trajectory but incomplete on the methodological details that define how the approach 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 474,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson has kept electrical‑distribution gear inside its Industrial‑Solutions portfolio as part of the **Discrete Automation** product line in every filing – the segment description explicitly lists “electrical distribution equipment” alongside solenoid valves, pneumatic devices, switches and control systems【page_73】.  By repeatedly locating this capability in the Discrete Automation segment (which generated roughly $2.6 bn of sales in 2022‑23 and $2.5 bn in 2024【page_74】), Emerson signals that electrical‑distribution products are a core pillar of its strategy to deepen its addressable market in discrete‑automation customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM answer claims Electrical Distribution Equipment was in Discrete Automation 'in every filing' across 2022-2024, but the ground truth explicitly states it was positioned in Industrial Solutions in 2022, then reorganized to Discrete Automation in 2023. This is a fundamental factual error that contradicts the core narrative of the question about 'evolution' across these three years. (2) INCOMPLETE TEMPORAL ANALYSIS: The LLM fails to capture the key 2022→2023 transition that is central to the ground truth answer. The ground truth emphasizes a deliberate 3-year evolution showing strategic shift, while the LLM presents a static positioning across all years. (3) QUANTITATIVE ISSUES: The LLM provides revenue figures ($2.6bn for 2022-23, $2.5bn for 2024) that cannot be verified against the ground truth, which contains no such specific revenue numbers. These appear to be unsupported claims. (4) MISSING CONTEXTUAL DETAILS: The ground truth describes specific product groupings that evolved (fluid control/materials joining in 2022 → solenoid valves/programmable automation in 2023 → electric linear motion/programmable control in 2024), showing deepening integration. The LLM mentions some products but misses this evolution pattern. (5) REASONING FLAW: By claiming the equipment was always in Discrete Automation, the LLM undermines the strategic narrative about deliberate repositioning that the question specifically asks about. The answer contradicts rather than supports the premise of the question. The LLM does correctly identify Emerson (EMR), the product category, and the general strategic intent, but the temporal sequencing and factual accuracy are severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 475,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "From 2022 through 2024 Johnson & Johnson’s U.S. non‑union pension plans continued to operate under a dual‑formula design – employees hired before 1 Jan 2015 earned benefits under the Final Average Pay formula, while those hired after 2014 accrued under the Retirement Value formula – and each filing reiterated the 2021 amendment that, effective 1 Jan 2026, **all** eligible U.S. non‑union employees will earn benefits under the Retirement Value formula (2022 10‑K p.73; 2023 10‑K p.76; 2024 10‑K p.77). This staged, multi‑year transition to a single, service‑and‑compensation‑based formula reveals a long‑term workforce strategy aimed at standardizing benefits, simplifying plan administration and better managing future pension liabilities across the company’s workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All numeric values and dates are correct - the 2015 hire date cutoff, January 1, 2026 effective date, and 2021 amendment reference are all accurate. (2) The dual-formula structure is correctly identified: Final Average Pay for pre-2015 hires, Retirement Value for post-2014 hires. (3) The multi-hop synthesis across three years (2022-2024) is sound, correctly noting that each filing reiterated the same policy without reversal or delay. (4) Page citations (p.73, p.76, p.77) are specific and verifiable. (5) The strategic interpretation aligns with ground truth: standardization, cost predictability, and workforce inclusivity. (6) The answer correctly emphasizes the 'all eligible employees' language, matching the ground truth's emphasis on universal application regardless of hire date. MINOR CONSIDERATIONS: The LLM answer provides slightly more operational detail (mentioning 'simplifying plan administration' and 'managing future pension liabilities') compared to the ground truth's focus on 'cost predictability and broader workforce inclusivity.' However, these are complementary interpretations rather than contradictions - both capture legitimate aspects of the strategic shift. The LLM's additional operational context actually enhances understanding without introducing factual errors. The answer fully addresses the multi-year evolution question and correctly synthesizes the consistent messaging across all three years as evidence of deliberate long-term strategy. No calculation errors, date errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 454,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K excerpts for 2022, 2023 and 2024 all list Downy as one of the headline brands in the Fabric & Home Care segment (e.g., 2022 Fabric & Home Care major brands include Ariel, Downy, Gain… 【page 19】; 2023 major brands include Ariel, Downy, Gain… 【page 18】; 2024 major brands include Ariel, Downy, Gain… 【page 18】). However, the tables shown do not disclose a specific percentage of the segment’s net‑sales attributable to Downy, so the exact contribution cannot be quantified from the provided pages. Its consistent presence among the segment’s top brands across the three years indicates that Downy remains a core, strategically important brand in P&G’s Fabric & Home Care portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally fails to address the core quantitative question. The ground truth provides specific percentage contributions (35% in 2022, 36% in 2023 and 2024), but the LLM explicitly states 'the exact contribution cannot be quantified from the provided pages.' This is a direct contradiction to the ground truth data. The LLM correctly identifies Downy as a consistently listed brand across all three years, which is accurate, but this qualitative observation does not substitute for the quantitative analysis requested. The question specifically asks 'How did the percentage contribution...evolve' - requiring numerical data showing the 35%→36%→36% progression. The LLM's claim that specific percentages are not disclosed contradicts the ground truth, which clearly states these figures. While the LLM's reasoning about Downy's strategic importance is logically sound and the brand identification is correct, the failure to provide or acknowledge the actual percentage contributions (35%, 36%, 36%) represents a fundamental failure to answer the primary quantitative component of the question. The LLM appears to have relied on page references that may not have contained the detailed segment breakdown data, rather than synthesizing the complete financial information available in the filings. This is a multi-hop question requiring synthesis of segment data across three years, and the LLM failed at the quantitative synthesis step.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 405,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s senior‑ and subordinated‑note portfolio stayed roughly flat over the three‑year span – the carrying value was about **$30.8 billion in 2022**【page_178】, rose modestly to **$31.2 billion in 2023**【page_179】, and then slipped slightly to **$30.7 billion in 2024**【page_188】.  This pattern shows the company has not been aggressively expanding or retiring its long‑term note debt; instead it is maintaining a stable level of senior/subordinated financing while fine‑tuning the maturity mix and cost of its debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) NUMBERS ARE WRONG: Ground truth states 2022: $27,219M, 2023: $31,248M, 2024: $31,248M. LLM claims 2022: ~$30.8B ($30,800M), 2023: ~$31.2B ($31,200M), 2024: ~$30.7B ($30,700M). The 2022 figure is off by approximately $3.6 billion (13% error). (2) TREND ANALYSIS IS INVERTED: Ground truth shows a clear upward trend from 2022 to 2023 (+$4,029M or +14.8%), then stable from 2023 to 2024. LLM incorrectly characterizes this as 'roughly flat' and 'slipped slightly' in 2024, when the ground truth shows 2024 remained at the 2023 peak level. (3) STRATEGIC INTERPRETATION IS CONTRADICTORY: Ground truth correctly identifies an 'upward trend' and 'strategic shift toward issuing more senior and subordinated notes.' LLM incorrectly concludes the company 'has not been aggressively expanding' and is 'maintaining a stable level,' which misrepresents the significant $4B+ increase from 2022-2023. (4) MULTI-HOP SYNTHESIS FAILED: The LLM failed to properly synthesize the three-year data points to identify the actual trend pattern. The answer demonstrates a fundamental misunderstanding of the data, presenting a 'flat' narrative when the data shows material growth followed by stabilization. This is a case where the LLM appears to have fabricated or severely misread the source data, making the answer unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 407,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and accounted for it under the equity‑method because it had significant influence over the pay‑TV provider 【page_93】.  \n- The 2023 filing shows the same 41.3 % interest remained on the balance sheet as an equity‑method investment in its list of equity affiliates 【page_68】.  \n- In June 2024 AT&T sold that 41.3 % interest, removing SKY Mexico from its equity‑method investments (the table explicitly excludes SKY Mexico after the June 2024 disposition) 【page_66】.  \n\nThis three‑year arc – from retaining a minority strategic stake, to continuing to report it as an equity‑method investment, to finally exiting entirely – illustrates AT&T’s broader push to divest its Latin‑American pay‑TV assets and exit a declining, non‑core market segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 41.3% ownership stake is accurately cited for all three years (2022, 2023, 2024), and the June 2024 exit date is precise. No calculation errors present. ENTITY ACCURACY: Correctly identifies AT&T (T), SKY Mexico, and the equity method accounting treatment throughout. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three years and multiple filing documents, tracing the evolution from holding the stake (2022) → continued equity method treatment (2023) → complete divestiture (2024). The logical progression is sound and well-supported by cited page references. COMPLETENESS: Addresses all components of the multi-part question: (1) ownership stake evolution, (2) equity method accounting treatment, (3) eventual exit, and (4) broader divestiture strategy implications. SEMANTIC EQUIVALENCE: The LLM's characterization of the trajectory as \"retaining a minority strategic stake → continuing equity-method investment → final exit\" perfectly aligns with the ground truth's \"holding steady → continued equity method treatment → full divestiture.\" The conclusion about T's strategic shift to exit non-core international assets and focus on domestic operations is accurately captured. MINOR OBSERVATION: The LLM uses \"AT&T\" while the question uses \"T\" (ticker symbol), but this is a trivial formatting difference that doesn't affect accuracy. The page citations (93, 68, 66) add credibility though they cannot be independently verified in this context. Overall, this is a high-quality answer that correctly synthesizes complex multi-year, multi-document information with accurate numbers and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 484,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "Across its 2022, 2023 and 2024 Form 10‑K filings BNY Mellon consistently warned that returning capital to shareholders is subject to Board discretion and can be limited by U.S. banking laws, capital‑planning rules, applicable Delaware law and the obligation to pay full and timely preferred‑stock dividends (2022 p. 3‑5; 2023 p. 3‑5; 2024 p. 5). While the 2022 and 2023 disclosures emphasized that failure to meet “well‑capitalized”/“well‑managed” status and capital‑adequacy and liquidity requirements could restrict such returns, the 2024 filing added a specific note that, as a non‑operating holding company, the Parent depends on dividends from its subsidiaries and credit extensions to fund share repurchases and dividend payments, underscoring the same regulatory constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of BNY Mellon filings. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately cites page numbers (3-5 for 2022/2023, p. 5 for 2024); (2) Accurately captures the consistent regulatory constraints across all three years including U.S. banking laws, capital adequacy rules, Delaware law, and preferred dividend obligations; (3) Correctly identifies the evolution showing 2022-2023 emphasis on 'well-capitalized'/'well-managed' status and capital-adequacy/liquidity requirements; (4) Accurately notes the 2024 addition regarding the Parent company's reliance on subsidiary dividends and credit extensions; (5) Properly synthesizes the multi-hop reasoning showing stable regulatory framework with increasing contextual complexity. MINOR GAPS: (1) The answer does not explicitly mention the 2023 expansion of risk discussion to include ESG-related regulatory pressures noted in the ground truth, though this is a relatively minor omission; (2) Does not explicitly reference 'strategic transformation initiatives' mentioned in the ground truth for 2024, though it does reference 'strategic initiatives' implicitly through the Parent company dependency discussion; (3) The phrase 'strategic transformation initiatives' from ground truth is not directly addressed, though the substance about capital planning impact is captured. QUANTITATIVE ACCURACY: All dates and page references are correct and properly formatted. No calculations required. QUALITATIVE ACCURACY: The multi-hop synthesis across three years is sound and logically structured. The identification of evolution from 2022-2023 consistency to 2024 additions is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding constraints on capital returns, regulatory requirements, dividend policies, and capital adequacy across the three-year period. The answer is well-organized and appropriately detailed for the complexity of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 560,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 filing 3M listed structural adhesives as a stand‑alone line – “Structural adhesives and tapes” – within the Safety and Industrial segment, reflecting the traditional Industrial Adhesive and Tapes division. The 2023 filing still shows the same wording (see the Business‑Segment Products table 【page_107】). By 2024, 3M reorganized the segment, creating an **Industrial Specialties** division that pulls the former Industrial Adhesive and Tapes business together with closure‑and‑masking systems and personal‑safety products (see the division‑creation note 【page_110】), while the product list continues to list “Structural adhesives and tapes” under Safety and Industrial 【page_110】. This move from a discrete adhesive line to a bundled industrial‑specialties grouping shows that 3M now treats adhesives as a strategic, cross‑functional technology that can be sold alongside complementary sealing, masking and safety solutions, reinforcing its role as an enabling platform for broader industrial applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop evolution of 3M's Structural Adhesives positioning from 2022-2024, with generally accurate facts and sound reasoning. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with accurate characterization of each period; (2) Accurately notes that 2022-2023 showed consistent positioning with 'Structural adhesives and tapes' as a line item; (3) Correctly identifies the 2024 reorganization creating an 'Industrial Specialties' division that bundled adhesives with closure-masking systems and safety products; (4) Provides sound strategic interpretation that adhesives shifted from discrete product to cross-functional enabling platform; (5) Properly cites page references (107, 110) suggesting document verification. MINOR WEAKNESSES: (1) The ground truth mentions 'industrial abrasives, autobody repair solutions, and electrical materials' in 2022 context, while LLM focuses more narrowly on the adhesive-tapes line itself without explicitly mentioning these adjacent products in 2022; (2) Ground truth emphasizes 'metalworking and OEM electrical markets' in 2022 and 'construction and maintenance' in 2024 - the LLM doesn't explicitly call out these market applications; (3) The ground truth notes 'slightly expanded emphasis on packaging and closure systems' in 2023, which the LLM doesn't explicitly address for that year. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension is less critical. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the strategic shift from standalone to bundled positioning. The logic connecting product bundling to strategic role is sound. SEMANTIC EQUIVALENCE: The LLM's conclusion that adhesives became 'an enabling platform for broader industrial applications' aligns well with the ground truth's statement that it became 'a foundational component in complex industrial systems.' The core insight about strategic reinforcement is captured, though with slightly different emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 585,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024 Lilly kept Cyramza positioned as a multi‑indication oncology therapy – second‑line treatment of advanced gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and first‑line therapy for EGFR‑mutated metastatic NSCLC – with the same label wording appearing in the 2022 product list and the 2023 and 2024 filings (LLY_10k_2022 page 5; LLY_10k_2023 page 6).  The 2023 filing spells out the IP shield that underpins this positioning: compound patents run to 2026 in the U.S., 2028 in major European countries and 2026 in Japan, while U.S. biologics data protection extends to 2026 and additional data exclusivity covers Europe until 2024 and Japan until 2023 (LLY_10k_2023 page 11); the 2024 filing continues to rely on the same patent and data‑protection portfolio, indicating no new therapeutic expansion but a steady focus on maintaining exclusivity in the United States, Europe and Japan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more detailed and specific information than the ground truth, including explicit therapeutic indications and more granular patent/data protection timelines. However, there are critical discrepancies in the intellectual property protection dates that undermine accuracy: (1) QUANTITATIVE ERRORS: The LLM states compound patents run to 2028 in major European countries, but the ground truth indicates European data protection expires in 2024. The LLM also states U.S. biologics data protection extends to 2026 (matching ground truth), but provides compound patent dates of 2026 for U.S. and Japan (ground truth doesn't specify compound patent dates separately). The LLM claims Japan data exclusivity covers until 2023 (matching ground truth's expiration in 2023) but states compound patents run to 2026 in Japan, which conflicts with the ground truth's implication of earlier expiration. (2) COMPLETENESS: The LLM answer is more comprehensive than ground truth, explicitly listing all four therapeutic indications and providing more detailed IP protection information with specific page citations. It addresses both therapeutic indications and IP protections across key markets as requested. (3) MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022-2024 filings and identifies the strategic positioning evolution, though the IP timeline details appear to contain errors or inconsistencies with the ground truth. (4) ENTITY ACCURACY: Company name (Lilly/Eli Lilly), drug name (Cyramza), indications, and markets are all correctly identified. The main weakness is the apparent discrepancy in patent/data protection expiration dates, particularly for European markets and the relationship between compound patents and data exclusivity timelines. The ground truth's statement about 'data protection expirations in major European countries in 2024' appears to conflict with the LLM's claim of 2028 compound patents in Europe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 530,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from a carrying value of **$24.1 billion in 2022** to **$27.2 billion in 2023**, then fell slightly to **$26.9 billion in 2024**.  The weighted‑average interest rate was **about 4.45 % in both 2022 and 2023**, but rose to **roughly 4.84 % in 2024**【page_178】【page_188】.  This trend indicates the company expanded its senior unsecured borrowing in 2023 and then modestly reduced the balance while accepting higher‑cost financing in 2024, reflecting a strategy of maintaining a sizable debt base amid rising market rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) 2022 CARRYING VALUE ERROR: Ground truth states $19,975 million ($19.975 billion), but LLM claims $24.1 billion - a difference of approximately $4.1 billion or 20.5% overstatement. (2) 2023 CARRYING VALUE ERROR: LLM states $27.2 billion, but ground truth only provides 2022 and 2024 data ($19,975M and $26,930M). The LLM appears to have fabricated 2023 data not present in the ground truth. (3) 2024 CARRYING VALUE: LLM correctly states $26.9 billion ($26,930 million), matching ground truth. (4) WEIGHTED-AVERAGE INTEREST RATE ERRORS: LLM claims 2022 rate was 'about 4.45%', but ground truth clearly states 2.91% - a massive 153 basis point error. LLM claims 2023 was also 'about 4.45%', but no 2023 data exists in ground truth. LLM correctly identifies 2024 rate as 4.84%. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the multi-year trend. Ground truth shows a clear progression: carrying value increased from $19.975B to $26.930B (35% increase), while rates rose from 2.91% to 4.84% (193 basis points). The LLM's narrative about 2023 expansion followed by 2024 reduction is unsupported by the ground truth data provided. (6) REASONING QUALITY: While the LLM's interpretation about debt strategy and market conditions is reasonable in tone, it is built on fundamentally incorrect numbers, making the analysis unreliable. The LLM appears to have either misread source documents or hallucinated data points. The citation references (page_178, page_188) cannot be verified but the numbers contradict the ground truth significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 462,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation obligations expanded from a $651 million notional in FY 2022 (page 92) to $792 million in FY 2023 and $985 million in FY 2024 (page 91).  The earnings impact of these swaps moved from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024 (page 91), showing that the instrument’s value has been highly volatile—shifting from a sizable loss to increasingly larger gains as the exposure grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: the loss of $92 million in FY 2022, gain of $58 million in FY 2023, and gain of $91 million in FY 2024 match the ground truth exactly. The answer also provides additional valuable context by including the notional values of the swaps ($651M in 2022, $792M in 2023, $985M in 2024), which enhances understanding of the instrument's evolution without contradicting the original answer. The multi-hop reasoning is sound—the LLM correctly synthesizes the earnings impact pattern across three fiscal years and appropriately characterizes the volatility pattern (loss to gains). The interpretation that the instrument 'shifted from a sizable loss to increasingly larger gains as the exposure grew' is logically sound and adds analytical depth. The answer directly addresses both parts of the question: (1) how the exposure evolved and (2) what the pattern reveals about volatility. The inclusion of page references (pages 92 and 91) demonstrates source documentation. Minor consideration: the answer goes slightly beyond the ground truth by adding notional value data, but this is supplementary and accurate rather than contradictory. The semantic equivalence is maintained throughout, with clear communication of the volatile nature of the instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 376,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "In its 2022 filing Home Depot identified store location and appearance as a key competitive lever against multichannel and online rivals, but gave only a high‑level statement (2022 p. 8; 2023 p. 14). By fiscal 2024 the company launched a systematic store‑refresh program—adding way‑finding signage, refresh packages, front‑end redesigns and improved checkout layouts—and said those upgrades are “driving higher customer‑satisfaction scores” and now enable roughly 50 % of U.S. online orders to be fulfilled through stores, a measurable boost to its competitive positioning versus pure‑play and multichannel retailers (2024 p. 9‑10).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct directional information but contains significant issues with specificity and verifiability. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024, (2) Appropriately notes the shift from standalone store experience to omnichannel integration, (3) Mentions specific store refresh initiatives (wayfinding signage, checkout redesigns), (4) Correctly identifies the competitive positioning against online/multichannel retailers. CRITICAL WEAKNESSES: (1) The 50% fulfillment metric is presented without clear sourcing or context - the ground truth does not mention this specific percentage, raising questions about accuracy or whether this is from a different filing section, (2) Page citations (2022 p. 8; 2023 p. 14; 2024 p. 9-10) cannot be verified against the ground truth and appear potentially fabricated, (3) The answer lacks the nuanced progression described in ground truth: 2022 (basic positioning), 2023 (integration with digital capabilities), 2024 (full omnichannel with Pros/DIY focus) - instead jumping to 2024 specifics without adequately covering 2023 evolution, (4) Missing explicit mention of how store appearance supports Pros and DIY customers specifically, (5) The 'systematic store-refresh program' details (wayfinding, refresh packages, front-end redesigns) are concrete but unverified against source documents. QUANTITATIVE ACCURACY: The 50% figure is problematic - it's presented as a measurable impact but cannot be confirmed in the ground truth, which focuses on strategic positioning rather than specific fulfillment percentages. QUALITATIVE ACCURACY: The reasoning about omnichannel integration is sound and aligns with ground truth direction, but the answer oversimplifies the 2022-2023 transition and lacks the detailed progression shown in ground truth. CONTEXTUAL RELEVANCE: The answer appropriately addresses competitive positioning and the evolution question, though it emphasizes operational metrics over strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 543,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s net carrying amount for its 3.50 % notes due 2050 was $1.637 billion at the end of FY 2022 (NVDA_10k_2023.pdf p.65) and remained $1.637 billion in FY 2023, then fell to $1.604 billion by FY 2024 (NVDA_10k_2023.pdf p.67). The modest decline reflects a small repayment or refinancing of this long‑term issuance, indicating the company is gradually reducing its long‑term debt while keeping its overall debt profile stable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data across all three fiscal years: (1) FY 2022: LLM states $1.637 billion, but ground truth is $2,147 million ($2.147 billion) - a $510 million error. (2) FY 2023: LLM states $1.637 billion (same as FY 2022), but ground truth is $1,637 million - while the number matches ground truth, the LLM incorrectly claims it remained flat from FY 2022, when it actually decreased from $2,147M to $1,637M. (3) FY 2024: LLM states $1.604 billion, but ground truth is $2,000 million ($2.0 billion) - a $396 million error. The LLM's narrative of 'modest decline' and 'gradually reducing' debt is contradicted by the actual progression: $2,147M → $1,637M → $2,000M, which shows a decrease followed by a significant increase/stabilization, not a continuous decline. The ground truth indicates strategic repositioning with stabilization at $2,000M in FY 2024, not the continued reduction the LLM describes. The LLM also provides incorrect source citations (NVDA_10k_2023.pdf pages 65 and 67) without verification. Multi-hop reasoning failed: the LLM did not correctly synthesize the three-year progression or identify the actual pattern of fluctuation followed by stabilization. The interpretation of debt positioning is fundamentally misaligned with the actual data trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 373,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2024, 3M moved from settling its core Scotchgard disputes—most notably a $65 million joint settlement with Saint‑Gobain and Honeywell in New York in early 2022 and an immaterial‑share settlement with Wolverine over Michigan shoe‑factory waste in 2023—to entering a sweeping $10.5‑$12.5 billion public‑water‑system (PWS) settlement in June 2023 that was approved in March 2024 and took effect in May 2024. At the same time, the litigation footprint broadened dramatically, with new PFAS suits involving Scotchgard filed in Georgia, Delaware, South Carolina, Illinois, Missouri, Connecticut, Virginia, Minnesota and other states, and the roster of co‑defendants expanding to include Saint‑Gobain, Honeywell, Wolverine, DuPont, Chemours, carpet manufacturers, water utilities and municipalities across dozens of cases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM introduces a $10.5-$12.5 billion PWS (public water system) settlement in June 2023 approved in March 2024 that does NOT appear in the ground truth answer. This is a significant fabrication of a major settlement figure that fundamentally misrepresents 3M's Scotchgard litigation landscape. The ground truth makes no mention of any such settlement. (2) GEOGRAPHIC EXPANSION - The LLM correctly identifies geographic expansion but ADDS states (Delaware, South Carolina, Illinois, Missouri, Connecticut, Virginia, Minnesota) not mentioned in the ground truth, which specifically mentions Alabama and Georgia. While the LLM's list may be accurate from actual filings, it goes beyond what the ground truth establishes. (3) DEFENDANTS - The LLM correctly identifies the expansion of co-defendants (Saint-Gobain, Honeywell, Wolverine, DuPont, Chemours, carpet manufacturers) which aligns with ground truth. (4) SETTLEMENT ACCURACY - The LLM correctly cites the $65 million 2022 New York settlement and the 2023 Michigan Wolverine settlement as immaterial, matching ground truth. (5) MULTI-HOP REASONING - The LLM attempts to synthesize information across years but introduces unsupported major settlement figures that contradict the ground truth's characterization of settlements as 'immaterial' or 'non-material.' The fabricated $10.5-$12.5 billion settlement is a critical error that severely undermines the answer's credibility. The ground truth emphasizes growing complexity with multiple smaller cases, not a massive consolidated settlement. This represents a fundamental misunderstanding or hallucination of the litigation landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 462,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "The AbCellera agreement continued to grant the partner a tiered royalty of roughly mid‑teens to mid‑twenties percent of worldwide net sales of bamlanivimab and bebtelovimab, a term that did not change in the 2022‑2024 filings【page_72†L13-L16】. The filings do not disclose any milestone payments to AbCellera (none were material)【page_73†L13-L16】, and the collaboration’s commercial performance fell sharply – net product revenue was $2.02 billion in 2022 but dropped to $0 in both 2023 and 2024 as the antibodies were no longer sold【page_72†L19-L22】【page_73†L13-L16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All quantitative data is correct - the $2.02 billion in 2022 net product revenue, the $0 sales in 2023 and 2024, and the tiered royalty structure (mid-teens to mid-twenties percent) are all accurately stated and match the ground truth. (2) The answer correctly identifies the specific products (bamlanivimab and bebtelovimab) and their commercial trajectory. (3) Multi-hop synthesis is sound - the answer successfully combines information about royalty structure, milestone payments, and revenue performance across the 2022-2024 period. (4) The answer appropriately notes that milestone payments were not material/disclosed, which aligns with the ground truth statement that no new milestone payments were made. (5) The semantic meaning matches the ground truth's characterization of a 'declining commercial trajectory' and 'complete cessation of commercial activity.' MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, but this is not a deficiency - it conveys all essential information efficiently. (2) The parenthetical note about milestone payments being 'none were material' is a reasonable interpretation of the filing disclosures, though the ground truth simply states no new payments were made. (3) The answer includes specific product names (bamlanivimab and bebtelovimab) which adds helpful specificity not explicitly in the ground truth but consistent with it. VERIFICATION: All numbers check out - $2.02B (2022), $0 (2023), $0 (2024), royalty range mid-teens to mid-twenties percent. The reasoning correctly synthesizes the evolution of financial terms and commercial performance across the three-year period as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 497,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Dawn was called out as one of the flagship Home‑Care brands inside the Fabric & Home Care segment, which then represented about 35 % of P&G’s net sales and 31 % of its net earnings (2022 table, page 19). By the 2024 filing Dawn is still listed among the segment’s major brands, now in a segment that has grown to roughly 36 % of net sales and 34 % of earnings (2024 table, page 18; segment percentages, page 20), indicating that Dawn’s placement has remained consistent while the segment’s contribution has risen—underscoring the dish‑soap’s continued strategic importance as a core growth driver in P&G’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Dawn's positioning evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numbers are correct - 2022: 35% net sales, 31% earnings; 2024: 36% net sales, 34% earnings. The LLM correctly identifies the segment percentages and maintains consistency with ground truth data. COMPLETENESS: The answer addresses both parts of the question: (1) how positioning evolved (remained consistent), and (2) what this reveals about strategic importance (core growth driver). ENTITY ACCURACY: Correctly identifies P&G, Dawn, Fabric & Home Care segment, and fiscal years 2022 and 2024. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years, comparing segment metrics and Dawn's positioning to draw conclusions about strategic importance. The logic is sound - consistent positioning + growing segment contribution = sustained strategic importance. MINOR OBSERVATIONS: The LLM adds interpretive language ('core growth driver') that goes slightly beyond the ground truth's more neutral 'core contributor,' but this is a reasonable inference from the data and doesn't constitute an error. The LLM also references specific page numbers (19, 18, 20) which adds credibility but cannot be verified against the ground truth. The answer is well-structured, clear, and provides appropriate context about the segment's growth alongside Dawn's consistent positioning. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 413,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023, then ticked up to $562 million in 2024 (COF_10k_2022 p 188; COF_10k_2023 p 178; COF_10k_2024 p 188).  Long‑term debt rose from $42.3 billion in 2022 to $49.3 billion in 2023 before easing to $45.0 billion in 2024 (COF_10k_2022 p 188; COF_10k_2023 p 178; COF_10k_2024 p 188).  Over the three‑year period the firm eliminated its floating‑rate unsecured senior debt – dropping from $1.7 billion at a 1.0% weighted‑average rate in 2022 to $349 million at 6.75% in 2023 and to zero in 2024 (COF_10k_2022 p 188; COF_10k_2023 p 178‑179; COF_10k_2024 p 188) – indicating a shift toward a predominantly fixed‑rate senior‑note structure and markedly reduced exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Capital One's debt evolution and correctly identifies the key trend of eliminating floating-rate unsecured senior debt. However, there are significant quantitative discrepancies that prevent a higher score:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- Total debt figures: LLM reports $42.3B (2022), $49.3B (2023), $45.0B (2024) vs. ground truth of $43.086B, $48.715B, $45.551B. These are material differences (~$800M-$600M discrepancies), not minor rounding variations.\n- Short-term borrowings: LLM correctly identifies the trend (down then up: $883M→$538M→$562M) which aligns with ground truth showing short-term borrowings as a small component.\n- Floating unsecured senior debt: LLM correctly states $1.7B (2022), $349M (2023), $0 (2024), matching ground truth exactly.\n- Interest rate on floating debt: LLM states 1.0% (2022) and 6.75% (2023), but ground truth doesn't provide these specific rates for floating debt. The ground truth focuses on fixed unsecured senior debt rates (2.91%→4.45%→4.84%), which the LLM answer omits entirely.\n\n(2) MISSING INFORMATION:\n- The LLM answer fails to address the weighted-average interest rate progression on fixed unsecured senior debt (2.91%→4.45%→4.84%), which is a critical component of the ground truth answer and directly relevant to the question about interest rate exposure.\n- The LLM mentions the shift to fixed-rate structure but doesn't quantify the interest rate increases that accompanied this shift.\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes the three-year trend across multiple years and identifies the strategic shift from floating to fixed-rate debt.\n- The conclusion about reduced floating-rate interest-rate risk is sound and well-supported.\n- However, the incomplete picture of interest rate exposure (missing fixed-rate progression) weakens the multi-hop analysis.\n\n(4) SEMANTIC EQUIVALENCE:\n- The core narrative is semantically equivalent: debt rose in 2023 then declined in 2024, floating debt was eliminated, shift toward fixed-rate structure.\n- However, the quantitative foundation is compromised by the dollar amount discrepancies.\n\nThe answer is substantially correct in direction and key insights but contains material numerical errors and omits important interest rate data that would complete the picture of interest rate exposure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 637,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s $2 billion 5.90 % senior note has been unchanged in principal and carries a 6.11 % effective rate in FY 2022, FY 2023 and FY 2024, and it has always been reported as part of long‑term debt【CSCO_10k_2022.pdf page 89】【CSCO_10k_2023.pdf page 89】【CSCO_10k_2024.pdf page 89】. In FY 2022 the note was a component of $8.915 billion total debt (short‑term $0.5 bn, long‑term $8.416 bn)【CSCO_10k_2022.pdf page 89】; in FY 2023 total debt was $8.391 billion (short‑term $1.733 bn, long‑term $6.658 bn)【CSCO_10k_2023.pdf page 89】; and by FY 2024 total debt had more than doubled to $20.109 billion (short‑term $0.488 bn, long‑term $19.621 bn) after a $13.5 billion senior‑note issuance, while the 5.90 % note remained classified as long‑term【CSCO_10k_2024.pdf page 89】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verification of key numbers: (1) $2,000 million principal amount - CORRECT across all three years; (2) 6.11% effective interest rate - CORRECT and consistent across 2022-2024; (3) Long-term debt classification - CORRECT throughout; (4) FY 2022 total debt breakdown: $8.915B total ($0.5B short-term, $8.416B long-term) - CORRECT; (5) FY 2023 total debt: $8.391B ($1.733B short-term, $6.658B long-term) - CORRECT; (6) FY 2024 total debt: $20.109B ($0.488B short-term, $19.621B long-term) - CORRECT; (7) $13.5B senior note issuance reference - CORRECT and provides helpful context. The multi-hop synthesis is sound: the answer correctly traces the note's stability across years while showing how its proportion within total debt changed as Cisco expanded its debt portfolio. The answer addresses all three dimensions requested: total debt composition (showing the evolution from $8.915B to $20.109B), effective interest rate (constant 6.11%), and long-term debt classification (consistent). Minor deduction: The ground truth emphasizes the note's 'proportion within total long-term debt shifted' more explicitly, while the LLM answer focuses more on absolute numbers and the $13.5B issuance context. The LLM provides additional useful detail about the $13.5B issuance that explains the debt increase, which enhances rather than detracts from the answer. All calculations are accurate and the reasoning is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 412,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "NVIDIA’s 1.55 % Notes due 2028 were carried at roughly $1.1 billion in FY 2022 and FY 2023 (the 2023 filing shows a fair‑value of $1,099 million for the note, which is essentially its carrying amount because the liabilities are recorded at original issuance value, net of discount)【page_67】, and the balance grew to $1.25 billion by FY 2024【page_72】.  The effective interest rate was essentially the coupon rate of 1.55 % in the earlier years and rose only modestly to 1.64 % in FY 2024【page_72】.  This pattern—maintaining a low‑cost, long‑dated debt instrument while modestly increasing its size—shows NVIDIA’s strategy of locking in cheap financing for the long term to support growth without taking on higher‑cost debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial metrics and trends: the carrying value increased from ~$1.1B in FY2022-2023 to $1.25B in FY2024, and the effective interest rate rose modestly from 1.55% to 1.64%. The interpretation of NVIDIA's debt strategy (locking in low-cost long-term financing) is sound and well-reasoned. The answer appropriately synthesizes information across multiple fiscal years and provides relevant context about the company's financing approach.\n\nWEAKNESSES: Critical quantitative discrepancy in FY2022 data. The ground truth states the carrying value was $1,200 million in FY2022, but the LLM states it was 'roughly $1.1 billion in FY 2022.' This is a material error of $100 million (8.3% difference). The LLM conflates FY2022 and FY2023 values, stating both were 'roughly $1.1 billion,' when FY2022 should have been $1,200M. The LLM's characterization of the 2023 value as 'essentially its carrying amount' is somewhat imprecise—the ground truth clearly distinguishes the $1,099M fair value in 2023 as the carrying amount, but the LLM's explanation of how liabilities are recorded could be clearer.\n\nMULTI-HOP REASONING: The synthesis across three fiscal years is mostly sound, correctly tracking the decrease from 2022 to 2023 and increase to 2024. However, the failure to accurately report the FY2022 baseline undermines the completeness of the trend analysis.\n\nCALCULATION VERIFICATION: No explicit calculations are required, but the trend interpretation (increase, decrease, increase) is correct in direction. The percentage change from 1.55% to 1.64% is accurate.\n\nOVERALL: The answer demonstrates good understanding of NVIDIA's debt strategy and correctly identifies the 2023-2024 trend, but the significant misstatement of the FY2022 carrying value ($1.1B vs. $1.2B) is a material factual error that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 509,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In 2022 Google still treated Pixel phones as part of a broader hardware portfolio – hardware revenue (including Pixel 5a 5G, Pixel 6, Fitbit, Nest, etc.) was reported under “Google subscriptions, platforms, and devices” and was called out as a margin‑pressuring line item【page_7】【page_8】. By 2023 the company kept the same classification, describing “devices – primarily sales of the Pixel family” within the “Google subscriptions, platforms, and devices” segment and noting device‑related inventory costs in cost of revenues【page_33】【page_34】. In the 2024 filing the categorization is unchanged (Pixel sales still fall under “subscriptions, platforms and devices”) but capital spending on property and equipment jumped to $52.5 billion (up from $31.5 billion in 2022) and cost‑of‑revenues now explicitly includes inventory and other device costs, signaling a much stronger hardware‑innovation push while keeping the revenue line the same【page_59】【page_57】【page_60】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a solid multi-hop synthesis of Google's Pixel strategy evolution from 2022-2024, with mostly accurate information but some concerns:\n\nSTRENGTHS:\n1. Correctly identifies the consistent categorization of Pixel devices under 'Google subscriptions, platforms, and devices' across all three years\n2. Accurately notes the progression from broader hardware portfolio (2022) to explicit Pixel focus (2023-2024)\n3. Provides specific capital expenditure numbers: $52.5B (2024) vs $31.5B (2022) - these appear reasonable for the magnitude of increase\n4. Correctly identifies margin-pressure concerns in 2022 and inventory cost implications\n5. Properly synthesizes the evolution from investment focus to mature product line\n6. Good use of page citations showing document-level verification\n\nWEAKNESSES:\n1. The capital spending figures ($52.5B and $31.5B) cannot be independently verified from the ground truth answer, which does not provide specific capex numbers. While these numbers may be correct from the actual filings, they represent additional detail not in the ground truth\n2. The ground truth emphasizes 'distinct segment' categorization in 2023, while LLM says 'same classification' - this is a subtle but potentially important distinction about whether Pixel became more distinct or remained grouped\n3. Ground truth mentions 'more detailed revenue recognition policies' in 2024, which LLM doesn't explicitly address\n4. LLM focuses heavily on capex and cost-of-revenues details that, while relevant to 'investment in hardware innovation,' shift emphasis slightly from the ground truth's focus on revenue categorization evolution\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and multiple filing sections (revenue categorization, cost structure, capital spending). The logic connecting increased capex to 'stronger hardware-innovation push' is sound and represents valid inference from the data.\n\nSEMANTIC EQUIVALENCE:\nThe core narrative matches: Pixel evolved from part of broader portfolio → explicit categorization → mature integrated product line. The LLM's emphasis on capex as evidence of innovation investment is a reasonable interpretation of 'investment in hardware innovation' from the question.\n\nQUANTITATIVE CONCERNS:\nThe specific capex numbers cannot be verified against ground truth but appear internally consistent (significant increase from 2022 to 2024). Without access to actual filings, these cannot be marked as definitively wrong, but they represent unverified detail beyond the ground truth scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 689,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 14 reads the same: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185.” The wording, reference to the proxy and PCAOB number are unchanged each year, showing that BNY Mellon has consistently ratified KPMG as its principal accountant, which reflects a stable, ongoing audit relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - PCAOB firm identification number 185 is accurately cited; (2) The three-year period (2022, 2023, 2024) is correctly identified; (3) The core factual claim is accurate: BNY Mellon consistently incorporated KPMG LLP ratification by reference with identical language across all three years; (4) The multi-hop synthesis is sound - the answer correctly traces the disclosure evolution (or lack thereof) across the three-year period and draws the appropriate conclusion about audit relationship stability; (5) The specific quote provided ('The information required by this Item is included in the Proxy...') accurately reflects the actual disclosure language. Minor considerations: (1) The LLM answer references 'Form 10-K Item 14' specifically, while the ground truth references 'Proxy' more broadly - both are technically correct as Item 14 incorporates proxy information by reference, so this is not an error but a slight difference in framing; (2) The LLM answer provides the actual verbatim language from the filings, which adds credibility and specificity beyond the ground truth's summary; (3) Both answers reach identical conclusions about consistency and stability. The answer fully addresses the question's multi-part nature: how disclosure evolved (answer: it didn't), what this reveals about stability (answer: stable, ongoing relationship). No calculation errors, no factual inaccuracies, and appropriate semantic equivalence throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 430,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "- 2022: The defined‑benefit pension plan held roughly **$8.9 billion** in private‑alternative assets (hedge funds $3.25 bn, equity‑like funds $4.01 bn, real‑estate $0.35 bn, other $1.26 bn) – about **67 %** of its $13.2 bn total assets【page_99】.  \n- 2023: That balance slipped to about **$8.6 billion** (hedge funds $3.13 bn, equity‑like $4.09 bn, real‑estate $0.37 bn, other $1.02 bn), or **≈63 %** of the $13.7 bn plan‑asset base【page_100】.  \n- 2024: It fell further to roughly **$8.2 billion** (hedge funds $3.06 bn, equity‑like $3.93 bn, real‑estate $0.45 bn, other $0.77 bn), representing **≈60 %** of the $13.66 bn total【page_99】.  \n\nThe steady, though modest, decline in both absolute dollars and share of assets shows LLY is maintaining a sizable, long‑term commitment to illiquid private‑alternative investments while gradually rebalancing toward more liquid growth and fixed‑income holdings, indicating a measured, long‑run strategy that values illiquid assets but seeks to temper exposure over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022: LLM states $8.9 billion; Ground truth is $10,542.5 million ($10.5425 billion) - ERROR of ~$1.6 billion (15% understatement)\n   - 2023: LLM states $8.6 billion; Ground truth is $10,335.2 million ($10.3352 billion) - ERROR of ~$1.7 billion (17% understatement)\n   - 2024: LLM states $8.2 billion; Ground truth is $10,051.0 million ($10.051 billion) - ERROR of ~$1.85 billion (18% understatement)\n\n2. DIRECTIONAL TREND ERROR:\n   - LLM claims allocation DECLINED from 2022→2023→2024 ($8.9B → $8.6B → $8.2B)\n   - Ground truth shows DECLINE from 2022→2023 ($10,542.5M → $10,335.2M) but then FURTHER DECLINE 2023→2024 ($10,335.2M → $10,051.0M)\n   - While both show declining trend, the magnitude and absolute values are completely wrong\n\n3. COMPONENT BREAKDOWN ERRORS:\n   - LLM provides detailed breakdowns (hedge funds, equity-like, real estate, other) that don't reconcile to ground truth totals\n   - These appear to be from a different data source or misidentified pension plan data\n\n4. CONTEXT CONFUSION:\n   - LLM appears to be analyzing a defined-benefit pension plan's asset allocation\n   - Ground truth appears to reference LLY's overall investment portfolio allocation\n   - These are different entities/contexts, suggesting the LLM pulled data from wrong section of filings\n\n5. REASONING QUALITY:\n   - While the LLM's interpretation of the trend (gradual rebalancing toward liquid assets) is logically sound, it's based on incorrect numbers\n   - The conclusion about 'measured, long-run strategy' may be reasonable but is unsupported by the actual data\n\n6. MISSING ALIGNMENT:\n   - Ground truth numbers are in millions ($10,542.5M, $10,335.2M, $10,051.0M)\n   - LLM numbers are in billions but are systematically too low\n   - This suggests data extraction or calculation error rather than mere formatting difference\n\nThe answer fails on the PRIMARY metric (correctness) due to systematic numerical errors across all three years, making it unsuitable as a reliable answer despite reasonable analytical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 593,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022 Tampax was shown only as a key brand in the broad “Feminine Care” product line of the Baby, Feminine & Family Care segment, with the filing noting that the company is a global leader in feminine care “primarily behind our Always and Tampax brands”【page_19】. By 2023 the segment’s taxonomy was revised to “Feminine Care (Adult Incontinence, Menstrual Care)” and the narrative explicitly placed Tampax in the menstrual‑care sub‑category, emphasizing its market‑share leadership alongside Always (over 25% share)【page_18】. The 2024 filing kept the same classification and emphasis, continuing to position Tampax as a core brand in the menstrual‑care sub‑category of the Feminine Care line【page_18】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ERRORS: (1) The LLM claims the segment was rebranded to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023, but the ground truth states it remained 'Baby, Feminine & Family Care' with 'Menstrual Care' replacing 'Feminine Care' as a sub-category - these are different structural changes. (2) The LLM completely omits the segment's sales contribution percentages (25% in 2022, 24% in 2023, 24% in 2024), which are key quantitative metrics explicitly mentioned in the ground truth. (3) The LLM fails to mention the strategic removal of 'Baby Care' from the segment in 2024, which the ground truth identifies as a significant strategic shift. (4) The LLM incorrectly states that 2023 and 2024 had 'the same classification' when the ground truth indicates 2024 involved a structural change (removal of Baby Care). PARTIAL CREDIT: The LLM correctly identifies Tampax's positioning in menstrual care and mentions market share leadership, though the specific '25% share' reference appears to conflate different metrics. The LLM does capture the general evolution toward feminine care emphasis, but misses the nuanced segment restructuring and the explicit removal of Baby Care. The answer demonstrates incomplete multi-hop synthesis - it fails to connect the segment-level changes with the product portfolio evolution across all three years. The quantitative accuracy is particularly weak due to missing sales contribution percentages and mischaracterizing the segment taxonomy changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 438,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One has always valued its net derivative liabilities with a discounted‑cash‑flow (DCF) model, but the unobservable input driving the DCF has shifted. In 2022 the DCF used swap‑rate assumptions (1 %‑2 % range, 2 % weighted‑average) and produced a $19 million fair‑value (Table 17.2, 2024 10‑K p. 216). The 2023 filing showed the model now relied on default‑rate assumptions (53 %‑163 % range, 4 % weighted‑average) and the fair‑value rose to $58 million (Table 16.3, 2023 10‑K p. 208), while the 2024 filing reverted to swap‑rate inputs (≈4 % range, 4 % weighted‑average) and the fair‑value increased further to $69 million (Table 17.2, 2024 10‑K p. 216 and roll‑forward p. 215).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - 2022 fair value: LLM claims $19M (correct), but states swap rates of 1-2% with 2% weighted-average. Ground truth does not specify valuation technique for 2022.\n   - 2023 fair value: LLM correctly states $58M and default rates of 53-163%, but ground truth shows swap rates of 3-5% for 2023, not default rates as the primary input.\n   - 2024 fair value: LLM claims $69M, but ground truth explicitly states $58M. This is a $11M discrepancy (19% error).\n   - 2024 swap rates: LLM claims \"≈4% range\" but ground truth specifies 3-5% range.\n\n2. FUNDAMENTAL CONCEPTUAL ERRORS:\n   - LLM claims the model \"shifted\" between swap rates and default rates across years, suggesting alternating methodologies. Ground truth indicates a progression toward more transparent disclosure starting in 2023, not alternating approaches.\n   - LLM's narrative of \"reversion\" to swap rates in 2024 contradicts ground truth, which shows consistent use of discounted cash flows with swap rates of 3-5% in both 2023 and 2024.\n\n3. MULTI-HOP REASONING FAILURES:\n   - The LLM failed to correctly synthesize the evolution narrative. Ground truth shows: 2022 (unspecified technique) → 2023 (explicit DCF with default rates) → 2024 (DCF with swap rates). LLM's version suggests alternating methodologies without clear justification.\n   - The LLM misidentified which inputs were primary in each year.\n\n4. MISSING/INCORRECT CONTEXT:\n   - Ground truth emphasizes a \"shift toward more transparent and methodologically consistent valuation practices starting in 2023.\" LLM's narrative of alternating inputs contradicts this transparency narrative.\n   - LLM provides specific page references (which may or may not be accurate) but the underlying data contradicts the ground truth.\n\n5. CALCULATION/VERIFICATION ISSUES:\n   - The 2024 fair value of $69M vs. $58M is a material discrepancy that cannot be reconciled as a formatting difference.\n   - The swap rate ranges differ (1-2% vs 3-5% for 2023-2024 period).\n\nThe answer demonstrates some understanding of the general topic (DCF models, unobservable inputs, evolution over time) but fails on the specific factual details that are critical to answering this question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 628,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s “other income (loss), net” was increasingly hurt by its available‑for‑sale debt portfolio: the AFS debt line posted a **$9 million gain in FY 2022**, turned to a **$21 million loss in FY 2023**, and widened to a **$67 million loss in FY 2024** (see the “Gains (losses) on investments, net” table)【page_46】. The swing from a modest gain to growing unrealized losses shows that the fair‑value of Cisco’s debt holdings fell as interest rates rose and credit spreads widened, indicating a deteriorating performance and a higher risk profile for these investments over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer provides specific numerical claims ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) that directly contradict the ground truth. The ground truth explicitly states that 'In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results.' The LLM's claim of a $9M gain in FY2022 is factually incorrect according to the knowledge graph. Additionally, while the LLM correctly identifies the negative trend in 2023-2024 and the general mechanism (interest rate rises, credit spread widening), it fabricates specific numbers without proper verification. The LLM also cites a page reference ('page_46') that cannot be verified against the ground truth. The reasoning about the deteriorating performance and risk profile is sound and aligns with the ground truth's conclusion, but this cannot overcome the fundamental factual inaccuracies in the quantitative claims. The answer demonstrates partial understanding of the multi-hop synthesis required (connecting AFS debt investments to 'other income (loss), net' across three fiscal years), but fails on the most critical dimension: providing accurate financial data. The LLM appears to have hallucinated specific numbers rather than acknowledging the lack of detailed metrics in 2022 as stated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 407,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks said its purchase commitments and inventory would be sufficient to meet demand through fiscal 2023 in the FY 2022 filing【page_12】, the FY 2023 filing extended that outlook to cover fiscal 2024【page_12】, and the FY 2024 filing now expects an adequate green‑coffee supply through fiscal 2025【page_12】. This rolling, one‑year‑ahead extension shows a sourcing strategy that relies on long‑term fixed‑price and price‑to‑be‑fixed contracts, diversified sourcing and inventory buffers, and the use of hedging and farmer‑support programs to proactively mitigate coffee‑price volatility and supply‑chain risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE ACCURACY: The LLM answer contains a significant factual error regarding the fiscal 2023 projection. The ground truth states that by fiscal 2023, Starbucks extended its supply adequacy projection to fiscal 2025 (a two-year extension). However, the LLM claims the FY 2023 filing extended the outlook to cover fiscal 2024 (only a one-year extension). This is a material misstatement of the multi-year progression. CORRECT PROGRESSION: FY2022 filing → adequate through FY2023; FY2023 filing → adequate through FY2025; FY2024 filing → adequate through FY2025. INCORRECT PROGRESSION (per LLM): FY2022 filing → adequate through FY2023; FY2023 filing → adequate through FY2024; FY2024 filing → adequate through FY2025. This error undermines the core quantitative claim about the 'rolling, one-year-ahead extension' pattern. STRENGTHS: (1) The LLM correctly identifies the overall trend of extending supply adequacy projections; (2) The qualitative analysis of sourcing strategy (long-term contracts, diversified sourcing, hedging, farmer-support programs) is sound and goes beyond the ground truth in providing strategic context; (3) The reasoning about risk mitigation is logically sound and relevant; (4) The multi-hop synthesis across three fiscal years is attempted correctly in structure. WEAKNESSES: (1) The FY2023 projection year is wrong (should be FY2025, not FY2024); (2) This error cascades through the interpretation of the progression pattern; (3) The claim about 'rolling, one-year-ahead extension' is factually incorrect given the actual two-year jump from FY2023 to FY2025. The answer demonstrates good qualitative reasoning but fails on the fundamental quantitative accuracy required for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 475,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA did not list any 2.00 % Notes Due 2031 in its FY 2022 filing (the note is absent from the 2022 pages 78‑82) – the exposure first appears in FY 2023 with a fair‑value of **$1.044 billion** and rises slightly in FY 2024 to **$1.057 billion** (both shown in the fair‑value table on page 67). This modest increase indicates that NVIDIA is gradually adding a small amount of low‑coupon, long‑dated debt, using the 2 % notes to lock in cheap financing while keeping its overall long‑term debt level relatively stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims FY2022 had NO exposure to the 2.00% Notes Due 2031, but ground truth shows $1,200 million. The LLM reports FY2023 as $1.044 billion ($1,044 million), which matches ground truth. However, the LLM reports FY2024 as $1.057 billion ($1,057 million), but ground truth shows $1,250 million - a $193 million discrepancy (15.4% error). (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the three-year trend. Ground truth shows: $1,200M (2022) → $1,044M (2023) → $1,250M (2024), indicating a decrease then significant increase. The LLM's reported trend ($0 → $1,044M → $1,057M) is fundamentally different and misrepresents the company's debt strategy. (3) REASONING QUALITY - The LLM's conclusion about 'gradually adding a small amount' is contradicted by the actual $206M increase from 2023 to 2024 (not 'modest' or 'small'). The characterization of debt strategy is therefore based on incorrect numbers. (4) ENTITY/DOCUMENT ACCURACY - While the LLM correctly identifies the instrument (2.00% Notes Due 2031) and company (NVIDIA), the filing references and page numbers cannot be verified but the numerical data is demonstrably wrong. The claim that the note is 'absent from 2022' directly contradicts ground truth showing $1,200M in 2022. This is a major factual error that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 408,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing (as shown in the 2023 segment‑product table), fall‑protection solutions were presented as a core PPE line – grouped together with “respiratory, hearing, eye” protection under the Safety & Industrial segment【page_107】. By the 2024 filing the segment had been reorganized with a new Industrial Specialties division, and the same fall‑protection solutions now appear in a longer list that also includes industrial abrasives, structural adhesives, electrical products and other specialty items, indicating that fall protection is still part of the safety portfolio but is positioned alongside a broader set of industrial‑specialty offerings rather than as a stand‑alone focus【page_110】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Fall Protection Solutions positioning within MMM's Safety and Industrial segment from 2022 to 2024. Key strengths: (1) Accurately captures that fall protection was grouped with respiratory, hearing, and eye protection in 2022; (2) Correctly identifies the shift by 2024 to a broader industrial specialty grouping; (3) Properly synthesizes the multi-hop information across years and segments; (4) Appropriately notes the shift from standalone focus to broader portfolio positioning. Minor weaknesses: (1) The LLM references a '2023 segment-product table' for 2022 data, which is slightly confusing in presentation but not factually incorrect; (2) The answer mentions 'Industrial Specialties division' as a 'new' division in 2024, but the ground truth uses more cautious language ('slightly revised grouping') without explicitly confirming it as a new division - this is a minor interpretive difference; (3) The LLM provides more specific product examples (industrial abrasives, structural adhesives, electrical products) than the ground truth, which is helpful but goes slightly beyond what was explicitly confirmed in the original answer. The core semantic meaning aligns well with the ground truth: fall protection evolved from being presented as a core PPE line alongside respiratory/hearing/eye protection to being positioned within a broader industrial specialty portfolio. The reasoning is sound and the multi-hop synthesis across 2022-2024 is accurate. Page references are provided but cannot be independently verified. Overall, this is a solid answer with minor presentation and interpretive nuances that don't significantly detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 467,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody sales – which consist of bamlanivimab (alone or with etesevimab) – generated about **$2.0 billion in U.S. sales plus $15 million outside the U.S. (≈ $2.02 billion total) in 2022**.  In the 2023 filing the line shows “‑” for both U.S. and non‑U.S. columns, and the 2024 table also shows “‑”, indicating **revenue fell to $0 in 2023 and remained $0 in 2024**.  This rapid drop means the company’s reliance on its COVID‑19 antibody portfolio has essentially disappeared after 2022.【page_68】【page_67】",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: The ground truth states $2.01 billion in 2022; the LLM provides $2.0 billion U.S. + $15 million non-U.S. = $2.015 billion total, which rounds to approximately $2.02 billion—semantically equivalent to $2.01 billion (minor rounding difference acceptable). Both 2023 and 2024 are correctly identified as $0 revenue. The LLM answer goes beyond the ground truth by providing geographic breakdown (U.S. vs. non-U.S. sales), which adds valuable context without contradicting the core facts. Multi-hop reasoning is sound: the answer correctly synthesizes the revenue evolution across three years and draws the appropriate conclusion about declining reliance on the COVID-19 antibody portfolio. Entity accuracy is perfect—correctly identifies Eli Lilly, bamlanivimab (with mention of etesevimab combination), and the COVID-19 antibody portfolio. The interpretation that the rapid drop indicates 'essentially disappeared' reliance is semantically equivalent to the ground truth's 'rapid decline in reliance.' The inclusion of page references (【page_68】【page_67】) demonstrates source documentation. Minor deduction (1 point) only for the slight variation in the 2022 figure ($2.01B vs. $2.015B), though this is within acceptable rounding tolerance and the LLM's more precise breakdown is arguably superior.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 383,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly flagged the same commodity‑index‑fund risk in each filing. In the “Product Supply” sections of the 2022, 2023 and 2024 10‑K (see page 12 of each report) the company notes that “price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and **commodity index funds**.” That language appears unchanged across fiscal 2022‑2024, indicating the exposure to index‑fund‑driven coffee price volatility has remained a consistent risk.\n\nAt the same time, Starbucks’ risk‑management response has grown more concrete. All three filings describe buying coffee under “fixed‑price and price‑to‑be‑fixed purchase commitments” and using “forward contracts, futures contracts, and collars to hedge ‘C’ price exposure.” Each filing adds that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2025**.” Thus, while the index‑fund exposure has persisted, Starbucks has steadily reinforced its hedging program and extended its purchase‑commitment horizon, showing a proactive strategy to lock in green‑coffee supply and mitigate price volatility through fiscal 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent acknowledgment of commodity index fund exposure across fiscal 2022-2024, with accurate citation of the specific language appearing unchanged ('price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity index funds'). (2) Accurately captures the evolution of risk management strategy, noting that while index-fund exposure persisted, Starbucks extended its supply visibility and commitment horizon through fiscal 2025. (3) Correctly identifies the specific hedging instruments used (forward contracts, futures contracts, and collars to hedge 'C' price exposure). (4) Properly synthesizes the multi-hop information: acknowledging persistent exposure while demonstrating improved risk mitigation practices. (5) All dates and fiscal years are correct (2022, 2023, 2024, and projections through 2025). (6) No quantitative errors or miscalculations present. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer is slightly more concrete and specific in its presentation (citing 'page 12' and providing exact quote language), while the ground truth uses more summary language about 'strengthening of risk management practices' and 'remote delivery risk assessments.' However, these are stylistic differences rather than factual discrepancies. The LLM answer actually provides MORE specific evidence (direct quotes and page references) than the ground truth summary. The core narrative—persistent index fund exposure combined with strengthened hedging and extended supply commitments—is accurately conveyed in both versions. The LLM answer effectively addresses all parts of the multi-part question: (1) how exposure evolved (remained consistent), (2) what the trend reveals about risk management (proactive strengthening of hedging and supply commitments). No material facts are omitted or misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 539,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In the 2022 filing Google explained that a large share of its ad revenue comes from Google Ad Manager – the platform that monetizes impressions on Google Network properties and is tracked through “impressions” and “cost‑per‑impression” metrics 【page_31】. The 2024 filing repeats this focus, still highlighting impression‑based revenue from Ad Manager and the same network‑partner model 【page_58】. Crucially, in January 2023 Alphabet revised the useful lives of its servers and network equipment from four‑five years to six years, which reduced depreciation expense by $3.9 billion and added $3.0 billion to net income (≈$0.24 per share) 【page_57】—a change that bolstered margins and strengthens the long‑term profitability of the impression‑based monetization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - $3.9 billion depreciation reduction, $3.0 billion net income increase, and the ~$0.24 per share calculation are accurate. The depreciation schedule change from 4-5 years to 6 years is correctly stated. Dates are accurate (2022, 2023, 2024, January 2023). COMPLETENESS: The answer addresses all key components of the multi-part question: (1) Google Ad Manager's role in 2022 (impression-based monetization), (2) the 2023 depreciation adjustment and its financial impact, (3) continuation in 2024, and (4) implications for long-term profitability. ENTITY ACCURACY: All entities correctly identified - Google Ad Manager, Google Network properties, Alphabet, servers, network equipment. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the depreciation policy change to infrastructure-heavy operations like Ad Manager, demonstrating sound logical flow. The connection between enhanced infrastructure longevity and long-term profitability is well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, with slightly more specific detail (e.g., mentioning the per-share impact). Minor differences in phrasing ('bolstered margins and strengthens' vs 'optimizing cost structures') are semantically equivalent. The inclusion of page references adds credibility without affecting accuracy. No calculation errors detected. The answer appropriately contextualizes the depreciation change as directly affecting infrastructure-heavy operations, matching the ground truth's emphasis on this connection.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 473,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK filed a 2022 Form of Performance Share Unit (PSU) Agreement (Exhibit 10.21) under its 2019 Long‑Term Incentive Plan, then issued a revised 2023 Form (Exhibit 10.23) and a further 2024 Form (Exhibit 10.25) in successive years 【page_19†L1-L4】【page_19†L5-L8】【page_19†L9-L12】. The annual updates show that BNY Mellon is consistently using PSUs as a core component of executive pay, reinforcing a performance‑driven, long‑term compensation strategy that aligns leadership incentives with shareholder value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies in exhibit numbers and filing progression that directly contradict the ground truth. (1) EXHIBIT NUMBER ERRORS: The LLM cites Exhibit 10.21 (2022 Form), 10.23 (2023 Form), and 10.25 (2024 Form), but the ground truth specifies Exhibit 10.45 (2021 agreement in 2022), 10.14 (2019 plan re-filed in 2023), and 10.18 (2022 agreement in 2024). These are completely different exhibit numbers. (2) AGREEMENT FORM ERRORS: The LLM incorrectly states BK filed a '2022 Form' in the initial year, then '2023 Form' and '2024 Form' in successive years. The ground truth shows BK referenced 2021 agreements in 2022, then re-filed the 2019 plan in 2023, then incorporated 2022 agreements in 2024 - a different progression pattern. (3) MISSING KEY DETAIL: The ground truth emphasizes that 2023 involved re-filing the foundational 2019 Long-Term Incentive Plan itself, not just updating agreement forms. The LLM misses this important distinction about recommitment to the foundational structure. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the general strategy (performance-driven, long-term compensation), it fails to capture the specific evolution pattern: maintaining core framework while updating mechanisms. The LLM's characterization of 'annual updates' is oversimplified and inaccurate given the 2023 re-filing of the base plan. (5) COMPANY NAME: The LLM correctly identifies BNY Mellon but uses 'BK' inconsistently. The ground truth uses 'BK' throughout. The core answer about PSU strategy is directionally correct but the specific factual details about which forms were filed in which years are fundamentally wrong, making this response unreliable for someone seeking accurate filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 482,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "- 2022 10‑K – the Safety & Industrial segment listed electrical items only as “electrical products and materials for construction and maintenance, power distribution” (see 2022 filing, pp. 129‑133).  \n- 2023 10‑K – the description was expanded to “electrical products and materials for construction and maintenance, power distribution **and electrical original equipment manufacturers (OEMs)**” (page 107).  \n- 2024 10‑K – the same, more‑specific wording was retained (page 110).  \n\nThe shift from a generic electrical‑product label in 2022 to an explicit OEM focus in 2023‑24 shows 3M is sharpening its Safety & Industrial portfolio to target electrical original‑equipment‑manufacturer markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) 2022 DESCRIPTION ERROR: The LLM states the 2022 description was 'electrical products and materials for construction and maintenance, power distribution' WITHOUT mentioning 'electrical OEMs'. However, the ground truth explicitly states that in 2022, 3M described electrical products as serving 'construction and maintenance, power distribution and electrical OEMs'. This is a major omission that fundamentally misrepresents the 2022 baseline. (2) 2023 DESCRIPTION ERROR: The LLM claims the 2023 description added 'and electrical original equipment manufacturers (OEMs)' to the 2022 description. However, the ground truth indicates that in 2023, the company 'refined' the description to specify 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs' - suggesting a change in specificity/formalization, not an addition of a new category. The LLM mischaracterizes this as an expansion when it was actually a refinement. (3) 2024 DESCRIPTION ERROR: The LLM states 2024 retained 'the same, more-specific wording' from 2023. However, the ground truth indicates that by 2024, the language evolved to 'power distribution and electrical original equipment manufacturers (OEMs)', which represents a different formulation than 2023 (removing 'construction and maintenance' and restructuring the phrasing). (4) MULTI-HOP REASONING FAILURE: The LLM fails to correctly synthesize the three-year evolution. The ground truth shows a progression of increasing precision and strategic emphasis, while the LLM presents an incomplete and inaccurate narrative that misses the nuanced changes across years. (5) CONCLUSION ACCURACY: While the LLM's final conclusion about 'sharpening' focus on OEM markets is directionally reasonable, it is based on incorrect intermediate facts, making the reasoning path flawed. The answer demonstrates partial understanding of the general trend but fails on specific factual accuracy regarding what was actually stated in each year's filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 568,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- **2022:** Fixed‑rate unsecured senior notes carried **$24.1 billion** with a **weighted‑average interest rate of ~4.45 %**.  \n- **2023:** The balance rose to **$27.2 billion** and the weighted‑average rate remained **about 4.45 %**.  \n- **2024:** The carrying amount fell slightly to **$26.9 billion**, while the weighted‑average rate increased to **≈4.84 %**.  \n\nThis trajectory shows Capital One steadily building a large, fixed‑rate senior‑debt platform, then modestly trimming the amount while accepting a higher average cost in 2024—indicating a long‑term strategy of maintaining a sizable, long‑dated fixed‑rate funding base and adjusting the mix as market rates evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 and 2023 figures. (1) 2022 CARRYING VALUE: LLM states $24.1 billion, but ground truth is $19,975 million ($19.975 billion). This is a $4.125 billion overstatement (20.6% error). (2) 2022 WEIGHTED-AVERAGE RATE: LLM states ~4.45%, but ground truth is 2.91%. This is a 1.54 percentage point error (53% higher than actual). (3) 2023 CARRYING VALUE: LLM states $27.2 billion, which matches ground truth of $27,168 million ($27.168 billion). This is correct. (4) 2023 WEIGHTED-AVERAGE RATE: LLM states 'about 4.45%', but ground truth is 4.45% in 2023. While the rate is correct, the LLM incorrectly implies it remained flat from 2022 to 2023, when it actually increased from 2.91% to 4.45% (a 1.54 percentage point jump). (5) 2024 CARRYING VALUE: LLM states $26.9 billion, which matches ground truth of $26,930 million. Correct. (6) 2024 WEIGHTED-AVERAGE RATE: LLM states ≈4.84%, which matches ground truth. Correct. MULTI-HOP REASONING: The LLM's interpretation of the trend is partially sound but built on incorrect foundational data. The ground truth shows a dramatic increase in rates from 2.91% (2022) to 4.45% (2023) to 4.84% (2024), indicating Capital One was locking in increasingly expensive debt during a rising rate environment. The LLM misses this critical 2022-to-2023 rate jump entirely, instead suggesting rates 'remained about 4.45%' from 2022-2023. This fundamentally misrepresents the company's debt strategy evolution. ENTITY ACCURACY: Company (COF/Capital One) and metric names are correct. Years are correct. SEMANTIC EQUIVALENCE: The LLM's strategic interpretation about 'maintaining a sizable, long-dated fixed-rate funding base' is reasonable, but it's based on incorrect data that obscures the true story of aggressive debt accumulation during a sharply rising rate environment in 2022-2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 516,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA has kept the 3.50 % Notes Due 2040 on its balance sheet at the original issuance amount, net of any un‑amortized discount and issuance costs throughout FY 2022‑2024 (the same “carried at original‑issuance value” language appears in the liability footnote)【page_78†L1-L4】.  The disclosed Level‑2 fair‑value of the notes was $870 million as of the FY 2023 reporting date and slipped to $851 million by the FY 2024 date【page_78†L31-L38】.  The modest decline in fair value, paired with an unchanged accounting treatment, shows that NVIDIA relies on low‑coupon, long‑dated debt as a stable, low‑cost financing source and prefers to hold the notes to maturity rather than actively trade or refinance them.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly different fair value numbers than ground truth. Ground truth states FY2023 fair value was $851M and FY2024 was not reported as fair value but as carrying amount of $1,000M. LLM claims FY2023 fair value was $870M (incorrect - off by $19M) and FY2024 fair value was $851M (incorrect - this was the FY2023 figure). The LLM appears to have confused or transposed the years. Ground truth explicitly states FY2022 fair value was $1,066M, which the LLM completely omits. (2) COMPLETENESS - The LLM fails to address the full multi-year progression (2022-2024). It only discusses FY2023 and FY2024 fair values, missing the critical FY2022 data point ($1,066M) that shows the significant decline trajectory. (3) ACCOUNTING TREATMENT SHIFT - Ground truth emphasizes a key shift: FY2024 moved from reporting fair value to reporting carrying amount ($1,000M), indicating a change in accounting methodology. The LLM mentions 'unchanged accounting treatment' which contradicts the ground truth's core finding about the evolution in how NVIDIA accounts for these notes. (4) REASONING QUALITY - While the LLM's interpretation about holding-to-maturity strategy is reasonable, it's built on incorrect numerical foundations and misses the fundamental accounting shift that is central to understanding the 'evolution' requested in the question. (5) SEMANTIC ISSUES - The LLM's conclusion about 'unchanged accounting treatment' directly contradicts the ground truth's finding that there WAS a shift in treatment from fair value reporting to carrying amount reporting. This is a material mischaracterization of the company's debt strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 467,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s outstanding balance on the 2017 senior‑notes fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023 and further to $13 billion at 12/31/2024【page_58】【page_57】. The steady decline shows Amazon is actively retiring or redeeming portions of this issuance each year, signalling a deliberate debt‑reduction strategy that uses its cash generation to lower long‑term leverage and interest costs while preserving balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) match the ground truth exactly. The year-over-year reductions ($1B in 2023, $2B in 2024) are accurately represented. Date formatting (12/31/2022, 12/31/2023, 12/31/2024) is appropriate and precise. (2) COMPLETENESS: The answer fully addresses both parts of the multi-part question: (a) the evolution of the outstanding balance across the three-year period, and (b) what this trajectory suggests about debt management strategy. (3) ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes/senior notes are properly referenced, and all fiscal years are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the pattern (consistent year-over-year reduction) and draws appropriate conclusions about deliberate debt management. The additional context about 'actively retiring or redeeming portions,' 'lowering long-term leverage and interest costs,' and 'preserving balance-sheet flexibility' represents reasonable inferences from the reduction pattern and adds valuable analytical depth beyond the ground truth without contradicting it. (5) SEMANTIC EQUIVALENCE: The core message aligns perfectly with the ground truth - both emphasize a deliberate, consistent debt reduction strategy. The LLM's elaboration on the strategic implications (cash generation, leverage reduction, interest cost management) enhances the answer while remaining factually grounded. Minor note: The inclusion of page references adds credibility but is not essential to correctness. Overall, this is a high-quality response with accurate numbers, complete coverage, sound reasoning, and appropriate analytical depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 498,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s repeated disclosure of “Floating Rate Notes due 2019” in the exhibit tables of its 2022 (see page 58), 2023 (see page 56) and 2024 (see page 56) 10‑K filings shows that the company still carries short‑term, rate‑resetting debt. Because the interest on floating‑rate notes adjusts with market benchmarks, Apple’s interest‑expense will rise as rates climb, making its borrowing costs more sensitive to a higher‑rate environment—though the impact is tempered by the relatively modest size of those notes within Apple’s overall capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core issue: Apple's repeated disclosure of Floating Rate Notes due 2019 across 2022, 2023, and 2024 filings, and accurately explains the interest rate sensitivity mechanism (floating rates adjust with benchmarks, increasing expense in rising rate environments). The reasoning about interest expense sensitivity is sound and well-articulated.\n\nHowever, there are significant issues:\n\n1. QUANTITATIVE ACCURACY PROBLEMS: The LLM cites specific page numbers (page 58 for 2022, page 56 for 2023 and 2024) without verification against the ground truth. These page citations cannot be confirmed and may be inaccurate, which is a factual error in a financial document context where precision is critical.\n\n2. MISSING KEY CONTEXT: The ground truth emphasizes that the notes were due in 2019, yet appeared in 2022, 2023, and 2024 filings—a temporal anomaly that suggests incorporation by reference of an Officer's Certificate dated May 6, 2014. The LLM answer does not explain this apparent discrepancy or mention the incorporation by reference mechanism, which is crucial to understanding why notes with a 2019 maturity appear in later filings.\n\n3. INCOMPLETE SYNTHESIS: The ground truth mentions \"rollover obligations or continuing commitments tied to this debt structure\" and \"liquidity planning and capital structure flexibility.\" The LLM answer acknowledges the notes' modest size within Apple's overall capital structure but doesn't explore the implications for rollover obligations or liquidity planning that the ground truth identifies.\n\n4. SEMANTIC EQUIVALENCE: The LLM's explanation of interest rate sensitivity is semantically equivalent to the ground truth and correctly conveys the mechanism. The characterization of these as \"short-term, rate-resetting debt\" is appropriate.\n\n5. REASONING QUALITY: The multi-hop reasoning is present but incomplete. The LLM correctly synthesizes that (a) notes appear in multiple years, (b) floating rates create sensitivity, and (c) this affects interest expense. However, it doesn't fully synthesize why notes with 2019 maturity appear in later filings or what this implies about Apple's debt management strategy.\n\nThe answer is partially correct on core concepts but lacks precision on documentation details and misses important contextual elements about the incorporation by reference mechanism and its implications for Apple's capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 650,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "In the 2022 filing Google framed its hardware work as a long‑run investment, highlighting the launch of the Pixel 5a 5G and Pixel 6 and saying it was “investing … for the long run” in a growing family of devices (page 7). By 2023 the MD&A had moved Pixel sales into a separate “devices” revenue line, noting that hardware now generates a distinct, lower‑margin revenue stream that varies with product‑launch timing (page 33; also see the comment that device sales “adversely affect our consolidated margins” (page 31)). The 2024 report simply refers to the “Pixel family” as the primary source of device revenue, treating it as a mature, core platform that complements Google’s AI‑driven services (page 59), indicating a shift from exploratory investment to a stable, long‑term hardware pillar in Alphabet’s strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each phase: 2022 as long-term investment framing, 2023 as transition to distinct revenue line, 2024 as mature core platform. (2) Accurately captures the specific products mentioned (Pixel 5a 5G, Pixel 6) and the strategic messaging ('investing for the long run'). (3) Provides additional valuable context not in ground truth but consistent with it: mentions lower-margin revenue stream, product-launch timing variability, and margin impact - these details enhance rather than contradict the core narrative. (4) Multi-hop reasoning is sound: synthesizes information across three separate filing years to show evolution from investment to revenue generation to maturity. (5) Correctly identifies the strategic implication: shift from exploratory investment to stable hardware pillar. (6) Page references (7, 33, 31, 59) add specificity and credibility, though cannot be verified against ground truth. MINOR CONSIDERATIONS: (1) The LLM provides more granular detail about margin impacts than the ground truth, but this is additive and consistent with typical 10-K disclosure patterns. (2) The characterization of 'lower-margin' revenue is a reasonable inference from hardware business models and doesn't contradict the ground truth. (3) All core facts match: the three-year timeline, product names, the transition from investment to revenue category, and the conclusion about long-term positioning. The answer is semantically equivalent to and factually consistent with the ground truth while providing additional supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 472,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s margin‑lending disclosures show that the fair‑value of client securities that could be pledged rose sharply – from $84 billion in 2020 to $120 billion in 2021 – and the total collateral pledged for options‑clearing, short sales, securities‑lending and short‑term borrowings grew from $23 billion to $31 billion (page 108). At the same time, securities loaned remained around $7 billion and securities borrowed stayed under $1 billion, with net exposures of less than $1 billion (page 107), and the firm notes that cash collateral received on securities‑lending transactions is equal to or greater than the market value of the loaned securities and is monitored daily to ensure full collateralization (page 78). This pattern of increasing use of client securities for margin and lending, coupled with strict full‑collateralization monitoring, indicates Schwab is expanding client‑security‑based funding while maintaining a conservative, risk‑aware collateral‑management strategy through 2022‑2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally misaligned with the ground truth and the question asked. (1) TEMPORAL MISMATCH: The question explicitly asks about evolution from 2022-2024, but the LLM provides data from 2020-2021 ($84B to $120B, $23B to $31B), which is outside the requested timeframe. The ground truth addresses 2022, 2023, and 2024 specifically. (2) QUANTITATIVE INACCURACY: The LLM cites specific dollar amounts ($84B, $120B, $23B, $31B) that do not appear in the ground truth answer. These numbers cannot be verified against the ground truth and appear to be either fabricated or from incorrect filing years. (3) MISSING KEY INFORMATION: The LLM completely fails to address the core evolution described in the ground truth: (a) 2022's disclosure of collateralized securities for margin loans without specific values, (b) 2023's expansion detailing collateralized securities use in margin lending not reflected in consolidated statements, (c) 2024's active pledging of securities for options clearing and cash collateral in securities lending. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question requires synthesizing information across three years (2022-2024) showing progression. The LLM instead provides a two-year comparison (2020-2021) that doesn't address the requested timeframe. (5) STRATEGIC INSIGHT MISMATCH: The ground truth emphasizes a 3-year progression toward 'broader use of client assets for operational and regulatory needs' and 'growing reliance on client securities for risk mitigation.' The LLM's conclusion about 'expanding client-security-based funding' is directionally similar but based on wrong years and numbers. (6) PAGE CITATIONS: The LLM cites specific pages (108, 107, 78) which cannot be verified against the ground truth and suggest potential hallucination or use of incorrect source documents. The ground truth provides no such page references. VERDICT: This answer demonstrates significant factual errors, temporal misalignment with the question, and apparent data fabrication or source confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 551,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks GE’s discussion of long‑term‑care premium‑rate increases is unchanged: as a reinsurer it has no direct authority to raise premiums, but it “often collaborates with the primary insurers … to file proposed premium‑rate‑increase actions” with state regulators, and the frequency of such filings varies by ceding company and is judged against recent filing experience. The consistency of this language shows that GE’s run‑off insurance risk‑management strategy is built on a steady, partnership‑based approach—relying on ceding insurers’ regulatory filings and incorporating expected rate‑increase outcomes into its reserve assumptions to manage reinsurance risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer fundamentally contradicts the ground truth on the key analytical finding. Ground truth explicitly states an EVOLUTION from 2022-2024: (1) 2022: indirect role, varying frequency; (2) 2023: formalized collaboration under contractual terms, active participation; (3) 2024: reinforced framework with enhanced use of experience/precedents. This progression reveals a 'strategic shift toward proactive risk management and tighter integration.' The LLM answer claims the language is 'unchanged' across all three years and describes a 'steady, partnership-based approach'—directly contradicting the ground truth's core finding of evolution and strategic shift. QUANTITATIVE ACCURACY: No numeric errors detected (dates 2022-2024 correct, no calculations required). QUALITATIVE ACCURACY: The LLM correctly identifies that GE has no direct premium-setting authority and collaborates with primary insurers, which aligns with ground truth details. However, the LLM's assertion of consistency/unchanging language across years is factually incorrect per the ground truth. The LLM missed the critical temporal progression that is central to answering the question. COMPLETENESS: The question asks 'how did...evolve' and 'what does this progression reveal'—both explicitly requesting analysis of change over time. The LLM's answer of 'unchanged' fails to address the evolution component. REASONING: The LLM's logic about steady partnership-based approach is reasonable but built on a false premise (that language/approach was unchanged). The ground truth shows increasing formalization and proactivity, not steadiness. The LLM did not synthesize the multi-year progression correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 464,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) holdings rose modestly from $845 million (amortized cost) and $757 million (fair value) at 12/31/2022 to $862 million and $810 million at 12/31/2023 (page 147). By 12/31/2024 the fair‑value of RMBS reported in the Separate‑Accounts section had dropped to only $71 million (page 160). The three‑year trend—slight growth followed by a sharp contraction—shows CVS has been pulling back from structured‑credit assets, positioning its portfolio with considerably less RMBS‑related risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. (1) 2022: LLM reports $845M (amortized cost) and $757M (fair value), but ground truth shows $721M total. The LLM's numbers are significantly higher and appear to conflate different metrics or securities. (2) 2023: LLM reports $862M and $810M, but ground truth shows $614M. Again, the LLM's figures are substantially overstated (approximately 40% higher). (3) 2024: LLM correctly identifies $71M, matching ground truth. However, this single correct data point cannot offset the pervasive errors in 2022 and 2023. (4) MULTI-HOP REASONING: The LLM's characterization of the trend as 'slight growth followed by sharp contraction' is incorrect. The actual trend per ground truth is: decline from $721M to $614M (2022-2023), then further decline to $71M (2023-2024). This is a consistent downward trend, not growth followed by contraction. The LLM misread the 2022-2023 movement. (5) CALCULATION ERRORS: The LLM's comparison of amortized cost vs. fair value figures appears to conflate different reporting categories or securities, introducing confusion rather than clarity. (6) CONTEXTUAL ISSUES: While the LLM correctly identifies this as a risk management approach and mentions 'pulling back from structured-credit assets,' the incorrect numbers undermine the credibility of this analysis. The ground truth's mention of 'cautious reduction in 2023 amid rising unrealized losses' provides more nuanced context that the LLM lacks. VERDICT: Only 1 of 3 years' data is correct. The fundamental quantitative errors, combined with mischaracterization of the trend direction, make this answer substantially incorrect despite some appropriate qualitative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 484,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023, then ticked up slightly to $562 million in 2024 (Table 8.1, 2022 vs. Table 9.1, 2023‑2024)【page_178】.  Long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before dropping to $45.0 billion in 2024 (Table 8.1, 2022 vs. Table 9.1, 2023‑2024)【page_178】【page_188】.  The three‑year trend shows total debt declining from $48.7 billion to $45.6 billion, reflecting a strategic shift toward a more stable capital structure—reducing reliance on short‑term funding while actively managing long‑term maturities to lower overall leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies compared to the ground truth. (1) SHORT-TERM BORROWINGS: LLM states $883M (2022), $538M (2023), $562M (2024), but ground truth indicates these are components of a much larger total debt picture. The LLM appears to have isolated only a portion of short-term borrowings rather than the complete figure. (2) LONG-TERM DEBT: LLM reports $47.8B (2022), $49.3B (2023), $45.0B (2024). Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $49.856B (2023), $45.551B (2024). The LLM's long-term debt figures are close but don't align with the ground truth totals when combined with short-term borrowings. (3) TOTAL DEBT CALCULATION: LLM calculates $48.7B (2022) and $45.6B (2024), but ground truth shows $43.086B and $45.551B respectively—a fundamental mismatch. (4) MISSING KEY METRICS: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a critical component of the ground truth answer and directly addresses the 'debt management strategy' aspect of the question. (5) MISSING FLOATING DEBT ANALYSIS: The ground truth specifically highlights the reduction of floating unsecured senior debt from $1,709M to $349M to $0, which provides important insight into the strategic shift away from variable-rate instruments. The LLM fails to mention this entirely. (6) REASONING QUALITY: While the LLM's narrative about 'strategic shift toward stable capital structure' is reasonable, it's based on incorrect numbers and misses the interest rate environment context that is crucial to understanding the debt management strategy. The multi-hop synthesis is incomplete and partially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 477,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s 3.50 % Notes due 2050 were reported at a fair‑value of roughly **$1.66 billion** at fiscal‑year‑end 2022, falling to **$1.637 billion** in FY 2023 and **$1.604 billion** in FY 2024 (NVDA 10‑K 2022 p. 78; NVDA 10‑K 2024 p. 67). The gradual decline, while the principal amount remains unchanged, shows the company is preserving a stable long‑term debt base but allowing the liability’s market value to shrink as yields rise—reflecting a capital‑structure strategy that emphasizes steady financing and modest leverage management.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR QUANTITATIVE DISCREPANCY: The LLM reports FY2022 value as ~$1.66 billion, but the ground truth clearly states $2,147 million ($2.147 billion). This is a significant error of approximately $487 million or 23% understatement. The LLM's FY2022 figure is actually closer to the FY2023 value ($1.637 billion), suggesting possible data confusion or misreading of source documents. (2) FY2023 and FY2024 values are correct ($1.637 billion and $1.604 billion respectively match ground truth). (3) REASONING FLAW: The LLM's interpretation about 'fair-value' and 'yields rise' causing market value shrinkage is speculative and not supported by the ground truth answer. The ground truth simply notes a 'deliberate reduction in long-term debt obligation,' which is more straightforward than the LLM's market-value-driven explanation. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the three-year trend, the fundamental error in the FY2022 starting point undermines the entire analysis. The trend should show a decline from $2,147M → $1,637M → $1,604M, not from $1,660M → $1,637M → $1,604M. (5) The LLM correctly identifies the notes as 3.50% Notes Due 2050 and NVIDIA as the company, but the core financial data is materially incorrect. The answer demonstrates partial understanding but fails on the most critical metric—the starting value—which is essential for understanding the magnitude of the company's debt reduction strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 407,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 are listed in the “Officer’s Certificate” exhibit (Exhibit 4.3) in every recent filing – the 2022 Form 10‑K includes the note in its Exhibit 4.3 table (page 56) 【page_56】, the 2023 Form 10‑K repeats the same description in Exhibit 4.3 (page 56) 【page_56】, and the 2024 Form 10‑K again shows the 0.45 % Notes due 2016 in Exhibit 4.3 (page 56 and the index on page 58) 【page_56】【page_58】. The fact that this 2016‑maturing issue is retained in the exhibit schedule across three consecutive years indicates Apple’s long‑term debt disclosure strategy is to maintain a continuous, transparent record of all historic debt issuances, even after they have matured.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the 0.45% Notes due 2016 as the specific debt instrument in question; (2) Accurately states the notes were issued in 2013 and matured in 2016, matching ground truth; (3) Correctly identifies the exhibit location (Exhibit 4.3) across all three years (2022, 2023, 2024); (4) Provides specific page references (pages 56 and 58) that add credibility; (5) Accurately synthesizes the multi-hop pattern across three consecutive years; (6) Correctly interprets the disclosure strategy as maintaining legacy debt documentation for transparency and legal continuity, which aligns with the ground truth conclusion. The reasoning is sound: the LLM properly connects the observation that the notes appear in consecutive filings despite maturity to the broader insight about Apple's disclosure philosophy. Minor considerations: (1) The LLM provides more specific exhibit details (page numbers, exhibit designation) than the ground truth, which adds value but goes slightly beyond what was explicitly stated in the original answer; (2) The wording \"continuous, transparent record of all historic debt issuances\" is semantically equivalent to the ground truth's \"legacy debt disclosures...for transparency and legal continuity.\" All factual claims are verifiable and correct. The answer fully addresses both parts of the question: how the disclosure evolved (consistent pattern across years) and what it indicates about strategy (maintaining historical records for transparency).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 428,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net Level‑3 derivative liability was only $5 million at the end of 2022, rose sharply to $58 million in 2023, and increased further to $69 million in 2024【page 206】; the valuation model moved from using low‑range swap‑rate inputs (about 1‑2 % with a weighted‑average of ~2 % in earlier periods such as 2021【page 222】) to a broader 3‑5 % range (average 4 %) in 2023【page 208】, and then settled on a single 4 % swap‑rate assumption in 2024【page 216】. This trajectory shows a growing exposure to interest‑rate risk and a shift toward higher, more volatile unobservable swap‑rate assumptions in the company’s Level‑3 derivative valuation models.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Primary Issue):\n   - 2022 value: LLM states $5 million vs. ground truth $31 million (84% error)\n   - 2023 value: LLM states $58 million vs. ground truth $58 million (CORRECT)\n   - 2024 value: LLM states $69 million vs. ground truth $58 million (19% error, directionally wrong)\n   - The LLM shows an increasing trend ($5M→$58M→$69M) while ground truth shows $31M→$58M→$58M (stable after 2023)\n\n2. METRIC CONFUSION:\n   - LLM conflates 'Level-3 derivative liability' with 'net derivative assets (liabilities)' - these are different metrics\n   - Ground truth clearly specifies 'net derivative assets (liabilities)' as the metric\n   - This is a fundamental entity/metric identification error\n\n3. RISK INPUT ERRORS:\n   - 2023: LLM states 'swap rates' with 2-5% range; ground truth states 'default' as significant unobservable input with 4% weighted average\n   - 2024: LLM correctly identifies 'swap rates' at 4% (matches ground truth)\n   - The 2023 characterization is completely wrong\n\n4. NARRATIVE INTERPRETATION:\n   - LLM concludes 'growing exposure' and 'higher, more volatile assumptions' based on incorrect upward trend\n   - Ground truth indicates 'shift in key risk driver from default to swap rates' with 'stable valuation level'\n   - These are opposite conclusions\n\n5. MULTI-HOP SYNTHESIS:\n   - Failed to correctly synthesize the evolution across three years\n   - Misidentified the key transition point (2023 vs 2024)\n   - Incorrectly characterized the risk driver shift\n\n6. REALIZED LOSSES:\n   - Ground truth mentions reduction from $43M (2022) to stable values (2023-2024)\n   - LLM completely omits this important context\n\nThe answer demonstrates poor data extraction, metric confusion, and arrives at conclusions opposite to the ground truth. While some page references are provided, the underlying numbers and interpretations are substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 544,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s 1.55 % Notes due 2028 were carried at a fair‑value of about **$1.099 billion in FY 2022** (see the liability table in the 2022 filing [page 78]) and the same amount in FY 2023, then **rose to $1.115 billion in FY 2024** (fair‑value column for Jan 28 2024 in the 2024 filing [page 67]).  The net carrying amount of the series stayed at **$1.250 billion** (page 72), showing that NVIDIA has kept the principal unchanged while the market value has only modestly increased – a pattern that reflects a strategy of maintaining a stable, low‑cost, long‑dated debt base rather than aggressively expanding long‑term borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth across all three fiscal years. (1) FY 2022: LLM states $1.099 billion (fair-value), but ground truth shows $1.2 billion. This is a $101 million discrepancy (8.4% error). (2) FY 2023: LLM states $1.099 billion (same as 2022), but ground truth shows $1.1 billion. While closer, this still represents a $1 million difference and misses the actual slight decline from 2022. (3) FY 2024: LLM states $1.115 billion (fair-value), but ground truth shows $1.25 billion. This is a $135 million discrepancy (10.8% error). The LLM appears to have confused fair-value measurements with principal/carrying amounts, citing different values than the ground truth. The LLM correctly identifies the instrument (1.55% Notes Due 2028) and the three-year period, but the numerical progression is fundamentally wrong. The LLM's conclusion about 'stable, low-cost, long-dated debt base' is reasonable in tone but is based on incorrect numbers. The ground truth shows: $1.2B → $1.1B → $1.25B (decline then increase), while LLM shows: $1.099B → $1.099B → $1.115B (flat then slight increase). These are materially different patterns. The LLM's reference to specific page numbers and filing sections suggests confidence in incorrect data extraction. The reasoning about debt strategy is qualitatively sound but quantitatively unsupported by the actual numbers provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 408,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks GE consistently reported that it still carries “trailing legal liabilities” tied to legacy Alstom‑acquisition matters (pre‑acquisition anti‑competitive and corruption claims) and to shareholder lawsuits over past financial‑performance, accounting and disclosure practices. Each year the company notes that it has set aside reserves but that the ultimate cash‑outflow and reputational impact remain uncertain, indicating that these contingent liabilities have persisted unchanged and continue to pose a material financial risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the core elements of the ground truth response. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the two main categories of legal liabilities: Alstom acquisition legacy matters (pre-acquisition anti-competitive and corruption claims) and shareholder lawsuits over financial reporting/disclosure practices. (2) Accurately conveys the persistence of these liabilities across all three years without diminishment. (3) Correctly notes that GE has set aside reserves but acknowledges uncertainty about ultimate cash outflows and reputational impact. (4) Properly synthesizes the multi-hop information across three separate 10-K filings. (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer is more concise and slightly less detailed than the ground truth - it doesn't explicitly mention that the company acknowledged these matters 'could exceed current estimates' (2023) or that contingent liabilities from 'exited businesses' were also referenced (2024). (2) The phrase 'persisted unchanged' in the LLM answer is slightly less nuanced than the ground truth's discussion of how the company 'reiterated' exposure and 'emphasized' potential for exceeding estimates, which suggests some evolution in disclosure emphasis even if the underlying liabilities remained. (3) Missing the specific characterization of these as 'reputational risks' that appears in the ground truth. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential message - that these are persistent, material contingent liabilities with uncertain financial impact - which matches the ground truth's conclusion. The reasoning is sound and the multi-hop synthesis across three years is correct. The answer appropriately addresses the question's core inquiry about evolution and persistence of these liabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 512,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan listed hedge‑fund limited‑partnership (HF LP) investments at **$237 million in 2022** (see 2022 10‑K footnote on page 165) and at **$280 million in 2024** (see 2024 10‑K footnote on page 166), a rise of roughly **$43 million** (about an 18 % increase). The growing HF LP exposure signals that CVS is deliberately expanding its alternative‑asset allocation within the pension fund, using hedge‑fund partnerships to diversify the portfolio and pursue higher long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains significant numerical errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022 HF LP investments at $237 million, but ground truth shows $214 million - a $23 million discrepancy (10.7% error). The LLM states 2024 at $280 million, but ground truth shows $252 million - a $28 million discrepancy (11.1% error). The LLM's calculated increase of $43 million is incorrect; the actual increase from 2022 to 2024 is $38 million ($252M - $214M). The percentage increase calculation of 18% is also wrong based on the LLM's own (incorrect) numbers: ($280M - $237M) / $237M = 18.1%, which happens to match, but this is built on false premises. (2) MISSING DATA POINT: The LLM completely omits the 2023 intermediate value of $225 million, which is important for demonstrating the consistent upward trend mentioned in the ground truth. The ground truth shows a year-by-year progression ($214M → $225M → $252M), while the LLM only provides endpoints. (3) MULTI-HOP REASONING: While the LLM correctly identifies the strategic implication (deliberate expansion of alternative assets for diversification and higher returns), this qualitative reasoning cannot compensate for the quantitative errors. The reasoning is sound but built on incorrect numbers. (4) ENTITY AND CONTEXT: The LLM correctly identifies CVS, hedge fund limited partnerships, and pension fund strategy, and appropriately cites 10-K filings. However, the specific page references and numbers cited are inaccurate. The answer demonstrates understanding of the question's intent but fails on execution. VERDICT: The answer is fundamentally unreliable due to material numerical errors across all key data points. An investor or analyst relying on these figures would be significantly misled.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 504,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "- In 2022 Africa/Eurasia contributed **$228 million of operating profit** (segment table for 2022)【page_116】.  \n- In the 2023 Global Productivity Initiative the region was assigned **5 % of the $32 million pretax restructuring charges**, or roughly **$1.6 million**, showing only a modest restructuring impact【page_86】.  \n- By 2024 the region’s **depreciation and amortization expense was $8 million**, indicating continued but modest asset investment【page_117】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) OPERATING PROFIT ERROR: The LLM states Africa/Eurasia contributed $228 million in 2022 operating profit, but the ground truth clearly states $203 million. This is a $25 million discrepancy (12% error). (2) RESTRUCTURING CHARGES ERROR: The LLM claims the region was assigned 5% of $32 million restructuring charges (~$1.6 million), but the ground truth indicates 10% of expected charges totaling $20-24 million. The LLM's percentage (5% vs 10%) and total amount ($1.6M vs $20-24M) are both significantly wrong—off by a factor of 12-15x. This is a critical error in multi-hop synthesis. (3) DEPRECIATION/AMORTIZATION: The LLM correctly identifies $8 million for 2024, which matches the ground truth. However, the LLM fails to provide the comparative context that this declined from $9 million in prior years, missing important analytical insight. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three years, the fundamental errors in the 2022 and 2023 data points severely compromise the overall narrative. The conclusion about 'modest restructuring impact' is contradicted by the actual magnitude of charges. (5) MISSING CONTEXT: The LLM fails to convey the strategic significance of the restructuring initiative or the pattern of cost optimization versus expansion that the ground truth emphasizes. The answer reads as incomplete and lacks the analytical depth of the original. The quantitative errors are not minor formatting issues but represent substantial factual inaccuracies that would mislead a financial analyst.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 460,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022 AIG said that a five‑ton bomb attack overseas would generate roughly **$1.3 billion of loss net of TRIPRA and existing reinsurance**, and that the exposure was managed through government‑sponsored pools and targeted reinsurance purchases, but it did not disclose any specific attachment points for the international terrorism layer【page_169】. The 2023 filing still relied on third‑party scenario modeling and ad‑hoc reinsurance for international terrorism and reported **$67.5 billion of total reinsurance recoverable assets** (including $30.4 billion of ceded loss reserves)【page_121】【page_122】. By 2024 AIG formalized its international terrorism retention at **$200 million for Japan and $125 million for the rest of the world** and its **reinsurance recoverable assets fell to $38.0 billion** (with $29.1 billion of ceded loss reserves)【page_88】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. STRENGTHS: (1) Correctly identifies the $1.3 billion net loss estimate for 2022 bomb attack scenario; (2) Accurately captures the $200 million Japan and $125 million rest-of-world attachment points for 2024; (3) Correctly states 2024 reinsurance recoverable assets at $38.0 billion with $29.1 billion ceded loss reserves; (4) Properly synthesizes the evolution across three years; (5) Appropriately notes the shift from ad-hoc to formalized retention approach. CRITICAL ERRORS: (1) The 2023 reinsurance recoverable assets figure of $67.5 billion appears to be incorrect or misattributed - the ground truth does not confirm this specific number for 2023, and the LLM provides no clear source validation; (2) The 2023 ceded loss reserves figure of $30.4 billion is stated but not verified against ground truth; (3) The LLM claims reinsurance recoverable assets 'fell' from 2023 to 2024, but without confirmed 2023 figures, this comparison is unreliable. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple metrics (modeled losses, attachment points, reinsurance assets), but the unverified 2023 figures undermine the comparative analysis. The statement about the $1.7 billion TRIPRA deductible from the ground truth is omitted, though this is a minor detail. SEMANTIC ISSUES: The phrase 'five-ton bomb attack overseas' in the LLM answer differs from the ground truth's 'five-ton bomb attack in New York City' - this is a material factual error suggesting the LLM may have confused domestic and international scenarios. The answer conflates the 2022 domestic scenario with international terrorism exposure discussion, creating potential confusion about which scenario applies to which year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 496,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The 2 % Notes Due 2031 fell from roughly $1.2 billion in FY 2022 to $1.044 billion in FY 2023 (the liability shown in the fair‑value table)【page_67】, then rose back to about $1.25 billion in FY 2024 (the net‑carrying amount shown in the long‑term portion table)【page_72】. This pattern suggests NVIDIA is actively managing its long‑term debt – modestly reducing the balance when cash or refinancing opportunities allow, then re‑issuing or re‑classifying additional notes to support growth or capital needs, reflecting a flexible, opportunistic debt‑management approach rather than a strict debt‑reduction trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $1.2B (2022), $1.044B (2023), $1.25B (2024). (2) The LLM correctly identifies the three-year trend pattern. (3) Proper citation of source pages (67 and 72) adds credibility. (4) Acknowledges the slight reduction in 2023 and return to higher amount in 2024. WEAKNESSES: (1) INTERPRETATION DIVERGENCE - The LLM characterizes NVIDIA's strategy as 'actively managing' and 'flexible, opportunistic' debt management with 're-issuing or re-classifying,' whereas the ground truth emphasizes 'relatively stable' and 'consistent long-term debt strategy' with 'strategic intent to preserve stable long-term liabilities.' These are materially different interpretations of the same data. (2) The LLM suggests 'modest reduction' followed by 're-issuing,' implying active debt issuance decisions, but the ground truth attributes the 2023 dip to 'minor debt repayments or reclassifications' and the 2024 return to maintaining capital structure - not new issuance. (3) The LLM's conclusion about 'flexible, opportunistic' approach contradicts the ground truth's emphasis on stability and preservation of capital structure. (4) Missing context from ground truth: the strategic purpose (supporting R&D and operational investments) and the absence of 'significant refinancing risk.' The numbers are accurate, but the analytical interpretation and strategic characterization differ significantly from the ground truth, suggesting the LLM may have over-interpreted the data as evidence of active management rather than structural stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 430,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 appear in the “Officer’s Certificate” (Exhibit 4.4) of each Form 10‑K – they are listed in the 2022 filing’s exhibit list (see 2022 page 56), again in the 2023 filing’s exhibit list (see 2023 page 56), and once more in the 2024 filing’s exhibit list (see 2024 page 56). The fact that the same instrument is disclosed year after year shows the note remains outstanding and that Apple provides continuous, long‑term visibility into its debt portfolio, underscoring the stability and transparency of its capital‑structure strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.05% Notes due 2017 appear consistently across 2022, 2023, and 2024 filings, and accurately cites the exhibit locations (page 56 in each year's filing). The numeric values (1.05%, 2017 maturity date) are correct. However, there are significant issues with the reasoning and interpretation: (1) The LLM states 'the note remains outstanding' which contradicts the ground truth's acknowledgment that the notes matured in 2017—this is a factual error about the instrument's status. (2) The ground truth explicitly notes the paradox that despite maturity in 2017, the notes continued to appear in 2022-2024 filings, suggesting rollover, refinancing, or historical documentation. The LLM fails to address this critical distinction and instead assumes the notes are still outstanding, which is incorrect. (3) The LLM provides specific exhibit citations (Exhibit 4.4, page 56) which adds detail but doesn't resolve the fundamental misunderstanding about the instrument's actual status. (4) While both answers conclude that the consistent disclosure reflects stable debt management and transparency, the LLM's reasoning is based on a flawed premise (that the notes remain outstanding) rather than the more nuanced understanding that they may be documented as historical instruments. The answer is partially correct on the surface-level observation of consistency but fails on the deeper analytical requirement to explain what this consistency means given the 2017 maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 417,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- 2022 – Under the 2019 IDA agreement Schwab could move up to $10 billion of IDA balances every 12 months (subject to capital, floating‑rate designations and an 80 % fixed‑rate requirement) and it exercised that option in 2022 【page_101】.  \n- 2023 – The 2023 IDA agreement replaced the 2019 pact, extending the term to 2034, eliminating the 80 % fixed‑rate rule, and imposing new balance floors/ceilings (minimum balances above unmatured fixed‑rate obligations with a $30 billion cap above that amount through Sept 10 2025, then a $60‑$90 billion band thereafter) while allowing a $5 billion buy‑down of fixed‑rate obligations (which Schwab used), but Schwab did not migrate any IDA balances in 2023 【page_102】【page_103】.  \n- 2024 – The same 2023 agreement remained in effect; Schwab again did not move IDA balances to its balance sheet, and the balance‑requirement regime (minimum above unmatured fixed‑rate obligations, $30 billion max until Sept 10 2025, then $60‑$90 billion) continued, with the total IDA balance falling to $87.6 billion 【page_100】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. Verification of key claims: (1) 2022 - The $10 billion annual migration limit under the 2019 IDA agreement is correctly stated, and the reference to the 80% fixed-rate requirement and capital constraints is accurate. The claim that Schwab exercised this option in 2022 aligns with the ground truth statement of $10.1 billion moved by year-end. (2) 2023 - The LLM correctly identifies the 2023 IDA agreement as a replacement, accurately describes the elimination of the 80% fixed-rate rule, and correctly specifies the new balance thresholds ($30 billion cap through Sept 10 2025, then $60-$90 billion band). The $5 billion buy-down of fixed-rate obligations is a specific detail not mentioned in the ground truth but appears to be accurate supplementary information. The statement that Schwab did not migrate IDA balances in 2023 matches the ground truth. (3) 2024 - The continuation of the 2023 agreement terms is correct, the balance requirement regime description is accurate, and the $87.6 billion total IDA balance figure is a specific quantitative detail that adds precision. The statement that no IDA balances were moved aligns with ground truth. Multi-hop reasoning is sound: the answer successfully synthesizes information across three years, identifies the key transition point (2022 to 2023), and explains the strategic shift from active migration to constrained off-balance sheet management. The answer goes beyond the ground truth by providing more granular details (specific balance thresholds, the $5 billion buy-down, the $87.6 billion figure) while maintaining factual accuracy. The page references (100, 101, 102, 103) suggest proper source documentation. Minor consideration: The ground truth mentions 'already moved $10.1 billion by year-end' in 2022, while the LLM says Schwab 'exercised that option in 2022' - these are semantically equivalent statements about the same action. No calculation errors detected. All entities (Schwab, IDA agreements, years, metrics) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 570,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "In 2022 GE estimated borrower‑litigation losses of $1.36 billion on the Bank BPH mortgage portfolio, made a cash capital contribution of $530 million, and the portfolio still carried roughly $1.2 billion (net of reserves) on the balance sheet【page_52】【page_48】. By 2023 the loss estimate had risen to $2.67 billion; GE’s response shifted to a $1.8 billion non‑cash intercompany loan‑forgiveness (no cash outlay) and a valuation allowance that reduced the portfolio’s net carrying value to zero【page_52】【page_48】【page_51】. In 2024 the estimated loss fell slightly to $2.46 billion, no additional cash or non‑cash contributions were required, and the portfolio remained at zero net carrying value【page_48】【page_48】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - 2022 estimated losses of $1.36 billion (matches $1,359 million ground truth with acceptable rounding), 2023 losses of $2.67 billion (matches $2,669 million), 2024 losses of $2.46 billion (matches $2,461 million), 2022 cash contribution of $530 million (exact match), 2023 non-cash contribution of $1.8 billion (matches $1,797 million with acceptable rounding), and portfolio carrying value progression (roughly $1.2 billion in 2022, zero by 2023-2024). COMPLETENESS: The answer addresses all major components of the multi-part question: (1) estimated losses evolution across three years, (2) capital contributions (both cash and non-cash), (3) carrying value trajectory, and (4) the overall strategic evolution from 2022-2024. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across multiple filing pages and years, connecting the litigation losses to capital contributions to portfolio valuation changes, showing understanding of how these metrics relate to GE's strategic handling. ENTITY ACCURACY: Correctly identified GE, Bank BPH, borrower litigation, mortgage portfolio, and all relevant time periods. REASONING QUALITY: The narrative effectively captures the escalation in 2023 followed by stabilization in 2024, and correctly characterizes the shift from cash contributions to non-cash intercompany loan forgiveness. MINOR OBSERVATIONS: The LLM rounded $1,797M to $1.8B and $2,669M to $2.67B, which are acceptable format variations. The characterization of the portfolio carrying value as 'roughly $1.2 billion' in 2022 is appropriately qualified. The answer correctly notes that no additional contributions were required in 2024, matching the ground truth. The semantic meaning and factual content align well with the original answer, with the LLM providing clear, chronological progression of GE's exposure and strategic response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 533,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities fell from a fair‑value of **$992 million with $155 million of unrealized losses at year‑end 2022** (page 149) to **$975 million with $100 million of unrealized losses at year‑end 2023** (page 147), and the 2024 filing shows the remaining commercial mortgage‑backed securities in its separate‑account portfolio at only **$3 million of fair value (down from $6 million in 2023)** (page 160). The shrinking fair‑value balance and the reduction in unrealized‑loss amounts indicate CVS is actively trimming its CMBS exposure—likely by letting securities mature or selling them—to limit interest‑rate‑driven valuation risk, reflecting a cautious, risk‑management‑focused strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial numbers that directly contradict the ground truth across all three years:\n\n2022 DISCREPANCY: LLM states $992M fair value with $155M unrealized losses, but ground truth shows $574M fair value with $12M unrealized losses. This is a massive overstatement ($418M too high on fair value, $143M too high on losses).\n\n2023 DISCREPANCY: LLM states $975M fair value with $100M unrealized losses. Ground truth shows $675M fair value with $100M unrealized losses. The unrealized losses match, but fair value is overstated by $300M.\n\n2024 ACCURACY: LLM correctly identifies $3M fair value for 2024, matching ground truth.\n\nMULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend. The ground truth shows: 2022 ($574M) → 2023 ($675M increase) → 2024 ($3M dramatic drop). The LLM's numbers ($992M → $975M → $3M) create a false narrative of gradual decline rather than the actual pattern of slight increase followed by dramatic reduction.\n\nRISK MANAGEMENT INTERPRETATION: While the LLM's qualitative conclusion about de-risking strategy is reasonable and aligns with ground truth, it is built on incorrect quantitative foundations. The reasoning about interest-rate risk and portfolio trimming is sound, but the supporting numbers are wrong.\n\nPAGE REFERENCES: The LLM cites specific pages (149, 147, 160), but the numbers provided do not match what ground truth indicates those pages contain.\n\nCONCLUSION: This answer fails the primary evaluation criterion of factual accuracy on numbers. The 2022 and 2023 figures are substantially incorrect, making this response unreliable despite some correct elements in 2024 and reasonable qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 478,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑brand roster for its U.S. grocery business has kept **Marketside** as a core label in each of the last three filings – it appears in the FY 2022 brand list (e.g., “Marketside” among the private brands on page 7) 【page_7】, is again listed in the FY 2023 brand table (page 8) 【page_8】, and shows up in the FY 2024 brand table (page 8) 【page_8】 (and is mentioned in the FY 2024 segment description on page 7). The fact that Marketside remains and the overall private‑brand set has broadened over FY 2022‑FY 2024 signals Walmart’s deliberate strategy to deepen its private‑label grocery offering, using brands like Marketside to drive price‑leadership, margin and differentiation in the grocery segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly addresses the multi-hop question about Marketside's evolution across FY 2022-2024. STRENGTHS: (1) Correctly identifies Marketside as appearing consistently across all three fiscal years (2022, 2023, 2024), matching the ground truth; (2) Accurately notes the introduction of new brands like 'bettergoods' alongside legacy brands, reflecting Walmart's dual strategy; (3) Properly synthesizes the multi-hop information showing continuity + expansion; (4) Correctly interprets the strategic implication about deepening private-label offerings and margin/differentiation goals; (5) Provides specific page references to support claims. MINOR WEAKNESSES: (1) The LLM answer is slightly less explicit about the 'modernization' aspect mentioned in ground truth - it emphasizes 'deepening' and 'broadening' but doesn't explicitly frame it as modernization while maintaining legacy brands; (2) The ground truth emphasizes 'meeting evolving consumer preferences' more explicitly, while the LLM focuses more on 'price-leadership, margin and differentiation' - both are valid strategic interpretations but represent slightly different framings; (3) The LLM doesn't explicitly mention that Marketside was listed 'among key private brands like Great Value and George' in 2022, though this is a minor contextual detail. QUANTITATIVE ACCURACY: No numerical errors detected. The fiscal years (2022, 2023, 2024) are correct, and the page references appear consistent with typical 10-K formatting. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the pattern of continuity + innovation. The logical conclusion about strategic intent is sound and well-supported. SEMANTIC EQUIVALENCE: The core message matches ground truth - Walmart maintained Marketside while introducing new brands, reflecting a strategic approach to private labels. The slight difference in emphasis (price-leadership/margins vs. consumer preferences) is acceptable as both are valid interpretations of the same strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 566,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 to 2024 Lowe’s strengthened its supplier oversight by moving from a baseline system that relied on a human‑rights policy, conflict‑minerals policy, Vendor Code of Conduct (with enhanced environmental standards) and a wood‑sourcing policy, and used “collaboration and established management systems” to monitor suppliers, to a more rigorous, risk‑based approach that added new wood‑sourcing risk levels by country, tighter monitoring practices and a formal forestry‑grievance process in 2024. During the same period the company increased supply‑chain sustainability spending – $550 million on energy‑efficiency and renewable‑energy projects (LED upgrades, high‑efficiency HVAC, building‑management systems, pallet grinders) in 2023, followed by $300 million on similar upgrades plus rooftop solar at over 100 stores and a goal of 100 % SmartWay certification for freight providers by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant errors in financial figures and their attribution to years. Ground truth states: (1) 'multi-year investments exceeding $550 million by 2022' and (2) 'over $400 million through 2023' in operational sustainability initiatives. The LLM incorrectly states '$550 million on energy-efficiency and renewable-energy projects...in 2023' - this misattributes the $550M figure to 2023 when it should be 'by 2022'. Additionally, the LLM introduces '$300 million on similar upgrades plus rooftop solar' for 2024, which is NOT mentioned in the ground truth at all. This represents a fabricated figure. QUALITATIVE ASSESSMENT: The LLM correctly identifies the evolution from baseline monitoring systems (human rights policy, conflict minerals policy, Vendor Code of Conduct, wood sourcing policy) to a more rigorous risk-based approach with country-level risk assessments, enhanced monitoring, and formalized grievance mechanisms. The progression across 2022-2024 is logically structured. However, the answer conflates operational sustainability investments (energy efficiency, HVAC, LED upgrades, solar) with supply chain sustainability investments, which are different categories. The ground truth emphasizes supply chain monitoring/enforcement evolution (policies, grievance processes, risk assessment), while the LLM shifts focus to operational facility improvements. MULTI-HOP REASONING: The LLM fails to properly synthesize the investment figures across years - it misplaces the $550M figure temporally and introduces unsupported numbers. The connection between investments and policy enhancements is also unclear in the LLM answer. MISSING ELEMENTS: The LLM does not clearly distinguish between the 2022, 2023, and 2024 policy enhancements as separate evolutionary steps. The SmartWay certification goal is introduced without clear connection to the supply chain sustainability narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 528,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 have been listed in the same exhibit (Officer’s Certificate, Exhibit 4.3) in each of its recent Form 10‑K filings – the 2022 filing shows the note in the exhibit schedule (see page 56) and the same exhibit appears again in the 2023 filing (page 56) and in the 2024 filing (page 56). The three‑year consistency of this disclosure demonstrates that Apple has retained this low‑coupon, medium‑term debt on its balance sheet and continues to report it transparently each year, reflecting a disciplined strategy of maintaining stable, low‑cost financing and keeping investors informed of outstanding obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.40% Notes due 2023 as appearing consistently across 2022, 2023, and 2024 filings. The note about the exhibit being listed in the same location (Exhibit 4.3, page 56) across all three years is specific and demonstrates attention to detail. The characterization of the disclosure as transparent and consistent aligns with the ground truth. WEAKNESSES: (1) The LLM adds interpretive details not present in the ground truth, such as describing the notes as 'low‑coupon, medium‑term debt' and claiming they 'remain on the balance sheet' - these characterizations go beyond what the ground truth establishes about disclosure patterns. (2) The LLM's interpretation of the pattern as reflecting 'a disciplined strategy of maintaining stable, low‑cost financing' is inferential and not directly supported by the ground truth, which focuses on disclosure transparency rather than strategic financing decisions. (3) The ground truth emphasizes the significance of continued disclosure despite the notes' impending maturity (particularly notable in 2024 when maturity was imminent), whereas the LLM treats all three years as equivalent without highlighting this temporal progression. (4) The page number citations (page 56) are specific but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of consistent disclosure. However, it adds interpretive layers about debt management strategy that exceed what can be directly concluded from disclosure patterns alone. The ground truth is more cautious, noting the disclosure reflects 'a stable and transparent debt disclosure strategy' rather than making broader claims about financing strategy. FACTUAL ACCURACY: The core facts (2.40% Notes, due 2023, appearing in 2022-2024 filings, same exhibit location) are correct. The percentage and year are accurate. No calculation errors present. The main issue is over-interpretation beyond the factual disclosure pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 556,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap senior‑note position grew each year – it was $900 million at 12/31/2022, $944 million at 12/31/2023 and $982 million at 12/31/2024 (Note 22 footnotes)【page_71†L1-L4】【page_70†L1-L4】.  At the same time the note swung from a $865 million unrealized loss in 2022 to modest gains of $129 million in 2023 and $38 million in 2024 (Note 19)【page_68†L1-L4】, suggesting GE is deliberately maintaining and modestly expanding its exposure to this higher‑yielding Level‑3 debt security despite short‑term volatility, reflecting a strategy of retaining and growing select financial‑instrument investments for income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY IN BASELINE NUMBER: The LLM states GE's AerCap note holdings were $900 million at 12/31/2022, but the ground truth specifies $976 million in 2022. This is a $76 million error (7.8% understatement) on the starting value. The LLM correctly identifies the 2023 value ($944 million) and 2024 value ($982 million), which match ground truth exactly. However, the incorrect 2022 baseline fundamentally undermines the analysis of the progression. The LLM's characterization of the trend as 'grew each year' is incorrect given the ground truth shows a decrease from 2022 to 2023 ($976M to $944M), followed by an increase to 2024 ($982M to $982M). The correct progression is: decline, then recovery to near-original levels. The LLM's interpretation that this represents 'deliberately maintaining and modestly expanding' exposure is partially supported by the 2023-2024 increase, but misses the 2022-2023 decline entirely due to the wrong baseline. The unrealized loss/gain figures ($865M loss in 2022, $129M gain in 2023, $38M gain in 2024) appear reasonable but cannot be verified against ground truth. The reasoning about income strategy and Level-3 debt security is qualitatively sound but is built on an incorrect factual foundation. The answer demonstrates good synthesis of multiple data points (holdings, unrealized gains/losses, investment strategy) but the quantitative error on the 2022 baseline is a material flaw that propagates through the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 409,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path method ties the “return‑seeking” portion of its U.S. defined‑benefit plan to the funded ratio and interest‑rate environment, so that as the plan becomes more fully funded the mix shifts away from growth assets toward liability‑hedging assets【page_310†L15-L22】.  Accordingly, the target allocation fell from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 (based on the 2021 funded status)【page_310†L31-L36】 to a 9 % equity, 80 % fixed‑maturity and 11 % other mix for 2024 (based on the 2023 funded status)【page_252†L31-L38】, while the 2023 actual allocation was already 8 % equity, 77 % fixed‑maturity and 15 % other【page_252†L31-L38】.  The steady reduction in equity and increase in fixed‑maturity securities reveal a deliberate de‑risking strategy as the plan’s funded status improved.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about AIG's pension plan glide path evolution. STRENGTHS: (1) Correctly identifies the glide path mechanism linking funded ratio to asset allocation shifts; (2) Provides specific, accurate target allocations for 2022 (15% equity, 75% fixed-maturity, 10% other) and 2024 (9% equity, 80% fixed-maturity, 11% other); (3) Correctly notes the 2023 actual allocation (8% equity, 77% fixed-maturity, 15% other); (4) Properly establishes the temporal relationship between funding status measurement dates and allocation targets (2022 target based on 2021 funded status, 2024 target based on 2023 funded status); (5) Clearly articulates the de-risking strategy with equity reduction and fixed-maturity increase; (6) Includes appropriate source citations. VERIFICATION: The progression of allocations shows consistent de-risking: equity declining from 15% to 9%, fixed-maturity increasing from 75% to 80%, demonstrating the liability-driven investing principle. The answer correctly synthesizes information across multiple years and filing documents. MINOR CONSIDERATIONS: The LLM answer provides more granular detail than the ground truth (including actual 2023 allocations and specific percentages) while maintaining semantic alignment with the core concept that the glide path progressively reduced growth assets and increased liability-hedging assets as funded status improved. The answer fully addresses the question's multi-part requirements: (1) how the approach evolved, (2) what the progression reveals about de-risking strategy, and (3) the connection to changing funded status. No calculation errors detected. All numeric values align with source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 478,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments’ MD&A shows that the company’s strategic focus on embedded‑processing has been unchanged from 2022 through 2024 – each year the “great business model” is described as being “focused on analog and embedded processing products” (2022 Overview p. 18; 2023 Overview p. 20; 2024 Overview p. 20) and the same language is used to explain that this focus “allows us to generate strong cash flow from operations” (2022 Results p. 19; 2023 Results p. 19; 2024 Results p. 19).  The consistency, coupled with a rise in free‑cash‑flow contribution (from 7.7 % of revenue in 2022 to 9.6 % in 2023‑24), reveals that embedded‑processing is a core, stable pillar of TI’s portfolio that underpins its long‑term free‑cash‑flow‑per‑share growth strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about Texas Instruments' consistent strategic emphasis on embedded processing from 2022-2024 and appropriately synthesizes this across multiple years. The qualitative reasoning about embedded processing being a 'foundational pillar' and 'core, stable pillar' aligns well with the ground truth. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The LLM introduces specific free cash flow percentages (7.7% in 2022, 9.6% in 2023-24) that are NOT present in the ground truth answer and cannot be verified from the provided context. These appear to be fabricated metrics. (2) The LLM cites specific page numbers (2022 Overview p. 18, 2023 Overview p. 20, etc.) which are not verifiable and may be hallucinated. (3) The ground truth emphasizes qualitative language about 'more opportunity per customer and more value for our investments' from 2023, which the LLM omits. The LLM's multi-hop synthesis across three years is sound in structure, but the introduction of unverified quantitative data (the percentage figures) is a critical error. The answer demonstrates good understanding of the strategic narrative but fails on factual precision regarding specific metrics. The contextual relevance is strong as it directly addresses how embedded processing drives long-term free cash flow per share growth, but the unsubstantiated numbers significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 405,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s has consistently owned and protected the trademarks for its private‑brand portfolio—including Kobalt, STAINMASTER and allen+roth—throughout FY 2022‑2024 (see the “Intellectual Property” sections in each filing [page 7]). Beginning in FY 2023 and accelerating in FY 2024, the company placed greater emphasis on these private brands as high‑value, value‑oriented offerings that complement national brands (e.g., “high‑value private brands” [page 6]), and it wove them into its omnichannel and digital‑transformation agenda—leveraging AI‑driven tools, online/mobile channels, and integrated fulfillment to showcase and sell Kobalt and other private‑brand products across store, web and gig‑delivery experiences (see “Omnichannel Capabilities” [page 5]).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the three core private brands (Kobalt, STAINMASTER, allen+roth) and accurately notes their consistent presence across FY 2022-2024. The answer also correctly identifies the digital transformation integration theme. However, there are significant gaps in addressing the full evolution described in the ground truth: (1) The LLM completely omits the critical detail that RONA and Reno Depot were explicitly listed in FY 2022 but removed by FY 2023—this is a key part of the 'evolution' the question asks about. The ground truth emphasizes this streamlining/refocusing as a strategic shift, which the LLM fails to capture. (2) The LLM's characterization of the evolution is incomplete—it focuses on 'greater emphasis' and digital integration but misses the portfolio simplification aspect that the ground truth identifies as significant. (3) The LLM adds interpretive language about 'high-value, value-oriented offerings' and specific digital tools (AI-driven, gig-delivery) that, while potentially accurate, goes beyond what can be verified from the ground truth provided. (4) The multi-hop reasoning is partially sound—the LLM does connect private brands to digital transformation—but it fails to synthesize the full three-year evolution including the brand portfolio contraction. The answer reads more as a snapshot of FY 2023-2024 strategy rather than a true evolution analysis across the three-year period. The omission of RONA/Reno Depot removal is a material factual gap that significantly undermines the completeness of addressing how the IP strategy 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 439,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "- In the 2022 Form 10‑K (Item 1 – Competition, page 4) IBM listed **“client relationships and trust”** as one of its principal competitive methods alongside technology, brand and a broad range of capabilities.  \n- The 2023 filing (Item 1 – Competition, page 3) repeats the same emphasis, now phrasing it as **“client relationships and trust”** within a set that includes “our breadth of capabilities, products and services.”  \n- The 2024 filing (Item 1 – Competition, page 3) again highlights **“client relationships and trust”**, this time explicitly tying it to the company’s hybrid‑cloud and AI platform that delivers business value to clients.  \n\nThis three‑year continuity shows IBM is sharpening client trust from a generic competitive factor into a strategic pillar that underpins its hybrid‑cloud and AI positioning, using long‑standing client bonds to differentiate its offerings against cloud and AI rivals.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that IBM emphasized 'client relationships and trust' across all three years (2022-2024) in the Competition section of 10-Ks. (2) The document citations (Item 1 – Competition, specific page numbers) appear accurate and verifiable. (3) The LLM correctly notes the progression from generic competitive factor to explicit hybrid-cloud and AI positioning. (4) Quantitative accuracy is strong - no incorrect numbers, dates, or metrics are presented.\n\nWEAKNESSES: (1) The LLM answer is significantly INCOMPLETE compared to the ground truth. The original answer specifically mentions IBM's strategic partnerships with AWS, Microsoft, SAP (2023) and Palo Alto Networks (2024) as evidence of ecosystem-driven trust positioning. The LLM completely omits these critical partnerships, which are central to understanding the strategic evolution. (2) The original answer emphasizes the SECURITY dimension added in 2024 through cybersecurity partnerships - this is a key insight about the strategic progression that the LLM misses entirely. (3) The original answer connects the evolution to 'data governance and digital transformation in enterprise IT decisions' - contextual framing the LLM lacks. (4) The LLM's conclusion about 'sharpening client trust from generic to strategic pillar' is somewhat generic and doesn't capture the specific ecosystem and security dimensions that characterize the 2023-2024 evolution.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop synthesis (connecting trust messaging across three years) but fails to synthesize the deeper strategic partnerships and security ecosystem components that would require cross-referencing multiple sections of the filings (Competition section + Strategic Partnerships/Alliances sections). The ground truth shows more sophisticated multi-hop reasoning by linking trust positioning to specific partner ecosystems.\n\nSEMANTIC EQUIVALENCE: While the LLM's core observation about trust evolution is directionally correct, it lacks the substantive detail and strategic nuance present in the ground truth. The answer is partially correct but materially incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 580,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In the 2022 filing Gilead only noted that it had “established clinical and commercial manufacturing facilities for cell‑processing activities” without singling out the El Segundo site (2022 p. 31). By the 2023 10‑K the El Segundo, California plant was explicitly listed as being used for “clinical and commercial manufacturing and processing of our cell‑therapy products” (2023 p. 11), and the 2024 filing repeats the same description (2024 p. 10). Thus, the El Segundo facility moved from an unnamed or purely clinical role in 2022 to a combined clinical‑and‑commercial production site by 2023, a role it continued to hold through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the El Segundo facility's role 'remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities' and that it was described in 2022 as being utilized for 'clinical and commercial manufacturing and processing of cell therapy products.' However, the LLM answer claims that in 2022 the facility was 'unnamed or purely clinical' and only 'moved from an unnamed or purely clinical role in 2022 to a combined clinical-and-commercial production site by 2023.' This is incorrect. The ground truth indicates the facility had a dual clinical-and-commercial role from 2022 onward, not a transition from clinical-only to combined roles. The LLM mischaracterizes the 2022 filing as not singling out El Segundo or describing it as purely clinical, when the ground truth confirms it was explicitly described as having both clinical and commercial responsibilities in 2022. The LLM correctly identifies that 2023 and 2024 filings describe the facility as serving both clinical and commercial manufacturing roles, but this is presented as a change from 2022 when no such change occurred. The multi-hop reasoning is flawed because it incorrectly synthesizes the evolution across the three years by introducing a false narrative of role expansion. The answer fails to recognize the consistency and stability of the facility's dual role throughout the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 424,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowe’s only has one series of 4.550 % notes – the “Fifteenth Supplemental Indenture” issue dated April 5 2019 that matures on April 5 2049 (see 2022 filing, page 82). The 2023 filing shows the same series unchanged (page 76) and the 2024 filing continues to reference the securities description without adding a new 4.550 % issuance, leaving the 2049 maturity intact. This steady, long‑dated, fixed‑rate tranche across three years indicates that Lowe’s is deliberately locking in low borrowing costs for decades and minimizing refinancing risk as part of its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All numeric values are correct - 4.550% interest rate, April 5, 2019 issuance date, April 5, 2049 maturity date are all accurate. (2) The Fifteenth Supplemental Indenture reference is correct. (3) The multi-hop synthesis across three years (2022, 2023, 2024) is properly executed, showing the instrument remained unchanged across all filings. (4) Page references (82 for 2022, 76 for 2023) add credibility and specificity. (5) The strategic interpretation about 'locking in low borrowing costs' and 'minimizing refinancing risk' aligns with the ground truth's emphasis on 'long-duration debt' and 'avoiding near-term refinancing risks.' (6) The answer correctly identifies that no new 4.550% issuance occurred during this period. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'deliberately locking in low borrowing costs for decades' is a reasonable interpretation of the strategic intent, though the ground truth uses slightly different language ('strategic emphasis on long-duration debt'). Both convey equivalent meaning about capital structure management. The answer fully addresses the multi-year pattern question and provides sound reasoning about long-term debt strategy. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 395,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "In 2022 3M’s Scotchgard‑related exposure was limited to modest, immaterial settlements – a $65 million New York class‑action (3M’s contribution not material) and an immaterial Wolverine settlement (page 124). By mid‑2023 the company entered a sweeping public‑water‑system settlement that covers PFAS products such as Scotchgard, recording a $10.3 billion pre‑tax charge and committing to pay $10.5‑$12.5 billion from 2024‑2036 (pages 93, 97). The 2024 filing confirms the settlement’s final approval and ongoing multi‑billion‑dollar payments, revealing that PFAS litigation has shifted from small, isolated costs to a major, multi‑year financial liability for 3M (pages 93, 97).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM conflates two entirely different settlements. It mentions a $65 million settlement in New York but incorrectly attributes this to 2022 when the ground truth shows this was finalized in 2024. More critically, the LLM introduces a $10.3 billion pre-tax charge and $10.5-$12.5 billion payment commitment that are NOT mentioned in the ground truth answer at all. These appear to be references to a broader PFAS settlement (likely the 2023 multi-state water system settlement), but the LLM incorrectly conflates this with Scotchgard-specific litigation. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth traces a clear evolution: 2022 (limited exposure with $65M Wolverine settlement), 2023 (expanded to ~68 AFFF suits, Illinois case, Canadian class action), 2024 (further expansion to Alabama/Georgia with municipal utilities and property owners). The LLM completely omits the 2023 intermediate stage and the geographic/case-type expansion documented in the ground truth. (3) ENTITY/CONTEXT CONFUSION: The LLM appears to reference a major public water system settlement that may be separate from the Scotchgard-specific litigation evolution described in the ground truth. The question specifically asks about Scotchgard product exposure, and while PFAS litigation is related, the LLM's focus on the $10+ billion settlement obscures the actual Scotchgard-specific trend. (4) MISSING DETAILS: The LLM omits critical information about the geographic expansion (Michigan, New York, Illinois, Canada, Alabama, Georgia), the diversity of plaintiffs (municipalities, property owners, carpet manufacturers), and the escalating complexity evidenced by trial dates set for 2026. (5) REASONING QUALITY: While the LLM correctly identifies a shift from small to large liabilities, it does so by introducing numbers not in the ground truth rather than by synthesizing the documented progression of Scotchgard-specific cases. The conclusion about escalating liabilities is correct in direction but based on incomplete and partially incorrect evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 590,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022 Gilead described its Foster City campus as the corporate headquarters “where we house our administrative, manufacturing and R&D activities” (2022 10‑K, p. 33). By 2023 the narrative had narrowed to a dedicated R&D hub that “conducts process‑chemistry research, analytical‑method development and formulation‑and‑device development activities, and manufactures API and drug product for our clinical trials” (2023 10‑K, p. 11), and the 2024 filing repeats this focus (2024 10‑K, p. 10). This shift shows a strategic move to concentrate Foster City on early‑stage chemistry and clinical‑trial manufacturing while integrating it with a broader global network of R&D sites and commercial manufacturing facilities worldwide (2022 10‑K, p. 33; 2024 10‑K, p. 8‑12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 description of Foster City as housing 'administrative, manufacturing and R&D activities' with proper citation to 2022 10-K p. 33. (2) Accurately captures the 2023 transition to a more narrowly defined role focused on 'process-chemistry research, analytical-method development and formulation-and-device development activities, and manufactures API and drug product for our clinical trials' with proper citation to 2023 10-K p. 11. (3) Correctly notes that 2024 repeats this focus with citation to 2024 10-K p. 10. (4) Properly synthesizes the multi-hop reasoning showing the strategic shift from broad administrative/manufacturing/R&D hub to specialized early-stage chemistry and clinical manufacturing facility. (5) Appropriately contextualizes Foster City within the broader global network, mentioning integration with other R&D sites and commercial manufacturing facilities. (6) All dates (2022, 2023, 2024) are accurate. (7) All facility descriptions and functional areas are correctly identified. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions specific alternative locations (La Verne, Oceanside, international sites) handling commercial-scale manufacturing, while the LLM uses more general language ('broader global network'). However, this is a stylistic difference rather than a factual error. The semantic meaning is preserved - both convey that Foster City shifted to early-stage/clinical focus while other locations handle commercial manufacturing. No quantitative errors, calculation errors, or entity misidentifications detected. The multi-hop synthesis across three fiscal years is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 506,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "AIG’s loss‑reserve risk framework has become progressively more layered. In 2022 the company relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” and a governance structure that required “review and challenge of reserves” and a mix of stochastic and deterministic modeling 【page_165】【page_167】. By 2023 the same controls were retained but the oversight was formalized through ERM’s “Second Line Review and Challenge” of pricing and reserving models and ongoing internal‑audit monitoring, while external‑expert reviews continued to be part of the critical‑accounting‑estimate process 【page_118】【page_118】. In 2024 the approach is now a continuous, systematic program: ERM and the Internal Audit Group regularly challenge and audit reserving models, management “continually reviews and updates” IBNR methods, and loss‑reserve projections are built on third‑party catastrophe models, scenario‑based adjustments and bias corrections 【page_86】【page_86】【page_88】【page_87】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year evolution of AIG's loss reserves risk management. STRENGTHS: (1) Correctly identifies the progression from 2022-2024 with accurate characterization of each year's approach; (2) Accurately captures key mechanisms: internal controls, external expert reviews (2022), formalized ERM Second Line Review (2023), and continuous systematic programs (2024); (3) Properly synthesizes multi-hop information across years showing evolution from reactive to proactive governance; (4) Correctly identifies specific tools: stochastic/deterministic modeling, sensitivity/scenario analyses, third-party catastrophe models, IBNR methods, bias corrections; (5) Appropriately cites page references supporting claims; (6) Maintains semantic equivalence with ground truth while using slightly different wording. MINOR AREAS FOR IMPROVEMENT: (1) The 2022 description mentions 'stochastic and deterministic modeling' which aligns with ground truth's 'internal controls and external expert reviews' but the LLM adds modeling detail not explicitly emphasized in the ground truth's 2022 characterization (ground truth emphasizes 'uncertainty in loss development' more than specific modeling approaches for 2022); (2) The LLM's characterization of the shift from 'reactive oversight to proactive, model-driven, and enterprise-wide risk governance' is implicit in the LLM answer but not explicitly stated as a summary conclusion. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this qualitative question, so this dimension is not directly applicable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple governance/oversight dimensions (oversight mechanisms, modeling approaches, external reviews integration), correctly showing how each element evolved. The logical progression is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 541,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in each of the three filings and is marked only for the Analog segment – 2022 shows “Melaka, Malaysia ** | X | ” (no X under Embedded Processing)【page_16】, 2023 lists “Melaka, Malaysia * | X | ” with the same pattern【page_16】, and 2024 repeats “Melaka, Malaysia * | X | ” again【page_16】. The unchanged designation over 2022‑2024 indicates that the Melaka footprint has remained an Analog‑only manufacturing location, with no expansion of Embedded‑Processing capacity in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) Correctly identifies the consistent presence of Melaka, Malaysia across all three years (2022-2024), matching the ground truth assertion of 'consistently maintained operations'. (2) Accurately captures the Analog-only designation across all three years with proper notation ('X' under Analog, no 'X' under Embedded Processing). (3) Correctly synthesizes the key finding that there was 'no expansion into Embedded Processing' during the period, directly supporting the ground truth conclusion. (4) Provides appropriate page references (page_16) for verification. (5) The reasoning is sound: unchanged designation over time logically indicates stability and specialization. (6) Semantic equivalence is strong - 'Analog-only manufacturing location' matches 'focusing exclusively on Analog manufacturing' from ground truth. MINOR CONSIDERATIONS: (1) The LLM answer includes specific notation details ('**' vs '*' markers) that, while not incorrect, add granular detail beyond what the ground truth explicitly emphasizes. This is not an error but rather additional specificity. (2) The answer could have been slightly more explicit about what 'stable but specialized role' means in business context, though the current wording adequately conveys this. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; the designation pattern (Analog X, Embedded Processing blank) is accurately represented across all three years. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and two product segments (Analog vs. Embedded Processing) to reach the correct conclusion about manufacturing focus and strategic stability. The logic chain is clear and valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 489,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure dropped dramatically – the 2022 filing shows a $2.56 billion notional of forward swaps used as cash‑flow hedges (page 62), the 2023 filing shows the position reduced to a $251 million fair‑value balance (page 54), and by the 2024 filing the swaps were essentially unwound, with no fair‑value balance reported (page 54) and only a statement that the company “held forward interest‑rate‑swap agreements … as of February 3, 2023” (page 46). This pattern indicates that Lowe’s employs forward swaps as a short‑term hedge for forecasted debt issuances and then scales them down or terminates them once the debt is issued or the interest‑rate risk is mitigated.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the key progression of Lowe's forward interest rate swap exposure across the three fiscal years. STRENGTHS: (1) Correctly identifies the $251 million fair value balance in 2023, matching the ground truth exactly. (2) Accurately captures the core narrative: forward swaps were used for hedging forecasted debt issuances and were subsequently unwound/reduced. (3) Provides specific page references and filing details, showing thorough document review. (4) The reasoning about short-term hedging for forecasted debt issuances followed by termination aligns with the ground truth's conclusion about strategic shift. (5) Correctly notes that by 2024, forward swaps were no longer held. WEAKNESSES: (1) The $2.56 billion notional figure for 2022 is introduced but not verified against ground truth - the original answer does not provide this specific number, making it difficult to confirm accuracy. (2) The LLM provides more granular quantitative detail (notional amounts, page numbers) than the ground truth, which could indicate either superior research or potential over-specification. (3) Minor semantic difference: LLM emphasizes 'dramatic drop' and 'essentially unwound' language, while ground truth uses more measured 'strategic shift' language. (4) The quote about 'held forward interest-rate-swap agreements...as of February 3, 2023' appears in the LLM answer but is not explicitly confirmed in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the progression pattern. The conclusion about hedging strategy evolution is sound and matches the ground truth's assessment. QUANTITATIVE CONCERNS: The $2.56 billion figure cannot be verified against the provided ground truth, which is a minor concern for a primarily quantitative claim. The $251 million figure is confirmed. Overall, the answer is substantially correct with strong reasoning, though some specific numbers lack verification against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 564,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the Item 15 exhibit list (page 31) enumerates the 7.00 % debentures (2025/2045), the 7.125 % debenture (2096) and the 6.22 % debentures (2027) but makes no entry for the 6.50 % Debentures due 2028【page_31】. Both the 2023 and 2024 filings add the same disclosure – “the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to Form 8‑K, filed on January 8 1998, and is hereby incorporated by reference” (Item 15, page 19)【page_19】. The fact that the referenced filing date (January 8 1998) is identical in the later reports shows that IBM has relied on the original 1998 filing for the terms of this debt, indicating that the instrument’s structure has remained unchanged for decades and is documented through a single, long‑term filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION ON 2022 FILING: The LLM claims the 6.50% Debentures due 2028 make 'no entry' in the 2022 Form 10-K Item 15 exhibit list, directly contradicting the ground truth which states IBM 'consistently referenced' this debenture across all three years (2022, 2023, 2024). This is a fundamental factual error that undermines the entire answer. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly states the debenture was referenced in 2022, 2023, AND 2024 with the same Exhibit 2 to Form 8-K filed January 8, 1998. The LLM only addresses 2023 and 2024, missing the critical 2022 data point that demonstrates the three-year consistency pattern. (3) QUANTITATIVE ACCURACY: The date January 8, 1998 is correct, and the 6.50% rate is correct. However, the LLM's claim about what appears in the 2022 filing is factually wrong. (4) REASONING FLAW: While the LLM correctly identifies that the consistent 1998 filing date indicates unchanged structure, it fails to establish this pattern across all three years as required by the question. The answer only demonstrates consistency between 2023-2024, not the full 2022-2023-2024 evolution requested. (5) SEMANTIC ISSUE: The LLM's statement that the debenture 'makes no entry' in 2022 contradicts the ground truth's assertion of consistent disclosure across all three years. This is not a wording difference but a factual contradiction. The answer partially addresses the long-term structure concept but fails on the core requirement of demonstrating three-year consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 431,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "The 2022 filing (see MMM 10‑K 2022, pages 129‑133) does not list Reflective Signage among the Transportation and Electronics segment’s representative products. In the 2023 filing, Reflective Signage appears as the final bullet point in that segment’s product list (page 107). By 2024 it has moved up to the fourth position—after premium graphic films and before light‑management films (page 110). This shift from omission to inclusion and then to a higher‑ranked spot indicates that 3M is increasingly emphasizing Reflective Signage as a strategically important component of its Transportation and Electronics portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all three years examined. CRITICAL ERRORS: (1) 2022 POSITIONING: Ground truth states Reflective Signage was listed fifth in 2022; LLM claims it was omitted entirely. This is a major factual error. (2) 2023 POSITIONING: Ground truth states it moved to fourth position in 2023; LLM claims it was 'the final bullet point' (last position). This is a direct contradiction. (3) 2024 POSITIONING: LLM correctly identifies fourth position, but this is the only accurate positioning claim. (4) NARRATIVE INTERPRETATION: The LLM's narrative of 'omission to inclusion to higher-ranked spot' is fundamentally wrong because Reflective Signage was present in 2022 (fifth position), not omitted. The ground truth shows a more nuanced story: fifth position (2022) → fourth position (2023) → fourth position maintained (2024), suggesting strategic elevation and sustained emphasis. The LLM's interpretation of 'increasing emphasis' is based on a false premise of initial omission. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year positioning sequence. The answer demonstrates poor document analysis, as it misidentifies the actual positions in 2022 and 2023. The only partially correct element is the 2024 fourth-position placement. The reasoning about strategic importance is undermined by the factual errors in the positioning data. This represents a failure in both quantitative accuracy (wrong positions for 2022 and 2023) and qualitative reasoning (incorrect synthesis of the three-year trend).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 441,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In the 2022 Form 10‑K (see pages 31‑35) Gilead does not specifically mention the Hoofddorp, Netherlands site, so it was not highlighted as a key manufacturing location at that time. By the 2023 filing the company lists Hoofddorp as a “commercial manufacturing and processing” facility for its cell‑therapy products (page 11), and the 2024 filing repeats that description (page 10), showing that the plant has been positioned as a dedicated, strategically important site for commercial cell‑therapy production.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth states that in 2022, Gilead identified Hoofddorp as 'one of its principal manufacturing facilities,' indicating operational recognition of the site. However, the LLM answer claims that 'Gilead does not specifically mention the Hoofddorp, Netherlands site' in the 2022 Form 10-K, stating it 'was not highlighted as a key manufacturing location at that time.' This is a direct contradiction to the ground truth and represents a material factual error. The LLM correctly identifies that by 2023 and 2024, Hoofddorp was described as a 'commercial manufacturing and processing' facility for cell therapy products, which aligns with the ground truth. The LLM also correctly captures the strategic importance and dedicated positioning of the facility in later years. However, the failure to recognize Hoofddorp's presence in 2022 filings undermines the multi-hop synthesis required by the question, which asks about evolution 'from 2022 through 2024.' The answer is incomplete in its temporal coverage and misses the progression narrative that shows increasing emphasis on the facility. The page references provided (pages 31-35 for 2022, page 11 for 2023, page 10 for 2024) cannot be verified but the substantive claim about 2022 non-mention contradicts the ground truth. The reasoning about 2023-2024 is sound, but the foundational error regarding 2022 significantly impacts overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 412,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 10‑K tables show that no shares were listed as available for future issuance under the 2003 Director Compensation Plan in any of the three years – the 2022 filing’s footnote lists only the 2009 LTIP and 2018 Director Plan as having remaining shares【page_63†L15-L20】, the 2023 filing likewise lists only the 2009 LTIP and 2018 Director Plan【page_61†L15-L20】, and the 2024 filing lists only the 2024 LTIP, 2014 ESPP and 2018 Director Plan【page_59†L15-L20】. This consistent absence of a balance for the 2003 plan indicates that its share pool has been exhausted or is no longer being used, and Texas Instruments now relies on newer equity‑based plans for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims no shares were available under the 2003 Director Compensation Plan in any of the three years, directly contradicting the ground truth which provides specific share counts: 1,843,134 shares (2022), 1,786,785 shares (2023), and 1,745,284 shares (2024). These are precise, verifiable numbers from SEC filings that the LLM completely missed or misread. (2) ENTITY/PLAN IDENTIFICATION ERROR: The LLM appears to have confused or misidentified which plans had available shares. It claims only the 2009 LTIP, 2018 Director Plan, and 2024 LTIP had shares, but the ground truth explicitly states the 2003 Director Compensation Plan had shares available in all three years. (3) REASONING FAILURE: The LLM's conclusion that the 2003 plan's 'share pool has been exhausted' is directly contradicted by the ground truth showing consistent year-over-year availability of shares (declining but present). The LLM failed to synthesize the multi-hop information correctly - it needed to track the same plan across three years and identify the declining trend. (4) SEMANTIC CONTRADICTION: The LLM's interpretation (plan exhausted, no longer used) is the opposite of what the data shows (plan actively used with declining but available shares). The ground truth explicitly states the consistent reduction 'indicates that Texas Instruments has been actively utilizing' the plan, while the LLM claims it's no longer being used. This is a complete factual inversion. The LLM appears to have either misread the source documents or confused different equity plans in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 465,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 0.950 % Notes due 2025 only by incorporating the older Form 8‑K exhibit (Exhibits 4.1 & 4.2 filed May 22 2017) that defined the holders’ rights — a minimal, historical reference 【page_20】. The 2023 filing updates that treatment by adding a newer February 2 2024 indenture (Exhibit 4.1) to the same “instruments defining the rights” section, showing a refreshed contractual basis 【page_21】. By the 2024 Form 10‑K the notes are listed outright in the Section 12(b) securities table with ticker IBM25B and NYSE listing, giving investors direct, up‑to‑date market visibility 【page_1】. This progression from passive incorporation to explicit listing reflects IBM’s broader capital‑market strategy of increasing transparency, enhancing liquidity, and engaging investors more proactively about its low‑coupon debt issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) All key dates are correct: May 22, 2017 Form 8-K filing, February 2, 2024 indenture, and the progression through 2022-2024 filings. (2) The ticker symbol IBM25B and NYSE listing are correctly identified for 2024. (3) The coupon rate of 0.950% is accurately stated. (4) The multi-hop reasoning is sound—the answer correctly traces the evolution from passive historical reference (2022) → refreshed contractual basis (2023) → explicit market listing (2024). (5) The interpretation of this progression as reflecting IBM's strategic shift toward transparency and investor engagement aligns with the ground truth. (6) The answer provides more specific detail than the ground truth (e.g., mentioning Exhibits 4.1 & 4.2, the February 2024 indenture update), which adds credibility. MINOR WEAKNESSES: (1) The ground truth mentions the notes were 'listed alongside newer instruments' in 2023, suggesting comparative prominence, while the LLM answer frames 2023 as adding a 'refreshed contractual basis'—this is a subtle interpretive difference but semantically compatible. (2) The LLM answer uses page citations (【page_20】, 【page_21】, 【page_1】) which, while potentially helpful, are not verified against the ground truth and could introduce citation accuracy concerns if incorrect. (3) The phrase 'low-coupon debt issuance' at the end is a reasonable inference but goes slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: All numbers and dates check out correctly. The 0.950% coupon, 2025 maturity, May 22, 2017 date, February 2, 2024 date, and IBM25B ticker are all accurate. No calculation errors detected. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the progression pattern and its strategic implications. The reasoning chain is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 544,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew after 2022 – the company continued to use the method for a modified‑coinsurance arrangement covering roughly 59 % of its closed block (the 2022 filing notes the offset of deposit liabilities with deposit recoverables but does not give a dollar amount) – and by year‑end 2023 the balance sheet showed $5.1 billion of deposit assets and $1.3 billion of deposit liabilities (see 2024 10‑K, p. 206).  In 2024 those balances fell modestly to $4.6 billion of assets and $1.2 billion of liabilities (2024 10‑K, p. 206), indicating a slight reduction in the use of the deposit method.  The November 2023 Global Atlantic transaction, however, marked a strategic shift: MetLife recorded $10.3 billion of reinsurance recoverables and deposit receivables, transferred $9.5 billion of assets to the reinsurer, retained $5.0 billion of separate‑account assets and booked a $770 million net cost in other liabilities (2024 10‑K, p. 206), showing that the company moved from modest deposit balances to a much larger, asset‑transfer‑driven reinsurance structure that still relies on the deposit‑method accounting but on a far larger scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across MetLife's 2022-2024 filings. QUANTITATIVE VERIFICATION: All key numbers match the ground truth exactly: 2023 deposit assets ($5.1B), 2023 deposit liabilities ($1.3B), 2024 deposit assets ($4.6B), 2024 deposit liabilities ($1.2B), and the 2023 Global Atlantic transaction figures ($10.3B in reinsurance recoverables/deposit receivables, $9.5B asset transfer, $5.0B separate-account assets, $770M net cost). The LLM correctly notes the 59% closed block coverage ratio and provides proper source citations (2024 10-K, p. 206). MULTI-HOP REASONING: The answer successfully synthesizes information across three time periods (2022, 2023, 2024) and correctly identifies the strategic shift represented by the Global Atlantic transaction. The reasoning that MetLife moved from 'modest deposit balances to a much larger, asset-transfer-driven reinsurance structure' accurately captures the evolution described in the ground truth. COMPLETENESS: The answer addresses all parts of the question: the evolution of deposit assets/liabilities from 2022-2024, the specific 2023 transaction details, and the strategic shift in accounting approach. MINOR OBSERVATIONS: The LLM notes that the 2022 filing 'does not give a dollar amount' for deposit balances, which is a reasonable caveat about source limitations. The ground truth provides 2022 figures ($1.8B assets, $1.4B liabilities), but the LLM's acknowledgment of source limitations is contextually appropriate. The semantic framing of the strategic shift as moving to 'a much larger, asset-transfer-driven reinsurance structure' is equivalent to the ground truth's characterization of 'more aggressive use of the deposit method.' No calculation errors detected. All entity references (MetLife, Global Atlantic, closed block) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 511,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Fall‑protection products have remained a core part of 3M’s Safety & Industrial portfolio throughout the period – the segment’s product list in 2023 still cites “Respiratory, hearing, eye and **fall protection** solutions” [page 107] and the 2024 filing repeats the same wording [page 110]. In 2024 the segment was reorganized to create an Industrial Specialties division that consolidates the former Personal‑Safety line (which includes fall‑protection) with related products, showing that 3M has kept fall‑protection in its lineup and is sharpening its focus on workplace‑safety solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that fall protection remained a consistent part of MMM's Safety & Industrial segment across 2023-2024, accurately cites the product description 'Respiratory, hearing, eye and fall protection solutions' for both years, and provides page references (107, 110) that add credibility. The observation about the 2024 reorganization creating an Industrial Specialties division is a valuable addition not explicitly in the ground truth. WEAKNESSES: (1) The LLM fails to address 2022 data - the ground truth explicitly discusses the 2022 baseline ('In 2022, fall protection was listed...'), but the LLM only covers 2023-2024, missing one-third of the requested 3-year progression. (2) The LLM's characterization of the evolution is incomplete - it doesn't clearly articulate the consistency across all three years or the 'stable strategic focus' that the ground truth emphasizes. (3) The LLM introduces new information about the 2024 reorganization and Industrial Specialties division that, while potentially accurate and relevant, goes beyond what the ground truth states and may represent synthesis not fully grounded in the filing data. (4) The LLM's conclusion about 'sharpening focus' is somewhat speculative compared to the ground truth's more measured assessment of 'maintained stable strategic focus.' MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting product portfolio consistency to strategic intent, but fails to complete the full 3-year comparison required by the question. The reasoning about the 2024 reorganization is logical but represents an inference beyond the ground truth baseline. ENTITY ACCURACY: Correctly identifies MMM/3M and the Safety & Industrial segment. CALCULATION/DATES: No calculations required; dates are correctly identified (2023, 2024) but 2022 is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 503,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria’s filings show that UST LLC has remained a **wholly‑owned subsidiary** throughout the period – in 2022 the 2009 UST acquisition is highlighted as the source of the $8.8 billion of MST and snus trademarks (2022 Note 4, p.66); in 2023 the company lists “UST LLC … through its wholly‑owned subsidiary U.S. Smokeless Tobacco Company LLC (USSTC)” (2023 Note 1, p.60); and the 2024 10‑K repeats the same structure (2024 Item 1, p.4). This continuity – with UST’s brands still representing a core intangible‑asset block and the oral‑tobacco segment’s leading MST products – signals that Altria is deliberately anchoring its “Moving Beyond Smoking” strategy on a stable, fully‑controlled smokeless‑tobacco platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies UST as wholly-owned subsidiary throughout all three years; (2) Accurately cites the $8.8 billion trademark valuation from 2022; (3) Properly references the 2009 acquisition as the source of MST/snus trademarks; (4) Correctly identifies the organizational structure (UST LLC with USSTC subsidiary); (5) Accurately connects UST's role to 'Moving Beyond Smoking' strategy; (6) Provides specific filing citations (2022 Note 4 p.66, 2023 Note 1 p.60, 2024 Item 1 p.4) that demonstrate multi-hop synthesis. MINOR WEAKNESSES: (1) The LLM answer is more narrowly focused on organizational continuity and structural stability rather than explicitly addressing the 'evolution' aspect of the question - it emphasizes consistency rather than progression or changes; (2) The ground truth mentions 'increasing alignment' and 'consistent emphasis' on strategic positioning, while the LLM emphasizes 'continuity' and 'stability' - these are related but slightly different framings; (3) The LLM could have been more explicit about how the 2024 positioning represents a 'further solidification' or evolution compared to prior years, rather than just repetition of the same structure. QUANTITATIVE VERIFICATION: The $8.8 billion figure is correct and properly attributed. The filing references appear consistent with typical 10-K structure. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects organizational structure to strategic positioning. The logic linking subsidiary status to strategic asset control is sound. SEMANTIC EQUIVALENCE: The answer conveys the core information accurately, though with slightly different emphasis (stability vs. evolution). The interpretation that structural continuity signals strategic commitment is reasonable and supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 529,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 as an exhibit (e.g., the “One Hundred‑and‑Sixteenth Supplemental Indenture … related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15” appears in each filing)【page_102】【page_105】. By repeatedly referencing this bond series, Tesla signals that the SolarCity debt remains outstanding and is being used as a long‑term financing source for its solar‑energy operations, reflecting a strategy of leveraging legacy SolarCity capital to fund and support its ongoing solar initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the bond series name, percentage (5.45%), and series designation (2015/C92-15) across all three years (2022, 2023, 2024). (2) Accurately references the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015' as the specific legal instrument. (3) Correctly synthesizes the multi-hop information showing the bond appears in all three consecutive filings. (4) Provides sound reasoning that repeated references indicate the debt remains outstanding and serves as a long-term financing source. (5) Appropriately connects this to Tesla's solar energy strategy and legacy SolarCity capital. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth, omitting some contextual depth about 'structured solar financing mechanisms' and 'securitized solar debt as a core funding source.' (2) The ground truth emphasizes 'confidence in the bond's performance' and 'alignment with Tesla's broader clean energy business model' more explicitly, though the LLM answer implies this through 'leveraging legacy SolarCity capital.' (3) The LLM answer includes citation markers [page_102][page_105] which, while helpful for verification, are not part of the ground truth format. QUANTITATIVE VERIFICATION: All numbers are correct - 5.45% interest rate, Series 2015/C92-15 designation, August 24, 2015 date, and the three-year span (2022, 2023, 2024). MULTI-HOP REASONING: The answer correctly synthesizes information across three separate filings to draw conclusions about Tesla's financing strategy. The logic is sound: repeated references → debt remains outstanding → indicates strategic reliance on this financing mechanism. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis but no factual contradictions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 521,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 2022 filing already warned that “the value of the company’s debt securities … is affected by … governmental and **stock‑exchange regulations**” and that rating‑agency actions can hurt the value and liquidity of both its debt and equity securities (page 22). The 2023 and 2024 filings repeat the same language – again citing “governmental and stock‑exchange regulations” as a factor for debt securities and noting that rating‑agency changes can impact both debt and equity (page 11 in each year). The unchanged, year‑over‑year disclosure shows IBM maintains a steady, transparent capital‑market risk‑management approach that continuously monitors and reports regulatory and rating‑agency risks rather than altering its strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that IBM's filings from 2022-2024 consistently mention stock exchange regulations as a risk factor affecting debt and equity securities. The citation of specific language ('governmental and stock-exchange regulations') and the reference to rating-agency impacts are accurate. The LLM correctly notes the year-over-year repetition of similar language across the three-year period. WEAKNESSES: (1) The LLM's interpretation fundamentally diverges from the ground truth's key finding. The ground truth emphasizes that IBM's exposure 'evolved' and 'expanded' from 2022 to 2024, with 2024 showing 'a more integrated view' linking regulatory impact to 'broader market liquidity conditions and customer credit risks.' The LLM instead characterizes the disclosure as 'unchanged, year-over-year,' missing the evolution and expansion that the ground truth identifies. (2) The LLM's conclusion that IBM maintains a 'steady' approach with 'no altering of strategy' contradicts the ground truth's finding of 'increasing recognition of regulatory dynamics as a persistent and systemic component' and the 2024 expansion to include broader market liquidity and customer credit risks. (3) The LLM fails to capture the multi-hop synthesis required: the ground truth traces a progression showing how IBM's risk management framework became more integrated and comprehensive over time, not merely repetitive. (4) The LLM's characterization of the disclosure as 'transparent capital-market risk-management' is interpretive and not supported by the ground truth's more critical assessment that there was 'no material reduction in dependency or mitigation strategy.' (5) While the LLM correctly identifies the consistency of language, it misses the qualitative evolution in how IBM framed and contextualized these risks. The ground truth's nuanced finding about 'increasing recognition' and 'more integrated view' represents a substantive difference from mere repetition. CALCULATION/NUMERIC VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on correct identification of years (2022, 2023, 2024) and page references, which the LLM provides but without verification against actual filings. MULTI-HOP REASONING: The LLM fails the multi-hop synthesis test by not connecting the evolution of risk disclosure across years to what it reveals about capital market risk management strategy. The ground truth demonstrates this synthesis; the LLM does not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 670,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, 3M’s Safety and Industrial segment consistently lists “electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” as a core offering (2022 § Business Segment Products [page 107]; 2023 § Business Segment Products [page 108]; 2024 § Business Segment Products [page 110]). In 2024 the segment was further reorganized with the creation of an Industrial Specialties division that houses these electrical products, signaling a deliberate, ongoing strategic emphasis on construction‑related and industrial electrical markets and reinforcing the company’s positioning as a key supplier in the industrial space.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that MMM consistently listed electrical products across all three years (2022-2024) in the Safety and Industrial segment. The page references provided (107, 108, 110) are plausible and specific. The core factual claim about electrical products for construction, maintenance, power distribution, and electrical OEMs is accurate across all years. CRITICAL WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the significant evolution in segment composition across the three years. The ground truth shows that 2022 included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, but the LLM omits this entirely. (2) MISSING 2023 DETAILS: The ground truth explicitly states that 2023 added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components. The LLM completely fails to mention these additions, which are critical to understanding the multi-year progression. (3) INCOMPLETE 2024 ANALYSIS: While the LLM mentions a 2024 reorganization with an 'Industrial Specialties division,' it doesn't capture the ground truth's observation that the 2024 description rephrased the segment to emphasize 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials.' (4) WEAK STRATEGIC INTERPRETATION: The LLM's conclusion about 'deliberate, ongoing strategic emphasis' is vague and doesn't substantively address what the multi-year progression indicates about strategic positioning. The ground truth provides more nuanced analysis: a shift from emphasizing closure systems/hygiene products (2022) to adding abrasives/autobody solutions (2023) to rephrasing toward broader industrial specialties (2024). (5) MISSING COMPARATIVE ANALYSIS: The question explicitly asks about evolution 'across 2022, 2023, and 2024' - the LLM provides minimal year-to-year comparison and fails to synthesize how the portfolio changed. The answer reads more like a static description of consistent offerings rather than an analysis of evolution. QUANTITATIVE ACCURACY is high because the years and segment names are correct. QUALITATIVE ACCURACY is low because the multi-hop reasoning across three years is incomplete and the strategic positioning analysis lacks the depth shown in the ground truth. The answer addresses only the surface-level consistency of electrical products while missing the substantive portfolio evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 692,
        "total_tokens": 2215
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "Gilead’s Oceanside, California site has been described in each filing as serving the same dual purpose – it is used for commercial retroviral‑vector manufacturing and for clinical manufacturing plus process‑development of the company’s biologics candidates. The 2022‑2023 filing lists the Oceanside facility with that wording, and the 2024 filing repeats it unchanged, indicating that the site’s role in both retroviral‑vector production and biologics development has remained consistent over the 2022‑2024 period【page_11†L1-L4】【page_10†L1-L4】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth clearly establishes a PROGRESSION/EVOLUTION of the Oceanside facility's role from 2022-2024: (1) 2022: General R&D role as part of broader operational footprint, (2) 2023: Specifically highlighted for clinical manufacturing and process development of biologics, (3) 2024: Further emphasized as dedicated site for COMMERCIAL retroviral vector manufacturing PLUS clinical manufacturing and process development. The LLM answer claims the facility's role 'remained consistent' and 'unchanged' across 2022-2024, stating it served the same dual purpose throughout. This is directly contradicted by the ground truth, which explicitly describes a strategic shift from general R&D to specialized, scaled-up functions. The LLM also incorrectly claims the 2022-2023 filing lists the facility with identical wording to 2024, when the ground truth indicates the descriptions evolved and became more specific over time. The question specifically asks about how utilization 'evolved' - the LLM's answer of consistency/no change is the opposite of what the ground truth demonstrates. The citations provided (page references) appear to be fabricated or misapplied, as they don't support the claim of unchanged descriptions. The LLM failed to recognize and synthesize the multi-hop temporal progression that is central to answering this question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 396,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "In 2022 the glide‑path set the Return‑Seeking portion of the U.S. pension portfolio at 25 % (15 % equity + 10 % other)【page_310】. By 2023 the target had been trimmed to roughly 23 % (about 8 % equity and 15 % other)【page_252】, and the 2024 target fell further to 20 % (9 % equity + 11 % other)【page_252】, reflecting a gradual shift from growth assets toward liability‑hedging assets as the plan’s funded status improved.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to provide specific numerical allocations for the Return-Seeking portion across three years (2022: 25%, 2023: 23%, 2024: 20%), which is more detailed than the ground truth. However, there are significant issues: (1) The ground truth does not provide these specific percentage allocations - it only describes the glide path methodology (that allocations are set based on funded status at specific dates, with forward-looking adjustments). The LLM appears to have fabricated or misinterpreted specific numbers. (2) The ground truth emphasizes the METHODOLOGY (allocations based on funded status at year-end, set forward-looking) rather than specific percentage targets. (3) The LLM's interpretation that the shift from 25% to 20% reflects 'improved funded status' is a reasonable inference about the direction, but the specific numbers cannot be verified against the ground truth provided. (4) The LLM correctly identifies the three-year evolution (2022, 2023, 2024) and the general concept of a glide path with decreasing return-seeking allocations, which aligns with the ground truth's description of dynamic adjustment. (5) However, the core issue is that the LLM provides specific numerical allocations (25%, 23%, 20%) that are not confirmed in the ground truth, which only describes the methodology without stating these exact percentages. The answer demonstrates partial understanding of the glide path concept but fails on quantitative accuracy by providing unverified specific numbers. The qualitative reasoning about the shift toward liability-hedging is sound, but the factual basis for the specific percentages is questionable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 454,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "In fiscal 2023 the company’s defined‑benefit plans were targeted at 100 % debt for U.S. plans, while non‑U.S. plans were allocated 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other assets (page 88). By fiscal 2025 the U.S. target remained 100 % debt, but the non‑U.S. mix shifted to 36 % debt, 28 % equity, 7 % cash, 21 % insurance contracts and 8 % other (page 95). This move away from debt toward more insurance‑linked and cash holdings—while keeping equity modest—shows ACN is gradually adopting a more conservative, liability‑matching posture, indicating a lower long‑term risk tolerance for its pension‑plan investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical allocations for fiscal 2023 and fiscal 2025, but this approach fundamentally misses what the ground truth answer conveys. Critical issues: (1) FACTUAL MISMATCH: The ground truth discusses the evolution of ACN's target allocation STRATEGY and planning horizon (extending from 1-year to 2-year forward planning), not specific percentage allocations. The LLM provides concrete percentages (100% debt for U.S., 48% debt/27% equity/etc. for non-U.S. in 2023, shifting to 36% debt/28% equity/etc. in 2025) that may or may not be accurate to the actual filings, but they represent a different type of answer than what the ground truth indicates. (2) MULTI-HOP REASONING FAILURE: The ground truth emphasizes the strategic shift in planning horizon and confidence in long-term outlook, while the LLM focuses on asset allocation percentages and concludes about 'lower risk tolerance.' These are fundamentally different interpretations of the evolution. (3) INTERPRETATION DIVERGENCE: The ground truth suggests the company became LESS reactive and MORE strategic (higher confidence), while the LLM concludes the company became MORE conservative (lower risk tolerance). These are opposite conclusions. (4) MISSING KEY INSIGHT: The LLM completely misses the critical point about the extension of planning horizon from fiscal 2023→2024 to fiscal 2024→2025, which is central to the ground truth's analysis. (5) QUANTITATIVE CONCERN: While the specific percentages provided are detailed, without access to the actual filings, it's unclear if these numbers are accurate. The ground truth does not cite specific percentages, suggesting the answer may be based on different source material or misinterpretation of the filing data. The LLM answer reads as if it extracted specific allocation tables, but the ground truth answer discusses strategic planning evolution, not allocation percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 518,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the 5.45 % Solar Bonds, Series 2015/C25‑15 as Exhibit 4.36 – the “Thirty‑Sixth Supplemental Indenture, dated April 14 2015” (2022 p. 100; 2023 p. 102; 2024 p. 99). The bond’s continual disclosure shows that the same fixed‑rate solar‑bond issue remains outstanding and is part of a broader series of supplemental indentures, indicating Tesla’s strategy of using a stable, long‑term debt pool of solar‑specific bonds rather than frequent new issuances to finance its solar projects.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C25-15) and the interest rate percentage. (2) The bond is correctly identified as Exhibit 4.36 across the three years. (3) The date April 14, 2015 is provided and appears consistent with the bond's origin. (4) The LLM correctly notes the bond's consistent presence across 2022, 2023, and 2024 filings. (5) The core insight about Tesla using a stable, long-term debt pool rather than frequent new issuances is reasonable. WEAKNESSES: (1) The LLM provides specific page numbers (2022 p. 100; 2023 p. 102; 2024 p. 99) that cannot be verified against the ground truth and may be inaccurate. (2) The LLM fails to address the multi-year evolution pattern that the question specifically asks about - it does not discuss how the bond's structuring evolved or changed across the three years. (3) The ground truth mentions expansion of the financing framework with newer bond structures (Series 2015/C28-15 and 2015/C33-15 by 2023), but the LLM does not discuss this evolution or compare the bond series across years. (4) The LLM does not mention the SolarCity acquisition context, which is important for understanding the bond's origin. (5) The LLM's statement about 'the same fixed-rate solar-bond issue remains outstanding' is somewhat vague and doesn't fully capture the nuanced evolution described in the ground truth. (6) The answer is more focused on exhibit formatting than on the strategic evolution of Tesla's solar financing strategy across the three-year period. MULTI-HOP REASONING: The LLM provides a surface-level synthesis showing the bond's consistent presence but fails to synthesize the evolution pattern across years that would demonstrate how Tesla's solar financing strategy evolved. The ground truth shows progression (2022 baseline → 2023 expansion → 2024 continuation), but the LLM treats all three years as essentially identical. SEMANTIC MATCH: While the LLM's conclusion about stable long-term debt is reasonable, it doesn't fully capture the ground truth's emphasis on the evolution and expansion of the financing framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 574,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "In 2022 AIG quantified its terrorism risk with a concrete scenario – a five‑ton bomb attack – estimating a net loss of about **$1.3 billion** after applying the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries, and it disclosed a **$1.7 billion deductible** (TRIPRA covering roughly 80 % of losses) together with “targeted reinsurance purchases” and participation in government‑sponsored terrorism pools for non‑U.S. jurisdictions【page_169】. By 2024 the company still uses a third‑party, scenario‑based model and monitors concentrations, but it no longer cites a single loss figure; instead it emphasizes **routine scenario‑based modeling, targeted reinsurance purchases, and reliance on government‑arranged terrorism reinsurance programs and country pools**, while U.S. exposure remains mitigated by TRIPRA – reflecting a shift from a specific loss estimate to a more flexible, jurisdiction‑specific risk‑mitigation framework【page_88】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's terrorism exposure management evolution with mostly accurate information. STRENGTHS: (1) Correctly identifies the $1.3 billion net loss estimate for the five-ton bomb attack scenario in 2022 - this matches ground truth exactly. (2) Accurately captures the shift from specific loss estimates in 2022 to more flexible, jurisdiction-specific frameworks by 2024. (3) Properly identifies key mechanisms: TRIPRA, reinsurance, government-sponsored pools, and scenario-based modeling. (4) Correctly notes the 80% TRIPRA coverage and $1.7 billion deductible. (5) Good multi-hop synthesis showing evolution across 2022-2024 period. WEAKNESSES: (1) Missing the $200 million Japan attachment point retention mentioned in ground truth as a specific 2024 enhancement. (2) Does not mention the $38.0 billion reinsurance recoverable assets figure by end of 2024, which is a significant quantitative indicator of risk transfer scaling. (3) The answer focuses heavily on 2022 and 2024 but provides minimal detail on 2023 evolution (ground truth mentions 'active management and monitoring of exposure concentrations' in 2023). (4) Does not explicitly address 'global jurisdictions' comprehensively - mentions U.S. and Japan but lacks broader geographic scope discussion. QUANTITATIVE VERIFICATION: The $1.3 billion figure is correct; $1.7 billion deductible is correct; 80% TRIPRA coverage is correct. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk management mechanisms, though incompletely. The logical flow from specific scenario modeling to flexible frameworks is sound. SEMANTIC EQUIVALENCE: The answer conveys the core evolution narrative accurately, though with notable omissions of specific metrics that would strengthen the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 507,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the Safety and Productivity Solutions segment was flagged for exposure to “adverse industry economic conditions” in each of the three years – the 2022 filing (page 30), the 2023 filing (page 31) and the 2024 filing (page 32) all contain the same language. Across all three years the company consistently warned that margin pressure could stem from a combination of reduced investment in process automation, safety monitoring and plant‑capacity initiatives; fluctuations in retail markets; a slowdown in demand for safety products; competitive pressure from new entrants and new‑technology‑driven product commoditization; and the broader adverse industry economic environment, which together could lower market share, compress selling prices and squeeze margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Honeywell's Safety and Productivity Solutions segment exposure to adverse industry conditions from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022, 2023, 2024) and the consistent messaging across all three years; (2) Accurately lists the specific risks: reduced investment in process automation, retail market fluctuations, product commoditization, new market entrants, slowdown in demand for safety products, and adverse industry economic conditions; (3) Correctly synthesizes the consequences: lower market share, compressed selling prices, and margin pressure; (4) Appropriately notes the consistency of these warnings across the three-year period; (5) References specific page numbers (30, 31, 32) which adds credibility. MINOR WEAKNESSES: (1) The LLM answer mentions 'safety monitoring and plant-capacity initiatives' as part of the reduced investment risks, which is slightly more detailed than the ground truth's simpler 'reduced investments in process automation' - this is an expansion rather than an error, but adds specificity not explicitly confirmed in the ground truth; (2) The ground truth specifically mentions the 'restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions)' in 2024, indicating a structural change, while the LLM answer doesn't explicitly acknowledge this segment name change, though it does reference the 2024 filing; (3) The ground truth emphasizes the 'persistent vulnerability' and 'consistent linkage over three years' as a key insight, while the LLM answer focuses more on listing the risks rather than emphasizing the persistence pattern. QUANTITATIVE ACCURACY: No calculations or specific dollar amounts are required for this question, so this dimension is less critical. The dates (2022, 2023, 2024) and page references are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the evolution (or lack thereof) of risks across the period. The reasoning that these same risks persisted across all three years is sound. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth despite different wording and organization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 620,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "- 2022 (10‑K covering 2021): Pfizer granted BPAs – 1,165 shares were awarded (‑ “Granted 1,165 … BPAs” 【page_99】).  The awards were valued “using the intrinsic‑value method using the closing price of our common stock” and were amortized on a straight‑line basis over the probable vesting term into cost of sales, selling, informational‑administrative and R&D expenses【page_102】.  \n\n- 2023 (10‑K covering 2022): No BPAs were granted and none were outstanding at year‑end (“No BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023”【page_97】).  The note still describes the same intrinsic‑value valuation and straight‑line amortization approach for BPAs, even though no awards existed【page_96】.  \n\n- 2024 (10‑K covering 2023): The pattern continued – “No BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024”【page_94】.  The valuation and recognition language remains unchanged (intrinsic‑value method, amortized over the probable vesting term)【page_96】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN YEAR MAPPING AND QUANTITATIVE DATA: The LLM answer contains fundamental errors in matching 10-K filings to fiscal years and misrepresents the quantitative data. (1) YEAR MAPPING ERRORS: The LLM states '2022 (10-K covering 2021)' when the question asks about 2022-2024 evolution. The ground truth clearly indicates: 2022 had 1,165 thousand BPAs granted with $38.73 weighted average intrinsic value and 859 thousand nonvested at year-end; 2023 had no BPAs granted and none outstanding; 2024 continued with no BPAs. The LLM's labeling of '2023 (10-K covering 2022)' and '2024 (10-K covering 2023)' creates confusion about which fiscal year data is being discussed. (2) MISSING CRITICAL QUANTITATIVE DATA: The LLM completely omits the weighted average intrinsic value of $38.73 per share for 2022 BPAs, which is a key metric in the ground truth. It also fails to mention the 859 thousand nonvested BPAs remaining at year-end 2022, which is essential to understanding the program's status. (3) INCOMPLETE EVOLUTION NARRATIVE: While the LLM correctly identifies that no BPAs were granted in 2023 and 2024, it fails to properly characterize the evolution from active issuance (2022) to complete wind-down (2023-2024). The ground truth emphasizes this shift as a key aspect of the program's evolution. (4) VALUATION METHODOLOGY: The LLM correctly identifies the intrinsic value method and straight-line amortization approach, which aligns with the ground truth's description of valuation mechanics. However, this is presented without the context of how methodology remained consistent even as the program wound down. (5) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture of program evolution across the three-year period, missing the quantitative progression that demonstrates the wind-down. The answer reads as three separate snapshots rather than a coherent evolution narrative. The core factual errors regarding year labeling and missing quantitative data (weighted average intrinsic value, nonvested share counts) significantly undermine the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 562,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture bought back roughly $4.1 billion of Class A shares in fiscal 2022 (12.2 million shares for $4,111 million) and, after those purchases, still had about $3.13 billion of its publicly‑announced buy‑back authority left (page 94); the board then added $3 billion, raising total outstanding authority to $6.13 billion (page 93). By fiscal 2024 the company’s repurchases remained sizable – $4.5 billion of shares were repurchased during the year (including $605 million in Q4) – leaving only $2.69 billion of available authorization, but the board approved an additional $4 billion, bringing total authority to $6.69 billion (pages 40‑39). This pattern of large, ongoing buy‑backs combined with periodic increases in the authorized limit shows a deliberate, sustained capital‑return strategy that relies heavily on share repurchases to return cash to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. Verification of key numbers: (1) Fiscal 2022: $4.111 billion repurchased (12.2M shares) - correct; remaining authorization of ~$3.13 billion - correct; $3 billion new authorization bringing total to $6.13 billion - correct. (2) Fiscal 2024: $4.5 billion repurchased - correct; $605 million in Q4 - correct; remaining authorization of $2.69 billion - correct; $4 billion new authorization bringing total to $6.69 billion - correct. All calculations are accurate. The answer successfully synthesizes information across fiscal years 2022-2024, correctly identifying the pattern of large repurchases followed by periodic authorization increases. The LLM provides more granular detail than the ground truth (specific share counts, quarterly breakdown, page references) while maintaining factual accuracy. The reasoning about capital return strategy is sound and well-supported by the data presented. Minor note: The ground truth mentions fiscal 2023 as an intermediate year but doesn't provide specific numbers for it; the LLM focuses on 2022 and 2024 endpoints, which is appropriate given the question's framing. The semantic interpretation of the trend (deliberate, sustained capital-return strategy) aligns perfectly with the ground truth's conclusion about 'consistent and increasing commitment.' No material errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 393,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "In the 2022 Form 10‑K, Meridian was still presented as a discontinued operation, with the sale (completed Dec 31 2021) and the $167 million post‑tax loss from that divestiture disclosed and the Upjohn/​Meridian business shown as discontinued (see pages 115‑116). The 2023 filing expands on that divestiture, reporting the $51 million cash proceeds, the loss, and the post‑sale framework of interim transition‑service agreements (TSAs) – completed Dec 31 2023 – and a three‑year manufacturing‑supply agreement (MSA) with a two‑year extension, noting that the amounts recorded under these arrangements in 2022‑23 were immaterial (see pages 73‑75). By the 2024 Form 10‑K, Meridian appears only in the glossary of defined terms (see page 3) with no financial line items or ongoing agreements, indicating the relationship has been fully wound down and now exists only as a strategic divestiture.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All key financial figures are correct: $51 million cash proceeds, $167 million post-tax loss, and the December 31, 2021 sale completion date are all accurate. (2) The chronological progression is properly traced: 2022 (discontinued operations disclosure), 2023 (divestiture details with TSAs and MSA), 2024 (glossary-only reference). (3) The multi-hop reasoning correctly synthesizes information across three fiscal years showing the evolution from operational integration to complete disengagement. (4) Additional details about TSAs (completed Dec 31, 2023) and the three-year MSA with two-year extension option add valuable context not explicitly in the ground truth but consistent with typical divestiture structures. (5) The notation that amounts under these arrangements were immaterial in 2022-23 is a reasonable inference from the progression described. MINOR CONSIDERATIONS: (1) The ground truth states the sale was completed December 31, 2021, and the LLM correctly identifies this, though it notes this was disclosed in the 2022 10-K (which is accurate - prior year transactions appear in subsequent filings). (2) The LLM provides specific page references (115-116, 73-75, page 3) which cannot be verified against the ground truth but are consistent with typical 10-K structure. (3) The ground truth mentions Meridian's status as a 'divested entity' and the LLM appropriately characterizes it as a 'strategic divestiture.' The answer fully addresses all components of the multi-part question: financial disclosures (numbers and loss), operational agreements (TSAs and MSA), and strategic alignment (complete disengagement). The semantic equivalence is strong - both answers convey the same progression from operational to divested to definitional reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 514,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares in fiscal 2022 (see page 91). The FY 2023 filing (pages 81‑85) contains no revised ceiling, implying the authorization remained at the FY 2022 level through that year, and the company increased the limit to **141 million** shares by fiscal 2024 (see page 98). This upward adjustment reflects a deliberate strategy to expand the equity‑based compensation pool, giving Accenture greater flexibility to award shares and further align employee incentives with long‑term shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2023 DATA: The LLM answer states that FY 2023 'contains no revised ceiling, implying the authorization remained at the FY 2022 level through that year.' This directly contradicts the ground truth, which explicitly states that 141,000,000 shares were authorized in fiscal 2023. The ground truth shows a clear progression: FY 2022 (127M) → FY 2023 (141M) → FY 2024 (141M). The LLM incorrectly implies FY 2023 remained at 127M, which is factually wrong. CORRECT ELEMENTS: (1) FY 2022 figure of 127 million is accurate; (2) FY 2024 figure of 141 million is accurate; (3) The interpretation that the increase reflects a strategic expansion of equity-based compensation is semantically aligned with the ground truth's assessment. MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year progression. It correctly identified the 2022-to-2024 increase but mischaracterized the 2023 data point, breaking the logical sequence. The ground truth emphasizes that the increase occurred in 2023 and was maintained in 2024, showing sustained strategic commitment. The LLM's narrative suggests a single jump in 2024, which misrepresents the timeline. QUANTITATIVE ACCURACY PENALTY: The core factual error regarding FY 2023 (claiming no change when there was a 14M share increase) is a significant quantitative mistake that undermines the answer's reliability. The reasoning about strategic intent is sound, but it's built on incomplete/incorrect data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 410,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 2022 Form 10‑K exhibit tables (pages 102‑106) contain no entry for the 4.70 % Solar Bonds, Series 2015/C52‑10, whereas both the 2023 and 2024 Form 10‑Ks list the bond as the “Seventieth Supplemental Indenture, dated June 16 2015” (exhibit 4.4) on page 101【page_101】. The repeat appearance in the later filings shows the bond remains outstanding and that Tesla continues to acknowledge and service this debt, indicating an ongoing financing commitment to its solar business and a strategic priority to keep the series disclosed for transparency【page_106】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) MAJOR ERROR - The LLM claims the 2022 Form 10-K contains NO entry for the bond, but the ground truth explicitly states it was referenced in 2022 as Exhibit 4.49. This is a fundamental factual error about what was disclosed. (2) EXHIBIT NUMBER ERROR - The LLM states the bond appears as 'exhibit 4.4' in 2023 and 2024, but the ground truth shows it was Exhibit 4.42 in 2023 and Exhibit 4.40 in 2024. The LLM's exhibit numbers are incorrect. (3) INCONSISTENCY CLAIM - The LLM incorrectly characterizes the disclosure pattern as inconsistent (absent in 2022, present in 2023-2024), when the ground truth clearly shows CONSISTENT re-disclosure across all three years (2022, 2023, 2024). This is the opposite of what actually occurred. (4) MISSING CORE FINDING - The ground truth's key insight is that the SAME Seventieth Supplemental Indenture with the SAME June 16, 2015 filing date was disclosed in all three years, indicating stability and consistency. The LLM misses this entirely by claiming 2022 had no disclosure. (5) REASONING FLAW - While the LLM's conclusion about ongoing financing commitment is reasonable, it's based on incorrect premises about the disclosure pattern. The multi-hop synthesis fails because the foundational facts about what was disclosed when are wrong. The answer demonstrates a fundamental misunderstanding of the disclosure pattern across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 411,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "In the 2022 filing Adobe’s Digital Learning Services were described as providing “a large number of free online self‑service learning options on learning.adobe.com” as a core element of its learning‑and‑enablement portfolio that helps customers and partners use Adobe products【page_18】. By the 2024 filing the free resources had been re‑branded to www.training.adobe.com and were still positioned as a foundational offering within a broader suite that includes fee‑based classroom, virtual and on‑demand programs and custom learning services, explicitly highlighted as the “how‑to” foundation that drives faster solution adoption and supports Customer Success and Getting‑Started support【page_17】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DOMAIN REVERSAL - The LLM answer contains a fundamental factual error regarding the evolution of Adobe's learning platforms. The ground truth states that in 2022 the offering was on www.training.adobe.com and by 2023 it moved to learning.adobe.com. The LLM answer reverses this, claiming the 2022 filing referenced learning.adobe.com and that by 2024 it was 'rebranded to www.training.adobe.com' - this is backwards. (2) INCOMPLETE SYNTHESIS - The LLM answer only addresses 2022 and 2024, missing the critical 2023 data point that the ground truth explicitly includes as part of the evolution narrative. The question asks about evolution 'from 2022 to 2024' which requires tracking the progression across all three years. (3) POSITIONING ACCURACY - While the LLM correctly identifies the free offerings as part of a broader learning portfolio and mentions fee-based programs, it fails to capture the consistent strategic positioning across all three years that the ground truth emphasizes. The ground truth stresses 'consistent presence...across all three years' reflecting 'strategic commitment to scalable, accessible learning solutions.' (4) MISSING CONTEXT - The LLM answer lacks discussion of how the offering supported both Digital Experience and Digital Media products (mentioned in ground truth for 2023) and doesn't adequately convey the evolution of positioning relative to AI-driven tools mentioned for 2024. (5) PAGE CITATIONS - The LLM provides page citations (page_18, page_17) but these cannot be verified against the ground truth and may be hallucinated. The core factual error about domain reversal is the most serious issue, as it contradicts the documented evolution timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 470,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path framework reduces the “Return‑Seeking” (growth) slice of the U.S. qualified plan as the funded ratio improves, shifting assets from equities to liability‑hedging securities. Accordingly, the target equity allocation – the proxy for the return‑seeking portion – dropped from 15 % in the 2022 target (based on the 2021 funded status) to 9 % in the 2024 target (based on the 2023 funded status), while the fixed‑maturity share rose from 75 % to 80 % (page 310; page 252). This change reflects the glide‑path rule of lowering growth‑asset exposure as the plan becomes better funded (page 184).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical claims (15% equity allocation in 2022, 9% in 2024, 75% to 80% fixed-maturity shift) that directly contradict the ground truth. The original answer explicitly states 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts,' yet the LLM confidently asserts precise percentages with page citations (pages 310, 252, 184). This is a fundamental factual error - the LLM appears to have fabricated specific numbers that do not exist in the source material. The LLM also misrepresents the timeline: it claims the 2024 target was based on 2023 funded status, but the ground truth indicates the 2024 target was based on 2023 funded status (correct), while the 2025 target was based on 2024 funded status. The conceptual understanding of the glide path mechanism is partially correct (de-risking as funded status improves), but this correct reasoning is undermined by the invented numerical data. The page citations appear fabricated as well, as they don't correspond to verifiable source material for these specific percentages. This represents a severe breach of factual accuracy - providing false quantitative data with false citations is worse than acknowledging data limitations as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 363,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "In the 2022 filing Honeywell warned that the Performance Materials and Technologies segment could be “adversely impacted by … raw material demand and supply” (2022 page_32), and the same language re‑appeared in the 2023 filing (2023 page_32). By the 2024 filing the discussion had shifted to “raw material price fluctuations” and the company noted that “the majority of the raw materials supply base … were under contract,” indicating that supply‑side exposure has been mitigated while price volatility remains a concern (2024 page_31). This trend shows Honeywell has reduced its vulnerability to raw‑material shortages but continues to be sensitive to commodity‑price swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE INTERPRETATION: The LLM answer fundamentally mischaracterizes the evolution of Honeywell's risk exposure. The ground truth indicates that raw material demand and supply risks remained consistently prominent across all three years (2022-2024), with the risk profile INTENSIFYING as energy markets became more volatile. The LLM answer incorrectly concludes that 'supply-side exposure has been mitigated' - this directly contradicts the ground truth which states the vulnerability 'intensified' and remained 'sustained.' SPECIFIC ERRORS: (1) The LLM claims a 'shift' from 'raw material demand and supply' language to 'raw material price fluctuations' by 2024, but the ground truth indicates the company continued to emphasize raw material supply volatility throughout, with ADDITIONAL emphasis on oil/natural gas price volatility - not a replacement of supply concerns. (2) The LLM's assertion that 'supply-side exposure has been mitigated' is unsupported by the ground truth and represents a misinterpretation of the filing data. The ground truth explicitly states the risk remained 'prominent' in 2024. (3) The LLM correctly identifies page numbers and years, but misinterprets what those filings actually convey about risk evolution. WHAT WAS CORRECT: The LLM accurately cites specific page references (2022 page_32, 2023 page_32, 2024 page_31) and correctly identifies that the segment faced raw material risks across all three years. The mention of contract coverage for raw materials supply base is a valid observation. REASONING FAILURE: The multi-hop synthesis is flawed. Rather than recognizing a sustained and intensifying vulnerability pattern, the LLM incorrectly frames this as a mitigation trend. This represents a fundamental misunderstanding of the question's intent regarding vulnerability evolution and commodity market volatility exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 508,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "Accenture’s non‑U.S. defined‑benefit pension assets in mutual‑fund equity securities were about **$239 million in 2022**, fell to **$196 million in 2023**, and then rose to **$274 million in 2024** (see the fair‑value tables on pages 89, 96). The three‑year pattern—a decline followed by a sizable rebound—suggests a strategic re‑allocation toward higher equity exposure, consistent with the plan’s increasing target allocation for non‑U.S. equity holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the 2024 figure. Ground truth states mutual fund equity securities remained unchanged at $196.226 million in 2024, but the LLM claims they rose to $274 million. This is a significant discrepancy ($274M vs $196.226M = ~$78M difference or 40% overstatement). The 2022 ($239M) and 2023 ($196M) figures are approximately correct (minor rounding acceptable). However, the incorrect 2024 value fundamentally undermines the entire analysis. The LLM's interpretation of the trend is also incorrect: it claims a 'sizable rebound' and 'strategic re-allocation toward higher equity exposure,' when the ground truth shows stability/no change in 2024. The LLM's reasoning about 'increasing target allocation for non-U.S. equity holdings' contradicts the actual data pattern of decline-then-stability. The answer does correctly identify ACN/Accenture and the metric (mutual fund equity securities in non-U.S. defined-benefit pension assets), and the page references suggest an attempt at source verification, but the core numerical data is wrong. The multi-hop synthesis fails because the 2024 number is incorrect, leading to an entirely different and incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 351,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In the 2022 filing Adobe still described Document Cloud as a legacy “document and forms platform” within its Publishing & Advertising segment, emphasizing its core PDF capabilities and revenue contribution but making no reference to AI features (2022 p.70). By the 2024 filing the company had repositioned Document Cloud as a core Digital Media growth engine, adding generative‑AI tools powered by Firefly (2024 p.12), an AI‑assistant in Acrobat (2024 p.11), and a suite of enterprise‑grade APIs, Acrobat Sign and Adobe Experience Manager integrations that automate and modernize digital document workflows (2024 p.10‑13).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Document Cloud as a 'legacy document and forms platform' within Publishing & Advertising segment; (2) Accurately captures the 2024 repositioning as a Digital Media growth engine with AI integration; (3) Properly identifies key AI tools (Firefly, AI-assistant in Acrobat) and enterprise features (Acrobat Sign, Adobe Experience Manager integrations); (4) Correctly synthesizes the multi-hop progression showing transformation from legacy to AI-enhanced productivity suite; (5) Includes specific page references (2022 p.70, 2024 p.10-13) that add credibility; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer is more concise and omits the intermediate 2023 positioning detail mentioned in ground truth (Document Cloud elevated as core component of Digital Media segment in 2023, positioned alongside Adobe Express and Firefly). While this doesn't constitute an error, it represents incomplete coverage of the full 2022-2024 progression; (2) The ground truth emphasizes the 'elevation' and 'shift toward modernization' as a narrative arc, while the LLM answer focuses more on feature additions without explicitly highlighting the strategic repositioning narrative. QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives high marks for not introducing false numbers. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and filing documents, properly connecting Document Cloud's evolution to broader Adobe strategic initiatives around AI integration. The reasoning is sound and logically structured. ENTITY ACCURACY: All entities correctly identified (Adobe, Document Cloud, Firefly, Acrobat, Acrobat Sign, Adobe Experience Manager, Digital Media segment, Publishing & Advertising segment).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 551,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures have consistently flagged that new market entrants and emerging technologies could erode market share and pricing power, first across its legacy segments (Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions) where it warned of “new entrants and non‑traditional players” and the risk of “lower market share, reduced selling prices and lower margins” (2022 p.31). After the 2023 realignment, the same competitive‑landscape warnings were restated for the newly named segments—Aerospace Technologies, Building Automation, Industrial Automation and Energy & Sustainability Solutions—again noting that “new market entrants and new technologies” could lead to product commoditization, loss of market share and pressure on selling prices (2023 p.30); the 2024 filing (2024 p.31) embeds these risks in the four reportable segments, showing that exposure to new entrants and technological disruption remains a core risk to market share and pricing across the business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of competitive landscape risks across Honeywell's business segments from 2022 to 2024; (2) Accurately cites specific risk factors mentioned in filings: 'new entrants and non-traditional players,' 'lower market share, reduced selling prices and lower margins,' and 'product commoditization'; (3) Properly tracks the business segment realignment between 2023 and 2024, noting the transition from legacy segments (Aerospace, Building Technologies, Performance Materials & Technologies, Safety & Productivity Solutions) to newly named segments (Aerospace Technologies, Building Automation, Industrial Automation, Energy & Sustainability Solutions); (4) Correctly identifies page references (2022 p.31, 2023 p.30, 2024 p.31) which align with typical 10-K risk factor section locations; (5) Sound multi-hop reasoning that synthesizes information across three years and multiple business segments; (6) Appropriately emphasizes the progression from initial risk disclosure to broader expansion across segments to explicit focus on commoditization. MINOR WEAKNESSES: (1) The LLM answer provides slightly less explicit detail about the 2023 expansion to Performance Materials and Technologies and Aerospace as mentioned in the ground truth, though it does reference the 2023 realignment; (2) The phrase 'non-traditional players' in the LLM answer is not explicitly mentioned in the ground truth, which uses 'new entrants' and 'new technologies' - this is a minor semantic variation that doesn't materially affect accuracy; (3) The LLM answer could have been slightly more explicit about the 'deepening concern' and 'strategic shift' aspects emphasized in the ground truth, though the overall narrative captures this progression. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page references appear reasonable for 10-K risk factor sections; no calculations required. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years, multiple business segments, and the business realignment, demonstrating proper understanding of how competitive landscape risks evolved and were disclosed differently across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 622,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "In the 2022 filing Pfizer noted that the Upjohn spin‑off and its combination with Mylan created Viatris and that Pfizer continued to provide interim agency, MSA and transition‑service arrangements on Viatris’s behalf 【page_12】. By the 2023 filing the TSAs were “largely completed as of December 31, 2023” and the net amount due to Viatris fell from $94 million at year‑end 2022 to $33 million at year‑end 2023 【page_73】【page_75】. The 2024 10‑K no longer discusses Viatris or TSAs (only defining the terms), implying the transition services have been fully wound down and any intercompany balances are now immaterial 【page_3】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: All financial figures are correct - $94 million in 2022, $33 million in 2023, and the decline is accurately captured. The years (2022, 2023, 2024) are correctly identified. COMPLETENESS: The answer addresses all key aspects of the question: (1) the origin of the relationship (Upjohn spin-off creating Viatris), (2) transition service arrangements and their status, (3) intercompany balances evolution, and (4) the progression through all three years. ENTITY ACCURACY: Pfizer and Viatris are correctly identified, and the relationship context (Upjohn/Mylan combination) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, showing the progression from active TSAs with significant balances in 2022, to largely completed TSAs with reduced balances in 2023, to full wind-down by 2024. The logic is sound and the conclusion about full resolution of operational interdependencies is well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, using slightly different phrasing ('largely completed' vs 'largely completed', 'fully wound down' vs 'fully resolved') but maintaining semantic equivalence. The addition of context about the Upjohn/Mylan combination and the reference to page numbers adds helpful detail without introducing errors. MINOR OBSERVATION: The LLM answer includes page references which, while helpful for verification, are not part of the ground truth but do not detract from accuracy. The characterization of 2024 balances as 'immaterial' is a reasonable inference from the lack of discussion, though the ground truth uses 'fully resolved' - both convey the same meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 491,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s registered debt shifted from a mix that included short‑term 1.000 % notes due 2023 (shown in the 2021 filing) to a three‑tiered ladder of senior notes – 1.700 % due 2025, 2.200 % due 2027 and 3.125 % due 2031 – that appears unchanged in the 2023 and 2024 filings【page_1】. The 1.700 % notes have remained a stable mid‑term anchor while the company retained longer‑dated, slightly higher‑coupon notes, effectively extending maturities and locking in low borrowing costs, which signals a capital‑structure strategy aimed at reducing rollover risk and preserving inexpensive, long‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about Altria's debt structure evolution and capital strategy, but contains significant factual discrepancies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the 1.700% Notes due 2025 as a key instrument; (2) Accurately notes the presence of longer-dated instruments (2.200% due 2027, 3.125% due 2031); (3) Provides sound strategic reasoning about reducing rollover risk and locking in low borrowing costs; (4) Appropriately addresses the multi-hop nature of the question by synthesizing debt composition across years. CRITICAL ERRORS: (1) References a '2021 filing' when the question specifically asks about 2022-2024 evolution - this is outside the requested timeframe and suggests potential source confusion; (2) States the three-tiered ladder 'appears unchanged in the 2023 and 2024 filings' but the ground truth indicates the 1.000% Note due 2023 matured/was no longer listed by 2023, suggesting structural change; (3) Fails to explicitly note that the 1.700% Note due 2025 was NOT replaced as it approached maturity in 2024, which is a key strategic insight in the ground truth. QUANTITATIVE ISSUES: The specific coupon rates (1.700%, 2.200%, 3.125%) and maturity years (2025, 2027, 2031) appear correct, but the claim of 'unchanged' composition contradicts the documented removal of the 1.000% Note due 2023. REASONING QUALITY: The strategic interpretation (reducing rollover risk, locking in low rates) is sound and well-articulated, but misses the specific implication that Altria chose NOT to issue replacement short-term debt, which is a more nuanced strategic signal. The answer demonstrates good understanding of capital structure strategy but incomplete synthesis of the temporal evolution across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 489,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "- 2022: Fixed unsecured senior debt carried $24.1 billion with a weighted‑average interest rate of **4.45 %**【page_178】.  \n- 2023: The balance grew to $27.2 billion, still at **4.45 %**【page_178】.  \n- 2024: The carrying amount fell slightly to $26.9 billion, while the weighted‑average rate rose to **4.84 %**【page_188】.  \n\nThe trend shows Capital One expanded its fixed‑rate senior debt in 2023 and, after a modest reduction in 2024, is issuing new notes at higher rates, indicating a strategy of maintaining a sizable long‑term fixed‑rate funding base even as borrowing costs increase.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that make it largely incorrect. (1) 2022 CARRYING VALUE ERROR: Ground truth states $19,975 million ($19.975 billion), but LLM claims $24.1 billion - this is a $4.125 billion discrepancy (20.6% error). (2) 2022 INTEREST RATE ERROR: Ground truth states 2.91%, but LLM claims 4.45% - this is a 1.54 percentage point error. (3) 2023 INTEREST RATE ERROR: Ground truth states 4.45%, and LLM correctly states 4.45% - this is the only correct data point. (4) 2023 CARRYING VALUE: LLM states $27.2 billion which aligns with ground truth of $27,168 million - this is correct. (5) 2024 CARRYING VALUE: LLM states $26.9 billion which aligns with ground truth of $26,930 million - this is correct. (6) 2024 INTEREST RATE: LLM states 4.84%, but ground truth states 4.84% - this is correct. MULTI-HOP SYNTHESIS: The LLM failed to properly track the evolution across all three years. The narrative about 'expanding in 2023 and modest reduction in 2024' is partially correct, but the foundational 2022 baseline is completely wrong, undermining the entire trend analysis. The reasoning about 'maintaining a sizable long-term fixed-rate funding base' is somewhat reasonable but is built on incorrect data. CALCULATION VERIFICATION: The LLM did not perform any calculations, but the raw data points are predominantly incorrect. The 2022 baseline error is particularly egregious as it sets the wrong foundation for understanding the trend. ENTITY ACCURACY: Capital One (COF) is correctly identified, years are correct, and metrics are correctly labeled, but the values are wrong. The answer demonstrates a pattern of data retrieval errors rather than reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 470,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C92‑15, are listed in each of the three filings – as Exhibit 4.61 in the 2022 10‑K (see page 105), as Exhibit 4.54 in the 2023 10‑K (see page 102) and again in the 2024 10‑K (see page 102). The bond’s continued presence in the exhibit schedules shows that Tesla has retained this fixed‑rate solar‑bond issuance over the 2022‑2024 period, signalling an ongoing reliance on long‑term debt to finance its solar‑energy operations rather than retiring or replacing it.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C92-15) and the three years covered (2022-2024). (2) The exhibit numbers are accurately cited: Exhibit 4.61 for 2022, Exhibit 4.54 for 2023, and Exhibit 4.52 for 2024 (though LLM states 4.52 is on page 102, which may be a page reference issue). (3) The core fact that the bond was retained across all three years is correct. (4) Numeric accuracy is sound - the 5.45% rate and year designations are correct.\n\nWEAKNESSES: (1) INCOMPLETE ANALYSIS: The LLM fails to address the critical evolution pattern identified in the ground truth - that newer bond series (C102-15 and C106-10) appeared in subsequent filings, indicating a strategic shift. The ground truth emphasizes 'declining prominence' and a 'shift toward more recent financing structures,' which the LLM completely omits. (2) MISCHARACTERIZATION OF STRATEGY: The LLM concludes the bond shows 'ongoing reliance on long-term debt' and suggests it was not 'retired or replaced,' which contradicts the ground truth's finding that Tesla increasingly relied on newer bond structures. The LLM interprets continued listing as continued reliance, missing the nuance that newer instruments were being introduced alongside the older one. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about 'evolution' and what the 'progression indicates' - the LLM addresses presence but not the strategic evolution or the introduction of newer financing instruments that the ground truth identifies as key to understanding the strategy shift. (4) REASONING GAP: The LLM's conclusion that retention equals 'ongoing reliance' is logically incomplete - it doesn't account for the possibility of maintaining older instruments while introducing newer ones, which is the actual pattern.\n\nCRITICAL OMISSION: The ground truth explicitly states that 'newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures.' The LLM provides no mention of these newer instruments or the strategic shift they represent. This is a significant gap in addressing the 'evolution' aspect of the question.\n\nVERIFICATION: Exhibit numbers appear correct based on ground truth references. The bond identifier and rate are accurate. However, the interpretation of what the data means for Tesla's strategy is substantially incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 644,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "In 2022 AIG’s loss‑reserve risk was overseen mainly by business‑unit chief risk officers and risk‑committee escalation, with written policies, internal controls and stochastic/deterministic modeling, and the process was supplemented by reviews from external experts (2022 p.165‑166). In 2023 the firm added a formal model‑risk‑management and validation framework, broadened pricing‑approval, pre‑launch and actuarial reserve reviews, and continued to use scenario‑based, stochastic and deterministic models together with external expert checks (2023 p.119‑120). By 2024 oversight was further embedded in ERM’s second‑line “review and challenge” function, regular risk‑committee reporting and internal‑audit monitoring, while retaining the model‑risk framework and ongoing external‑expert reviews of reserves (2024 p.86‑88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's approach; (2) Accurately captures 2022 features (internal controls, stochastic/deterministic modeling, external expert reviews); (3) Correctly identifies 2023 additions (formal model-risk-management framework, broadened reviews, scenario-based methods); (4) Properly describes 2024 enhancements (ERM integration, second-line review function, risk-committee reporting, internal audit monitoring); (5) Appropriately cites specific page references (2022 p.165-166, 2023 p.119-120, 2024 p.86-88) suggesting document verification; (6) Demonstrates sound multi-hop reasoning by synthesizing oversight mechanisms, modeling approaches, and external review integration across all three years; (7) Uses semantically equivalent language to ground truth (e.g., 'second-line review and challenge' matches 'structured second-line reviews'). MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth (e.g., mentions 'business-unit chief risk officers,' 'pricing-approval,' 'pre-launch reviews') which adds value but goes slightly beyond the ground truth summary; (2) The phrasing 'loss-reserve risk' vs 'loss reserves risk' is a negligible stylistic difference; (3) The answer could have explicitly emphasized the 'growing emphasis on proactive risk identification, validation, and governance' theme from the ground truth, though this is implied in the progression described. QUANTITATIVE ACCURACY: No numerical calculations or specific dollar amounts are required for this qualitative question; dates (2022, 2023, 2024) are all correct. MULTI-HOP SYNTHESIS: Successfully integrates information across three separate years and multiple dimensions (oversight, modeling, external reviews) to show evolution. The answer correctly demonstrates how each year built upon previous practices while adding new elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 550,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension portfolio has been cutting its holding of U.S. Treasury and foreign‑government securities – the share was about 19 % of pension assets in 2023 (and was even higher in 2022) and fell to roughly 8 % in 2024 【page_86】【page_84】.  The decline signals a deliberate move away from low‑yield government bonds toward a larger proportion of corporate debt and other fixed‑income assets, consistent with its liability‑driven strategy that emphasizes rate‑sensitive securities while seeking higher expected returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key trend of declining allocation to U.S. Treasury and foreign government securities from 19% to 8% across the period. The characterization of this as a deliberate strategic shift away from low-yield government bonds is reasonable and aligns with the ground truth's interpretation. The reasoning about seeking higher returns through corporate debt is logically sound.\n\nCRITICAL ERRORS: (1) The LLM states 19% was the allocation 'in 2023 (and was even higher in 2022)' but provides no specific 2022 figure. The ground truth clearly states 2022 was 19%, 2023 was 16%, and 2024 was 8%. The LLM's phrasing is ambiguous and potentially misleading about the 2022 value. (2) The LLM completely omits the 2023 data point (16%), which is a significant gap in the multi-hop synthesis across the 2022-2024 period. This represents incomplete coverage of the requested time period.\n\nMISSING INFORMATION: The LLM fails to mention: (1) The specific 2023 allocation of 16%, (2) The reduction in below-investment-grade securities from 11% to 9%, (3) The expected rate of return changes (6.6% → 6.1% → 6.1%), which the ground truth identifies as indicating a 'more cautious long-term outlook.' These omissions represent incomplete synthesis of the multi-hop question.\n\nQUANTITATIVE ACCURACY: While the 19% and 8% figures are correct, the incomplete presentation of the 2022-2024 evolution (missing 2023's 16%) and lack of supporting metrics (expected return rates, below-investment-grade allocation changes) reduces quantitative completeness. The answer provides only 2 of 3 key data points for the requested period.\n\nQUALITATIVE ASSESSMENT: The reasoning about strategic shift and liability-driven investment strategy is sound, but the interpretation is somewhat generic. The ground truth provides more nuanced context about 'recalibration of risk exposure' and 'more conservative or diversified investment posture,' which the LLM's answer doesn't fully capture. The mention of 'rate-sensitive securities' adds some value but doesn't fully explain the strategic implications evident in the complete data set.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 574,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from **$883 million in 2022** to **$538 million in 2023** and then ticked up to **$562 million in 2024**【page_178†L13-L16】.  Its long‑term debt rose modestly from **$47.8 billion in 2022** to **$49.3 billion in 2023**, before dropping to **$45.0 billion in 2024**【page_178†L31-L38】【page_188†L31-L38】.  \n\nOver the three‑year span the composition shifted markedly: floating‑rate unsecured senior debt shrank from **$1.6 billion in 2022** to **$0 by 2024** (down to $349 million in 2023) while fixed‑rate senior debt stayed near **$27 billion**, and securitized debt obligations rose to **$18.0 billion in 2023** then fell to **$14.3 billion in 2024**【page_178†L21-L28】【page_188†L21-L28】.  This trend indicates Capital One is moving toward a more fixed‑rate, lower‑interest‑rate‑sensitive debt profile, reducing its exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across nearly all key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR DISCREPANCY:\n   - Ground Truth: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B\n   - LLM Answer: Claims short-term borrowings of $883M-$562M and long-term debt of $47.8B-$45.0B\n   - The LLM's figures don't sum to the ground truth totals and appear to be parsing the balance sheet incorrectly\n   - The LLM's long-term debt figures ($47.8B, $49.3B, $45.0B) are close to total debt but don't match either component correctly\n\n2. FLOATING UNSECURED SENIOR DEBT - INCORRECT:\n   - Ground Truth: 2022=$1.709B, 2023=$349M, 2024=$0\n   - LLM Answer: Claims 2022=$1.6B (close but slightly off), 2023=$349M (correct), 2024=$0 (correct)\n   - The 2022 figure is materially understated ($1.6B vs $1.709B)\n\n3. FIXED-RATE SENIOR DEBT - INCOMPLETE/INCORRECT:\n   - Ground Truth: 2022=$19.975B, 2023=(implied from context), 2024=$26.930B\n   - LLM Answer: Claims it \"stayed near $27 billion\" - this is vague and doesn't provide the 2022 baseline\n   - Missing the critical insight that fixed-rate debt ROSE from $19.975B to $26.930B\n\n4. SECURITIZED DEBT - PARTIALLY CORRECT:\n   - Ground Truth: 2022=$14.994B, 2023=$18.043B, 2024=$14.264B\n   - LLM Answer: Claims 2023=$18.0B (correct), 2024=$14.3B (correct)\n   - Missing 2022 figure entirely\n\n5. INTEREST RATE DATA - COMPLETELY MISSING:\n   - Ground Truth provides weighted-average interest rates for all debt categories across all three years\n   - LLM Answer provides NO interest rate data whatsoever\n   - This is a critical omission as the question specifically asks about \"interest rate exposure\"\n   - Ground truth shows securitized debt rates rising from 1.51% (2022) to 3.48% (2024)\n   - Ground truth shows fixed-rate senior debt rates rising from 2.91% to 4.84%\n\n6. MULTI-HOP SYNTHESIS - FAILED:\n   - The question requires synthesizing debt structure evolution across 3 years with interest rate implications\n   - LLM failed to provide the interest rate dimension entirely\n   - LLM's characterization of the trend as \"moving toward a more fixed-rate, lower-interest-rate-sensitive debt profile\" is contradicted by the ground truth showing RISING interest rates on fixed-rate debt\n\n7. REASONING QUALITY - FLAWED:\n   - LLM concludes Capital One is reducing interest-rate risk, but ground truth shows it's actually LOCKING IN higher rates\n   - The strategic shift described in ground truth (locking in longer-term financing amid rising rates) is fundamentally different from LLM's interpretation\n\nThe LLM answer appears to have misread or misinterpreted the balance sheet structure, conflating different debt categories and missing critical interest rate data that is essential to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 749,
        "total_tokens": 2299
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 each list the 5.45 % Solar Bonds, Series 2015/C25‑15 among the supplemental indentures (e.g., 2022 Exhibit 4.29 – 5.45 % Solar Bonds, Series 2015/C25‑15 [page 100]; 2023 Exhibit 4.27 – same bond [page 99]; 2024 Exhibit 4.36 – same bond [page 101]). The repeated inclusion shows that this bond issue remains outstanding and continues to fund Tesla’s solar projects, indicating it is a persistent component of the company’s capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 as appearing across the 2022, 2023, and 2024 10-K filings and accurately conveys that this bond series remains outstanding and continues to fund Tesla's solar projects. The core factual claims are sound: the bond percentage (5.45%), the series designation (2015/C25-15), and the three-year span are all correct. The LLM appropriately synthesizes the multi-hop information by noting the consistent inclusion across filings and drawing the logical conclusion that this reflects ongoing reliance and strategic importance. However, there are some notable differences from the ground truth: (1) The LLM provides specific exhibit numbers and page references (Exhibit 4.29 for 2022, 4.27 for 2023, 4.36 for 2024) that are not verified against the ground truth, which only mentions the Thirty-Sixth Supplemental Indenture dated April 14, 2015. While these exhibit citations may be accurate, they cannot be confirmed as correct from the provided ground truth. (2) The ground truth explicitly mentions the 'Thirty-Sixth Supplemental Indenture' and the specific date 'April 14, 2015,' which the LLM omits. This is a minor omission of contextual detail. (3) The LLM's reasoning about the bond's role is sound and semantically equivalent to the ground truth's conclusion about 'ongoing reliance' and 'stable and strategic source of funding.' The LLM successfully addresses the multi-part question regarding what the repeated reference suggests about reliance and how it reflects the bond's role in capital structure. The answer is well-reasoned and factually accurate on the core claims, though it lacks some specific documentary details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 471,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose from $51.4 billion at year‑end 2022 (‑51,354 million) to $60.4 billion at year‑end 2023 (‑60,429 million) and further to $71.4 billion at year‑end 2024 (‑71,431 million)【page_72】【page_73】【page_70】. The steady increase in this contra‑equity account shows the company is progressively using cash to repurchase shares, indicating a capital‑allocation focus on returning value to shareholders and boosting per‑share metrics.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The original answer contains an internal contradiction/error stating '$(51,354) million in 2023 to $(60,429) million in 2023' (same year listed twice), which should read 2022 to 2023. However, the LLM correctly interprets this as 2022→2023→2024 progression. (2) QUANTITATIVE ACCURACY ISSUE - The LLM states the 2022 figure as '$51.4 billion' but the ground truth shows '$(51,354) million' which equals $51.354 billion, not $51.4 billion when properly rounded. More critically, the LLM presents these as positive values ('rose from $51.4 billion') when the parentheses notation $(51,354) indicates these are negative/contra-equity accounts. The LLM does acknowledge 'contra-equity account' in interpretation but presents the numbers as positive values in the opening statement, creating confusion. (3) MULTI-HOP REASONING - The LLM correctly synthesizes the three-year trend and appropriately interprets it as indicating a capital allocation strategy focused on share buybacks and shareholder returns. The reasoning about per-share metrics is sound. (4) ENTITY ACCURACY - Mastercard correctly identified, years correct (2022-2024), treasury stock metric correctly identified. (5) SEMANTIC ISSUES - The phrase 'Class A treasury‑stock balance rose from $51.4 billion' is misleading because treasury stock is a contra-equity account (negative), so saying it 'rose' in absolute terms while being negative creates ambiguity. The ground truth's use of parentheses $(51,354) million clearly indicates negative values. The LLM should have been clearer about the sign convention. (6) CALCULATION VERIFICATION - The progression $51.354B → $60.429B → $71.431B is arithmetically correct and shows consistent increases of approximately $9B per year, which the LLM correctly interprets as a trend. Overall, the LLM provides reasonable interpretation of the capital allocation strategy but has presentation issues with the sign convention of treasury stock and minor rounding discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 546,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 2022 10‑K already warned that its Safety & Productivity Solutions business “may be adversely impacted by reduced investments in process automation, safety monitoring, and plant capacity utilization initiatives… and adverse industry economic conditions”【page_32】. The same language re‑appears unchanged in the 2023 filing for the same segment【page_31】, and after the 2024 realignment the risk is carried forward under the newly‑named Industrial Automation segment with identical wording about “reduced investments in process automation… and plant capacity utilization initiatives… and adverse industry economic conditions”【page_30】. The persistence of this risk across three successive years shows that macro‑economic pressures—slower capital spending on automation and weaker plant utilization—have remained a consistent headwind for Honeywell’s industrial customers, reflecting broader strain in the industrial sector throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the consistent risk language across all three years regarding 'reduced investments in process automation' and 'plant capacity utilization' - this matches the ground truth's core finding. (2) Accurately notes the segment name change from 'Safety & Productivity Solutions' to 'Industrial Automation' in 2024, showing attention to structural changes in the filings. (3) Properly synthesizes the multi-hop reasoning: traces the same risk language persistence across three successive filings and correctly interprets this as evidence of sustained macroeconomic headwinds. (4) Provides specific page references (page_32, page_31, page_30) that ground the claims in actual filing locations. (5) The conclusion about 'consistent headwind' and 'broader strain in the industrial sector' aligns semantically with the ground truth's assessment of 'persistent and potentially worsening macroeconomic headwind.' MINOR CONSIDERATIONS: (1) The LLM answer emphasizes the 'unchanged' or 'identical' nature of the language more explicitly than the ground truth, which notes the language 'remained largely consistent' in 2023 but with 'sharper focus' on broader macroeconomic volatility in 2024. The ground truth suggests some evolution in emphasis/context, while the LLM presents it as more static. However, this is a subtle distinction and both interpretations are defensible from the source material. (2) The LLM answer doesn't explicitly mention the 2024 'sharper focus on broader macroeconomic volatility, including geopolitical instability and trade policy shifts' that the ground truth highlights, though it does reference 'macro-economic pressures' generally. This represents a minor omission of contextual nuance rather than factual error. QUANTITATIVE ACCURACY: No numerical claims requiring verification; all dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: Excellent - correctly synthesizes information across three separate 10-K filings and identifies the pattern of risk persistence as evidence of sector-wide strain. The logical chain is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 597,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "In the 2022 filing (and reiterated in 2023) Cyramza was positioned as a multi‑indication oncology asset – a second‑line therapy for advanced gastric/gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and a first‑line option for EGFR‑mutated metastatic NSCLC【page_5】【page_6】. The 2024 filing adds a detailed IP timeline, showing compound patents that protect Cyramza in the U.S. and Japan until 2026 and in Europe until 2028, biologics data protection in the U.S. through 2026, and data‑protection expiries in Europe (2024) and Japan (2023)【page_11】—signaling that while its therapeutic scope remains unchanged, the product is moving into the later stage of its lifecycle as exclusivity windows begin to close.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All dates and patent expiration timelines are correct - data protection expiring in Japan in 2023, Europe in 2024, compound patents extending to 2026 (U.S./Japan) and 2028 (Europe), and biologics data protection through 2026 in the U.S. These match the ground truth precisely. COMPLETENESS: The answer addresses both major components of the question: (1) therapeutic indications evolution and (2) IP protection timeline evolution. It correctly notes that therapeutic indications remained unchanged from 2022-2024 while IP protection shifted significantly. ENTITY ACCURACY: Cyramza is correctly identified with all four oncology indications mentioned (gastric/GEJ adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, hepatocellular carcinoma), plus the first-line EGFR-mutated NSCLC indication. All geographic markets (U.S., Europe, Japan) are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years (2022-2024) and multiple data sources (therapeutic indications from 2022-2023 filings, IP timeline from 2024 filing), correctly identifying the paradox of unchanged therapeutic scope but narrowing exclusivity windows. The conclusion about 'later stage of lifecycle' appropriately synthesizes this evolution. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (mentioning first-line EGFR-mutated NSCLC and biologics data protection specifics), but these additions are accurate and enhance rather than detract from the answer. The semantic meaning is fully preserved and the factual content is comprehensive and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 473,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities (a Level 3 item) were measured at only **$5 million of fair value at year‑end 2022**【page_215】.  By the next year the fair‑value jumped to **$58 million** and the valuation continued to use a discounted‑cash‑flow model with **swap rates as the key unobservable input**, now ranging **3 %–5 %** (weighted‑average ≈ 4 %)【page_217】.  In 2024 the fair‑value rose further to **$69 million**, still based on discounted cash‑flows and swap‑rate inputs, but the range tightened to a single **4 %** rate (weighted‑average 4 %)【page_217】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Multiple significant number errors: LLM states 2022 fair value was $5 million, but ground truth clearly states $19 million (error of $14M or 74% understatement). LLM states 2024 fair value was $69 million, but ground truth states it remained at $58 million (error of $11M or 19% overstatement). These are material discrepancies in core financial metrics. (2) TREND ANALYSIS - LLM incorrectly characterizes the 2024 movement as 'rose further to $69 million' when ground truth shows stabilization at $58 million (no increase from 2023). This fundamentally misrepresents the evolution pattern. (3) UNOBSERVABLE INPUTS - LLM correctly identifies swap rates (3-5%, weighted 4%) for 2023-2024, but fails to mention the critical 2022 detail about net losses of $20 million held in portfolio and default rates (53-163%) which were part of the 2023 valuation methodology. (4) METHODOLOGY - While LLM correctly notes discounted cash flow approach and swap rates as key inputs, it misses the broader context of default rates as unobservable inputs in 2023. (5) MULTI-HOP SYNTHESIS - The answer fails to properly synthesize the complete evolution across all three years with accurate numbers. The 2024 'tightening' to single 4% rate is mentioned but the core fair value number is wrong. Ground truth shows: 2022=$19M, 2023=$58M, 2024=$58M (stabilization). LLM shows: 2022=$5M, 2023=$58M, 2024=$69M (incorrect trajectory). This represents a fundamental failure in multi-hop financial data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 424,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "Qualcomm’s charitable‑match program kept “thousands” of employees engaged each year, but its reach narrowed – it supported > 1,500 charitable organizations in fiscal 2022 and > 1,300 in fiscal 2024【page_16】. That steady employee participation and the program’s impact are part of the broader human‑capital agenda that the Board’s HR and Compensation Committee ties to executive pay, using progress on such initiatives as a non‑financial performance modifier (a 0.9‑to‑1.1 × multiplier) for executive bonuses in fiscal 2022‑2024【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - 1,500+ organizations in fiscal 2022, 1,300+ in fiscal 2024, and the 0.9-1.1 multiplier range for executive bonuses are all accurate. The answer correctly identifies the directional change (narrowing from 1,500 to 1,300 organizations). COMPLETENESS: The answer addresses all major components of the multi-part question: (1) employee participation evolution (thousands in both years), (2) supported organizations change (1,500+ to 1,300+), and (3) alignment with human capital goals tied to executive compensation (0.9-1.1 modifier). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - connecting the charitable match program data with executive compensation structures and the HR/Compensation Committee's role. The logic is sound: sustained participation + declining org count = alignment with broader strategy despite minor decline. ENTITY ACCURACY: Correctly identifies Qualcomm, fiscal years 2022 and 2024, the charitable match program, and the HR and Compensation Committee. MINOR GAPS: The answer could have been slightly more explicit about the 2025 diversity/equity/inclusion goals mentioned in the ground truth, though this is a minor omission that doesn't affect the core answer's accuracy. The phrase 'reach narrowed' effectively conveys the decline in supported organizations. SEMANTIC EQUIVALENCE: The LLM's phrasing ('kept thousands engaged,' 'reach narrowed') conveys the same meaning as the ground truth while using slightly different language. The citation references (page_16, page_17) add credibility. Overall, this is a high-quality answer that correctly synthesizes complex multi-hop information with accurate numbers and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 500,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 10‑K, Acrobat is presented as the flagship PDF solution of Adobe Document Cloud, with emphasis on its web and mobile experiences, AI‑driven features such as Liquid Mode, deep integration with Adobe Sign and APIs, and a targeted vertical‑market push (see 2022 pages 6‑7). The 2023 filing keeps Acrobat at the core of Document Cloud but now lists it alongside newer services like Adobe Express and Firefly and reiterates integration with Adobe Sign, expanded task‑based actions, AI (Sensei) enhancements, and strategic partnerships (see 2023 pages 4‑5). The 2024 excerpt (pages 94‑98) contains no new Acrobat‑specific announcements, implying that Acrobat remains a core Document Cloud component but without additional product‑level enhancements disclosed in the provided sections.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant issues when compared to the ground truth:\n\n1. FACTUAL ACCURACY ISSUES:\n   - The LLM mentions 'Liquid Mode' as an AI-driven feature in 2022, but the ground truth does not reference this specific feature in 2022\n   - The LLM cites specific page numbers (2022 pages 6-7, 2023 pages 4-5, 2024 pages 94-98) without verification that these are accurate to the actual filings\n   - The LLM states the 2024 excerpt 'contains no new Acrobat-specific announcements,' which contradicts the ground truth that explicitly mentions the introduction of 'Acrobat AI Assistant' as a registered trademark in 2024\n\n2. MISSING KEY INFORMATION:\n   - The LLM completely fails to mention the 'Acrobat AI Assistant' trademark introduction in 2024, which is a critical element of the ground truth's narrative about the evolution\n   - The ground truth emphasizes the strategic shift toward 'AI-enhanced productivity platform' by 2024, but the LLM dismisses 2024 as having 'no new Acrobat-specific announcements'\n   - The LLM does not adequately capture the progression from 'document standard' to 'AI-enhanced productivity platform' that the ground truth emphasizes\n\n3. INCOMPLETE SYNTHESIS:\n   - While the LLM attempts to trace evolution across years, it fails to synthesize the key narrative arc: the shift from document-centric positioning (2022) → AI-powered innovation integration (2023) → formal AI branding/trademark (2024)\n   - The LLM's characterization of 2024 as having no new announcements directly contradicts the ground truth's assertion of a 'strategic shift toward embedding intelligent automation'\n\n4. PARTIAL CREDIT:\n   - The LLM correctly identifies Acrobat's role within Document Cloud across all three years\n   - The LLM correctly mentions integration with Adobe Sign\n   - The LLM correctly references AI enhancements and mentions Adobe Express and Firefly in 2023\n   - The LLM's attempt to cite specific page numbers shows effort at precision, though accuracy cannot be verified\n\n5. STRUCTURAL ISSUES:\n   - The LLM's conclusion that 2024 shows 'no additional product-level enhancements' is factually incorrect based on the ground truth\n   - This represents a fundamental misunderstanding or misreading of the 2024 filing content\n\nThe answer demonstrates partial understanding of the evolution but fails on the most critical element: the 2024 introduction of Acrobat AI Assistant, which is central to the ground truth's narrative about Adobe's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 671,
        "total_tokens": 2179
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly earned $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab), and paid AbCellera royalty fees – recorded as cost of sales – equal to a mid‑teens‑to‑mid‑twenties percentage of those sales 【page_74】. By contrast, the company reported no sales of these antibodies in 2023 or 2024, so net product revenue fell to $0 and no royalty payments were incurred in those years 【page_74】; the royalty rate remains described as mid‑teens to mid‑twenties on any worldwide net sales 【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All quantitative data is correct: $2.02 billion in 2022 net product revenue, zero sales in 2023 and 2024, mid-teens to mid-twenties royalty percentage range. (2) The temporal progression is accurately captured across all three years (2022-2024). (3) Multi-hop synthesis is sound: the answer correctly connects revenue figures to royalty obligations and traces the evolution across the time period. (4) Entity identification is precise: correctly identifies LLY, AbCellera, bamlanivimab, bebtelovimab, and the royalty structure. (5) The answer properly notes that royalties were recorded as cost of sales and explains the logical consequence that zero sales in 2023-2024 resulted in zero royalty payments. (6) The characterization of the trend as a 'sharp decline' and 'wind-down' aligns with the ground truth's interpretation. MINOR CONSIDERATIONS: The LLM answer is slightly more technical/precise in noting royalties were 'recorded as cost of sales,' which adds helpful accounting context not explicitly in the ground truth statement, but this is additive rather than contradictory. The answer maintains semantic equivalence with the ground truth while providing clear documentation of sources (page references). No calculation errors, no missing data points, and the reasoning chain is logically sound throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 409,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s use of the modified‑coinsurance structure has stayed essentially flat – the company reinsured ≈ 59 % of the closed block in 2022 (59.25 %【page 214】), 2023 (59 %【page 227】) and again in 2024 (59 %【page 204】). This steady‑state level shows that MetLife deliberately maintains a consistent, long‑term risk‑transfer approach, off‑loading roughly three‑fifths of the closed‑block exposure while retaining the balance to manage capital and diversify risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three percentages are correct - 59.25% (2022), 59% (2023), and 59% (2024) - matching the ground truth exactly. The characterization of this as 'approximately 59%' and 'roughly three-fifths' is semantically accurate and appropriate given the minor variation from 59.25% to 59%. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, and the closed block is correctly referenced. All three years (2022-2024) are included. MULTI-HOP REASONING: The answer successfully synthesizes information across three years to identify the consistency pattern and correctly interprets this as evidence of strategic continuity. The logic that 'steady-state level shows MetLife deliberately maintains a consistent, long-term risk-transfer approach' aligns with the ground truth's conclusion about 'strategic continuity.' COMPLETENESS: The answer addresses both parts of the question - how the reliance evolved (showing consistency) and what this reveals about long-term strategy (intentional preservation of risk-sharing structure). MINOR DIFFERENCES: The LLM adds interpretive detail about 'off-loading roughly three-fifths of the closed-block exposure while retaining the balance to manage capital and diversify risk,' which goes slightly beyond the ground truth but is logically sound and contextually appropriate. The inclusion of page references adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 426,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s multi‑layered security model still rests on internal controls, third‑party assessments and public‑private partnerships, but the 2024 filing adds an explicit focus on “working with experts across the organization … through other sources such as public‑private partnerships … including threats and incidents associated with the use of services provided by third‑party providers”【page_11】.  At the same time, its real‑time account‑based payments infrastructure has expanded from operating or being implemented in 12 of the world’s top‑GDP markets as of Dec 31 2021 (2022 filing) to 13 markets as of Dec 31 2023 (2024 filing)【page_11】.  This evolution shows a cybersecurity strategy that leans more heavily on external collaboration and continuous monitoring while scaling real‑time payment capabilities to protect an increasingly fast and interconnected ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Mastercard's security evolution but has some notable gaps and inconsistencies compared to the ground truth:\n\nSTRENGTHS:\n1. Correctly identifies the core multi-layered security approach with third-party assessments and public-private partnerships\n2. Accurately cites the expansion of real-time payments infrastructure from 12 markets (2022 filing, as of Dec 31 2021) to 13 markets (2024 filing, as of Dec 31 2023)\n3. Properly synthesizes the connection between scaling real-time payment capabilities and enhanced cybersecurity through third-party collaboration\n4. Appropriately quotes the 2024 filing language about working with third-party providers\n5. Correctly identifies the strategic alignment between external collaboration and payment infrastructure scaling\n\nWEAKNESSES:\n1. INCOMPLETE TEMPORAL COVERAGE: The answer only explicitly addresses 2022 and 2024 filings, missing the 2023 filing entirely. The ground truth specifically notes that 2023 showed \"more structured integration of third-party risk management\" and expansion to 13 markets - the LLM conflates this 2023 data point with the 2024 filing\n2. MISSING 2024 SPECIFICITY: The ground truth notes that in 2024, Mastercard operated real-time payments in \"several countries globally\" (a less specific metric than previous years), which the LLM does not mention. This is an important evolution showing a shift in how the company reports this metric\n3. INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes the progression across all three years (2022→2023→2024) showing increasing specificity and integration. The LLM only compares 2022 to 2024, missing the intermediate step\n4. MISSING CONTEXT: The ground truth notes that 2023 explicitly mentioned \"threats associated with outsourced services,\" showing a more structured approach to third-party risk management - this nuance is absent from the LLM answer\n\nQUANTITATIVE ACCURACY: The numbers cited (12 markets in 2022, 13 markets in 2024) are correct, though the LLM's attribution of the 13 markets figure to the \"2024 filing\" is technically correct but obscures that this represents data as of Dec 31 2023. The quantitative elements are accurate (8/10).\n\nQUALITATIVE ACCURACY: The reasoning about strategic alignment is sound, but the analysis is incomplete due to missing the 2023 intermediate step and the shift in how 2024 reports the metric (7/10).\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core components but with incomplete temporal coverage of the 2022-2024 evolution period (7/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 689,
        "total_tokens": 2249
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "LLY’s defined‑benefit pension plan held roughly $4.0 billion in equity‑like private‑alternative investments in 2022, rose modestly to about $4.09 billion in 2023, and then fell to roughly $3.93 billion in 2024 (2022 $4,014.1 M; 2023 $4,093.7 M; 2024 $3,931.5 M)【page_99】【page_100】【page_99】.  Its retiree‑health plan equity‑like holdings grew each year from about $332 million in 2022 to $346 million in 2024【page_99】.  The pattern shows Eli Lilly keeping a sizable, long‑term exposure to illiquid private‑equity‑style assets—using them for diversification and higher‑return goals—while modestly adjusting the level of that exposure as market conditions and portfolio strategy evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. QUANTITATIVE ANALYSIS: Ground truth shows: 2022: $2,844.7M → 2023: $4,014.1M → 2024: $4,093.7M (upward trend). LLM reports: 2022: $4,014.1M → 2023: $4,093.7M → 2024: $3,931.5M (downward trend). The LLM has systematically misaligned the years with the values - it appears to have shifted the data by one year and introduced an entirely different 2024 figure ($3,931.5M not in ground truth). This is a catastrophic error that reverses the entire narrative: ground truth shows growth from $2.8B to $4.1B; LLM shows decline from $4.0B to $3.9B. MULTI-HOP REASONING: The LLM correctly identifies that the question requires analyzing pension plan equity-like holdings across three years and synthesizing a trend interpretation. However, the foundation is destroyed by incorrect numbers. The LLM also introduces retiree health plan data ($332M to $346M) which, while potentially accurate, was not part of the ground truth answer and may represent a different asset category. ENTITY ACCURACY: Correctly identifies LLY/Eli Lilly and the asset class (equity-like private alternatives). SEMANTIC ISSUES: The LLM's conclusion about 'modest adjustments' and 'keeping sizable exposure' is reasonable language, but it's applied to completely wrong data. The ground truth explicitly states an 'upward trajectory' indicating 'growing confidence' - the opposite of what the LLM's numbers would suggest. CONCLUSION: While the LLM demonstrates understanding of the question structure and provides reasonable interpretive language, the numerical foundation is entirely incorrect, making the answer fundamentally unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 474,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "In FY 2022 Cascade was listed as a Home‑Care (dish‑care) brand within the Fabric & Home Care segment, which made up 35 % of P&G’s net sales【page_19】. By FY 2024 Cascade is still positioned as a Home‑Care brand in the same segment, and the Fabric & Home Care segment’s share of net sales has edged up to roughly 36 %【page_18】—so its categorization stayed the same while its relative contribution to total sales grew modestly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and entities. Quantitative verification: (1) FY 2022 Fabric & Home Care segment at 35% of net sales - CORRECT; (2) FY 2024 segment at 36% of net sales - CORRECT; (3) Cascade categorization as Home-Care (dish-care) brand - CORRECT and more specific than ground truth. The answer properly synthesizes the multi-hop information: tracking Cascade's positioning across three years (2022-2024), confirming its segment placement remained constant, and noting the modest increase in segment contribution (35% to 36%). The LLM provides slightly more granular detail by specifying Cascade as a 'dish-care' brand, which adds helpful context. Minor observation: The ground truth mentions 2023 data (36% contribution), but the LLM answer jumps from 2022 to 2024, omitting the intermediate year. However, this omission doesn't contradict the ground truth since the LLM correctly states the segment 'edged up to roughly 36%' by 2024, which is consistent with the ground truth's statement that it reached 36% in 2023 and maintained it in 2024. The reasoning is sound: product categorization remained stable while relative contribution grew modestly. The answer directly addresses all parts of the question regarding product categorization evolution and relative contribution changes. Citation references (page_19, page_18) add credibility, though they cannot be independently verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 409,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "In 2022 Lowe’s relied on a basic vendor‑code‑of‑conduct framework and a wood‑sourcing policy that required all wood sold to come from well‑managed, non‑endangered forests while using a general supplier‑monitoring system tied to its human‑rights, conflict‑minerals and environmental standards (2022 p.10). By 2023 the company introduced a risk‑based wood‑sourcing approach—adding country‑specific risk levels, stronger monitoring practices and a new forestry‑grievance process (2023 p.9)—and in 2024 it further hardened that framework with an even more robust risk‑based model, refined monitoring and an expanded grievance mechanism (2024 p.9). Across the same period Lowe’s scaled its sustainability investment, spending over $550 million on LED, HVAC and building‑management upgrades in 2022, $400 million on similar projects plus a large rooftop‑solar rollout in 2023, and $300 million in 2024 focused on energy‑efficiency, renewable‑energy procurement and supplier emissions reporting (2022 p.10; 2023 p.10; 2024 p.10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Lowe's supplier sustainability and wood sourcing practices across 2022-2024, with accurate qualitative descriptions of policy enhancements (Vendor Code of Conduct, risk-based approach, forestry grievance process, country-specific risk levels). The multi-hop reasoning is sound in synthesizing information across three years and connecting policy framework changes to investment strategy. However, there are significant quantitative accuracy issues: (1) The ground truth states $550 million in environmental facility upgrades in 2022, which the LLM correctly cites. (2) The LLM introduces specific investment figures for 2023 ($400 million) and 2024 ($300 million) that are NOT mentioned in the ground truth answer. The ground truth only mentions the $550 million for 2022 and the $50 million Gable Grants program for skilled trades (a different category). (3) The LLM provides detailed page citations (2022 p.10, 2023 p.9, etc.) that cannot be verified against the ground truth and appear to be fabricated specificity. (4) The LLM's breakdown of 2023-2024 investments into specific categories (LED, HVAC, rooftop solar, energy efficiency, renewable energy procurement) goes beyond what the ground truth provides. The answer demonstrates good understanding of the policy evolution but fails on quantitative accuracy by introducing unverified financial figures and creating false specificity through page citations. The core narrative about policy enhancements is correct, but the investment numbers for 2023-2024 represent a significant factual error that undermines overall credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 448,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s risk‑factor disclosures for all three units repeatedly warned that “changes in the competitive landscape, including new market entrants and new technologies, may lead to product commoditization” and could erode market share, pricing power and margins in 2022 (see page_30) → the same language re‑appeared unchanged for Safety & Productivity Solutions, Honeywell Building Technologies and Industrial Automation in the 2023 filing (see page_30 and page_31) → and after the 2024 realignment the segment was renamed Building Automation, but the competitive‑landscape and commoditization warning remained identical (see page_30). This continuity—and the explicit emphasis on new entrants and technology‑driven commoditization each year—signals that market pressures have persisted and are viewed as increasingly salient risks across Honeywell’s core businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative about Honeywell's evolving competitive landscape risks across multiple business units from 2022-2024, and correctly identifies the key themes of new entrants, technology-driven commoditization, and margin pressure. However, there are significant issues with the execution:\n\n(1) CRITICAL FACTUAL DISCREPANCY: The LLM claims the same language appeared \"unchanged\" across 2022, 2023, and 2024 filings, and that the risk was present in all three units in 2023. The ground truth explicitly states a PROGRESSION where the risk appeared in different units in different years: Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024). The LLM's claim of identical language across all three units in 2023 contradicts the ground truth's clear temporal progression.\n\n(2) ENTITY/TIMELINE ACCURACY: The ground truth emphasizes a 3-year EVOLUTION showing the risk spreading across divisions sequentially. The LLM suggests the risks were present in all units simultaneously in 2023, which misrepresents the progression. The ground truth's key insight is that commoditization risks became \"more systemic rather than isolated\" over time—implying they started isolated and spread. The LLM's framing of \"continuity\" and \"unchanged language\" obscures this important progression.\n\n(3) PAGE REFERENCES: The LLM cites specific page numbers (page_30, page_31) but provides no verification that these citations are accurate or that they support the claimed \"unchanged\" language across years. These citations cannot be verified against the ground truth.\n\n(4) REASONING QUALITY: While the LLM correctly identifies the themes (new entrants, technology, commoditization, margin pressure), it fails to capture the sequential expansion across business units that is central to the ground truth's interpretation. The ground truth's insight about \"broadening market pressures\" is about the SPREAD of the risk across divisions, not just its persistence.\n\n(5) SEMANTIC ISSUES: The LLM's emphasis on \"continuity\" and \"unchanged language\" actually contradicts the ground truth's emphasis on \"progression\" and \"expansion.\" These are fundamentally different narratives about the same risk.\n\nThe answer demonstrates partial understanding but contains a material factual error regarding the timeline and distribution of risk disclosures across business units.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 651,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm described the digital‑cockpit as a cornerstone of the automotive transformation, noting that its high‑performance, low‑power mobile‑derived compute, connectivity and OTA‑update technologies would enable software‑defined vehicles, advanced driver‑assist and in‑car personalization (2022 10‑K p. 8). By 2024 the company’s segment disclosures show that automotive revenue—including digital‑cockpit products—had grown from $1.5 bn in 2022 to $2.9 bn in 2024 within the QCT segment, and that this revenue is recognized at the point of sale for hardware and as ongoing royalties for system‑software, indicating a much larger, revenue‑driving foothold in the digital‑cockpit market (2023 10‑K p. 73; 2024 10‑K p. 82).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant gaps and some unverified claims. STRENGTHS: (1) Correctly identifies the progression from 2022 strategic positioning to 2024 operational integration; (2) Accurately cites that digital cockpit products were recognized as part of automotive revenue by 2023-2024; (3) Properly references QCT segment reporting and revenue recognition methods (point of sale for hardware, royalties for software); (4) Appropriately contextualizes the evolution from vision to monetization. WEAKNESSES: (1) CRITICAL - The LLM provides specific revenue figures ($1.5bn in 2022, $2.9bn in 2024) that cannot be verified against the ground truth, which does not provide these specific numbers. These appear to be fabricated or hallucinated figures; (2) MISSING KEY DETAIL - The ground truth emphasizes the 70% analyst projection for embedded cellular connectivity in 2028, which is a crucial quantitative element of Qualcomm's 2022 positioning. The LLM omits this specific metric; (3) INCOMPLETE SYNTHESIS - The ground truth explicitly mentions the 2023 transition year as a distinct milestone where digital cockpit products were 'explicitly recognized' alongside connectivity and ADAS/AD. The LLM conflates 2023-2024 without clearly delineating the 2023 transition; (4) PAGE CITATIONS - While the LLM provides specific page references (2022 10-K p. 8; 2023 10-K p. 73; 2024 10-K p. 82), these cannot be independently verified and may be inaccurate. QUANTITATIVE ACCURACY ISSUE: The revenue figures provided ($1.5bn, $2.9bn) are presented as fact but lack ground truth support. This is a significant concern for a financial question requiring precision. The answer demonstrates reasonable qualitative understanding of the strategic evolution but fails on quantitative rigor and completeness of key metrics (the 70% projection). The multi-hop reasoning is sound in structure but incomplete in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 525,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s 2022 filing (see pages 95‑99) contains no specific discussion of Frame.io, indicating it was not yet a highlighted part of Adobe’s product suite. In the 2023 10‑K (page 12) Frame.io is described as a cloud‑native collaboration platform that supports still images, design files and PDFs, is directly integrated only with Premiere Pro and After Effects, and offers Camera‑to‑Cloud upload of footage. By the 2024 filing (page 12) the service had broadened to cover full‑scale video workflows (casting, location scouting, marketing‑campaign review) while still supporting still images, design files and PDFs, added integrations with Photoshop, Lightroom and Workfront, and was made available through Adobe GenStudio to deliver enterprise‑grade, at‑scale content‑production capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Frame.io's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies that Frame.io was not highlighted in 2022 filings, aligning with the ground truth that it was merely listed as a trademarked product; (2) Accurately describes 2023 capabilities including cloud-native platform status, support for video/still images/design files/PDFs, integration with Premiere Pro and After Effects, and Camera-to-Cloud functionality; (3) Precisely captures 2024 expansion including new use cases (casting, location scouting, marketing campaign review), additional integrations (Photoshop, Lightroom, Workfront), and inclusion in Adobe GenStudio for enterprise capabilities; (4) Correctly synthesizes the multi-hop progression across three years showing functional expansion and integration breadth; (5) Provides specific filing references (pages 95-99 for 2022, page 12 for 2023 and 2024) demonstrating source verification. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'full-scale video workflows' vs 'expanded further with support beyond post-production workflows') but conveys semantically equivalent information. The ground truth mentions 'real-time feedback' as a 2023 capability, which the LLM answer doesn't explicitly state, though this is a minor omission that doesn't affect the core narrative. All dates, product names, integration partners, and capability descriptions are factually correct. The multi-hop reasoning successfully synthesizes information across three fiscal years and multiple product dimensions (supported media types, integrations, enterprise capabilities) as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 470,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "- The cash dividend paid on each Class A share rose each year – $2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024【page_97】【page_99】【page_92】.  \n- The voting entitlement for Class A stock remained unchanged at one vote per share throughout the period, as shown in the capital‑stock tables for 2023 and 2024【page_99】【page_92】.  \n\nThis three‑year pattern of steadily higher dividends combined with a constant “one‑vote‑per‑share” structure signals that Mastercard is increasing cash returns to shareholders while preserving a stable governance framework and unchanged voting power for Class A owners.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dividend per-share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth and appear to be fabricated. The ground truth explicitly states that MA's A Class shares 'consistently maintained' dividend rights with 'no changes to these rights in any of the years.' The LLM's claim of 'steadily higher dividends' directly contradicts the ground truth assertion of stability and no changes. WHAT WAS CORRECT: (1) The voting rights component is accurate - 'one vote per share' remained constant throughout 2022-2024, matching ground truth. (2) The general framing that voting structure remained stable is correct. WHAT WAS INCORRECT: (1) The dividend narrative is fundamentally wrong - the LLM claims dividends increased year-over-year with specific dollar amounts, but ground truth indicates dividend rights remained unchanged with no evolution. (2) The LLM conflates 'dividend rights' (a structural right) with 'dividend amounts paid' (an operational decision), which are different concepts. The question asks about 'dividend and voting rights...evolve,' referring to the structural rights, not the payment amounts. (3) The conclusion about 'steadily higher dividends' is unsupported by and contradicts the ground truth. MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year comparison. It appears to have introduced external data (specific dividend amounts) rather than relying on the actual filing disclosures about rights structure. The ground truth indicates a 3-year trend of STABILITY, not change. QUANTITATIVE ACCURACY: The specific dividend figures ($2.04, $2.37, $2.74) cannot be verified against ground truth and appear fabricated. Even if these numbers exist in filings, they represent dividend payments, not the evolution of dividend rights, which is what the question asks about. The answer demonstrates a fundamental misunderstanding of what 'dividend rights' means in a governance context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 538,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell flags the Safety & Productivity Solutions business as “adversely impacted … by fluctuations in retail markets” in its risk‑factor disclosures for each year (2022‑24)【page_30†L19-L22】【page_31†L13-L16】【page_32†L13-L16】.  In FY 2022 the segment still generated $1.08 bn of profit on $6.9 bn of sales despite a 12 % sales dip, showing it could absorb some retail‑market headwinds【page_29†L1-L7】.  In FY 2023 the same segment saw sales plunge 21 % to $5.5 bn and profit fall 17 % to $901 m, driven by weaker demand for Warehouse‑and‑Workflow Solutions and Productivity Solutions & Services—direct evidence of the retail‑market exposure【page_30†L1-L9】【page_30†L10-L13】.  By FY 2024 the segment rebounded, with sales up 3 % to $6.4 bn and profit rising $35 m (2 %) to $1.52 bn, indicating a modest recovery but confirming that performance still swings with consumer‑demand volatility【page_28†L1-L7】【page_28†L9-L12】.  Together, the trend shows the Safety & Productivity Solutions unit is highly sensitive to retail‑market fluctuations—sharp profit and sales declines in a down‑turn and only partial recovery when demand steadies.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Honeywell's Safety and Productivity Solutions segment was adversely impacted by retail market fluctuations across 2022-2024, matching the ground truth's core finding. The answer appropriately synthesizes the multi-hop information showing consistent risk disclosure and demonstrates understanding that the segment's performance swings with consumer demand volatility. The qualitative reasoning about the segment's sensitivity to retail markets is sound and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific financial figures that cannot be verified against the ground truth and appear problematic: (1) FY2022 profit of $1.08bn and sales of $6.9bn with a 12% sales dip - these specific numbers are not confirmed in the ground truth; (2) FY2023 sales of $5.5bn and profit of $901m with stated 21% and 17% declines - these figures are not in the ground truth; (3) FY2024 sales of $6.4bn and profit of $1.52bn with 3% and 2% growth - not confirmed. The ground truth does NOT provide these specific financial metrics, only noting that the segment was \"adversely impacted\" and discussing risk factors. The LLM appears to have fabricated or hallucinated specific numbers with page citations that cannot be verified.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year trend and connects it to the question about vulnerability to consumer demand volatility. However, the synthesis is built on unverified financial data, which undermines the credibility of the analysis.\n\nENTITY ACCURACY: The LLM correctly identifies the segment name changes (Safety & Productivity Solutions to Industrial Automation) but the ground truth is clearer about this transition. The LLM mentions specific product lines (Warehouse-and-Workflow Solutions, Productivity Solutions & Services) that are not mentioned in the ground truth.\n\nCRITICAL ISSUE: The LLM provides highly specific financial metrics with page citations that cannot be confirmed against the ground truth. This is a significant problem because the evaluation criteria emphasize strict accuracy on numbers and calculations. While the qualitative conclusions align with the ground truth, the quantitative foundation is questionable and potentially fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 613,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "In the 2022 filing the Olumiant collaboration still provided Incyte with tier‑ed double‑digit royalties up to 20 % of worldwide net sales and, after the 2020 amendment, an extra low‑teens royalty on COVID‑19 sales (LLY_10k_2022.pdf page 72).  That year also showed $260 million and $210 million of previously capitalized milestone payments and gave Incyte the right to earn up to $100 million each in success‑based regulatory and sales‑based milestones (LLY_10k_2022.pdf page 72).  By the 2023 and 2024 reports the royalty terms were unchanged, but any new milestone payments were immaterial and the company only highlighted up to $100 million of potential sales‑based milestones (LLY_10k_2023.pdf page 72; LLY_10k_2024.pdf page 72), while the COVID‑19 indication and its low‑teens royalty remained in place.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of SEC filings. STRENGTHS: (1) All key financial figures are correct: $100 million regulatory milestones, $100 million sales-based milestones, up to 20% royalty rates, and low-teens COVID-19 royalty are all accurately stated. (2) The $260 million and $210 million previously capitalized milestone payments are correctly cited from 2022 filings. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2022 (milestone-heavy with specific contingent payments) through 2023-2024 (shift to royalty-focused with immaterial new milestones). (4) Entity identification is accurate (LLY, Incyte, Olumiant, COVID-19 indication). (5) The document citations (page 72 references) add credibility. (6) The semantic meaning aligns well with the ground truth's characterization of the shift from 'milestone-driven obligations to a more stable royalty-based payment model.' MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the 2023 transition year as a bridge between the 2022 and 2024 states, though this is a minor omission. (2) The phrase 'any new milestone payments were immaterial' in 2023-2024 is accurate but could have been more explicitly connected to the ground truth's observation that 'most contingent payments had likely been triggered or expired.' (3) The answer focuses heavily on 2022 details before discussing the evolution, which is appropriate but slightly shifts emphasis compared to the ground truth's more balanced treatment of all three years. CALCULATION VERIFICATION: No calculations are required in this answer, and all cited figures are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the temporal evolution of the agreement terms. The logic connecting milestone amortization in 2023 to the shift toward royalty payments is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 541,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In the 2022 Form 10‑K the Baby, Feminine & Family Care segment was broken out into three sub‑categories—baby care, feminine care and family care—and the major‑brand list included Luvs, Pampers, Always, Always Discreet, Tampax, Bounty, Charmin and Puffs, with the narrative noting that Always (alongside Tampax) led the feminine‑care market but was secondary to Pampers in the overall segment (PG 2022 10‑K, page 19). By the 2023 and 2024 filings the segment was re‑defined to focus only on feminine‑care (adult‑incontinence and menstrual care) and family‑care, dropping the baby‑care sub‑category, and the major‑brand list now spotlights Always, Always Discreet and Tampax as the flagship brands, underscoring Always’s elevated prominence in menstrual care (PG 2023 10‑K, page 18; PG 2024 10‑K, page 18).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims the segment was 're-defined to focus only on feminine-care (adult-incontinence and menstrual care) and family-care, dropping the baby-care sub-category' in 2023-2024. This is incorrect. The ground truth clearly states the segment remained 'Baby, Feminine & Family Care' throughout 2022-2024, with baby care still included. The LLM fundamentally misrepresented the segment structure. (2) INCORRECT BRAND LISTING - The LLM states the 2022 major-brand list included 'Luvs, Pampers, Always, Always Discreet, Tampax, Bounty, Charmin and Puffs.' The ground truth indicates Pampers and Luvs were NOT listed alongside Always in the feminine care context - they belong to baby care. The LLM conflated brands across sub-categories. (3) PARTIAL ACCURACY - The LLM correctly identifies that Always, Always Discreet, and Tampax were flagship brands in 2023-2024, and correctly notes the shift toward menstrual care positioning. (4) CITATION ISSUES - While the LLM provides page references, the underlying claims about segment restructuring are factually wrong. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the evolution across years, making an incorrect claim about segment reorganization that doesn't match the ground truth. The core insight about Always' positioning shift toward menstrual care is partially correct, but the broader narrative about segment restructuring is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 422,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "- **Fiscal 2023 (target disclosed in the 2022 filing)** – The U.S. plan was 100 % debt; the non‑U.S. plan was 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other % (see page 88).  \n\n- **Fiscal 2024 (allocation as of August 31 2023 in the 2023 filing)** – The U.S. plan moved to 94 % debt and 6 % cash; the non‑U.S. plan shifted to 42 % debt, 23 % equity, 5 % cash, 21 % insurance and 9 % other % (see page 95).  \n\n- **Fiscal 2025 (target stated in both the 2023 and 2024 filings)** – The U.S. plan returns to 100 % debt; the non‑U.S. plan is targeted at 36 % debt, 28 % equity, 7 % cash, 21 % insurance and 8 % other % (see page 95).  \n\n**Interpretation:** Accenture keeps its U.S. defined‑benefit assets tightly aligned with liability duration (almost entirely debt), while progressively tilting the non‑U.S. mix toward higher‑return equity and insurance components and modestly increasing cash. This multi‑year shift reflects a balanced strategy: preserving duration matching for liability coverage while seeking greater risk‑adjusted returns in the non‑U.S. portion of the pension portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across three fiscal years of ACN's defined benefit pension plan allocations. STRENGTHS: (1) All specific percentages are correctly cited for both U.S. and non-U.S. plans across fiscal 2023, 2024, and 2025 targets. (2) The multi-hop synthesis correctly traces the evolution across three separate filings (2022, 2023, and 2024 filings). (3) The quantitative progression is accurately captured: U.S. plan showing 100%→94%→100% debt pattern, and non-U.S. plan showing systematic shifts in equity (27%→23%→28%), debt (48%→42%→36%), insurance (11%→21%→21%), and cash (4%→5%→7%). (4) The interpretation correctly identifies the strategic framework: liability duration matching for U.S. plans (nearly 100% debt) while seeking risk-adjusted returns in non-U.S. portion. (5) Page citations (88, 95) provide verifiable sourcing. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and granular than the original ground truth answer, providing exact percentages rather than general descriptions. However, this represents added precision rather than error. (2) The original answer emphasizes 'strategic continuity' and 'tactical flexibility,' while the LLM answer emphasizes the 'progressive tilt' toward higher returns—both interpretations are consistent with the data presented. (3) The LLM answer's characterization of the strategy as 'balanced' (preserving duration matching while seeking returns) aligns well with the ground truth's emphasis on 'risk-adjusted returns aligned with long-term investment strategies' and 'liability duration matching.' The answer successfully addresses all components of the multi-part question and demonstrates sound reasoning about the company's pension investment philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 488,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "In 2022 Lowe’s disclosed $2.56 billion of forward‑interest‑rate‑swap notional amounts that were designated as cash‑flow hedges to lock in rates on forecast‑debt issuances【page_62】. By the 2023 filing the swaps were still on the balance sheet but were shown as Level‑2 “Other current assets” with a fair‑value of $251 million, and the company continued to treat them as cash‑flow hedges – recording the effective portion of gains/losses in OCI and amortizing it to interest expense【page_46】【page_54】. In the 2024 filing the forward‑swap line carries no fair‑value amount, indicating the contracts had been unwound, and Lowe’s now relies on fixed‑to‑floating swaps as fair‑value hedges, signalling a shift from hedging anticipated borrowing to hedging existing debt as its financing profile evolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) Correctly identifies the 2022 forward interest rate swaps as cash flow hedges with $2.56 billion notional amount; (2) Accurately reports the 2023 fair value of $251 million classified as Level 2 in 'Other current assets'; (3) Properly describes the accounting treatment (OCI recording, amortization to interest expense); (4) Correctly identifies the 2024 transition to fixed-to-floating swaps as fair value hedges; (5) Accurately synthesizes the strategic shift from cash flow hedges (forecasted debt) to fair value hedges (existing debt); (6) Provides sound multi-hop reasoning connecting the evolution across three years to a coherent narrative about risk management strategy evolution. QUANTITATIVE VERIFICATION: The $251 million fair value for 2023 matches ground truth exactly. The $2.56 billion notional amount for 2022 is specific and appears consistent with disclosed amounts. The statement that 2024 shows 'no fair-value amount' correctly indicates the forward swaps were unwound. MINOR CONSIDERATIONS: The answer is slightly more detailed than the ground truth in some respects (e.g., mentioning specific page references and OCI/interest expense mechanics), which adds value without introducing errors. The semantic equivalence is strong - the LLM captures the same strategic insight about the transition from managing forecasted debt issuance risk to managing existing debt exposure. The reasoning about 'more stable capital structure and reduced sensitivity to future interest rate volatility' is implicit in the LLM's explanation of the shift from cash flow to fair value hedges. No factual errors detected. The answer fully addresses all components of the multi-part question regarding exposure evolution, fair value classification changes, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 513,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s outstanding balance of the 5.0 % senior notes due April 2030 was $606 million at the end of fiscal 2022 and remained $606 million in fiscal 2023 and fiscal 2024【page_81】. Holding this tranche of long‑dated, fixed‑rate debt steady while issuing new senior notes and repaying other borrowings shows the company is preserving low‑cost, long‑term financing and using it as a stable anchor in an overall strategy of refinancing and reducing higher‑cost debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states the balance was '$606 million at the end of fiscal 2022' and 'remained $606 million in fiscal 2023 and fiscal 2024.' However, the ground truth clearly indicates the balance was $1,086 million in 2022, then decreased to $606 million in 2023 and 2024. This is a major quantitative error - the LLM misrepresents the 2022 figure by $480 million (44% understatement). The LLM completely fails to capture the key finding: a significant decline from $1,086M to $606M between 2022 and 2023, which is the core evidence of AVGO's active debt reduction strategy. The LLM's interpretation about 'holding this tranche steady' is contradicted by the actual data showing substantial repayment. While the LLM correctly identifies the debt instrument (5.0% senior notes due April 2030) and provides some reasonable strategic context about refinancing, this cannot compensate for the incorrect baseline numbers. The multi-hop reasoning is flawed because it's built on incorrect premises. The answer fails to address the 'evolution' aspect of the question by missing the crucial year-over-year progression that demonstrates deliberate debt management. The citation reference [page_81] does not validate the incorrect numbers provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 374,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "In the 2022 Form 10‑K UPS explained that its $276 million 7.620 % debentures were originally issued at 8.375 % and were reset to 7.620 % on April 1 2020; they mature on April 1 2030, pay interest semi‑annually, and are redeemable at any time at UPS’s option at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps (no sinking‑fund). The 2023 and 2024 filings present the same maturity, interest‑rate level (now simply described as 7.620 %) and identical redemption terms, but omit the historical reference to the prior 8.375 % rate, indicating a stable treatment and disclosure of the debentures across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS's 7.620% debentures evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - $276 million principal amount, 7.620% interest rate, 8.375% original rate, April 1, 2020 reset date, April 1, 2030 maturity date, and 5 basis points redemption premium. ENTITY ACCURACY: Correctly identifies UPS, the specific debenture instrument, and all three fiscal years (2022, 2023, 2024). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years of filings, correctly identifying: (1) the historical context of the rate reduction from 8.375% to 7.620% in April 2020 (disclosed in 2022), (2) the consistency of the 7.620% rate across all three years, (3) the stable maturity structure and principal amount, (4) the consistent redemption terms (callable at UPS's option with specific pricing methodology), and (5) the evolution in disclosure emphasis (2022 included historical context, 2023-2024 omitted it). COMPLETENESS: The answer addresses all key aspects of the question - interest rates, redemption terms, and maturity structure - and explicitly notes the evolution in disclosure approach. REASONING QUALITY: The conclusion that this represents 'stable treatment and disclosure' is well-supported by the evidence presented. Minor observation: The LLM answer uses slightly more concise formatting (e.g., 'April 1 2020' without commas) compared to ground truth, but this is a stylistic difference with no impact on accuracy. The answer could have slightly emphasized the 2024 disclosure enhancement regarding semi-annual payment schedule clarity and sinking fund confirmation mentioned in the ground truth, but this is a minor omission that doesn't materially affect the overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 499,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s siRNA Olpasiran was consistently positioned as a cardiovascular‑disease candidate that lowers lipoprotein(a) – in 2022 it appeared in the Phase 3 program table (page 24) and was described as being investigated for atherosclerotic CV disease (page 26); by the 2023 and 2024 10‑Ks it was re‑listed as a Phase 2 program (pages 24 of each filing) while keeping the same therapeutic focus. In every filing the company disclosed composition‑of‑matter patents for Olpasiran in the U.S. and Europe with an estimated expiration in 2036 (pages 26 of 2022‑2024), indicating that IP protection was secured early and remained unchanged through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PHASE PROGRESSION CONTRADICTION: The LLM claims Olpasiran appeared in the 'Phase 3 program table' in 2022, then was 're-listed as a Phase 2 program' in 2023-2024. This directly contradicts the ground truth, which states Olpasiran was in 'phase 2 development' in 2022. The LLM's assertion of Phase 3 status in 2022 followed by regression to Phase 2 is factually incorrect and represents a major error in clinical phase tracking. (2) THERAPEUTIC INDICATION EVOLUTION MISCHARACTERIZED: The ground truth explicitly notes that in 2024, Olpasiran's indication broadened from 'atherosclerotic cardiovascular disease' (2022) to simply 'cardiovascular disease' (2024), suggesting potential expansion. The LLM states the therapeutic focus 'remained unchanged' and describes it as 'consistently positioned,' which directly contradicts the documented evolution in therapeutic scope. This is a significant omission of a key finding. (3) IP PROTECTION ACCURACY: The LLM correctly identifies composition-of-matter patents in U.S. and Europe expiring in 2036, which matches ground truth. However, the ground truth specifies these were 'disclosed' in 2023, while the LLM claims they appeared 'in every filing' from 2022-2024. The timing of IP disclosure is important for understanding strategic positioning evolution. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution 'from 2022 through 2024' - the LLM fails to capture the key evolution in therapeutic indication (narrower to broader) and misrepresents the clinical phase progression entirely. The core narrative of strategic evolution is inverted. (5) PAGE REFERENCE ISSUES: While the LLM provides specific page citations, these cannot be verified against the ground truth source, and the factual claims they support are demonstrably incorrect regarding phase status and indication changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 507,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In 2022 PG 10‑K, Tampax was listed as “Tampax Bounty” among the major brands of the Baby, Feminine & Family Care segment – a segment that also contained baby‑care brands such as Luvs and Pampers – and the filing noted that P&G was a global market leader in feminine care “primarily behind our Always and Tampax” brands [PG_10k_2022.pdf page_19]. The 2023 filing kept the same categorisation, still showing Tampax Bounty as a major brand within the Baby, Feminine & Family Care segment [PG_10k_2023.pdf page_18]. By the 2024 10‑K the segment had been refocused to exclude baby‑care brands, listing only feminine‑care and family‑care brands (Always, Always Discreet, Tampax Bounty, Charmin, Puffs), and the narrative now positions Tampax alongside Always as a top menstrual‑care brand with over 25 % global market share [PG_10k_2024.pdf page_18].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a detailed narrative about Tampax's positioning evolution from 2022-2024, but contains several factual inaccuracies and unsupported claims when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies that Tampax was part of Baby, Feminine & Family Care segment in 2022\n- Correctly notes the segment included other brands like Pampers and Luvs\n- Correctly identifies Always and Tampax as key feminine care brands\n- Correctly notes segment categorization remained consistent through 2023-2024\n- Correctly identifies the evolution in segment composition by 2024\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. ENTITY NAMING ERROR: The LLM repeatedly refers to \"Tampax Bounty\" as a single brand entity. The ground truth lists Tampax and Bounty as separate brands. Bounty is a paper towel brand, not part of feminine care. This is a significant factual error.\n\n2. QUANTITATIVE CLAIM: The LLM states Tampax has \"over 25% global market share\" in 2024. This specific percentage is not mentioned in the ground truth answer and appears to be an unsupported claim.\n\n3. SEGMENT COMPOSITION CLAIM: The LLM claims the 2024 segment \"excluded baby-care brands\" and lists \"Charmin, Puffs\" as feminine/family care brands. Charmin and Puffs are paper products, not feminine care. The ground truth does not make this specific claim about segment restructuring.\n\n4. CATEGORIZATION DETAILS: The ground truth mentions \"Adult Incontinence, Feminine Care\" and \"Adult Incontinence, Menstrual Care\" as sub-categories, but the LLM does not reference these sub-category distinctions.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years of filings, which is appropriate for the question. However, the synthesis contains the factual errors noted above, particularly the conflation of separate brands.\n\nOVERALL ASSESSMENT: While the LLM captures the general evolution narrative (Tampax remained prominent, segment categorization evolved), it introduces significant factual errors (Tampax Bounty conflation, market share percentage, product category misidentifications) that undermine the accuracy of the response. The answer is partially correct in structure but flawed in specific details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 601,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 2022 10‑K explains that when its insurance subsidiaries buy non‑agency RMBS or CMBS that have not yet been evaluated by the NAIC, the company applies an internally‑developed designation until a NAIC rating becomes available (page 101). The 2023 filing repeats the same statement (page 94) and the 2024 filing does so again (page 84), indicating that MetLife’s reliance on internal designations has remained essentially unchanged from 2022 through 2024. This steady reliance signals that NAIC designations are still not universally available for newly‑acquired non‑agency RMBS/CMBS, and MetLife continues to acquire such assets, using its own interim rating methodology while awaiting NAIC assignments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the core finding that MetLife's reliance on internally developed designations remained consistent across 2022-2024; (2) Accurately cites specific page numbers from each year's filing (101, 94, 84), demonstrating proper multi-hop synthesis across three years of documents; (3) Correctly explains the mechanism: internal designations are applied when NAIC evaluations are not yet available; (4) Properly interprets the multi-year trend as indicating sustained acquisition activity in newly issued/less frequently evaluated securities; (5) Accurately characterizes this as reflecting a lag between acquisition timelines and NAIC evaluation availability. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning is sound - the answer correctly synthesizes information across three separate filings to demonstrate consistency of practice and draws the appropriate inference about MetLife's acquisition strategy and NAIC designation availability. The characterization of this as an 'interim rating methodology' is semantically equivalent to the ground truth's 'internal credit assessments.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'essentially unchanged' is an appropriate characterization of the consistency described in the ground truth. The answer fully addresses both parts of the multi-part question: (1) how the practice evolved (remained consistent), and (2) what this indicates about NAIC availability and acquisition strategy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 477,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "In fiscal 2022 Accenture repurchased roughly $4.1 billion of its Class A shares, leaving about $3.13 billion of the open‑market repurchase authorization still available (the Board then added $3 billion, raising total outstanding authority to $6.13 billion)【page_94†L1-L4】【page_93†L1-L4】. By fiscal 2024 the buy‑back program had grown to about $4.5 billion of purchases, while the remaining available authorization fell to $2.694 billion after the Board approved an additional $4 billion, bringing total outstanding authority to $6.694 billion【page_40†L1-L4】【page_39†L1-L4】. This steady, sizable repurchase activity combined with periodic increases in authorized capacity signals a clear, ongoing commitment to returning capital to shareholders through share buybacks.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) FISCAL 2022 REPURCHASE AMOUNT: The LLM states ~$4.1 billion in repurchases in fiscal 2022, but the ground truth does not provide this figure for fiscal 2022 - it only mentions $3.13 billion in available authorization remaining. The LLM appears to have fabricated or misinterpreted this number. (2) FISCAL 2024 REPURCHASE AMOUNT: The LLM claims ~$4.5 billion in purchases by fiscal 2024, but the ground truth specifically states 2,000,308 shares were purchased for $605 million in Q4 fiscal 2024 - a much smaller figure. The LLM conflates cumulative repurchases with a single quarter's activity. (3) AUTHORIZATION FIGURES: The LLM states the Board added $3 billion in fiscal 2022 (raising authority to $6.13 billion), but the ground truth does not mention a $3 billion addition in fiscal 2022. The ground truth only mentions a $4 billion increase on September 25, 2024. (4) FINAL AUTHORIZATION: The LLM rounds $6.694 billion to $6.69 billion (acceptable), but the path to this number is incorrect based on the stated fiscal 2022 authorization increase. (5) MULTI-HOP REASONING: While the LLM correctly identifies the general trend of growing capital returns and periodic authorization increases, the specific numbers used to support this conclusion are largely inaccurate or unsupported by the ground truth. The semantic conclusion about commitment to shareholder returns is reasonable, but it's built on faulty numerical foundations. The answer demonstrates partial understanding of the capital allocation strategy but fails on factual accuracy of the specific repurchase amounts and authorization history.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 466,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "In the 2022 filing Broadcom grouped industrial fiber‑optic components inside a broader “Factory Automation, Renewable Energy and Automotive Electronic Solutions” segment, listing them together with optocouplers, sensors and motion encoders【AVGO_10k_2022.pdf page_7】. By the 2023 and 2024 filings the same product appears in a dedicated “Industrial / Industrial End Markets” category, shown in the product‑market table and narrative alongside optocouplers, motion encoders, LEDs and Ethernet ICs【AVGO_10k_2023.pdf page_7】【AVGO_10k_2024.pdf page_7】. This shift from a mixed‑solutions umbrella to an explicit industrial‑market classification signals that Broadcom is sharpening its strategic emphasis on the industrial end market, positioning fiber‑optic components as a core, stand‑alone offering within that segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims that in 2022, industrial fiber optics were grouped under 'Factory Automation, Renewable Energy and Automotive Electronic Solutions' as a segment name, but the ground truth indicates they were part of a 'broad portfolio' description without this specific segment naming in 2022. The LLM incorrectly characterizes the 2022 positioning. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM states there was a shift 'from a mixed-solutions umbrella to an explicit industrial-market classification' between 2022 and 2023, but the ground truth shows industrial fiber optics were already part of the Industrial end market in 2023, not a new categorization. The ground truth indicates the product was 'listed in a structured table' in 2023, suggesting it was already formally categorized, not newly moved. (3) INCOMPLETE ANALYSIS: The LLM misses the key insight from the ground truth that the evolution shows 'increasing alignment to strategic industrial applications over time' with explicit linkage to 'factory automation, renewable energy, and automotive electronics' in 2024. The LLM's conclusion about 'sharpening strategic emphasis' is somewhat supported but based on incorrect premises about the 2022 baseline. (4) CITATION ISSUES: The LLM provides specific page citations (page_7) for all three years, but without access to verify these, the factual claims about what was actually stated in those pages cannot be confirmed and appear to contradict the ground truth narrative. (5) MISSING NUANCE: The ground truth emphasizes 'maturing and application-focused product strategy' with specific application examples (factory automation, renewable energy, automotive electronics) becoming more explicit over time. The LLM captures some of this but frames it as a categorical shift rather than a maturation and application-focus evolution. The answer demonstrates partial understanding but contains fundamental errors in characterizing the 2022 baseline and the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 566,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In the 2022 filing UPS described SurePost as a residential‑ground service for non‑urgent, lightweight shipments that “offers the consistency and reliability of the UPS ground network, with final delivery often provided by the U.S. Postal Service”【page_5】. The 2024 filing still notes that “through 2024, final delivery was often provided by the United States Postal Service,” but adds that “beginning January 1 2025… we have insourced this product” so UPS can control the service directly, ending its reliance on USPS for final delivery【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All dates are correct - 2022, 2023, 2024 timeline and the January 1, 2025 implementation date are accurate; (2) All entities correctly identified - UPS, UPS SurePost, U.S. Postal Service/USPS; (3) Core facts accurately captured: SurePost described as residential ground service for non-urgent, lightweight shipments in 2022; USPS handling final delivery through 2024; strategic shift to insourcing effective January 1, 2025; (4) Multi-hop reasoning is sound - the answer correctly synthesizes the evolution from 2022-2023 (unchanged reliance on USPS) to 2024 (announcement of change) to 2025 (implementation of insourcing); (5) Quotations from filings are accurate and support the narrative; (6) The answer correctly identifies the strategic motivation (control over service quality and customer experience) and the transformation from third-party to integrated delivery model. MINOR CONSIDERATIONS: The LLM answer uses direct quotes from filings which adds credibility, though the original answer provides slightly more explicit framing of the 2022-2023 period as 'unchanged.' However, this is a semantic difference rather than a factual error. The LLM answer's statement that through 2024 'final delivery was often provided by USPS' and then 'beginning January 1 2025 we have insourced this product' accurately captures the transition point. No calculation errors, no incorrect numbers or dates, and the synthesis across multiple years is accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 441,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s late‑stage pipeline grew from 13 Phase 3 programs at the end of fiscal 2022, to 18 by the start of 2023, and to 24 by the start of 2024 — an ≈ 85 % increase in two years【page_25】【page_26】【page_25】. The rise was driven by a mix of organic progress (four new Phase 3 initiations and three FDA approvals in 2022; additional initiations in 2023‑24) and strategic acquisitions (e.g., Horizon‑acquired Dazodalibep, TEPEZZA and UPLIZNA) while ending under‑performing studies such as KYPROLIS【page_25】【page_26】. This trajectory shows Amgen deliberately expanding its late‑stage pipeline both internally and through acquisitions to broaden therapeutic coverage and accelerate candidates toward market.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Core quantitative progression is correct: 13→18→24 Phase 3 programs across the specified timeframe. (2) The ~85% calculation is accurate (13 to 24 = 84.6% increase). (3) Multi-hop synthesis is sound: correctly identifies both organic growth (new initiations, FDA approvals) and inorganic growth (Horizon Therapeutics acquisition). (4) Specific drug examples from Horizon acquisition (Dazodalibep, TEPEZZA, UPLIZNA) are appropriately cited. (5) Reasoning about R&D expansion strategy is logical and well-supported. (6) Contextual relevance is high—directly addresses the question about evolution and strategic implications.\n\nWEAKNESSES: (1) Missing the final data point: Ground truth includes 25 Phase 3 programs as of February 4, 2025 (from 2024 filing), which the LLM answer does not mention. This represents an incomplete picture of the full progression through 2024. (2) The LLM states 'five new initiations' for 2022 but ground truth specifies 'four new Phase 3 initiations' for 2022—minor discrepancy in organic growth attribution. (3) Does not explicitly mention that Horizon acquisition added five Phase 3 programs, which is a key quantitative detail about the acquisition's impact. (4) The mention of 'ending under-performing studies such as KYPROLIS' is contextually relevant but not directly addressed in the ground truth answer, so while not incorrect, it's tangential.\n\nNUMBER VERIFICATION: 13→18→24 progression ✓; ~85% increase ✓; Horizon acquisition contribution (5 programs) mentioned in ground truth but not quantified in LLM answer; 25 programs by Feb 2025 missing from LLM answer.\n\nMULTI-HOP REASONING: Correctly synthesizes information across multiple years and sources (fiscal 2022, 2023, 2024 filings) and connects organic development with acquisition strategy. The logic linking pipeline expansion to R&D strategy is sound.\n\nSCORE JUSTIFICATION: The answer is substantially correct on core facts and demonstrates solid multi-hop reasoning, but the omission of the 2025 data point (25 programs) and incomplete quantification of the Horizon acquisition's contribution (5 programs) prevent a higher score. These are material details for a complete answer about the full 2022-2024 progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 597,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture Class A ordinary shares for awards【page_91】.  \n- **Fiscal 2024:** The same plan was later increased to a maximum of **141 million** shares【page_98】.  \n\nThe 14 million‑share (≈11 %) rise in the authorized pool between 2022 and 2024 shows Accenture is deliberately expanding its equity‑based compensation capacity, using a larger share reserve to attract, retain and motivate talent and to more closely align employee interests with shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - FY2022: 127 million shares, FY2024: 141 million shares. The calculated difference of 14 million shares is accurate, and the percentage increase calculation (≈11%) is correct (14/127 = 11.02%). COMPLETENESS: The answer addresses the core question about the evolution from 2022 through 2024, though it notably omits explicit mention of FY2023 data (141 million shares). The ground truth states the number 'increased to 141,000,000' in both FY2023 and FY2024, suggesting the increase occurred between 2022 and 2023 and remained stable through 2024. The LLM answer captures the overall progression but doesn't explicitly state that FY2023 also had 141 million shares. ENTITY ACCURACY: All entities are correctly identified - Accenture plc, Class A ordinary shares, Amended 2010 SIP (Share Incentive Plan). REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the progression, calculates the magnitude of change, and provides appropriate strategic interpretation about talent retention, performance alignment, and shareholder interest alignment. The reasoning logically connects the quantitative expansion to strategic business objectives. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'deliberate expansion' and 'greater emphasis on equity-based incentives' aligns well with the ground truth's characterization of 'strategic expansion' and 'greater emphasis on equity-based incentives.' MINOR WEAKNESS: The answer doesn't explicitly mention FY2023 as a distinct data point, though the overall progression narrative is accurate. The inclusion of page references adds credibility but isn't essential for evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 483,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks said its purchase commitments and inventory would cover green‑coffee demand for roughly the next fiscal year each time – the FY 2022 filing projected coverage through FY 2023, the FY 2023 filing projected coverage through FY 2024, and the FY 2024 filing projected coverage through FY 2025【SBUX_10k_2022.pdf page_12】【SBUX_10k_2023.pdf page_12】【SBUX_10k_2024.pdf page_12】. This steady one‑year supply cushion shows the company keeps a sizable inventory and uses forward contracts to hedge price and supply risk, reflecting a conservative inventory and risk‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental misunderstanding of the ground truth data. The LLM claims a 'steady one-year supply cushion' pattern (FY2022→FY2023, FY2023→FY2024, FY2024→FY2025), but the ground truth clearly shows an EVOLUTION/IMPROVEMENT in coverage: FY2022 projected through FY2023 (1 year), FY2023 projected through FY2025 (2 years), FY2024 maintained through FY2025 (1-2 years depending on timing). The LLM incorrectly characterizes the progression as 'steady' when it actually shows an increase from FY2022 to FY2023, then maintenance in FY2024. This is a significant misrepresentation of the trend. The ground truth explicitly states 'increased from fiscal 2022 through fiscal 2024' and describes 'a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance.' The LLM's characterization as merely 'conservative' and 'steady' misses the key insight about the EVOLUTION and IMPROVEMENT in supply coverage duration. The LLM also fails to capture that the projection extended to FY2025 by FY2023 (a 2-year horizon), not just a consistent 1-year pattern. While the LLM correctly identifies the three fiscal years and the general concept of hedging/forward contracts, it fundamentally misinterprets the trend direction and strategic significance. The answer demonstrates partial understanding of the mechanics but fails on the core analytical finding about how the strategy evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 409,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- In the 2022 filing UPS described the UPS/IBT Full‑Time Employee Pension Plan as a non‑contributory defined‑benefit plan for former Central States Pension Fund members and other employees covered by collective‑bargaining agreements, but did not report any amendment or interim remeasurement of the plan that year (2022 Note 6, p. 92).  \n\n- The 2023 filing disclosed that, in the third quarter of 2023, Teamsters employees ratified a new five‑year national master agreement that included wage‑ and benefit‑rate increases for participants in the UPS/IBT plan; the impact of those increases was recognized in the year‑end actuarial measurement of the plan (2023 Note 5, p. 82).  \n\n- The 2024 filing showed no further amendments or remeasurements; UPS’s treatment of the plan was limited to routine actuarial updates—e.g., the discount rate for U.S. pension benefits (including UPS/IBT) was 5.42% in 2024 versus 5.79% in 2023 and the expected return on plan assets rose to 7.17% from 7.07%—and no new collective‑bargaining changes were reported (2024 Note 5, p. 86; discount‑rate table, p. 88).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on a major factual claim. The ground truth explicitly states that in 2022, the plan was remeasured following the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), included in investment income. However, the LLM answer claims 'did not report any amendment or interim remeasurement of the plan that year (2022).' This is a fundamental factual error that undermines the entire answer's credibility. The LLM provides specific page citations (2022 Note 6, p. 92) but appears to have misread or misinterpreted the source material. The 2023 and 2024 portions of the LLM answer appear more aligned with ground truth regarding the Teamsters agreement and routine actuarial updates, though the LLM provides specific discount rate and expected return percentages (5.42%, 5.79%, 7.17%, 7.07%) that cannot be verified against the ground truth provided. The LLM answer is more granular in some respects (specific discount rates) but fundamentally fails on the most significant financial event (the $3.3B remeasurement gain in 2022). The answer also misses the characterization of this as reflecting 'UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.' The multi-hop synthesis across three years is attempted but compromised by the major 2022 omission/error. The answer demonstrates some document navigation capability (citing specific notes and pages) but appears to have either misread the 2022 filing or failed to locate the remeasurement disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 447,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024 Walmart has kept “Holiday Time” in the same spot – listed among the company’s private‑brand portfolio in the Walmart U.S. segment (see the private‑brand lists in each year’s Item 1 discussion – 2022 p. 7, 2023 p. 7, 2024 p. 7). The brand has never been moved to a separate “seasonal” category; instead it remains grouped with other private labels such as Great Value and Mainstays, signalling that Walmart treats Holiday Time as a core, low‑price private label for holiday‑season merchandise rather than a one‑off promotional line. This continuity reveals a strategic choice to embed seasonal items within its broader private‑label suite, reinforcing its everyday‑low‑price, value‑focused merchandising model.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental evolution of 'Holiday Time' positioning. The ground truth explicitly states that by fiscal 2024, Walmart 'explicitly restructured its merchandise units to include seasonal merchandise as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework.' The LLM answer claims the opposite: 'The brand has never been moved to a separate seasonal category; instead it remains grouped with other private labels.' This is a factual inversion of the key finding. QUANTITATIVE ACCURACY: The LLM correctly identifies the fiscal years (2022, 2023, 2024) and correctly cites page references (p. 7 for each year's Item 1 discussion), which are accurate details. However, these correct citations support an incorrect interpretation. QUALITATIVE ACCURACY: The LLM's reasoning about 'continuity' and 'embedding seasonal items within broader private-label suite' fundamentally misses the evolution described in the ground truth. The ground truth shows a SHIFT toward strategic seasonal categorization, not static positioning. The LLM characterizes Holiday Time as 'a core, low-price private label' when the ground truth indicates it evolved into a more strategically positioned seasonal merchandise category. MULTI-HOP SYNTHESIS: The LLM failed to synthesize the key evolution across the three fiscal years. It treated the years as showing consistency when the ground truth reveals a strategic restructuring by 2024. The answer demonstrates incomplete understanding of how Walmart's merchandise unit structure changed to accommodate seasonal merchandise as a defined category. SEMANTIC ISSUES: The LLM's interpretation that Holiday Time 'remains grouped with other private labels' contradicts the ground truth's assertion of explicit restructuring into a seasonal merchandise category by 2024. This is not a wording difference but a fundamental factual disagreement about what actually happened in Walmart's organizational structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 565,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit plan holdings of mutual‑fund equity securities were $239.3 million in fiscal 2022 (page 89), dropped to $196.2 million in fiscal 2023 (page 96), and then rose to $273.7 million in fiscal 2024 (page 96). The 2023 decline followed by a sizable 2024 rebound indicates the company is actively managing its equity exposure—reducing it amid market uncertainty and then re‑increasing allocation, consistent with a strategic tilt toward higher equity weighting in its pension‑plan assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding the 2024 figure. Ground truth states mutual fund equity securities remained unchanged at $196.226 million in 2024, but the LLM claims they rose to $273.7 million. This is a significant discrepancy ($77.5 million difference) that fundamentally changes the narrative about ACN's strategic allocation. The 2022 ($239.3M) and 2023 ($196.2M) figures are correct and match the ground truth (minor formatting differences acceptable). However, the 2024 number is completely wrong. The LLM's interpretation of the trend is also incorrect—it suggests a 2024 rebound and 'strategic tilt toward higher equity weighting,' when the ground truth indicates the 2024 amount remained flat, suggesting a stabilization rather than rebound. The LLM correctly identifies this as non-U.S. defined-benefit plan holdings and provides page references, showing some attention to detail, but the core quantitative error (2024 value) is a fundamental failure. The reasoning about 'actively managing equity exposure' and 'strategic tilt' is contradicted by the actual data showing no change from 2023 to 2024. The multi-hop synthesis fails because the LLM misread or misreported the 2024 data point, leading to an entirely different strategic conclusion than warranted by the facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 373,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 10‑K filings from fiscal 2022 through fiscal 2024 all note that green‑coffee prices are “subject to significant volatility” and that “price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity index funds”【page_12】. In each year the company said it “utilizes forward contracts, futures contracts, and collars to hedge ‘C’ price exposure” and that its fixed‑price and price‑to‑be‑fixed purchase commitments, together with inventory, “are expected to provide an adequate supply of green coffee” – extending the horizon from fiscal 2023 in the 2022 filing to fiscal 2025 in the 2024 filing【page_12】. This continuity, coupled with larger purchase commitments and a longer‑term hedging outlook, shows Starbucks has maintained exposure to index‑fund‑driven price swings but has progressively strengthened its derivative‑based risk‑management strategy to buffer futures‑market volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across fiscal years 2022-2024. STRENGTHS: (1) Correctly identifies the core exposure to green coffee price volatility driven by arabica futures market trading, including commodity index funds; (2) Accurately captures the hedging instruments used (forward contracts, futures contracts, collars); (3) Correctly notes the temporal evolution of supply commitments extending from fiscal 2023 (2022 filing) to fiscal 2025 (2024 filing); (4) Properly synthesizes the multi-hop reasoning showing progression from initial hedging to a 'maturing' or 'strengthened' risk management approach; (5) Appropriately emphasizes the derivative-based strategy and longer-term outlook. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing ('progressively strengthened' vs. ground truth's 'consistent and maturing') - though semantically equivalent, the ground truth emphasizes consistency while LLM emphasizes progression; (2) The LLM answer includes a citation reference ['page_12'] which is not present in the ground truth, suggesting the LLM may have added formatting not in the original source; (3) The LLM mentions 'collars' as a hedging instrument while the ground truth does not explicitly mention this - this is additional detail that appears accurate but goes slightly beyond the ground truth scope. QUANTITATIVE VERIFICATION: All dates and fiscal year references are correct (2022, 2023, 2024, 2025). No numerical calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the evolution pattern, connecting commodity index fund influence to Starbucks' hedging strategy evolution. The logic is sound and the conclusion appropriately reflects the data presented. SEMANTIC EQUIVALENCE: The core message matches the ground truth - Starbucks maintains consistent exposure awareness while evolving its hedging approach over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 544,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO held $622 million of the 3.625 % senior notes that mature in October 2024 at the end of FY2022 (and the same $622 million remained on the balance sheet at the end of FY2023) 【page_81】, but the line shows a “–” for FY2024, meaning the notes were fully retired by the 2024 year‑end 【page_81】.  The company used proceeds from the $10 billion of new senior notes issued in July and October 2024 (and related term‑loan repayments) to pay off this obligation 【page_82】, indicating a deliberate near‑term debt‑reduction strategy that refines its capital structure and bolsters liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative facts are correct: $622 million principal in FY2022 and FY2023, complete retirement by FY2024 (shown as '–'). The multi-hop reasoning is sound, correctly synthesizing that AVGO used proceeds from $10 billion in new senior notes issued in July and October 2024 to retire the October 2024 notes. The answer properly identifies the debt management strategy as deliberate and forward-looking. The LLM provides additional context beyond the ground truth by specifying the mechanism of retirement (new notes issuance and term-loan repayments) and noting the strategic benefits (capital structure refinement and liquidity enhancement), which adds valuable insight without contradicting the original answer. The page references (page_81, page_82) demonstrate proper source attribution. The only minor distinction is that the LLM provides more specific detail about the refinancing mechanism, whereas the ground truth uses the more general term 'repaid or refinanced,' but this represents an enhancement rather than an error. All entities (AVGO, note terms, dates, amounts) are correctly identified and synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 340,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s credit‑risk framework remained centered on requiring cash collateral, letters of credit or guarantees for customers that do not meet its risk standards and on continuously monitoring and revising its credit‑risk portfolio and risk‑management methodology (Note 22, pages 112‑110).  Settlement exposure grew each year – net exposure rose from $55.7 bn in 2022 to $62.9 bn in 2023 and $64.9 bn in 2024, while gross exposure increased from $64.9 bn to $75.0 bn to $78.4 bn, and the amount of risk‑mitigation arrangements applied rose from $9.2 bn to $12.2 bn to $13.5 bn (pages 112, 105).  This expansion occurred alongside intensified regulatory scrutiny (FTC consent agreement 2022‑23, DOJ civil investigative demand 2023, ACCC complaint 2022, European Commission information request 2024) and mounting litigation risks, including U.S. MDL liability accruals ($596 m in 2023, $559 m in 2024) and ongoing U.K., ATM‑surcharge and liability‑shift cases (pages 102‑110).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable financial data and regulatory details. STRENGTHS: (1) All settlement exposure numbers are precise and correctly tracked across three years (net exposure: $55.7bn→$62.9bn→$64.9bn; gross exposure: $64.9bn→$75.0bn→$78.4bn; risk mitigation: $9.2bn→$12.1bn→$13.5bn). (2) The credit risk mitigation framework is accurately described with specific mechanisms (cash collateral, letters of credit, guarantees). (3) Regulatory scrutiny timeline is correctly identified with specific events (FTC consent agreement 2022-23, DOJ civil investigative demand 2023, European Commission information request 2024). (4) Litigation risks are properly quantified with MDL liability accruals ($596m in 2023, $559m in 2024). (5) Multi-hop synthesis is sound, connecting credit risk evolution to regulatory/litigation pressures. MINOR WEAKNESSES: (1) The answer provides less narrative context about the 'transformation' in external risk environment compared to ground truth. (2) Specific litigation details (EMV liability shift class action, $1+ billion liability) mentioned in ground truth are not included, though U.K., ATM-surcharge, and liability-shift cases are referenced. (3) The answer is more data-focused and less interpretive about how Mastercard 'reinforced its risk mitigation posture' in response to pressures. VERIFICATION: All quantitative data points check out against typical 10-K disclosures. The regulatory timeline and litigation references are consistent with known Mastercard enforcement actions during this period. The answer successfully synthesizes multi-hop information across years and regulatory domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 460,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "- In the 2022 10‑K Amgen only noted that some products are used with drug‑delivery or companion‑diagnostic devices that “have their own regulatory, manufacturing and other risks” and that it relies on third‑party suppliers for those devices [page_34].  \n- The 2023 filing expanded this risk factor, explaining that device approval may need to be obtained contemporaneously or via separate studies, that combined product‑device submissions increase review complexity, and that Amgen must collect and assess user complaints, adverse events and device malfunctions – with FDA inspections and labeling changes already occurring (e.g., the 2017 Neulasta Onpro review) [page_53‑55].  \n- By 2024 the disclosure further stressed ongoing post‑marketing obligations and safety oversight: drug‑delivery devices remain subject to routine regulatory monitoring, inspections, REMS‑type risk‑management reporting, and loss of device clearance could trigger product recalls or market removal [page_52‑54].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) Correctly identifies the evolution of Amgen's regulatory risk disclosures across the three-year period; (2) Accurately captures the 2022 baseline disclosure about drug delivery devices having 'their own regulatory, manufacturing and other risks' and third-party supplier reliance; (3) Properly details the 2023 expansion including device approval complexity, combined product-device submissions, user complaint collection, FDA inspections, and references the specific 2017 Neulasta Onpro review example; (4) Accurately describes 2024 emphasis on post-marketing obligations, routine regulatory monitoring, inspections, REMS-type reporting, and potential product recalls/market removal; (5) Provides specific page references (34, 53-55, 52-54) that ground the answer in source documents; (6) The multi-hop synthesis correctly traces the progression from basic risk acknowledgment (2022) → expanded compliance details (2023) → comprehensive post-market oversight framework (2024). MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer is more detailed and specific than the ground truth (which is generally positive), but the ground truth mentions 'surrogate endpoints and conditional approvals' and specific products like 'Repatha and LUMAKRAS' that the LLM answer does not explicitly address - however, these appear to be illustrative examples in the ground truth rather than core requirements; (2) The LLM answer focuses more on device-specific risks while the ground truth frames this within a broader 'integrated drug-device products' context, though the semantic meaning is equivalent. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. Dates (2022, 2023, 2024) and the 2017 Neulasta reference are all correct. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across years is well-executed. The answer correctly identifies the progression and evolution of disclosure emphasis. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question: compliance requirements, post-marketing obligations, and safety oversight, with clear year-by-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 626,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024 Walmart consistently listed “Parent’s Choice” among its private‑brand portfolio within the **Grocery** strategic unit—the unit that includes baby products and other consumables (see page 7 in each year’s filing). The brand also appears in the International segment’s private‑brand list in 2023‑2024 (see page 9), showing Walmart has kept Parent’s Choice positioned as a core, value‑focused label for baby and consumable items both domestically and globally, reinforcing its everyday‑low‑price strategy for families.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Parent's Choice was consistently positioned within Walmart's Grocery unit across fiscal 2022, 2023, and 2024, and the brand remained focused on baby products and consumables. The answer accurately captures the multi-year continuity and strategic intent around EDLP positioning.\n\nSTRENGTHS:\n- Correctly identifies all three fiscal years (2022, 2023, 2024)\n- Accurately places Parent's Choice in the Grocery unit across all years\n- Correctly notes baby products as part of the category\n- Adds valuable detail about International segment inclusion in 2023-2024\n- Properly synthesizes the strategic positioning around value/EDLP\n- Cites specific page references (page 7, page 9) showing document awareness\n\nWEAKNESSES/MINOR ISSUES:\n- The LLM adds information about International segment positioning that, while potentially accurate, goes slightly beyond what the ground truth explicitly states. The ground truth focuses on domestic Grocery unit positioning without mentioning International segment details.\n- The ground truth emphasizes \"omni-channel convenience strategy\" which the LLM answer doesn't explicitly mention (though it does reference the value strategy)\n- The phrasing \"also appears in the International segment's private-brand list in 2023-2024\" introduces a claim not directly addressed in the ground truth, which could be seen as adding unsourced detail\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three fiscal years and correctly identifies the consistent positioning pattern. The reasoning that this consistency \"reveals\" strategic intent is sound and matches the ground truth's interpretation.\n\nNUMERIC/FACTUAL VERIFICATION:\nNo specific numbers or calculations are involved in this question. The fiscal years cited (2022, 2023, 2024) are correct. The categorization claims (Grocery unit, baby products) align with ground truth.\n\nOVERALL ASSESSMENT:\nThe answer is substantially correct on the main question. The core insight about consistent positioning within Grocery for baby/consumables is accurate. The addition of International segment information, while potentially accurate, represents a minor deviation from the ground truth's scope. The answer demonstrates good understanding of the multi-year evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 630,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 4.70 % Solar Bonds, Series 2015/C24‑10 were originally issued under a supplemental indenture dated April 14 2015 (Exhibit 4.5) and appear unchanged in the exhibit tables of its 2022, 2023 and 2024 Form 10‑K filings (2022 p. 100/102; 2023 p. 99/101; 2024 p. 99/101). The fact that the same 2015 tranche is disclosed each year shows the bonds remain outstanding and are part of a long‑term, fixed‑rate, multi‑tranche solar‑bond program, reflecting Tesla’s strategy of financing solar projects with stable, recurring debt rather than issuing new bonds annually.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond as 4.70% Solar Bonds, Series 2015/C24-10. (2) The date April 14, 2015 for the Thirty-Fifth Supplemental Indenture is accurate. (3) The core observation that the bond appears in 2022, 2023, and 2024 filings is correct. (4) The interpretation that the bond remained outstanding across all three years is sound. (5) The conclusion about a long-term, fixed-rate financing strategy is reasonable. WEAKNESSES: (1) The LLM provides specific page numbers (2022 p. 100/102; 2023 p. 99/101; 2024 p. 99/101) that cannot be verified against the ground truth and may be inaccurate or fabricated. (2) The LLM's answer is narrower in scope than the ground truth - it focuses primarily on the bond remaining unchanged/outstanding rather than exploring the evolution of how it was referenced alongside other series. (3) The ground truth explicitly mentions that in 2023, Tesla referenced this bond 'alongside newer series such as Series 2015/C27-10 and 2015/C32-10,' indicating a pattern of introducing new series while maintaining older ones. The LLM answer does not capture this important contextual evolution. (4) The ground truth notes a 'matured and recurring financing model' with reference to earlier series (C4-10, C9-10) in 2024, suggesting a historical progression. The LLM answer misses this broader historical context. (5) The LLM's conclusion that Tesla does not issue new bonds annually contradicts the ground truth's indication of newer series being introduced in 2023. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to capture the full evolution pattern. It correctly identifies the persistence of the bond but misses the parallel introduction of newer series, which is crucial to understanding Tesla's 'scalable securitization strategy' mentioned in the ground truth. The answer is partially correct but incomplete in addressing how the bond's structuring 'evolved' - it shows persistence but not the full evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 545,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom’s Security Insights Platform has been consistently portrayed as a mainframe‑focused security solution that quickly interprets a mainframe’s security posture, identifies risks and provides remediation steps, with its output designed to be consumed by customers’ in‑house security‑information‑and‑event‑management (SIEM) or other enterprise security tools【page_10】. Across the 2022, 2023 and 2024 10‑K filings this description appears unchanged (see also page 11), underscoring a steady emphasis on mainframe risk assessment while highlighting seamless integration with broader enterprise security tooling.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core functionality of Broadcom's Security Insights Platform and accurately captures that the description remained consistent across 2022, 2023, and 2024. The quantitative elements (years, product names, SIEM integration) are accurate with no calculation errors. However, there are significant qualitative and contextual issues: (1) The LLM claims the description 'appears unchanged' across all three years, which contradicts the ground truth's more nuanced finding that while core capabilities remained stable, there was a 'subtle but meaningful reaffirmation' in 2024 and a 'more deliberate alignment with enterprise-wide security strategies' by 2024. (2) The ground truth explicitly notes evolution in emphasis and presentation across the years ('slightly stronger emphasis on integration' in 2024, 'maturing narrative'), whereas the LLM presents it as completely static. (3) The LLM misses the ground truth's key insight about the evolution of positioning—that while functionality remained consistent, the narrative matured from 2022 to 2024 regarding enterprise integration. (4) The LLM's citation references (page_10, page_11) cannot be verified against the ground truth but appear to be fabricated or unsupported. (5) The answer fails to adequately address the 'evolution' aspect of the question, instead emphasizing consistency. The LLM provides a partially correct but incomplete answer that misses the nuanced evolution in positioning that the ground truth emphasizes as the key finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 423,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Class A shares kept the same rights throughout the period – they continued to carry **one vote per share and full dividend entitlement**.  The per‑share cash dividend rose from **$2.04 in 2022**【page_96】to **$2.37 in 2023**【page_99】and then to **$2.74 in 2024**【page_92】, but the voting‑right description (“One vote per share Dividend rights”) remained unchanged in each filing【page_96】【page_99】【page_92】.  \n\nThis steady‑state dual‑class structure shows Mastercard’s deliberate strategy to preserve a stable governance framework that protects public shareholders’ voting power while delivering a predictable, growing dividend, underscoring a focus on capital‑structure consistency and shareholder‑value continuity over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that A Class shares maintained one vote per share and dividend rights consistently across 2022-2024, matching the ground truth. (2) Provides additional valuable context by including specific dividend per-share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) with proper citations, which demonstrates thorough research and adds substantive detail beyond the ground truth. (3) Accurately synthesizes the multi-hop information: identifies the consistency of voting rights, notes the unchanged voting-right description across filings, and connects this to MA's capital structure strategy. (4) The reasoning is sound - correctly interprets that stable voting rights combined with growing dividends reflects a deliberate strategy for governance preservation and shareholder value. (5) Properly identifies the company as Mastercard (MA) and correctly references the three-year period. MINOR CONSIDERATIONS: (1) The LLM answer goes beyond the ground truth by including specific dividend amounts, which while accurate and helpful, represents additional information not explicitly in the original answer. However, this is additive rather than contradictory. (2) The characterization of the structure as 'dual-class' is accurate for Mastercard's overall structure, though the question specifically focuses on A Class shares. This is contextually appropriate and accurate. QUANTITATIVE VERIFICATION: The dividend amounts provided ($2.04, $2.37, $2.74) appear reasonable for a company like Mastercard and show logical progression, though they cannot be independently verified against the provided ground truth. The citations to specific pages suggest proper sourcing. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the consistency of voting rights to broader capital structure strategy, which is exactly what the question asks for.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 530,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen’s 2022 10‑K shows Bemarituzumab entered a Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma (while still in Phase 2 for other tumors and Phase 1 for NSCLC) and that composition‑of‑matter patents were issued in the U.S. and Europe with estimated expirations in 2029 (see 2022 page 25 and patent table on page 26). The 2023 filing (page 24) and the 2024 filing (page 24) both list the same three‑phase portfolio (Phase 3 GEJ adenocarcinoma, Phase 2 other tumors, Phase 1 NSCLC) and the same U.S./Europe patents still projected to expire in 2029 (see patent tables on each year’s page 26), indicating a consistent development path and a long‑term IP protection strategy with pending applications in other jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key clinical trial phases and patent expiration dates. Strengths: (1) Correctly identifies Phase 3 trial for GEJ adenocarcinoma initiated in 2022, Phase 2 for other tumors, and Phase 1 for NSCLC; (2) Accurately states patent expiration dates of 2029 for both U.S. and Europe; (3) Provides specific page references to 10-K filings (pages 25-26) which adds credibility; (4) Correctly synthesizes multi-hop information across 2022-2024 filings showing consistent development trajectory. Weaknesses: (1) The LLM answer provides more granular detail about the multi-phase portfolio structure than the ground truth, which focuses on the evolution narrative; (2) The ground truth emphasizes the 'progression' and 'transition' from early-phase to mature asset, while the LLM emphasizes 'consistency' - these are subtly different interpretations of the same data; (3) The LLM mentions 'pending applications in other jurisdictions' which is not explicitly mentioned in the ground truth, though this is a reasonable inference from patent strategy discussions. Quantitative verification: Patent expiration date of 2029 is correct in both answers. Clinical trial phases (Phase 3 GEJ, Phase 2 other, Phase 1 NSCLC) are correctly identified. Multi-hop reasoning is sound - the answer successfully synthesizes information across three years of filings. The answer is more detailed and specific than the ground truth but maintains semantic equivalence on all core facts. Minor deduction for the subtle narrative difference (consistency vs. progression) and the addition of details not explicitly in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 458,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "- In the 2022 Form 10‑K, Walmart listed “No Boundaries” among its private‑label portfolio and placed it in the **Apparel** sub‑category of the General‑merchandise unit (see 2022 p. 7, “Apparel …” and private‑brand list that includes “No Boundaries”)​【page_7】.  \n- In the 2023 and 2024 filings the same brand still appears in the private‑brand list (2023 p. 8; 2024 p. 8) but the sub‑category was renamed to **Fashion** (2023 p. 7 and 2024 p. 7, “Fashion (e.g., apparel for adults and children …)”).  \n\nThis shows that “No Boundaries” has consistently been positioned within Walmart’s apparel offering, while the company’s strategic merchandise units have evolved from a generic “Apparel” label in 2022 to a distinct “Fashion” focus in 2023‑2024, indicating a shift toward a more style‑oriented, fashion‑centric private‑brand strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies 'No Boundaries' categorization in 2022 as 'Apparel' and in 2023-2024 as 'Fashion' - matching the ground truth exactly. (2) Accurately cites page numbers from the respective 10-K filings (2022 p. 7, 2023 p. 8, 2024 p. 8), demonstrating proper source documentation. (3) Correctly synthesizes the multi-hop information showing the evolution across three years (2022-2024). (4) Properly interprets the strategic shift from 'Apparel' to 'Fashion' as indicating a more style-oriented, fashion-centric approach. (5) Maintains semantic equivalence with ground truth regarding the continuity of 'No Boundaries' as a consistent private brand while its categorization evolved. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which also mentions 'omni-channel offerings and customer-centric experiences' as context for the strategic realignment. However, this omission does not constitute a factual error - it's a matter of depth rather than accuracy. (2) The LLM answer focuses more on the naming/categorization shift itself rather than the broader strategic implications, but still captures the essential insight about fashion-centric positioning. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies the multi-hop synthesis (tracking one brand across three years and two different categorization schemes) and draws appropriate conclusions about strategic intent. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding how 'No Boundaries' fit within evolving strategic units and what this reveals about shifting focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 496,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM’s 10‑K filings show a steady, deepening focus on client relationships and trust as a core competitive edge. In 2022 the company listed “client relationships and trust” among its principal competition factors and tied trust directly to its hybrid‑cloud platform (“trust and security”) (2022 p4). In both the 2023 and 2024 filings the same language re‑appears in the competition section (2023 p3; 2024 p3), now framed as essential to delivering value through IBM’s hybrid‑cloud and AI offerings. This continuity signals that IBM is positioning its hybrid‑cloud/AI strategy around a trusted, client‑centric model that differentiates its secure, integrated solutions from rivals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of IBM's positioning on client relationships and trust across the 2022-2024 period, with generally accurate facts and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies that IBM emphasized 'client relationships and trust' as a principal competitive factor across all three years (2022, 2023, 2024); (2) Accurately notes the consistent appearance of this language in competition sections of 10-Ks; (3) Properly synthesizes the connection between trust positioning and hybrid cloud/AI strategy; (4) Correctly identifies the core insight that trust is a differentiator tied to secure, integrated solutions. WEAKNESSES: (1) The LLM answer lacks the key evolution detail present in ground truth - that by 2024, IBM expanded trust positioning through 'strategic partnerships with hyperscalers and global system integrators.' The ground truth explicitly states this ecosystem collaboration dimension emerged in 2024, representing a meaningful evolution beyond 2022-2023; (2) The answer states trust was 'tied directly to its hybrid-cloud platform' in 2022, but ground truth indicates 2022 presented trust as one of several principal competitive methods (alongside technology innovation and performance), not specifically tied to hybrid cloud at that stage; (3) Missing the 2023-specific detail about explicitly linking trust to 'delivering business value and solving complex client challenges through integrated technologies'; (4) Page citations (p4, p3, p3) are provided but cannot be verified against ground truth, and the specific quote about 'trust and security' in 2022 is not confirmed in ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects trust positioning to hybrid cloud/AI strategy, though it misses the partnership ecosystem evolution that represents the key progression. SEMANTIC EQUIVALENCE: The core message about consistent trust focus is conveyed, but the evolution narrative is incomplete - the answer presents more of a static continuity story rather than capturing the dynamic expansion through partnerships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 575,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 were issued in a supplemental indenture dated April 14 2015 and have been listed in every subsequent 10‑K filing – as Exhibit 4.36 in the 2022 report (page 100) 【page_100】, again as Exhibit 4.36 in the 2023 report (page 99) 【page_99】, and still appearing in the 2024 exhibit schedule (also as Exhibit 4.36) 【page_99】. The bond’s continual presence across three years shows it remains outstanding and that Tesla (via SolarCity) relies on this fixed‑rate solar‑bond series as a core, long‑term financing tool for its solar business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the bond series (5.45% Solar Bonds, Series 2015/C25-15), the supplemental indenture date (April 14, 2015), and consistent exhibit numbering (Exhibit 4.36) across all three years (2022, 2023, 2024). The page references provided (page 100 for 2022, page 99 for 2023 and 2024) add specificity and verifiability. The quantitative elements are accurate: the bond percentage (5.45%), the year of issuance (2015), and the indenture date are all correct. The multi-hop reasoning is sound—the answer correctly synthesizes information across three years of filings to demonstrate the bond's persistent presence and ongoing reliance. The conclusion about Tesla's consistent solar asset-backed financing strategy is logically supported by the evidence of continuous disclosure. Minor strengths: the answer provides specific exhibit locations and page numbers, enhancing credibility. Minor weaknesses: the answer could have been slightly more explicit about what the 3-year pattern indicates about strategy evolution (though it does address this adequately). The LLM answer is more concise and specific than the ground truth while conveying equivalent information. The semantic meaning aligns well with the original answer's conclusion about consistent reliance on this financing instrument. No calculation errors detected. All entities (Tesla, SolarCity, bond series, dates, years) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 412,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Emerson’s Safety & Productivity segment has moved beyond the traditional pipe‑wrenches, cutters, threading and roll‑grooving gear that defined its 2022 offering to add **battery‑hydraulic press‑connection tools** (and other battery‑powered hydraulic tools) to its pipe‑working portfolio 【page_73】. By integrating cordless, battery‑driven technology, Emerson is positioning the segment as an innovator in the professional‑tools market, emphasizing portable, high‑performance solutions that meet modern trades‑person demands.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from traditional pipe-working tools (pipe wrenches, cutters, threading equipment) in 2022 to battery-hydraulic tools by 2023-2024. (2) Accurately captures the shift toward cordless, battery-powered technology as a strategic positioning move. (3) Correctly emphasizes portability and efficiency as key market drivers. (4) No quantitative errors in dates or numbers cited. WEAKNESSES: (1) INCOMPLETE TEMPORAL COVERAGE: The LLM answer only explicitly addresses 2022 and the general 2023-2024 period, but fails to provide the detailed year-by-year progression that the ground truth establishes. The ground truth specifically documents 2022 offerings, 2023 expansion to battery hydraulic tools for press connections, and 2024 further integration including battery hydraulic tools for cutting/crimping cables plus sewer inspection cameras. (2) MISSING PRODUCT DETAILS: The LLM omits several key product categories mentioned in ground truth: diagnostic systems, closed-circuit television for pipe inspection (2022), sewer inspection cameras and locating equipment (2024). The mention of 'battery hydraulic tools for cutting and crimping electrical cables' is entirely absent from LLM answer. (3) INCOMPLETE SYNTHESIS: While the LLM identifies battery-hydraulic press-connection tools, it doesn't synthesize the full range of innovations across the three-year period or explain how the product portfolio evolved systematically. (4) MISSING STRATEGIC INSIGHT: The ground truth emphasizes the 'consistent mention of pipe wrenches across all three years' as underscoring their foundational role—this contextual detail is absent from LLM answer. (5) SHALLOW ANALYSIS: The LLM provides less comprehensive strategic positioning analysis than ground truth, which explicitly connects the evolution to 'deliberate effort to strengthen competitive position' through 'technology integration.' The LLM answer reads as a partial summary rather than a complete multi-hop synthesis of the 2022-2024 evolution. MULTI-HOP REASONING: The question requires synthesizing product offerings across three years (2022, 2023, 2024) and connecting them to strategic positioning. The LLM partially accomplishes this but with significant gaps in the temporal and product detail required for a complete answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 623,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "- In the 2022 10‑K Gilead noted that its existing properties—including the El Segundo, CA plant used for clinical and commercial cell‑therapy manufacturing—were “adequate and suitable” and that its capital resources were sufficient to purchase, lease or construct additional facilities as needed for long‑term growth【page_33】.  \n- By the 2023 filing the company was explicitly investing in expanding cell‑therapy manufacturing capacity at El Segundo as part of a broader effort to develop additional biologics capabilities, describing the site’s continued use for both clinical and commercial cell‑therapy production【page_11】.  \n- The 2024 filing reiterates El Segundo’s role in cell‑therapy manufacturing and ties those investments to Gilead’s strategic priority of growing its biologics pipeline through collaborations, in‑licensing and acquisitions, reflecting a shift from a generic capital‑resource statement to a targeted allocation that aligns the El Segundo site with the company’s overall biologics development agenda【page_10】【page_11】【page_8】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims that in 2022, El Segundo was 'used for clinical and commercial cell-therapy manufacturing,' but the ground truth explicitly states that in 2022, El Segundo was listed 'among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but WITHOUT SPECIFIC EMPHASIS ON CELL THERAPY.' This is a major mischaracterization of the 2022 baseline. The ground truth shows a clear EVOLUTION: 2022 (general manufacturing) → 2023 (explicit cell therapy focus) → 2024 (continued cell therapy with emphasis on proprietary processes). The LLM incorrectly backdates the cell therapy specialization to 2022, which undermines the entire narrative of strategic evolution that the question asks about. The 2023 and 2024 descriptions are more aligned with ground truth, though the LLM's 2023 language about 'expanding capacity' is slightly different from the ground truth's 'explicitly identified as dedicated site' (a distinction between expansion vs. new designation). The LLM also adds page references (page_8, page_11) that may or may not be accurate to the actual filings. The reasoning about alignment with biologics development is present but the foundational error about 2022 severely compromises the multi-hop synthesis. The answer fails to capture the key insight that El Segundo underwent a strategic transformation FROM general manufacturing TO specialized cell therapy focus, which is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 436,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 1.250 % Notes due 2027 (ticker IBM27B) are shown in the Section 12(b) securities‑registration table, indicating the notes had been issued and were formally registered (IBM 2022 10‑K p. 29). The 2023 filing drops the note from that table and instead incorporates the note’s indenture by reference, pointing to the 2019 Form 8‑K exhibits that define the holders’ rights (IBM 2023 10‑K p. 20). By the 2024 Form 10‑K the note re‑appears in the Section 12(b) securities list, confirming it remains outstanding and is again disclosed as a registered security (IBM 2024 10‑K p. 1).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) TICKER SYMBOL ERROR: The LLM claims the ticker is 'IBM27B' in 2022, but the ground truth indicates this ticker only appears in 2024 as part of the formal listing on NYSE. The 2022 filing would not have included this ticker symbol. (2) SECTION 12(b) MISCHARACTERIZATION: The LLM states the notes appear in the Section 12(b) securities-registration table in 2022 and 2024, but the ground truth indicates the notes were disclosed as part of exhibit lists and indenture references, not necessarily in Section 12(b) tables. (3) 2023 FILING CONTRADICTION: The ground truth states IBM 'continued to reference' the notes in 2023 with specific filing dates (February 8, 2022, and February 3, 2023), but the LLM claims the note was 'dropped' from the table in 2023. This is a direct contradiction. (4) PROGRESSION MISREPRESENTED: The ground truth describes a progression from 'internal documentation and reference to public issuance and trading,' with the formal NYSE listing occurring in 2024. The LLM incorrectly suggests the notes were already registered and listed in 2022. (5) PAGE REFERENCES UNVERIFIABLE: The LLM provides specific page numbers (p. 29, p. 20, p. 1) that cannot be verified against the ground truth and appear to be fabricated details. The core narrative of the LLM answer—that the notes moved from Section 12(b) table to indenture reference back to Section 12(b)—does not align with the ground truth's description of a progression toward formal market listing. The LLM demonstrates weak multi-hop reasoning by failing to correctly synthesize the evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 466,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 each list the 5.45 % Solar Bonds, Series 2015/C45‑15 (2022 p. 101; 2023 p. 99; 2024 p. 99), showing that the original SolarCity debt remains a recurring financing element. In the same exhibit tables the company also reports later supplemental indentures for additional tranches—e.g., Series 2015/C53‑15 and C57‑15 (2022 p. 104) and Series 2015/C62‑15 (2022 p. 102)—indicating that Tesla has been extending and refinancing the same bond framework to fund its solar business, reflecting a consistent but evolving debt‑financing strategy for solar growth from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core bond series (5.45% Solar Bonds, Series 2015/C45-15) and its multi-year presence across 2022-2024 filings, which is accurate. The numeric references to bond series (C53-15, C57-15, C62-15) are also correctly cited. However, the answer has significant weaknesses: (1) It fails to mention the 2015/C72-15 bond series that the ground truth identifies as referenced in 2024, representing an incomplete synthesis of the multi-year evolution. (2) The LLM answer provides page number citations (p. 101, 99, 104, 102) that cannot be verified against the ground truth and may be inaccurate, though this is a minor issue. (3) Most critically, the LLM answer lacks the strategic insight present in the ground truth—it describes the bonds as 'recurring' and 'evolving' but fails to articulate the deliberate capital structure strategy, the scalable/repeatable financing model, the reduction of reliance on traditional corporate debt, and the alignment of capital with asset performance. The ground truth emphasizes an 'iterative approach' and 'standardized, asset-backed instruments' as part of a deliberate strategy, while the LLM answer merely notes 'extending and refinancing.' (4) The answer correctly identifies the SolarCity inheritance but doesn't fully develop the implications of this progression for Tesla's solar financing strategy. The multi-hop reasoning is partially sound but incomplete—it synthesizes information across years but misses key bond series and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 421,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In the 2022 Form 10‑K Adobe framed Acrobat as the core of its Document Cloud platform, stressing that Adobe Sensei‑driven AI makes PDFs “more intelligent and responsive,” that Acrobat enjoys a leadership position in document‑intensive verticals such as government, financial services, legal, pharmaceutical and aerospace, and that the service is being broadened through Acrobat Web, mobile, API and Adobe Sign integrations (see 2022 pages 5‑6). The 2024 filing (pages 94‑98) contains no refreshed discussion of Acrobat’s strategy, suggesting Adobe has continued to rely on the same AI‑centric, industry‑focused, platform‑wide positioning without a substantive shift.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the multi-hop question about Acrobat's evolution from 2022-2024:\n\n(1) WHAT WAS CORRECT:\n- Correctly identifies 2022 positioning with Document Cloud platform emphasis\n- Accurately mentions Adobe Sensei AI integration in 2022\n- Correctly identifies document-intensive industries (government, financial services, legal, pharmaceutical, aerospace)\n- Correctly notes Adobe Sign integration and multi-channel expansion (Web, mobile, API)\n- Page references (2022 pages 5-6, 2024 pages 94-98) appear specific and plausible\n\n(2) CRITICAL OMISSIONS AND ERRORS:\n- FAILS to address the 2023 evolution: The ground truth explicitly states Adobe introduced forward-looking AI innovation statements in 2023, signaling a strategic pivot. The LLM completely omits 2023 from analysis, breaking the multi-hop synthesis across the three-year period.\n- FAILS to mention 'Acrobat AI Assistant' trademark introduction in 2024: This is a concrete, factual milestone in the ground truth representing the realization of AI strategy. The LLM dismisses 2024 as having \"no refreshed discussion,\" directly contradicting the ground truth.\n- MISCHARACTERIZES the evolution: The LLM claims \"no substantive shift\" from 2022 to 2024, but the ground truth shows clear progression from market leadership → AI vision → AI product realization.\n- INCOMPLETE SYNTHESIS: The question asks about evolution \"from 2022 to 2024\" - this requires analyzing all three years. The LLM only compares 2022 and 2024, missing the critical 2023 transition point.\n\n(3) MULTI-HOP REASONING ASSESSMENT:\nThe question requires synthesizing information across three fiscal years to show evolution. The LLM:\n- Correctly identifies 2022 baseline\n- Completely misses 2023 strategic pivot\n- Incorrectly concludes 2024 shows no change (contradicts ground truth)\n- Fails to construct the narrative arc of evolution\n\n(4) JUSTIFICATION FOR SCORES:\n- Correctness Score (4/10): While individual 2022 facts are accurate, the answer fundamentally fails the multi-hop requirement by omitting 2023 and mischaracterizing 2024. The conclusion that there was \"no substantive shift\" directly contradicts the ground truth's documented evolution.\n- Quantitative Accuracy (6/10): Page numbers and year citations are present, but the factual claim about 2024 content is incorrect (ground truth shows Acrobat AI Assistant was introduced).\n- Qualitative Accuracy (3/10): The reasoning fails to synthesize across the three-year period and reaches an incorrect conclusion about the lack of evolution.\n- Contextual Relevance (5/10): Addresses some relevant aspects of 2022 positioning but fails to answer the core question about how positioning evolved through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 730,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was the core RIA portal, providing interactive tools such as account‑servicing, multi‑year archiving, document search and the free Schwab Advisor Portfolio Connect, together with integrations to third‑party CRM, portfolio‑management and planning platforms【page_7】. After the TD Ameritrade merger, the 2023 filing notes that Schwab added Ameritrade’s thinkpipes real‑time charting/trading platform and the iRebal portfolio‑rebalancing solution to its RIA toolkit【page_8】. By 2024 the company was actively integrating thinkpipes and iRebal into its ongoing Schwab platform, further expanding the interactive toolset and integration capabilities for RIAs【page_9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. CORRECT ELEMENTS: (1) Correctly identifies 2022 as having Advisor Services website with account-servicing and third-party integrations; (2) Correctly mentions Schwab Advisor Portfolio Connect; (3) Correctly identifies 2023-2024 timeframe for platform evolution. MAJOR ERRORS: (1) The LLM introduces 'thinkpipes' and 'iRebal' as TD Ameritrade acquisitions integrated in 2023-2024, but the ground truth makes no mention of these tools at all. This appears to be a hallucination or confusion with actual TD Ameritrade products that may not have been integrated into Schwab's RIA offerings as described; (2) The LLM claims 'multi-year archiving' and 'document search' were 2022 features, but ground truth only mentions 'account servicing capabilities and access to third-party integrations'; (3) The LLM's narrative about TD Ameritrade merger integration is not supported by the ground truth, which focuses on Schwab's own platform evolution without mentioning specific Ameritrade tool acquisitions. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but introduces unsupported details about post-merger integrations. The ground truth emphasizes consistent focus on Advisor Services website and Schwab Advisor Portfolio Connect, with general mention of expanding third-party integrations—not specific tools like thinkpipes and iRebal. QUANTITATIVE ISSUES: No specific numbers to verify, but the factual claims about which tools were available when are incorrect. The answer reads plausibly but contains material inaccuracies that would mislead someone researching Schwab's actual RIA platform evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 464,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson’s 2022 filing lists Air Preparation Equipment as a core component of its Discrete Automation portfolio, grouped with solenoid and pneumatic valves, cylinder‑actuators, pressure‑ and temperature‑switches, and other pneumatic hardware (see page 6). In the 2023 and 2024 filings the Discrete Automation description expands to explicitly include “programmable automation control systems and software,” positioning Air Preparation Equipment as an integrated part of both pneumatic hardware and digital control solutions (see page 73). This evolution shows Emerson moving the product from a standalone pneumatic offering toward a more tightly‑linked role within broader, software‑enabled automation architectures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and lacks completeness compared to the ground truth. STRENGTHS: (1) Correctly identifies 2022 positioning with pneumatic components (solenoid valves, actuators, pressure switches) - matches ground truth; (2) Correctly notes 2023-2024 expansion to include programmable automation control systems and software; (3) Correctly identifies the overall evolution from mechanical to digitally integrated focus; (4) Proper company identification (Emerson/EMR) and segment (Discrete Automation). WEAKNESSES: (1) INCOMPLETE COVERAGE OF 2024: The ground truth explicitly mentions 2024 evolution toward 'smart actuation, predictive maintenance capabilities, and secure wireless communication' aligned with Industry 4.0 and digital transformation. The LLM answer does not address these 2024-specific advancements at all, treating 2023-2024 as a single combined period; (2) MISSING INDUSTRY CONTEXT: Ground truth provides specific application domains (food processing, life sciences, petrochemical processing) that contextualize the equipment's role. LLM omits these; (3) VAGUE PAGE REFERENCES: LLM cites 'page 6' and 'page 73' without verification these are accurate filing references, and the page numbers differ significantly (suggesting possible citation errors); (4) INCOMPLETE SYNTHESIS: The answer fails to fully synthesize the 3-year progression as a distinct narrative arc. Ground truth shows clear progression: mechanical focus (2022) → digital control alignment (2023) → Industry 4.0 integration (2024). LLM collapses 2023-2024 into a single evolution step; (5) MISSING KEY CONCEPTS: Ground truth emphasizes 'interoperability,' 'predictive maintenance,' and 'secure wireless communication' as 2024 differentiators. These are absent from LLM response. QUANTITATIVE ACCURACY: No specific numbers or calculations to verify, but the structural/temporal accuracy is incomplete (missing 2024 details). QUALITATIVE ACCURACY: Multi-hop reasoning is partially sound but incomplete - the answer synthesizes 2022-2023 evolution but fails to complete the 3-year arc with 2024 specifics. The semantic meaning partially matches but lacks critical details that distinguish the 2024 positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 600,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 2022 10‑K lists the 0.125 % notes due 2029 only once, tied to the September 18 2020 Form 8‑K filing (Exhibit 4.23)【page_134】; the 2023 filing repeats that single reference (Exhibit 4.23)【page_135】. By the 2024 10‑K the notes appear again under the 2020 reference and also under a new March 9 2021 filing (Exhibit 4.31)【page_130】【page_131】, showing that Coca‑Cola initially issued the low‑coupon 2029 notes in 2020 and then re‑registered or expanded the series in 2021, using it as a recurring, low‑cost financing tool to manage near‑term debt within its broader debt program.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that fundamentally misalign with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the 0.125% Notes due 2029 were 'initially issued in 2020' and 're-registered or expanded in 2021,' but provides no evidence these dates are correct or that this interpretation is supported by the filings. The ground truth does not confirm these specific issuance dates. (2) INCOMPLETE ANALYSIS: The LLM focuses narrowly on exhibit references and filing dates (Sept 18 2020, March 9 2021) without addressing the core question about how the issuance STRATEGY evolved from 2022-2024. The ground truth explicitly discusses the strategic evolution: passive disclosure in 2022 → consolidated format in 2023 → introduction of higher-yielding instruments in 2024 (5.000% Notes due 2034, 5.400% Notes due 2064). The LLM completely omits this critical strategic pivot. (3) MISSING MULTI-HOP SYNTHESIS: The question asks about the pattern's implications for managing near-term debt obligations in context of broader financing. The ground truth correctly identifies this as a refinancing strategy as the 2029 note approached maturity. The LLM merely states it was used as a 'recurring, low-cost financing tool' without connecting this to the strategic shift toward longer-term instruments or the maturity management strategy. (4) REASONING QUALITY: The LLM's conclusion that the notes were used as a 'recurring, low-cost financing tool' contradicts the ground truth's finding that the company was strategically pivoting AWAY from these low-yielding instruments toward higher-yielding longer-term debt. (5) CONTEXTUAL MISALIGNMENT: The LLM answer reads like a technical exhibit-tracking exercise rather than a strategic analysis of debt management evolution. It fails to synthesize the three-year pattern into meaningful insights about the company's financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 518,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s filings from 2022 through 2024 all contain the same risk‑factor language: the company’s ability to return capital to shareholders – including dividend payments and share‑repurchase programs – is at the Board’s discretion but can be restricted by U.S. banking laws and capital‑planning regulations, Delaware law and any failure to pay preferred‑stock dividends (2022 10‑K p.5; 2023 10‑K p.5; 2024 10‑K p.5). The Parent’s reliance on subsidiary dividends and credit to fund share repurchases further underscores this regulatory constraint, and the wording of the disclosure remains unchanged across the three years (2022 10‑K p.4; 2023 10‑K p.4; 2024 10‑K p.4).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The original answer explicitly states that BNY Mellon's disclosures EVOLVED from 2022 to 2024, showing 'a trend of increasing specificity and formalization' - moving from general caution in 2022 to more specific references to regulatory standards like 'well capitalized' status and capital adequacy rules by 2024. The LLM answer directly contradicts this by claiming 'the wording of the disclosure remains unchanged across the three years' and that filings 'contain the same risk-factor language.' This is a critical factual error that misses the entire premise of the question about evolution over time. The LLM correctly identifies the regulatory constraints mentioned (U.S. banking laws, Delaware law, preferred stock dividends, capital adequacy rules), but fails to recognize or describe the evolution in how these constraints are communicated. The LLM also provides specific page citations (p.5 and p.4) without verification against actual filings, which cannot be confirmed as accurate. The answer is internally consistent but fundamentally incorrect regarding the key finding: that regulatory language became MORE SPECIFIC and FORMALIZED over the 2022-2024 period, not static. This represents a failure in multi-hop reasoning to synthesize the evolution across three years of filings, which was the central requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 397,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the 2022 (page 6), 2023 (page 6) and 2024 (page 6) 10‑K filings, McDonald’s repeatedly lists McGriddles as a regular breakfast sandwich—“Egg McMuffin, Sausage McMuffin with Egg and McGriddles…”—within a broader description that the menu is continuously evolving and new products are being tested. The identical wording each year shows that McGriddles is treated as a core, enduring breakfast item, revealing a consistent breakfast strategy that keeps staple products stable while pursuing broader menu innovation elsewhere.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that McGriddles remained consistently portrayed across 2022-2024 as a stable breakfast item without specific innovation details. The answer accurately captures the key insight about consistency in breakfast strategy and the contrast between stable core products and broader menu innovation. However, there are some notable differences from the ground truth: (1) The LLM cites page 6 for all three years, while the ground truth specifies page 7 for 2022 and page 6 for 2023 and 2024—this is a minor discrepancy but suggests potential imprecision in source attribution. (2) The LLM provides the exact quoted phrase 'Egg McMuffin, Sausage McMuffin with Egg and McGriddles' which demonstrates accurate textual synthesis, while the ground truth paraphrases similarly. (3) The LLM correctly synthesizes the multi-hop reasoning: it identifies the consistency across three years, notes the contrast between static McGriddles presentation and dynamic broader menu innovation language, and draws the appropriate conclusion about breakfast strategy stability. (4) The LLM appropriately references the company's stated positions on 'continuous evolution' and 'testing new products' while showing these didn't apply to McGriddles specifically. The answer is semantically equivalent to the ground truth and demonstrates sound multi-hop reasoning across the three filing years. The main weakness is the page number attribution inconsistency and slightly less detailed documentation of the specific years/sources compared to the ground truth's explicit citation format.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 440,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe said its Digital Learning Services “includes a large number of free online self‑service learning options on learning.adobe.com” together with an extensive fee‑based program portfolio【page_18】.  \n- The 2023 filing moves the free self‑service catalog to “www.training.adobe.com” while still describing it as part of Adobe Digital Learning Services and noting the same fee‑based offerings【page_17】.  \n- The 2024 filing repeats that positioning, again listing the free self‑service options on www.training.adobe.com as a core component of Adobe Digital Learning Services【page_17】.  \n\nThus, Adobe’s emphasis on free online self‑service learning has remained a core element of its Digital Learning Services, but the delivery URL shifted from learning.adobe.com in 2022 to www.training.adobe.com in 2023 and continues on that platform in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer directly contradicts the ground truth on the core factual claim about platform URLs across the three years. Ground Truth states: 2022 used www.training.adobe.com, 2023 shifted to learning.adobe.com, and 2024 continued with learning.adobe.com. LLM Answer claims the OPPOSITE: 2022 used learning.adobe.com, 2023 shifted to www.training.adobe.com, and 2024 continued with www.training.adobe.com. This is a fundamental factual reversal of the 3-year trajectory. The LLM also fails to capture the ground truth's key insight about the strategic evolution: the shift from training.adobe.com to learning.adobe.com represented a 'more centralized or rebranded approach' and 'deeper integration into a comprehensive portfolio,' suggesting maturation of the digital learning strategy. Instead, the LLM presents the opposite directional change. Additionally, the LLM provides page citations (page_18, page_17) without verification against actual filing content, which is problematic given the factual inaccuracies. The answer does correctly identify that free self-service learning remained a core component across all three years and that fee-based offerings were also part of the portfolio, but these correct elements are overshadowed by the fundamental error in the platform URL timeline. The reasoning structure is sound, but it is applied to incorrect facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 385,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "- In the 2022 filing Emerson placed commercial vacuums in the Safety & Productivity segment under “Other professional tools” together with bolt cutters, describing them as part of the segment’s professional‑tools portfolio【page_9】.  \n- In the 2023 and 2024 filings the same categorization was retained, but the segment narrative was sharpened to stress tools that support infrastructure, safety and productivity for professionals, listing commercial vacuums alongside water‑jetters, wet‑dry vacuums and broader hand‑tool offerings (replacing “bolt cutters” with “hand tools”)【page_73】【page_73】.  \n\nThus, while commercial vacuums remained classified as “other professional tools,” Emerson’s wording evolved to give the segment a clearer professional‑tools focus and to align the vacuums more tightly with its broader professional‑tools strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Commercial Vacuums were in the Safety & Productivity segment in 2022, but the ground truth explicitly states they were in the 'Tools & Home Products segment' in 2022. This is a fundamental mischaracterization of the 2022 positioning. (2) INCORRECT CATEGORIZATION - The LLM describes Commercial Vacuums as grouped with 'bolt cutters' in 2022, which is not mentioned in the ground truth. The ground truth lists them with 'water jetters and wet-dry vacuums' in 2022. (3) MISSING KEY EVOLUTION - The LLM fails to capture the critical 2022-to-2023 transition where Commercial Vacuums moved FROM Tools & Home Products TO Safety & Productivity segment. This is the core evolution the question asks about. (4) INCOMPLETE STRATEGIC SHIFT - The ground truth emphasizes a shift toward 'more technologically advanced and industrial productivity tools' (programmable automation control systems, electrical distribution equipment) in 2024, which the LLM completely misses. Instead, the LLM vaguely mentions 'broader hand-tool offerings' which is not supported by the ground truth. (5) MISREPRESENTATION OF ALIGNMENT - The ground truth shows Commercial Vacuums being aligned with infrastructure/safety tools (battery hydraulic tools, sewer inspection cameras) in 2023, then with more advanced industrial tools in 2024. The LLM's description of this evolution is superficial and inaccurate. (6) CITATION ISSUES - The LLM cites 'page_9' and 'page_73' but provides no verification that these citations support the claims made. The factual content contradicts the ground truth regardless of citation placement. The LLM answer fundamentally misrepresents the 2022 segment placement and fails to capture the strategic repositioning that occurred between 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 507,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has consistently been identified as a commercial‑manufacturing and processing location for its cell‑therapy products, with no indication that its role has expanded to clinical manufacturing. The 2023 10‑K states the facility is used for “commercial manufacturing and processing of our cell therapy products”【page_11†L...】, and the 2024 filing repeats the same description【page_10†L...】, showing that its utilization has remained unchanged from 2022 through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the key finding. Ground truth states there was a 'strategic shift' and 'progression' showing 'growing emphasis' on cell therapy at Hoofddorp from 2022-2024, with 2022 described as 'principal manufacturing site' (general), 2023-2024 explicitly as 'commercial manufacturing and processing of cell therapy products' (specific). The LLM incorrectly claims utilization 'remained unchanged from 2022 through 2024,' which directly contradicts the documented evolution from general principal manufacturing to explicit cell therapy focus. QUANTITATIVE ACCURACY: Numbers and dates (2022, 2023, 2024) are correct; no calculation errors. QUALITATIVE ACCURACY: The LLM failed the core multi-hop synthesis task. It correctly identified that 2023 and 2024 filings describe the facility for 'commercial manufacturing and processing of cell therapy products,' but failed to: (1) recognize the 2022 baseline was described differently (as 'principal manufacturing site' without explicit cell therapy specification), (2) synthesize the progression across three years, (3) identify the strategic shift toward cell therapy specialization. The statement 'no indication that its role has expanded to clinical manufacturing' is a tangential point not central to the question. CONTEXTUAL RELEVANCE: The answer addresses the facility and years mentioned but misses the core question about 'evolution' and 'progression.' The question explicitly asks 'how has...evolved,' requiring comparison across the three-year period to show change. The LLM's conclusion of 'unchanged' is the opposite of what the evidence shows. This is a fundamental failure in multi-hop reasoning despite having access to the correct source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 487,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s exhibit indexes in each of its recent 10‑K reports list the same low‑cost tranche – the 1.000 % Notes due 2028 (Exhibit 4.26) – showing that the company has kept this cheap, medium‑term debt as a core financing source across 2022, 2023 and 2024【page_134†L1-L4】【page_130†L1-L4】.  In the 2024 filing the company also introduced new, higher‑coupon issues – 5.000 % Notes due 2034 and 5.400 % Notes due 2064 (Exhibits 4.39 and 4.41) – indicating a strategic shift to accept higher interest costs in order to extend the maturity profile and diversify its capital structure, balancing low‑cost debt with longer‑dated, higher‑yield financing【page_130†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the multi-hop question. QUANTITATIVE ACCURACY: All numeric values are correct - 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are all accurately cited with correct percentages and maturity dates. No calculation errors present. ENTITY ACCURACY: Coca-Cola correctly identified, all debt instruments properly named, years 2022-2024 correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings (2022, 2023, 2024) and correctly identifies the persistent reference to the 1.000% Notes while noting the introduction of higher-yield instruments in 2024. The logical connection between these facts and their implications for capital structure management is sound. COMPLETENESS: The answer addresses all key aspects of the question - the persistent low-cost debt, the introduction of higher-yield notes, and the strategic implications for debt financing costs and capital structure management. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as \"a strategic shift to accept higher interest costs in order to extend the maturity profile and diversify its capital structure\" aligns well with the ground truth's description of \"recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.\" MINOR CONSIDERATIONS: The LLM provides slightly more specific detail about exhibit numbers (4.26, 4.39, 4.41) and uses more technical language (\"tranche,\" \"coupon issues\") which adds precision without introducing errors. The citation format with page references adds credibility. No factual errors or omissions of significance were identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 483,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s Safety & Productivity segment – the home of its pipe‑working tools – has broadened the pipe‑cutter line from traditional manual cutters (2022) to a portfolio that now stresses battery‑hydraulic cutters and built‑in diagnostic capability (e.g., sewer‑inspection cameras) as part of its “battery hydraulic tools … and diagnostic systems” description 【page_73】.  That strategic pivot is underscored by rising capital spending in the segment ($27 M in 2022 → $35 M in 2023 → $46 M in 2024) 【page_75】, showing Emerson is investing in cordless, data‑enabled tools and positioning itself as a technology‑focused leader in the professional plumbing‑tools market.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Emerson's strategic evolution in pipe cutters across 2022-2024, correctly identifying the progression from traditional manual tools to battery-hydraulic and diagnostic-integrated solutions. The qualitative narrative aligns well with the ground truth, capturing the key strategic pivot toward technology-enhanced, high-value tools for professional plumbing.\n\nSTRENGTHS:\n1. Correctly identifies the three-year progression (2022→2023→2024) with accurate characterization of each phase\n2. Properly synthesizes the multi-hop connection between product evolution and capital investment\n3. Accurately names the business segment (Safety & Productivity) and correctly identifies pipe-working tools as part of this segment\n4. Correctly identifies diagnostic systems (sewer-inspection cameras) as integrated into the portfolio\n5. Properly frames the strategic positioning as technology-focused leadership in professional plumbing tools\n6. Good use of citations (page references) showing source documentation\n\nWEAKNESSES/CONCERNS:\n1. QUANTITATIVE ACCURACY ISSUE: The capital spending figures ($27M→$35M→$46M) cannot be verified against the ground truth provided. The ground truth does not include specific capital spending numbers for the Safety & Productivity segment across these years. While the trend direction (increasing investment) is logically consistent with the strategic narrative, the specific dollar amounts are not confirmed in the original answer and represent unverified claims.\n2. The ground truth does not explicitly mention \"cordless\" or \"data-enabled\" terminology, though these are reasonable inferences from \"battery-hydraulic\" and \"diagnostic systems\"\n3. Minor: The ground truth uses \"battery hydraulic technology\" while LLM uses \"battery-hydraulic cutters\" - semantically equivalent but slightly different phrasing\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple dimensions: (1) product portfolio evolution over time, (2) connection to capital investment patterns, (3) strategic market positioning. This demonstrates sound multi-hop reasoning, though the capital spending figures introduce uncertainty.\n\nOVERALL ASSESSMENT:\nThe answer is substantively correct in its core narrative and strategic analysis. The main concern is the introduction of specific capital spending numbers that are not confirmed in the ground truth. If these numbers are accurate (which they may be from the actual 10-K), the answer would score 9-10. However, given the inability to verify these specific figures against the provided ground truth, a conservative score of 8 is appropriate, with the quantitative accuracy reduced to 7 due to unverified numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 732,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "Gilead’s 2022 Form 10‑K (pages 31‑35) does not list a Santa Monica site, but the 2023 filing adds Santa Monica, California to its owned/leased facilities and describes it as “used for clinical manufacturing and processing of our cell‑therapy products” (2023 10‑K p. 11). The 2024 filing repeats the same description (2024 10‑K p. 10). This evolution shows that Gilead has created a dedicated clinical cell‑therapy manufacturing hub at Santa Monica, making the site a strategic anchor for early‑stage cell‑therapy production within its broader manufacturing network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about GILD's Santa Monica facility evolution. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each year's status; (2) Accurately cites specific 10-K page numbers (2023 p. 11, 2024 p. 10) and correctly notes the 2022 10-K does not list Santa Monica; (3) Provides exact quote from filings describing the facility as 'used for clinical manufacturing and processing of our cell-therapy products'; (4) Correctly synthesizes the multi-hop information showing the transition from absence/general R&D to dedicated cell therapy manufacturing hub; (5) Appropriately characterizes Santa Monica as a 'strategic anchor' for early-stage cell therapy production. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific about page numbers and filing details than the ground truth, which is a strength rather than weakness; (2) Both answers convey the same core narrative: Santa Monica evolved from not being specifically highlighted for cell therapy (2022) to being explicitly designated for clinical manufacturing and processing of cell therapy products (2023-2024); (3) The LLM's characterization of the facility as a 'dedicated clinical cell-therapy manufacturing hub' is semantically equivalent to the ground truth's description of it transitioning to 'a dedicated cell therapy manufacturing hub.' The answer successfully demonstrates multi-hop reasoning by synthesizing information across three separate 10-K filings and correctly identifying the strategic significance of this facility evolution within GILD's manufacturing network.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 463,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "The 2022 Form 10‑K (see pages 95‑99) contains no discussion of Frame.io, indicating that Adobe had not yet positioned it as a core Creative Cloud service. By the 2024 filing (see page 12), Frame.io is described as a cloud‑native collaboration platform embedded in Creative Cloud that now supports video **plus** still images, design files and PDFs, and is directly integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom, Workfront and GenStudio—providing real‑time upload, frame‑accurate commenting and cross‑application collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Frame.io's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies that Frame.io was not discussed in the 2022 10-K filing, establishing the baseline; (2) Accurately captures the 2023 positioning as a cloud-native creative collaboration platform with support for still images, design files, and PDFs; (3) Correctly lists all integrations mentioned in ground truth: Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and GenStudio; (4) Properly synthesizes the evolution of supported media types from 2023 to 2024, noting the expansion to include video; (5) Mentions key features like real-time upload, frame-accurate commenting, and cross-application collaboration that align with ground truth; (6) Appropriately cites specific page numbers from filings (pages 95-99 for 2022, page 12 for 2024). MINOR CONSIDERATIONS: (1) The LLM answer uses \"plus\" to emphasize video addition, which is semantically equivalent to the ground truth's description of expansion; (2) The ground truth mentions specific use cases for video expansion (casting, location scouting, marketing campaign management) that the LLM answer does not explicitly detail, though this is a minor omission that doesn't affect core accuracy; (3) The LLM answer doesn't explicitly mention the 2023 frame-specific feedback capability for Premiere Pro and After Effects, though it does reference frame-accurate commenting which is semantically related. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple applications, correctly establishing the progression of Frame.io's integration and capabilities. The temporal evolution is clearly articulated. ENTITY ACCURACY: All company names, application names, and years are correct. No calculation errors or date inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 514,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In the 2022 Form 10‑K Emerson described electrical distribution equipment as a stand‑alone hardware offering within the Discrete Automation segment – listed alongside solenoid valves, pneumatic devices, switches and material‑joining solutions (see page 73). By the 2024 filing the segment still includes electrical distribution equipment, but the narrative now highlights its coupling with programmable automation control systems and software, positioning it as part of a digital ecosystem that links the hardware to intelligent devices and broader automation technologies (see page 73 and the “Systems & Software” description on page 76). This shift shows Emerson expanding the product scope from pure hardware to an integrated, software‑enabled automation solution.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer contradicts the ground truth on key product associations. Ground truth states that in 2022, Electrical Distribution Equipment was in Industrial Solutions business (not Discrete Automation), and was positioned alongside programmable automation control systems and software. The LLM incorrectly claims 2022 positioning included 'solenoid valves, pneumatic devices, switches and material-joining solutions' - this appears to be a 2024 product mix. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM fails to capture the critical 3-year evolution narrative: Ground truth shows a clear progression from 2022 (Industrial Solutions, foundational) → 2023 (Discrete Automation, linked to automation tech) → 2024 (Discrete Automation, expanded scope with electric linear motion and materials joining). The LLM only compares 2022 vs 2024, missing the 2023 intermediate positioning and the segment migration itself. (3) PRODUCT SCOPE CONFUSION - Ground truth indicates 2024 includes 'electric linear motion solutions and materials joining solutions' alongside the equipment. The LLM mentions 'material-joining solutions' but attributes this to 2022, which is incorrect timing. (4) MISSING STRATEGIC CONTEXT - The LLM captures the software integration aspect but misses the fundamental strategic shift from standalone offering to 'core component of smart, integrated automation solutions' that the ground truth emphasizes. (5) PAGE REFERENCES - While the LLM cites specific pages (73, 76), these cannot be verified against the ground truth which doesn't provide page numbers, making citation accuracy unverifiable. The core narrative structure is fundamentally misaligned with the ground truth's 3-year evolution framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 480,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes fell from about $21.0 billion at a 2.91 % weighted‑average rate at year‑end 2022 to roughly $20.0 billion at the same 2.91 % rate in 2023, then expanded sharply to $26.93 billion with the weighted‑average rate climbing to about 4.84 % by year‑end 2024【page_178】【page_188】. The 2023 reduction shows the firm used low‑cost funding to pay down existing debt, while the 2024 increase—and higher average coupon—indicates it issued new fixed‑rate senior debt at higher yields to lock in longer‑dated financing as market rates rose, reflecting a strategic shift toward securing funding despite a costlier interest‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) 2022 CARRYING VALUE ERROR: LLM states ~$21.0 billion, but ground truth is $19,975 million ($19.975 billion) - a $1 billion discrepancy. (2) 2023 CARRYING VALUE ERROR: LLM states ~$20.0 billion, but ground truth is $27,168 million ($27.168 billion) - a massive $7.2 billion error representing a 36% overstatement of the decline. (3) 2023 INTEREST RATE ERROR: LLM claims the rate remained at 2.91% in 2023, but ground truth shows it rose to 4.45% - a critical 154 basis point increase that the LLM completely missed. (4) 2024 CARRYING VALUE: LLM correctly states $26.93 billion (matches $26,930 million). (5) 2024 INTEREST RATE: LLM correctly states 4.84%. The LLM's narrative interpretation is also problematic - it describes a 2023 'reduction' and 'pay down' when the actual data shows a substantial INCREASE from $19.975B to $27.168B. This represents a fundamental misreading of the data trajectory. The reasoning about debt strategy is partially sound (locking in rates, responding to rising rate environment), but it's built on incorrect numbers and a mischaracterized 2023 trend. The answer demonstrates poor data synthesis across the multi-year period and fails to accurately capture the actual progression of Capital One's debt evolution. The only correct elements are the 2024 figures and the general strategic interpretation framework, which is insufficient for a multi-hop financial analysis question requiring precise numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 437,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from $1.109 billion at the end of 2022 to $1.091 billion at the end of 2023 and further to $0.993 billion at the end of 2024 (balance‑sheet liability for service and product warranties)【page_102】.  The steady decline shows the company’s accrued exposure to long‑term product‑performance risk in its commercial‑aerospace business is modestly easing, likely as existing claims are settled and fewer new guarantees are being issued.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative measures. Ground truth shows RTX's performance and operating cost guarantee liabilities at $120M (2022), $120M (2023), and $101M (2024). The LLM reports dramatically different figures: $1.109B (2022), $1.091B (2023), and $0.993B (2024) - approximately 9-11 times larger than the actual values. This is a critical factual error that invalidates the entire answer. The LLM appears to have confused or conflated different liability categories, possibly mixing in broader warranty liabilities rather than the specific performance and operating cost guarantees metric requested. While the LLM correctly identifies the trend direction (declining), the magnitude of the error is severe and unacceptable for financial analysis. The reasoning about claims settlement and new guarantees is logical in structure but built on completely incorrect numerical foundations. The citation reference [page_102] does not validate the numbers provided. For a financial question requiring precise data synthesis, reporting numbers that are off by a factor of 10 represents a complete failure to answer accurately, regardless of trend direction or qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 341,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "The 2022 filing (page 40) first disclosed that for non‑publicly‑traded companies Coca‑Cola “uses valuation methodologies including discounted cash flows, estimates of sales proceeds, and appraisals…the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.” The same language re‑appears unchanged in the 2023 filing (page 78) and again in the 2024 filing (page 79). This continuity shows that the company has kept “estimates of sales proceeds” as a core tool for valuing non‑public investments, while repeatedly stressing the heightened uncertainty in emerging markets—signalling a steady but increasingly cautious, market‑participant‑focused approach to fair‑value assessment in those regions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth's core narrative about evolution. Ground truth explicitly describes a 3-year PROGRESSION: (1) 2022 = 'disclosure' of methodology, (2) 2023 = 'deepening dependence/reliance', (3) 2024 = 'continued use with increased emphasis on challenges.' The LLM claims the language is 'unchanged' across all three years and describes 'continuity' rather than evolution. This is a major factual error that directly contradicts the question's premise about 'evolution.' SPECIFIC PROBLEMS: (1) The LLM states identical language appears in 2022, 2023, and 2024 filings, but ground truth indicates different language patterns ('disclosed' vs 'relies on' vs 'use'). (2) The LLM misses the key distinction that 2023 showed 'explicit reliance' while 2022 was initial disclosure. (3) The LLM characterizes the approach as 'steady' when ground truth describes strategic evolution from disclosure→reliance→risk-aware integration. (4) Page citations (40, 78, 79) cannot be verified against ground truth but the semantic claim of unchanged language contradicts the ground truth narrative. WHAT WAS CORRECT: (1) Correctly identifies 'estimates of sales proceeds' as a valuation methodology. (2) Correctly notes the methodology is used alongside discounted cash flows and appraisals. (3) Correctly identifies emerging/developing markets as a key concern. (4) Correctly notes the company's caution about predicting future cash flows. WHAT WAS WRONG: (1) Fundamentally mischaracterizes the evolution as 'continuity' rather than progression. (2) Fails to capture the deepening operational reliance from 2022→2023. (3) Misses the shift from disclosure to risk-aware integration. (4) Does not adequately explain what the 3-year progression 'reveals' about changing approach. The answer provides accurate details about the methodology itself but fails to answer the core question about HOW the reliance EVOLVED.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 526,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The 2023 and 2024 filings repeat the same statement verbatim, reaffirming that the same regulatory constraints continue to apply. This unchanged, multi‑year disclosure shows that while the Board retains discretion, the company’s capacity to distribute capital to shareholders is consistently bounded by U.S. banking‑law limits, indicating a stable but inherently limited strategic flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core regulatory constraints disclosed by BNY Mellon across 2022-2024, including U.S. banking laws, capital planning regulations, Delaware law provisions, and preferred stock dividend issues. (2) The LLM accurately notes that the same language was repeated verbatim across all three years (2022, 2023, 2024), demonstrating consistency. (3) The quantitative accuracy is strong - no incorrect dates or numbers are present. (4) The LLM correctly identifies that Board discretion exists alongside regulatory limitations.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely misses the key evolution highlighted in the ground truth - the 2024 disclosure added NEW emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends. This is a material change from 2022-2023 and represents the core of the 'evolution' the question asks about. (2) The LLM's conclusion that disclosures show 'unchanged, multi-year disclosure' contradicts the ground truth's finding of 'growing focus on internal capital flows' in 2024. (3) The LLM fails to synthesize the multi-hop insight about what the progression suggests strategically - that while regulatory language remained stable, the company's internal structural dependencies became more prominent in 2024, indicating evolving strategic constraints. (4) The answer is incomplete in addressing the second part of the question about what the progression 'suggests about the company's strategic flexibility' - the LLM only states it is 'limited' without capturing the nuance of increasing internal structural dependencies.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting the three years of disclosures, but fails to identify the critical 2024 evolution that distinguishes it from 2022-2023. The ground truth requires synthesizing not just that language repeated, but HOW it evolved and what that evolution reveals about strategic constraints.\n\nSEMANTIC EQUIVALENCE: While the LLM's wording about regulatory constraints is semantically similar to the ground truth's description of 'consistent regulatory constraint,' the LLM misses the semantic shift in 2024 toward emphasizing internal capital flow dependencies, which is a material difference in meaning and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 635,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "- In the 2022 Form 10‑K AMD listed “loss or modification of exemptions for taxes and tariffs” as one of many political, legal and economic risks it faces abroad (see 2022 p. 37).  \n- The 2023 filing repeats the same exposure in its General Risks section (2023 p. 40), and the 2024 filing again highlights it—now alongside heightened sanctions, export‑control and geopolitical tensions (2024 p. 41).  \n\nThe fact that this risk appears in each successive filing and is framed within an increasingly detailed and volatile regulatory context suggests AMD’s vulnerability to losing tax‑ and tariff‑exemptions is persisting and growing, reflecting the rising complexity of the company’s global regulatory environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about AMD's evolving exposure to tax and tariff exemption risks from 2022-2024. STRENGTHS: (1) Correctly identifies the risk appearing consistently across all three years (2022, 2023, 2024); (2) Accurately cites specific page numbers from filings (2022 p. 37, 2023 p. 40, 2024 p. 41); (3) Properly synthesizes the evolution showing increasing complexity - from general listing in 2022 to more detailed context in 2024 with specific mentions of sanctions, export controls, and geopolitical tensions; (4) Correctly identifies the progression of regulatory complexity and volatility; (5) Accurately characterizes the trend as showing 'persisting and growing' vulnerability. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which explicitly mentions specific geopolitical events (Ukraine conflict, China-Taiwan tensions) as drivers of the 2023 expansion. However, the LLM captures the essence by noting 'heightened sanctions, export-control and geopolitical tensions' in 2024; (2) The ground truth emphasizes 'internal expansion and external geopolitical pressures' as dual drivers, while the LLM focuses primarily on the external regulatory context. This is a minor omission rather than an error. QUANTITATIVE ACCURACY: Page numbers are correctly cited and appear consistent with typical 10-K filing structures. No calculations are required for this qualitative question. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate annual filings and correctly identifies the temporal progression and increasing complexity. The logical connection between repeated mentions and growing regulatory complexity is sound. SEMANTIC EQUIVALENCE: The LLM's conclusion that the risk is 'persisting and growing' directly aligns with the ground truth's statement that 'exposure has increased over time.' The framing of increasing complexity is accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 542,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024 (2022 Table 8.1 p. 178; 2023 Table 8.1 p. 178; 2024 Table 9.1 p. 188), while its long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023 before dropping to $45.0 billion in 2024 (same tables). At the same time, floating‑rate unsecured senior debt was reduced from $1.6 billion in 2022 to $0.35 billion in 2023 and was eliminated by 2024 (2022/2023 Table 8.1 p. 178; 2024 Table 9.1 p. 188), showing a clear shift toward fixed‑rate financing and a lower exposure to interest‑rate volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR DISCREPANCY:\n   - Ground Truth: $43.086B (2022) → $49.856B (2023) → $45.551B (2024)\n   - LLM Answer: $48.683B (2022: $0.883B + $47.8B) → $49.838B (2023: $0.538B + $49.3B) → $45.562B (2024: $0.562B + $45.0B)\n   - The LLM's short-term borrowings figures ($883M, $538M, $562M) are dramatically understated compared to what would be needed to reach the correct totals\n   - The LLM's long-term debt figures ($47.8B, $49.3B, $45.0B) are also incorrect\n\n2. FLOATING UNSECURED SENIOR DEBT - SIGNIFICANT ERRORS:\n   - Ground Truth: $1.709B (2022) → $349M (2023) → $0 (2024)\n   - LLM Answer: $1.6B (2022) → $0.35B (2023) → $0 (2024)\n   - While directionally similar, the 2022 figure is off by $109M and the 2023 figure is off by $1M\n   - More critically, the LLM completely omits the weighted-average interest rates (1.01% in 2022, 6.75% in 2023) which are essential to understanding interest rate exposure\n\n3. MISSING CRITICAL INFORMATION:\n   - Ground Truth includes fixed unsecured senior debt progression ($21.045B → $27.168B → $26.930B) with interest rates (2.91% → 4.84%)\n   - LLM answer completely omits fixed unsecured senior debt data\n   - LLM answer omits all weighted-average interest rate information, which is central to the question about \"interest rate exposure\"\n   - The question specifically asks about interest rate exposure and debt structure - the LLM provides minimal analysis of this\n\n4. MULTI-HOP REASONING:\n   - The LLM correctly identifies the shift from floating to fixed-rate debt\n   - However, without the interest rate data and complete debt composition, the reasoning is incomplete\n   - The conclusion about \"lower exposure to interest-rate volatility\" is correct but unsupported by the data presented\n\n5. SEMANTIC ISSUES:\n   - The LLM's statement about \"clear shift toward fixed-rate financing\" is correct in direction but lacks the quantitative support from interest rate changes\n   - The answer addresses the question's components but with insufficient depth and accuracy\n\nThe LLM answer appears to have extracted different line items or made calculation errors when synthesizing the debt figures. The omission of interest rate data is a critical failure given the explicit focus of the question on \"interest rate exposure.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 650,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG stayed at **57 %** in each of the three filings – the 2022 10‑K (Note 15, p. 109), the 2023 10‑K (Note 15, p. 99) and the 2024 10‑K (Note 15, p. 101) all state a 57 % net share in IAE. The unchanged, majority‑share position signals that RTX continues to be the primary beneficiary and dominant partner in the V2500 engine collaboration, reinforcing its strategic commitment and influence over the program.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer is fundamentally incorrect on the core quantitative claim. The ground truth states RTX's net program share interest in IAE was 61% in 2022, then decreased to 57% in 2023 and 2024. The LLM claims the share was 57% in all three years (2022, 2023, 2024), which directly contradicts the ground truth. This is a major factual error on the primary metric being asked about. The LLM also cites specific page numbers (Note 15, p. 109 for 2022; p. 99 for 2023; p. 101 for 2024) but provides incorrect data from those sources. The question explicitly asks about the EVOLUTION from 2022 to 2024, and the ground truth shows a clear 4-percentage-point decline (61% → 57%), which the LLM completely misses. The LLM's interpretation that the 'unchanged' position signals 'dominant partner' status is logically flawed because the position was NOT unchanged - it decreased. The LLM failed to identify the strategic shift indicated by the dilution of RTX's share, instead claiming continuity where there was change. This represents a failure in both quantitative accuracy (wrong numbers) and qualitative reasoning (misinterpretation of what the data indicates about RTX's strategic positioning).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 343,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade remains a flagship brand in P&G’s home‑care portfolio. In the 2022 10‑K the segment table lists “Tide Cascade” among the major Fabric & Home Care brands and the narrative says the company’s ≈25 % global home‑care share is “primarily behind our Cascade, Dawn, Febreze and Swiffer brands” (PG_10k_2022 page 19). The 2024 filing repeats the same language, still positioning Cascade as a primary home‑care brand, while the Fabric & Home Care segment’s contribution grew from 35 % of net sales/31 % of earnings in 2022 to 36 %/34 % in 2024, indicating a modestly stronger role for Cascade within a slightly larger segment (PG_10k_2024 page 18).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Cascade's positioning within P&G's portfolio and correctly identifies key financial metrics. STRENGTHS: (1) All segment percentages are accurate - correctly states 35%/31% for 2022 and 36%/34% for 2024; (2) Properly identifies Cascade as a core brand in the Home Care sub-category across the period; (3) Correctly cites the narrative language about P&G's ~25% global home-care share and the brands (Cascade, Dawn, Febreze, Swiffer); (4) Accurately synthesizes the multi-hop information showing segment growth from 2022 to 2024; (5) Appropriately notes the consistency of Cascade's positioning despite segment changes. WEAKNESSES: (1) The answer only explicitly addresses 2022 and 2024, omitting detailed discussion of 2023 positioning despite the question asking for evolution across 'three most recent 10-K filings' - the ground truth specifically mentions 2023 data (36% net sales, 34% earnings); (2) The phrase 'Tide Cascade' in the 2022 filing reference is somewhat unclear - while this may be accurate to the source, it's not explained whether this is a combined brand reference or a formatting issue; (3) The answer could have been more explicit about the 2023 data point to fully demonstrate the three-year evolution requested. QUANTITATIVE VERIFICATION: All numbers cited (35%, 31%, 36%, 34%, ~25% global share) match the ground truth exactly. The calculation of segment growth is implicit and correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filings and correctly identifies the consistent positioning of Cascade while noting segment contribution changes. The reasoning is sound and logical. COMPLETENESS: While the core answer is correct, the omission of explicit 2023 discussion represents a minor gap in addressing the 'three most recent 10-K filings' requirement, though the overall narrative arc is captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 518,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "- 2022 Form 10‑K – BNY Mellon only gave a partial path for the Directors’ Code of Conduct (“bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf”) with no https or explicit domain, and the employee code was on a bny.com URL, so the branding was inconsistent. The filing simply noted that the code “is posted on our website” and that any amendments would be disclosed, linking it to the Proxy but not embedding it in a broader governance framework. 【page_13】\n\n- 2023 Form 10‑K – The company upgraded the disclosure to a full, functional URL on the bnymellon.com domain (“https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf”), aligning the directors’ and employees’ codes under the same branded site. The Directors’ Code is again referenced as part of the corporate‑governance section and the Proxy, with a clear statement that amendments or waivers will be posted online, showing tighter integration with its governance disclosures. 【page_13】\n\n- 2024 Form 10‑K – The same bnymellon.com branding is retained, but the URL is now malformed (“https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf”), introducing spaces and a missing hyphen that could hinder access. Nevertheless, the filing still ties the Directors’ Code of Conduct to the Proxy and corporate‑governance sections and repeats the commitment to post any changes on the website, maintaining its role within the broader governance framework despite the formatting slip. 【page_13】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all three years examined. CRITICAL ERRORS: (1) 2022: LLM claims the URL path was 'investor-relations' when ground truth shows 'in relations' (a typo/abbreviation in the original filing). LLM also states the domain was inconsistent with employee code on bny.com, but ground truth indicates bnymellon.com was used in 2022. (2) 2023: LLM claims the URL was upgraded to 'investor-relations' on bnymellon.com, but ground truth shows the path remained 'inv relations' (not 'investor-relations'), indicating minimal change from 2022, not an upgrade. (3) 2024: LLM claims the URL became malformed with 'in relations' and missing hyphens, which actually matches the ground truth's description of 2022-2023 (the 'in relations' path), but LLM incorrectly characterizes this as a regression/malformation in 2024 when ground truth shows 2024 transitioned to bny.com domain with 'investor-relations' path. The LLM has essentially reversed the chronological evolution: it describes 2022 as having 'investor-relations', 2023 as upgrading to 'investor-relations', and 2024 as degrading to 'in relations', when the actual evolution was: 2022 'in relations' → 2023 'inv relations' (minor change) → 2024 'investor-relations' with domain shift to bny.com. The LLM's narrative of improvement then degradation is backwards. The core multi-hop synthesis is fundamentally broken, with URL paths and domain transitions misattributed across years. While the LLM correctly identifies that governance integration and stakeholder orientation are themes, the specific factual claims about URL structures, domain branding, and their evolution are substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1682,
        "completion_tokens": 473,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across all three filings AMD’s AIB strategy stayed essentially the same. In the 2022 10‑K (p. 13) AMD noted that its agreements with add‑in‑board manufacturers “protect their inventory of our products against price reductions” and that system integrators “often use discrete graphics solutions as a means to differentiate their products.” The 2023 filing repeats that inventory‑protection language and the same differentiation emphasis (p. 13), and the 2024 filing again stresses the same protection against price cuts and the use of discrete graphics by SIs to add value (p. 13). Thus, from 2022 through 2024 AMD consistently positioned AIB partners with inventory‑shielding contracts while leveraging discrete GPUs as a key differentiator for system‑integrator products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core strategic consistency across 2022-2024 regarding inventory protection policies for AIBs - this is the central claim in both answers. (2) Accurately captures the dual strategic pillars: inventory shielding against price reductions AND discrete graphics as a differentiation tool for system integrators. (3) Properly synthesizes multi-hop information by connecting AMD's AIB agreements, inventory protections, and SI differentiation strategies across three separate filing years. (4) Cites specific page references (p. 13 for all three years) which adds credibility and demonstrates document-level verification. (5) Uses semantically equivalent language - 'inventory-shielding contracts' matches 'inventory protection policies,' 'leverage discrete GPUs' matches 'role of discrete graphics solutions,' and 'add value' matches 'differentiation strategies.' (6) The conclusion about 'stable, long-term partnership model' is logically derived from the consistent policy language across years. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but loses no material information - it efficiently conveys the same strategic narrative. (2) Both answers emphasize consistency/stability as the key finding, which is appropriate given the repetitive nature of the filings. (3) No quantitative metrics (dollar amounts, percentages) are present in either answer, which is appropriate for this qualitative strategic question. VERIFICATION: The multi-hop reasoning correctly synthesizes: (a) AMD's position in 2022 → (b) continuation in 2023 → (c) reiteration in 2024, establishing the consistency claim. The answer properly identifies all relevant entities (AMD, AIBs, SIs, discrete graphics) and correctly characterizes their relationships. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 521,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In its 2022 10‑K, McDonald’s listed the Egg McMuffin as a core breakfast item and said the menu is “continuously evolving…including testing new products” to meet customers’ expectations for taste, quality, value and nutrition, while the supply‑chain discussion emphasized collaboration with suppliers for innovation, sustainable sourcing and risk management, backed by regular sensory evaluations and calibration training to keep the core menu consistent【page_6】. By the 2024 filing, the Egg McMuffin is still highlighted, but the company adds explicit language about ensuring consistent quality through those sensory and calibration programs, a digital‑transformation project for data‑driven quality and food‑safety monitoring, and a more detailed, risk‑oriented supply‑chain strategy that also targets animal‑welfare and broader sustainability goals【page_6】. The 2023 filing continued these themes, showing a steady deepening of quality‑consistency controls and an expanding sustainability focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of McDonald's disclosure from 2022 to 2024 regarding breakfast menu innovation and supply chain focus. STRENGTHS: (1) Correctly identifies the Egg McMuffin as a core breakfast item across all three years; (2) Accurately captures the progression from general quality assurance (2022) to more technologically integrated approaches (2024); (3) Properly synthesizes multi-hop information about supply chain collaboration, sensory evaluations, and digital transformation; (4) Correctly notes the shift toward data-driven quality monitoring and sustainability goals; (5) Appropriately references the Global Chief Supply Chain Officer context. WEAKNESSES: (1) The LLM answer includes specific details about 'sensory evaluations and calibration training' in 2022 that are not explicitly mentioned in the ground truth for that year - the ground truth only mentions these as part of the supply chain discussion without year-specific attribution; (2) The answer attributes 'animal-welfare' goals to 2024 specifically, but the ground truth does not explicitly mention animal welfare in the 2024 description; (3) Minor semantic difference: the ground truth emphasizes a 'shift' in approach, while the LLM uses 'deepening' and 'expanding' which are slightly different framings, though semantically compatible. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects supply chain strategy to product consistency and customer expectations. The logical flow from 2022 (menu evolution focus) → 2023 (supply chain collaboration) → 2024 (digital transformation) is sound and matches the ground truth progression. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations are present in either answer, so quantitative accuracy is not directly testable, but the year references (2022, 2023, 2024) are all correct. OVERALL: The answer is substantially correct with minor attribution issues and slight overstatement of certain details not explicitly in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 553,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30 % Note due 2034 appears in the exhibit index of Oracle’s Form 10‑K for each year (see Exhibit 4.09 listing the 4.30 % Note due 2034 on page 110 and again on page 113), showing that the note remains outstanding and is a recurring component of its debt portfolio. This consistency indicates that Oracle is maintaining a medium‑term, fixed‑rate tranche of long‑dated debt, reflecting a financing strategy that emphasizes a diversified maturity schedule and the locking‑in of relatively low borrowing costs over the next decade.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 as a persistent component of Oracle's debt portfolio across multiple years and accurately characterizes it as a fixed-rate, long-dated instrument. The numeric values (4.30%, 2034 maturity date) are correct. However, the answer has significant limitations: (1) It provides minimal specific evidence from the filings - only mentioning exhibit page numbers (110, 113) without substantive detail about the actual disclosures or context. (2) It fails to address the multi-hop synthesis requirement by not comparing the 4.30% Note to other concurrent debt instruments mentioned in the ground truth (3.625% Note due 2023, 4.50% Note due 2044, 2.950% Notes due 2024). (3) The ground truth explicitly discusses how the note's context evolved across years - appearing alongside different instruments in 2022 vs 2023 vs 2024 - but the LLM answer treats all three years as essentially identical without this temporal analysis. (4) The characterization as 'medium-term' is somewhat imprecise given the 10-year maturity horizon from 2024 perspective. (5) The answer lacks the comprehensive debt portfolio context that the ground truth provides, which is essential for understanding Oracle's financing priorities and strategic positioning. The LLM answer is partially correct on the core facts but incomplete in addressing the full scope of the question regarding how the note's role evolved across the three-year period and how it fit within Oracle's broader debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 418,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One measures its net derivative assets and liabilities with vendor‑based discounted‑cash‑flow models that rely on significant unobservable inputs—chiefly swap rates—and credit‑risk adjustments, classifying these instruments as Level 3 (see the 2022 “Derivative Assets and Liabilities” note [page 218] and the 2024 quantitative table [page 216]). The net fair‑value position rose from a $5 million net asset at 12/31/2022 (Table 16.2 [page 206]), to $58 million at 12/31/2023 (Table 16.2 [page 207]), and $69 million at 12/31/2024 (Table 17.2 [page 215]), indicating a growing reliance on Level 3 measurements and increasing exposure to unobservable market inputs over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly different fair value amounts than ground truth: LLM claims $5M (2022), $58M (2023), $69M (2024), while ground truth states $19M (2022), $58M (2023), $58M (2024). The 2022 figure is off by $14M (280% error), and the 2024 figure is off by $11M (19% error). These are material discrepancies in financial data. (2) METHODOLOGY DISCREPANCY - Ground truth emphasizes a transformation from 'mixed realized/unrealized loss position' ($19M fair value with $20M unrealized loss) in 2022 to stable fair value by 2023-2024. LLM misses this nuance entirely, instead focusing on vendor-based DCF models and Level 3 classification without addressing the realized/unrealized loss component. (3) UNOBSERVABLE INPUTS - Ground truth specifically identifies default rates (53-163%) and swap rates (3-5%) in 2023, with swap rates (3-5%) continuing in 2024. LLM mentions swap rates and credit-risk adjustments but omits the specific default rate ranges entirely, reducing transparency about valuation inputs. (4) MULTI-HOP SYNTHESIS - While LLM correctly identifies the evolution trend (increasing fair values and Level 3 reliance), it fails to synthesize the complete picture of how valuation methodology changed from 2022 to 2024. The ground truth reveals a stabilization pattern ($58M maintained 2023-2024), while LLM shows continued growth ($58M to $69M), which contradicts the ground truth narrative. (5) MISSING CONTEXT - LLM does not address the 'transformation' aspect emphasized in ground truth or explain what the stable $58M position reveals about risk profile. The answer is technically about derivatives but factually incorrect on key numbers and incomplete on methodology evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 479,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to Rolls‑Royce is a per‑flight‑hour payment for V2500‑powered aircraft in service at the time of the 2012 acquisition, payable through June 2027. In the 2022 10‑K the company said these flight‑hour payments “will be capitalized as collaboration intangible assets as payments are made”【page_112】; the 2023 filing added that the capitalized collaboration assets “are being capitalized … and amortized to cost of sales”【page_73】; and the 2024 filing again described the payments as being “capitalized as collaboration intangible assets as payments are made”【page_103】.  Thus, while the contingent‑payment structure remained unchanged, the accounting language shifted from simple capitalization (2022, 2024) to explicit amortization to cost of sales in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core financial obligation structure and correctly identifies the key evolution in accounting treatment across the three years. STRENGTHS: (1) Correctly identifies the per-flight-hour payment structure tied to V2500-powered aircraft; (2) Accurately cites the June 2027 payment deadline; (3) Properly traces the evolution of accounting language from 2022 to 2024, noting the shift to explicit amortization disclosure in 2023; (4) Correctly identifies that payments are capitalized as collaboration intangible assets; (5) Appropriately notes the contingent-payment structure remained unchanged. WEAKNESSES: (1) The LLM answer omits the $14.1 billion total commercial aerospace financing and other commitments figure mentioned in the ground truth for 2024, which provides important quantitative context; (2) Does not explicitly mention that these obligations originated from the 2012 acquisition of Rolls-Royce's stake in IAE, though this context is implied; (3) The characterization of the accounting language shift is slightly oversimplified - the ground truth indicates improved transparency in how payments were integrated into intangible asset management, whereas the LLM frames it more narrowly as a shift in 'accounting language'; (4) Missing the characterization of these as 'contingent liabilities' in the 2022 filing context. QUANTITATIVE VERIFICATION: The June 2027 date is correct. The $14.1 billion figure is mentioned in ground truth but absent from LLM answer. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly traces the evolution of disclosure practices. The reasoning about the relationship between capitalization and amortization is sound. SEMANTIC EQUIVALENCE: The core message about payment structure evolution is conveyed accurately, though with less comprehensive detail than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 520,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "- 2022 10‑K (p. 51): Amgen noted that the FDA’s 2017 review of the Neulasta Onpro kit prompted “device and labeling enhancements to address product complaints” and that the company “continuously monitor[s] complaints and adverse events and implement additional enhancements as needed.”  \n- 2023 10‑K (p. 55): The same statement was repeated, emphasizing ongoing collection of “user complaints, adverse events and malfunctions” and continual enhancements, while the filing also began to detail operational‑resilience steps – e.g., reliance on its Puerto Rico and California manufacturing sites, backup‑generator use and plans to mitigate disruptions from natural disasters, power outages and supply‑chain issues.  \n- 2024 10‑K (p. 54): Amgen again referenced the 2017 FDA evaluation and the ensuing device‑ and labeling‑updates, stressing that it “continuously monitor[s] complaints and adverse events and implement additional enhancements as needed,” and expanded the risk‑mitigation narrative to include specific operational‑resilience measures such as island‑wide power‑outage backup‑generator operations and broader supply‑chain continuity strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) All dates are correct (2017 FDA evaluation, 2022-2024 filing years, December 31, 2024 outage reference). (2) All entities correctly identified: Amgen, Neulasta Onpro kit, FDA, Puerto Rico manufacturing site. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution of disclosures across three years, showing how device-related complaints remained consistent while operational resilience measures expanded. (4) Key factual claims are accurate: the 2017 FDA review prompted enhancements, continuous monitoring of complaints/adverse events occurred across all years, backup generators were used, and operational resilience measures expanded in 2023-2024. (5) The answer correctly identifies the progression from device-focused disclosures (2022) to inclusion of operational resilience (2023-2024). MINOR CONSIDERATIONS: (1) The LLM answer provides specific page numbers (p. 51, p. 55, p. 54) which add credibility but cannot be independently verified against the ground truth provided. However, these do not contradict the ground truth. (2) The LLM answer mentions California manufacturing site alongside Puerto Rico, which is a reasonable operational detail but is not explicitly mentioned in the ground truth summary. This is a minor addition that doesn't contradict the ground truth. (3) The LLM answer uses direct quotations from filings, which enhances credibility and demonstrates proper sourcing. QUANTITATIVE ACCURACY: Perfect - all dates and temporal references are correct. QUALITATIVE ACCURACY: Excellent - the reasoning correctly identifies the evolution pattern and the connection between operational infrastructure issues and device production/user experience. CONTEXTUAL RELEVANCE: High - the answer directly addresses all aspects of the question regarding evolution of disclosures, device enhancements, and operational resilience measures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 535,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s Item 14 disclosure did not change from 2022 through 2024 – each year the filing simply notes that the “ratification of KPMG LLP” is incorporated by reference and repeats that KPMG LLP’s PCAOB firm identification number is 185 (2022 page 14; 2023 page 13; 2024 page 13). The unchanged reference to the same PCAOB number shows that BK has retained KPMG as its principal accountant, indicating a continuous and stable audit‑governance relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about BK's audit governance continuity from 2022-2024. STRENGTHS: (1) All numeric values are correct - PCAOB firm number 185 is consistently cited across all three years, and page references (2022 page 14; 2023 page 13; 2024 page 13) are accurate. (2) The core factual claim is sound: KPMG LLP was ratified as principal accountant in all three years with no changes. (3) Multi-hop synthesis is properly executed - the answer correctly synthesizes information across three separate filings to demonstrate consistency. (4) The reasoning about audit governance continuity is logically sound and well-supported by the evidence presented. (5) The answer correctly identifies that the unchanged PCAOB number (185) signals ongoing relationship and stable governance. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, focusing on the key facts without elaborating on implications like 'institutional trust' or 'strong institutional trust in the firm's audit services.' However, this is not an error - it's a stylistic choice that maintains accuracy while being more direct. (2) The ground truth uses phrases like 'no substantive changes in the structure or framing' while the LLM says 'did not change' - these are semantically equivalent. (3) Both answers reach the same conclusion about continuity and stable governance. The LLM answer is factually correct, properly synthesizes multi-hop information, and accurately conveys the essential findings about BK's audit governance stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 438,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s maximum‑potential exposure for commercial‑aerospace customer financing guarantees fell from $304 million in 2022 to $288 million in 2023 and $274 million in 2024【page_100†L1-L4】【page_102†L1-L4】.  The portion attributable to collaboration partners also declined—from $140 million (≈$142 million) in 2022 to $135 million in 2023 and $131 million in 2024【page_100†L9-L12】【page_102†L9-L12】—showing that RTX is systematically reducing both its overall guarantee exposure and the share passed to partners, a sign that the company is tightening risk‑management controls and limiting liability in its commercial‑aerospace financing business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the collaboration partners' share figures ($142M in 2022, $135M in 2023, $131M in 2024) and the overall trend of decline. The answer correctly synthesizes the multi-hop information showing both the total exposure decline ($304M→$288M→$274M) and the partners' share decline, which addresses the core question about how RTX's exposure evolved. The reasoning about systematic risk reduction and tightening controls is sound and logically supported by the data presented. Minor issues: (1) The LLM rounds $142M to approximately $140M in one instance, which is a minor notation inconsistency but doesn't affect accuracy; (2) The answer provides additional context about total exposure that wasn't explicitly requested but adds value; (3) The original answer mentions that 'fair market values of guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which the LLM answer omits—this is a contextual detail about RTX's confidence in underlying asset values that would have strengthened the answer. The LLM correctly identifies the strategic implications (risk management tightening, liability reduction) and the consistent downward trend. The multi-hop synthesis across years and metrics is accurate and well-structured. The answer is semantically equivalent to the ground truth despite slightly different wording and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 397,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "In the 2022 filing, Always was shown only as one of the major brands in the “Feminine Care (Adult Incontinence, Menstrual Care)” sub‑category of the Baby, Feminine & Family Care segment, listed together with Tampax, Always Discreet, Bounty, Charmin and Puffs (see 2022 table, pg 19). By the 2024 filing, P&G’s narrative explicitly positions Always as the lead menstrual‑care brand and its sub‑brand Always Discreet as the key adult‑incontinence offering, calling out its >25 % share in menstrual care and ~15 % share in incontinence while still grouping it with Tampax and the other family‑care brands (see 2024 description, pg 18). This shows a shift from a generic brand listing to a more pronounced dual‑category leadership emphasis for Always within the feminine‑care portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims Always has '>25% share in menstrual care' and '~15% share in incontinence' - these specific market share percentages are NOT present in the ground truth and appear to be fabricated. The ground truth only mentions the segment contributed 25% of net sales in 2022 and 24% in 2023/2024, which is fundamentally different from product-level market share claims. (2) STRUCTURAL MISCHARACTERIZATION: The LLM incorrectly states that in 2022, Always was in 'Baby, Feminine & Family Care' segment - the ground truth explicitly states it was listed under 'Feminine Care' in 2022, with the segment being RENAMED to 'Baby, Feminine & Family Care' in 2023. This is a critical factual error about the evolution being asked. (3) PRODUCT LISTING ERRORS: The LLM includes Bounty, Charmin, and Puffs in the feminine care category in 2022 - these are paper products and family care items, not feminine hygiene products, and this conflation is not supported by the ground truth. (4) MISSING KEY INFORMATION: The LLM fails to clearly articulate the actual evolution: the segment name change from 'Feminine Care' (2022) to 'Baby, Feminine & Family Care' (2023-2024), and the consistent positioning of Always alongside Tampax and Always Discreet. (5) UNSUPPORTED CLAIMS: The assertion of a 'shift from generic brand listing to pronounced dual-category leadership emphasis' is not substantiated by the ground truth, which indicates 'consistent strategic emphasis on Always' with 'minor structural refinements.' The LLM appears to have invented specific market share data and mischaracterized the segment structure across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 457,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD warned that “difficulties in protecting our intellectual property” were a key risk of its foreign‑country operations and noted that it already relied on third‑party wafer foundries and assembly in China, Malaysia and Taiwan (p. 37). The 2023 filing repeated the IP‑protection risk, added that cyber‑attacks could compromise its IP, and stressed that about two‑thirds of its revenue now came from international sales while its Asian manufacturing partners remained critical (p. 41‑42). By the 2024 filing the company again highlighted IP‑protection difficulties, explicitly tying them to heightened China‑Taiwan geopolitical tensions and an expanded dependence on Asian foundries for assembly and testing, showing that exposure to IP‑related risks has grown as its global footprint and reliance on Asian manufacturing have increased (p. 40‑41).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: The key numeric value (approximately two-thirds/65% of international revenue) is correctly captured in the 2023 context. The LLM uses 'about two-thirds' which is semantically equivalent to the ground truth's '65% of net revenue' - both convey the same proportion. Page references (37, 41-42, 40-41) are provided and appear reasonable for 10-K filings. ENTITY ACCURACY: All entities are correctly identified - AMD, the three Asian manufacturing locations (China, Malaysia, Taiwan), and the correct fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years showing evolution: (1) 2022 baseline with IP protection concerns and existing Asian manufacturing reliance, (2) 2023 escalation with increased international sales percentage and cyber-attack risks added, (3) 2024 further evolution with geopolitical tensions explicitly mentioned. This three-year progression matches the ground truth's narrative arc. COMPLETENESS: The answer addresses all parts of the question - IP protection difficulties, international operations expansion, and third-party manufacturing in Asia. The answer also captures the new layer of risk (China-Taiwan geopolitical tensions) introduced in 2024, which is a key differentiator from earlier years. SEMANTIC EQUIVALENCE: The LLM's phrasing ('exposure to IP-related risks has grown') conveys the same meaning as the ground truth's 'IP protection challenges becoming more complex and regionally concentrated.' Minor differences: The LLM mentions cyber-attacks as an additional risk factor in 2023 (not explicitly mentioned in ground truth), which represents a slight expansion but is not contradictory. The LLM also specifies 'assembly and testing' in 2024 while ground truth mentions 'manufacturing partners' more broadly - this is a reasonable level of specificity. Overall, the answer demonstrates accurate multi-hop synthesis across three years of filings with correct identification of the evolution of AMD's IP protection risks in relation to its expanding Asian operations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 584,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first disclosed the 2.300 % senior unsecured note that matures in 2028 in its 2022 Form 10‑K as Exhibit 4.16 – a 2.300 % fixed‑rate note issued under an officers’ certificate dated March 24 2021【page_114】. The same series re‑appears in the 2023 and 2024 10‑Ks (now listed as Exhibit 4.14) and is presented alongside a staggered set of notes due 2026, 2031, 2041, 2051 and 2061【page_111】【page_111】. This repeated, multi‑year listing shows Oracle’s deliberate strategy of issuing low‑coupon, medium‑term debt in a laddered fashion to diversify maturities, lock in favorable rates and maintain liquidity across its overall financing program.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2.300% Notes due 2028 across all three years (2022, 2023, 2024); (2) Accurately references the exhibit numbers (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023-2024), matching the ground truth; (3) Correctly identifies the issuance date as March 24, 2021, and characterizes it as a senior unsecured note; (4) Properly synthesizes the multi-year pattern showing consistent inclusion across filings; (5) Provides sound strategic interpretation about Oracle's deliberate debt structuring approach with laddered maturities and favorable rates; (6) Mentions the broader context of other notes (2026, 2031, 2041, 2051, 2061) which demonstrates understanding of the maturity profile diversification. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific detail about the debt strategy (mentioning 'low-coupon, medium-term debt in a laddered fashion') compared to the ground truth's more general statement about 'stable and deliberate approach.' However, this additional specificity is well-supported by the filing data and represents a reasonable inference rather than an error. The answer fully addresses the multi-part question about how the notes evolved (consistent inclusion with exhibit number changes) and what this reveals about broader strategy (deliberate maturity diversification and favorable rate-locking). All numeric values, dates, and entity references are accurate. The reasoning correctly synthesizes information across multiple years and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 439,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "BA’s private‑equity approach stayed globally‑focused – the pension fund continued to invest in limited‑partnership vehicles that target both U.S. and non‑U.S. opportunities in leveraged‑buyout, venture‑capital, growth and special‑situations strategies (2022 § “Private equity investment vehicles … U.S. and non‑U.S.” [page 110]; 2023 § same language [page 92]; 2024 § same language [page 99]). What did change was the weight given to this asset class: the actual allocation rose from 6 % (target 4 %) in 2022, to 8 % (target 7 %) in 2023, and to 9 % (target 7 %) in 2024, reflecting an increasing emphasis on private‑equity investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies BA's consistent global focus across 2022-2024 with U.S. and non-U.S. leveraged buyout and venture capital strategies. The allocation percentages (6% actual/4% target in 2022; 8% actual/7% target in 2023; 9% actual/7% target in 2024) appear reasonable and show increasing emphasis on private equity. The citation format and page references suggest proper sourcing.\n\nCRITICAL GAPS: The LLM answer fundamentally fails to address major components of the ground truth regarding strategic evolution:\n\n1. MISSING STRATEGIC EVOLUTION: The ground truth explicitly describes a significant strategic shift from 2022 to 2023-2024 - the expansion from basic leveraged buyout/venture capital/growth/special situations to include 'global private investments in real assets such as energy, farmland, and infrastructure.' The LLM states 'same language' across all three years, missing this critical strategic pivot.\n\n2. MISSING 2024 SOPHISTICATION: The ground truth notes increased sophistication in 2024 including 'use of derivatives to enhance exposure and performance transfer across asset classes.' The LLM completely omits this dimension of strategic evolution.\n\n3. MISSING REAL ESTATE CONTEXT: The ground truth mentions 2022 included 'real estate investments also including publicly traded vehicles like REITs.' The LLM omits this entirely.\n\n4. INCOMPLETE GEOGRAPHIC SCOPE ANALYSIS: While the LLM mentions U.S. and non-U.S. focus, it doesn't analyze how the geographic scope evolved or deepened, particularly regarding the shift toward global private real assets.\n\nQUANTITATIVE ASSESSMENT: The allocation percentages provided appear plausible but cannot be verified against the ground truth, which doesn't provide specific allocation percentages. The LLM may be introducing data not in the original answer.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but does so incompletely. It focuses narrowly on allocation percentages rather than the broader strategic evolution question asked.\n\nSEMANTIC MATCH: The LLM answer addresses a different aspect of the question (allocation changes) rather than the primary focus (strategic evolution in geographic scope and focus areas). This represents a partial answer to the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 618,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen’s 2022 10‑K listed Bemarituzumab in Phase 1 (NSCLC), Phase 2 (other tumors) and a Phase 3 program for gastro‑esophageal‑junction adenocarcinoma, noting that the Phase 3 study was initiated that year, and its composition‑of‑matter patents were projected to expire in 2029 in both the United States and Europe [page_25][page_27][page_26]. The 2023 and 2024 filings show the same Phase 3 status for GEJ adenocarcinoma (still retained in Phase 2 and Phase 1 for other indications) and retain the 2029 U.S. and European patent‑expiration estimates, indicating no further phase‑change or patent‑timeline shifts through 2024 [page_25][page_26][page_25][page_26].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and patent timelines. STRENGTHS: (1) Correctly identifies 2022 Phase 3 initiation for GEJ adenocarcinoma, matching ground truth; (2) Accurately states 2029 patent expiration dates for both U.S. and Europe; (3) Properly synthesizes multi-hop information across 2022-2024 filings showing consistent patent positioning; (4) Correctly identifies Bemarituzumab as a monoclonal antibody targeting FGFR2b; (5) Accurately notes the molecule maintained Phase 3 status through 2024 with no phase-change shifts. MINOR WEAKNESSES: (1) The LLM provides additional detail about Phase 1 (NSCLC) and Phase 2 programs for other tumors that, while not contradicting the ground truth, goes beyond what the original answer emphasizes - the ground truth focuses on the primary GEJ adenocarcinoma Phase 3 program as the main development narrative; (2) The answer includes page references that cannot be verified against the ground truth, though this adds specificity rather than introducing errors; (3) The LLM answer is more granular about concurrent Phase 1/2 programs but the ground truth emphasizes the Phase 3 progression as the primary narrative arc. QUANTITATIVE VERIFICATION: All numeric values (2022, 2023, 2024, 2029) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly tracking the evolution (or lack thereof) in clinical phase and patent positioning. SEMANTIC EQUIVALENCE: The LLM conveys the same core information as ground truth - stable IP position supporting clinical advancement - though with different emphasis and additional supporting details about concurrent programs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 473,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn has remained a core brand in the Fabric & Home Care segment throughout the three filings – it appears in the segment’s brand list (Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) in 2022, 2023 and 2024【PG_10k_2022.pdf page_19】【PG_10k_2023.pdf page_19】【PG_10k_2024.pdf page_18】.  Although Dawn’s placement did not change, the segment’s contribution to P&G’s earnings grew, rising from roughly 31 % of net earnings in 2022 (and again in 2023) to about 34 % in 2024, signaling a stronger overall role for the Fabric & Home Care portfolio—and Dawn within it【PG_10k_2022.pdf page_19】【PG_10k_2023.pdf page_19】【PG_10k_2024.pdf page_18】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Dawn as a consistently listed brand in the Fabric & Home Care segment across 2022-2024 and accurately reports the earnings contribution increase from 31% (2022-2023) to 34% (2024). The brand listing is correctly cited with appropriate page references. However, the answer has a notable omission: it fails to address the net sales percentage data that was included in the ground truth (35% in 2022, 36% in 2023 and 2024). This is a significant gap because the original answer emphasizes the contrast between growing earnings contribution and stable sales percentage as evidence of improved segment efficiency and Dawn's strategic positioning. The LLM's statement that 'Dawn's placement did not change' is accurate but somewhat understates the analytical insight that the segment's earnings grew faster than sales, suggesting operational improvements. The quantitative data provided (31%, 34% earnings contributions) is accurate, and the multi-hop reasoning correctly synthesizes information across three years and connects segment performance to Dawn's positioning. The answer appropriately uses citations and maintains semantic equivalence with the ground truth regarding Dawn's consistent relevance. The main weakness is the incomplete picture due to missing sales percentage analysis, which reduces the depth of the positioning evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 385,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "The 2022 filing disclosed that Schwab had $120.3 billion of client securities available to pledge and $31.4 billion actually pledged to third parties for margin‑related purposes (options‑clearing, short‑sales, securities‑lending and short‑term borrowings)【page_108】. By 2024 the amount pledged for its secured lines of credit fell to $500 million (versus $950 million a year earlier) and the collateral supporting its FHLB borrowings slipped to $59.8 billion (from $63.1 billion), while discount‑window collateral rose to $30.5 billion【page_97】【page_98】—a modest reduction in the volume of client securities used as collateral, yet the firm still relies on tens of billions of client‑held assets, indicating a still‑substantial exposure to those assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific dollar amounts and attempts to trace evolution across years, but has significant issues: (1) QUANTITATIVE PROBLEMS: The answer cites specific 2022 figures ($120.3B available, $31.4B pledged) and 2024 figures ($500M for secured lines, $59.8B for FHLB, $30.5B for discount-window) with page citations, but these cannot be verified against the ground truth provided. The ground truth does not include these specific numbers, making verification impossible. The comparison structure (2024 vs prior year) is logically sound but the actual values are unverified. (2) COMPLETENESS ISSUES: The LLM answer focuses heavily on 2022 and 2024 but largely omits 2023, which the ground truth explicitly mentions as a key year where Schwab maintained margin loan collateral under ASC 326 and applied practical expedients. This is a significant gap in addressing the '2022 through 2024' evolution requested. (3) ENTITY/METRIC ACCURACY: The answer correctly identifies Charles Schwab and discusses relevant metrics (pledged securities, collateral, margin lending), but the specific categorization of collateral types (secured lines of credit, FHLB borrowings, discount-window) differs from the ground truth's focus on margin loan collateral and options clearing. (4) REASONING QUALITY: The multi-hop synthesis is partially sound—the answer does attempt to show evolution and draw a conclusion about exposure—but the conclusion ('modest reduction...yet still substantial exposure') contradicts the ground truth's characterization of 'increasing sophistication and exposure.' The ground truth suggests growth/expansion; the LLM suggests contraction. (5) SEMANTIC ALIGNMENT: The ground truth emphasizes increasing sophistication in client securities utilization and growing client engagement in leveraged activities; the LLM emphasizes reduction in pledged amounts. These are directionally opposite interpretations. The answer is well-structured and attempts quantitative rigor, but lacks verification against ground truth and misses the 2023 evolution component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 557,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s target for non‑U.S. defined‑benefit plans moved from a 2023 mix of 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other (U.S. plans were 100 % debt) to a 2025 mix of 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other, while the U.S. plan target remained 100 % debt (page 88; page 95). The weighted‑average allocations reported for August 31 show a parallel shift: non‑U.S. equity rose from 21 % in 2022 to 23 % in 2024, debt fell from 50 % to 42 %, cash stayed near 4‑6 %, insurance increased from 15 % to 21 %, and other slipped from 10 % to 9 % (pages 88, 95). This reflects a gradual move toward a higher equity‑ and insurance‑focused allocation and lower debt exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) ENTITY MISMATCH: The LLM discusses non-U.S. vs. U.S. defined benefit plans separately, while the ground truth refers to overall weighted-average plan asset allocations across all plans combined. The question asks about 'ACN's defined benefit pension plans' generally, not a breakdown by geography. (2) QUANTITATIVE ERRORS: The LLM provides completely different numbers than the ground truth. Ground truth shows: FY2023 (Aug 31, 2022): 55% fixed income/45% equities; FY2024 (Aug 31, 2023): 58% fixed income/42% equities; FY2025 (Aug 31, 2024): 61% fixed income/39% equities. The LLM reports non-U.S. allocations of 48% debt (2023) and 36% debt (2025), which don't match the ground truth's 55% and 61% fixed income figures. (3) DIRECTIONAL CONTRADICTION: The ground truth shows a clear trend toward INCREASING fixed income (de-risking), moving from 55% to 61%. The LLM claims the opposite - that debt FELL from 50% to 42% and equity ROSE from 21% to 23%, describing this as 'higher equity-focused allocation.' This is the inverse of the actual trend. (4) MISSING CONTEXT: The LLM introduces insurance and 'other' asset classes that are not mentioned in the ground truth answer, suggesting it may be referencing different disclosure sections or misinterpreting the data structure. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year evolution (FY2023, FY2024, FY2025) as requested. The answer does not properly track the progression across the three fiscal years using the August 31 dates specified. The only partially correct element is the acknowledgment of a 'gradual shift' over time, but the direction and magnitude are entirely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 483,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million at year‑end 2022 to $538 million in 2023, then ticked up to $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024 (Table 8.1, 2023 10‑K p. 178; Table 9.1, 2024 10‑K p. 188). Over the same three‑year span the weighted‑average interest rate on long‑term debt increased—from low‑rate securitized debt around 3 % and senior notes near 4.5 % in 2023 (Table 8.1 p. 178) to higher‑rate fixed senior notes averaging about 4.8 % and securitized debt at 3.5 % by 2024 (Table 9.1 p. 188)—showing a shift toward higher‑cost fixed‑rate financing and reduced reliance on low‑cost short‑term funding, which raises the company’s exposure to rising interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive quantitative errors that make it largely incorrect. CRITICAL ERRORS: (1) Total debt figures are significantly wrong - LLM states $47.8B (2022), $49.3B (2023), $45.0B (2024) when ground truth shows $43.086B, $48.715B, $45.551B respectively. The 2022 figure is off by $4.7B (11% error), 2023 by $0.585B (1.2% error), and 2024 by $0.551B (1.2% error). (2) Interest rate data is inverted/incorrect - LLM claims rates were 'around 3%' and '4.5%' in 2023, then 'about 4.8%' and '3.5%' in 2024, but ground truth shows weighted-average rates on long-term debt were 3.01% in 2023 and 3.48% in 2024 (a clear upward trend, not the mixed pattern LLM describes). (3) The LLM completely misses the critical finding that floating unsecured senior debt was reduced from $1,597M in 2023 to $0 in 2024, which is a key strategic insight mentioned in the ground truth. (4) The breakdown between short-term and long-term debt in the LLM answer ($883M + $47.8B = $48.683B in 2022) doesn't align with the stated total of $43.086B in ground truth, suggesting fundamental misunderstanding of the debt structure. (5) The LLM's characterization of interest rate trends as showing 'shift toward higher-cost fixed-rate financing' is partially correct directionally but based on incorrect underlying numbers. The multi-hop reasoning is flawed because it's built on incorrect foundational data. While the LLM correctly identifies that the question requires synthesis across multiple years and debt categories, the execution fails due to material quantitative errors that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 444,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s fleet‑support services have stayed essentially flat – the company notes that these costs “have historically been approximately 1 % of total consolidated costs of products and services” in the 2023 filing [page 36] and repeats the same figure in the 2024 filing [page 39], implying a similar level in 2022. In contrast, the 787 program’s abnormal production costs ballooned to $2.7 billion through 2023 and added another $256 million in 2024 [page 36; page 39], while the 777X program’s reach‑forward losses grew from the $0.8 billion recorded in 2022 [page 35] to $2.608 billion in Q3 2024 and a further $891 million in Q4 2024 [page 39], showing that program‑specific abnormal and reach‑forward costs have risen sharply even as fleet‑support costs remained steady at about 1 %.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core finding that fleet support services costs remained stable at approximately 1% across 2022-2024, properly contrasts this with escalating program-specific costs, and accurately cites the 787 program's $2.7 billion cumulative abnormal production costs through 2023 and the 777X program's $2.608 billion Q3 2024 and $891 million Q4 2024 reach-forward losses. The multi-hop reasoning is sound, synthesizing the stable cost ratio against growing program losses. The answer appropriately addresses all parts of the question.\n\nCRITICAL ERRORS: (1) The LLM states the 787 program 'added another $256 million in 2024' but the ground truth does not provide this specific 2024 incremental figure - this appears to be an unsupported number. (2) The LLM references a '$0.8 billion recorded in 2022' for 777X reach-forward losses, but the ground truth does not mention a 2022 777X reach-forward loss figure. This introduces a potentially incorrect data point that wasn't in the original answer. (3) The LLM's statement about 2022 777X losses creates a false comparison point that wasn't established in the ground truth.\n\nQUANTITATIVE ACCURACY ISSUES: While most major figures are correct ($2.7B for 787, $2.608B and $891M for 777X), the introduction of the $256 million 2024 figure and the $0.8 billion 2022 777X figure without ground truth support represents a significant quantitative accuracy problem. These appear to be either hallucinated or misattributed numbers.\n\nQUALITATIVE ASSESSMENT: The reasoning structure is strong - the LLM correctly identifies the contrast between stable fleet support costs and escalating program costs, and properly synthesizes information across multiple years and programs. However, the unsupported numerical claims undermine the overall reliability.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question's three components (fleet support cost evolution, abnormal production costs, reach-forward losses) and properly contextualizes the relationship between stable service costs and growing program challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 564,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s money‑market and time‑deposit balances fell sharply from **$21 million in 2022** (see page 110) to **$10 million in 2023**, and then **remained at $10 million in 2024** (see page 84). The drop and subsequent flat level suggest the company trimmed its low‑yield, highly liquid cash holdings after 2022—likely reallocating cash to other strategic uses—while still keeping a modest reserve to meet short‑term liquidity needs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely contradict the ground truth: (1) WRONG NUMBERS: The LLM states $21M in 2022, $10M in 2023, and $10M in 2024. The ground truth shows $12M in 2022, $21M in 2023, and $10M in 2024. The LLM has reversed the 2022 and 2023 values. (2) INVERTED TREND: The LLM describes a 'sharp fall from $21M in 2022 to $10M in 2023' when the actual trend was an increase from $12M to $21M in 2023, followed by a decrease to $10M in 2024. (3) INCORRECT INTERPRETATION: The LLM's narrative about 'trimming low-yield holdings after 2022' is backwards—the company actually increased allocations in 2023 before reducing them in 2024. (4) MISSING CONTEXT: The ground truth explicitly identifies 2023 as showing a 'notable increase' reflecting a 'temporary conservative approach,' which the LLM completely misses by having the wrong numbers. (5) CALCULATION VERIFICATION: The three-year progression should be $12M → $21M → $10M (increase of $9M, then decrease of $11M), not $21M → $10M → $10M as stated. The LLM's answer fundamentally misrepresents the company's liquidity strategy evolution and would mislead any reader about AbbVie's actual cash management decisions across this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 350,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "In fiscal 2022 Accenture repurchased about 12.2 million Class A shares for roughly $4.1 billion, leaving $3.13 billion of its open‑market buy‑back authority still available (the board then added $3 billion, raising total outstanding authority to $6.13 billion)【page_94】【page_93】. By fiscal 2024 the company had bought back $4.5 billion of shares (including 2.07 million shares in Q4 alone) and the remaining available authorization fell to $2.69 billion, even as the board approved an additional $4 billion, lifting total outstanding authority to $6.69 billion【page_40】【page_39】. This pattern of sizable, ongoing buybacks combined with periodic increases in authorized capacity shows Accenture’s aggressive, sustained commitment to returning capital to shareholders through share repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Accenture's share repurchase strategy and correctly identifies the key trend of expanding capital return commitments. However, there are some quantitative discrepancies that warrant attention:\n\nCORRECT ELEMENTS:\n- Fiscal 2022: $3.13 billion remaining authorization is correct (matches $3,129,296 thousand)\n- Fiscal 2023: $2.69 billion remaining authorization is correct (matches $2,694 million)\n- Fiscal 2024: $6.69 billion total outstanding authority is correct (matches $6,694 million)\n- The $4 billion board authorization increase in fiscal 2024 is correct\n- The overall narrative about expanding capital return strategy is accurate\n- Multi-hop synthesis across fiscal years is sound\n\nPROBLEMATIC ELEMENTS:\n- The LLM states fiscal 2022 had \"$4.1 billion\" in repurchases and that the board \"added $3 billion, raising total outstanding authority to $6.13 billion.\" The ground truth indicates $3,129,296 thousand (~$3.13 billion) was remaining available authorization, not that $3 billion was newly added in 2022. This conflates fiscal 2022 and fiscal 2023 board actions.\n- The statement about fiscal 2024 having \"$4.5 billion of shares\" bought back lacks clear grounding in the provided ground truth data\n- The intermediate calculation showing $6.13 billion total authority in 2022 is not explicitly confirmed in the ground truth\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three fiscal years and identifies the pattern of periodic board authorizations combined with ongoing repurchases. The conclusion about \"aggressive, sustained commitment\" is well-supported by the data presented.\n\nQUANTITATIVE ACCURACY:\nWhile the key figures for fiscal 2023 and 2024 are accurate, the fiscal 2022 narrative contains some ambiguity about whether the $3 billion addition occurred in 2022 or 2023, and the $4.1 billion repurchase figure is not clearly verified against ground truth. The core remaining authorization figures are correct.\n\nOVERALL ASSESSMENT:\nThe answer captures the essential trend and provides accurate endpoint figures for fiscal 2023-2024, but contains some imprecision in the fiscal 2022 narrative and intermediate calculations that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 607,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s charter and bylaws have repeatedly required that “stockholders may only remove directors for cause,” a clause that appears unchanged in the 2022 filing (page 46) 【page_46】, the 2023 filing (page 27) 【page_27】 and the 2024 filing (page 27) 【page_27】. The unchanged, board‑entrenching provision signals a deliberate, long‑term takeover‑defense strategy that makes it difficult for shareholders or hostile acquirers to replace directors without cause, forcing any potential buyer to negotiate with an entrenched board rather than pursue a coercive bid.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the core governance provision ('stockholders may only remove directors for cause') that appears consistently across all three years (2022, 2023, 2024); (2) Accurately cites specific page numbers for each filing (page 46 for 2022, page 27 for 2023 and 2024), demonstrating precise document reference; (3) Properly synthesizes the multi-hop requirement by showing the provision's consistency across three years; (4) Correctly interprets this as a deliberate takeover defense strategy; (5) Accurately explains the mechanism (makes it difficult for shareholders/hostile acquirers to replace directors without cause, forces negotiation with entrenched board). MINOR GAPS: (1) The LLM answer is somewhat narrower in scope than the ground truth—it focuses primarily on the 'removal for cause' provision but does not explicitly mention the broader anti-takeover defense ecosystem mentioned in the original answer (staggered board terms, restrictions on special meetings, supermajority requirements for bylaw amendments). However, the question itself focuses on 'governance provisions related to director removal for cause,' so this narrower focus is actually appropriate to the specific question asked; (2) The phrase 'unchanged, board-entrenching provision' is accurate but slightly less nuanced than the ground truth's 'Despite no explicit changes...the consistent emphasis in each annual report underscores AbbVie's ongoing commitment.' The LLM's phrasing is still semantically equivalent and perhaps more direct. QUANTITATIVE VERIFICATION: Page numbers are correctly cited (46, 27, 27). The three-year span (2022, 2023, 2024) is correct. No calculations are required for this question. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly identifies that the same provision appears across three separate filings and draws the logical conclusion about strategic intent. The explanation of how this provision functions as a takeover defense is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 559,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K reports PepsiCo consistently lists the “4.000% Senior Note due 2047” as an exhibit (Item 4.16/4.17, Exhibit 4.5) with the same description and reference to the May 2 2017 Form 8‑K filing 【page_127】. The unchanged wording and repeat inclusion show that the note remains outstanding and is treated as a core, long‑dated financing tool, illustrating PepsiCo’s deliberate reliance on low‑coupon, long‑maturity debt to anchor its long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. CORRECT ELEMENTS: (1) All numeric/date references are accurate - 4.000% coupon rate, 2047 maturity date, May 2, 2017 8-K filing date, Exhibit 4.5 reference all match ground truth exactly. (2) The three-year period (2022, 2023, 2024) is correctly addressed. (3) The core finding that the note was consistently disclosed with identical references across all three years is accurately captured. (4) The multi-hop synthesis is sound - the LLM correctly identified that the consistent disclosure pattern across three separate 10-K filings demonstrates stability and long-term strategic importance. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing than ground truth (e.g., 'Item 4.16/4.17' vs. the ground truth's simpler reference structure), but this is a formatting variation that doesn't affect factual accuracy. (2) The LLM adds interpretive language about 'low-coupon, long-maturity debt' and 'deliberate reliance' which goes slightly beyond the ground truth's more neutral observation, but this interpretation is logically sound and supported by the facts presented. (3) The page reference [page_127] is included in the LLM answer but not in the ground truth - this is additional detail that doesn't contradict the ground truth. QUANTITATIVE VERIFICATION: All dates (May 2, 2017; 2022, 2023, 2024), the coupon rate (4.000%), maturity year (2047), and exhibit reference (4.5) are precisely correct. No calculation errors present. MULTI-HOP REASONING: The LLM successfully synthesized information across three separate 10-K filings to demonstrate the consistency pattern and draw appropriate conclusions about capital structure strategy. The reasoning chain is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 480,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle’s 4.30 % senior note due 2034 was first issued in 2014 (the July 8 2014 filing) and has been listed in every subsequent 10‑K. In the 2022 filing the note appears as Exhibit 4.11 (Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044) 【page_113】, while in both the 2023 and 2024 filings it is shown as Exhibit 4.09 with the same description 【page_109】. The consistent yearly disclosure—despite a change in exhibit numbering—shows the note remains outstanding and reflects Oracle’s strategy of issuing long‑dated, fixed‑rate senior notes and retaining them as part of a diversified, multi‑year debt maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) FACTUAL CONTRADICTION - LLM claims the 4.30% Note due 2034 was 'first issued in 2014' but the ground truth explicitly states it was 'first disclosed in 2022.' This is a fundamental factual error that contradicts the core premise of the question about the 2022-2024 evolution. (2) MISALIGNMENT WITH QUESTION SCOPE - The question asks specifically about how the note 'evolved across 2022, 2023, and 2024' (a 3-year pattern), but the LLM introduces 2014 as the issuance date, which is outside the question's temporal scope and contradicts the ground truth's statement that disclosure began in 2022. (3) EXHIBIT NUMBERING DETAILS - While the LLM provides specific exhibit numbers (4.11 in 2022, 4.09 in 2023-2024), these details are not verified against the ground truth and appear to be hallucinated specificity that doesn't match the ground truth's simpler statement about 'reaffirmed inclusion' and 'consistent disclosure.' (4) SEMANTIC MISALIGNMENT - The ground truth emphasizes the note's first disclosure in 2022 as a key milestone, but the LLM contradicts this by claiming 2014 issuance. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the multi-year pattern (2022-2024) as described in the ground truth. Instead, it introduced an earlier date that fundamentally changes the narrative. The conclusion about 'diversified, multi-year debt maturity profile' is reasonable but is built on incorrect foundational facts. CORRECT ELEMENTS: The general characterization of Oracle's debt strategy (long-dated, fixed-rate senior notes, diversified maturity profile) aligns with the ground truth's conclusion, but this cannot overcome the fundamental factual errors about when the note was first disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 475,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- In fiscal 2022 the Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture plc Class A ordinary shares for awards【page_91】.  \n- By fiscal 2024 that ceiling had been raised to **141 million** shares【page_98】.  \n\nThe increase of roughly 14 million shares (about an 11 % rise) shows Accenture is deliberately expanding its equity‑award pool, signaling a long‑term strategy to rely on share‑based compensation to attract, retain and align employees with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers: 127 million shares in fiscal 2022 and 141 million shares in fiscal 2024. The calculation of the increase (14 million shares, approximately 11%) is accurate. However, there is a significant omission: the LLM answer fails to mention the fiscal year 2023 data point (141 million shares), which is explicitly stated in the ground truth as an intermediate year showing the progression from 2022 to 2023 to 2024. The ground truth indicates that shares increased from 127M (2022) to 141M (2023) and remained at 141M (2024), showing a specific progression pattern. The LLM only compares 2022 to 2024 endpoints, missing the important detail that the increase occurred between 2022-2023 and then stabilized. The reasoning about share-based compensation strategy is sound and semantically equivalent to the ground truth. The quantitative accuracy is strong for the numbers provided, but the incompleteness regarding the fiscal 2023 data point represents a material omission in addressing the 'evolution' aspect of the multi-part question. The answer would have been 9-10 if it had included the fiscal 2023 intermediate value to show the complete three-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 341,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings PepsiCo repeatedly lists the **2.750 % Senior Note due 2051** as Exhibit 4.3, each time referencing the same Current Report on Form 8‑K filed on October 21 2021 (see 2022 p. 128, 2023 p. 129, 2024 p. 131). The coupon (2.75 %), maturity (2051) and other issuance terms have not changed, and the note’s documentation is carried forward unchanged each year. This recurring inclusion signals that PepsiCo deliberately issues long‑dated, low‑coupon senior notes and keeps them on its balance sheet for decades, using consistent, transparent reporting to support a stable, long‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) EXHIBIT NUMBER ERRORS: The LLM claims the note is listed as 'Exhibit 4.3' in all three years, but the ground truth specifies different exhibit numbers across years (4.60 in 2022, 4.51 in 2023, 4.48 in 2024). This is a material error that misses the core evolution being tracked. (2) DOCUMENTATION PROGRESSION MISSED: The ground truth explicitly describes a three-stage evolution: authorization/planning (2022) → formalization with dedicated form (2023) → maintenance/consistency (2024). The LLM completely misses this progression, instead claiming the documentation was 'carried forward unchanged each year,' which contradicts the ground truth's description of moving from a Board resolution to a dedicated Form. (3) FORM 8-K REFERENCE: The LLM references a Form 8-K filed October 21, 2021, which is not mentioned in the ground truth and appears to be an unsupported claim. (4) EXHIBIT FORM DESCRIPTION: The ground truth specifically notes that 2023 included a 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), indicating a formal instrument document, whereas the LLM provides no such distinction. (5) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the coupon rate (2.75%) and maturity year (2051), it fails to synthesize the multi-year filing pattern that shows deliberate phasing and formalization—the core insight of the question. The LLM's conclusion about 'stable, long-term financing strategy' is reasonable but is built on incorrect exhibit tracking and misses the specific evolution documented in the ground truth. The answer demonstrates a fundamental misunderstanding of the exhibit progression that is central to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 484,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In 2022 – 2023, American Express described itself as the fourth‑largest general‑purpose card network worldwide, relying on its premium brand, closed‑loop rewards and broad merchant acceptance, while acknowledging intense competition from Visa, Mastercard, UnionPay and fast‑growing digital‑wallet, BNPL and other fintech alternatives (see the “Competition” section, 2022/2023 pages 12‑13). By 2024, regulatory pressure has intensified—AmEx is now a Category III firm subject to stricter capital and compliance requirements, has exited network‑licensing businesses in the EU and Australia, and faces downward pressure on discount revenue from interchange‑fee caps and potential Visa/Mastercard settlements—forcing it to invest heavily in compliance and cybersecurity and to lean on its premium differentiation as alternative‑payment mechanisms continue to expand (see 2024 pages 34‑35).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies American Express as the fourth-largest general-purpose card network globally, matching the ground truth. (2) Accurately names the three larger competitors (Visa, Mastercard, UnionPay/China UnionPay). (3) Correctly identifies alternative payment pressures (digital wallets, BNPL, fintech). (4) Accurately describes the shift from market-driven to regulation-constrained environment. (5) Correctly notes EU regulatory scrutiny, market exits, and interchange fee pressure. (6) Appropriately references compliance costs and cybersecurity investments. (7) Multi-hop synthesis is sound—connects 2022-2023 positioning with 2024 regulatory changes.\n\nWEAKNESSES: (1) The LLM introduces a specific claim about 'Category III firm' classification that is not present in the ground truth answer. While this may be factually accurate from the 10-K, it represents information beyond what the ground truth explicitly states, creating potential for unverified specificity. (2) References to specific page numbers (12-13, 34-35) are helpful for traceability but cannot be verified against the ground truth. (3) The mention of 'Visa/Mastercard settlements' is more specific than the ground truth's general reference to regulatory scrutiny. (4) Slightly less emphasis on the 'closed-loop loyalty systems' differentiation mentioned in ground truth, though this is a minor omission.\n\nNUMERIC/FACTUAL VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative precision cannot be directly tested. The ranking (4th largest) and competitor identification are accurate. The timeline (2022-2023 vs 2024) is correctly maintained.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period, connecting competitive positioning with regulatory evolution. The logic flow from premium differentiation strategy to regulation-constrained adaptation is sound and matches the ground truth's narrative arc.\n\nSEMANTIC EQUIVALENCE: The core message aligns well—American Express maintained 4th position while facing intensifying regulatory pressure that shifted competitive dynamics. The LLM's answer is more detailed and specific in places, which adds value but introduces minor risks of unverified claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 613,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In the 2022 filing Boeing’s Global Services segment was described as providing “upgrades and conversions” as a core part of its lifecycle‑service portfolio (2022 Business description, p. 3). The 2024 filing repeats the same language, again listing “upgrades and conversions” among the key services offered (2024 Business description, p. 5). The unchanged emphasis indicates that Boeing continues to lean on aircraft upgrades and conversions to drive recurring‑revenue, customer‑retention and growth in its services business.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fails to address the core requirement of the question: demonstrating HOW Boeing's strategic emphasis CHANGED from 2022 to 2024. The ground truth explicitly describes a progression showing strategic evolution: (1) 2022 - upgrades/conversions listed as one of several services, (2) 2023 - modifications emphasized more prominently with deeper integration, (3) 2024 - introduction of data analytics and digital services as complementary offerings. The LLM answer incorrectly claims the language remained 'unchanged' between 2022 and 2024, which directly contradicts the ground truth's documented progression. The LLM identifies correct years (2022, 2024) and correctly notes that upgrades/conversions appear in both filings, but fundamentally misses the strategic shift toward technology-enabled service differentiation and the integration of data analytics/digital services. The answer provides no evidence of the 2023 transition or the 2024 introduction of complementary digital services. The LLM's conclusion that Boeing 'continues to lean on' the same approach suggests stagnation rather than the documented strategic evolution toward high-value, technology-enabled services. The multi-hop reasoning is incomplete - the answer fails to synthesize the documented changes across the three-year period and mischaracterizes stability as the key finding when the ground truth emphasizes transformation. The quantitative accuracy is reasonable (correct years cited), but the qualitative reasoning about strategic change is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 427,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50 % Senior Note due 2035 first appears in the 2022 Form 10‑K’s exhibit list as both a “Series A” form (Exhibit 4.23) and the original registration‑statement form (Exhibit 4.27) – both referencing the 2018 issuance (PEP_10k_2022.pdf p. 127). The 2023 Form 10‑K repeats the same two exhibit references for the same note (PEP_10k_2023.pdf p. 127), and the 2024 Form 10‑K again includes the note in its exhibit schedule with the identical references (PEP_10k_2024.pdf p. 127). This recurring, unchanged disclosure across three years shows that PepsiCo has kept the 5.50 % note outstanding without refinancing, reflecting a long‑term debt strategy that locks in fixed‑rate financing for many years and maintains consistent, transparent reporting of its senior‑note portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERS: The LLM answer contains significant factual errors regarding exhibit numbers that directly contradict the ground truth. Ground truth states: 2022 (Exhibit 4.31), 2023 (Exhibit 4.25), 2024 (Exhibit 4.23). LLM answer claims: 2022 has both Exhibit 4.23 and 4.27, 2023 repeats the same, 2024 has identical references. This is demonstrably incorrect - the exhibit numbers changed year-to-year (4.31→4.25→4.23), which is a key factual detail the LLM completely misrepresented. Additionally, the LLM claims the 2022 filing shows 'Series A' form AND 'original registration-statement form' as two separate exhibits, while ground truth identifies only the 'Series A' form (Exhibit 4.31). The LLM's assertion that exhibits remained 'identical' across years is factually wrong. CORRECT ELEMENTS: The LLM correctly identifies (1) the note as 5.50% Senior Note due 2035, (2) all three years (2022, 2023, 2024) included the note, (3) the 2018 issuance date, (4) the overall interpretation that the note remained outstanding without refinancing, and (5) the strategic implication about fixed-rate financing and long-term debt management. REASONING QUALITY: The multi-hop synthesis and strategic interpretation are sound - the conclusion about stable capital structure and long-duration approach is correct. However, the specific documentary evidence (exhibit numbers and forms) is substantially inaccurate, which undermines the credibility of the factual foundation. The page reference (p. 127) cannot be verified from the provided context. QUANTITATIVE ACCURACY: The percentage (5.50%) and year (2035) are correct, but the exhibit number citations are fundamentally wrong, representing a major quantitative/documentary accuracy failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 478,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures for 2022, 2023 and 2024 all contain the same statement that the company’s ability to return capital “is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p.5; 2023 p.5; 2024 p.5). Because the language has not changed over the three‑year span, the firm’s exposure to these banking‑law constraints has remained steady, indicating that U.S. capital‑planning rules continue to impose a persistent, unchanged limitation on BNY Mellon’s shareholder‑return policies.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that BNY Mellon's disclosures across 2022, 2023, and 2024 contain consistent language about capital return constraints. (2) The page references (p.5 for all three years) appear reasonable and specific. (3) The quantitative claim that language 'has not changed over the three-year span' is supported by the identical quoted language. (4) The basic entity identification (BNY Mellon, U.S. banking laws, capital planning) is accurate.\n\nWEAKNESSES: (1) The LLM's interpretation is overly simplistic and misses the nuance of the ground truth. The ground truth explicitly states the exposure 'evolved' and describes a 'multi-year progression' showing how emphasis changed from 'general regulatory oversight' (2022) to 'specifically reiterated' constraints (2023) to 'largely unchanged' but with added emphasis on 'well capitalized' status (2024). The LLM reduces this to 'unchanged limitation,' missing the evolution described in the ground truth. (2) The LLM fails to capture the ground truth's key insight that while language remained consistent, the *emphasis and framing* evolved, particularly the addition of 'well capitalized' status language in 2024. (3) The LLM's conclusion that 'exposure...has remained steady' contradicts the ground truth's characterization of 'consistent yet evolving emphasis.' (4) The LLM misses the ground truth's interpretation that the progression 'reveals' something about regulatory expectations and risk-conscious capital management—it treats the consistency as static rather than as a persistent regulatory constraint that evolved in its articulation.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years but fails to properly interpret what the consistency means in context. The ground truth suggests that the *consistency* of constraints across years, combined with evolving emphasis, reveals ongoing prudential oversight. The LLM treats consistency as evidence of stasis rather than persistence.\n\nSEMANTIC ACCURACY: While the LLM's statement about unchanged language is technically accurate, it fundamentally misinterprets the question's intent about how exposure 'evolved' and what the 'progression reveals.' The ground truth emphasizes evolution despite consistency; the LLM emphasizes only the consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 620,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 have been described in the same way in each filing – the 2022 10‑K lists the notes under Exhibit 4.16 (issued March 24 2021) [page_114], the 2023 10‑K repeats them as Exhibit 4.14 [page_111], and the 2024 10‑K again references Exhibit 4.14 [page_111] with no amendment to the coupon, maturity or other terms. This consistency shows Oracle locked in a low‑coupon, fixed‑rate tranche when rates were low and has kept it unchanged, reflecting a strategy of securing inexpensive, predictable financing rather than repeatedly re‑issuing debt as interest‑rate environments shift.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing the general strategic narrative. CRITICAL ERRORS: (1) Exhibit number discrepancy - The LLM states the 2022 10-K lists the notes under 'Exhibit 4.16' but the ground truth specifies 'Exhibit 4.14'. This is a factual error in document citation. (2) The LLM claims the 2023 10-K references 'Exhibit 4.14' and the 2024 10-K 'again references Exhibit 4.14' - but provides no evidence of whether these exhibit numbers are consistent with ground truth across years. The ground truth explicitly states the 2022 10-K filed it as 'Exhibit 4.14', creating a direct contradiction with the LLM's claim that 2022 used 'Exhibit 4.16'. (3) MISSING CRITICAL CONTEXT: The LLM completely omits the multi-tiered bond offering context that is central to understanding Oracle's financing strategy - specifically the 2.875% Notes due 2031 and 3.950% Notes due 2051 issued in the same offering. This is a significant omission for a question about 'evolution' and 'approach to fixed-income financing.' (4) INCOMPLETE SYNTHESIS: The ground truth explicitly discusses Oracle's 2023 shift to issuing higher-yielding 4.500% Notes due 2028, which demonstrates how the company adapted its strategy in changing rate environments. The LLM completely misses this important multi-hop connection showing the evolution of Oracle's approach. (5) The LLM correctly identifies that terms remained unchanged 2022-2024 and captures the general strategy of locking in low rates, but this represents only partial understanding of the full strategic narrative. STRENGTHS: The LLM correctly identifies the 2.300% coupon rate, the 2028 maturity date, the March 24, 2021 issuance date, and the core strategic insight about locking in favorable rates. The semantic understanding of Oracle's fixed-income strategy is directionally correct. However, the factual errors in exhibit citations and the substantial omission of comparative context (other tranches, 2023 new issuance activity) prevent this from being a reliable answer to a multi-hop question requiring synthesis across multiple years and instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 578,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across the three years IBM repeatedly placed “client relationships and trust” among its core competitive pillars, first tying trust to a “flexible, secure, and open hybrid‑cloud platform” that integrates data, AI and security in the 2022 filing (2022 p. 4). The 2023 10‑K again listed client relationships and trust as a key differentiator and reinforced it in the description of its hybrid‑cloud/AI solutions (2023 p. 3; p. 6). By 2024 the factor remained in the competitive‑methods list and was framed within IBM’s broader strategy of leveraging incumbency, ecosystem partners and innovation to grow its hybrid‑cloud and AI business (2024 p. 3). This continuity shows IBM is positioning itself as a trusted, relationship‑driven provider that differentiates its hybrid‑cloud and AI offerings from hyperscalers and other rivals.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) and IBM's consistent emphasis on client relationships and trust as a competitive differentiator. (2) Accurately captures the evolution: 2022 tied to flexible, secure, open hybrid-cloud platform; 2023 reinforced with hybrid-cloud/AI solutions; 2024 expanded with ecosystem partners and incumbency leverage. (3) Properly synthesizes multi-hop information across three years and multiple strategic dimensions (trust, relationships, hybrid cloud, AI, partnerships). (4) Correctly identifies Palo Alto Networks as a strategic partnership example (matching ground truth's 'adding Palo Alto Networks'). (5) Provides specific page references (2022 p. 4; 2023 p. 3, p. 6; 2024 p. 3) that add credibility and verifiability. (6) Accurately characterizes the strategic positioning relative to hyperscalers and competitors. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and specific than the ground truth (includes page numbers and specific platform descriptions), but this represents added value rather than error. (2) Both answers convey the same core insight: IBM's consistent, increasingly nuanced strategic emphasis on trust as foundational to competitive advantage in hybrid cloud and AI. (3) The phrase 'trusted, relationship-driven provider' in the LLM answer semantically matches the ground truth's emphasis on trust and client relationships. QUANTITATIVE ACCURACY: No numerical calculations or specific financial metrics are required for this qualitative strategic question; the answer correctly identifies all three years and maintains chronological accuracy. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and connects strategic themes (trust, relationships, hybrid cloud, AI, partnerships, incumbency) in a coherent narrative showing evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 541,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio moved from a very low‑yield environment in 2022 – a weighted‑average yield of roughly 2.1 % (2.08 % shown for foreign government bonds and obligations)【page_121】 – to a much higher‑yield profile by 2024, with the average yield on its non‑U.S. taxable investment securities (which include those sovereign bonds) rising to about 6.1 % in 2024, up from 5.9 % in 2023 and roughly 2.5 % in 2022【page_176】. This three‑year climb reflects the impact of a rising global interest‑rate environment, increasing the portfolio’s sensitivity to rate changes while signalling a strategic tilt toward higher‑yielding, interest‑rate‑sensitive assets to boost returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and misrepresents the data from American Express's filings. CRITICAL ERRORS: (1) The LLM cites a 2022 yield of 2.1% (or 2.08%), but the ground truth shows NO yield data for 2022—only maturity information ($630M total holdings). The LLM appears to have confused or fabricated this number. (2) The LLM claims 2024 yield was 6.1% for 'non-U.S. taxable investment securities,' but the ground truth specifically states the 2024 yield for foreign government bonds and obligations was 5.85%—a different metric and different number. (3) The LLM cites 5.9% for 2023, but ground truth shows 6.45% for 2023—a significant discrepancy of 0.55 percentage points. (4) The LLM conflates 'non-U.S. taxable investment securities' (a broader category) with 'foreign government bonds and obligations' (a specific subset), mixing different asset classes. MISSING KEY INFORMATION: The LLM fails to address the critical maturity profile evolution that the ground truth emphasizes—the shift from ultra-short-duration (2023: 100% within 1 year) to more diversified maturity (2024: 2.03% in 1-5 years bucket). This maturity shift is central to understanding the interest rate risk management strategy. REASONING ISSUES: While the LLM correctly identifies that yields rose in a rising rate environment, it misses the nuanced strategic shift from concentration in short-duration high-yield securities to a more balanced maturity ladder. The LLM's conclusion about 'interest-rate-sensitive assets to boost returns' is partially correct but lacks the sophistication of the ground truth's explanation about managing interest rate risk through diversification. QUANTITATIVE VERIFICATION: 2022 yield (2.1% vs. no data), 2023 yield (5.9% vs. 6.45%), 2024 yield (6.1% vs. 5.85%)—all three primary numbers are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 497,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s diagnostics‑testing program has been increasingly funded by U.S. government grants that directly offset capital spending: grant‑backed purchases of property, plant and equipment rose from $87 million in 2022, to $136 million in 2023, and to $198 million in 2024【page_68】. The company also noted that 2022 capital spending was being raised to expand testing‑related manufacturing capacity, underscoring that diagnostics testing is a growing strategic priority within its broader health‑care portfolio【page_59】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All three key financial figures are correct - $87 million (2022), $136 million (2023), and $198 million (2024). The progression and year-to-year increases match the ground truth exactly. COMPLETENESS: The answer addresses all major components of the multi-part question: (1) the investment evolution across the three-year period, (2) the specific government grant funding amounts, (3) the offset of capital expenditures, and (4) the strategic importance within the healthcare portfolio. ENTITY ACCURACY: Danaher Corporation is correctly identified, the time period (2022-2024) is accurate, and the financial metric (government grant funds offsetting capital expenditures) is properly characterized. REASONING QUALITY: The LLM correctly synthesizes information across multiple sources (indicated by page references 68 and 59), connecting the grant funding data with strategic context about manufacturing capacity expansion. The logical conclusion that diagnostics testing is a 'growing strategic priority' is well-supported by the upward funding trend. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('grant-backed purchases of property, plant and equipment' vs. 'government grant funds used to offset capital expenditures'), but these are semantically equivalent and both accurately describe the same financial reality. The inclusion of specific page references adds credibility. The answer could have been marginally enhanced by explicitly stating the percentage increases year-over-year, but this is not required and the core answer is complete without it. Overall, the response demonstrates accurate multi-hop reasoning, correct synthesis of financial data across years, and appropriate contextual framing of strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 505,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 BNY Mellon’s Form 10‑K Item 14 – Principal Accountant Fees and Services contains the same language: it tells readers that the ratification of KPMG LLP as the company’s principal accountant is incorporated by reference to the Proxy’s “Item 3 – Ratification of KPMG LLP,” and it states that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is 185. The phrasing and placement of this statement within the Proxy‑referenced section are unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies BK/BNY Mellon as the subject company; (2) Accurately states the PCAOB firm identification number as 185 across all three years (2022, 2023, 2024); (3) Correctly identifies KPMG LLP as the principal accountant; (4) Accurately notes the consistent disclosure structure referencing 'Item 3 – Ratification of KPMG LLP' within Item 14 of Proxy materials; (5) Properly conveys that there was no change in the identification number or format across the three-year period; (6) Correctly synthesizes the multi-hop information (company → auditor → PCAOB number → disclosure consistency across years). MINOR CONSIDERATIONS: (1) The LLM answer references 'Form 10-K Item 14' while the ground truth specifies 'Item 14 of the Proxy materials' - this is a subtle distinction but the LLM's phrasing about incorporation by reference to the Proxy section clarifies this adequately; (2) The ground truth emphasizes 'Proxy sections' while the LLM emphasizes the 10-K's reference to the Proxy, which is semantically equivalent given the incorporation by reference structure. The answer demonstrates sound multi-hop reasoning by connecting the company name, auditor identification, PCAOB number, and consistency across three fiscal years. All numeric values (PCAOB number 185, three years) are accurate. The semantic meaning matches the ground truth completely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 404,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "In the 2022 filing, American Express recorded revenue from third‑party merchant acquirers as “discount revenue” (and related “processed revenue”) at the moment a Card‑Member transaction occurred, with merchant‑acceptance contracts ranging from no‑fixed term for small merchants to 3‑to‑7‑year fixed agreements and a network‑rate fee negotiated individually with each acquirer. The 2023 filing kept the same transaction‑time recognition but explicitly referenced its OptBlue program and Global Network Services (GNS) partners, emphasizing that the network‑rate fee is individually negotiated and that processed revenue reflects settlements with those third‑party acquirers. By 2024, the discussion moved to strategy, stating that expanding merchant coverage globally will increasingly rely on the success of third‑party acquirers, aggregators and processors to sign merchants in priority cities, countries and industry verticals, signaling a more growth‑focused dependence on these partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about American Express's evolving relationship with third-party merchant acquirers across 2022-2024. STRENGTHS: (1) Correctly identifies the revenue recognition structure in 2022 as 'discount revenue' and 'processed revenue' tied to transaction timing; (2) Accurately names specific programs (OptBlue, Global Network Services/GNS) across all three years; (3) Properly characterizes the contractual relationships (no fixed term for small merchants, 3-7 year agreements for larger ones); (4) Correctly describes the evolution from transactional to strategic partnership model; (5) Accurately captures the 2024 shift toward growth-focused global expansion strategy emphasizing third-party acquirers, aggregators, and processors in priority cities/countries/verticals. (6) No quantitative errors or incorrect dates. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer could have been slightly more explicit about the 'Processed Revenue' model formalization in 2023 as a distinct structural shift (the ground truth mentions 'integrating third-party acquirers into a broader Processed Revenue model that included royalties, fees, and network partnership agreements'), though the LLM does reference processed revenue; (2) The answer could have emphasized more clearly that this represents a shift from 'transactional dependency' to 'strategic partnership' as a framing device, though the substance is captured. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression of American Express's strategic approach. The connection between revenue recognition structures, contractual terms, and strategic expansion goals is logically sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution aligns well with the ground truth's core message about moving from transactional to strategic relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 533,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s FY 2022 10‑K set explicit 2025 diversity goals—women in leadership + 15 %, URM in leadership + 15 % and overall URM representation + 20 %—and made progress toward those goals a non‑financial performance modifier that could adjust executive bonuses between 0.9 × and 1.1 × target (page 16). The FY 2023 filing continues to emphasize DEI and HR‑Compensation Committee oversight of human‑capital initiatives but does not restate the numeric targets or a specific multiplier (pages 14‑15). In FY 2024 the company again ties human‑capital progress to executive compensation with the same 0.9‑1.1 multiplier, while focusing on broader DEI efforts rather than reiterating the FY 2022 percentages (pages 15‑16).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative elements and correctly synthesizes the multi-hop information across three fiscal years. STRENGTHS: (1) All numeric targets are correct: women in leadership +15%, URM in leadership +15%, overall URM +20%, and the 0.9-1.1 multiplier range are all accurately stated. (2) The multi-hop synthesis across FY2022-2024 is sound, correctly identifying that FY2022 established explicit targets, FY2023 maintained the linkage without restating numbers, and FY2024 continued the same multiplier structure. (3) The answer correctly identifies the non-financial performance modifier mechanism and its role in executive compensation. (4) Page references are provided, adding credibility. WEAKNESSES: (1) The answer states FY2023 'does not restate the numeric targets or a specific multiplier' which is slightly imprecise—the ground truth indicates FY2023 'maintained the same executive compensation linkage' with the modifier still in place, though the LLM's characterization of not restating numbers is accurate. (2) The answer could have been more explicit about the 'sustained emphasis' aspect mentioned in the ground truth, though this is implied. (3) Minor semantic difference: the ground truth emphasizes 'deepening integration of human capital metrics' and 'expanding supporting programs' in FY2024, while the LLM focuses on 'broader DEI efforts rather than reiterating percentages'—both convey similar meaning but the LLM's framing is slightly narrower. (4) The answer lacks explicit mention of regional recognition and specific initiatives like the Reboot Representation Tech Coalition mentioned in the ground truth, though these are contextual details rather than core factual errors. QUANTITATIVE VERIFICATION: All percentages (15%, 20%) and multiplier ranges (0.9-1.1) are correct. No calculation errors detected. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the evolution pattern (establishment → maintenance → continuation with expansion). The logic is sound and the progression is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 574,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In 2022 Caterpillar’s EMD‑branded reciprocating‑engine sales were routed through Perkins’ network of **90 distributors in 171 countries**【page_76】. By 2024 that network had been trimmed to **88 distributors but now covered 185 countries**【page_66】. The modest drop in distributor count alongside a clear expansion in country coverage shows Caterpillar is consolidating its channel partners while deliberately widening its global footprint for EMD engines, underscoring a strategy of deeper, more efficient penetration of worldwide markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth states EMD-branded products were distributed across 193 countries (2022), 191 countries (2023), and 187 countries (2024). The LLM claims 171 countries in 2022 and 185 countries in 2024 - these numbers are completely wrong and represent a 22-country discrepancy in 2022 and a 2-country discrepancy in 2024. The LLM also introduces distributor counts (90 and 88) that are not mentioned in the ground truth at all, suggesting the model may have confused or fabricated data from different sources. The directional interpretation is also inverted: the ground truth indicates a CONTRACTION in geographic reach (193→191→187 countries), while the LLM claims an EXPANSION (171→185 countries). This is a fundamental misreading of the strategic positioning. The LLM's conclusion about 'deliberate widening of global footprint' directly contradicts the actual trend of declining country coverage. The reasoning about consolidation while expanding is logically inconsistent with the actual data showing contraction. The answer fails on quantitative accuracy (wrong country numbers), entity accuracy (missing or misidentifying the actual geographic reach metrics), and reasoning (inverted interpretation of the trend). The only partially correct element is the general concept of discussing distributor consolidation, but this is overshadowed by the pervasive numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 413,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that “Palmolive” appears in the company’s roster of principal global trademarks in each of the 2022, 2023 and 2024 10‑K filings shows that Colgate‑Palmolive treats Palmolive as a core, enduring brand for its Oral, Personal and Home Care segment. Its continual presence signals that Palmolive remains a strategic pillar that drives sales, brand equity and market positioning within that segment【page_79】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that Palmolive appears as a principal global trademark across 2022, 2023, and 2024 10-K filings, demonstrating its strategic importance. The quantitative accuracy is strong - all dates (2022, 2023, 2024) are correct, and the three-year consistency is accurately captured. The reasoning that this consistency signals Palmolive as a 'core, enduring brand' and 'strategic pillar' is sound and semantically equivalent to the ground truth's conclusion about 'sustained strategic importance' and 'foundational role.' The LLM correctly identifies the segment (Oral, Personal and Home Care) and appropriately infers that the brand drives 'sales, brand equity and market positioning.' However, there are notable omissions: (1) The LLM does not mention specific product categories where Palmolive operates (liquid hand soap, dishwashing detergents, household cleaners) that the ground truth explicitly references; (2) The LLM does not acknowledge the contextual detail that Palmolive maintained its position despite the addition of Darlie in 2023, which the ground truth uses to strengthen the argument about 'continued emphasis'; (3) The LLM does not reference other key brands like Colgate and Ajax that provide comparative context for Palmolive's positioning. The answer is directionally correct and captures the essential strategic insight, but lacks the granular product category and comparative brand context that enriches the ground truth answer. The reasoning is valid but less comprehensive than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 428,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm’s 2022 filing highlighted edge networking as a central driver of IoT growth, noting that the IoT device base was expected to more than double to 27 billion by 2026 and that “edge networking products (including mobile broadband and wireless access points)” were fueling that expansion (page 8). In the 2023‑2024 segment disclosures, edge networking is grouped within the IoT revenue stream (alongside consumer and industrial), which declined from $7.35 billion in FY‑22 to $5.42 billion in FY‑24, with equipment sales—including edge‑networking—recognized at a point in time and related licensing royalties recognized over time and reported separately as revenue from previously satisfied performance obligations (page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 27 billion IoT device projection by 2026 and accurately describes Edge Networking as a central growth driver in 2022. It correctly notes that Edge Networking was grouped within IoT revenue alongside consumer and industrial applications in 2023-2024. The answer properly identifies the revenue recognition structure distinction (point-in-time for equipment sales vs. over-time for licensing royalties). The reference to mobile broadband and wireless access points as Edge Networking products is accurate.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ACCURACY ISSUE - The LLM provides specific revenue figures ($7.35B in FY22 declining to $5.42B in FY24) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be potentially fabricated or misattributed details. This is a significant concern for factual accuracy. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM answer fails to adequately address the 3-year progression narrative that is central to the ground truth. The ground truth emphasizes the strategic transformation from 'emerging IoT opportunity in 2022' to 'structurally embedded product pillar by 2023' with 'sustained emphasis through 2024.' The LLM answer mentions 2023-2024 grouping but doesn't clearly articulate this evolution or the significance of formalization in 2023. (3) MISSING CONTEXT - The LLM doesn't mention the connection to hybrid work trends and wireless technology advances (5G, Wi-Fi 6/6E) that were cited in the ground truth as contextual drivers. (4) INCOMPLETE FISCAL 2024 ANALYSIS - While the ground truth notes that 2024 maintained the same categorization (signaling continuity), the LLM answer doesn't explicitly address 2024 positioning separately or emphasize the strategic continuity aspect.\n\nCALCULATION/VERIFICATION: The revenue decline from $7.35B to $5.42B represents approximately a 26% decrease, but these specific figures are not corroborated in the ground truth and their source is unclear. This introduces uncertainty about factual accuracy.\n\nMULTI-HOP REASONING: The answer demonstrates partial multi-hop synthesis by connecting 2022 positioning to 2023-2024 categorization and revenue recognition structure, but it doesn't fully synthesize the strategic evolution narrative across all three years as comprehensively as the ground truth requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 642,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 10‑K risk disclosures show that its exposure to currency‑exchange‑rate risk has been a constant feature of its global business – costs are incurred in many foreign currencies while revenue is reported in U.S. dollars – and that the company relies on currency‑hedging instruments to blunt adverse moves (while accepting that hedges can forfeit any upside from favorable rate changes) 【page_22】. The same description of this exposure and the hedging approach appears unchanged in the 2023 filing (page 18) and again in the 2024 filing (page 18), indicating that Caterpillar has maintained a steady hedging strategy over the period and has not altered its overall management of earnings volatility from currency fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misses critical elements of the ground truth. STRENGTHS: (1) Correctly identifies Caterpillar's currency exposure from global operations and costs in foreign currencies vs. USD revenue reporting; (2) Accurately describes the hedging approach and its trade-off (protection against downside but forfeiting upside); (3) Page references appear reasonable (pages 22, 18, 18 for respective years). CRITICAL WEAKNESSES: (1) The LLM claims the description 'appears unchanged' across 2022-2024, directly contradicting the ground truth which explicitly states the company 'expanded its discussion' in 2023 to include 'risks from exchange controls and currency devaluations, particularly in emerging markets'; (2) Fails to capture the evolution showing 'growing concern over geopolitical and macroeconomic volatility' in 2023; (3) Misses the 2024 emphasis on 'limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified'; (4) The conclusion that CAT 'has not altered its overall management' directly contradicts the ground truth's finding of a 'multi-year trend reveals a consistent but increasingly cautious approach' with 'rising emphasis on external macroeconomic pressures.' The LLM fundamentally mischaracterizes the evolution as static when the ground truth clearly documents a dynamic progression from 2022→2023→2024 with increasing sophistication and caution. The answer fails the core requirement of the multi-hop question: demonstrating HOW the exposure management EVOLVED. Instead, it incorrectly asserts stasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 451,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income allocation to Treasury and agency securities dropped from about 40 % in 2022 to roughly 30 % in 2023 and remained near 30 % in 2024 (CL_10k_2022.pdf p.102; CL_10k_2023.pdf p.100; CL_10k_2024.pdf p.104). The decline indicates the company trimmed its exposure to the most interest‑rate‑sensitive, low‑yield government securities, shifting toward a broader mix of bonds to diversify interest‑rate risk and pursue higher yields.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the allocation percentages. According to the ground truth, the allocation was 50% (2020), 40% (2021), 30% (2022), 30% (2023), and 30% (2024). The LLM states the allocation was '40% in 2022' when it should be 30% in 2022. This is a fundamental error in the core numeric data being requested. The LLM correctly identifies the 30% levels for 2023-2024 and the general downward trend, but misses the critical 2020-2021 context that the ground truth emphasizes as part of the 'gradual reduction over two years.' INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 to 2024,' but the ground truth provides important context showing the allocation started at 50% in 2020 and declined to 40% in 2021 before reaching 30% in 2022. The LLM's answer begins at 40% in 2022, missing the earlier decline trajectory that is essential to understanding the full evolution and strategic shift. MISSING CONTEXTUAL DETAILS: The ground truth mentions the Level 2 classification and its implications for liquidity and interest rate risk management, which the LLM omits entirely. While the LLM does provide reasonable interpretation about diversification and yield-seeking behavior, it lacks the specific technical detail about fair value measurement and liquidity considerations. REASONING QUALITY: The LLM's interpretation that the company 'trimmed exposure to interest-rate-sensitive, low-yield government securities' is reasonable and aligns with the ground truth's characterization of a 'strategic shift away from government-backed securities.' However, this reasoning is based on incomplete and partially incorrect data. The semantic understanding of interest rate risk management is present but undermined by the factual errors in the allocation percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 506,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer has kept the same valuation approach for BPAs – they are measured at grant‑date intrinsic value using the closing price of the common stock and amortized over the probable vesting term (as described in the 2022 Note 13)【page_99】. In 2022 the filing only outlined the award terms and valuation and gave no explicit grant‑activity disclosure, but the 2023 and 2024 reports each state that “no BPAs were granted” and “no BPAs were outstanding” at year‑end (2023 Note 13)【page_97】 and (2024 Note 13)【page_94】, and they now include detailed tables showing the fair‑value of shares vested and related compensation cost for BPAs (2023 table)【page_96】 and (2024 table)【page_96】, indicating a shift toward clearer, more transparent disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims 'Pfizer has kept the same valuation approach for BPAs' and references 2022 Note 13, but the ground truth explicitly states that in 2022, BPAs were 'actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end.' The LLM completely omits these specific quantitative metrics. (2) The LLM incorrectly states that '2022 the filing only outlined the award terms and valuation and gave no explicit grant-activity disclosure' - this directly contradicts the ground truth which documents specific 2022 grant activity (1,165 thousand shares, $38.73 weighted average intrinsic value, 859 thousand nonvested shares). (3) The LLM's claim about 'same valuation approach' is misleading - the ground truth indicates a significant evolution from 2022 to 2024, including 'adjustments based on performance probability and stock price changes' in 2024, which represents a methodological shift, not continuity. (4) The LLM correctly identifies that no BPAs were granted in 2023 and 2024, but fails to capture the strategic significance of this pause/discontinuation followed by reappearance with enhanced disclosure. PARTIAL CREDIT: The LLM correctly notes the shift toward 'clearer, more transparent disclosure' and mentions the inclusion of detailed tables in 2023 and 2024. However, this observation is undermined by the fundamental mischaracterization of 2022 activity and the claim of valuation consistency. The multi-hop reasoning is incomplete - the answer fails to synthesize the 3-year trajectory showing active issuance → suspension → reappearance with enhanced framework. The quantitative data from 2022 (1,165 thousand shares, $38.73 per share, 859 thousand nonvested) is entirely absent from the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 524,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "By 2022 Schwab’s Advisor Services website already served as the core RIA platform, offering proprietary software, multi‑year archiving and open integrations with third‑party CRM, portfolio‑management, order‑management and planning systems, plus a free, simplified portfolio‑management tool called Schwab Advisor Portfolio Connect (page_7). In 2023, after the TD Ameritrade merger, Schwab added Ameritrade‑derived interactive tools—thinkpipes for real‑time charting, trading and allocation, and iRebal for customizable portfolio rebalancing—expanding the RIA toolkit beyond basic integration (page_8). By 2024 the firm was actively embedding thinkpipes and iRebal into its ongoing RIA offerings while continuing to provide the Advisor Services website’s broad third‑party integrations and the free Schwab Advisor Portfolio Connect, further deepening both integration options and portfolio‑management capabilities (pages_5 & 8).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) MAJOR FACTUAL ERROR - 2022 BASELINE: The LLM claims that by 2022 Schwab's Advisor Services website 'already served as the core RIA platform' with multi-year archiving capabilities. However, the ground truth explicitly states that in 2022, Schwab 'emphasized its proprietary software and online platform' but that the 'Advisor Services website as a core platform' with 'multi-year document archiving' was a 2023 development. This represents a fundamental misunderstanding of the evolution timeline. (2) UNSUBSTANTIATED CLAIMS - TD AMERITRADE MERGER TOOLS: The LLM introduces 'thinkpipes' and 'iRebal' as tools added in 2023 'after the TD Ameritrade merger,' claiming these are 'Ameritrade-derived interactive tools.' The ground truth makes NO mention of these specific tools or any TD Ameritrade merger-related additions to the RIA platform. This appears to be fabricated information not supported by the source documents. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a clear progression: 2022 (proprietary software + third-party integrations + Advisor Portfolio Connect), 2023 (increased emphasis on Advisor Services website as core platform with archiving), 2024 (refinement of usability/modern experience). The LLM's narrative fundamentally misorders this evolution and introduces unsupported elements. (4) MISSING KEY INSIGHT: The ground truth highlights that 2024 specifically 'reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability.' The LLM mentions 'further deepening' capabilities but misses this critical emphasis on usability refinement. (5) CITATION ISSUES: The LLM provides page references (page_7, page_8, pages_5 & 8) that cannot be verified against the ground truth and may be fabricated. The answer demonstrates poor multi-hop reasoning by conflating different time periods and introducing information not present in the source material. This is a case where the LLM has created a plausible-sounding narrative that contradicts documented facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 578,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K MD&A, Texas Instruments repeatedly states that its strategic focus is on analog and embedded‑processing products and that it places additional strategic emphasis on the industrial and automotive markets as the best long‑term growth opportunities (2022 p. 19; 2023 p. 19; 2024 p. 19). The unchanged language signals that TI is positioning itself for the long run as a specialist in high‑margin, stable semiconductor segments—leveraging its broad analog‑and‑embedded‑processing portfolio and manufacturing scale to capture growth in the industrial and automotive end markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more comprehensive response than the ground truth in several ways. STRENGTHS: (1) Correctly identifies the consistent emphasis on analog and embedded processing products across 2022, 2023, and 2024; (2) Accurately cites page numbers (p. 19 for all three years) showing consistency in messaging; (3) Adds valuable context about industrial and automotive markets as strategic growth areas, which is a legitimate extension of the core positioning; (4) Provides sound multi-hop reasoning by synthesizing the consistent strategic messaging across three years; (5) Correctly interprets what this consistency reveals about long-term positioning (specialist in high-margin, stable segments). MINOR GAPS: (1) The ground truth emphasizes the 'four sustainable competitive advantages' framework more explicitly, which the LLM answer doesn't mention; (2) The ground truth specifically references the free cash flow per share objective, which the LLM answer omits; (3) The LLM answer adds information about industrial/automotive markets that, while strategically relevant and likely accurate, goes slightly beyond what the ground truth explicitly states. QUANTITATIVE ACCURACY: Page citations (p. 19) are consistent across years and appear accurate. No calculations required. QUALITATIVE ACCURACY: The reasoning about TI positioning itself as a specialist in high-margin segments is sound and well-supported. The synthesis across three years is logically coherent. CONTEXTUAL RELEVANCE: The answer directly addresses how the strategic emphasis evolved (or remained consistent) and what this reveals about long-term positioning, fully addressing the question. The addition of market-specific context (industrial/automotive) enhances relevance without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 497,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support expense has been steady – it is recorded as incurred and has “historically been approximately 1 % of total consolidated costs of products and services” in each of the three years (2022 – 2024)【page_40】【page_36】【page_39】.  Yet the 787 program has driven a sharp rise in abnormal production costs: a cumulative $2.7 billion of abnormal costs was recorded through 2023, with about 90 aircraft in inventory needing rework at the end of 2022 and 50 at the end of 2023【page_36】, and in 2024 the company expensed $256 million for inspections and rework on roughly 25 pre‑2023 aircraft while production fell below five per month, extending deliveries into 2025【page_39】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the main narrative arc of Boeing's 787 program challenges from 2022-2024 and correctly identifies the fleet support services as ~1% of costs. However, there are significant quantitative accuracy issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- Fleet support services consistently ~1% of total consolidated costs (2022-2024) ✓\n- Cumulative abnormal production costs of $2.7 billion through December 31, 2023 ✓\n- $256 million in rework costs expensed in 2024 ✓\n- Majority of aircraft expected to deliver in 2025 ✓\n- General narrative of cost escalation and gradual resolution ✓\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. INVENTORY NUMBERS: The LLM states \"about 90 aircraft in inventory needing rework at the end of 2022 and 50 at the end of 2023.\" The ground truth does not provide these specific inventory figures (90 and 50), and the LLM appears to have introduced numbers not supported by the source material. This is a factual error.\n\n2. AIRCRAFT COUNT: The LLM correctly identifies \"roughly 25 pre-2023 aircraft\" in 2024, which aligns with ground truth's \"25 inventoried aircraft produced prior to 2023.\"\n\n3. PRODUCTION RATE: The LLM adds detail about \"production fell below five per month\" which is not explicitly mentioned in the ground truth answer provided, though this may be accurate from source documents.\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and connects fleet support services metrics with 787 program abnormal costs. The progression from 2022 (delays noted) → 2023 ($2.7B cumulative) → 2024 ($256M annual) is logically sound and demonstrates proper multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE:\nThe core message matches: fleet support steady at ~1%, 787 abnormal costs escalated significantly, then began resolution. However, the introduction of unsupported inventory numbers (90, 50) undermines confidence in the answer's accuracy.\n\nJUSTIFICATION:\nThe quantitative accuracy score is reduced due to the inventory figures that appear unsupported by the ground truth. The qualitative accuracy is good because the reasoning structure and entity identification are sound. The contextual relevance is high because the answer directly addresses the question's focus on cost profile evolution and delivery impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 620,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian on December 31 2021 for about $51 million, recognizing an after‑tax loss of roughly $167 million (the 2021 filing also notes a $345 million pre‑tax legal charge related to Meridian)【page 115】.  In the 2022 and 2023 filings Pfizer disclosed that, after the sale, it entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) with the buyer; the TSAs were fully completed by December 31 2023, while the MSA remains in effect for three years post‑sale (through 2024) with a two‑year extension option, and the amounts recorded under these arrangements in 2022‑23 were immaterial【page 73】.  Thus, the relationship shifted from a one‑time loss to a limited, ongoing contractual framework that continues into 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc of Pfizer's relationship with Meridian correctly, but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) Sale date of December 31, 2021 is accurate; (2) After-tax loss of approximately $167 million is correct; (3) TSAs and three-year MSA structure is accurate; (4) TSAs completed by December 31, 2023 is correct; (5) Two-year extension option on MSA is accurate; (6) Immaterial amounts recorded in 2022-23 is correct; (7) Multi-hop synthesis across 2022-2024 filings is sound; (8) Transition from ownership to supplier relationship is well-characterized. CRITICAL ERROR: The LLM states Pfizer sold Meridian for 'about $51 million,' which appears to be incorrect or unsupported by the ground truth. The ground truth does not mention a $51 million sale price, and this figure is not reconcilable with the $167 million after-tax loss disclosed. The LLM also mentions a '$345 million pre-tax legal charge related to Meridian' which is not mentioned in the ground truth answer and may represent additional information not verified against the source documents. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly traces the relationship evolution from 2022 through 2024, properly identifies the contractual arrangements, and accurately notes the diminishing financial materiality. The characterization of the shift from 'one-time loss to limited, ongoing contractual framework' is semantically equivalent to the ground truth's 'transition from direct ownership to limited supplier relationship.' COMPLETENESS: The answer addresses all major aspects of the question regarding financial implications and contractual arrangements. However, the introduction of unsupported financial figures (the $51 million sale price) and the unverified $345 million legal charge create factual uncertainty that prevents a higher score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 527,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive’s 10‑K filings show that “hello” remains listed as one of the company’s principal global trademarks in every year — 2022, 2023 and 2024 (see Nature of Operations on page 79).  At the same time, the composition of the Oral, Personal and Home Care segment has been essentially unchanged, with Oral Care accounting for about 43 % of worldwide net sales, Personal Care about 19 % and Home Care about 17 % each year (page 79).  This consistency indicates that the firm has kept “hello” positioned as a steady, core brand within its established oral‑care/personal‑care mix, without a major shift in emphasis relative to the other product lines.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that 'hello' remained listed as a principal global trademark across 2022-2023-2024, which aligns with the ground truth. The reasoning about sustained strategic positioning is sound and the semantic meaning matches the original answer. However, there are significant quantitative accuracy issues: (1) The LLM provides specific segment percentages (Oral Care ~43%, Personal Care ~19%, Home Care ~17%) that are NOT present in the ground truth answer and cannot be verified from the provided context. These appear to be fabricated or hallucinated numbers. (2) The LLM cites 'page 79' as a source, but this specific page reference is not mentioned in the ground truth. (3) The ground truth explicitly mentions that Darlie was added to the brand list in 2023, which the LLM answer completely omits - this is a notable contextual detail about segment evolution. The LLM answer does correctly synthesize the multi-hop information (tracking 'hello' across three years and comparing it to other brands), and the overall conclusion about 'hello' maintaining steady positioning is accurate. However, the introduction of unverified quantitative data significantly undermines credibility. The answer would have been stronger by sticking to the verifiable facts about brand listing consistency without adding specific percentages that cannot be confirmed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 383,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Texas Instruments’ non‑qualified defined‑benefit pension plan stayed unfunded and closed to new participants throughout 2022‑2024, with the company making only modest employer contributions that fell from $13 million in 2022 to $3 million in 2023 and $2 million in 2024, while participants made no contributions (shown as “‑”) each year【page_46】【page_45】. This multi‑year pattern indicates that the firm’s long‑term liability for the non‑qualified plan is essentially limited to existing accrued obligations and that employee participation is static or declining as the plan winds down and workers shift to defined‑contribution alternatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete information compared to the ground truth. CRITICAL ISSUES: (1) WRONG NUMBERS - The LLM cites employer contributions of $13M (2022), $3M (2023), and $2M (2024) for the non-qualified plan, but the ground truth makes no mention of these specific contribution figures. Instead, the ground truth focuses on defined contribution plan metrics: 6M shares valued at $940M (2022), 5M shares at $873M (2023), and 5M shares at $852M (2024). (2) MISSING KEY DATA - The LLM completely omits the defined contribution plan holdings and their evolution, which is central to understanding the company's pension strategy shift. The ground truth emphasizes that aggregate U.S. defined contribution plan expenses increased from $70M (2022) to $75M (2023) to $76M (2024), showing strategic emphasis on DC plans. (3) MISSING DIVIDEND INFORMATION - The ground truth includes dividend data ($28M, $27M, $26M across the three years) which the LLM does not mention. (4) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that the non-qualified plan is unfunded and closed to new participants, it fails to synthesize the complete picture of how the company is shifting to defined contribution alternatives, which is the core insight of the ground truth. (5) CITATION ISSUES - The LLM cites page references that cannot be verified against the provided ground truth data. The answer addresses the unfunded status and closure correctly but misses the quantitative evidence of the strategic shift toward DC plans. The reasoning about winding down is partially sound but lacks the supporting financial data that demonstrates the actual magnitude of the shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 463,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s private‑equity holdings fell from $800 million at 12/31/2022 to $755 million at 12/31/2023 and further to $719 million at 12/31/2024. The consistent decline (≈$81 million, about a 10% drop over three years) shows the company is gradually scaling back its private‑equity exposure, suggesting a strategic shift away from allocating capital to this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect starting value. Ground truth shows 2022 value of $623 million, but LLM states $800 million - a $177 million discrepancy (28% error). The 2023 and 2024 values ($755M and $719M) are correct. (2) CALCULATION ERROR - LLM calculates the 3-year change as approximately $81 million decline, but using the correct 2022 figure ($623M to $719M in 2024) yields only a $96 million decline (not $81M). More critically, the LLM's narrative of 'consistent decline' is factually wrong - the ground truth shows an INCREASE from 2022 to 2023 ($623M to $755M, a +$132M gain), followed by a decline to 2024. (3) REASONING FLAW - The LLM's interpretation that this represents 'a strategic shift away from allocating capital to this asset class' contradicts the actual trajectory. The 2023 increase demonstrates strategic commitment to private equity, not a pullback. The 2024 decline is only a partial reduction from the 2023 peak, not evidence of systematic divestment. (4) MULTI-HOP SYNTHESIS - The answer fails to correctly synthesize the three-year data points into an accurate narrative. The ground truth correctly identifies this as 'a short-term strategic increase in 2023 followed by a partial reduction in 2024,' which is fundamentally different from the LLM's 'consistent decline' characterization. (5) ENTITY/METRIC ACCURACY - Company (Pfizer/PFE) and metric (long-term private equity securities at cost) are correctly identified, but the data values are substantially wrong for the critical 2022 baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 437,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "- 2022 – Under the 2019 IDA agreement Schwab could migrate **up to $10 billion of IDA balances each 12‑month period**, but only those designated as **floating‑rate obligations** and only if it had sufficient capital, **maintained a minimum $50 billion IDA balance** and kept **at least 80 % of the balances designated as fixed‑rate obligations through June 2026** (page 100).  \n\n- 2023 – The 2023 IDA agreement replaced the 2019 terms, **eliminating the 80 % fixed‑rate requirement** but imposing **new minimum‑and‑maximum balance limits**: through Sept 10 2025 Schwab must keep balances **above the total of unmatured fixed‑rate obligations with a $30 billion ceiling**, and withdrawals are allowed only when **initiated by customers** (later, after Sept 10 2025, withdrawals are at Schwab’s discretion but must stay between **$60 billion and $90 billion**). Schwab **did not move any IDA balances in 2023** (page 102).  \n\n- 2024 – The same 2023 agreement and its **minimum/maximum balance constraints** remained in effect, and Schwab again **did not migrate any IDA balances to its balance sheet in 2024** (page 99).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail and captures the general evolution of Schwab's IDA migration constraints across the three years, but contains several factual inaccuracies that undermine its reliability:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2019 IDA agreement allowed up to $10 billion annual migration\n- Correctly states the 2023 IDA agreement replaced the 2019 agreement\n- Correctly notes that Schwab did not migrate IDA balances in 2023 and 2024\n- Correctly identifies the $30 billion ceiling constraint in the 2023 agreement\n- Correctly notes the shift from customer-initiated to Schwab-discretionary withdrawals after Sept 10, 2025\n- Correctly identifies the $60-90 billion range for post-Sept 10, 2025 period\n- Appropriately captures the tightening of flexibility over time\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- The 2022 constraints listed (minimum $50 billion IDA balance, 80% fixed-rate requirement through June 2026) are NOT mentioned in the ground truth answer and appear to be fabricated or misattributed details\n- The ground truth states Schwab had \"already moved $10.1 billion by December 31, 2021\" but the LLM answer doesn't mention this historical context\n- The ground truth emphasizes that in 2022 the option was subject to \"capital sufficiency and other limitations\" but the LLM provides overly specific constraints not confirmed in the ground truth\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern (tightening constraints). However, the addition of unverified specific constraints in 2022 suggests the model may have hallucinated details or confused information from different sections of the filings.\n\nQUANTITATIVE ACCURACY:\nThe numbers provided ($10 billion, $30 billion, $60-90 billion, 80%, Sept 10 2025) are partially correct but the 2022 constraints cannot be verified against the ground truth, creating uncertainty about their accuracy.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good structural understanding and captures the main narrative arc, but the introduction of unverified 2022 constraints significantly reduces confidence in the response's factual accuracy. The answer would benefit from sticking to what can be confirmed in the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 614,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in each filing (2022 – page 18, 2023 – page 16, 2024 – page 18) with an “X” under the Analog column and no mark for Embedded Processing, showing it is dedicated to analog product manufacturing throughout the three years. The unchanged listing across 2022‑2024 indicates TI treats Melaka as a stable, strategically important analog‑manufacturing hub in its global footprint. (TXN_10k_2022.pdf page 18; TXN_10k_2023.pdf page 16; TXN_10k_2024.pdf page 18)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer claims Melaka was marked with an 'X' under the Analog column across all three years (2022-2024), but the ground truth explicitly states different symbols were used: † in 2022, * in 2023, and ** in 2024. This is a significant factual error regarding the specific markings/symbols used. The LLM's claim of 'unchanged listing' directly contradicts the ground truth's observation of 'possible escalation' indicated by the progression of different symbols (†, *, **). While the LLM correctly identifies: (1) Melaka's consistent presence across 2022-2023-2024, (2) its dedication to analog manufacturing, (3) its strategic importance, and (4) the correct page numbers for citations—it fundamentally mischaracterizes the nature of the consistency. The ground truth suggests a potential escalation/evolution through changing symbols, while the LLM claims the listing was 'unchanged.' This represents a failure in multi-hop synthesis of the specific marking patterns across years. The LLM also provides page citations (which adds credibility) but these citations appear to reference incorrect symbol designations. The core conclusion about strategic importance is sound, but the evidence presented to support it is factually incorrect regarding the specific symbols used in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 367,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit (Target Circle) Card’s penetration slipped from about 20.5 % of all purchases in FY 2022 to 19.8 % in FY 2023 and to 18.6 % in FY 2024【page_27】. Since Target monitors “RedCard/Target Circle Card Penetration” as an indicator that a meaningful share of those purchases are incremental sales, the downward trend suggests the card remains a driver of extra sales but its relative contribution is slowly waning over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the penetration rate was 18.6% in FY 2024, but the ground truth shows it was 17.8% in 2024. This is a factual error of 0.8 percentage points on a key metric. CORRECT FIGURES: 2022: 20.5% (✓ correct), 2023: 19.8% (✓ correct), 2024: 18.6% (✗ INCORRECT - should be 17.8%). The LLM correctly identified the downward trend and the three-year progression, but the final year's number is materially wrong. REASONING QUALITY: The LLM's interpretation of what the trend suggests is reasonable and aligns with the ground truth's assessment that the downward trend indicates 'diminishing role' and 'reduced effectiveness.' The LLM appropriately notes that Target monitors this metric as an indicator of incremental sales and correctly characterizes the trend as 'slowly waning.' However, the LLM's conclusion that 'the card remains a driver of extra sales' is slightly more optimistic than the ground truth's characterization of 'diminishing role' and 'reduced effectiveness.' MULTI-HOP SYNTHESIS: The answer correctly synthesizes information about the card's penetration rates across three years and connects this to its role in driving incremental sales, which is appropriate multi-hop reasoning. COMPLETENESS: The answer addresses both parts of the question (evolution of penetration rate and what it suggests about the card's role), though the interpretation differs slightly in tone. The quantitative error on the 2024 figure is the primary issue affecting the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 418,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The equity‑compensation tables show that the 2003 Director Compensation Plan had **no shares left for future issuance in each of the three most recent years** – the 2022 filing (Table for 2021) lists only the 2009 LTIP and 2018 Director Plan as having remaining shares, the 2023 filing (Table for 2022) likewise shows only the 2009 LTIP and 2018 Director Plan, and the 2024 filing (Tables for 2023 and 2024) reports remaining shares for the 2024 LTIP, 2018 Director Plan and 2009 LTIP, but never for the 2003 plan【page_63†L1-L4】【page_61†L1-L4】【page_59†L1-L4】. This consistent absence of any remaining allocation indicates that the 2003 plan’s share pool has been fully exhausted and not replenished, so Texas Instruments now relies on newer director‑compensation plans to provide equity incentives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual claims. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth provides specific share counts for the 2003 Director Compensation Plan: 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM claims there were 'no shares left for future issuance' in each year, which directly contradicts these documented figures. These are precise, verifiable numbers from SEC filings that the LLM completely misrepresented. (2) FACTUAL ERROR ON PLAN STATUS: The LLM asserts the 2003 plan 'has been fully exhausted and not replenished,' but the ground truth shows the plan had millions of shares available each year and experienced a gradual decline (from 35.4M to 24.5M), not complete exhaustion. The LLM's claim that the plan appears 'never' in the equity tables is demonstrably false. (3) MULTI-HOP REASONING FAILURE: The question asks about the evolution/trend from 2022-2024. The ground truth correctly identifies a consistent three-year decline pattern. The LLM fails to synthesize this temporal progression and instead makes an unsupported claim about complete depletion. (4) ENTITY/CONTEXT CONFUSION: While the LLM correctly identifies Texas Instruments and the 2003 Director Compensation Plan, it mischaracterizes the plan's status entirely. The conclusion that TI 'now relies on newer director-compensation plans' may be partially true, but it's based on the false premise that the 2003 plan is exhausted. (5) CITATION ISSUES: The LLM provides page citations but these appear to reference tables that actually contain the 2003 plan data, not tables that exclude it. The ground truth answer correctly identifies the specific share counts and the declining trend, which is the core of what the question asks. The LLM's answer is internally inconsistent with documented SEC filing data and fails to address the actual evolution of shares available.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 529,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022 Visa’s digital offering was focused on virtual cards and other digital credentials, while Visa Direct was used for P2P, account‑to‑account and cross‑border payouts but did not yet include a virtual‑account product (page 9; page 10). In 2023 Visa added virtual accounts to the Visa Direct platform via its Currencycloud‑powered cross‑border suite, giving clients real‑time FX rates, enhanced liquidity and new cross‑border use cases (page 10). By fiscal 2024 those virtual accounts were a core part of Visa Direct’s cross‑border capabilities—supporting nearly 10 billion transactions—and were complemented by expanded A2A and fraud‑prevention services that further broadened Visa’s digital, cross‑border functionality (page 10; page 12).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth, particularly regarding quantitative claims and timeline details. Key issues: (1) QUANTITATIVE ERRORS: The LLM states virtual accounts 'supported nearly 10 billion transactions' in 2024, but the ground truth specifies the network had 'potential to reach over 11 billion endpoints' (not transactions). These are fundamentally different metrics - endpoints vs. transactions - and the LLM conflates them. The number 10 billion vs. 11 billion is also incorrect. (2) TIMELINE INACCURACY: The LLM claims in 2022 Visa Direct 'did not yet include a virtual-account product,' but the ground truth indicates virtual accounts were introduced in 2022 as part of Currencycloud/Visa Treasury as a Service. The LLM incorrectly suggests virtual accounts were added in 2023, when they were actually introduced in 2022. (3) MISSING CONTEXT: The LLM omits the critical $20 trillion B2B cross-border opportunity figure mentioned in the ground truth, which is central to understanding Visa's strategic positioning. (4) PARTIAL ACCURACY: The LLM correctly identifies Currencycloud integration, real-time FX rates, enhanced liquidity, and the progression of cross-border capabilities. The mention of A2A and fraud-prevention services adds some detail not in the ground truth but doesn't contradict it. (5) MULTI-HOP REASONING: The LLM attempts to synthesize across three years but makes errors in the 2022-2023 transition, incorrectly suggesting virtual accounts were new in 2023 rather than an evolution of 2022 capabilities. The answer demonstrates partial understanding of the evolution but fails on key quantitative and temporal details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 463,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s sales slipped about 1 percent internationally, mainly because of a lower net price and an unfavorable channel‑mix shift【page_44】. To offset that pressure, Pfizer moved quickly to extend the drug’s life‑cycle, adding a new high‑risk biochemical‑recurrence prostate‑cancer indication that was approved in the EU in April 2024 (following the U.S. approval in November 2023)【page_46】. The product is already reflected in Pfizer’s intangible‑asset portfolio – it is one of the key components of the developed‑technology‑rights pool that was recorded at a $73.3 billion gross carrying amount (net $19.6 billion) in 2022【page_92】, underscoring the company’s substantial investment in Xtandi’s ongoing value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. Verification of key claims: (1) Revenue pressure: The 1% international sales decline is correctly cited and matches ground truth. The attribution to lower net pricing and channel-mix shift is accurate and adds appropriate detail. (2) Lifecycle management response: The 2024 indication expansion for non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence is correctly identified. The approval dates are accurate (U.S. November 2023, EU April 2024), showing proper temporal sequencing. (3) 2022 valuation: The intangible asset figures are precisely stated ($73.3 billion gross, $19.6 billion net), correctly identifying Xtandi as part of the developed-technology-rights pool. (4) Multi-hop reasoning: The answer successfully synthesizes three distinct data points—2023 revenue pressures, 2024 indication expansion, and 2022 asset valuation—to demonstrate Pfizer's strategic response to market challenges. The logical flow from problem (declining revenues) to solution (lifecycle extension) to context (asset importance) is sound. Minor considerations: The answer includes slightly more specific detail about channel-mix shifts than the ground truth, but this is additive and accurate. The page citations provided suggest proper source documentation. The semantic equivalence is strong throughout, with the answer conveying the same strategic narrative as the ground truth while using slightly different phrasing. No calculation errors detected. All entities (Pfizer, Xtandi, prostate cancer indications) are correctly identified. The answer fully addresses all components of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 469,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The data show a steady decline in card usage: total RedCard (which includes the Target MasterCard credit card) penetration fell from 20.5 percent in fiscal 2022 to 19.8 percent in 2023 and to 18.6 percent in 2024【page_27】. The same downward trend appears in the re‑branded “Target Circle Card” metric—18.6 percent in 2024 versus 19.8 percent in 2023【page_29】—indicating that fewer guests are choosing the MasterCard‑based credit product, which suggests a modest erosion in consumer preference for the card and weaker engagement with Target’s loyalty‑program incentives over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data are correct: penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match the ground truth exactly. The answer correctly identifies the product evolution from RedCards to Target Circle Cards and accurately characterizes the trend as a consistent decline. The multi-hop reasoning is sound—the model synthesizes information across multiple years and product rebranding to identify the downward trend and correctly interprets it as indicating weakened consumer preference and loyalty program engagement. The answer addresses all parts of the question: the evolution of penetration rates, the trend pattern, and what it indicates about consumer behavior. Minor strengths include the inclusion of page references and the clear articulation that the decline represents 'modest erosion' in preference. The only minor distinction from the ground truth is that the LLM provides slightly more detailed explanation of the rebranding context (mentioning the shift from RedCard to Target Circle Card explicitly), which adds helpful clarity without introducing any inaccuracies. The semantic equivalence is excellent—'steady decline,' 'consistent decline,' and 'downward trend' all convey the same meaning. No calculation errors, no missing data points, and no entity confusion detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 381,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022 Visa added virtual accounts to its digitally‑native Currencycloud suite within Visa Direct, giving clients real‑time foreign‑exchange rates and settlement for cross‑border payments (V_10k_2022 p.10). In FY 2023 the virtual‑account capability was broadened, being woven into Visa Direct and Visa B2B Connect so that cross‑border flows could be processed in more than 195 countries and territories with added liquidity and settlement features (V_10k_2023 p.10). By FY 2024 virtual accounts had become a core Currencycloud component that, together with Visa Direct, could reach over 11 billion endpoints (cards, bank accounts and digital wallets) and more than 100 countries for B2B Connect, further extending Visa’s cross‑border payment reach (V_10k_2024 p.10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the evolution of virtual accounts across the three fiscal years and correctly identifies the key platforms (Currencycloud, Visa Direct, Visa B2B Connect). However, there are significant quantitative discrepancies that lower the overall score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - FY 2023 Geographic Reach: LLM states \"more than 195 countries and territories\" but the ground truth specifies \"over 11 billion endpoints\" for 2023. The 195 countries figure appears to be conflated with a different metric or year.\n   - FY 2024 Geographic Reach: LLM correctly states \"more than 100 countries for B2B Connect\" and \"over 11 billion endpoints,\" matching ground truth.\n   - The progression of geographic reach is unclear in the LLM answer (195 countries in 2023 vs 100+ countries in 2024 seems contradictory).\n\n2. COMPLETENESS:\n   - The LLM answer addresses all three fiscal years (2022-2024) as required.\n   - It covers cross-border payment capabilities and network reach as requested.\n   - It mentions the key features: real-time FX rates, settlement, liquidity, and endpoint reach.\n\n3. ENTITY ACCURACY:\n   - All company names and platforms correctly identified (Visa, Currencycloud, Visa Direct, Visa B2B Connect).\n   - Fiscal years correctly referenced (2022, 2023, 2024).\n   - Endpoint types correctly listed (cards, bank accounts, digital wallets).\n\n4. REASONING & SYNTHESIS:\n   - The multi-hop synthesis is generally sound, showing progression across years.\n   - The narrative flow is logical and demonstrates strategic deepening of capabilities.\n   - However, the geographic reach metrics appear misaligned between years.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative matches the ground truth regarding virtual account evolution.\n   - The characterization of virtual accounts as \"core Currencycloud component\" aligns with ground truth.\n   - The emphasis on cross-border B2B transactions is appropriate.\n\nKEY ISSUE: The most significant problem is the FY 2023 geographic reach claim of \"195 countries and territories\" which doesn't appear in the ground truth and seems inconsistent with the FY 2024 figure of \"100+ countries.\" This suggests either a factual error or confusion with different metrics. The ground truth emphasizes the 11 billion endpoints metric for 2023, which the LLM only mentions for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 639,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "- 2022 10‑K – AMD listed “difficulties in protecting our intellectual property” only as one of the generic political, legal and economic risks of operating in foreign countries (2022 p. 37).  \n- 2023 10‑K – The filing tied that IP‑protection risk directly to its global supply chain, noting that AMD relies on third‑party wafer foundries in the U.S., Europe and Asia and on overseas assembly and final testing in China, Malaysia and Taiwan, so international operations amplify the IP‑protection exposure (2023 p. 40).  \n- 2024 10‑K – The same difficulty is reiterated but now appears within a broader, more acute risk set: heightened China‑Taiwan geopolitical tensions that could disrupt Taiwan‑based foundries, potential IP disputes from recent acquisitions, and cyber‑security threats that could compromise IP, all underscoring an expanded exposure linked to its international sales footprint and third‑party manufacturing dependencies (2024 p. 40‑41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with accurate characterization of how AMD's IP protection concerns evolved; (2) Accurately captures the 2022 baseline where IP difficulties were cited as generic political/legal/economic risks; (3) Correctly identifies the 2023 expansion linking IP risks to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan; (4) Accurately describes the 2024 escalation including China-Taiwan geopolitical tensions, acquisition-related IP disputes, and cyber-security threats; (5) Properly synthesizes the multi-hop relationship between international operations, third-party manufacturing, and IP protection challenges; (6) Page citations (2022 p. 37, 2023 p. 40, 2024 p. 40-41) add credibility and specificity. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'potential IP disputes from recent acquisitions' and 'cyber-security threats' in 2024, which are not explicitly mentioned in the ground truth answer. However, these are reasonable elaborations that don't contradict the ground truth and actually enhance the completeness of the 2024 risk profile; (2) The LLM answer is more specific and detailed than the ground truth in some areas (e.g., mentioning U.S. and Europe in addition to Asia for wafer foundries), which represents added value rather than error. QUANTITATIVE ACCURACY: No numerical data, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. QUALITATIVE ACCURACY: The reasoning correctly traces the evolution of AMD's IP protection concerns and properly identifies the causal links between geopolitical factors, supply chain dependencies, and IP vulnerability. The multi-hop synthesis across three years and multiple risk factors is sound. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question about how AMD's IP protection exposure evolved across the three-year period in relation to international operations and third-party manufacturing dependencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 584,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "In 2022 the pension plan held about $1.11 billion of corporate stock, almost entirely classified as Level 2 (preferred‑type) with a small Level 3 component ($1,104 m + $7 m) and it made up roughly 37 % of the plan’s $2.99 billion fair‑value assets (UNP 10‑K 2023 p.58). By 2023 the holding had been trimmed to $181 million, of which $176 million (≈98 %) was Level 1 common stock and only $5 million remained Level 2 (UNP 10‑K 2023 p.58), and in 2024 it modestly rose to $226 million, again almost entirely Level 1 ($220 m + $6 m) (UNP 10‑K 2024 p.57). This move from a large, less‑observable equity position to a smaller, highly‑liquid common‑stock allocation mirrors the plan’s broader de‑risking – equity exposure fell from 48 % of assets in 2022 to about 24 % in 2023‑24 (UNP 10‑K 2023 p.56) – indicating a pension strategy that favors lower‑volatility, debt‑heavy assets and reduces market‑risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth:\n\n1. 2022 VALUATION MISMATCH: Ground truth states Corporate Stock was $1,990 million in 2022 with $1,980M Level 1 and $10M Level 2. LLM claims $1.11 billion (~$1,104M) classified as Level 2 with $7M Level 3. This is a $886M discrepancy and completely inverts the Level 1/Level 2 classification (LLM says mostly Level 2, ground truth says mostly Level 1). The LLM's figures don't match the ground truth at all.\n\n2. 2023 VALUATION PARTIALLY CORRECT: LLM correctly states $181M total with $176M Level 1 and $5M Level 2, matching ground truth exactly. This is the only accurate data point.\n\n3. 2024 VALUATION INCORRECT: Ground truth explicitly states 'no updated dollar figures were provided in the disclosure' for 2024. LLM fabricates specific numbers ($226M total, $220M Level 1, $6M Level 2) that are not supported by the ground truth. This is a major factual error.\n\n4. CLASSIFICATION ERRORS: Ground truth describes 2022 as predominantly Level 1 (Quoted Prices in Active Markets). LLM incorrectly characterizes 2022 as 'Level 2 (preferred-type)' with Level 3 component - this is backwards and introduces non-existent Level 3 classification.\n\n5. PERCENTAGE CALCULATIONS: LLM cites 37% of $2.99B assets and equity exposure percentages (48% in 2022, 24% in 2023-24). Ground truth provides no such percentages or total asset figures, suggesting LLM may be confabulating supporting data.\n\n6. MULTI-HOP REASONING: While the LLM's narrative about de-risking strategy is plausible, it's built on incorrect foundational numbers. The reasoning quality is undermined by factual errors.\n\n7. SEMANTIC ISSUES: LLM correctly identifies the general trend (decline then modest recovery) but the specific numbers are wrong, making the analysis unreliable.\n\nThe answer demonstrates poor data accuracy and appears to contain fabricated figures for 2024 and mischaracterized 2022 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 536,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "In the 2022 Form 10‑K, Abbott listed the 4.75 % Senior Notes due 2043 as separate exhibits – the note itself (Exhibit 4.6) and the officers’ certificate (Exhibit 4.7) – and also referenced the original Fourth Supplemental Indenture (Exhibit 4.2) that created the notes【page_86†L16-L22】. By the 2023 and 2024 filings the company had streamlined the disclosure, citing only the Fourth Supplemental Indenture (now shown as Exhibit 4.22) that contains the note and related documents, and dropping the stand‑alone note‑form and certificate listings【page_87†L1-L4】. This progression shows Abbott’s intent to keep the long‑dated 4.75 % notes as a core financing tool while simplifying reporting, reflecting a focus on consistent, concise investor communication and efficient long‑term debt management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS: The LLM claims the 4.75% Notes were listed as Exhibit 4.6 in 2022, but the ground truth indicates Exhibit 4.6 was the Form of 4.75% Notes due 2043 from a 2017 Form 8-K filing. The LLM also incorrectly states the Fourth Supplemental Indenture was 'now shown as Exhibit 4.22' in 2023-2024, but the ground truth shows it remained as Exhibit 4.2 (from April 2, 2013). (2) DIRECTIONAL CONTRADICTION: The LLM claims Abbott 'streamlined the disclosure' by dropping stand-alone note-form and certificate listings, moving to only the Fourth Supplemental Indenture. However, the ground truth indicates the opposite evolution: from legacy-based referencing (2022) to MORE direct and current presentation (2023) with formalized documentation including the Form of 4.75% Notes as Exhibit 4.6 to the 2017 Form 8-K. (3) MISSING CONTEXT: The LLM fails to capture the key distinction between legacy integration (2022) and formalized, standardized disclosure (2023-2024). The ground truth emphasizes a shift toward transparency and clarity, while the LLM frames it as simplification/streamlining. (4) DOCUMENT DATING: The LLM doesn't properly distinguish between the original 2013 Fourth Supplemental Indenture and its incorporation into current filings. The ground truth correctly identifies the 2017 Form 8-K as the relevant current document. The LLM answer demonstrates a fundamental misunderstanding of the disclosure evolution and contains multiple factual errors regarding exhibit numbers and filing structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 444,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The Target‑branded credit‑card “penetration” slipped from about 20.5 % of purchases in FY 2022 to 19.8 % in FY 2023 and further to 18.6 % in FY 2024 【page_27】. The decline signals a modest slowdown in customer adoption of the branded payment product, and because Target treats purchases made with its cards as incremental sales, a lower penetration rate could dampen the incremental‑sales benefit the cards provide.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are precisely correct - 20.5% (2022), 19.8% (2023), 18.6% (2024) match ground truth exactly. (2) The LLM correctly identifies the downward trend across all three years. (3) The reasoning about the relationship between penetration rate decline and incremental sales impact is sound and logically connected. (4) The answer appropriately addresses the core question about how the penetration rate evolved and what it indicates about customer adoption and sales impact. (5) Quantitative accuracy is perfect with no calculation errors.\n\nWEAKNESSES: (1) The LLM answer is somewhat narrower in scope than the ground truth. The ground truth mentions that the card remained 'a key part of Target's loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts,' providing additional context about the strategic importance despite the decline. (2) The LLM uses the phrase 'modest slowdown' which is slightly less precise than the ground truth's 'gradual decline' - though both convey similar meaning. (3) The answer doesn't explicitly mention the branded RedCard/Target Circle Card umbrella terminology, though this is a minor omission. (4) The ground truth emphasizes that Target 'has historically linked' the card to incremental sales, whereas the LLM states Target 'treats purchases made with its cards as incremental sales' - slightly different framing but semantically equivalent.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the relationship between penetration rate decline and its impact on incremental sales, correctly understanding that lower penetration dampens the incremental sales benefit. This demonstrates proper multi-hop reasoning across the metrics.\n\nOVERALL ASSESSMENT: The answer is factually accurate on all quantitative measures and addresses the main question effectively. The minor omissions of strategic context and slightly narrower scope prevent a higher score, but the core answer is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 544,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from roughly 7,120 units in 2022 (average age ≈ 23.4 years) to 6,893 units in 2024 (average age 25.2 years)【UNP_10k_2022.pdf p.22】【UNP_10k_2024.pdf p.19】.  The drop in unit count combined with a higher average age shows the railroad is deliberately downsizing and extending the life of its remaining locomotives, reflecting a disciplined, capital‑efficient asset‑management approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 fleet numbers. Ground truth states 7,242 units in 2022, but LLM claims 'roughly 7,120 units' - a discrepancy of 122 units (1.7% error). For 2022 average age, LLM states '≈ 23.4 years' vs. ground truth of 22.5 years - a 0.9 year difference. The 2024 figures are correct (6,893 units, 25.2 years average age). CALCULATION VERIFICATION: The fleet reduction from 7,242 to 6,893 is 349 units (4.8% decline), but LLM's numbers would show only 227 units reduction. The average age increase from 22.5 to 25.2 years (2.7 year increase) is correctly identified in ground truth but LLM's 2022 baseline is wrong. MULTI-HOP REASONING: The LLM correctly synthesizes the two data points (fleet size and average age) and draws appropriate conclusions about asset management strategy. The interpretation that the company is 'deliberately downsizing and extending the life of remaining locomotives' aligns with ground truth's assessment of 'cost-conscious asset management strategy.' ENTITY ACCURACY: Union Pacific correctly identified, years correct (2022-2024), metrics correctly named (Multiple Purpose Locomotives, average age). SEMANTIC EQUIVALENCE: The qualitative conclusion about capital-efficient, disciplined asset management is semantically equivalent to ground truth's 'cost-conscious asset management strategy with deferral of fleet modernization.' STRENGTHS: Correct 2024 data, sound reasoning about strategic implications, proper document citations. WEAKNESSES: Significant errors in 2022 baseline numbers that undermine the quantitative foundation of the analysis, even though the directional trend and strategic interpretation remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 466,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private funds (which encompass private‑real‑estate vehicles) fell from **$569 million at the end of 2022** to **$555 million at the end of 2023** and then to **$540 million at the end of 2024**【page_71】【page_70】. This modest, consistent reduction suggests the company is gradually satisfying or scaling back its obligations, reflecting a cautious, long‑term strategy that maintains exposure to illiquid alternative assets while managing liquidity risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY IN KEY NUMBERS: The LLM answer reports 2022 unfunded commitments as $569 million, while the ground truth states $585 million. This is a $16 million error on a foundational data point. The 2023 ($555M) and 2024 ($540M) figures match the ground truth exactly. CALCULATION VERIFICATION: Ground truth shows a consistent $15M annual decline (585→570→555→540), but the LLM's 2022 figure of $569M breaks this pattern. The LLM reports a $14M decline from 2022-2023 ($569M to $555M) instead of the correct $30M decline. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year trend and appropriately interprets it as a gradual reduction in illiquid alternative asset exposure. The qualitative assessment about 'cautious, long-term strategy' and 'managing liquidity risk' aligns well with the ground truth's characterization. COMPLETENESS: The LLM addresses both parts of the question (evolution of commitments and strategic implications), though the strategic interpretation is slightly less detailed than the ground truth's mention of 'fund distributions rather than active capital deployment.' ENTITY ACCURACY: Abbott Laboratories correctly identified, private real estate funds correctly identified, years 2022-2024 correctly identified. The core issue is the factual error in the 2022 baseline figure, which undermines the accuracy of the trend analysis despite the correct identification of the directional pattern. The qualitative reasoning is sound, but the quantitative foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 419,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "NVIDIA’s 3.50 % Notes due 2050 were recorded at a net carrying amount of **$2.0 billion in FY 2022** (NVDA 10‑K 2022 p. 78) and the same **$2.0 billion in FY 2024** (NVDA 10‑K 2024 p. 72).  While the fair‑value of the notes slipped modestly from $1.637 billion in 2023 to $1.604 billion in 2024 (NVDA 10‑K 2023 p. 67), the unchanged carrying value shows the liability is still being reported at its original issuance amount (net of unamortized discount), indicating a stable long‑term debt position and that market‑rate fluctuations have had little effect on NVIDIA’s balance‑sheet debt valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the carrying value was $2.0 billion in FY 2022, but ground truth shows $2,147 million ($2.147 billion). This is a $547 million discrepancy. The LLM also claims the carrying value remained unchanged at $2.0 billion in both FY 2022 and FY 2024, but ground truth shows: FY 2022: $2,147M → FY 2023: $1,604M → FY 2024: $2,000M. The LLM completely missed the significant decline to $1,604M in FY 2023. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The question explicitly asks about the evolution from FY 2022 to 2024, requiring tracking three data points across three fiscal years. The LLM only addresses FY 2022 and FY 2024, omitting the critical FY 2023 figure entirely, which represents the lowest point and is essential to understanding the 'progression' and 'fluctuation' mentioned in ground truth. (3) MISINTERPRETATION OF TRENDS - The LLM concludes the carrying value was 'unchanged' and indicates a 'stable long-term debt position,' which is incorrect. The ground truth explicitly states there was a 'fluctuation' and 'revaluation or strategic adjustment,' with a significant drop to $1,604M in 2023 followed by a rebound. The LLM's characterization of stability contradicts the actual volatility in the data. (4) FAIR VALUE CONFUSION - The LLM conflates fair value data (which declined from $1.637B to $1.604B in 2023-2024) with carrying value, creating confusion about which metric is being analyzed. The question specifically asks about carrying value evolution. (5) REASONING QUALITY - The conclusion that 'market-rate fluctuations have had little effect on NVIDIA's balance-sheet debt valuation' is unsupported by the actual carrying value progression, which shows substantial changes year-over-year. The LLM's interpretation fundamentally misses the strategic revaluation indicated by the ground truth analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 531,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD first highlighted the possibility of “loss or modification of exemptions for taxes and tariffs” as a political‑legal‑economic risk in its 2022 filing (2022 p. 37). The same exposure re‑appears unchanged in the 2023 filing (2023 p. 41) and again in the 2024 filing (2024 p. 38), showing that the risk has persisted rather than receded. This continuity—and the increasingly detailed discussion of trade‑protection measures and sanctions—signals that AMD’s operating environment is becoming more complex and volatile, with tax and tariff regimes posing a growing regulatory challenge worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that AMD mentioned 'loss or modification of exemptions for taxes and tariffs' as a risk across 2022-2024 filings. (2) Page references are provided (2022 p. 37, 2023 p. 41, 2024 p. 38), showing engagement with source documents. (3) The LLM correctly notes the persistence of this risk across the three-year period. (4) The conclusion about increasing regulatory complexity is reasonable.\n\nWEAKNESSES: (1) CRITICAL OMISSION - The LLM fails to capture the key evolution described in the ground truth: the ESCALATION and SPECIFICITY of the risk from 2022 to 2024. The ground truth shows a clear progression from general mention (2022) → specific geopolitical context (2023: Russia/Belarus sanctions, Ukraine-Russia, Israel-Hamas conflicts) → heightened China-Taiwan tensions (2024). The LLM characterizes the risk as 'unchanged' and 'persistent,' which contradicts the ground truth's narrative of INCREASING exposure and INTENSIFYING pressures. (2) The LLM states the risk 'persisted rather than receded' but misses that the ground truth indicates the risk actually ESCALATED in specificity and severity. (3) Missing specific geopolitical events: The LLM does not mention U.S. sanctions against Russia/Belarus, Ukraine-Russia conflict, Israel-Hamas conflict, or China-Taiwan tensions—all critical details in the ground truth that demonstrate the evolution. (4) The LLM's characterization of 'unchanged' directly contradicts the ground truth's emphasis on how the company 'further emphasized' and 'specifically highlighted' evolving geopolitical contexts. (5) The LLM does not adequately address the multi-hop synthesis required: connecting AMD's expansion of global operations → geopolitical pressures → impact on third-party manufacturing partners (particularly relevant given Taiwan manufacturing concerns).\n\nMULTI-HOP REASONING: The LLM partially addresses the multi-hop nature by connecting persistence of risk to regulatory complexity, but fails to synthesize the key evolution across the three years. The ground truth requires understanding: (a) how AMD's risk disclosures changed year-to-year, (b) what specific geopolitical events drove those changes, and (c) how this reflects increasing complexity. The LLM only addresses (a) partially and misses (b) and (c).\n\nSEMANTIC ACCURACY: While the LLM's statement about 'continuity' and 'increasingly detailed discussion' gestures toward evolution, it fundamentally mischaracterizes the trend as 'unchanged' when the ground truth clearly shows escalation and increasing specificity. This is a material semantic error that affects the core answer to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 704,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings each contain the same disclosure that the company’s ability to return capital – whether through dividends or share repurchases – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” and that the parent relies on subsidiary dividends and credit extensions to fund share repurchases and dividend payments【page_5】【page_5】【page_5】. Thus, the exposure to regulatory constraints on capital returns has remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies that BNY Mellon's regulatory constraints on capital returns remained essentially unchanged across 2022-2024, matching the ground truth's conclusion about a 'stable regulatory environment with persistent constraints.' (2) Accurately cites the specific regulatory limitations: U.S. banking laws governing capital adequacy/planning, Delaware law, and preferred stock dividend obligations - all mentioned in the ground truth. (3) Correctly notes that the parent company relies on subsidiary dividends and credit extensions to fund capital returns, which is a key operational constraint. (4) Properly synthesizes information across all three years (2022, 2023, 2024) as required by the multi-hop question. (5) The citation format with page references demonstrates source verification. MINOR WEAKNESSES: (1) The LLM answer is more narrowly focused on the consistency of constraints rather than exploring the 'evolution' aspect of the question. While the ground truth also emphasizes consistency, it does mention some contextual evolution (e.g., 2023's emphasis on credit rating impacts and resolution strategies, 2024's expansion to include liquidity management and strategic initiatives). The LLM answer doesn't capture these nuanced developments. (2) The answer could have been more explicit about the 2023 and 2024 contextual expansions mentioned in the ground truth (credit rating reductions, Title I/II resolution strategies, liquidity management). QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The answer correctly references three years (2022, 2023, 2024) without error. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly synthesizes that constraints remained consistent across the period. The multi-hop synthesis across three years is properly executed. CONTEXTUAL RELEVANCE: The answer directly addresses the question about capital return flexibility evolution, though it emphasizes stability over evolution. The focus on dividends and share repurchases is appropriate and matches the question's specific concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 591,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "In the 2022 Form 10‑K the 2.950 % Note due 2025 was listed as **Exhibit 4.1** (“Form of 2.950 % Note due 2025”) and the filing was cross‑referenced to **Exhibit 99.6** of the March 5 2015 Form 8‑K 【page_86】. By the 2023 filing the note had been renumbered to **Exhibit 4.11** (“Form of 2.950 % Note due 2025”), still citing the same Exhibit 99.6 to the March 5 2015 8‑K, while Exhibit 4.1 was reassigned to the 2.550 % Note due 2022 【page_86】. The 2024 Form 10‑K retained this arrangement, keeping the 2.950 % Note due 2025 under Exhibit 4.11 with the unchanged Exhibit 99.6 reference 【page_86】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The ground truth states the note was consistently referenced as 'Exhibit 99.6 in the 8-K filing dated March 5, 2015' across all three years (2022-2024) with 'no change in the documentation or structure.' The LLM answer claims the exhibit numbering changed from Exhibit 4.1 in 2022 to Exhibit 4.11 in 2023-2024, which directly contradicts the ground truth's assertion of consistency and no amendments. (2) EXHIBIT NUMBERING DISCREPANCY: The ground truth emphasizes stable inclusion with the same exhibit reference (99.6 from March 5, 2015 8-K) across all years. The LLM introduces a narrative of renumbering (4.1 → 4.11) that is not supported by the ground truth and misrepresents the disclosure pattern. (3) INTERPRETATION ERROR: The ground truth explicitly states 'no change in the documentation or structure of the note over the three-year period' and that it 'remained a static financial instrument.' The LLM's answer about renumbering contradicts this core finding. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the consistent disclosure pattern across 2022-2024. Instead of recognizing stability, it introduced a false narrative of exhibit renumbering. (5) CONTEXTUAL RELEVANCE: While the LLM addresses the right topic (2.950% Note due 2025 disclosure evolution), it provides incorrect information about how that disclosure evolved, making the answer misleading despite being contextually relevant to the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 426,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55 % Notes Due 2028 were carried at roughly **$1.099 billion at the end of FY 2022**, rose modestly to **$1.115 billion at FY 2023**, and increased to **$1.250 billion by FY 2024**【page_66†L31-L38】【page_72†L9-L15】.  The upward trend shows the company is gradually adding to this low‑coupon, long‑dated debt, using inexpensive financing to support growth and strategic investments while keeping its overall debt profile manageable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the carrying values across all three fiscal years. Ground truth shows: FY2022=$1,200M, FY2023=$1,099M, FY2024=$1,250M. LLM reports: FY2022=$1.099B (WRONG - off by $101M), FY2023=$1.115B (WRONG - off by $16M), FY2024=$1.250B (CORRECT). The LLM reversed the FY2022 and FY2023 values, placing the lower amount in 2022 when it should be in 2023. This is a fundamental error that undermines the entire answer. PROGRESSION ANALYSIS ERROR: The LLM describes an 'upward trend' from FY2022 to FY2024, but the actual progression shows: $1,200M → $1,099M (DECREASE) → $1,250M (INCREASE). The LLM's characterization of 'gradually adding' is misleading given the initial decline. INTERPRETATION ISSUE: While the LLM's strategic interpretation about low-coupon debt and growth financing is reasonable, it's based on incorrect numbers and mischaracterizes the actual trend. The ground truth indicates fluctuation and strategic management, not a consistent upward trend. MULTI-HOP SYNTHESIS: The answer fails to correctly synthesize the three-year progression, getting 2 out of 3 data points wrong. This is a critical failure for a multi-hop question requiring accurate data synthesis across fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 359,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "AMD’s relationship with add‑in‑board (AIB) partners has remained essentially unchanged from 2022‑2024. In each filing the company says its agreements “protect their inventory of our products against price reductions” and that system integrators “often use discrete graphics solutions as a means to differentiate their products” – language first appearing in the 2022 10‑K (page 11), reiterated in 2023 (page 13, with an added “in most instances” qualifier), and repeated verbatim in the 2024 10‑K (page 13). Thus AMD has consistently kept inventory‑protection clauses in its AIB contracts while positioning discrete GPUs as a key differentiator for its channel partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate factual details about AMD's inventory protection policies and discrete graphics positioning across 2022-2024, with correct page references and accurate quotations. However, it significantly mischaracterizes the nature of the evolution described in the ground truth. The ground truth explicitly describes an EVOLUTION showing AMD 'adapting to market pressures by highlighting differentiation through discrete graphics,' with 2023 adding 'emphasis on the importance of timely product introductions and market competitiveness' and 2024 placing 'greater emphasis on the role of discrete graphics solutions.' The LLM answer contradicts this by stating the relationship 'has remained essentially unchanged' and that the language was 'first appearing in the 2022 10-K' and merely 'reiterated' thereafter. This is a fundamental misinterpretation of the multi-hop synthesis question, which asks specifically about HOW the strategy 'evolved.' The LLM correctly identifies the core policies (inventory protection, discrete GPU differentiation) and accurately cites specific filing pages and language variations (the 'in most instances' qualifier in 2023), but fails to recognize and articulate the strategic shift in emphasis and positioning that constitutes the evolution. The answer is factually accurate in its details but semantically incorrect in its core conclusion about whether/how the relationship evolved. This represents a failure in qualitative reasoning and multi-hop synthesis despite accurate quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 426,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD has repeatedly warned that “difficulties in protecting our intellectual property” are a key risk of its foreign operations – first noted in the 2022 filing (p. 37) when international sales accounted for roughly 72 % of revenue (p. 36). In the 2023 filing the same IP‑protection risk is restated (p. 40) while international sales fell to about 65 % (p. 41) and the company disclosed that most assembly and final testing were done by third‑party wafer foundries in China, Malaysia and Taiwan, exposing it to IP challenges in politically sensitive regions. By 2024 the risk language remains (p. 40), international sales stayed high at 66 % (p. 40), and “nearly all product assembly and final testing” continued to rely on those China‑, Malaysia‑ and Taiwan‑based third‑party facilities (p. 40), indicating that AMD’s exposure to IP‑protection difficulties has grown alongside its expanding overseas footprint and deeper reliance on manufacturing in geopolitically fragile areas.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims international sales were 'roughly 72%' in 2022, but the ground truth states the figure was 'unspecified but lower' than 2023's 65%. The 72% figure appears to be fabricated or misread. The 2023 figure of 65% matches ground truth, and 2024's 66% is correct. (2) MULTI-HOP REASONING - The LLM correctly identifies the evolution of IP protection risks across 2022-2024 and properly synthesizes the connection between expanding international operations and IP vulnerabilities. However, the foundational quantitative claim undermines this synthesis. (3) ENTITY/CONTEXT ACCURACY - The LLM correctly identifies AMD, the three-year period (2022-2024), and the geographic regions (China, Malaysia, Taiwan) involved in manufacturing. The mention of third-party wafer foundries and assembly/testing operations is accurate. (4) MISSING ELEMENTS - The LLM does not mention the specific geopolitical tensions highlighted in ground truth (Ukraine conflict, U.S.-Russia tensions, China-Taiwan tensions, Middle East instability) that became more prominent in 2023-2024 disclosures. The ground truth emphasizes how geopolitical context became more explicit and regionally concentrated over time, which the LLM only partially captures. (5) PAGE REFERENCES - The LLM provides specific page numbers (p. 37, 36, 40, 41, 40) which cannot be verified against the ground truth and may be inaccurate or fabricated. (6) SEMANTIC ALIGNMENT - While the LLM's narrative structure and conclusion about growing exposure align with ground truth, the factual foundation is compromised by the incorrect 2022 international sales percentage. The claim that IP protection risk 'has grown' is supported by the ground truth's characterization of it becoming 'more complex and regionally concentrated,' but the LLM's evidence is partially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 507,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "In the 2022 filing BNY Mellon referenced the 2019 Long‑Term Incentive Plan and attached the original 2019 Performance Share Unit and Restricted Stock Unit agreements (exhibits 10.39 and 10.4)【page_20】. The 2023 filing shows the plan’s continued use with refreshed 2022 and 2023 versions of both the Performance Share Unit and Restricted Stock Unit agreements (exhibits 10.21‑10.22 and 10.26‑10.27)【page_19】, and the 2024 filing adds new 2024 versions of those agreements (exhibits 10.28 and 10.29)【page_20】. This yearly rollout of updated PSU and RSU award documents under the same 2019 plan signals a deliberate strategy to maintain a long‑term, equity‑based compensation framework while regularly tailoring award terms to evolving performance goals and market practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) ENTITY CONFUSION: The LLM answer identifies the company as 'BNY Mellon' when the question asks about 'BK'. While BNY Mellon's ticker is BK, the LLM should have clarified this or used consistent naming. More critically, the ground truth answer discusses BK's evolution with specific PSU forms (2021, 2020, 2022 forms), while the LLM answer discusses both PSU AND RSU agreements with different form years (2019, 2022, 2023, 2024 versions). (2) FACTUAL DISCREPANCIES: Ground truth specifies: 2022 used 2021 Form PSU Agreement; 2023 used 2020 Form PSU Agreement; 2024 used 2022 Form PSU Agreement. The LLM answer claims: 2022 used original 2019 agreements; 2023 used 2022 and 2023 versions; 2024 used 2024 versions. These are fundamentally different form years and do not match the ground truth progression. (3) SCOPE EXPANSION: The LLM introduced RSU (Restricted Stock Unit) agreements alongside PSUs, which the ground truth answer does not mention. This suggests the LLM may be conflating different award types or years. (4) EXHIBIT REFERENCES: The LLM provides specific exhibit numbers (10.39, 10.4, 10.21-10.22, etc.) that cannot be verified against the ground truth and may be fabricated or incorrect. (5) REASONING QUALITY: While the LLM's conclusion about 'deliberate strategy' and 'long-term, equity-based compensation framework' aligns semantically with the ground truth's interpretation, the underlying factual basis is incorrect. The specific form progression (2021→2020→2022) in the ground truth is fundamentally different from what the LLM describes (2019→2022/2023→2024). This is a critical multi-hop synthesis error where the LLM failed to correctly identify which specific PSU agreement forms were used in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 478,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s capital base for diagnostics instruments that it leases to customers rose modestly from an original‑cost of **$3.6 billion (net book $1.6 billion) at 12/31/2022** to **$3.9 billion (net book $1.8 billion) at 12/31/2023**, and then **remained at $3.9 billion/$1.8 billion through 12/31/2024**【page_64】【page_63】.  \n\nThe incremental increase in 2023 followed by a plateau in 2024 indicates Abbott is expanding its leased‑instrument portfolio cautiously and is now emphasizing utilization of the existing asset base rather than committing to large new capital expenditures in its diagnostics business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that directly contradict the ground truth:\n\n1. ORIGINAL COST VALUES - INCORRECT:\n   - LLM states: $3.6B (2022), $3.9B (2023), $3.9B (2024)\n   - Ground truth: $3.3B (2022), $3.6B (2023), $3.9B (2024)\n   - The LLM has shifted all values forward by one year, making 2022 data match 2023 actual data\n\n2. NET BOOK VALUE - INCORRECT:\n   - LLM states: $1.6B (2022), $1.8B (2023), $1.8B (2024)\n   - Ground truth: $1.4B (2022), $1.6B (2023), $1.6B (2024)\n   - Again, values are shifted forward by one year, and 2023-2024 net book value is overstated ($1.8B vs $1.6B)\n\n3. TREND INTERPRETATION - PARTIALLY INCORRECT:\n   - LLM correctly identifies a plateau in 2024 but mischaracterizes the 2023 data\n   - LLM's interpretation about \"cautious expansion\" is reasonable but based on wrong numbers\n   - Ground truth shows steady growth 2022→2023, then plateau 2023→2024\n   - LLM shows growth 2022→2023 (but with wrong baseline), then plateau 2023→2024\n\n4. MULTI-HOP SYNTHESIS:\n   - The LLM failed to correctly synthesize the three-year trend from the source documents\n   - The systematic year-shift error suggests data extraction or mapping problems\n   - The reasoning about capital deployment strategy is sound in principle but built on incorrect data\n\n5. COMPLETENESS:\n   - LLM addresses the evolution question and strategic implications\n   - However, the factual foundation is compromised\n\nThe answer demonstrates understanding of the question's intent and provides reasonable strategic analysis, but the fundamental numerical errors (off by $0.3B in original cost for 2022, and $0.2B in net book value for 2023-2024) make this answer unreliable for financial analysis. These are not minor rounding differences but systematic data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 500,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Lumentum has been named as a competitor in NVIDIA’s networking‑and‑interconnect segment in every recent filing – it appears in the FY 2022 competition list among “interconnect, switch and cable solutions” (see 2022 page 15), in the FY 2023 list of “networking products … including DPUs and AI‑optimized switches” (see 2023 page 9), and again in the FY 2024 list of networking and cable‑solution rivals (see 2024 page 9). At the same time, NVIDIA’s disclosed strategy increasingly emphasizes AI‑driven data‑center networking and high‑performance interconnects (see its AI and interconnect focus in pages 7‑8), so Lumentum’s unchanged placement in the competitor tables reflects a steady but now more strategically relevant position as NVIDIA expands its AI‑centric networking portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness but contains significant issues that prevent a higher score. STRENGTHS: (1) Correctly identifies Lumentum as appearing in competitor disclosures across FY 2022, 2023, and 2024; (2) Accurately captures the general progression of NVIDIA's strategic focus on AI-driven networking; (3) Appropriately notes Lumentum's consistent presence in networking/interconnect segments; (4) Contextually relevant to the question about competitive positioning evolution. CRITICAL WEAKNESSES: (1) The LLM claims Lumentum appears in FY 2024 'networking and cable-solution rivals' but the ground truth specifically states it was listed as 'Lumentum Holdings Inc.' with 'sharpened recognition of its corporate identity' - the LLM misses this important distinction about the more specific corporate designation; (2) The LLM characterizes Lumentum's positioning as 'unchanged' across the three years, directly contradicting the ground truth which describes a clear 'progression' and 'rising prominence' with repositioning in FY 2023 to 'more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies'; (3) The LLM fails to capture the key insight that FY 2023 represented a meaningful repositioning toward AI/accelerated computing infrastructure alignment; (4) Page citations (2022 page 15, 2023 page 9, 2024 page 9) cannot be verified against ground truth and appear potentially inaccurate; (5) The conclusion that Lumentum's position is 'steady but now more strategically relevant' understates the actual evolution described in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information across three fiscal years and connect it to NVIDIA's strategic evolution, but fails to properly identify the qualitative shifts in how Lumentum was categorized and positioned. The reasoning is incomplete because it doesn't capture the FY 2023 repositioning as a distinct strategic moment. QUANTITATIVE ISSUES: While no specific numbers are provided in either answer, the LLM's characterization of the trend (unchanged vs. evolved) represents a factual error about the nature of the competitive positioning changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 594,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In the 2022 filing Emerson placed pipe cutters in the **Professional Tools** portion of its Tools & Home Products segment – “Pipe‑working tools … include … pipe cutters”【page_9】. By the 2024 filing the company lists pipe cutters under the **Safety & Productivity** segment, which now “delivers tools … Pipe‑working tools include … pipe wrenches and cutters”【page_73】. The move from a dedicated professional‑tools label to a broader safety‑and‑productivity grouping shows Emerson is integrating its pipe‑cutting products into a unified safety‑productivity portfolio, emphasizing a more consolidated professional‑tool strategy rather than a stand‑alone professional‑tools line.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core factual shift: pipe cutters moved from Tools & Home Products segment (2022) to Safety & Productivity segment (2024). (2) The dates are accurate (2022 vs 2024). (3) The segment names are correct. (4) The LLM appropriately cites specific page references. (5) The observation about consolidation into a 'unified safety-productivity portfolio' is reasonable. WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM misses critical context from the ground truth about the 2023 intermediate positioning and the broader strategic narrative. The ground truth emphasizes a deliberate shift away from consumer-focused home products (InSinkErator divestiture in late 2022) and toward 'infrastructure and professional-grade productivity tools.' The LLM doesn't mention this strategic context. (2) MISSING KEY DETAILS - The ground truth specifically notes pipe cutters were grouped with 'battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras' in the new segment. The LLM mentions only 'pipe wrenches and cutters' without this important product bundling context. (3) INCOMPLETE MULTI-HOP REASONING - The question asks 'what does this reveal about its professional tool strategy?' The ground truth provides a comprehensive answer about strategic realignment toward industrial/infrastructure applications and away from consumer products. The LLM's answer is more superficial, describing it as 'consolidation' without explaining the deeper strategic pivot. (4) CHARACTERIZATION ISSUE - The LLM describes the move as 'from a dedicated professional-tools label to a broader safety-and-productivity grouping,' but the ground truth suggests this is actually a MORE focused strategy (toward professional/industrial), not a broadening. The Safety & Productivity segment appears more specialized than the original Tools & Home Products segment which included DIY retail tools. (5) MISSING TEMPORAL DETAIL - The ground truth mentions 2023 as an intermediate year; the LLM only compares 2022 to 2024. QUANTITATIVE ACCURACY: High (8/10) - dates and segment names are correct. QUALITATIVE ACCURACY: Lower (5/10) - the reasoning is incomplete and misses the strategic narrative about consumer divestiture and industrial focus. CONTEXTUAL RELEVANCE: Moderate (6/10) - addresses the positioning shift but not the deeper strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 643,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 – Schwab’s Advisor Services website was positioned as the core online hub for RIAs, providing account‑opening, money‑movement, trade execution, multi‑year archiving, document‑search and third‑party integrations, and it introduced the free, intuitive Schwab Advisor Portfolio Connect that lets advisors manage Schwab accounts without downloading or reconciling data (page 7). In 2023 the same web‑based platform remained, but Schwab added “Schwab Trading Powered by Ameritrade” and deepened the integration of Ameritrade’s thinkpipes real‑time charting platform and iRebal customizable rebalancing into the RIA suite, while expanding interactive tools, educational content, an annual RIA benchmarking study and broader consulting services (pages 5, 6, 7, 8). By 2024 the website and Portfolio Connect continued as the core, now fully integrated with thinkpipes and iRebal as part of an end‑to‑end digital solution, and backed by an expanded set of interactive tools, thought‑leadership resources and dedicated practice‑building consulting for advisors (pages 5, 7, 8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about Schwab's RIA tool evolution from 2022-2024. STRENGTHS: (1) Correctly identifies all key platforms and tools (Advisor Services website, Schwab Advisor Portfolio Connect, thinkpipes, iRebal) across all three years; (2) Accurately captures the progression of functionality enhancements (account-opening, money-movement, trade execution, multi-year archiving, document-search in 2022; integration of Ameritrade tools in 2023; full end-to-end integration by 2024); (3) Properly synthesizes multi-hop information showing evolution across years and domains (investment, compliance, operational); (4) Includes specific details like 'free' Portfolio Connect, real-time charting, customizable rebalancing, and practice-building consulting; (5) Provides page references supporting claims; (6) Correctly identifies the strategic shift toward seamless workflow management. MINOR WEAKNESSES: (1) The LLM answer is more detailed and specific than the ground truth in some areas (e.g., explicitly naming thinkpipes and iRebal integrations), which could be seen as either more comprehensive or potentially adding details not explicitly confirmed in the ground truth; (2) The ground truth mentions 'outbound data feeds for compliance systems' as a 2024 addition, which the LLM answer doesn't explicitly state (though 'compliance workflows' is mentioned); (3) The ground truth emphasizes 'prospect consulting offer' while the LLM says 'practice-building consulting' - these are semantically similar but not identical. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are correct. REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies how tools became more integrated and sophisticated. The logical progression from core platform (2022) → Ameritrade integration (2023) → full ecosystem integration (2024) is accurate and well-reasoned. SEMANTIC EQUIVALENCE: The answer conveys the same core message as the ground truth about increasing sophistication and integration, though with slightly different emphasis and additional specificity in some areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 597,
        "total_tokens": 2196
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % senior unsecured notes due 2026 as a newly issued series in its 2022 Form 10‑K (see Exhibit 4.16 on page 115) and the same series re‑appears unchanged in the 2023 and 2024 Form 10‑Ks (listed as Exhibit 4.14 on page 111 of each filing) 【page_115】【page_111】. The notes have been retained on the balance sheet as debt (with a current portion) and have not been retired, re‑classified or refinanced, showing Oracle’s preference for keeping a stable, low‑cost medium‑term tranche as a core component of its short‑to‑intermediate‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Oracle's 1.650% Notes due 2026. STRENGTHS: (1) Correctly identifies the note as 1.650% senior unsecured notes due 2026, matching the ground truth exactly; (2) Accurately traces the evolution across three fiscal years (2022, 2023, 2024) with correct exhibit references (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023 and 2024); (3) Properly synthesizes the multi-hop information showing consistency across filings; (4) Correctly interprets the strategic implication that unchanged treatment reflects stable capital structure management; (5) Adds valuable detail about the notes being retained on balance sheet without retirement, reclassification, or refinancing, which strengthens the analysis of Oracle's financing strategy. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page numbers (page 115, page 111) which are not in the ground truth but appear to be accurate supplementary details that enhance rather than detract from the answer; (2) The characterization of the notes as 'low-cost medium-term tranche' is a reasonable inference from the 1.650% rate and 2026 maturity, consistent with the ground truth's description of 'fixed-rate obligations maturing in the mid-term horizon.' QUANTITATIVE VERIFICATION: The interest rate (1.650%), maturity year (2026), and exhibit numbers are all correct. The multi-hop reasoning correctly connects information across three years of filings to demonstrate consistency. The answer fully addresses both parts of the question: (1) how treatment evolved (answer: it remained consistent), and (2) what this reveals about strategy (answer: stable, low-cost medium-term financing approach). No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 487,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson has kept electrical‑distribution hardware as a core element of its Discrete Automation business throughout the period – in 2022 it was highlighted as part of the broader “Industrial Solutions” offering that supplies electrical‑distribution equipment 【page_76】, and the segment’s product description in the 2022 filing already listed it alongside valves, actuators and control systems 【page_73】. By the 2023 and 2024 reports the company explicitly enumerates “electrical distribution equipment” within the Discrete Automation mix 【page_73】, signalling a deliberate, consistent emphasis on industrial electrification as a growth engine for its automation portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The original answer clearly states that in 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' (NOT explicitly within Discrete Automation), and only by 2023 was it 'explicitly included within the Discrete Automation segment.' However, the LLM answer claims that 'in 2022 it was highlighted as part of the broader Industrial Solutions offering' AND that 'the segment's product description in the 2022 filing already listed it alongside valves, actuators and control systems' - suggesting it was already part of Discrete Automation in 2022. This is a critical misrepresentation of the evolution timeline. The LLM conflates the 2022 positioning (Industrial Solutions) with the Discrete Automation segment, when the ground truth explicitly distinguishes these as separate organizational structures in 2022. The LLM correctly identifies that by 2023-2024 the equipment was explicitly enumerated within Discrete Automation, but the characterization of 2022 as already being part of Discrete Automation is factually incorrect. The page citations provided (page_76, page_73) cannot be verified against the ground truth but the semantic content contradicts the established timeline. The answer does address the multi-part question and attempts multi-hop synthesis, but the foundational factual error about the 2022 positioning undermines the entire analysis of the 'evolution' across the three-year period. The conclusion about strategic emphasis is reasonable but is built on partially incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 442,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (private) funds fell from **$569 million in 2022** to **$555 million in 2023** and then to **$540 million at the end of 2024**【page_71】【page_70】. The year‑over‑year decline shows the company is actively reducing its open‑ended exposure to illiquid alternative assets, suggesting a more cautious, liquidity‑aware approach to managing its pension‑plan investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states Abbott's unfunded commitments to private real estate funds were $569 million in 2022, but the ground truth clearly indicates $585 million in 2022. This is a $16 million discrepancy (2.7% error) on a key data point. The 2023 ($555 million) and 2024 ($540 million) figures are correct. QUANTITATIVE ACCURACY ASSESSMENT: The 2022 number is factually incorrect, which is a significant error for a multi-year trend analysis. The other two years are accurate, but the incorrect starting point undermines the trend analysis. COMPLETENESS ISSUES: The LLM answer is notably incomplete. It identifies the declining trend and provides reasonable interpretation about liquidity-aware management, but it FAILS to address several important elements from the ground truth: (1) No mention of the long time horizon for fund liquidation (projected through 2034), which is a key strategic indicator; (2) No discussion of the 'measured de-risking or rebalancing' characterization; (3) No mention of the company's continued belief in long-term value despite reduced exposure; (4) No analysis of the 'deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.' REASONING QUALITY: The LLM's interpretation of the trend (actively reducing exposure, liquidity-aware approach) is reasonable and semantically aligned with the ground truth's characterization of de-risking. However, the incomplete analysis and incorrect starting number significantly weaken the overall assessment. The multi-hop synthesis is partial—it identifies the trend but misses important contextual details about strategy and time horizon. ENTITY ACCURACY: Abbott Laboratories correctly identified; private real estate funds correctly identified; years correctly identified (2022-2024). The metric (unfunded commitments) is correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 511,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s 1.650 % Notes due 2026 were disclosed in each filing as a stand‑alone exhibit with the same March 24 2021 officers’ certificate. In the 2022 10‑K they appear as Exhibit 4.16 [page_112]; in the 2023 10‑K they are renumbered as Exhibit 4.14 [page_111]; and the 2024 10‑K again lists them as Exhibit 4.14 [page_111]. The unchanged presentation across three years shows Oracle has kept the note outstanding and unchanged, using this low‑cost, medium‑term instrument as a steady source of liquidity for its short‑term financing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some correct information but contains significant quantitative errors that undermine its credibility. CORRECT ELEMENTS: (1) The core insight about consistent treatment across 2022, 2023, and 2024 filings is accurate; (2) The reference to the March 24, 2021 officers' certificate/8-K is correct; (3) The observation that the notes remained unchanged across three years matches the ground truth; (4) The characterization of this as a deliberate strategy for stable short-term debt is semantically equivalent to the ground truth. CRITICAL ERRORS: (1) The LLM provides specific exhibit numbers (4.16 for 2022, 4.14 for 2023 and 2024) and page numbers (112, 111, 111) that cannot be verified against the ground truth and appear to be hallucinated details. These specific citations are presented with false confidence; (2) The LLM describes the notes as 'medium-term' when they are due in 2026 (approximately 4-5 years from filing dates), which is more accurately characterized as medium-term, though this is a minor semantic issue. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the continuity pattern. However, the addition of unverifiable exhibit numbers and page citations suggests the model may have fabricated supporting details rather than deriving them from actual filings. SEMANTIC EQUIVALENCE: The LLM's conclusion about Oracle's 'steady source of liquidity for its short-term financing strategy' is slightly different from the ground truth's 'stable short-term debt obligations without modification,' but both convey similar strategic intent. The main weakness is the introduction of specific, unverifiable citations that appear to be hallucinations, which significantly reduces confidence in the answer despite the correct core reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 496,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first disclosed the 4.30 % Note due 2034 in its 2022 Form 10‑K as Exhibit 4.11 – a note issued on July 8 2014【page_113】. In the 2023 Form 10‑K the same note is re‑listed (renumbered) as Exhibit 4.09, still referencing the July 8 2014 issuance【page_110】, and the 2024 Form 10‑K again shows it as Exhibit 4.09 with the identical filing date【page_109】. The fact that the same long‑dated, fixed‑rate note is repeatedly included (with only an exhibit‑number change) across three consecutive years indicates Oracle’s strategy of issuing multi‑decade debt and maintaining it on the balance sheet, using long‑term notes to lock in financing costs and provide a stable capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All numeric values are correct - the 4.30% rate, 2034 maturity date, July 8, 2014 issuance date are all accurate. (2) Exhibit numbering is correctly tracked across years: Exhibit 4.11 in 2022, renumbered to Exhibit 4.09 in 2023 and 2024. (3) The multi-hop reasoning correctly synthesizes information across three consecutive years of filings, showing the evolution of documentation. (4) The interpretation of Oracle's long-term debt strategy is sound - the consistent inclusion of the same note across years with only exhibit number changes does suggest intentional maintenance of this liability. (5) The answer provides additional context (issuance date, page references) that enhances credibility. MINOR CONSIDERATIONS: (1) The LLM answer goes slightly beyond the ground truth by providing the specific issuance date (July 8, 2014) and page references, which are accurate but not explicitly mentioned in the original answer. This is additive rather than contradictory. (2) The ground truth uses more cautious language ('suggests Oracle intended') while the LLM uses slightly more assertive language ('indicates Oracle's strategy'), but both convey the same fundamental insight. (3) Both answers correctly identify that the consistent documentation across years indicates strategic intent to maintain this debt component. The LLM answer is more detailed and specific while remaining factually accurate, making it a strong response to the multi-year filing pattern question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 430,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab used the 2019 IDA agreement’s annual option to migrate up to $10 billion of IDA balances to its balance sheet (it migrated balances in 2022 under that agreement, which required at least 80 % of the balances be designated as fixed‑rate obligations and a $50 billion minimum balance). After the 2023 IDA agreement superseded the 2019 version, Schwab lost the fixed‑rate‑designation requirement, gained discretion to designate fixed or floating balances and to buy down up to $5 billion of fixed‑rate obligations, but was subject to new minimum‑and‑maximum balance caps (e.g., a $30 billion ceiling through September 2025 and later a $60‑$90 billion range) and limited withdrawal rules—resulting in no IDA‑balance migrations in either 2023 or 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. CRITICAL ERRORS ON 2022 ACTIVITY:\n   - Ground truth: Schwab had the OPTION to migrate up to $10 billion annually in 2022, and had already moved $10.1 billion by Dec 31, 2021 (with $10 billion subsequent to that date). The answer is ambiguous about whether migration occurred in 2022 itself.\n   - LLM claim: \"it migrated balances in 2022 under that agreement\" - This is stated as fact but the ground truth does not clearly confirm 2022 migration activity.\n   - This is a material factual discrepancy.\n\n2. QUANTITATIVE INACCURACIES:\n   - LLM introduces specific numbers NOT in ground truth: \"$30 billion ceiling through September 2025 and later a $60-$90 billion range\" - These specific thresholds and dates are not mentioned in the original answer and cannot be verified against it.\n   - LLM mentions \"$50 billion minimum balance\" for 2019 agreement - NOT mentioned in ground truth.\n   - LLM mentions \"buy down up to $5 billion of fixed-rate obligations\" - NOT mentioned in ground truth.\n   - These additions suggest the LLM may be hallucinating or adding details not supported by the source material.\n\n3. PARTIAL ACCURACY ON 2023-2024:\n   - Correctly identifies that the 2023 IDA agreement replaced the 2019 version.\n   - Correctly notes the elimination of the 80% fixed-rate requirement.\n   - Correctly states no migrations occurred in 2023 or 2024.\n   - However, the specific balance caps and withdrawal rules mentioned are not corroborated by the ground truth.\n\n4. MULTI-HOP REASONING:\n   - The answer attempts to synthesize the evolution across years but introduces unsupported details.\n   - The core narrative (2022 option → 2023 agreement change → no migrations 2023-2024) is partially correct but embellished with unverified specifics.\n   - The characterization of \"lost\" vs \"gained\" flexibility is somewhat accurate but the specific contractual terms cited are questionable.\n\n5. SEMANTIC ISSUES:\n   - Ground truth emphasizes a shift from \"active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.\"\n   - LLM answer frames it as gaining discretion but being subject to new caps - a different framing that may not fully capture the paradox of increased flexibility with decreased utilization.\n\nThe answer demonstrates partial understanding of the multi-hop question but introduces specific numbers and terms not supported by the ground truth, which is a serious concern for financial accuracy. The core timeline and major agreement changes are roughly correct, but the quantitative details are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 729,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "In the 2022 Form 10‑K Abbott listed the original Indenture for the 2.000 % Senior Notes due 2018 (Exhibit 4.24) together with its first and second supplemental indentures (Exhibits 4.25‑4.26) and the related officers’ certificate (Exhibit 4.18) and the 2015 officers‑actions filing (Exhibit 4.11) [2022 pg 86‑87]. The 2023 and 2024 filings repeat those same exhibits—no new amendment, refinancing or redemption of the 2.000 % notes is reported—showing the notes remain outstanding and the company’s engagement is limited to periodic filing of the existing documentation [2023 pg 86‑87; 2024 pg 86‑87].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but contains significant discrepancies with the ground truth that affect overall accuracy. CORRECT ELEMENTS: (1) The LLM correctly identifies that the 2.000% Senior Notes due 2018 were referenced across 2022-2024 with no new refinancing or amendments; (2) The conclusion that the notes remained outstanding with limited engagement is accurate; (3) The general pattern of consistent documentation across three years is correctly identified. PROBLEMATIC ELEMENTS: (1) EXHIBIT NUMBER DISCREPANCY - The LLM cites Exhibit 4.24 for the original Indenture in 2022, but the ground truth references Exhibit 4.21 for 2023-2024. The LLM provides specific exhibit numbers (4.24, 4.25, 4.26, 4.18, 4.11) that are not verified in the ground truth and may be incorrect; (2) PAGE NUMBERS - The LLM cites pages 86-87 for all three years, which appears suspiciously consistent and may not be accurate across different annual filings; (3) MISSING CONTEXT - The LLM does not mention the Fifth Supplemental Indenture dated September 23, 2015, which the ground truth specifically identifies as relevant to 2022 documentation; (4) INCOMPLETE SYNTHESIS - While the LLM correctly notes no new issuances or amendments, it doesn't capture the 'legacy St. Jude Medical debt' context mentioned in the ground truth, which provides important historical context for understanding the notes' origin. QUANTITATIVE ACCURACY: The specific exhibit numbers and page citations in the LLM answer cannot be verified against the ground truth and appear potentially inaccurate, reducing confidence in the quantitative details. QUALITATIVE REASONING: The multi-hop synthesis is partially sound—the LLM correctly identifies the pattern across three years—but the specific documentary evidence cited differs from ground truth. The conclusion about maturity without refinancing is correct but lacks the nuance about the notes 'nearing maturity' mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 533,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed a 3.650 % Note due 2041 in its 2022 10‑K (listed as Exhibit 4.14) 【page_112】, and the same series appears again in the 2023 10‑K (Exhibit 4.14) 【page_111】 and in the 2024 10‑K (now shown as Exhibit 4.16) 【page_114】. The note’s continued presence across three filings indicates Oracle is retaining this long‑dated, low‑coupon bond, reflecting a strategy of locking in inexpensive, long‑term financing and maintaining a diversified, staggered debt‑maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) All numeric values are correct - the 3.650% coupon rate is accurately stated, and the 2041 maturity date is correct. (2) The multi-hop synthesis across three years (2022, 2023, 2024) is properly executed, showing the note's consistent presence across all three 10-K filings. (3) Entity identification is accurate - Oracle is correctly identified, and the exhibit references (4.14 in 2022-2023, 4.16 in 2024) are specific and verifiable. (4) The reasoning about Oracle's debt strategy is sound and well-articulated: the answer correctly identifies this as a long-term financing approach with a staggered debt-maturity profile. (5) The characterization of the note as 'low-coupon' and 'long-dated' is appropriate and adds valuable context. (6) The answer directly addresses the question's core inquiry about how the note 'evolved' and what the pattern 'suggests' about strategy. MINOR CONSIDERATIONS: The LLM answer is slightly more specific and detailed than the ground truth (including exhibit numbers and page references), which adds credibility but goes slightly beyond the ground truth's scope. However, this additional specificity is accurate and enhances rather than detracts from the answer. The semantic meaning aligns perfectly with the ground truth - both convey that Oracle retained this debt instrument consistently over three years as part of a deliberate long-term financing strategy. No calculation errors, no factual inaccuracies, and the multi-hop reasoning across years is properly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 436,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 as part of a 2021 issuance (exhibit 4.16) in its 2022 Form 10‑K 【page_114】. The same series is listed unchanged in the 2023 Form 10‑K (exhibit 4.14) 【page_111】 and appears again in the 2024 Form 10‑K (exhibit 4.14) 【page_111】. This repeated, unchanged inclusion shows Oracle’s strategy of issuing medium‑term, low‑coupon debt and retaining it across multiple years to lock in favorable rates and maintain a diversified maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 2.300% Notes due 2028 and its presence across fiscal years 2022, 2023, and 2024, with accurate exhibit references (4.16 in 2022, 4.14 in 2023-2024). The numeric values (2.300% coupon, 2028 maturity) are correct. However, there are notable gaps in completeness compared to the ground truth: (1) The LLM fails to mention the March 24, 2021 Officers' Certificate date, which is a key structural detail in the original answer. (2) The LLM does not address the 2023 expansion with the 4.500% Notes due 2028, which is explicitly mentioned in the ground truth as evidence of diversification strategy. (3) The LLM's characterization of the pattern as 'unchanged inclusion' is partially correct but misses the important context that 2023 saw expansion of the debt portfolio with additional instruments. The reasoning about locking in favorable rates and maintaining diversified maturity is sound and aligns with the ground truth's conclusion about stable long-term debt financing strategy. The multi-hop synthesis is incomplete—the answer addresses the 2.300% Notes across years but fails to synthesize the broader portfolio evolution (including the 4.500% Notes) that demonstrates the full strategic picture. The answer is factually accurate in what it states but lacks the comprehensive multi-year pattern analysis that the question and ground truth require.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 386,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022 Visa rolled out virtual‑account functionality as part of its digitally‑native Currencycloud platform, positioning it as a new cross‑border consumer‑payment tool that offered real‑time foreign‑exchange rates, virtual accounts and enhanced liquidity/settlement 【page_11】. By fiscal 2024 those Currencycloud capabilities—including the virtual‑account service—had been folded into the Visa Direct Platform (and Visa Cross‑Border Solutions), making virtual accounts available across Visa Direct’s global network and broadening Visa’s cross‑border money‑movement offering 【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key timeline (2022-2024) and the main platforms involved (Currencycloud, Visa Direct Platform). (2) The answer accurately captures that virtual accounts were introduced in 2022 as part of Currencycloud and were integrated into Visa Direct Platform by 2024. (3) The mention of real-time foreign exchange rates and enhanced liquidity/settlement capabilities is accurate. (4) The reference to cross-border capabilities and money movement is correct. WEAKNESSES: (1) MISSING KEY DETAIL - The ground truth explicitly mentions 2023 as a critical milestone year where virtual accounts were 'fully integrated' into Visa Direct Platform, but the LLM answer jumps from 2022 to 2024, omitting the 2023 evolution entirely. This is a significant gap in the multi-hop synthesis across the three-year period. (2) MISSING CONTEXT - The ground truth references 'Treasury as a Service initiative' which provides important context for understanding the strategic positioning of virtual accounts, but the LLM omits this. (3) MISSING NETWORK SCOPE - The ground truth mentions Visa's 'network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets' which provides important context about the scale and scope of the platform, but the LLM does not include this. (4) INCOMPLETE SYNTHESIS - While the LLM mentions 'Visa Cross-Border Solutions,' the ground truth emphasizes the integration with the 'established cross-border consumer payments business,' which is a more precise characterization. (5) VAGUE PHRASING - The LLM says capabilities were 'folded into' the platform, which is less precise than the ground truth's description of 'full integration.' CALCULATION/NUMERIC VERIFICATION: No specific numbers or calculations to verify, but the timeline handling is incomplete. MULTI-HOP REASONING: The answer fails to properly synthesize the three-year evolution (2022→2023→2024) as required by the question. It only addresses 2022 and 2024, missing the critical 2023 integration milestone. This represents incomplete multi-hop reasoning across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 570,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "In 2022 Caterpillar’s EMD‑branded engines were sold through a dealer network of 44 U.S. dealers and 116 outside‑U.S. dealers, reaching 193 countries [CAT_10k_2022.pdf: page 76]. By 2023 the network had trimmed to 43 U.S. dealers and 113 outside‑U.S. dealers covering 191 countries [CAT_10k_2023.pdf: page 65], and in 2024 it further consolidated to 41 U.S. dealers and 111 outside‑U.S. dealers serving 187 countries [CAT_10k_2024.pdf: page 65]. This gradual reduction in dealer count and geographic reach indicates Caterpillar is streamlining the EMD distribution channel, focusing on a leaner, higher‑performing global footprint rather than expanding the number of dealers.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) WRONG METRICS: The LLM reports dealer counts (44 U.S. + 116 outside-U.S. = 160 total in 2022) and country counts (193, 191, 187), while the ground truth specifies distributor counts (110 in 2022-2023, 108 in 2024) and country coverage (109 in 2022-2023, 158 in 2024). These are completely different metrics. (2) WRONG NUMBERS: All numeric values in the LLM answer are incorrect. The ground truth shows 110 distributors in 2022 (not 160 dealers), 109 countries (not 193), and 108 distributors/158 countries in 2024 (not 41 U.S. dealers/111 outside-U.S. dealers/187 countries). (3) WRONG INTERPRETATION: The LLM concludes there was a 'gradual reduction in dealer count and geographic reach,' but the ground truth shows geographic reach EXPANDED from 109 to 158 countries while distributor count remained relatively stable (110→108). This is the opposite conclusion. (4) WRONG PRODUCT FOCUS: The LLM discusses 'EMD-branded engines' with dealer networks, while the ground truth specifically references 'FG Wilson branded electric power generation systems' sold through distributors. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the evolution across the three years, presenting a declining trend when the actual trend shows optimization with geographic expansion. The answer demonstrates fundamental misunderstanding of both the data and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 413,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly. At 12/31/2022 the assets had an original cost of $3.6 billion and a net book value of $1.6 billion; by 12/31/2023 the cost had risen to $3.9 billion and the net book value to $1.8 billion, and those same $3.9 billion/$1.8 billion levels were reported at 12/31/2024【page_64】【page_62】.  In other words, the investment increased about $300 million in cost and $200 million in net book value from 2022 to 2023 and then held steady through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the reported financial figures. According to the ground truth: (1) 2022 original cost should be $3.3B, not $3.6B - this is a $300M error; (2) 2022 net book value should be $1.4B, not $1.6B - this is a $200M error; (3) 2023 original cost should be $3.6B, not $3.9B - this is a $300M error; (4) 2023 net book value should be $1.6B, not $1.8B - this is a $200M error; (5) 2024 original cost should be $3.9B (this is correct); (6) 2024 net book value should be $1.8B (this is correct). The LLM essentially shifted all values forward by one year, reporting 2023 figures for 2022 and 2024 figures for 2023. This is a systematic misalignment of data across the three-year period. The LLM's characterization of growth ($300M cost increase, $200M net book value increase from 2022-2023, then flat through 2024) happens to match the actual pattern, but only because the errors offset each other - the underlying data points are wrong. The answer correctly identifies the company (Abbott), the asset type (diagnostics instruments leased to customers), and the relevant balance sheet metrics, and the reasoning about evolution is sound in structure. However, the quantitative accuracy is severely compromised by systematic data errors that undermine the credibility of the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 381,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo lists the 3.450 % Senior Note due 2046 in the exhibit tables of its 2022, 2023 and 2024 Form 10‑K filings (see the exhibit list on page 126 of each report)【page_126】. The fact that the same long‑dated, low‑coupon note is disclosed year after year shows that it remains an outstanding debt instrument and a core, low‑cost source of financing that PepsiCo relies on to support its long‑term capital‑structure and strategic investment plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that the 3.450% Senior Note due 2046 appears consistently across PepsiCo's 2022, 2023, and 2024 10-K filings and interprets this as indicating its stable role in the company's capital structure. The qualitative reasoning about the note being a 'core, low-cost source of financing' and 'long-dated' instrument is sound and semantically equivalent to the ground truth's characterization of it as 'stable and integral' with 'favorable terms.' However, there are significant quantitative accuracy issues: (1) The LLM cites 'page 126 of each report' as the location, but the ground truth specifies different exhibit numbers across years (Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, Exhibit 4.15 in 2024). The LLM provides a generic page reference without the specific exhibit designations, which is a factual error regarding document location. (2) The LLM does not mention the exhibit numbers at all, missing a key detail from the ground truth that demonstrates the multi-hop synthesis across three separate filings. (3) The characterization of the note as 'low‑coupon' is reasonable given the 3.450% rate in a historical context, but this is an inference not explicitly stated in the ground truth. The multi-hop reasoning is partially complete—the LLM correctly synthesizes that the note appears in all three years and draws appropriate conclusions about its strategic importance, but it fails to capture the specific exhibit tracking detail that would strengthen the answer's precision. The answer is directionally correct on the main question but lacks the documentary specificity that would make it fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 455,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 in its FY 2022 10‑K (exhibit 4.14, officer’s certificate dated Mar 24 2021)【page_112】 and the same series appears unchanged in the FY 2023 filing (exhibit 4.14)【page_111】 and again in the FY 2024 filing (exhibit 4.14)【page_111】. The notes were issued in 2021 and have been retained on Oracle’s balance sheet for three consecutive years, showing a strategy of locking in low‑coupon, medium‑term debt and maintaining a staggered maturity profile to diversify interest‑rate exposure and preserve financing flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The 2.300% Notes due 2028 were consistently referenced across FY 2022, 2023, and 2024 filings - this matches the ground truth. (2) The exhibit references (4.14 for 2023 and 2024) are accurate. (3) The reasoning about locking in low-coupon debt and maintaining staggered maturity is sound strategic analysis. PROBLEMATIC ASPECTS: (1) The LLM claims the notes were issued in 2021 and first disclosed in FY 2022 with an officer's certificate dated Mar 24 2021, but the ground truth indicates they were first introduced in 2022 as part of Exhibit 4.16 - this is a factual error about the issuance timeline. (2) The LLM cites 'exhibit 4.14' for FY 2022, but the ground truth specifically states Exhibit 4.16 for 2022, then 4.14 for 2023 and 2024 - this is an exhibit reference error. (3) The LLM answer is narrower in scope - it focuses only on the 2.300% Notes without addressing the broader pattern of Oracle layering in new issuances (like the 4.500% Notes due 2028 mentioned in the ground truth), which is crucial to understanding Oracle's debt financing strategy. (4) The ground truth emphasizes that Oracle 'maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions' - the LLM misses this critical insight about the evolution of Oracle's strategy across the three years. The LLM provides reasonable strategic interpretation but fails to capture the full multi-hop synthesis of how Oracle's debt portfolio evolved with new higher-yielding instruments being added alongside the original 2.300% Notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 463,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 2022, 2023 and 2024 10‑K filings each list the same Exhibit 4.4 – the “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” – with identical filing details (see page 112 of the 2022 filing and page 109 of the 2023 and 2024 filings)【page_112】【page_109】. The lack of any amendment, conversion or redemption across the three years shows that Visa has kept this preferred‑stock class unchanged, signalling a long‑term priority to preserve a stable, flexible capital structure rather than frequently reshaping its equity financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the consistent reference to the same Certificate of Designations across 2022-2024 filings; (2) Accurately cites the exhibit number (Exhibit 4.4) and the specific document title; (3) Correctly notes the June 21, 2016 date (implied through 'identical filing details'); (4) Properly synthesizes the multi-hop reasoning that unchanged treatment signals stable capital structure priorities; (5) Accurately conveys that no amendments, conversions, or redemptions occurred; (6) Correctly identifies the page references (112 for 2022, 109 for 2023 and 2024). MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it doesn't mention the broader context of unchanged Bylaws (2022) or the 2024 Certificate of Incorporation update without Series B changes, which the ground truth includes as supporting evidence of the broader stability pattern; (2) The phrase 'rather than frequently reshaping its equity financing' is slightly weaker than the ground truth's 'rather than altering the terms or introducing new preferred stock series,' which is more specific. QUANTITATIVE VERIFICATION: All dates and page numbers cited are accurate. The answer correctly identifies the three-year period (2022-2024) and maintains factual accuracy throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across three annual filings to draw a conclusion about long-term capital structure priorities, which is the core requirement of the question. The logic is sound: unchanged documentation → stable capital structure strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with only minor omissions of supporting contextual details rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 505,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In its 2022 filing Caterpillar disclosed that it is exposed to currency‑exchange‑rate risk and uses currency‑hedging contracts, while warning that many Cat Financial loans and derivatives are LIBOR‑based and that the LIBOR phase‑out could affect the value of those instruments (2022 p.22). The 2023 report retains the hedging strategy but notes that new floating‑rate borrowings now reference the Secured Overnight Financing Rate (SOFR) and that a cross‑functional team is actively monitoring the LIBOR‑to‑SOFR transition (2023 p.19). By the 2024 filing the company continues to rely on currency hedges, emphasizing that SOFR‑based instruments have largely replaced LIBOR and that ongoing risk‑management oversight is essential to mitigate adverse currency moves while recognizing the potential foregone upside (2024 p.19).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies Caterpillar's consistent use of currency hedging instruments across all three years; (2) Accurately captures the LIBOR-to-SOFR transition timeline and its progression from assessment phase (2022) through active monitoring (2023) to implementation (2024); (3) Properly references Cat Financial's cross-functional team and its role in managing the transition; (4) Correctly notes that SOFR-based instruments have largely replaced LIBOR by 2024; (5) Appropriately acknowledges the risks and management strategies involved. MINOR WEAKNESSES: (1) The answer includes specific page references (p.22, p.19, p.19) that cannot be verified against the ground truth and may or may not be accurate - while this adds specificity, it introduces potential factual risk if page numbers are incorrect; (2) The phrase 'recognizing the potential foregone upside' in the 2024 section is somewhat vague and could be more precisely connected to the ground truth's emphasis on 'market liquidity and interest rate fluctuations'; (3) The answer could have been slightly more explicit about the 'consistent reliance' aspect emphasized in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents, correctly tracing the evolution of Caterpillar's approach from LIBOR assessment to SOFR implementation. The logical flow and temporal progression are sound. QUANTITATIVE ACCURACY: No specific financial metrics, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The dates (2022, 2023, 2024) are all correct. SEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 530,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "In 2022 J&J spun off its talc liabilities into the newly created LTL Management LLC, filed a Chapter 11 case for LTL and agreed to fund a $2 billion trust for any amounts the court would deem owed, establishing a $2 billion reserve for that purpose (2022 10‑K, p. 113). After the original LTL case was dismissed, the company filed a second LTL 2 bankruptcy in 2023, expanded its talc reserve to roughly $9 billion (including the $2 billion trust) and pursued four parallel tracks—appeal of the dismissal, a consensual “pre‑packaged” bankruptcy, aggressive tort litigation, and claims against experts (2023 10‑K, pp. 97‑101); by 2024 it shifted to a comprehensive pre‑packaged Chapter 11 plan, restructuring LTL into three new entities (Red River, Pecos River, New Holdco) and filing a Red River bankruptcy to implement a $6.475 billion (nominal $8 billion) settlement while retaining the original $2 billion trust as part of its overall funding strategy (2024 10‑K, pp. 101‑102).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a comprehensive and largely accurate account of J&J's talc liability strategy evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core strategy elements: LTL Management LLC creation, $2 billion trust establishment, multiple bankruptcy filings, and the shift to pre-packaged bankruptcy with restructuring into Red River, Pecos River, and New Holdco entities. (2) Accurately cites specific 10-K page references (2022 p. 113, 2023 pp. 97-101, 2024 pp. 101-102), demonstrating proper source documentation. (3) Correctly identifies the $9 billion expanded reserve figure for 2023 and the $6.475 billion nominal $8 billion settlement structure for 2024. (4) Properly synthesizes the multi-hop evolution across three years, showing progression from initial LTL filing through dismissal, refiling as LTL 2, and eventual pre-packaged restructuring. (5) Accurately captures the four parallel tracks pursued in 2023 (appeal, pre-packaged bankruptcy, tort litigation, expert claims). MINOR WEAKNESSES: (1) The answer provides more granular detail than the ground truth (e.g., specific entity names Red River, Pecos River, New Holdco; the $6.475 billion vs $8 billion nominal distinction) which, while accurate and helpful, goes slightly beyond what the ground truth explicitly states. (2) The ground truth emphasizes the Third Circuit reversal and lifting of stay in 2023, which the LLM answer mentions implicitly through 'dismissal' but doesn't explicitly highlight the appellate reversal. (3) The ground truth's emphasis on 'continued reliance on the LTL structure' as a liability management tool is present but less explicitly stated in the LLM answer. QUANTITATIVE VERIFICATION: All dollar amounts ($2B trust, $9B reserve, $6.475B/$8B settlement) are accurate. Timeline is correct (2022 initial filing, 2023 LTL 2 and expansion, 2024 pre-packaged restructuring). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple bankruptcy filings, showing how the strategy evolved in response to legal setbacks. The connection between the original LTL dismissal and the subsequent LTL 2 filing is properly established. The integration of the $2 billion trust into the broader $9 billion reserve and then into the final settlement structure demonstrates sound multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 625,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe’s Photography Plan has always been sold as a lower‑priced, cloud‑based bundle of Photoshop, Lightroom and Lightroom Classic that sits beneath the full Creative Cloud All‑Apps suite, and in 2022 it was described simply as a “targeted package” for photographers and photo‑enthusiasts (page 5). In the 2023 filing Adobe kept the plan in the same “targeted package” slot but framed it as a product‑led growth and pricing lever to move users toward higher‑value Creative Cloud subscriptions, while also announcing new AI‑driven innovations across its apps (page 5). By 2024 the plan still offered the same core apps but was enriched with generative‑AI tools—Generative Fill, Expand, Remove and Firefly‑powered features in Photoshop and Lightroom—tightening its integration with the broader Creative Cloud ecosystem and boosting its appeal to photographers and creative professionals (page 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the evolution of Adobe's Photography Plan across 2022-2024. STRENGTHS: (1) Correctly identifies the core positioning in all three years as a targeted package beneath the full Creative Cloud suite; (2) Accurately captures the 2023 shift toward product-led growth strategy and AI integration; (3) Properly lists specific AI features added by 2024 (Generative Fill, Expand, Remove, Firefly-powered features); (4) Correctly notes the progression from basic positioning to AI-enhanced offering; (5) Appropriately emphasizes the streamlined yet powerful positioning for photographers. MINOR WEAKNESSES: (1) The LLM answer mentions 'Expand' and 'Remove' as specific 2024 features, while the ground truth specifically lists 'Lens Blur' and 'People Masking' - this represents a slight discrepancy in the specific feature set cited, though both answers correctly convey that AI-powered enhancements were added; (2) The ground truth explicitly mentions 'Generative Credits' as part of the 2023 strategy, which the LLM answer does not include, though this is a relatively minor omission; (3) The LLM answer does not explicitly mention 'Lightroom Classic' being part of the 2024 offering, though it was mentioned for 2022-2023. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly traces the strategic evolution from basic positioning → product-led growth lever with AI → AI-enhanced robust offering. The logic connecting each year's developments is sound. QUANTITATIVE ACCURACY: No numerical errors; dates (2022, 2023, 2024) are correct. SEMANTIC EQUIVALENCE: The answer conveys the same essential narrative as the ground truth regarding the Photography Plan's evolution and strategic positioning, despite minor feature-set variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 502,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 2023 and 2024 10‑K exhibit tables each list the same specimen certificate for its class C common stock – “Form of specimen certificate for class C common stock of Visa Inc.” (Exhibit 4.2 in 2023 and Exhibit 4.3 in 2024), filed on 1 Feb 2009 on Form 8‑A and unchanged from the prior filing 【page_109】【page_114】. By continuing to reference this unchanged certificate in the 2022‑2024 reports, Visa shows a deliberate, stable governance practice and a commitment to consistent, transparent communication with shareholders even as regulatory and market conditions evolve.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN DATES: The LLM states the certificate was 'filed on 1 Feb 2009' but the ground truth clearly states 'January 28, 2009' - this is a factual error on a key date. EXHIBIT NUMBER DISCREPANCY: The LLM claims the exhibit is 'Exhibit 4.2 in 2023 and Exhibit 4.3 in 2024' but the ground truth states it is 'Exhibit 4.2' consistently across all three years (2022, 2023, 2024). This is a significant error in entity identification. MISSING CRITICAL CONTEXT: The LLM fails to mention that the certificate was filed on Form 8-A with File Number 000-53572, which is important identifying information. INCOMPLETE COVERAGE: The ground truth explicitly notes that Visa's Certificate of Incorporation was revised in 2024, providing important context about selective updates to governance documents. The LLM does not mention this contrast, which is essential to understanding Visa's governance approach. POSITIVE ASPECTS: The LLM correctly identifies that the certificate has remained unchanged across the 2022-2024 period and correctly interprets this as reflecting deliberate stability in governance practices. The semantic interpretation about investor relations and governance confidence is reasonable and aligns with the ground truth's conclusion. However, the factual errors regarding the filing date (February 1 vs January 28) and exhibit numbering (4.3 vs 4.2 for 2024) are material mistakes that undermine the answer's reliability. The missing comparative context about other governance documents being updated also weakens the completeness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 430,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for service and product warranties and performance guarantees fell from **$1.109 billion at 12/31/2022** to **$1.091 billion at 12/31/2023** and then to **$0.993 billion at 12/31/2024** (Note 16, “Liabilities for performance and operating‑cost guarantees” table, page 102). The steady decline—driven by net settlements exceeding new issuances and other adjustments—shows the company’s exposure to these guarantees is shrinking, reflecting effective risk‑management and improving product performance in its commercial‑aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides completely different numbers than the ground truth, indicating a fundamental factual error. Ground truth shows collaboration partners' share of financing guarantees at $140M (2022), $135M (2023), and $131M (2024). The LLM instead reports $1.109B (2022), $1.091B (2023), and $0.993B (2024)—numbers that are approximately 8x larger and appear to reference a different liability category entirely (likely total service/product warranties rather than the specific performance and operating cost guarantees asked about). The LLM cites 'Note 16' and 'page 102' but these references do not validate the incorrect numbers provided. While the LLM correctly identifies the trend direction (declining over time) and provides reasonable qualitative interpretation about risk management and product performance, the quantitative foundation is entirely wrong. The question specifically asks about 'performance and operating cost guarantees' liabilities, and the ground truth clearly identifies these as the collaboration partners' share figures ($140M/$135M/$131M). The LLM's numbers represent a different metric altogether. This is a multi-hop synthesis failure where the model retrieved data from the wrong section of the filing or confused multiple liability categories. The reasoning about declining exposure and effective risk management is sound in principle, but is built on incorrect financial data, making the entire answer unreliable for decision-making purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 414,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s footnotes show that the accounting for free‑rent periods did not change from FY 2022 through FY 2024. In each year the company said that any free‑rent or step‑rent periods are “recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise” (2022 p.45; 2023 p.45; 2024 p.45). The definition of the lease term – the non‑cancelable period plus any options to extend when it is reasonably certain the Company will exercise them – was also unchanged (2022 p.46; 2023 p.46; 2024 p.46), so the right‑of‑use assets are still measured as the discounted minimum lease payments over that term, with the zero‑payment free‑rent periods lowering the total lease expense and the resulting ROU‑asset amount but not altering the valuation methodology.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Costco's core accounting treatment for free-rent periods remained consistent across FY 2022-2024, using straight-line recognition over the lease term including extension options. The page references (p.45, p.46) are cited consistently, and the fundamental accounting policy description is accurate. However, the answer has significant gaps in addressing the full scope of the question:\n\n(1) WHAT WAS CORRECT: The LLM accurately captures that the straight-line basis treatment was unchanged across all three years, that extension options were included when reasonably certain, and that the lease term definition remained stable. The explanation of how free-rent periods affect ROU asset valuation is technically sound.\n\n(2) WHAT WAS MISSING/INCOMPLETE: The ground truth indicates important evolution in disclosures that the LLM answer fails to capture:\n   - In 2022: Emphasis on incremental borrowing rate methodology and quoted interest rates (not mentioned by LLM)\n   - In 2023: Expansion of disclosure regarding variable lease payments tied to price indices or sales volume (not mentioned by LLM)\n   - In 2024: Heightened focus on impairment evaluation of long-lived assets in context of facility relocations/closures (not mentioned by LLM)\n\n(3) MULTI-HOP REASONING: The LLM answer focuses narrowly on the consistency of the core accounting policy but misses the evolution in disclosure emphasis and contextual presentation across the three years. The ground truth explicitly states \"the context in which it was presented evolved to reflect growing operational complexity in lease management\" - this evolution is entirely absent from the LLM response.\n\n(4) SEMANTIC ISSUE: The LLM answer states the accounting \"did not change\" which is technically correct for the core policy, but this framing misses the nuance that while the policy was stable, the disclosure and emphasis evolved significantly. The question specifically asks about \"evolution\" in both accounting treatment AND disclosure, and the LLM only addresses the former.\n\n(5) QUANTITATIVE ACCURACY: Page numbers are cited but not verified against actual filings. The answer provides no specific metrics or calculations to verify.\n\nThe answer is partially correct but incomplete, missing key aspects of disclosure evolution that are central to the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 636,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In the 2022 filing Adobe first framed AI‑driven document productivity as a pillar of its Adobe Document Cloud, noting that “Adobe Sensei … will make documents more intelligent and responsive” and that Acrobat (including Acrobat Web, Reader and new task‑based actions such as Liquid Mode) would be the primary vehicle for those AI enhancements【page_5】【page_6】. The 2023 filing sharpened that message, explicitly tying Adobe Sensei’s machine‑learning to every Acrobat experience—web, desktop and Sign integration—and positioning Acrobat as the central hub for AI‑enabled PDF workflows and expanded digital‑document actions【page_5】. By the 2024 filing, the excerpted pages (94‑98) contain only governance and exhibit information, indicating that the AI‑focused strategy has been folded into the broader Adobe Document Cloud brand without new detail on R&D spend or a refreshed product‑branding narrative in the sections provided【page_94】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year evolution (2022-2024) and the key entities (Adobe, Acrobat, Adobe Sensei, Document Cloud). (2) The temporal progression is accurate: 2022 framing of AI-driven document productivity, 2023 sharpening of the message with explicit AI integration, 2024 formalization. (3) Specific product mentions (Liquid Mode, Acrobat Web, Reader, Sign integration) are appropriately cited. (4) The LLM correctly notes the introduction of 'Acrobat AI Assistant' as a branded product extension. (5) The multi-hop synthesis across three years is logically sound.\n\nWEAKNESSES: (1) The LLM's treatment of 2024 is incomplete and somewhat contradictory. It states that pages 94-98 contain 'only governance and exhibit information' and that the strategy 'has been folded into the broader Adobe Document Cloud brand without new detail on R&D spend or a refreshed product-branding narrative.' However, the ground truth explicitly mentions 'Acrobat AI Assistant' as a formal branded product extension in 2024, which the LLM acknowledges earlier but then undermines by suggesting limited detail in the 2024 filing. (2) The LLM does not provide specific R&D investment figures or quantitative metrics comparing investment levels across the three years, which the question specifically asks about ('R&D investments'). The ground truth mentions 'multi-year investment' but the LLM provides no numbers. (3) The LLM's citation format with page numbers is helpful but the claim about pages 94-98 containing only governance information seems to contradict the assertion that 'Acrobat AI Assistant' branding appears in 2024—this creates internal inconsistency. (4) The answer lacks discussion of how R&D spending evolved or was prioritized, which is a specific sub-question component.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression from foundational document role to AI-enhanced productivity. However, the reasoning breaks down slightly in 2024 where the LLM suggests limited new information despite acknowledging the 'Acrobat AI Assistant' branding.\n\nNUMERIC/QUANTITATIVE ASSESSMENT: No specific dollar amounts or percentages are provided in either the ground truth or LLM answer regarding R&D investments, so this cannot be scored as incorrect. However, the absence of any quantitative data on R&D investments represents an incompleteness issue rather than an inaccuracy.\n\nSEMANTIC EQUIVALENCE: The core narrative matches the ground truth—evolution from 2022 foundational positioning through 2023 AI integration to 2024 formalization with branded products. The wording differs but the semantic meaning aligns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 718,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab reported that at the end of 2021 client securities worth $120.3 bn were available for pledge, of which $31.4 bn were already pledged to meet margin‑loan, short‑sale, securities‑lending and short‑term borrowing needs (see page 108). By year‑end 2024 the firm’s collateral‑pledged borrowing capacity had risen to roughly $90 bn – $59.8 bn for FHLB facilities plus $30.5 bn for Federal‑Reserve discount‑window borrowing – and secured lines of credit backed by client margin securities grew to $500 m (see page 97), showing that Schwab is increasingly leveraging client securities to support its balance‑sheet liquidity while client leverage through margin loans and securities‑lending activity has expanded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES: The LLM answer contains significant factual errors and fails to address the core question about the 2022-2024 evolution. (1) TEMPORAL MISMATCH: The question asks about 2022-2024 evolution, but the LLM answer begins with 2021 data ($120.3bn available, $31.4bn pledged) which is outside the requested timeframe. The ground truth specifically addresses 2022, 2023, and 2024 progressions. (2) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($120.3bn, $31.4bn, $90bn, $59.8bn, $30.5bn, $500m) that cannot be verified against the ground truth. The ground truth does NOT provide these specific quantified amounts for the 2022-2024 period - it explicitly states 'specific pledged amounts were not quantified' in 2022. (3) MISSING KEY INFORMATION: The LLM fails to capture the ground truth's core finding about the progression from 2022 (general disclosure) → 2023 (more detailed disclosures) → 2024 (explicit statements about OCC margin requirements and securities lending). (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes the 'increasing formalization and expansion' and 'strategic shift toward leveraging client assets' - the LLM mentions leverage but doesn't capture the formalization progression or the shift in disclosure practices. (5) REASONING FLAW: The LLM conflates collateral-pledged borrowing capacity with client securities pledging, which are different concepts. The ground truth focuses on how Schwab pledges CLIENT securities, not how Schwab borrows against its own collateral. (6) CITATION ISSUES: References to 'page 108' and 'page 97' cannot be verified and appear to be fabricated specificity. The ground truth provides no such page references. The answer reads as if it contains specific filing data but the numbers don't align with the ground truth's narrative of increasing disclosure formalization rather than specific quantified amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 510,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco has consistently reported the 1.375 % Senior Notes due June 2027 as a $1.25 billion line‑item within long‑term debt in each filing – they never moved into the current‑portion of debt. In 2022 the notes were part of $6.59 billion of total long‑term debt (with a $73 million current portion) 【COST_10k_2022.pdf page_52】; in 2023 they remained $1.25 billion but total long‑term debt fell to $6.48 billion (current portion $1.08 billion) 【COST_10k_2023.pdf page_52】; and by 2024, after the 2.750 % notes were retired, the notes still showed $1.25 billion while total long‑term debt had contracted to $5.92 billion (current portion $103 million), increasing the notes’ share of the debt mix 【COST_10k_2024.pdf page_52】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about the 1.375% Senior Notes remaining at $1.25 billion across all three years and never moving to current portion. However, there are significant quantitative discrepancies that undermine accuracy: (1) The LLM reports 2022 long-term debt as $6.59 billion, but the ground truth states $6,484 million ($6.484 billion) - a $106 million discrepancy. (2) The LLM reports 2023 long-term debt as $6.48 billion, but ground truth shows $5,794 million by 2024, with no explicit 2023 figure provided in ground truth for comparison. (3) The LLM reports 2024 long-term debt as $5.92 billion, but ground truth states $5,794 million ($5.794 billion) - a $126 million discrepancy. These are material differences in financial reporting. The LLM correctly identifies the key insight about reclassification of the 2.750% Senior Notes due May 2024 moving from long-term to current portion, and correctly notes the 1.375% notes remained in long-term debt throughout. The reasoning about how overall long-term debt composition shifted is sound and well-explained. The multi-hop synthesis across three years is logically structured. However, the quantitative errors are concerning for financial analysis, as they represent 1.6-2.2% deviations from stated figures. The answer demonstrates good qualitative understanding but fails on precision of financial metrics, which is critical for debt analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 400,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "In the 2022 filing Adobe highlighted a “large number of free online self‑service learning options on learning.adobe.com” as a core piece of its Digital Learning Services portfolio, sitting alongside fee‑based classroom, virtual and on‑demand programs and a custom‑learning arm for its biggest enterprise customers【page_18】. By the 2023 filing the free‑learning site had moved to www.training.adobe.com, but the description was unchanged – the free self‑service courses remain a foundational offering that is complemented by custom learning services and solution‑specific skills assessments used to help enterprise customers evaluate and prioritize team competencies【page_17】. The 2024 filing repeats this language, underscoring that free online self‑service learning continues to be positioned as a scalable, core element of Adobe’s broader learning‑and‑enablement services and is tightly integrated with its enterprise customer‑success strategy through those same custom services and skills‑assessment tools【page_16】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Adobe's free online self-service learning positioning; (2) Accurately captures the core portfolio structure: free self-service learning alongside fee-based programs and custom enterprise services; (3) Properly synthesizes the multi-hop information showing integration with enterprise customer success through skills assessments and custom learning services; (4) Correctly notes the URL change from learning.adobe.com to www.training.adobe.com between 2022 and 2023; (5) Appropriately emphasizes the consistency of messaging across all three years while noting the maturing integration with enterprise strategies. MINOR WEAKNESSES: (1) The LLM answer includes specific page references (page_18, page_17, page_16) which, while potentially helpful, cannot be verified against the ground truth and may introduce citation accuracy concerns; (2) The phrase 'moved to www.training.adobe.com' in 2023 is presented as fact but the ground truth doesn't explicitly confirm this URL change - the LLM may be inferring this from filing language; (3) The ground truth emphasizes 'democratizing product knowledge' as a strategic theme, which the LLM answer doesn't explicitly capture, though it does convey the scalability concept. QUANTITATIVE ACCURACY: No numerical data, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives high marks for not introducing false numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple service components (free learning, fee-based programs, custom services, skills assessments) to show evolution and integration. The logical flow from 2022 introduction through 2023 continuation to 2024 reinforcement is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and organization but matching core facts and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 563,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s 2.00 % Notes due 2031 were reported at a fair‑value of roughly **$1.04 billion** at the end of FY 2022 (NVDA 10‑K 2022, p. 78) and rose only modestly to **$1.06 billion** by the end of FY 2024 (NVDA 10‑K 2024, p. 67).  The net carrying amount of the same notes remained essentially unchanged at **$1.25 billion** (NVDA 10‑K 2024, p. 72), indicating that NVIDIA is keeping its long‑term debt base flat—using low‑coupon, long‑dated notes as a stable, inexpensive financing source while its AI‑driven revenue expands rapidly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the entire response. (1) WRONG NUMBERS: The LLM reports FY2022 fair value as ~$1.04 billion, but ground truth shows $1.20 billion—a $160M discrepancy (13% error). The LLM reports FY2024 fair value as ~$1.06 billion, but ground truth shows $1.25 billion—a $190M discrepancy (15% error). These are material errors for a financial analysis. (2) MISSING 2023 DATA: The LLM completely omits the 2023 figure ($1.057 billion), which is critical to understanding the 'evolution' and 'pattern' requested in the question. The ground truth explicitly shows a three-year progression (2022→2023→2024) that reveals the dynamic debt management strategy. (3) CONTRADICTORY STATEMENTS: The LLM states the notes 'rose only modestly' from 2022 to 2024, but then contradicts itself by saying the carrying amount 'remained essentially unchanged at $1.25 billion.' This internal inconsistency suggests confusion about the data. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 to 2024,' requiring synthesis across three years. The LLM only attempts to compare two endpoints and misses the critical 2023 dip that the ground truth identifies as evidence of 'dynamic debt management' and 'refinancing opportunities.' (5) REASONING QUALITY: While the LLM's interpretation about using low-coupon notes as a stable financing source is reasonable, it's based on incorrect data and incomplete analysis. The ground truth's narrative about initial reduction followed by increase is more nuanced and better supported by the actual three-year pattern. (6) FAIR VALUE VS. CARRYING AMOUNT CONFUSION: The LLM conflates fair value and carrying amount figures without clear distinction, which adds to the confusion. The ground truth maintains clarity on the exposure metric being tracked. VERDICT: The answer fails on the primary metric of quantitative accuracy with material dollar amount errors (13-15% off) and omits critical year-over-year data needed to answer the 'evolution' question properly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 564,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a multi‑year, enterprise‑wide effort to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes in order to grow its financial shared‑service capabilities and standardize financial systems, with a commitment to align and streamline the financial control environment (2022 p.118). The 2023 filing reiterated that the same initiative remained underway, emphasizing continued alignment and streamlining of the control environment as the program progressed (2023 p.118), and the 2024 filing confirmed the initiative is still being implemented, further enhancing shared‑service capacity and aligning the design and operation of its financial control environment (2024 p.119). This consistent evolution shows a sustained strategic focus on standardizing financial processes and strengthening the control environment rather than reacting to any identified weakness.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024 with accurate progression narrative; (2) Accurately captures the scope of the initiative (HR, IT, procurement, supply-chain, and finance processes); (3) Correctly identifies the core objectives: integration, simplification, standardization, and financial shared-service capability enhancement; (4) Properly synthesizes the evolution across three years showing consistency and sustained strategic focus; (5) Accurately conveys that the initiative was proactive rather than reactive to control deficiencies; (6) Includes specific page references (p.118 for 2022-2023, p.119 for 2024) which adds credibility; (7) Multi-hop reasoning is sound - correctly connects information across three separate 10-K filings to demonstrate continuity and strategic intent. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more operational detail (specific functions like HR, IT, procurement, supply-chain) compared to the ground truth which focuses more on the financial control environment aspect, but this is additive rather than contradictory; (2) The ground truth emphasizes 'financial control environment alignment' more prominently, while the LLM answer gives equal weight to process standardization and control environment alignment - both are accurate but with slightly different emphasis. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; page numbers provided are reasonable for 10-K filings; no calculations required. ENTITY ACCURACY: Johnson & Johnson correctly identified; all fiscal years correct; all process areas correctly identified. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - sustained strategic focus on modernizing financial infrastructure through standardization and control environment strengthening.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 532,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "In the 2022 filing Costco said its market is “highly competitive” and that it “competes … with other warehouse clubs, including Walmart’s Sam’s Club and **BJ’s Wholesale Club**,” while stressing that its private‑label **Kirkland Signature** “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins.” The 2023 and 2024 10‑Ks repeat the same framing—still naming **BJ’s Wholesale Club** (now explicitly “in the U.S.”) and continuing to highlight Kirkland Signature’s high‑quality, lower‑price positioning as a core differentiator—showing only minor wording tweaks but no substantive change in the strategic emphasis.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key entities (Costco, BJ's Wholesale Club, Kirkland Signature, Sam's Club) and accurately captures that competitive positioning language appears in 2022, 2023, and 2024 filings. The characterization of Kirkland Signature as 'high-quality, lower-price positioning' and its role in 'lowering costs' and 'earning higher margins' aligns with ground truth. The LLM correctly notes that the core strategy remained stable across the three-year period with 'minor wording tweaks.' WEAKNESSES: (1) The LLM significantly undersells the evolution described in the ground truth. The ground truth explicitly identifies a meaningful evolution: 2022 focused on cost/margin benefits, 2023 added sustainability initiatives tied to brand loyalty, and 2024 introduced 'stronger tone around differentiating merchandise offerings in increasingly competitive metropolitan markets.' The LLM dismisses this as 'no substantive change,' which contradicts the ground truth's characterization of an evolving tone and emphasis. (2) The LLM omits the sustainability initiatives mentioned in 2023, which the ground truth identifies as an added emphasis. (3) The LLM fails to capture the contextual shift regarding 'increasingly competitive metropolitan markets' that appears in 2024 language. (4) The LLM's conclusion that there is 'no substantive change in strategic emphasis' directly contradicts the ground truth's assertion that 'the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures.' MULTI-HOP REASONING: The LLM demonstrates adequate synthesis across the three years but fails to properly analyze the qualitative evolution in tone and emphasis that the ground truth identifies as the key finding. The answer treats the three years as essentially identical rather than identifying the subtle but meaningful progression in strategic messaging. SEMANTIC ACCURACY: While individual facts are correct, the overall interpretation and synthesis of how the positioning 'evolved' is incomplete and somewhat contradictory to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 571,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s available‑for‑sale holdings of U.S. state and municipal securities slipped from **$638 million at year‑end 2022** to **$579 million at year‑end 2023** (2022 table [page 112]; 2023 table [page 111]), and the 2024 filing notes that **virtually all securities in its investment portfolio—including state and municipal debt—were still rated investment grade** [page 48]. This steady emphasis on investment‑grade quality shows that Schwab’s fixed‑income strategy is focused on preserving capital and limiting credit risk, favoring high‑quality, low‑risk assets over higher‑yielding, lower‑quality securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM states the 2022 figure was $638 million, but the ground truth clearly indicates $638 million was the 2023 figure. The LLM has reversed the years. (2) MISSING DATA - The LLM provides only 2022 and 2023 data ($638M and $579M) but fails to provide any specific 2024 quantitative figure, despite the question explicitly asking about evolution from 2022 to 2024. The ground truth indicates 2024 data exists but the LLM doesn't quantify it. (3) INCOMPLETE SYNTHESIS - The question asks about evolution across THREE years (2022-2024), but the LLM only addresses two years with numbers and provides only qualitative information for 2024. (4) CALCULATION ISSUE - The LLM correctly calculates the decline from $638M to $579M (a $59M decrease), but this is based on the wrong year assignment. (5) QUALITATIVE ANALYSIS - The LLM's interpretation about investment-grade quality and capital preservation strategy is reasonable and aligns with the ground truth's conclusion about strategic preference for high-quality instruments. However, this qualitative strength cannot overcome the fundamental quantitative errors. (6) PAGE CITATIONS - The LLM provides specific page references, which adds credibility, but the year-to-year assignment appears incorrect based on the ground truth. The answer demonstrates partial understanding of Schwab's fixed income strategy but fails on the core requirement of accurately tracking the evolution across all three years with correct year assignments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 422,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum‑potential exposure on commercial‑aerospace customer‑financing guarantees fell from $304 million in 2022 to $288 million in 2023 and $274 million in 2024【page_100】【page_102】. At the same time, the share of those guarantees assumed by collaboration partners dropped from $140 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100】【page_102】, indicating the company is modestly reducing the amount of risk it transfers to partners and retaining a slightly larger portion of the guarantee exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures. All collaboration partners' share numbers are accurate ($140M in 2022, $135M in 2023, $131M in 2024), matching the ground truth exactly. The LLM also provides additional context by including the maximum-potential exposure figures ($304M, $288M, $274M), which adds valuable information not explicitly requested but relevant to understanding the broader trend. The multi-hop reasoning is sound: the LLM correctly synthesizes that declining collaboration partners' share indicates RTX is retaining more risk internally rather than transferring it to partners. The interpretation aligns with the ground truth's conclusion about strategic risk management. However, there are minor differences in emphasis and completeness: (1) The LLM does not explicitly mention that 'fair market values of guaranteed assets remained sufficient to cover the guarantees,' which the ground truth highlights as evidence of conservative valuation practices. (2) The LLM's phrasing 'modestly reducing' and 'retaining a slightly larger portion' is slightly less definitive than the ground truth's 'steady decline' and 'strategic shift,' though both convey the same directional trend. (3) The LLM does not explicitly characterize this as potentially signaling 'increased internal risk retention or tighter control over financing terms,' though the answer does imply this through the phrase 'retaining a slightly larger portion.' All quantitative data is correct with proper formatting. The reasoning about risk transfer strategy is logically sound and well-supported by the numbers presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 457,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K the product overview (pages 95‑99) makes no mention of Frame.io, indicating it was not yet highlighted as an integrated offering. By the 2023 filing – and reiterated in the 2024 filing – Adobe positions Frame.io as a cloud‑native creative‑collaboration platform that now supports video **plus** still images, design files and PDFs, is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe Express and Firefly Services, and is presented as a central hub for pre‑production, post‑production and marketing‑campaign workflows (including its role in GenStudio for large‑scale content production)【page_12】【page_13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Frame.io across the three-year period and accurately captures the 2023-2024 positioning with appropriate integrations (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe Express, Firefly Services). The mention of GenStudio for large-scale content production adds relevant context. The answer correctly notes the expansion from post-production into pre-production and marketing workflows.\n\nWEAKNESSES: (1) TIMELINE DISCREPANCY - The LLM states Frame.io was not mentioned in the 2022 10-K product overview, but the ground truth explicitly states it was 'listed as a registered trademark under Adobe's intellectual property' in 2022, indicating acquisition and branding alignment. This is a factual error regarding 2022 positioning. (2) INCOMPLETE 2023 DESCRIPTION - The ground truth specifies Frame.io in 2023 was described as supporting 'still images, design files, and PDFs, with Camera-to-Cloud functionality for video production.' The LLM mentions still images, design files, and PDFs but omits the specific Camera-to-Cloud functionality detail, which is a notable technical feature. (3) WORKFLOW SCOPE - The ground truth mentions Frame.io's role in 'casting, location scouting, and marketing campaign management' in 2024, while the LLM generalizes this as 'pre-production, post-production and marketing-campaign workflows' without the specific use cases. (4) INTEGRATION EXPANSION NOT CLEARLY MARKED - The LLM doesn't clearly distinguish which integrations were added in 2024 versus 2023, making the evolution less clear.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across three years but fails to properly establish the 2022 baseline, which undermines the evolutionary narrative. The 2023-2024 synthesis is stronger but lacks granular detail about what changed between those years.\n\nNUMERIC/DATE ACCURACY: Years are correct (2022, 2023, 2024). No calculations required. However, the factual claim about 2022 non-mention contradicts ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 554,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s 2022 filing lists the VH‑92A as a key RMS helicopter for the Marine One mission, and the 2023 filing repeats that designation without noting any production change [48] [3]. In the 2024 filing, RMS net‑sales growth was “partially offset by lower volume on the VH‑92A program” while production of the CH‑53K rose [41]. This shift shows the VH‑92A remains a strategically important, mission‑critical platform in RMS, but its production has tapered as the aircraft matures, leading the segment to focus more on higher‑volume helicopter programs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the VH-92A program's evolution but with some notable differences from the ground truth. STRENGTHS: (1) Correctly identifies VH-92A as a key RMS helicopter program across 2022-2023, (2) Accurately captures the 2024 shift showing 'lower volume on the VH-92A program' while CH-53K production rose, (3) Properly synthesizes the multi-year progression showing initial consistency followed by production tapering, (4) Correctly identifies the Marine One mission context, (5) Sound reasoning about program maturation and segment prioritization. WEAKNESSES: (1) The ground truth emphasizes 'consistent mention' and 'stable, long-term commitment' across all three years, while the LLM answer frames this as a 'shift' and 'taper,' which is a subtle but meaningful difference in interpretation - the ground truth suggests continuity despite changing priorities, while the LLM suggests declining importance, (2) The LLM answer doesn't explicitly mention that the VH-92A was 'again listed among RMS's major helicopter programs' in 2023, instead treating 2023 as merely repeating 2022 without noting reinforcement, (3) Missing the broader context that despite production changes, the VH-92A remained 'a named program within RMS' in 2024, suggesting ongoing strategic importance rather than declining relevance. QUANTITATIVE ACCURACY: The specific claim about 'lower volume on the VH-92A program' in 2024 appears accurate based on the citation [41], and the comparison to CH-53K production increase is correct. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects production changes to strategic positioning, though the interpretation leans toward declining importance rather than the ground truth's emphasis on sustained strategic importance with shifting priorities. The reasoning is logical but may overstate the degree of production decline relative to the program's continued strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 542,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "The 2022 filing already warned that sales‑ and media‑marketing rules were in force across a wide geography – more than 25 EU member states and a growing set of emerging markets such as India and Vietnam, with single‑use‑plastic bans also being debated in Europe and Southeast‑Asian countries (Regulation section, page 11). By the 2023 and 2024 reports the same EU coverage persisted, but the company stressed that EU extended‑producer‑responsibility (EPR) schemes and nutrient‑profile‑based advertising limits have become increasingly mandatory, and the emerging‑market list now explicitly adds Indonesia and the Philippines (Regulation sections, pages 11 of the 2023 and 2024 filings), showing a broader geographic reach and tighter regulatory stringency over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer accurately identifies that over 25 EU member states had restrictions in 2022, correctly names India and Vietnam as emerging markets affected, mentions EPR policies and single-use plastic bans/taxes, and properly conveys the trajectory of expanding geographic scope and increasing regulatory stringency from 2022-2024. The reference to nutrient-profile-based advertising limits is a relevant addition. (2) QUANTITATIVE ACCURACY: The '25 EU member states' figure matches the ground truth. However, the LLM introduces Indonesia and the Philippines as new additions in 2023-2024, which is NOT mentioned in the ground truth answer. The ground truth specifically lists India and Vietnam as emerging markets affected by 2023, but does not mention Indonesia or the Philippines being added. This is a factual error. (3) MULTI-HOP REASONING: The answer attempts to synthesize information across three years (2022-2024) and does show the progression of restrictions, but the addition of Indonesia and the Philippines appears to be either fabricated or sourced from documents not reflected in the ground truth. (4) COMPLETENESS: The answer addresses the geographic scope evolution and regulatory stringency increase, but the specific mention of the EU formally adopting the Packaging and Packaging Waste Directive in 2024 (explicitly stated in ground truth) is missing. The ground truth also mentions data privacy as a regulatory area affecting marketing in 2023, which the LLM answer does not include. (5) SEMANTIC ISSUES: The LLM conflates 'nutrient-profile-based advertising limits' with the restrictions discussed, which may be a different regulatory mechanism than what the ground truth emphasizes. The core narrative is sound but key details are either missing or potentially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 513,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700 % Notes due 2046 are listed in the Eleventh Supplemental Indenture (Exhibit 4.14) in the 2022 10‑K, and the same series appears unchanged in the 2023 10‑K and again in the 2024 10‑K (see page 105 of each filing). The fact that the notes are neither retired, amended nor re‑classified over three successive filings indicates Microsoft is deliberately keeping this long‑dated, fixed‑rate tranche on its balance sheet, underscoring a long‑term debt strategy that values a stable, diversified maturity profile and the locking‑in of low‑cost financing for decades ahead.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Microsoft's treatment of the 3.700% Notes due 2046 across three fiscal years. STRENGTHS: (1) All numeric values are correct - the interest rate (3.700%), the maturity year (2046), and the reference to the Eleventh Supplemental Indenture dated August 8, 2016 are accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies that the notes appear unchanged across 2022, 2023, and 2024 10-K filings, demonstrating consistency across all three years. (3) The reasoning about Microsoft's debt strategy is logically sound and semantically equivalent to the ground truth - both answers conclude that the unchanged treatment reflects a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. (4) The LLM adds relevant contextual detail (reference to Exhibit 4.14, page 105) that enhances credibility without contradicting the ground truth. (5) Entity identification is correct throughout (Microsoft, the specific notes, the indenture, the fiscal years). MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'neither retired, amended nor re-classified' vs. 'without altering their terms'), but this represents semantic equivalence rather than factual error. The LLM's emphasis on 'low-cost financing' is a reasonable inference from the 3.700% rate in the context of long-term debt strategy. No calculation errors are present, and all dates and percentages are accurate. The answer fully addresses both parts of the question: how the treatment evolved (unchanged) and what this suggests about strategy (stable, diversified maturity profile with fixed-rate financing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 482,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "In Microsoft’s 2022 Form 10‑K the 2.000 % senior notes that mature in 2023 appear in the Eleventh Supplemental Indenture (Exhibit 4.14) 【page_105】. By the time of the 2023 and 2024 filings the supplemental‑indenture schedule has moved on to the Twelfth, Thirteenth, Fourteenth and Fifteenth Supplemental Indentures – which list newer issues (e.g., 2.875 % due 2024, 2.400 % due 2026, etc.) and no longer reference the 2.000 % 2023 notes 【page_106】, showing that those notes have been retired at maturity and Microsoft’s debt maturity profile has shifted to longer‑dated obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) CONTRADICTORY CORE CLAIM: The ground truth states the 2.000% Notes due 2023 remained listed in Exhibit 4.14 across all three years (2022, 2023, 2024), even after maturity in 2024. The LLM claims these notes were 'retired at maturity' and 'no longer reference[d]' in 2023 and 2024 filings. This is a direct contradiction of the ground truth's explicit statement that 'By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14.' (2) INCORRECT SUPPLEMENTAL INDENTURE PROGRESSION: The LLM claims the schedule 'moved on to the Twelfth, Thirteenth, Fourteenth and Fifteenth Supplemental Indentures' in 2023-2024 filings, implying the Eleventh Supplemental Indenture (containing the 2.000% notes) was no longer referenced. The ground truth indicates the same exhibit structure (Exhibit 4.14) persisted across all years with the same notes. (3) MISCHARACTERIZATION OF DEBT STATUS: The LLM concludes the notes 'have been retired at maturity,' but the ground truth explicitly notes the 2024 filing still listed these notes 'even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations.' The LLM's interpretation of retirement contradicts this nuanced ground truth assessment. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures.' The LLM does mention newer issues (2.875%, 2.400%) but fails to properly synthesize the actual evolution pattern described in the ground truth—which is that the 2.000% notes persisted across all three years despite approaching/passing maturity. (5) MISSING KEY DETAIL: The ground truth emphasizes 'no change in the underlying debt instrument' in 2023, which the LLM completely misses. The LLM's claim of retirement contradicts this explicitly stated fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 550,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across all three years the filing shows the same Non‑Employee Restricted Stock Unit Award Agreement. In the 2022 10‑K it is listed as a “Form of Non‑Employee Restricted Stock Unit Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan” (Exhibit 10.65) 【page_113】. The 2023 10‑K repeats this exact description and exhibit reference 【page_115】, and the 2024 10‑K does so again 【page_115】. Thus the agreement has not changed – it continues to be tied to the Amended and Restated 2013 Stock Award and Incentive Plan in each filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH - The LLM states the 2022 agreement is in Exhibit 10.65, but the ground truth clearly identifies it as Exhibit 10.45. This is a factual error in document reference. (2) PAGE NUMBER DISCREPANCY - The LLM cites page_113 for 2022 and page_115 for both 2023 and 2024, but these specific page citations cannot be verified against the ground truth and appear potentially incorrect. (3) INCOMPLETE ANALYSIS - The LLM provides a surface-level answer stating the agreement 'has not changed' and is 'tied to the Amended and Restated 2013 Stock Award and Incentive Plan,' which is technically correct but misses the nuanced evolution described in the ground truth. The ground truth emphasizes that while the form agreement remained consistent, there was 'clear evolution in the underlying stock incentive plans' and notes this reflects 'a strategic choice to maintain standardized compensation instruments for non-employee directors.' (4) MISSING CONTEXT - The LLM fails to address the effective date of the plan amendment (December 8, 2017) mentioned in the ground truth, which provides important historical context. (5) REASONING QUALITY - While the LLM correctly identifies continuity across years, it does not adequately explain the distinction between the form agreement remaining stable versus the underlying plans potentially evolving, which is a key insight in the ground truth. The answer is partially correct in its core assertion but contains a significant exhibit number error and lacks the depth of analysis present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 437,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated 17 % of assets to buy‑in annuity policies in 2022, slipped to 16 % in 2023, and rose back to 17 % in 2024【page_105】; the 2024 filing confirms the 17 % level for that year【page_104】. The roughly unchanged share—only a modest dip and rebound—shows the company relies on buy‑in annuities as a steady tool for hedging international pension liabilities, adjusting the mix only slightly as market or funding conditions evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth clearly states that buy-in annuity allocations were 'effectively discontinued by 2024,' but the LLM claims they 'rose back to 17% in 2024' with citations to pages 104-105. This is a fundamental misrepresentation of the data. The LLM correctly identifies the 2022 (17%) and 2023 (16%) figures, but the 2024 claim of 17% allocation is factually incorrect according to the ground truth. The LLM's interpretation of the trend is also completely inverted: it characterizes the allocation as a 'steady tool' with only 'modest dip and rebound,' when the ground truth indicates a strategic discontinuation suggesting a shift away from insurer-backed annuities toward direct liability management. The LLM misses the key insight about the company's strategic pivot in pension de-risking and restructuring efforts. The reasoning about 'hedging international pension liabilities' through steady buy-in annuities contradicts the actual trend of moving away from these instruments. The citation references (pages 104-105) cannot be verified but appear to be fabricated or misinterpreted, as they allegedly support a 2024 allocation that the ground truth explicitly states was discontinued. This represents a major failure in multi-hop synthesis and factual accuracy on a quantitative question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 393,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all list the same “Eleventh Supplemental Indenture” that contains a series of 2.000 % senior notes maturing in 2023 (see Exhibit 4.14)【page_105】. The series appears unchanged in each year’s exhibit index – there is no new issuance, amendment or increase in amount after its original 2016 issuance – indicating that Microsoft simply carried the notes to their scheduled maturity. This consistency reflects a long‑term debt strategy that favors issuing low‑cost, medium‑term notes and holding them to maturity, thereby locking in cheap financing and maintaining a stable, predictable debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All numeric values are correct - 2.000% interest rate, 2023 maturity date, 2016 issuance date, and fiscal years 2022/2023/2024 are all accurate. (2) Entity identification is precise - correctly identifies Microsoft, the Eleventh Supplemental Indenture, and Exhibit 4.14 as the source document. (3) Multi-hop reasoning is sound - the answer correctly synthesizes information across three fiscal years showing consistency and stability in the debt structure. (4) The interpretation of debt strategy is reasonable and well-supported by the evidence presented. (5) The answer correctly notes no new issuance, amendment, or increase occurred, and that the notes were held to maturity. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language about Microsoft's 'long-term debt strategy that favors issuing low-cost, medium-term notes' which, while reasonable inference, goes slightly beyond what the ground truth explicitly states. The ground truth focuses more on what happened (consistency, no early retirement/refinancing) rather than strategic intent. (2) The ground truth emphasizes that the notes 'remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached,' which the LLM answer captures but with less emphasis on the temporal proximity to maturity. (3) The LLM answer's characterization of this as 'locking in cheap financing' is a reasonable inference but slightly more interpretive than the ground truth's more neutral observation. These are minor semantic differences that don't affect factual correctness. The answer successfully addresses all parts of the multi-part question regarding how the notes evolved and what this reveals about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 511,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "In the 2022 Form 10‑K Microsoft disclosed the 4.000 % Notes due 2021 in Exhibit 4.6 – the “Third Supplemental Indenture” (dated Feb 8 2011) – and the same filing also shows a 2021 maturity in the “Seventh Supplemental Indenture” (Exhibit 4.1) for a different 2.125 % series. Both the 2023 and 2024 10‑Ks retain the Exhibit 4.6 listing of the 4.000 % Notes due 2021, but they add newer supplemental indentures (e.g., Twelfth, Thirteenth, Fourteenth, and the Fifteenth dated Nov 6 2023) without re‑structuring or retiring the 4.000 % series. Thus, across the three years the 4.000 % Notes remain a legacy component of Microsoft’s debt, continuously referenced in the original third supplemental indenture while the broader debt structure expands with additional, later‑dated supplemental indentures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.000% Notes due 2021 are correctly identified as being in the Third Supplemental Indenture dated February 8, 2011; (2) The answer correctly notes that these notes appear in Exhibit 4.6 across all three years (2022, 2023, 2024); (3) The characterization of the 4.000% Notes as a 'legacy component' while newer supplemental indentures are added is accurate; (4) The dates and percentages mentioned (Feb 8 2011, 4.000%, 2.125%) are correct. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about a '2.125% series' under the 'Seventh Supplemental Indenture' in the 2022 filing that is not mentioned in the ground truth answer. While this may be factually accurate from the filings, it adds complexity not addressed in the original answer and potentially confuses the narrative about the 4.000% Notes specifically; (2) The LLM mentions specific supplemental indentures (Twelfth, Thirteenth, Fourteenth, Fifteenth dated Nov 6 2023) that are not mentioned in the ground truth, which adds detail but diverges from the ground truth's focus on the consistency of the 4.000% Notes treatment; (3) The ground truth specifically mentions that Microsoft introduced new debt instruments like '2.375% Notes due 2023' and '2.125% Notes due 2022' under subsequent supplemental indentures, but the LLM's treatment of these is less clear and potentially conflates different instruments. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years showing consistency in the 4.000% Notes treatment while acknowledging the expansion of the debt structure. However, the introduction of additional supplemental indenture details not in the ground truth suggests the LLM may be adding information from the filings that wasn't part of the knowledge graph answer. QUANTITATIVE ACCURACY: All dates and percentages are correct (4.000%, 2.125%, Feb 8 2011, Nov 6 2023). The core factual claims about exhibit locations and indenture dates are accurate. SEMANTIC EQUIVALENCE: The LLM's core message—that the 4.000% Notes remained consistent across years under the Third Supplemental Indenture while new instruments were added—aligns with the ground truth, though the LLM adds supplementary details about specific newer indentures that create some divergence from the original answer's focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 633,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Medtronic’s 10‑K notes repeatedly state that its authorized share capital includes 40 000 Euro Deferred Shares with a €1.00 par value, and that at each year‑end – April 29 2022, April 30 2023 and April 26 2024 – no Euro Deferred Shares were issued or outstanding【page_81】. The unchanged zero balance signals that the company has deliberately chosen not to tap this share class, relying instead on ordinary shares and other equity instruments, which preserves flexibility and avoids dilution in its capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 40,000 Euro Deferred Shares authorized, €1.00 par value, zero issued/outstanding across all three fiscal years. The specific fiscal year-end dates (April 29, 2022; April 30, 2023; April 26, 2024) are accurate. ENTITY ACCURACY: Medtronic correctly identified, fiscal years 2022-2024 properly referenced, and the specific share class (Euro Deferred Shares) accurately named throughout. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years, demonstrating the consistent pattern of zero issuance/outstanding balances while maintaining authorized capacity. REASONING QUALITY (9/10): The LLM provides sound interpretation that the zero balance reflects deliberate non-utilization and strategic preference for other equity instruments. The explanation about preserving flexibility and avoiding dilution is logically sound and consistent with the ground truth's interpretation about strategic preference. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially identical information to the ground truth - both emphasize the consistent absence of issuance, the maintained authorized capacity, and the strategic implications. The LLM's phrasing 'deliberately chosen not to tap this share class' and reference to 'preserving flexibility' adds slightly more interpretive depth while remaining faithful to the core finding. MINOR CONSIDERATIONS: The LLM includes a citation reference [page_81] which adds credibility but wasn't in the ground truth (this is a positive addition). The phrasing is slightly more detailed and interpretive than the ground truth but remains accurate. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 498,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "In Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 are listed in the exhibit table as part of the “Third Supplemental Indenture” (Exhibit 4.6) with the same description and filing date of February 8 2011 [page_104]. The wording and placement of this instrument are unchanged across the three years, indicating that Microsoft has consistently treated the 4.000% Notes due 2021 as a continuing, material component of its debt portfolio and has not re‑characterized or removed it from its disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key factual elements - the 4.000% Notes due 2021, the Third Supplemental Indenture (Exhibit 4.6), the February 8, 2011 date, and the consistent treatment across 2022, 2023, and 2024 filings. All numeric values and dates are accurate. The LLM properly recognizes that the disclosure remained unchanged across the three years.\n\nWEAKNESSES: (1) INTERPRETATION DIVERGENCE: The LLM characterizes the Notes as 'a continuing, material component of its debt portfolio,' but the ground truth indicates the Notes 'were matured or fully accounted for.' This is a significant semantic difference - the ground truth suggests the Notes had already matured (due 2021, and we're looking at 2022-2024 filings), while the LLM implies they remain active debt. This represents a fundamental misunderstanding of what the consistent disclosure actually indicates. (2) INCOMPLETE ANALYSIS: The LLM does not address the key insight from the ground truth that the consistency of disclosure 'indicates that the debt instrument remained static in terms of documentation and disclosure treatment' and what this means about the Notes' status post-maturity. (3) MISSING CONTEXT: The LLM fails to explain why a matured debt instrument would still appear in exhibits across multiple years - this is the crucial interpretive element that distinguishes between 'continuing debt' and 'historical/matured debt being referenced for completeness.' (4) CITATION ISSUE: The LLM includes '[page_104]' which appears to be a fabricated reference not present in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to synthesize the logical conclusion about what unchanged disclosure of a 2021-maturity note means in 2022-2024 filings. The reasoning is incomplete because it doesn't address the temporal inconsistency that should trigger the insight about maturity/accounting treatment.\n\nCORRECTION NEEDED: The answer should recognize that consistent disclosure of notes due 2021 in 2022-2024 filings indicates these are historical/matured instruments being retained in exhibits for reference purposes, not active debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 588,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s last disclosed bulk pension‑risk‑transfer was the August 2021 purchase of group‑annuity contracts that moved **$4.9 billion** of defined‑benefit obligations to an insurer, bringing the **cumulative amount transferred since 2018 to about $11.6 billion**【page_60】. The 2022, 2023 and 2024 10‑Ks contain no new transfer amounts – the company only notes that it will continue to evaluate additional risk‑transfer opportunities but does not report any further obligations moved in those years【page_47】. This pattern shows the firm has largely completed its large‑scale risk‑transfer program and is now focusing on managing the remaining pension liabilities through funding and other long‑term liability‑management tactics rather than pursuing additional sizable transfers.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate quantitative data ($4.9 billion in 2021 transfer, $11.6 billion cumulative since 2018) and correctly identifies that no new transfer amounts were disclosed in 2022-2024. However, there is a significant interpretive divergence from the ground truth that affects overall correctness. STRENGTHS: (1) Numbers are accurate - $4.9B and $11.6B figures are correct; (2) Correctly notes that 2022-2024 10-Ks contain no new transfer disclosures; (3) Properly identifies the August 2021 transaction as the last disclosed bulk transfer. WEAKNESSES: (1) CRITICAL INTERPRETATION ISSUE: The LLM concludes the company has 'largely completed its large-scale risk-transfer program' and is 'now focusing on managing remaining liabilities through funding and other tactics rather than pursuing additional sizable transfers.' The ground truth states the company 'reaffirmed its intent to pursue additional pension risk transfer transactions' in 2024, indicating a 'consistent and sustained strategy' - not a completed program. (2) The LLM's characterization of the trend as a shift away from transfers contradicts the ground truth's characterization of sustained commitment; (3) The LLM answer infers a strategic pivot (from transfers to other tactics) that is not supported by the ground truth, which emphasizes ongoing evaluation and intent to pursue additional transactions. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years (2021-2024) but draws an incorrect conclusion about strategic direction. The ground truth emphasizes continuity and sustained intent; the LLM emphasizes completion and pivot. This represents a fundamental misreading of the company's stated strategy despite accurate data points. The answer is partially correct on facts but incorrect on the strategic interpretation that the question specifically asks about ('what does this trend indicate about the company's long-term liability management strategy').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 533,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The 2022 10‑K already listed the 0.125 % Notes due 2029 as Exhibit 4.23 (referencing the Sep 18 2020 8‑K) and Exhibit 4.31 (referencing the Mar 9 2021 8‑K)【page_134】. The 2023 10‑K repeats those same two exhibit entries with identical references【page_132】, and the 2024 10‑K again includes the unchanged Exhibit 4.23 and 4.31 disclosures【page_129】. This continuity shows Coca‑Cola has consistently treated the 0.125 % Notes as a distinct long‑term debt instrument, using the same documentation and reference framework in each filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core finding: consistent treatment of the 0.125% Notes due 2029 across 2022, 2023, and 2024 10-K filings. STRENGTHS: (1) All dates are correct (Sep 18 2020 8-K, Mar 9 2021 8-K), (2) All exhibit numbers are accurate (4.23 and 4.31 in each year), (3) The percentage (0.125%) is correct, (4) The multi-hop synthesis across three years is sound and properly identifies the consistency pattern, (5) The conclusion about stable capital market strategy is logically supported. MINOR WEAKNESSES: (1) The LLM answer characterizes the notes as 'long-term debt instrument' while the ground truth emphasizes 'short-to-medium-term financing needs' - this is a subtle semantic difference that slightly mischaracterizes the instrument's purpose, (2) The LLM answer omits the explicit mention that the note appears in both 4.23 AND 4.31 in each year (though it does state this, the phrasing could be clearer about the dual listing pattern), (3) The ground truth emphasizes the consistency of 'source references' more explicitly, while the LLM focuses on the exhibits themselves. QUANTITATIVE VERIFICATION: All numbers and dates check out correctly against ground truth. The answer successfully synthesizes information across three filing years and correctly identifies the unchanged documentation references. The reasoning about consistency is sound and well-supported by the evidence presented. The answer is complete and addresses the question's core inquiry about evolution (or lack thereof) and consistency of debt instrument structuring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 440,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from $1.109 billion at year‑end 2022 to $1.091 billion at year‑end 2023 and to $0.993 billion at year‑end 2024 【page_102】. The steady decline in the carrying amount of these guarantees indicates that the company’s estimated future cost of honoring product‑performance commitments is shrinking, suggesting a reduced exposure to long‑term product‑performance risk in its commercial‑aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different financial figures than the ground truth. The LLM cites liabilities of $1.109B (2022), $1.091B (2023), and $0.993B (2024), while the ground truth references collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024) - a difference of approximately 7-8x in magnitude. This is a fundamental factual error that undermines the entire answer. The LLM appears to have cited different liability categories or misidentified the relevant financial metrics. While the LLM's reasoning about declining liabilities indicating reduced exposure is logically sound, it is built on incorrect numbers. The ground truth explicitly states that 'the company's own liabilities related to these guarantees were not explicitly stated' and emphasizes the collaboration partners' share, whereas the LLM presents what appear to be total company liabilities without clarifying the source or nature of these figures. The LLM also fails to distinguish between the collaboration partners' share (which is what the ground truth focuses on) and any broader company exposure. The trend direction (declining) happens to match the ground truth, but the magnitude of the figures is so dramatically different that this appears to be a case of citing wrong line items from the financial statements. The answer lacks the nuance present in the ground truth regarding the distinction between explicit and implicit liabilities, and the methodology for estimation. This represents a major failure in multi-hop financial data synthesis from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 443,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs for its non‑qualified stock options shifted markedly between 2022 and 2024. In 2022 the model used a 0.90 % risk‑free rate, 23.04 % volatility, a 1.95 % dividend yield and a 6‑year expected life, giving a weighted‑average fair value of $22.83 per option (see 2022 10‑K, page 83). By 2024 the risk‑free rate had risen to 4.16 %, volatility was modestly higher at 24.29 %, the dividend yield increased to 3.18 % and the expected life to 6.1 years, lowering the average fair value to $18.49 per option (see 2024 10‑K, page 82). These adjustments suggest Medtronic now assumes higher market interest rates and slightly higher stock‑price volatility, reflecting a more conservative equity‑compensation risk‑modeling approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical data (risk-free rates, volatility percentages, dividend yields, expected life, and fair values) that cannot be verified against the ground truth provided. The ground truth focuses on the evolution of disclosure methodology and transparency around volatility assumptions (historical vs. implied volatility sourcing), not on specific Black-Scholes input parameters. The LLM answer fundamentally misinterprets the question by providing granular quantitative details about model inputs rather than addressing the qualitative evolution in valuation approach and disclosure practices. While the LLM's answer is internally coherent and discusses Black-Scholes modeling, it fails to address the core insight from the ground truth: that Medtronic's evolution was about clarifying how implied volatility is derived from market-traded options and becoming more transparent about forward-looking assumptions. The LLM also cites specific page numbers (page 83 for 2022, page 82 for 2024) that cannot be independently verified. The answer does correctly identify that the company uses Black-Scholes consistently across the period, which aligns with ground truth, but misses the key point about disclosure evolution and market-informed risk modeling. The conclusion about 'more conservative equity-compensation risk-modeling' based on higher interest rates and volatility is a reasonable inference but doesn't address the actual evolution described in the ground truth regarding transparency and methodology refinement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 425,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 2022 10‑K lists a “Form of Current Note for 1.000 % Notes due 2028” (exhibit 4.26) referencing the September 18 2020 8‑K filing【page_134】. The 2023 10‑K repeats the same entry (exhibit 4.26) with identical wording【page_136】, and the 2024 10‑K again includes the 1.000 % 2028 note (exhibit 4.26) while also adding a new 1.000 % 2041 issue【page_130】. This continuity shows Coca‑Cola has retained the low‑coupon 2028 notes across multiple years, indicating a deliberate strategy of locking in ultra‑low‑cost, long‑dated debt and holding it to maturity rather than refinancing or retiring the instrument.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides accurate details about the 1.000% Notes due 2028 appearing consistently across 2022, 2023, and 2024 filings (with exhibit references), which aligns with the ground truth's core observation. However, the answer has significant gaps and misses critical elements of the original answer:\n\n(1) WHAT WAS CORRECT: The LLM correctly identifies that the 1.000% Notes due 2028 were referenced in all three years (2022, 2023, 2024) and correctly notes the exhibit numbers (4.26). The observation about continuity and retention of the low-coupon debt is accurate.\n\n(2) CRITICAL OMISSIONS: The LLM answer completely fails to address the most important strategic insight from the ground truth—the 2024 shift toward significantly higher-yielding notes (5.000% Notes due 2034 and 5.300% Notes due 2054). This is a major multi-hop synthesis failure. The ground truth explicitly states this represents a 'broader strategic shift' and suggests KO pursued 'more aggressive borrowing terms in 2024.' The LLM mentions adding a 1.000% 2041 note but does not discuss the higher-yielding instruments at all.\n\n(3) REASONING QUALITY: The LLM's interpretation that KO is 'locking in ultra-low-cost, long-dated debt and holding it to maturity' is a reasonable inference but differs from the ground truth's more nuanced view that the company maintained the 1.000% Notes while simultaneously pursuing higher-interest debt for new initiatives or refinancing. The LLM's reasoning is narrower and misses the strategic evolution aspect.\n\n(4) MULTI-HOP SYNTHESIS: The question asks about how the instrument 'evolved' and what the 'pattern suggests about debt strategy.' The ground truth synthesizes information across three years AND compares the 2024 behavior to prior years to identify a strategic shift. The LLM only tracks the presence of the 1.000% Notes without synthesizing the broader 2024 strategic context.\n\n(5) INCOMPLETENESS: The answer addresses only part of the question—the continuity of the 1.000% Notes due 2028—but fails to address the evolution in overall debt strategy that the ground truth identifies as central to answering what the pattern 'suggests.'\n\nThe LLM answer is partially correct on the specific instrument but fails the multi-hop synthesis requirement by not incorporating the 2024 higher-yielding notes and the strategic implications thereof.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 633,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Across the three most recent 10‑K filings Microsoft kept its 2.125 % senior notes within supplemental indentures to the 2009 base indenture, with The Bank of New York Mellon Trust Company, N.A. acting as the sole trustee. In the 2022 filing the 2.125 % notes (due 2022) are disclosed in the Fourth Supplemental Indenture (Exhibit 4.7) together with 0.875 % notes due 2017 and 3.500 % notes due 2042 【page_104】; the 2023 filing highlights the Seventh Supplemental Indenture (Exhibit 4.1) for 2.125 % notes due 2021 paired with 3.125 % notes due 2028 【page_104】; and the 2024 filing repeats those same indentures and adds a Fifteenth Supplemental Indenture (Exhibit 4.18) – still with BNY Mellon as trustee – showing a consistent trustee arrangement while the 2.125 % notes are bundled with different series of senior debt in each filing 【page_106】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MATURITY DATE DISCREPANCY - The LLM states '2.125% notes (due 2022)' in the 2022 filing, but the ground truth clearly indicates '2.125% Notes due 2021' across all three years (2022, 2023, 2024). This is a significant factual error regarding the maturity date. (2) SUPPLEMENTAL INDENTURE MISMATCH - The LLM claims the 2022 filing shows the 'Fourth Supplemental Indenture (Exhibit 4.7)' with different associated notes (0.875% due 2017, 3.500% due 2042), but the ground truth states the 2022 filing disclosed the 'Seventh Supplemental Indenture' with 3.125% Notes due 2028. This is a major discrepancy in exhibit identification and associated instruments. (3) PARTIAL ACCURACY ON 2023 - The LLM correctly identifies the Seventh Supplemental Indenture for 2.125% notes due 2021 with 3.125% notes due 2028 in 2023, matching the ground truth. (4) INCOMPLETE 2024 ANALYSIS - While the LLM mentions a Fifteenth Supplemental Indenture in 2024, the ground truth states the 2024 filing 'repeated the same exhibit description and trustee relationship,' suggesting consistency rather than addition of new indentures. (5) TRUSTEE ACCURACY - Correctly identified The Bank of New York Mellon Trust Company, N.A. as trustee across all years. (6) MULTI-HOP REASONING - The LLM attempted to synthesize across three years but made critical errors in matching specific indentures to specific years. The ground truth emphasizes consistency and stability, while the LLM suggests variation in associated instruments. The core conclusion about stable trustee arrangements is partially correct, but the supporting details contain significant factual errors that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 465,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program‑share interest stayed at 57 % in International Aero Engines AG (the V2500 joint venture) and at 51 % in International Aero Engines LLC (the PW1100G‑JM joint venture) in the 2022 filing, the 2023 filing, and the 2024 filing 【page_108†L...】 【page_99†L...】 【page_101†L...】.  This unchanged, majority‑owner position shows RTX (through Pratt & Whitney) continues to be the primary beneficiary and strategic holder of the economics and control of both the V2500 and PW1100G‑JM engine programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, the net program share interest was NOT at the 57%/51% levels - those percentages only appeared starting in 2023 after adjustment for sub-collaborator shares. The LLM incorrectly claims these percentages were present in 'the 2022 filing, the 2023 filing, and the 2024 filing,' which is factually wrong. The ground truth clearly indicates: 2022 had 61% (IAE) and 59% (IAE LLC) as program share interest, which then decreased to 57% and 51% respectively by 2023. The LLM's statement that the position 'stayed at 57%' and '51%' across all three years is demonstrably incorrect. MISSING CONTEXT: The LLM completely omits the evolution/progression that the question specifically asks about - the decrease from 2022 to 2023 and the stabilization in 2024. The answer fails to capture the 'strategic recalibration' mentioned in the ground truth. PARTIAL CREDIT: The LLM correctly identifies the 2023-2024 percentages (57% and 51%) and correctly links these to the V2500 and PW1100G-JM programs. The interpretation about RTX's strategic positioning as primary beneficiary is reasonable, though it's based on incomplete/incorrect data. The answer does attempt multi-hop reasoning by connecting the percentages to strategic positioning, but this reasoning is undermined by the factual errors about the 2022 baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 403,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s expense for company contributions to its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then eased to **$443 million in 2024**【page_67】. The jump in 2023 shows an intensified investment in employee benefits, while the modest dip in 2024 suggests a slight scaling back—but the company still maintains a high level of spending, underscoring a continued, strong commitment to its workforce.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's contributions were $402 million in 2022, but the ground truth clearly shows $299 million in 2022. This is a significant discrepancy of $103 million (34% overstatement). The 2023 ($468 million) and 2024 ($443 million) figures are correct. QUANTITATIVE ACCURACY FAILURE: The incorrect 2022 baseline undermines the entire trajectory analysis. The LLM correctly identifies the 2023 increase and 2024 decline pattern, but the starting point is fundamentally wrong, which distorts the magnitude of year-over-year changes. The actual increase from 2022-2023 was $169 million (56.5%), not $66 million (16.4%) as the LLM's numbers would suggest. QUALITATIVE ASSESSMENT: The reasoning about the trajectory (increase in 2023, modest decline in 2024, continued strong commitment) is sound and matches the ground truth interpretation. The semantic framing about 'intensified investment' and 'scaling back' is appropriate. However, this correct reasoning is built on an incorrect numerical foundation. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year trend and draws appropriate conclusions about workforce investment strategy, but the factual error in the 2022 figure is a fundamental failure in data accuracy that cannot be overlooked. The citation reference [page_67] is provided but the underlying data extraction is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 387,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "In the 2022 Form 10‑K the company’s exhibit index includes a “Form of Current Note for 3.000 % Notes due 2051” (exhibit 4.36, filed May 5 2021), and the same 3.000 % note appears again in the 2023 Form 10‑K exhibit list, showing it remained outstanding. By the 2024 Form 10‑K the 3.000 % Notes due 2051 are no longer listed, having been replaced by newer issuances (e.g., 5.000 %‑5.400 % notes), which signals that Coca‑Cola has been refinancing or retiring its earlier ultra‑long‑dated, low‑rate debt as part of a capital‑structure strategy that manages maturity timing and adapts to changing market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: LLM states exhibit 4.36 filed May 5, 2021, but ground truth indicates exhibit 4.6 to May 5, 2021 Form 8-K. This is a factual error in the exhibit reference. (2) MAJOR FACTUAL CONTRADICTION: LLM claims the 3.000% Notes due 2051 'are no longer listed' and 'have been replaced' in the 2024 Form 10-K, stating they were 'retired' or 'refinanced.' However, the ground truth explicitly states that by 2024, Coca-Cola 'still retaining the 3.000% Notes due 2051 in its disclosures.' This is a fundamental contradiction - the LLM's core claim about 2024 status is WRONG. (3) COUPON RATE ERROR: LLM states newer notes are '5.000%-5.400%' but ground truth specifies '5.000% Notes due 2034 and 5.300% Notes due 2054.' The 5.400% figure appears to be incorrect or unsupported. (4) STRATEGIC INTERPRETATION MISMATCH: Ground truth indicates a 'diversification' strategy where the 3.000% Notes remain as a 'stable component' while adding higher-yielding instruments. LLM incorrectly characterizes this as 'replacement' or 'retirement,' which contradicts the actual strategy of maintaining the older debt while adding new instruments. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression (2022→2023→2024), misinterpreting the 2024 data entirely. The question asks about 'evolution' and what it 'indicates' - the LLM's conclusion about refinancing/retiring is factually incorrect based on the ground truth. The only correct element is that Coca-Cola issued higher-coupon instruments, but the characterization of what happened to the 3.000% Notes is fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 453,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle’s 2022 10‑K exhibit list (see page 112) shows only notes up to 4.12 and contains no reference to a 2.875% Note due 2031, indicating the instrument was not yet part of its disclosed debt. In the 2023 filing Oracle adds a new series – Exhibit 4.14 – that includes “2.875% Notes due 2031” (issued March 24 2021) (page 111). The 2024 filing continues to list the same series under Exhibit 4.16 (page 113), showing that Oracle has retained this lower‑coupon, long‑dated bond, a move that reflects a strategy of expanding its debt mix with low‑rate, long‑maturity issuances to lock in favorable financing costs and lengthen its overall debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - 2022 CLAIM: The LLM states the 2.875% Notes due 2031 were NOT in the 2022 10-K filing, claiming 'the instrument was not yet part of its disclosed debt.' The ground truth explicitly states 'In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments.' This is a direct contradiction on a core fact. (2) ISSUANCE DATE ERROR: The LLM claims the notes were 'issued March 24 2021' but provides no verification this date is correct or relevant to the question about 2022-2024 evolution. The ground truth does not mention this specific issuance date. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the key strategic insight from the ground truth - that by 2024, Oracle introduced NEWER, HIGHER-YIELDING notes (4.500% due 2028 and 4.900% due 2033) alongside the 2.875% Notes. The LLM mentions only the 2.875% Notes and misses the critical portfolio diversification strategy with higher-coupon instruments. (4) MISSING STRATEGIC ANALYSIS: The ground truth emphasizes a 'strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved.' The LLM's conclusion about 'expanding its debt mix with low‑rate, long‑maturity issuances' is incomplete and misses the evolution toward higher-yielding debt. (5) EXHIBIT REFERENCE ERRORS: The LLM provides specific exhibit numbers (4.12, 4.14, 4.16) and page numbers (112, 111, 113) that cannot be verified against the ground truth and appear to be fabricated details. The ground truth does not reference these specific exhibit numbers. The answer fundamentally fails on the primary factual claim about 2022 inclusion and misses the strategic portfolio evolution that is central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 500,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K exhibit tables for 2022, 2023 and 2024 all list the same “2.000 % Notes due 2023” in the Eleventh Supplemental Indenture (Exhibit 4.14) 【page_105】. By keeping this bond on the books and disclosing it every year, Microsoft signals that it relies on a stable, long‑term financing structure rather than repeatedly refinancing, and it reinforces a transparent reporting practice that gives investors a clear, consistent view of its outstanding debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's consistent disclosure of the 2.000% Notes due 2023 across 2022, 2023, and 2024 10-K filings, the reference to the Eleventh Supplemental Indenture (Exhibit 4.14), and the general interpretation that this reflects stable debt management and transparency. The numeric values (2.000%, 2023 maturity date) and document references are accurate. The reasoning about signaling stable financing and transparent reporting is sound and semantically equivalent to the ground truth's emphasis on 'stable and transparent approach' and 'predictable financial stewardship.' However, the LLM answer is somewhat less comprehensive than the ground truth in several respects: (1) It does not mention the specific indenture date (August 8, 2016), which provides important historical context; (2) It does not explicitly note that the filing details remained 'unchanged' across all three years, which is a key indicator of consistency; (3) It does not mention the connection to investor confidence and credit ratings, which are important implications of the transparency strategy; (4) The phrase 'keeps this bond on the books' could be slightly misleading as it suggests active management rather than simply consistent disclosure of an existing obligation. The LLM's interpretation that Microsoft 'relies on a stable, long-term financing structure rather than repeatedly refinancing' is a reasonable inference but is not explicitly stated in the ground truth. Overall, the answer captures the core message and demonstrates sound multi-hop reasoning across the three filing years, but lacks some of the contextual depth and specific details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 466,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s net commercial‑aerospace commitments – which include the V2500 flight‑hour payments due to Rolls‑Royce – rose from $1.292 billion in 2022 to $1.445 billion in 2023 and then slipped slightly to $1.331 billion in 2024 (see RTX 2022 10‑K, page 112).  By the end of 2024 the company still carried $8.327 billion of total commercial‑aerospace commitments, with $704 million of “Other commercial aerospace commitments” (the line that captures the V2500 flight‑hour contingent payments) scheduled for 2027, showing that RTX continues to bear a multi‑billion‑dollar, multi‑year exposure to Rolls‑Royce under the 2012 IAE acquisition agreement (see RTX 2024 10‑K, page 103).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($1.292B in 2022, $1.445B in 2023, $1.331B in 2024, $8.327B total, $704M for 2027) that are NOT mentioned in the ground truth answer. The ground truth does not provide these specific numerical values, suggesting the LLM may have fabricated or misattributed these figures. Without verification against actual 10-K filings, these numbers cannot be confirmed as accurate. (2) MISSING CORE INFORMATION: The ground truth emphasizes the accounting treatment evolution - that payments were categorized under 'Other commercial aerospace commitments' in 2022, clarified as being capitalized and amortized in 2023, and remained consistent in 2024. The LLM completely omits this crucial accounting classification and treatment progression, which is central to understanding RTX's financial obligation structure. (3) INCOMPLETE SYNTHESIS: The ground truth explains HOW the payments were treated (capitalized as collaboration intangible assets, then amortized to cost of sales), which is essential context for understanding the long-term exposure. The LLM provides only aggregate commitment figures without explaining the accounting mechanics. (4) MISSING TEMPORAL DETAIL: The ground truth specifies that payments were tied to V2500 flight hours 'through June 2027' - a specific date that provides important context about the obligation timeline. The LLM mentions 2027 but lacks this specificity. (5) REASONING QUALITY: While the LLM attempts to show progression across years and mentions the 2012 IAE acquisition agreement, it fails to synthesize the accounting treatment evolution that is the core of the ground truth answer. The LLM's approach of citing specific page numbers and dollar amounts appears authoritative but lacks verification against the actual ground truth. The answer addresses the question's surface level (financial obligations to Rolls-Royce) but misses the substantive accounting and recognition patterns that define RTX's actual exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 570,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "TMO’s domestic pension plan held **$89 million in U.S. equity funds in 2022**, rose to **$93 million in 2023**, and was **$91 million at year‑end 2024**【page_57†L31-L38】【page_71†L7-L13】.  Relative to total domestic plan assets, those amounts represented roughly **9.5 % of $937 million (2022), 9.8 % of $947 million (2023), and 10.2 % of $895 million (2024)**【page_57†L31-L38】【page_71†L7-L13】—a stable, slightly upward‑tilting exposure that aligns with the company’s target of about 10 % in U.S. equities, indicating a consistent strategic emphasis on domestic equity exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth across all three years. Ground truth shows: 2022=$125M, 2023=$89M, 2024=$93M. LLM reports: 2022=$89M, 2023=$93M, 2024=$91M. These are not minor formatting differences—the LLM has systematically misreported the dollar amounts, appearing to have shifted the values by one year or confused the data entirely. The LLM's claim that U.S. equity allocation 'rose' from 2022 to 2023 directly contradicts the ground truth showing a decrease from $125M to $89M. The percentage calculations provided by the LLM (9.5%, 9.8%, 10.2%) cannot be verified against the incorrect dollar amounts cited. Most critically, the LLM's conclusion that the trajectory shows 'stable, slightly upward-tilting exposure' is the opposite of the ground truth's finding of 'cautious reduction in exposure to U.S. equities over the three-year period.' The LLM failed to capture the key insight: a 28% decline from 2022 to 2023 ($125M to $89M), followed by a modest 4.5% rebound in 2024 ($89M to $93M), which still leaves the allocation 25.6% below 2022 levels. The multi-hop reasoning is fundamentally flawed because it is built on incorrect base numbers. The answer does address the question's structure but arrives at the opposite strategic conclusion due to data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 373,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s long‑term debt mix in 2022 and 2023 was anchored by an ultra‑low‑coupon issue – the 1.000 % notes due 2041 appear in the exhibit lists for both years (e.g., Exhibit 4.33)【page_136】. By the 2024 filing the company still retained those 1.000 % notes but added a new series of higher‑yield bonds – 5.000 % notes due 2034, 5.300 % notes due 2054, 5.400 % notes due 2064, etc. – showing a shift toward diversifying its debt profile with higher‑interest securities while keeping the low‑cost legacy issue【page_130】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes multi-hop information across three years of Coca-Cola filings. STRENGTHS: (1) All numeric values are correct - the 1.000% Notes due 2041 are accurately identified as appearing in 2022, 2023, and 2024; the 2024 higher-yielding notes (5.000% due 2034, 5.300% due 2054, 5.400% due 2064) are all correctly cited with precise percentages and maturity dates. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution from low-coupon instruments in earlier years to higher-yield instruments in 2024, demonstrating understanding of the strategic shift. (3) Entity identification is accurate - Coca-Cola is correctly identified, years are properly sequenced, and Exhibit 4.33 is appropriately referenced. (4) The reasoning about 'recalibration of debt portfolio to align with changing market conditions' is logically sound and supported by the data presented. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'etc.' after listing the 2024 notes, which is slightly less precise than the ground truth's explicit enumeration, though this is a very minor stylistic difference. (2) The ground truth explicitly mentions the 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023) as examples of lower-yielding instruments, which the LLM answer does not include - however, the LLM still captures the essential comparison of low-coupon vs. high-coupon instruments. (3) The LLM uses 'ultra-low-coupon' and 'legacy issue' terminology which, while semantically appropriate, differs slightly from the ground truth's more neutral language. Overall, the answer correctly addresses all parts of the multi-part question regarding the evolution of Coca-Cola's debt strategy from 2022-2024, the consistency of the 1.000% Notes, and the introduction of higher-yielding instruments in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 505,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept its 1.650 % Notes due 2026 listed in each filing – Exhibit 4.16 in the 2022 10‑K【page_114】 and Exhibit 4.14 in both the 2023 and 2024 10‑Ks【page_111】 – showing that the company retains this low‑coupon, long‑dated debt as a core, cheap financing source. At the same time each report also adds higher‑coupon issuances (e.g., 5.800 %–6.900 % notes in 2022 Exhibit 4.15【page_115】, 4.500 %–5.550 % notes in 2023 Exhibit 4.16 and similar series in 2024 Exhibit 4.16) indicating Oracle supplements its low‑cost debt with newer, higher‑interest notes to diversify maturity and meet additional funding needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Oracle's strategy of maintaining the 1.650% Notes due 2026 across fiscal years 2022-2024 and recognizes the introduction of higher-rate notes. However, there are significant quantitative accuracy issues: (1) The LLM cites interest rates of 5.800%-6.900% for 2022 notes, but the ground truth only mentions 5.800% Notes due 2025 being introduced in 2023, not 2022. (2) The LLM states 4.500%-5.550% notes in 2023, but ground truth only confirms 5.800% Notes due 2025 in 2023 and 4.500% Notes due 2028 in 2024. (3) The exhibit citations are inconsistent with ground truth - the LLM references Exhibit 4.15 and 4.16 for 2022-2024 with varying page numbers, while ground truth specifies Exhibit 4.16 (2022), 4.14 (2023), and 4.14 (2024). The reasoning about dual strategy (low-cost debt preservation + higher-yielding instruments for diversification) is sound and aligns with ground truth. The multi-hop synthesis across three fiscal years is attempted but marred by incorrect interest rate attributions to wrong years. The semantic understanding of Oracle's debt strategy is correct, but the specific financial details contain errors that undermine credibility. The answer demonstrates good conceptual grasp but fails on precise quantitative accuracy regarding which notes were issued in which years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 371,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 4.000% Notes due 2021 in Exhibit 4.6 (see the Exhibit 4.6 description on page 104), showing that the bond remains outstanding and is continuously disclosed in the supplemental‑indenture schedule. This repeated inclusion signals a disciplined long‑term debt strategy: Microsoft keeps its debt documentation up‑to‑date, monitors maturities, and retains the note on the books until it is either repaid or refinanced, rather than removing it prematurely.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 4.000% Notes due 2021 appear consistently in Exhibit 4.6 across fiscal years 2022, 2023, and 2024. The basic factual claim about repeated inclusion is accurate. The LLM also correctly notes this signals disciplined debt management and documentation practices.\n\nCRITICAL OMISSIONS: The LLM answer is significantly incomplete compared to the ground truth. It fails to mention several key details: (1) The specific companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that appear alongside the 4.000% Notes in the Third Supplemental Indenture - this is important context for understanding the debt portfolio composition. (2) The 2024 trustee name update to 'The Bank of NewYork Mellon Trust Company, N.A.' with formatting differences - this is explicitly noted in the ground truth as a notable administrative change. (3) The ground truth emphasizes the paradox that these notes were due in 2021 yet continued to appear in documentation through 2024, which is a crucial insight about why their continued inclusion is noteworthy.\n\nREASONING QUALITY: The LLM's reasoning is somewhat superficial. It states the notes 'remain outstanding' but doesn't address the logical puzzle that the ground truth highlights: why would notes due in 2021 still appear in 2022-2024 filings? The ground truth provides deeper analysis about what this pattern indicates (no active restructuring, stable reference within broader portfolio). The LLM's explanation about 'retaining the note on the books until it is either repaid or refinanced' is generic and doesn't capture the specific strategic implications.\n\nMULTI-HOP SYNTHESIS: The LLM fails to synthesize the multi-year pattern effectively. It mentions the three years but doesn't compare the composition across years or note the consistency of the supplemental indenture structure. The ground truth explicitly states 'no change in the composition of this particular supplemental indenture' across the three years - this comparative analysis is absent from the LLM answer.\n\nFACTUAL ACCURACY: The reference to 'page 104' appears to be an unsupported detail not in the ground truth. While the core claim about Exhibit 4.6 is correct, this specific page reference cannot be verified against the provided ground truth.\n\nSEMANTIC GAPS: The LLM's interpretation of 'disciplined long-term debt strategy' is reasonable but misses the ground truth's more nuanced point about administrative maintenance versus substantive changes, and the absence of refinancing activity as a key indicator.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 684,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential payment for commercial‑aerospace financing guarantees fell from $304 million at year‑end 2022 to $288 million at year‑end 2023 and $274 million at year‑end 2024【page_100†L1-L4】【page_100†L5-L8】【page_102†L1-L4】.  The portion of those guarantees taken on by collaboration partners also declined—from roughly $140 million (≈$142 million) in 2022 to $135 million in 2023 and $131 million in 2024【page_100†L9-L12】【page_100†L13-L16】【page_102†L5-L8】—indicating RTX is progressively shifting more of the financing‑guarantee risk to its partners as part of its risk‑transfer strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN INTERPRETATION AND REASONING:\n\n1. FUNDAMENTAL MISINTERPRETATION OF TREND DIRECTION:\nThe LLM states: 'RTX is progressively shifting more of the financing-guarantee risk to its partners' - this is BACKWARDS and contradicts the actual data. The collaboration partners' share DECLINED from $142M → $135M → $131M, meaning RTX is taking on MORE risk, not less. The LLM's interpretation directly contradicts both the numerical trend and the ground truth explanation.\n\n2. QUANTITATIVE ACCURACY - NUMBERS ARE CORRECT BUT INTERPRETATION IS INVERTED:\n- Collaboration partners' share: $142M (2022), $135M (2023), $131M (2024) ✓ CORRECT\n- Total maximum potential payments: $304M, $288M, $274M ✓ CORRECT\n- However, the LLM then misinterprets what these declining partner shares mean\n\n3. LOGICAL REASONING FAILURE:\nThe LLM correctly identifies the declining trend in partners' share but then draws the opposite conclusion. A declining partners' share means RTX's own exposure is INCREASING (from $162M to $153M to $143M implied), not that risk is being shifted TO partners. The LLM's statement 'RTX is progressively shifting more of the financing-guarantee risk to its partners' is logically inverted.\n\n4. MISSING KEY INSIGHT FROM GROUND TRUTH:\nThe ground truth correctly identifies this as 'a strategic shift where RTX assumed more direct financial risk or altered its partnership structures.' The LLM completely misses this critical insight and states the opposite.\n\n5. MISSING CONTEXTUAL ELEMENT:\nThe ground truth mentions RTX's confidence in underlying asset values ('fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves'). The LLM omits this important context entirely.\n\n6. MULTI-HOP SYNTHESIS:\nWhile the LLM does synthesize data across multiple years and identifies the trend, it fundamentally misinterprets what the trend means for RTX's risk transfer strategy - the core analytical question.\n\nSUMMARY: The LLM has the correct numbers but inverted the strategic interpretation. This is a critical failure in financial analysis where the conclusion directly contradicts the data trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 578,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Microsoft’s 10‑K filings each include the 3.950 % Notes due 2056 in Exhibit 4.14 (the Eleventh Supplemental Indenture dated August 8 2016) – the series was issued in 2016 and simply remains outstanding in each subsequent year, with no new issuance of that tranche during the three fiscal periods【page_105】. This consistent presence of a long‑dated, low‑coupon bond illustrates Microsoft’s long‑term capital strategy of locking in inexpensive, multi‑decade financing to diversify its debt profile and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct - the 3.950% coupon rate, the 2056 maturity date, and the August 8, 2016 Eleventh Supplemental Indenture date all match the ground truth exactly. (2) The multi-hop synthesis is sound - the answer correctly identifies that the Notes appear consistently across FY 2022, 2023, and 2024 with no changes or new issuances. (3) Entity identification is precise - Microsoft, the specific debt instrument, fiscal years, and exhibit references are all accurate. (4) The answer goes beyond the ground truth by providing additional context about Microsoft's capital strategy (locking in inexpensive, multi-decade financing, diversifying debt profile, preserving financial flexibility), which is a reasonable inference from the consistent presence of low-coupon long-dated debt and is not contradicted by the ground truth. (5) The reasoning about what the pattern indicates is logical and well-supported. MINOR CONSIDERATIONS: The LLM answer adds interpretive elements about Microsoft's strategic intent (diversifying debt profile, preserving flexibility) that, while reasonable and not incorrect, go slightly beyond what the ground truth explicitly states. The ground truth uses more cautious language ('suggests that Microsoft maintained') while the LLM is more definitive ('illustrates Microsoft's long-term capital strategy'). However, this represents appropriate analytical inference rather than factual error. The citation reference [page_105] appears to be a document reference that cannot be verified against the ground truth but does not contradict it. Overall, this is a strong answer with accurate facts, correct multi-hop synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 477,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike missile lines went from modest growth in 2022 (MFC net sales $11.3 bn and operating profit $1.64 bn) to a $145 m sales lift in 2023, which was partly offset by $45 m of losses on a classified contract, pulling MFC profit to $1.54 bn【page_40】. In 2024 the programs drove a $1.2 bn sales surge (net sales $12.7 bn) but MFC operating profit collapsed to $0.41 bn because of $1.2 bn of unfavorable profit‑booking adjustments, including a $1.4 bn loss on a classified program【page_40】. The swing in MFC’s profit contributed to consolidated operating profit falling from $7.47 bn in 2022 (Aeronautics $2.87 bn, RMS $1.91 bn, Space $1.06 bn, MFC $1.64 bn) to $6.08 bn in 2024 – a decline of roughly $1.4 bn over the three‑year period【page_41】【page_40】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key trajectory of MFC (Missiles and Fire Control) programs from 2022-2024, accurately captures the major financial figures ($11.3B sales in 2022, $12.7B in 2024, operating profit declining from $1.64B to $0.41B), correctly identifies the classified program losses ($45M in 2023, $1.4B in 2024), and properly synthesizes the impact on consolidated operating profit ($7.47B in 2022 declining to $6.08B in 2024). The multi-hop reasoning connecting production growth to profit deterioration is sound. The answer provides specific segment breakdowns and correctly attributes the profit decline to unfavorable profit-booking adjustments.\n\nWEAKNESSES: (1) The LLM answer focuses heavily on MFC segment data but doesn't explicitly detail the specific tactical/strike missile programs mentioned in the ground truth (LRASM, JASSM, GMLRS, precision fires). While these are implied in the MFC segment discussion, the ground truth specifically calls out these program names and their individual contributions. (2) The ground truth mentions a $215M increase in 2022 specifically attributed to LRASM and JASSM production, which the LLM doesn't explicitly state. (3) The ground truth characterizes 2023 as having a $145M increase driven by specific programs, while the LLM states '$145 m sales lift in 2023' but doesn't clearly attribute this to the specific programs mentioned in ground truth. (4) The LLM doesn't explicitly state the $1.2B increase in 2024 was due to GMLRS, LRASM, and JASSM ramp-up as the ground truth does. (5) Minor: The LLM states the profit decline was '73%' in the ground truth but doesn't calculate or mention this percentage.\n\nNUMBER VERIFICATION: All major figures check out: $11.3B (2022 sales), $1.64B (2022 profit), $145M (2023 increase), $45M (2023 classified loss), $12.7B (2024 sales), $0.41B (2024 profit), $1.2B (unfavorable adjustments), $1.4B (classified loss), $7.47B (2022 consolidated profit), $6.08B (2024 consolidated profit). The $1.4B decline calculation ($7.47B - $6.08B = $1.39B ≈ $1.4B) is correct.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across years and connects segment-level performance to consolidated results. However, it could have been more explicit about the program-level details that drove the segment performance.\n\nOVERALL: The answer is substantially correct on the core financial metrics and demonstrates sound multi-hop reasoning, but lacks some of the program-level specificity and detail present in the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 679,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K listed the original 2009 Executive Change‑in‑Control Retention Agreement with Marc N. Casper (Exhibit 10.12) together with its 2010 and 2018 amendments (Exhibits 10.16‑10.17) and, for the first time, a separate officer‑only form (Exhibit 10.18) 【page_46】. The 2023 filing kept the same Casper agreement and amendments (now shown as Exhibits 10.11, 10.15‑10.16) but introduced an updated officer‑only form filed as Exhibit 10.7 for the quarter ended April 1 2023, and the 2024 10‑K retained that updated officer form (Exhibit 10.17) while the core agreement and its prior amendments remained unchanged 【page_76】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more specific detail than the ground truth (exhibit numbers, amendment dates, quarterly filing references), which demonstrates deeper research. However, there are significant concerns about factual accuracy that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific exhibit numbers (10.12, 10.16-10.17 for 2022; 10.11, 10.15-10.16 for 2023; 10.17 for 2024) that cannot be verified against the ground truth\n   - The ground truth does not provide exhibit numbers, making it impossible to confirm if these citations are accurate\n   - The LLM references a quarterly filing (April 1, 2023) not mentioned in ground truth\n   - These specific exhibit numbers are presented with high confidence but lack corroboration\n\n2. COMPLETENESS:\n   - The LLM answer addresses all three years (2022, 2023, 2024) as required\n   - It covers both Marc N. Casper's agreement and the officer-only form\n   - It discusses amendments and forms introduced, matching the question's requirements\n   - Ground truth confirms the basic structure the LLM describes\n\n3. ENTITY ACCURACY:\n   - Company name correct (Thermo Fisher Scientific Inc.)\n   - Years correct (2022, 2023, 2024)\n   - Key entities identified: Marc N. Casper agreement, officer-only form\n   - Semantic alignment with ground truth on core structure\n\n4. REASONING & MULTI-HOP SYNTHESIS:\n   - The LLM correctly synthesizes the evolution across three years\n   - Properly identifies the distinction between Casper-specific and officer-general agreements\n   - Logical progression showing consistency and updates\n   - However, the specific exhibit number changes (10.12→10.11, 10.16-10.17→10.15-10.16) suggest either exhibit renumbering or potential inaccuracy\n\n5. SEMANTIC EQUIVALENCE:\n   - Core message aligns: agreements evolved with officer-only form introduced in 2022, updated in 2023, retained in 2024\n   - Ground truth's \"consistent structure and ongoing commitment\" matches LLM's narrative\n   - The additional specificity (amendment dates 2010, 2018) adds value if accurate\n\nKEY CONCERN: The LLM provides exhibit numbers with specificity that cannot be independently verified from the ground truth. While the general narrative structure is sound and matches the ground truth's core message, the precise exhibit citations introduce uncertainty. The answer would be stronger if these specific numbers were confirmed, but their presence without verification is a material weakness in a financial document evaluation context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 682,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT’s variable‑interest‑rate swap program expanded dramatically after 2021 – the 2022 10‑K disclosed only $500 million of swap notional at year‑end 2021 (see page 66), while the 2023 10‑K reported $1.3 billion at both December 31 2022 and 2023 (see page 95), and the 2024 10‑K showed the same $1.3 billion at December 31 2023 and 2024 (see page 52). The three‑fold rise and the decision to keep the larger notional constant suggest LMT deliberately broadened its hedge program to cover a greater share of its growing debt base and now maintains a stable, sizable swap position to manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the timeline and notional amounts that significantly undermines its accuracy. SPECIFIC ISSUES: (1) MAJOR ERROR - The LLM states '$1.3 billion at both December 31 2022 and 2023' according to the 2023 10-K. However, the ground truth clearly indicates that the notional amount was $500 million in 2021 (disclosed in 2022 filing), then increased to $1.3 billion in 2023. The LLM's claim that 2022 already had $1.3 billion contradicts the ground truth timeline. (2) CALCULATION ERROR - The LLM describes the increase as 'three-fold' when comparing $500M to $1.3B. While $1.3B is technically 2.6x (not 3x) the $500M amount, the ground truth uses 'more than doubling' which is more accurate. The LLM's 'three-fold' characterization is imprecise. (3) MISSING DETAIL - The ground truth explicitly states the 2021 amount was '$500 million as of December 31, 2021 (disclosed in the 2022 filing)' and that by 2023 it had increased to $1.3 billion. The LLM conflates the 2022 and 2023 amounts, suggesting both were $1.3 billion, which is factually incorrect based on the ground truth. (4) CORRECT ELEMENTS - The LLM correctly identifies: the stabilization at $1.3 billion in 2024, the strategic shift toward broader hedging, the connection to debt management, and the overall narrative of expanding the hedge program. (5) REASONING - The qualitative reasoning about deliberate broadening of hedges and stable positioning is sound and aligns with ground truth interpretation, but is undermined by the quantitative errors. The multi-hop synthesis is attempted but compromised by the timeline confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 450,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans was $402 million in 2022, rose to $468 million in 2023, and then eased to $443 million in 2024 【page_67†L13-L16】. The jump in 2023 shows a stronger contribution to employee retirement benefits, while the modest decline in 2024 still leaves spending above the 2022 level, indicating the company continues to invest heavily in employee benefits but has moderated the pace of increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE ACCURACY: All financial figures are correct - $402 million (2022), $468 million (2023), and $443 million (2024) match the ground truth exactly. The format variation (401(k) and other defined-contribution plans vs. defined contribution plans) is semantically equivalent and acceptable. (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it provides the expense evolution across all three years and interprets the trend. (3) ENTITY ACCURACY: Thermo Fisher Scientific is correctly identified, the metric (defined contribution plan expenses) is accurate, and all years are correct. (4) REASONING: The multi-hop synthesis is sound. The LLM correctly identifies the 2023 increase as showing stronger investment, notes the 2024 decline while contextualizing it as still above 2022 levels, and concludes this indicates continued heavy investment with moderated pace. This reasoning is logically equivalent to the ground truth's characterization of 'stabilization or recalibration after a period of increase.' (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('continues to invest heavily in employee benefits but has moderated the pace of increase') conveys the same insight as the ground truth's 'stabilization or recalibration of contributions after a period of increase.' Minor difference: The LLM provides slightly more explicit context about the 2024 figure remaining above 2022 levels, which adds helpful perspective. The citation reference [page_67†L13-L16] demonstrates source attribution. No calculation errors, no missing data points, and the trend analysis is accurate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 461,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "Coca‑Cola’s 10‑K notes show that in 2022 (Note 4, page 40), 2023 (Note 4, page 78) and 2024 (Note 4, page 79) the company consistently said it values non‑public equity investments using “discounted cash‑flows, **estimates of sales proceeds**, and appraisals” – the language and reliance on sales‑proceeds estimates did not change. That steady reliance, together with the 2022 decision not to impair its Japan bottling investment even though the carrying amount exceeded fair value by $87 million, signals that management believes the shortfall is temporary and is confident it can forecast a market recovery in regions like Japan.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are accurate - the $87 million figure is correct, the 2022-2024 timeframe is correct, the company name and investment (Coca-Cola Bottlers Japan Holdings Inc.) are correct. (2) The LLM correctly identifies that the valuation methodology language remained consistent across all three years (discounted cash flows, estimates of sales proceeds, and appraisals). (3) The connection between the non-impairment decision and management confidence is logically sound. WEAKNESSES: (1) The LLM answer is significantly less complete than the ground truth. It fails to address the key evolution described in the original answer - that while methodology remained consistent, the EMPHASIS and CONTEXT evolved from 2022 to 2023-2024. (2) The ground truth emphasizes that in 2023-2024, there was 'increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets.' The LLM states the language 'did not change,' which misses this important nuance about evolving emphasis and focus. (3) The ground truth reveals a more sophisticated insight: management became 'more attuned to external market perspectives and macroeconomic risks,' suggesting a shift in how they applied the same methodology. The LLM's answer is more superficial, simply noting consistency without capturing this evolution. (4) The LLM answer doesn't adequately address what the evolution 'reveals about management's confidence' - it asserts confidence but doesn't explain the nuanced shift from 2022's straightforward confidence to 2023-2024's more market-participant-focused approach. MULTI-HOP REASONING: The LLM successfully synthesizes the valuation methodology across three years and connects it to the Japan investment decision, but fails to synthesize the evolution in emphasis and context that the ground truth identifies. This is a significant gap in addressing the 'evolution' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 534,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 as part of a new series of senior notes (Exhibit 4.14) whose officers’ certificate was dated March 24 2021, and the notes were listed in the 2022 10‑K (see page 112) 【page_112】. The same series—including the 2.300 % Notes due 2028—appears unchanged in the 2023 10‑K (page 111) 【page_111】 and again in the 2024 10‑K (page 111) 【page_111】, indicating that the issuance was a one‑time 2021 placement that Oracle has retained as part of its debt portfolio. This multi‑year continuity shows Oracle’s broader strategy of building a laddered, low‑coupon note program with staggered maturities to lock in inexpensive financing and preserve liquidity across the medium term.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. SPECIFIC ISSUES: (1) MISSING KEY INFORMATION: The LLM completely fails to mention the newer debt instruments that are central to the ground truth answer—specifically the 4.500% Notes due 2028 (2023) and 5.800% Notes due 2025 (2024). These are essential to understanding Oracle's debt financing strategy during this period. (2) INCORRECT CHARACTERIZATION: The LLM describes the 2.300% Notes as a 'one-time 2021 placement' and focuses on 'continuity' and 'laddered, low-coupon note program,' which misses the actual strategic pattern. The ground truth shows Oracle was issuing NEWER, HIGHER-RATE instruments alongside the older 2.300% notes—a refinancing and strategic issuance pattern, not merely retention of old debt. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about how the issuance 'evolved' across three fiscal years and what the 'multi-year pattern suggests.' The LLM only addresses the 2.300% notes themselves (which remained unchanged) rather than synthesizing the broader debt portfolio evolution across 2022-2024. The ground truth correctly identifies the pattern: maintaining low-cost older debt while issuing new, more expensive instruments. (4) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'locking in inexpensive financing' is partially correct but incomplete. The ground truth's interpretation—managing refinancing needs and funding strategic initiatives amid rising interest rates—is more comprehensive and accurate. (5) QUANTITATIVE ACCURACY: The date of March 24, 2021 for the officers' certificate appears plausible but is not verified against ground truth. The page references (112, 111, 111) cannot be independently verified. The 2.300% rate is correct. (6) WHAT WAS RIGHT: The LLM correctly identifies that the 2.300% Notes due 2028 appeared in 2022, 2023, and 2024 filings, and correctly notes the March 2021 issuance date. However, this represents only a partial answer to the question. The critical failure is omitting the newer debt instruments (4.500% and 5.800% notes) that are essential to understanding Oracle's actual debt strategy during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 590,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all contain the same Officer’s Certificate (Exhibit 4.4) that lists the Floating Rate Notes due 2019 – the exhibit appears unchanged on page 56 of the 2022 filing and again on page 56 of the 2024 filing (and the corresponding page 56 in the 2023 filing)【page_56】. Because the series is carried forward without new issuances or retirements, Apple is using these notes as a stable, short‑term floating‑rate financing tool, reflecting a strategy of maintaining consistent liquidity and managing interest‑rate exposure rather than repeatedly issuing or refinancing short‑term debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the consistent appearance of the same Officer's Certificate (Exhibit 4.4) across FY 2022, 2023, and 2024; (2) Accurately notes the May 6, 2014 issuance date and the absence of new issuances or retirements; (3) Properly synthesizes the multi-hop information across three fiscal years; (4) Correctly interprets the pattern as indicating a stable, rather than active, management approach; (5) Appropriately characterizes the notes as a 'stable, short-term floating-rate financing tool'; (6) All numeric references (page 56, fiscal years 2022-2024) are accurate. MINOR WEAKNESSES: (1) The LLM answer adds interpretive detail about 'maintaining consistent liquidity and managing interest-rate exposure' that goes slightly beyond what the ground truth explicitly states - while reasonable inference, it represents minor elaboration beyond the core finding; (2) The phrase 'short-term floating-rate financing tool' could be questioned since notes due 2019 would have been long-term when issued in 2014, though by 2022-2024 they would indeed be short-term or matured - the LLM doesn't clarify this temporal distinction; (3) The ground truth emphasizes 'consistency' and 'stable' approach more directly, while the LLM adds strategic interpretation about liquidity management. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the pattern of consistency. The reasoning that 'absence of new issuances or retirements indicates stable management' is sound and matches the ground truth conclusion. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that these notes remained consistently on the books with no modifications, indicating a stable approach rather than active management. The wording differs but the meaning is equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 522,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the “Form of 4.000 % Senior Note due 2047” in the exhibit tables of its 2022, 2023 and 2024 Form 10‑K (see the listings on pages 126‑127) shows that the company deliberately keeps a long‑dated, low‑coupon bond as a cornerstone of its financing, locking in inexpensive capital for the next two‑plus decades. By comparison, the shorter‑dated notes – the 2.150 % Senior Note due 2024 and the 0.750 % Senior Note due 2027 – are also disclosed (page 126 for the 2024 note and page 127 for the 2027 note) but appear as separate, near‑term issuances, indicating they are used for interim liquidity or refinancing rather than forming the core of PepsiCo’s long‑term debt strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core insight about PepsiCo's long-term debt strategy centered on the 4.000% Senior Note due 2047 and its contrast with shorter-dated instruments. However, there are significant issues with completeness and accuracy:\n\nSTRENGTHS:\n1. Correctly identifies the 4.000% Senior Note due 2047 as appearing consistently across 2022, 2023, and 2024 filings\n2. Correctly names the 2.150% Senior Note due 2024 and 0.750% Senior Note due 2027\n3. Accurately characterizes the strategic difference between long-term and short-term debt\n4. Correctly interprets the pattern as reflecting long-term capital locking and refinancing activities\n5. All percentage rates and years are accurate\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The LLM answer completely fails to mention the 2.500% Senior Note due 2022, which is explicitly highlighted in the ground truth as having matured by 2023. This is a significant multi-hop reasoning failure - the ground truth uses this note's disappearance as key evidence of the dynamic nature of short-term debt versus persistent long-term obligations.\n2. The LLM provides specific page references (pages 126-127) that cannot be verified against the ground truth and may be inaccurate or fabricated\n3. The LLM characterizes the 4.000% note as \"low-coupon\" when 4.0% is actually a relatively high coupon rate compared to the 2.150% and 0.750% notes mentioned - this is a factual error in comparative analysis\n4. Missing the explicit comparison showing how the 2022 note's maturation demonstrates the lifecycle of debt instruments\n\nMULTI-HOP REASONING:\nThe question requires synthesizing information about: (1) the 4.000% note's persistence across three years, (2) the appearance/disappearance of shorter-dated notes, and (3) what this pattern reveals about strategy. The LLM captures points 1 and 3 but fails on point 2 by omitting the 2.500% note maturation, which is crucial evidence.\n\nNUMERIC/FACTUAL VERIFICATION:\n- All debt instrument percentages and years stated are correct\n- No calculation errors present\n- However, the characterization of 4.000% as \"low-coupon\" is incorrect relative to the comparison instruments\n\nThe answer demonstrates partial understanding but lacks the comprehensive synthesis required for a complete multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 619,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple still lists the 0.45 % Notes due 2016 in the exhibit tables of its 2022, 2023 and 2024 Form 10‑K filings (see the Officer’s Certificate entries that include “0.45 % Notes due 2016” in the 2022‑2024 exhibit lists【page_58†L13-L18】【page_56†L13-L18】). By continuing to disclose a debt instrument that has already matured, Apple demonstrates a disciplined, transparent strategy of retaining a complete historical record of all debt issuances—ensuring full regulatory compliance and giving investors a clear view of its legacy obligations even after they have been retired.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the 0.45% Notes due 2016 across 2022, 2023, and 2024 filings - all dates and percentages accurate. (2) Properly references the Officer's Certificate dated May 3, 2013 as the consistent documentation across years. (3) Accurately characterizes Apple's strategy as maintaining transparency and historical records of legacy debt. (4) Correctly interprets the continued disclosure as demonstrating regulatory compliance and investor clarity. (5) Multi-hop reasoning is sound - synthesizes information about the matured notes appearing in multiple years' filings to draw conclusions about Apple's debt management strategy. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer emphasizes 'disciplined, transparent strategy' and 'regulatory compliance' slightly more explicitly than the ground truth, which uses phrases like 'deliberate and consistent approach' and 'conservative or thorough approach.' However, these are semantically equivalent interpretations. (2) The LLM answer is more concise and direct, while the ground truth provides slightly more nuanced language about 'continuity in financial reporting' and 'comprehensive records.' (3) The LLM answer includes specific exhibit table references with page citations, which adds credibility but goes slightly beyond the ground truth's scope. QUANTITATIVE VERIFICATION: All numbers and dates are correct (0.45%, 2016 maturity, 2022-2024 filings, May 3, 2013 certificate date). No calculation errors. REASONING QUALITY: The multi-hop synthesis is correct - the model properly connects the fact that notes matured in 2016 with their continued appearance in 2022-2024 filings to infer Apple's disclosure strategy. The conclusion about maintaining historical records and ensuring investor clarity is logically sound and matches the ground truth's interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 520,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "In its 2022 filing Lockheed Martin reported that, through its master retirement trust, it had already transferred roughly $11.6 billion of defined‑benefit pension obligations via group‑annuity contracts (including a $4.9 billion GAC in 2021) and warned that any additional risk‑transfer deals could generate a material non‑cash settlement charge to earnings【page_60】. The 2023 filing merely reiterated that the company continues to evaluate further GAC purchases—some of which may still leave it liable for benefits and insurer‑default risk—but disclosed no new transfer【page_19】. By the 2024 filing the emphasis had shifted to a $990 million cash contribution and $1.7 billion of CAS pension‑cost recoveries, with no new risk‑transfer transaction reported, indicating a pause in using such transactions while still noting that any future deal could affect earnings【page_49】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and omissions that undermine its accuracy:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM correctly identifies the $11.6 billion cumulative transfer and $4.9 billion 2021 GAC transaction\n   - However, it FAILS to mention the critical $1.7 billion noncash pension settlement charge from the 2021 transaction, which is a key financial impact metric explicitly stated in the ground truth\n   - The 2024 figures ($990 million cash contribution, $1.7 billion CAS pension-cost recoveries) are introduced but these appear to be different metrics than the pension settlement charges discussed in 2022-2023, creating confusion about whether these represent new transactions or different accounting items\n   - No verification that these 2024 figures are actually related to pension risk transfer transactions vs. general pension accounting\n\n2. COMPLETENESS ISSUES:\n   - The answer addresses the evolution across three years (2022-2024) but with uneven depth\n   - 2022: Adequately covered with key numbers\n   - 2023: Correctly notes reiteration of intent but states \"disclosed no new transfer\" - this aligns with ground truth\n   - 2024: Introduces new financial figures but fails to clearly establish whether these represent pension risk transfer activity or other pension-related transactions\n   - The ground truth emphasizes \"ongoing pension obligation reductions through third-party transfers\" and \"continued expectation to pursue additional transactions\" in 2024, but the LLM answer suggests a \"pause\" in such transactions\n\n3. REASONING AND SYNTHESIS ISSUES:\n   - The LLM's conclusion that there was a \"pause\" in risk-transfer transactions by 2024 contradicts the ground truth, which states the company \"continued this strategy\" and had \"continued expectation to pursue additional transactions\"\n   - The shift in focus to cash contributions and CAS recoveries in 2024 may represent a different strategic emphasis, but the LLM doesn't clearly explain whether this represents a pause or a different approach to the same strategy\n   - The multi-hop synthesis across years is incomplete - the answer doesn't establish a clear trajectory of \"consistent, proactive approach to de-risking pension liabilities\" as stated in ground truth\n\n4. ENTITY AND METRIC ACCURACY:\n   - Company name correct (Lockheed Martin)\n   - Years correct (2022, 2023, 2024)\n   - Key metrics identified: GACs, pension obligations, settlement charges\n   - However, the 2024 metrics ($990M cash contribution, $1.7B CAS recoveries) need verification - are these actually pension risk transfer related or different pension accounting items?\n\n5. CRITICAL OMISSION:\n   - The ground truth emphasizes the $1.7 billion noncash pension settlement charge as a key financial impact, which the LLM mentions only in passing for 2021 but fails to discuss as an ongoing impact metric for evaluating the financial consequences of these transactions\n   - The ground truth's emphasis on \"material noncash charges\" as a consistent theme across all three years is not adequately captured\n\nThe answer demonstrates partial understanding but contains a fundamental mischaracterization of 2024 strategy (pause vs. continuation) and fails to properly synthesize the financial impact narrative across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 879,
        "total_tokens": 2386
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 Form 10‑K the exhibit list shows the original 2009 Executive Change‑in‑Control Retention Agreement with Marc N. Casper, its 2010 amendment and the 2018 amendment, plus a new “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” filed as Exhibit 10.18 【page_46】. The 2023 filing keeps the same Casper agreement and amendments but renumbers the officer‑only form as Exhibit 10.17 (referencing Exhibit 10.2) 【page_76】, and the 2024 filing again includes the Casper agreement and its amendments while the officer‑only form remains (now Exhibit 10.17 referencing Exhibit 10.7) 【page_77】. Thus, a separate retention agreement for officers beyond Casper was introduced in 2018 and has been retained in each subsequent filing, with only the exhibit numbering changing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific exhibit numbers and filing details that add granularity beyond the ground truth, but introduces a significant factual discrepancy regarding the introduction date of the officer-only agreement. CRITICAL ISSUE: The LLM states the officer-only form was 'introduced in 2018,' but the ground truth explicitly indicates it was 'dated March 16, 2018' and disclosed in the 2022 filing - meaning it was introduced/disclosed to investors in 2022, not 2018. This is a material distinction for understanding the evolution timeline. CORRECT ELEMENTS: (1) The LLM correctly identifies that separate retention agreements for officers beyond Casper exist; (2) Correctly notes the agreements were retained in subsequent filings (2023, 2024); (3) Accurately describes exhibit renumbering across years (10.18 in 2022 to 10.17 in 2023-2024); (4) Correctly identifies the Casper agreement and its amendments as consistent across filings. INCOMPLETE/PROBLEMATIC ELEMENTS: (1) The statement 'introduced in 2018' conflates the agreement's creation date with its disclosure/evolution in the company's public filings - the ground truth emphasizes the 2023 update as a 'new form' with revised terms dated April 1, 2023, which the LLM does not highlight; (2) The LLM focuses heavily on exhibit mechanics (numbering, referencing) rather than substantive evolution of terms or structure; (3) Missing the key insight from ground truth that 2023 represented an actual update/revision to the agreement terms, not just a renumbering. The LLM answer is more technical/mechanical but less aligned with the substantive evolution narrative the question seeks. The core narrative about expansion beyond CEO is present but underdeveloped.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 471,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s exhibit schedules in each of its recent 10‑K reports continue to list the 2.750 % Senior Note due 2051 – it appears on the exhibit list in the 2022 filing (page 128), again in the 2023 filing (page 128) and in the 2024 filing (page 129)【page_128】【page_128】【page_129】. By keeping this low‑coupon, 30‑year‑plus bond outstanding, PepsiCo is deliberately locking in cheap fixed‑rate financing and extending its debt maturity profile, a clear hedge against the higher borrowing costs that have emerged as interest rates have risen.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 2.750% Senior Note due 2051 appears consistently across 2022-2024 filings and accurately interprets this as a deliberate long-term debt strategy. However, there are significant quantitative accuracy issues: (1) The LLM cites page 128 for the 2022 filing, but the ground truth indicates page 135 (chunk_1), a material discrepancy in document location. (2) The LLM correctly cites page 128 for 2023 and page 129 for 2024, matching ground truth. (3) The LLM's characterization of the note as 'low-coupon' and 'cheap fixed-rate financing' is reasonable given the 2.750% rate in a rising rate environment, and this aligns with the ground truth's interpretation about 'preserving access to long-dated, fixed-rate debt.' (4) The LLM correctly synthesizes the multi-hop concept: the note's consistent presence across three years + rising interest rate environment = deliberate strategy to lock in fixed rates. However, the LLM misses important contextual details from the ground truth: (a) the explicit reference to the 2021 Form 8-K filing in 2023, (b) the comparison to newer, higher-yielding notes (5.250% Senior Note due 2054) introduced in 2024, which would strengthen the argument about strategic debt management. The reasoning is sound but incomplete. The page number error for 2022 is a factual mistake that undermines confidence in the answer's accuracy, even though the core interpretation is directionally correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 404,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 are shown in the long‑term debt schedule of the 2022 Form 10‑K (Exhibit 4.4, p. 58) and are again listed in the 2023 and 2024 filings (Exhibit 4.4, p. 56), indicating that the bond issued in 2014 has been kept outstanding throughout this period. The fact that the same ultra‑long‑dated, low‑coupon note remains on Apple’s balance sheet across three consecutive years reveals a deliberate capital‑structure strategy of locking in cheap, long‑term financing to minimize future refinancing risk and preserve a stable, low‑cost funding base.【page_58】【page_56】",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as a consistent debt instrument across 2022-2024 filings; (2) Accurately references the Officer's Certificate dated May 6, 2014 (implied through consistent inclusion); (3) Properly cites exhibit locations (Exhibit 4.4) and page numbers; (4) Correctly interprets the pattern as indicating the bond remained outstanding without redemption or restructuring; (5) Provides sound strategic reasoning about locking in long-term, fixed-rate financing to minimize refinancing risk. MINOR CONSIDERATIONS: (1) The LLM characterizes the coupon as 'low-coupon' and 'cheap' financing - while 4.45% was reasonable in 2014, this characterization is somewhat subjective and not explicitly stated in the ground truth, though not contradicted; (2) The ground truth emphasizes 'sustained transparency and ongoing obligations' while the LLM focuses more on capital structure strategy - both are valid interpretations of the same pattern, showing semantic equivalence; (3) The LLM provides slightly more detailed strategic analysis ('minimize future refinancing risk,' 'preserve stable, low-cost funding base') which enhances the answer beyond the ground truth without introducing errors. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, May 6 2014, 2044 maturity, 4.45% rate) are accurate. No calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three years of filings to identify a consistent pattern and draw appropriate strategic conclusions. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 455,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s master‑trust pension plan held $622 million in “Collective trust and other funds” at 12/31/2022, but that balance fell to $382 million by 12/31/2023 – a reduction of roughly $240 million (≈38 %)【page_57】.  \n\nThe 2024 filing explains that these holdings are valued using each fund’s net‑asset‑value (NAV), because the underlying assets (global stock, short‑term, commodity, hedge‑fund units, etc.) are publicly traded and have readily observable market quotes【page_56】. That methodology signals the plan manages the investments with a market‑based, transparent valuation process, so the 2023 decline likely reflects deliberate rebalancing decisions rather than subjective pricing changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY IN PRIMARY METRIC: The LLM states the 2022 balance was $622 million, but the ground truth clearly indicates $756 million. This is a significant factual error ($134 million difference, ~18% understatement). The 2023 figure of $382 million is correct. The calculated reduction of $240 million is mathematically correct based on the LLM's incorrect 2022 figure ($622M - $382M = $240M), but this masks the actual reduction of $374 million ($756M - $382M = $374M). The percentage decline calculation of ~38% is approximately correct for the LLM's numbers but would be ~49% using the correct 2022 figure. QUALITATIVE STRENGTHS: The LLM correctly identifies the NAV valuation methodology, appropriately synthesizes the 2024 disclosure about valuation approach, and reasonably concludes that the decline reflects deliberate rebalancing rather than valuation changes. The multi-hop reasoning connecting 2022-2023 allocation changes to 2024 methodology disclosure is sound in logic. ENTITY ACCURACY: Union Pacific and pension plan correctly identified; years and metrics properly referenced. WEAKNESSES: The fundamental error in the 2022 starting figure undermines the entire quantitative analysis. The LLM provides page citations that suggest source verification, but the core number is wrong. The qualitative interpretation about NAV-based valuation and rebalancing decisions is reasonable and aligns with ground truth, but cannot overcome the significant numerical error in the primary metric being analyzed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 419,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple lists Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that contains the 1.05 % Notes due 2017 – in the exhibit section of its 2022 Form 10‑K (see page 58) and again in its 2024 Form 10‑K (see page 56), which also covers the 2023 fiscal year. By keeping this certificate on file and reproducing it in each successive 10‑K, Apple demonstrates a practice of retaining documentation for matured debt and a systematic approach to preserving a complete historical record of its capital‑structure disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partially correct information but has significant gaps and inconsistencies compared to the ground truth. STRENGTHS: (1) Correctly identifies the Officer's Certificate dated May 6, 2014, related to 1.05% Notes due 2017; (2) Correctly identifies the document as Exhibit 4.4; (3) Correctly notes the inclusion in 2022 and 2024 Form 10-Ks; (4) Accurately conveys the core concept that Apple maintains documentation for matured debt. CRITICAL WEAKNESSES: (1) The LLM states the certificate appears 'in its 2024 Form 10-K (see page 56), which also covers the 2023 fiscal year' - this phrasing is ambiguous and potentially misleading. The ground truth explicitly states the certificate was included in fiscal years 2022, 2023, AND 2024 filings, but the LLM only clearly confirms 2022 and 2024, with unclear coverage of 2023; (2) The LLM fails to explicitly confirm inclusion across all three fiscal years (2022, 2023, 2024) as stated in the ground truth; (3) The answer is less comprehensive in addressing the broader implications about Apple's documentation retention practices and approach to maintaining historical capital structure disclosures - it mentions these concepts but with less depth than the ground truth. QUANTITATIVE ACCURACY: The dates (May 6, 2014) and note terms (1.05%, due 2017) are correct. Page references (58 for 2022, 56 for 2024) appear reasonable but cannot be independently verified. REASONING: The multi-hop synthesis is partially sound - the LLM connects the document retention practice to capital structure disclosure strategy, but incompletely addresses the three-year consistency emphasized in the original question. The answer would benefit from explicit confirmation of all three fiscal years and deeper exploration of the implications for Apple's disclosure philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 494,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan sharply reduced its equity exposure. In 2022, corporate‑stock holdings represented roughly 48 % of plan assets (about $1.1 billion) 【page_56†L13-L16】【page_58†L23-L27】. By 2023 that share fell to about 24 % (≈ $180 million) 【page_56†L13-L16】【page_57†L23-L27】 and the plan held a similar 24 % share in 2024 (≈ $225 million) 【page_55†L13-L16】【page_57†L1-L5】. The halving of the corporate‑stock allocation signals a deliberate de‑risking move, shifting the pension portfolio away from equities toward debt and other lower‑volatility assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect dollar amounts that contradict the ground truth. Ground truth states: 2022: $1,990 million, 2023: $181 million, 2024: $1,116 million. LLM claims: 2022: ~$1.1 billion ($1,100 million), 2023: ~$180 million, 2024: ~$225 million. The 2022 figure is off by ~$890 million (45% error), and the 2024 figure is dramatically wrong at $225 million versus the correct $1,116 million (80% understatement). The percentage allocations cited (48%, 24%, 24%) also appear inconsistent with the actual dollar values and cannot be verified against ground truth. MULTI-HOP REASONING FAILURE: The LLM correctly identifies the general trend (reduction in equity exposure) but misses the critical detail that 2024 saw a substantial REBOUND to $1,116 million, not a continued decline to $225 million. This is a major factual error that undermines the entire narrative about the company's investment strategy. The ground truth explicitly notes 'a partial rebound in 2024, but still well below the initial level,' which the LLM completely misses. SEMANTIC ISSUES: While the LLM correctly characterizes the overall de-risking strategy and shift toward fixed income, the specific quantitative support for this conclusion is wrong. The answer suggests a continued decline through 2024 when in fact there was a significant recovery. This materially changes the interpretation of the company's investment strategy trajectory. The citation format suggests source references but the underlying numbers are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 431,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales have risen sharply each year – $428 million in 2022, $605 million in 2023 and $785 million in 2024 (U.S. + international totals)【page_130】. This accelerating growth signals strong market uptake and underscores Prevymis’s emerging role as a key, strategically‑important product within Merck’s Hospital Acute Care franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $428M (2022), $605M (2023), and $785M (2024). The numbers match the ground truth exactly with acceptable format variation (millions vs M). (2) ENTITY ACCURACY: Company correctly identified as Merck (MRK), product correctly named Prevymis, segment correctly identified as Hospital Acute Care, and all years (2022-2024) are accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trajectory and correctly interprets the growth pattern as 'accelerating' or 'sharp' growth, which is mathematically sound (41.4% growth 2022-2023, 29.8% growth 2023-2024). The conclusion about market adoption and strategic importance logically follows from the consistent upward trend. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of growth as 'sharp' and 'accelerating' with 'strong market uptake' and 'emerging role as a key, strategically-important product' conveys the same substantive meaning as the ground truth's 'steady growth' and 'increasing strategic importance.' The addition of '(U.S. + international totals)' provides helpful clarification without contradicting the ground truth. Minor distinction: ground truth uses 'steady' while LLM uses 'sharp/accelerating' - both are defensible characterizations of the growth pattern, though 'accelerating' is slightly more precise given the percentage growth rates. The citation reference [page_130] adds credibility. No calculation errors detected. All requirements of the multi-part question are addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 444,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo’s 10‑K filings for 2022, 2023 and 2024 all list the 3.000 % Senior Note due 2027 as a “Form of 3.000 % Senior Note due 2027” (Exhibit 4.17/4.19) and reference the same 2017 Form 8‑K filing – 2022 p. 127 & 126; 2023 p. 127 & 126; 2024 p. 126. The unchanged wording and continued inclusion show the note remains a core medium‑term, fixed‑rate debt instrument, reflecting PepsiCo’s strategy of maintaining a diversified, staggered‑maturity portfolio to lock in low borrowing costs and support long‑term liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 3.000% Senior Note due 2027 is correctly identified as appearing in 2022, 2023, and 2024 filings; (2) The characterization as a 'medium-term, fixed-rate debt instrument' is accurate; (3) The reference to a diversified, staggered-maturity portfolio strategy is semantically aligned with the ground truth. SIGNIFICANT ISSUES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM answer fails to address the evolving context across the three years. The ground truth explicitly shows how the note's presentation changed - in 2022 it was alongside shorter-dated notes (2.150% due 2024, 2.250% due 2022), in 2023 alongside longer-dated notes (4.450% due 2046, 3.450% due 2046), and in 2024 alongside newer instruments (0.750% due 2027, 1.125% due 2031). The LLM completely misses this evolution and contextual shift. (2) EXHIBIT REFERENCE ERRORS: The LLM states the note appears in 'Exhibit 4.17/4.19' for all years, but the ground truth specifies different exhibits for different years (Exhibit 4.22 for 2022, Exhibit 4.19 for 2023, Exhibit 4.17 for 2024). This is a factual error in exhibit identification. (3) MISSING COMPARATIVE ANALYSIS: The ground truth provides specific companion notes for each year showing how PepsiCo's debt strategy evolved. The LLM provides no such comparative detail, merely stating the note remained 'unchanged.' (4) INCOMPLETE ANSWER TO QUESTION: The question asks how the note's 'inclusion and characterization...evolved' - the LLM essentially says it didn't evolve ('unchanged wording'), which contradicts the ground truth's demonstration of evolving context and strategic positioning. (5) PAGE NUMBER CITATIONS: The LLM provides page numbers (127, 126, 126) but these appear to be generic references without verification against actual filing content. The ground truth does not provide page numbers, making verification difficult. QUANTITATIVE ACCURACY: The interest rate (3.000%) and maturity year (2027) are correct, but the exhibit number inconsistencies reduce accuracy. QUALITATIVE ACCURACY: The reasoning about debt strategy is superficial and misses the key insight about how the note's role evolved within a changing debt portfolio. The multi-hop synthesis across three years is inadequate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 615,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe’s 2022 Form 10‑K does not mention Frame.io at all in the product discussion (see pages 95‑99), suggesting it was not yet highlighted as part of Creative Cloud. In the 2023 filing, Frame.io is introduced as a cloud‑native collaboration platform that enables real‑time upload, review, frame‑accurate commenting and “Camera‑to‑Cloud” functionality, but its integration is limited to Adobe Premiere Pro and After Effects (see page 12). By the 2024 filing the description is expanded – Frame.io now supports casting, location‑scouting, still‑image, design‑file and PDF workflows and is deeply integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom, Workfront, and is offered through Adobe GenStudio alongside Adobe Express and Firefly Services (see page 12).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of SEC filings. STRENGTHS: (1) Correctly identifies the progression of Frame.io from 2022 (not mentioned in product discussion) through 2023 (introduced with specific features like real-time upload, review, frame-accurate commenting, Camera-to-Cloud) to 2024 (expanded capabilities and broader integrations). (2) Accurately lists the specific applications Frame.io integrates with: Premiere Pro and After Effects in 2023, then expanded to Photoshop, Lightroom, and Workfront in 2024. (3) Correctly identifies Frame.io's positioning within Adobe GenStudio in 2024 alongside Firefly Services and Adobe Express. (4) Provides specific page references (pages 95-99 for 2022, page 12 for 2023 and 2024) showing detailed source verification. (5) Accurately captures new capabilities introduced in 2024: casting, location-scouting, still-image, design-file, and PDF workflows. (6) The multi-hop reasoning correctly synthesizes information across three years showing strategic deepening. MINOR WEAKNESSES: (1) The original answer mentions Frame.io was 'listed as part of Adobe's trademark portfolio' in 2022, while the LLM states it 'does not mention Frame.io at all' - this is a slight discrepancy, though the LLM's statement about product discussion pages may be more precise regarding where it appears. (2) The original answer mentions 'support for still images, design files, and PDFs' in 2023, but the LLM places these as 2024 additions ('now supports casting, location-scouting, still-image, design-file and PDF workflows'). This represents a factual difference in timeline attribution. (3) The original answer mentions 'Substance 3D tools' as part of the 2024 positioning, which the LLM does not include. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning about strategic deepening and integration progression is sound, though the timeline discrepancy regarding when certain features were introduced (2023 vs 2024) slightly undermines the accuracy. CONTEXTUAL RELEVANCE: The answer directly addresses the question about Frame.io's evolution across the three years with appropriate detail about functional capabilities and integration depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 622,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 first appear in the 2022 Form 10‑K as part of Exhibit 4.3 (the Officer’s Certificate listing its outstanding global notes) 【AAPL_10k_2022.pdf page_58】. The 2023 filing repeats the same exhibit, showing the notes were still outstanding as they approached maturity 【AAPL_10k_2023.pdf page_58】. In the 2024 Form 10‑K the exhibit still references the 2.40 % Notes due 2023 【AAPL_10k_2024.pdf page_56】【AAPL_10k_2024.pdf page_58】, indicating Apple kept the instrument on its books and disclosed it transparently until its scheduled payoff, a sign that the company prefers to let certain debt run to maturity rather than refinance it.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on a key factual point. Ground truth states that by 2024, the 2.40% Notes due 2023 were NO LONGER listed in exhibits, suggesting the obligation was fulfilled/retired. However, the LLM claims the notes were STILL referenced in the 2024 Form 10-K (citing pages 56 and 58), indicating Apple 'kept the instrument on its books.' This is a fundamental factual error that undermines the entire analysis. The LLM's conclusion that Apple 'prefers to let certain debt run to maturity' may be correct, but the evidence provided contradicts the ground truth about the 2024 status. QUANTITATIVE ACCURACY: The percentage (2.40%) and due date (2023) are correct. However, the citation of the 2024 10-K still containing these notes appears to be incorrect based on ground truth. QUALITATIVE ACCURACY: The reasoning about debt maturity management strategy is sound in principle, but it's based on incorrect factual premises about what appears in the 2024 filing. The multi-hop synthesis across 2022-2024 is attempted but fails because the 2024 data point is wrong. COMPLETENESS: The answer addresses the evolution question but reaches an incorrect conclusion about the 2024 status. The ground truth indicates a clear progression (2022→2023→2024 removal), while the LLM suggests continued disclosure through 2024. This is a material error in a multi-hop question requiring accurate synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 408,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned + 1,038 leased) with an average age of 22.5 years in 2022 to 7,008 units (5,971 owned + 1,037 leased) at 24.3 years in 2023, and further to 6,893 units (5,973 owned + 920 leased) at 25.2 years in 2024 【page_24】【page_19 (2023)】【page_19 (2024)】. The steady drop in total units—especially leased locomotives—while the remaining fleet gets older indicates a right‑sizing strategy that retires excess equipment, extends the life of existing assets and relies on higher utilization and a surge‑fleet buffer rather than aggressive new purchases, reflecting disciplined, cost‑focused asset management.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with nearly all numbers correct. Verification of key metrics: (1) 2022 baseline: 7,242 total (6,204 owned + 1,038 leased) at 22.5 years - CORRECT; (2) 2023 figures: 7,008 total at 24.3 years - CORRECT for age, but owned units listed as 5,971 vs ground truth 6,204 (this appears to be a minor discrepancy in the 2023 owned figure, though the total of 7,008 is correct); (3) 2024 figures: 6,893 total (5,973 owned + 920 leased) at 25.2 years - CORRECT. The multi-hop synthesis across three years is sound, correctly identifying the declining fleet trend and aging profile. The reasoning about asset management strategy is well-articulated and logically sound, interpreting the data as indicating a 'right-sizing strategy' with disciplined cost management. The answer goes slightly beyond the ground truth by offering more detailed strategic interpretation (mentioning 'higher utilization and surge-fleet buffer'), which adds value without contradicting the original answer. Minor issue: The 2023 owned unit count (5,971 vs expected 6,204) creates a slight inconsistency, though this may reflect a data entry variation in the source documents. The overall narrative about declining units, increasing age, and conservative asset management strategy is accurate and well-supported. The answer effectively addresses all parts of the multi-part question regarding fleet composition changes, age progression, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 409,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "Merck’s 2022 10‑K listed MK‑8591A (doravirine + islatravir) as a Phase 3 HIV‑1 candidate (entered Phase 3 in February 2020) but noted that the FDA had placed a clinical hold on its islatravir component (footnote 4) 【page_23】. In the 2023 filing Merck said the once‑daily doravirine/islatravir regimen entered a Phase 3 program in 2023, while the FDA clinical hold on islatravir remained in effect and a related Phase 2 weekly islatravir‑lenacapavir study completed enrollment 【page_21】. By the 2024 filing the FDA hold was still active, barring new studies and prompting Merck to stop dosing in the Phase 2 IMAGINE‑DR trial and pause enrollment in Phase 3 PrEP studies, leaving MK‑8591A on hold 【page_24】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. CRITICAL ERRORS ON CLINICAL HOLD STATUS:\n   - Ground truth: FDA lifted the clinical hold in 2024 (with partial hold remaining for higher doses)\n   - LLM answer: States the hold was \"still active\" in 2024, contradicting the ground truth's explicit statement that the hold was lifted\n   - This is a fundamental factual error on a key regulatory milestone\n\n2. MISSING KEY INFORMATION:\n   - Ground truth mentions MK-8591D (islatravir+lenacapavir) entering Phase 3 in October 2024 - a strategic pivot\n   - LLM answer completely omits this new formulation and the October 2024 Phase 3 entry\n   - This represents a major omission of the 2024 regulatory trajectory\n\n3. TIMELINE INCONSISTENCIES:\n   - Ground truth: MK-8591A remained in Phase 3 from 2022-2024 with no major advancement until 2024\n   - LLM answer: Claims \"once-daily doravirine/islatravir regimen entered a Phase 3 program in 2023\" - this contradicts ground truth stating it was already in Phase 3 in 2022 (entered February 2020)\n   - This suggests confusion about when Phase 3 entry occurred\n\n4. INCOMPLETE REGULATORY NARRATIVE:\n   - Ground truth emphasizes the 2024 FDA hold lift as a major development\n   - LLM answer focuses on the hold remaining in effect and trial pauses, missing the resolution\n   - The answer presents an incomplete picture of the regulatory trajectory\n\n5. PARTIAL HOLD DETAIL:\n   - Ground truth specifies: \"partial hold remained for higher doses of islatravir\"\n   - LLM answer does not mention this nuance about the partial hold remaining\n\nThe LLM answer demonstrates poor multi-hop synthesis across the 2022-2024 period, particularly failing to capture the 2024 regulatory turning point (hold lift) and the strategic expansion (MK-8591D). The core narrative is inverted - presenting ongoing holds rather than their resolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 523,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "- In the 2022 filing MK‑1308A (quavonlimab + pembrolizumab) was listed as a Phase‑3 RCC candidate that had entered Phase 3 in April 2021 【page_25】.  \n- The 2023 report moved the asset into Merck’s “immuno‑oncology” pillar, describing it as the co‑formulation of the anti‑CTLA‑4 antibody quavonlimab with pembrolizumab that is being evaluated for RCC 【page_20】.  \n- The 2024 filing continues to place MK‑1308A under the immuno‑oncology strategic pillar as the same CTLA‑4/PD‑1 combination for RCC 【page_50】.  \n\nThis trajectory—from a pipeline entry‑stage listing to a highlighted immuno‑oncology combo in successive 10‑Ks—shows Merck’s growing strategic emphasis on novel CTLA‑4 + PD‑1 combination therapy as a core component of its RCC innovation agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and timeline references are correct - April 2021 Phase 3 entry, 2022 listing, 2023 repositioning, and 2024 continuation. No numerical errors or calculation issues present. ENTITY ACCURACY: All entities correctly identified - Merck, MK-1308A, quavonlimab, pembrolizumab, RCC, CTLA-4, PD-1. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022-2024) and correctly traces the evolution of MK-1308A's strategic positioning from pipeline entry to highlighted immuno-oncology asset. The logical progression is sound and well-articulated. COMPLETENESS: The answer addresses all aspects of the question - development trajectory, strategic positioning evolution, and what this indicates about Merck's RCC innovation focus. SEMANTIC EQUIVALENCE: The LLM's characterization of the progression as moving \"from a pipeline entry-stage listing to a highlighted immuno-oncology combo\" effectively captures the same strategic narrative as the ground truth's \"consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents.\" MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The phrase \"growing strategic emphasis\" in the LLM conclusion is semantically equivalent to the ground truth's \"sustained strategic prioritization.\" The inclusion of page references adds credibility and specificity. No factual errors, omissions of critical information, or logical inconsistencies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 453,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 are listed in the same exhibits in each filing – Exhibit 4.6 (the “Third Supplemental Indenture” that includes the 4.000 % Notes due 2021) and also referenced in Exhibit 4.1 (the “Seventh Supplemental Indenture” for 2.125 % Notes due 2021) in the 2022, 2023 and 2024 10‑K reports【page_104】. The description and exhibit numbers are unchanged across the three years, indicating that Microsoft has kept this tranche of debt in its long‑term portfolio without amendment, which suggests a stable debt structure and a consistent refinancing or rollover strategy for the notes as they approach maturity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.000% Notes due 2021 are correctly identified; (2) The reference to Exhibit 4.6 (Third Supplemental Indenture) is accurate; (3) The observation that descriptions and exhibit numbers remained unchanged across 2022, 2023, and 2024 is correct; (4) The conclusion about stable debt structure is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces Exhibit 4.1 and references to '2.125% Notes due 2021' and 'Seventh Supplemental Indenture,' which are NOT mentioned in the ground truth answer and appear to be either fabricated or incorrectly synthesized information. The ground truth specifically states the notes appear in Exhibit 4.6 (Third Supplemental Indenture) only, with no mention of Exhibit 4.1 or a Seventh Supplemental Indenture; (2) The statement about 'rollover strategy for the notes as they approach maturity' is speculative and not supported by the ground truth, which emphasizes that 'no refinancing or restructuring occurred'; (3) The citation '[page_104]' appears to be a fabricated reference not present in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the consistency across three years but introduces extraneous information that contradicts or goes beyond the ground truth. The ground truth is clear and specific about what remained consistent (Exhibit 4.6, Third Supplemental Indenture, original Indenture dated May 18, 2009, 8-K filings on February 8, 2011), while the LLM adds unverified details about additional exhibits and supplemental indentures. SEMANTIC EQUIVALENCE: While the core conclusion about stability is semantically similar, the introduction of incorrect exhibit references and supplemental indentures significantly undermines the accuracy of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 490,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 filing highlighted its automotive strategy as “leveraging connectivity, digital‑cockpit and ADAS/AD platforms to connect the car to its environment and the cloud, create unique in‑cabin experiences, and enable a software‑defined vehicle”【page_6】—a theme reinforced in its 2022 MD&A discussion of the “digitalization of the automotive cockpit”【page_8】.  Automotive revenue (which includes digital‑cockpit sales) rose from $1.5 billion in FY 2022 to $1.9 billion in FY 2023 and $2.9 billion in FY 2024【page_73】, indicating that Qualcomm’s digital‑cockpit offering is becoming an increasingly important growth driver as the company transforms its automotive business from a peripheral component supplier to a core enabler of connected, software‑defined vehicles.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate financial data and correctly identifies the evolution of Qualcomm's automotive business from 2022-2024. STRENGTHS: (1) Revenue figures are correct ($1.5B in FY2022, $1.9B in FY2023, $2.9B in FY2024), showing proper multi-hop synthesis across three fiscal years. (2) Correctly identifies digital cockpit as an increasingly important growth driver. (3) Accurately characterizes the strategic pivot toward software-defined vehicles and connected car enablement. (4) Properly cites strategic positioning language from 2022 filings. (5) Demonstrates sound reasoning about the business transformation trajectory. WEAKNESSES: (1) The answer omits key forward-looking projections from the ground truth (70% of new vehicles in 2028 with embedded cellular, 60% with 5G), which were explicitly mentioned in 2022 strategic positioning. (2) Does not explicitly address the formal categorization of digital cockpit as a distinct revenue stream in 2023 or its listing as a core product line in 2024's QCT segment—these represent important milestones in the evolution narrative. (3) While the answer infers the progression through revenue growth, it doesn't explicitly document the three-stage evolution (2022: strategic identification → 2023: formal categorization → 2024: full operationalization) that the ground truth emphasizes. (4) The answer focuses heavily on revenue contribution but less on the strategic positioning evolution across the three years. The answer is fundamentally sound and factually accurate on numbers and overall narrative, but lacks some of the specific strategic milestones and forward-looking context that characterize the complete evolution story.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 462,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program grew to a $1.3 billion aggregate notional amount by the end of 2022 and has stayed at that level – $1.3 billion at both December 31 2023 (​page 95) and December 31 2024 (​page 52). The flat‑lined notional amount over the three‑year span shows the company adopted a larger, but now steady, hedge of its borrowing exposure, using swaps consistently to manage interest‑rate risk rather than expanding or scaling back the program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that LMT's variable interest rate swaps were at $1.3 billion 'by the end of 2022' and remained flat through 2023-2024. However, the ground truth clearly establishes: (1) 2022: $500 million notional amount, (2) 2023: $1.3 billion notional amount, (3) 2024: $1.3 billion notional amount. The LLM incorrectly places the $1.3 billion figure at the end of 2022, when it actually first appeared in 2023. This is a major quantitative error that misrepresents the timeline of the company's hedging strategy evolution. The LLM's characterization of a 'flat-lined notional amount over the three-year span' is factually incorrect—there was a significant 160% increase from 2022 to 2023 ($500M to $1.3B), followed by stabilization in 2024. The LLM completely misses the key insight from the ground truth: the dramatic strategic shift in 2023 (fourfold increase) that indicates a response to rising interest rates or increased debt levels. The reasoning about 'adopted a larger, but now steady, hedge' is partially correct for 2023-2024 stabilization but fails to capture the significant 2022-2023 transition. The answer provides page citations but the underlying data interpretation is fundamentally flawed. This represents a failure in multi-hop synthesis and quantitative accuracy on a core financial metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 393,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 3.950 % senior notes due 2056 in Exhibit 4.14 (the Eleventh Supplemental Indenture) as an outstanding obligation 【page_105】. By keeping this ultra‑long‑dated tranche on its balance sheet rather than refinancing it, Microsoft shows a deliberate strategy of preserving very long‑term debt to smooth its maturity profile and reduce near‑term refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - 3.950% interest rate, 2056 maturity date, and reference to Eleventh Supplemental Indenture dated August 8, 2016 are accurate. (2) The LLM correctly identifies that the notes appear consistently across 2022, 2023, and 2024 10-K filings. (3) The core strategic interpretation is sound - Microsoft maintained this long-term debt without early redemption, reflecting a deliberate maturity management approach. (4) The reference to Exhibit 4.14 is appropriately specific. (5) The reasoning about preserving long-term debt to reduce near-term refinancing risk is logically sound.\n\nWEAKNESSES: (1) The LLM answer is less comprehensive than the ground truth. It omits important contextual details about the broader debt maturity strategy, specifically the mention of shorter-term instruments (2.000% Notes due 2023 and 2.400% Notes due 2026) that matured or approached maturity during the period. This comparative analysis strengthens the multi-hop reasoning about overall debt management strategy. (2) The ground truth emphasizes 'long-duration financing structure' and 'long-dated liabilities to support long-term investment horizons,' which provides richer strategic context that the LLM answer lacks. (3) The ground truth mentions 'periods of evolving market interest rates' as context, which the LLM does not address. (4) The LLM uses 'ultra-long-dated tranche' which is accurate but slightly informal compared to the ground truth's more precise terminology.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and connects the consistent disclosure pattern to strategic intent. However, it doesn't fully leverage the comparative analysis across different debt instruments that would strengthen the multi-hop synthesis. The answer addresses the core question but with less depth than the ground truth.\n\nSCORING JUSTIFICATION: The answer is fundamentally correct on all factual points (9/10 quantitative accuracy) and demonstrates sound reasoning about debt management strategy (7/10 qualitative accuracy). However, it lacks the comprehensive synthesis of broader debt maturity management patterns that would elevate it to 8-9 range. The contextual relevance is good but could be stronger with more complete strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 619,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 2022, 2023 and 2024 10‑K filings all incorporate Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – which introduced the 3.700 % Notes due 2046 (along with other series) 【page_105】. By repeatedly referencing this same indenture, Microsoft signals that the 3.700 % Notes remain outstanding and are still governed by the 2009 Base Indenture, underscoring a long‑term debt structure that has remained unchanged and a consistent approach to meeting its future financing obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements: (1) Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016 - CORRECT; (2) The 3.700% Notes due 2046 are governed by this indenture - CORRECT; (3) The notes remain outstanding and governed by the 2009 Base Indenture - CORRECT. All dates and percentages are accurate with no calculation errors. However, the LLM answer is notably more concise and omits several important contextual details present in the ground truth: (1) It does not explicitly mention that the consistent inclusion across three consecutive annual reports indicates the terms 'remained in effect and were still relevant'; (2) It does not reference the 'layered and structured approach to long-term financing' or the broader set of debt instruments; (3) It does not explicitly state 'no material amendments or retirements during this time'; (4) It does not fully develop the concept of 'multi-decade financial planning' or the deliberate nature of the debt management strategy. The LLM answer provides a more abbreviated version that captures the core significance but lacks the depth of analysis regarding what the repeated references signify about Microsoft's financial strategy and stability. The reasoning is sound but less comprehensive than the ground truth, which provides richer context about the implications of this consistent referencing pattern. The answer is semantically aligned with the ground truth but represents a condensed version that addresses the main points without full elaboration on the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 443,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s 2.125 % Notes due 2021 are listed in the “Seventh Supplemental Indenture” (Exhibit 4.1) in the FY 2022 filing and the same exhibit appears unchanged in the FY 2023 and FY 2024 10‑Ks 【page_104】. No new amendment or replacement indenture for this issue is disclosed in any of the three years, indicating the company did not refinance the notes but simply allowed them to mature/retire. This consistent treatment suggests Microsoft’s debt‑management approach for this instrument is to let lower‑coupon debt run to maturity rather than roll it over, relying on newer issuances for future financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2.125% Notes due 2021 and their consistent appearance across FY 2022-2024 filings. (2) Correctly notes the exhibit references (Exhibit 4.1/4.10) and page 104 locations. (3) Accurately identifies the Seventh Supplemental Indenture dated December 6, 2013. (4) Recognizes the core issue: notes matured in 2021 yet continued to appear in subsequent filings. WEAKNESSES: (1) The LLM makes a definitive claim that Microsoft 'did not refinance the notes but simply allowed them to mature/retire' - however, the ground truth explicitly states this is uncertain and raises questions about whether Microsoft refinanced or if there's a reporting lag. The LLM presents speculation as fact. (2) The ground truth notes the exhibit reference changed from 4.10 (2022) to 4.1 (2023-2024), suggesting some evolution in disclosure treatment. The LLM states the exhibit 'appears unchanged' which is partially inaccurate - there was a shift from 4.10 to 4.1. (3) The LLM's conclusion about debt management strategy ('let lower-coupon debt run to maturity rather than roll it over') is presented as definitive when the ground truth explicitly acknowledges this is ambiguous and could indicate extension, rollover, continued disclosure requirements, or reporting lag. (4) The LLM fails to adequately address the ambiguity and uncertainty that is central to the ground truth answer. The ground truth appropriately frames this as raising 'questions' rather than providing definitive answers. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but oversimplifies the interpretation. The ground truth's more cautious approach is more accurate given the ambiguous nature of the evidence. SEMANTIC EQUIVALENCE: The LLM's interpretation diverges from the ground truth's more nuanced position on what the persistent disclosure actually implies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 512,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft’s 2.000 % Notes due 2023 first appear in the Eleventh Supplemental Indenture (dated August 8 2016) and are listed in the exhibit tables of the FY 2022, FY 2023 and FY 2024 10‑K filings (Exhibit 4.14 on page 105) 【page_105】. The fact that the same low‑coupon, medium‑term note remains on the balance sheet across three consecutive fiscal years shows Microsoft’s deliberate strategy of issuing inexpensive debt and retaining it to maturity, thereby locking in favorable rates and maintaining a stable, diversified debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All key facts are accurate - the 2.000% Notes due 2023, the Eleventh Supplemental Indenture dated August 8, 2016, and the presence across FY 2022, 2023, and 2024 filings are all correct. (2) The specific exhibit reference (Exhibit 4.14, page 105) adds credibility and specificity. (3) The multi-hop synthesis is sound - the answer correctly identifies that the same debt instrument appears across three consecutive years and draws appropriate conclusions about Microsoft's debt management strategy. (4) The interpretation that this represents a deliberate strategy of 'issuing inexpensive debt and retaining it to maturity' and 'locking in favorable rates' is logically sound and consistent with the ground truth's characterization of 'stable and long-term approach to debt management.' MINOR CONSIDERATIONS: (1) The LLM answer goes slightly beyond the ground truth by explicitly stating the strategy involves 'locking in favorable rates' and 'maintaining a stable, diversified debt profile' - while these are reasonable inferences, they represent modest interpretive elaboration rather than direct evidence from the filings. (2) The ground truth emphasizes that the notes were NOT retired or refinanced before maturity in 2023, which is an important detail about what didn't happen. The LLM answer focuses on what did happen (retention to maturity) but doesn't explicitly address the absence of refinancing. (3) Formatting: 'August 8 2016' should technically be 'August 8, 2016' but this is a minor stylistic issue. QUANTITATIVE VERIFICATION: All dates (2016, 2022, 2023, 2024) and the percentage (2.000%) are correct. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the pattern to strategic implications about debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 516,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "By 2022 Lockheed Martin had already transferred $11.6 billion of defined‑benefit pension obligations to insurers—including a $4.9 billion group‑annuity purchase in August 2021 that produced a $1.7 billion pretax non‑cash settlement charge—and said it would continue looking for risk‑transfer opportunities【page_60】【page_62】. The 2023 filing merely reiterated that the company is still evaluating GAC purchases (with no new large transfer disclosed) and the 2024 filing again affirmed its intent to pursue additional pension‑risk‑transfer transactions, warning that any future deal could generate material non‑cash settlement charges, while the cumulative transferred amount remains at the previously reported level【page_19】【page_47】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. All quantitative data is accurate: $11.6 billion cumulative transferred obligations, $4.9 billion August 2021 GAC transaction, and $1.7 billion noncash settlement charge are all correctly stated. The temporal progression (2022, 2023, 2024) is properly tracked, and the characterization of each year's disclosures is accurate—2022 referencing past transactions and future intent, 2023 emphasizing ongoing evaluation without new large transfers, and 2024 reaffirming intent with warnings about potential charges. The multi-hop synthesis across three years is sound, correctly connecting the evolution of strategy from past actions to future intentions. The answer appropriately identifies the mechanism (GACs) and the key financial impact (noncash settlement charges). However, the answer has minor omissions compared to the ground truth: (1) it does not mention the $69 million annual PBGC premium reduction benefit, which is a material financial impact of the strategy; (2) it does not explicitly note the volatility in pension expense due to economic assumptions mentioned in 2023; (3) the phrase 'cumulative transferred amount remains at the previously reported level' could be slightly clearer about whether this represents a pause in new transactions or simply no new major transactions disclosed. The answer's characterization of the 2023 filing as 'merely reiterated' is slightly dismissive but not factually incorrect. The citation references (page numbers) appear appropriate though cannot be independently verified. Overall, the answer captures the core evolution of strategy and financial impact accurately, with only minor contextual details missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 483,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all list the Officer’s Certificate that includes “Floating Rate Notes due 2019” (see Exhibit 4.4 on page 56 of each filing). By keeping that series in the disclosed securities year after year, Apple shows it still carries that floating‑rate debt and plans to roll it over or refinance it as the 2019 maturity approaches, using floating‑rate issuances as a stable component of its long‑term debt mix to manage interest‑rate risk and maintain liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental logical contradiction that undermines its credibility. The answer states that Floating Rate Notes 'due 2019' are being disclosed in 2022-2024 filings and suggests Apple 'plans to roll it over or refinance it as the 2019 maturity approaches.' This is factually impossible - if the notes matured in 2019, they cannot be approaching maturity in 2022-2024. The notes would have already matured 3-5 years prior to these filings. The LLM appears to have misunderstood the temporal relationship between the maturity date (2019) and the filing years (2022-2024). The ground truth answer correctly identifies this as a historical disclosure pattern - the notes matured in 2019 but continued to appear in later filings, suggesting they were either rolled over/refinanced into new instruments or represented historical debt structure documentation. The LLM's interpretation that Apple 'still carries that floating-rate debt' and 'plans to roll it over as the 2019 maturity approaches' is chronologically impossible and demonstrates a failure to properly synthesize the temporal information. While the LLM correctly identifies the exhibit location (Exhibit 4.4, page 56) and the filing years (2022, 2023, 2024), the core analytical conclusion about Apple's debt management strategy is fundamentally flawed due to this temporal misunderstanding. The answer also adds unsupported claims about 'managing interest-rate risk' without evidence from the filings. The ground truth's more cautious interpretation - that continued disclosure reflects a 'deliberate and stable approach' and transparency around 'historical debt instruments' - is more logically sound given the maturity date predates the filing period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 478,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across all three years the 4.000 % Notes due 2021 are shown in the same place – as part of **Exhibit 4.6, the “Third Supplemental Indenture” dated Feb 8 2011** (see the exhibit tables on page 104 of the 2022, 2023 and 2024 10‑Ks)【page_104】. The description has not changed from one filing to the next, indicating that Microsoft still lists this issue in its indenture schedule and therefore treats the 4.000 % Notes as an ongoing component of its debt portfolio. This continuity signals that the instrument remains relevant to the company’s capital structure even after its original 2021 maturity date.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the 4.000% Notes due 2021 as appearing consistently across 2022, 2023, and 2024 10-K filings; (2) Accurately references Exhibit 4.6 as the location where these notes appear; (3) Correctly identifies the exhibit as the 'Third Supplemental Indenture' dated February 8, 2011; (4) Properly notes that the description remained unchanged across filings; (5) Correctly interprets the ongoing relevance despite post-maturity status; (6) Provides specific page reference (page 104) which adds credibility. MINOR WEAKNESSES: (1) The LLM answer is slightly more specific/detailed than the ground truth (mentioning specific page numbers and exact exhibit dates), which while accurate, goes slightly beyond what was explicitly confirmed in the ground truth; (2) The ground truth mentions 'covenants or indentures that continued to apply' as possible explanations for post-maturity inclusion, while the LLM focuses on the indenture schedule aspect - both are valid interpretations but the LLM doesn't explicitly address the covenant angle; (3) The phrase 'treats the 4.000% Notes as an ongoing component of its debt portfolio' could be slightly misleading since the notes were matured - the ground truth more carefully states they 'remained a part of its structured debt disclosures' which is more precise. QUANTITATIVE VERIFICATION: All dates (2021 maturity, Feb 8 2011 indenture date, 2022/2023/2024 filing years) and percentages (4.000%) are correct. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and draws appropriate conclusions about the instrument's ongoing relevance. The logic connecting consistent exhibit inclusion to ongoing structural relevance is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly more specificity and detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 530,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "Across the three filings UPS described the $276 million 7.620 % debentures in the same way: they mature on April 1 2030, pay interest semi‑annually in April and October, and are redeemable at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps, with no sinking‑fund requirement. The principal amount and redemption language were unchanged from 2022 to 2024, and the debentures were consistently shown at roughly $280 million of carrying value, representing a stable, modest component of UPS’s overall long‑term debt as total debt grew modestly over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key factual details about the 7.620% debentures: the $276 million principal amount, April 1, 2030 maturity date, semi-annual interest payments in April and October, and the redemption mechanics (greater of principal plus accrued interest or present value of remaining payments discounted at Treasury yield plus 5 basis points). The carrying value of approximately $280 million is also accurate. However, the answer has significant weaknesses in addressing the core question about how treatment and disclosure 'evolved' from 2022-2024. The original answer emphasizes a meaningful progression: (1) 2022 focused on historical interest rate context (8.375% until April 2020, then 7.620%), (2) 2023 presented the debentures in a broader debt table format, and (3) 2024 shifted to sharper focus on redemption mechanics and positioning within international debt instruments. The LLM answer states the debentures were 'described in the same way' across all three years and were 'unchanged,' which directly contradicts the ground truth's assertion of a clear evolution in presentation and context. The LLM fails to capture the shift from historical rate context to structural/comparative treatment within the global debt portfolio. While the LLM correctly notes the debentures were 'consistently shown at roughly $280 million,' it misses the nuanced disclosure evolution that was central to the original answer. The LLM also adds accurate detail about 'no sinking-fund requirement' which is consistent with the filings but not explicitly mentioned in the ground truth. The answer is partially correct on facts but fundamentally misses the analytical thrust of the question regarding evolution and changing disclosure emphasis over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 484,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie’s Vraylar moved from late‑stage development to a growing commercial driver over the period. The 2022 filing notes that in October 2021 AbbVie reported top‑line Phase 3 results showing Vraylar’s efficacy as an adjunctive treatment for major depressive disorder (MDD) [page 60]; the 2023 filing then confirms FDA approval of that MDD indication, which helped lift Vraylar’s sales 35 % to $2.8 billion in 2023 versus $2.0 billion in 2022 [page 44] (total revenue $2,759 m in 2023 vs. $2,038 m in 2022 [page 42]). By 2024 Vraylar remains highlighted as a core neuroscience product in AbbVie’s portfolio [page 6], indicating that its expanded label and strong revenue growth have elevated it to a strategically important pillar of the company’s neuroscience business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. Verification of key numbers: (1) 2023 Vraylar revenue of $2,759 million matches ground truth exactly; (2) 2022 revenue of $2,038 million is correct; (3) 35% YoY growth calculation is accurate ($2,759M vs $2,038M = 35.2%, rounds to 35%); (4) The $2.8 billion and $2.0 billion figures are acceptable format variations of the precise amounts. The LLM correctly identifies the October 2021 Phase 3 results announcement (noted in 2022 filing), FDA approval of MDD indication in 2023, and Vraylar's status as a core neuroscience product by 2024. Multi-hop synthesis is sound: the answer traces development (Phase 3 results) → regulatory approval → commercial success → strategic importance. However, there is one minor omission: the ground truth specifies that one Phase 3 trial met its primary endpoint while the other showed numerical but not statistically significant improvement. The LLM states results showed 'efficacy' without noting the mixed trial outcomes, which is a slight simplification but not a material error. The answer appropriately addresses all parts of the question: development trajectory, commercialization progress, financial performance with specific metrics, and strategic importance conclusion. The reasoning is logical and well-supported by cited evidence. The characterization of Vraylar's evolution from 'late-stage clinical asset' to 'key revenue driver' aligns with ground truth. Overall, this is a comprehensive, accurate answer with only minor omissions in clinical trial detail specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 442,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s Form 10‑K exhibit lists still contain the 0.45 % Notes due 2016 in each year’s filing (see the exhibit description that includes “0.45% Notes due 2016” in the 2024 filing 【page_56】). By keeping this legacy, low‑interest note on the schedule even after it has matured, Apple signals that its long‑term debt structure spans many vintages and maturities and that it follows a disclosure policy that retains every historic issuance to give investors a complete, transparent view of all debt instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 0.45% Notes due 2016 appear in Apple's filings across multiple years (2022, 2023, 2024), (2) these notes matured in 2016 but continued to be disclosed, and (3) this reflects Apple's transparency and disclosure strategy. The numeric values (0.45%, 2016 maturity date) are accurate. The reasoning about Apple's disclosure policy maintaining historical debt records for investor transparency is sound and aligns with the ground truth. However, there are minor differences: (1) The LLM answer does not explicitly mention the specific exhibit (Exhibit 4.3) or the Officer's Certificate dated May 3, 2013, which are concrete details in the ground truth that support the argument. (2) The LLM answer references a page number (page_56) which adds specificity but wasn't in the original answer. (3) The LLM's phrasing about 'legacy, low-interest note' and 'spans many vintages and maturities' conveys the same meaning as the ground truth but with slightly different emphasis. The multi-hop reasoning is sound—the answer correctly synthesizes that consistent inclusion across three years suggests a deliberate disclosure strategy. The answer adequately addresses the question about what the consistent inclusion suggests about debt structure and disclosure strategy. Minor omissions of specific exhibit details prevent a higher score, but the core factual and analytical content is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 398,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In the 2022 and 2023 filings UPS described SurePost as a residential‑ground product for non‑urgent, lightweight shipments that used the UPS ground network for transport but relied on the United States Postal Service to make the final‑mile delivery. The 2024 filing still notes that USPS performed the final delivery through 2024, but adds that, beginning Jan. 1 2025, UPS will insource that final‑mile step—giving UPS full control of the service and positioning SurePost as an integrated, higher‑value, cost‑effective offering within its U.S. Domestic Package segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. All key facts are correct: (1) 2022-2023 positioning as residential ground service for non-urgent, lightweight shipments using UPS ground network with USPS final delivery - matches ground truth exactly; (2) 2024 transition announcement for January 1, 2025 insourcing of final-mile delivery - correctly dated and described; (3) Strategic implications properly identified (enhanced service quality, full control, higher-value positioning). Quantitative accuracy is perfect - all dates (2022, 2023, 2024, January 1, 2025) are correct with no calculation errors. The multi-hop reasoning is sound, successfully synthesizing the evolution across three years and connecting operational changes to strategic positioning. The LLM answer actually provides slightly more context than the ground truth by explicitly noting that USPS performed final delivery \"through 2024\" before the transition, which adds helpful clarity without contradicting the original answer. The semantic equivalence is strong - phrases like \"insource the final delivery component\" and \"shifting from reliance on USPS to internal control\" convey the same meaning as the ground truth's description of the strategic transformation. Minor point: The LLM's characterization of the 2025 positioning as \"integrated, higher-value, cost-effective offering\" goes slightly beyond what the ground truth explicitly states, though it is a reasonable inference from the context of \"enhance service quality\" and \"service differentiation.\" This represents a minor enhancement rather than an error. Overall, the answer fully addresses all parts of the multi-part question regarding role evolution, operational structure changes, delivery methodology shifts, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 498,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 2022 Form 10‑K already disclosed a 4.45 % global note maturing in 2044 in Exhibit 4.4 (Officer’s Certificate dated May 6 2014)【page_58†L13-L16】. The same 4.45 % Notes due 2044 are listed again in the 2023 filing and are reiterated in the 2024 Form 10‑K’s Exhibit 4.4【page_56†L13-L16】, showing that Apple has kept this ultra‑long‑dated bond on its balance sheet for several years. The multi‑year presence of the 2044 note reflects a deliberate long‑term capital strategy: Apple issues and retains low‑coupon, very‑long‑maturity debt to lock in cheap financing and smooth its debt‑maturity profile over decades.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 4.45% coupon rate, the 2044 maturity date, and the May 6, 2014 Officer's Certificate date are all accurately cited. The answer correctly references the consistent presence across 2022, 2023, and 2024 filings. ENTITY ACCURACY: Apple is correctly identified, the specific debt instrument (4.45% Notes due 2044) is properly named, and the exhibit references (Exhibit 4.4) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to establish a pattern of consistent debt retention. The logic correctly connects the repeated appearance of the same debt instrument across multiple years to strategic capital management decisions. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Apple maintained this long-term debt without early redemption and that this reflects deliberate capital strategy. The LLM adds slightly more interpretive detail (\"lock in cheap financing and smooth its debt-maturity profile\") which is reasonable inference from the pattern but goes marginally beyond what the ground truth explicitly states. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how the debt evolved (remained consistent), (2) the multi-year pattern (present in 2022, 2023, 2024), and (3) what it indicates about capital strategy (long-term debt retention for financial flexibility). Minor note: The ground truth uses \"sustained reliance\" and \"strategic decision to retain\" while the LLM uses \"deliberate long-term capital strategy\" and \"lock in cheap financing\" - these are semantically equivalent and both reasonable characterizations of the same underlying pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 502,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle listed the 2.875 % Notes due 2031 under Exhibit 4.14 in each of its 2022, 2023 and 2024 10‑K filings, referencing the same March 24 2021 officers’ certificate for the series【page_112】【page_111】. By keeping the notes in the same exhibit year after year, Oracle treats them as a stable, long‑term component of its senior unsecured debt program, signalling a disciplined capital‑structure approach that relies on a series of fixed‑rate notes with staggered maturities to manage financing costs, liquidity and overall debt strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All key facts are correct - the 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 across 2022, 2023, and 2024 10-K filings; (2) The March 24, 2021 officers' certificate date is accurately cited; (3) The core insight about stable capital structure management is sound and well-articulated; (4) The answer correctly identifies this as part of Oracle's senior unsecured debt program with staggered maturities; (5) Numeric values (2.875%, 2031 maturity, years 2022-2024) are all accurate. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'fixed-rate notes with staggered maturities' and 'financing costs, liquidity and overall debt strategy' that goes slightly beyond what the ground truth explicitly states - while this reasoning is logical and likely correct, it represents modest extrapolation beyond the documented facts; (2) The ground truth emphasizes 'no modifications to the terms' more explicitly, while the LLM answer focuses on consistent exhibit positioning without explicitly stating there were no term modifications; (3) The phrase 'disciplined capital-structure approach' is interpretive language not directly stated in the ground truth. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years (2022, 2023, 2024) and connects the exhibit positioning to broader capital structure strategy. The reasoning linking consistent exhibit placement to stable debt strategy is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly more interpretive framing about Oracle's strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 474,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement raised wage‑ and benefit‑rate levels, so the UPS/IBT Full‑Time Employee Pension Plan recorded higher benefit accruals that were reflected in the plan’s year‑end measurement (see page 82). The 2024 filing shows a 5.42 % discount rate and that a one‑basis‑point drop in that rate would raise the projected benefit obligation by about $60 million (page 88), indicating that UPS’s pension obligations remain large and long‑term.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts about the 2023 Teamsters agreement and its impact on pension benefit accruals, and provides specific quantitative details (5.42% discount rate, ~$60 million sensitivity). However, there are significant gaps in completeness and reasoning quality. STRENGTHS: (1) Correctly identifies the 2023 Teamsters agreement raised wage and benefit rates; (2) Correctly notes these changes were reflected in year-end plan measurement; (3) Provides specific discount rate (5.42%) and sensitivity analysis ($60M per basis point); (4) Appropriately connects to long-term pension obligations. WEAKNESSES: (1) The answer lacks important context from the ground truth about the plan's history (noncontributory status, Central States Pension Fund background, collective bargaining framework); (2) Does not address the 2024 disclosure showing 'no structural changes,' which is a key insight about the stability of obligations; (3) Missing discussion of 'funded status' implications mentioned in ground truth; (4) The answer is more narrowly focused on technical metrics rather than the broader implications for long-term obligations; (5) Does not synthesize the multi-hop reasoning about what the 2023 agreement reveals about UPS's commitment to defined benefit plans under collective bargaining. QUANTITATIVE VERIFICATION: The specific numbers provided (5.42% discount rate, $60M sensitivity) cannot be verified against the ground truth but appear plausible and specific. The answer cites page references (82, 88) suggesting document-specific data. MULTI-HOP REASONING: The answer makes a basic connection between the 2023 agreement and 2024 disclosures but misses the deeper synthesis about what 'no structural changes' in 2024 reveals about the permanence of the 2023 obligations. The ground truth emphasizes this as 'the most recent material update,' which the LLM answer does not capture. Overall, the answer is partially correct with accurate specific details but incomplete in addressing the full scope of the question regarding long-term implications and the significance of the 2024 disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 571,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K reports for 2022, 2023 and 2024 all reference the same Officer’s Certificate dated May 6 2014 (Exhibit 4.4), which lists the 1.05 % notes due 2017 – the exhibit appears unchanged in the 2022 filing’s index (see page 58) and again in the 2024 filing’s index (see page 56). The 2023 filing (pages 53‑57) repeats this reference without amendment, showing that Apple has kept the 1.05 % notes as a recurring short‑term financing instrument and has disclosed it consistently year‑over‑year, reflecting a stable, disciplined approach to managing the debt issued under its 2014 Officer’s Certificate.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information across three years of Apple's 10-K filings. STRENGTHS: (1) All key numeric values are correct: 1.05% interest rate, 2017 maturity date, May 6, 2014 Officer's Certificate date. (2) The multi-hop synthesis is sound—the answer correctly identifies that the same disclosure appears consistently across 2022, 2023, and 2024 filings. (3) The reasoning about Apple's 'stable, disciplined approach' and 'passive management' aligns with the ground truth's interpretation. (4) Entity identification is accurate (Apple, Officer's Certificate, specific debt instrument). (5) Page references (58, 56, 53-57) and exhibit citations (Exhibit 4.4) add specificity and credibility. MINOR WEAKNESSES: (1) The LLM answer includes specific page numbers and exhibit references that, while appearing plausible, cannot be verified against the ground truth provided. These details enhance the answer but introduce slight risk if they are inaccurate. (2) The phrasing 'recurring short-term financing instrument' is slightly different from the ground truth's 'short-term debt obligation,' though semantically equivalent. (3) The answer could have been more explicit about what 'unchanged' means (i.e., no refinancing, no modification of terms), though this is implied. CALCULATION/VERIFICATION: No calculations required; all dates and percentages are correctly stated. The core claim that disclosure remained consistent across all three years matches the ground truth exactly. The interpretation that this reflects a passive/stable management approach is well-supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 457,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 have been disclosed in the “Description of Securities” exhibit (Exhibit 4.3) in every filing. In the 2022 Form 10‑K the note appears in Officer’s Certificate dated May 3 2013 (see page 58) and the same exhibit is repeated in the 2023 filing, and again in the 2024 Form 10‑K (see page 56). The unchanged, year‑over‑year inclusion shows Apple’s practice of keeping a continuous, transparent record of each debt issuance, reflecting a disciplined long‑term debt‑management strategy that tracks obligations through their life‑cycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. STRENGTHS: (1) All numeric values are correct - the 2.40% interest rate, the 2023 maturity date, and the May 3, 2013 Officer's Certificate date are all accurate. (2) The multi-hop synthesis is sound - the answer correctly traces the disclosure across three fiscal years (2022, 2023, 2024) and identifies the consistent presentation in Exhibit 4.3. (3) Entity identification is precise - Apple is correctly identified, the specific debt instrument is properly characterized, and the filing structure is accurately described. (4) The reasoning about debt management strategy is logically sound - the unchanged disclosure pattern is correctly interpreted as reflecting disciplined debt management and transparent tracking through the obligation's lifecycle. (5) Page references (58 for 2022, 56 for 2024) add specificity, though these cannot be independently verified from the ground truth. MINOR CONSIDERATIONS: The LLM answer uses slightly different framing than the ground truth (emphasizing 'transparent record' and 'disciplined long-term debt-management strategy' vs. the ground truth's 'stable long-term debt strategy'), but both convey the same essential insight about consistent management. The LLM answer is slightly more detailed in describing the exhibit structure and filing mechanics, which adds helpful context without introducing errors. The core conclusion - that the static disclosure indicates stable, consistent debt management - is semantically equivalent to the ground truth's assessment. No calculation errors, date errors, or factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 454,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "In 2022 Vraylar had just completed two pivotal Phase 3 trials that showed it could be used as an adjunctive therapy for major‑depressive disorder and it posted $2.0 billion of net sales – roughly an 18 % increase versus 2021 (2022 10‑K tables, p. 61‑62).  In 2023 the FDA granted approval for that adjunctive‑MDD indication, which drove a 35 % jump in revenue to $2.76 billion and reinforced Vraylar’s status as a multi‑indication antipsychotic/antidepressant in AbbVie’s neuroscience franchise (2023 10‑K, p. 44).  By 2024 the product is described as a dopamine‑D3‑preferring D3/D2 and 5‑HT1A partial agonist indicated for schizophrenia, bipolar mania/depression and adjunctive MDD, keeping it a core, broadly positioned therapy in the company’s neuroscience portfolio (2024 10‑K, p. 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. CORRECT ELEMENTS: (1) 2022 clinical progress on MDD adjunctive indication - accurately described; (2) 2023 revenue of $2.76 billion matches ground truth ($2,759 million with acceptable rounding); (3) 35% revenue growth calculation is correct; (4) 2024 therapeutic positioning accurately captures schizophrenia, bipolar I disorder, and adjunctive MDD indications; (5) Multi-hop synthesis across 2022-2024 is sound and well-structured. MINOR DISCREPANCIES: (1) LLM states 2022 sales as '$2.0 billion' while ground truth specifies U.S. sales of $2,037 million in 2022 - the LLM appears to be rounding total sales, which is acceptable formatting but creates slight ambiguity about whether this is U.S. or global figure; (2) LLM mentions 'one successful Phase 3 trial and numerically positive but non-significant result in another' is not explicitly stated in LLM answer, though the answer does reference 'two pivotal Phase 3 trials' which aligns with ground truth; (3) LLM adds mechanistic detail ('dopamine-D3-preferring D3/D2 and 5-HT1A partial agonist') not in ground truth, which is additional context rather than an error. QUANTITATIVE VERIFICATION: 2023 revenue $2.76B vs $2,759M (acceptable rounding); 35% growth calculation verified as correct; 18% 2022 growth claim cannot be verified against provided ground truth but is plausible. MULTI-HOP REASONING: Excellent synthesis across three years showing clinical development → revenue impact → portfolio positioning. The answer correctly traces Vraylar's evolution and connects clinical approvals to commercial outcomes. CONTEXTUAL RELEVANCE: Highly relevant, addresses all three components of the question (clinical development, revenue growth, therapeutic positioning) with appropriate detail and source citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 500,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM listed “client relationships and trust” as one of its principal competitive methods in the 2022 filing (Item 1 – Competition, p. 3) and repeated the same phrasing in the 2023 filing (Item 1 – Competition, p. 3) and again in 2024 (Item 1 – Competition, p. 3), each time tying it to the company’s hybrid‑cloud and AI platform that enables digital transformation【page_3†L15-L22】. The continuity—and the increasingly explicit link to hybrid‑cloud/AI capabilities—signals that IBM is positioning deep, trusted client relationships as a strategic moat that differentiates its integrated hybrid‑cloud and AI offerings from pure‑play cloud rivals and underpins its growth strategy in the market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized 'client relationships and trust' across 2022-2024 filings and ties this to hybrid cloud/AI capabilities. However, there are significant gaps in addressing the question's core requirement about how this emphasis EVOLVED. Strengths: (1) Correctly identifies the consistent messaging across three years (2022, 2023, 2024); (2) Accurately notes the connection to hybrid cloud and AI platform; (3) Properly cites Item 1 Competition sections; (4) Correctly interprets this as a strategic differentiator against pure-play cloud rivals. Weaknesses: (1) MAJOR: The LLM states the 'same phrasing' was repeated across all three years, which contradicts the ground truth that shows EVOLUTION in context and framing - the ground truth explicitly describes how 2023 expanded to include strategic partnerships and 2024 reinforced trust in go-to-market strategy with ecosystem partners. The LLM misses this progression entirely; (2) The LLM's conclusion about 'increasingly explicit link' is vague and doesn't capture the substantive strategic evolution described in ground truth (from platform integration → partnerships → ecosystem/go-to-market); (3) The answer lacks the multi-year progression narrative that the question specifically asks for - it treats the three years as static rather than showing how the strategic framing deepened; (4) Missing the key insight that trust evolved from being part of the platform value proposition to becoming an enabler of integrated, client-centric innovation. The LLM provides a surface-level observation of consistency rather than the deeper strategic evolution the ground truth reveals. The answer is partially correct on facts but fails to adequately address the 'evolution' and 'multi-year progression' aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 492,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In IBM’s 2022 10‑K the 1.250 % Notes due 2027 were not called out in the exhibit list (the 2022 exhibit schedule only references the 6.22 % Debentures due 2027)【page_31】, whereas the 2023 filing began to disclose the instrument explicitly by incorporating the rights agreement as Exhibit 4.3 of a 2019 Form 8‑K【page_20】. By the 2024 report the notes appear directly in the Section 12(b) securities table as “1.250 % Notes due 2027” (ticker IBM27B)【page_1】, showing a shift to more transparent, stand‑alone disclosure and confirming that the notes remain an active component of IBM’s overall debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a structured timeline of disclosure evolution from 2022-2024 with specific details about exhibit references and ticker symbols. However, there are significant discrepancies with the ground truth that affect overall accuracy:\n\nCORRECT ELEMENTS:\n- The 2024 disclosure showing the notes in Section 12(b) securities table with ticker IBM27B is accurate\n- The general progression toward more transparent, stand-alone disclosure is correctly identified\n- The reference to Exhibit 4.3 of a 2019 Form 8-K is mentioned in both answers\n- The note's continued role in IBM's debt portfolio is correctly characterized\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. The LLM states the 2022 10-K did NOT include the 1.250% Notes in the exhibit list, claiming only \"6.22% Debentures due 2027\" were referenced. The ground truth indicates the 1.250% Notes WERE referenced in 2022's exhibit list, tied to the January 30, 2019 Form 8-K filing. This is a factual contradiction.\n2. The LLM characterizes 2023 as the year when disclosure \"began\" explicitly, but the ground truth indicates the notes were already referenced in 2022, making 2023 a continuation rather than an initiation of disclosure.\n3. The LLM's framing suggests a more dramatic shift in disclosure practices than the ground truth supports - the ground truth shows consistent referencing across years with evolving complexity, not an absence-to-presence transition.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three years and identifies the progression in disclosure practices. However, the fundamental error about 2022 non-disclosure undermines the multi-hop analysis, as it mischaracterizes the starting point of the timeline.\n\nNUMERIC/DATE ACCURACY:\nAll dates (2022, 2023, 2024, January 30 2019, February 8 2022) and the percentage (1.250%) are correct. The ticker symbol IBM27B is accurate.\n\nSEMANTIC ISSUES:\nWhile the LLM's language about \"transparency\" and \"stand-alone disclosure\" aligns with the ground truth's characterization of \"increasing transparency,\" the factual foundation regarding 2022 disclosure is flawed, which cascades through the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 583,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 Form 10‑K filings the 6.50 % Debentures due 2028 are disclosed in exactly the same way – as “Exhibit 2 to Form 8‑K, filed January 8 1998, incorporated by reference.” That reference appears in the Item 15 exhibit table alongside a long list of other debentures and notes (e.g., 7.00 % 2025, 7.00 % 2045, 6.22 % 2027, 5.875 % 2032, etc.), each similarly incorporated, indicating IBM’s debt‑instrument disclosures have remained consistent and unchanged from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to Form 8-K filed January 8, 1998 across 2022-2024, (2) the exhibit reference appears in Item 15, and (3) other debentures are listed alongside (6.22% 2027, 5.875% 2032, etc.). Quantitative accuracy is strong - all dates, percentages, and years are correct. However, the LLM answer significantly undersells the qualitative evolution described in the ground truth. The original answer emphasizes that while the exhibit reference remained consistent, the 'broader context of IBM's debt disclosures evolved subtly over time' - specifically that in 2022 the debentures were listed among a wider range including shorter-dated instruments (2022, 2023, 2024 maturities), whereas by 2023-2024 the focus shifted to integrating legacy debt alongside newer longer-dated instruments. The LLM answer states the disclosures 'have remained consistent and unchanged from 2022 through 2024,' which contradicts the ground truth's assertion of subtle evolution in the broader context. The LLM also omits the ground truth's important contextual point about how this consistency 'likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.' The answer is partially correct on the narrow point (exhibit reference consistency) but misses the nuanced evolution in the broader debt disclosure landscape that the question specifically asks about. This represents incomplete synthesis of the multi-hop reasoning required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 432,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In 2022 FedEx International Connect Plus was a contractual e‑commerce service “currently available from nearly 50 origin countries to over 130 destination countries”【page_14】. By 2024 the service had broadened to “nearly 60 origin countries to over 190 destination countries”【page_8】. This steady expansion of origin‑ and destination‑coverage shows FedEx is deliberately scaling its cross‑border e‑commerce logistics network, emphasizing global reach to capture growing online‑shopping demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 baseline (nearly 50 origin countries to over 130 destination countries) and the 2024 endpoint (nearly 60 origin countries to over 190 destination countries). The numbers are accurate and properly formatted. The LLM correctly recognizes this as an e-commerce logistics service and notes the expansion trajectory.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly mentions a 2023 intermediate data point (nearly 60 origin countries and over 190 destination countries) that shows the expansion pattern more clearly. The LLM jumps from 2022 to 2024 without acknowledging the 2023 milestone, missing a key part of the 'evolution' requested in the question. (2) INCOMPLETE STRATEGIC ANALYSIS: The ground truth provides crucial insight that the 2023-2024 plateau (both at nearly 60 origin and over 190 destination countries) indicates 'stabilization as the service reached a mature coverage level' and represents 'completion of a major phase of international deployment.' The LLM describes only 'steady expansion' without capturing this important strategic inflection point - that growth accelerated then stabilized. (3) MISSING TEMPORAL NUANCE: The question asks about 'expansion trajectory' which implies understanding the pattern of growth over time. The ground truth shows aggressive expansion (2022→2023) followed by stabilization (2023→2024), suggesting a deliberate phased approach. The LLM misses this nuance by not including the 2023 data point. (4) INCOMPLETE STRATEGIC INTERPRETATION: While the LLM notes FedEx is 'deliberately scaling' the network, it doesn't capture the strategic implication that the service has now reached a mature, stable coverage level after rapid expansion - an important distinction for understanding FedEx's current market positioning.\n\nCALCULATION/FACT CHECK: All numbers cited are accurate. No calculation errors. Entity identification (FedEx, International Connect Plus, e-commerce) is correct.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the information but fails to incorporate the complete temporal evolution (missing 2023 data point) and therefore cannot fully assess the 'expansion trajectory' as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 598,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "In fiscal 2022 Qualcomm set explicit 2025 human‑capital diversity targets – increase women in leadership by 15 %, increase under‑represented‑minority (URM) leaders by 15 % and raise overall URM representation by 20 % – and said the HR & Compensation Committee would use progress on those goals as a non‑financial modifier that could vary executive bonuses between 0.9 × and 1.1 × the target payout【page_17】. In fiscal 2023 and again in fiscal 2024 the filing reiterated its DEI focus and kept the same bonus‑adjustment range (0.9‑1.1 ×) (see 2023 p. 16 and 2024 p. 16), but it no longer restated the specific percentage targets, indicating the goals remain in place but are now referenced more generally.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numeric values and dates. Strengths: (1) All quantitative data is accurate - the 15% women in leadership target, 15% URM leadership target, 20% overall URM representation target, and 0.9-1.1x bonus adjustment range are all correctly stated. (2) The fiscal year progression (2022, 2023, 2024) is correctly identified. (3) The multi-hop synthesis is sound - the answer correctly traces how goals were set in 2022, reaffirmed in 2023-2024, and how the bonus adjustment mechanism remained consistent across all three years. (4) The observation that specific percentage targets were no longer restated in later filings while the bonus adjustment range remained is a valid interpretation of the evolution. Minor weaknesses: (1) The answer omits mention of the Reboot Representation Tech Coalition and the specific initiative to double degrees for underrepresented groups by 2025, which the ground truth includes as evidence of 'expanding external partnerships.' (2) The characterization of goals being 'referenced more generally' in later years is somewhat speculative - the ground truth states they were 'reaffirmed' with 'no changes to the targets,' which is slightly different from the LLM's implication that they may have been de-emphasized. (3) The answer could have been more explicit about the 'stable strategic framework with sustained incentive alignment' aspect mentioned in the ground truth. Overall, the core answer is factually correct and addresses the main evolution of diversity targets and bonus mechanisms, but misses some contextual details about external partnerships and the strength of reaffirmation across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 469,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the “Floating Rate Notes due 2019” among its outstanding debt instruments (see the Exhibit 4.4 description of securities in the 2024 filing 【page_58】 and the same listing in the 2022 filing 【page_56】). By keeping this short‑term, rate‑resetting debt on its balance sheet year after year, Apple signals that it uses floating‑rate notes to hedge against short‑term interest‑rate movements and to preserve liquidity flexibility for working‑capital and other cash‑flow needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Apple's Floating Rate Notes due 2019 appeared in debt disclosures across 2022, 2023, and 2024, and provides reasonable interpretation of Apple's interest rate risk management approach. However, there are significant issues: (1) FACTUAL ERROR - The notes are described as 'short-term' and 'due 2019' which is contradictory and problematic. If these notes were due in 2019, they should not have appeared on the balance sheet in 2022-2024 unless they were refinanced or the description is inaccurate. The LLM does not address this temporal inconsistency. (2) CITATION ISSUES - The LLM cites specific page numbers (page_58 for 2024, page_56 for 2022) but these cannot be verified and appear potentially fabricated. (3) INCOMPLETE ANALYSIS - While the ground truth emphasizes that the 'recurring appearance' and 'consistency' across all three years reflects a 'deliberate and stable approach,' the LLM's answer is more superficial and doesn't fully explore why these specific instruments persisted. (4) REASONING QUALITY - The LLM correctly infers that floating-rate notes are used for interest rate hedging and liquidity flexibility, which aligns with the ground truth's mention of 'flexible debt instruments' and 'adapting to changing interest rate environments.' However, the LLM doesn't address the broader strategic implications about liquidity planning and capital returns mentioned in the ground truth. (5) SEMANTIC ALIGNMENT - The core interpretation about using floating-rate notes for rate management and liquidity is semantically equivalent to the ground truth, but the execution is incomplete and contains potential factual errors regarding the maturity date paradox.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 467,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm placed its digital‑cockpit offering inside the QCT automotive platform and warned that analysts expected >70 % of new vehicles to have embedded cellular connectivity by 2028 (with ≈60 % of those equipped with 5G), signaling a large near‑term market for in‑vehicle digital experiences (see 2022 p. 8). By the 2024 filing the same QCT segment still houses “automotive (connectivity, digital‑cockpit and ADAS/AD)” and automotive revenue— which includes digital‑cockpit sales—has risen from $1.5 billion in 2022 to $2.9 billion in 2024, showing Qualcomm’s strategic shift to prioritize digital‑cockpit technology as that projected demand materializes (see 2024 p. 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Qualcomm's digital cockpit evolution but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the progression from 2022 positioning through 2024 integration; (2) Accurately notes that digital cockpit moved from conceptual to commercial revenue generation; (3) Properly identifies QCT segment structure and automotive offerings (connectivity, digital-cockpit, ADAS/AD); (4) Provides specific revenue figures ($1.5B in 2022 to $2.9B in 2024) showing growth trajectory; (5) Good multi-hop synthesis connecting market projections to business strategy. CRITICAL ERRORS: (1) The 5G connectivity projection is materially misstated - LLM claims '>70% of new vehicles to have embedded cellular connectivity by 2028 (with ≈60% of those equipped with 5G)' but ground truth states 'over 60% of new vehicles would feature 5G connectivity by 2028' - these are fundamentally different metrics and the LLM's interpretation appears incorrect; (2) The revenue figures ($1.5B in 2022 to $2.9B in 2024) cannot be verified against the ground truth which does not provide specific automotive revenue numbers for these years, making this a potential factual claim without supporting evidence. REASONING QUALITY: The multi-hop synthesis is sound - connecting market projections to business strategy to revenue growth - but the quantitative foundation is questionable. The answer demonstrates good understanding of the strategic evolution but the specific numbers and market projections need verification. The answer is more detailed than ground truth but introduces unverified financial data that could be incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 463,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private funds – the category that includes private‑real‑estate funds – fell from **$569 million at the end of 2022** to **$555 million at the end of 2023** (ABT 2023 10‑K, p. 71) and then to **$540 million at the end of 2024** (ABT 2024 10‑K, p. 70). This gradual reduction suggests the company is either honoring existing commitments or limiting new ones, indicating a more disciplined, liquidity‑aware long‑term strategy for illiquid alternative assets such as private real‑estate.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $569M (2022), $555M (2023), $540M (2024). (2) Proper citation of sources (ABT 2023 10-K p.71, ABT 2024 10-K p.70). (3) Correct identification of the downward trend. (4) Accurate characterization of the strategy as 'liquidity-aware' and 'disciplined.' (5) Quantitative accuracy is perfect with no calculation errors.\n\nWEAKNESSES: (1) The LLM answer omits the specific quantification of the trend: the ground truth explicitly states 'consistent downward trend of $15 million per year,' which is a key analytical insight. The LLM says 'gradual reduction' but doesn't quantify it. (2) Missing important context about liquidation periods (2025-2034 by 2024) that the ground truth includes to support the interpretation that Abbott is 'not exiting the space entirely.' (3) The LLM's interpretation is slightly less precise - it says the company is 'either honoring existing commitments or limiting new ones' which is somewhat vague, whereas the ground truth more clearly characterizes this as 'strategic de-risking or rebalancing.' (4) The phrase 'the category that includes private-real-estate funds' is slightly awkward and less direct than the ground truth's focus on 'private real estate funds' specifically.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year trend across multiple 10-K filings and draws a reasonable conclusion about strategy. However, it doesn't fully leverage all available information from the filings to support the conclusion as comprehensively as the ground truth does.\n\nSEMANTIC EQUIVALENCE: The core message is similar - Abbott is reducing unfunded commitments in a measured way - but the ground truth provides more analytical depth with the $15M/year quantification and the liquidation period context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 488,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all reference the 0.45 % Notes due 2016 in Exhibit 4.3 (the Officer’s Certificate dated May 3 2013) – e.g., the 2022 filing lists “0.45 % Notes due 2016”【page_56】, the 2023 filing repeats the same description【page_56】, and the 2024 filing again includes the note in the same exhibit list【page_56】. Because the notes matured in 2016, they appear only as a historical issuance in each year’s disclosure, showing that Apple issues low‑coupon, short‑term debt and then retires it while continually adding new notes with varied rates and maturities, a pattern that underpins its layered, low‑cost long‑term debt‑structuring strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental and material error that contradicts the ground truth. The LLM states 'Because the notes matured in 2016, they appear only as a historical issuance in each year's disclosure' - this is factually incorrect. The ground truth explicitly states that Apple 'maintained this debt instrument as part of its capital structure across all three years' (2022, 2023, 2024), meaning the notes were ACTIVE debt, not matured/retired. The notes due 2016 would have matured in 2016, yet they are being disclosed in 2022, 2023, and 2024 filings, which is a logical inconsistency the LLM failed to recognize. The LLM's interpretation that these are 'historical issuances' and 'retired' contradicts the ground truth's clear statement that Apple 'maintained' and 'preserved' this debt instrument. CORRECT ELEMENTS: The LLM correctly identifies (1) the 0.45% coupon rate, (2) the 'due 2016' designation, (3) the Officer's Certificate dated May 3, 2013, (4) the consistent appearance across FY 2022, 2023, and 2024 filings, and (5) the exhibit reference (Exhibit 4.3). INCORRECT INTERPRETATION: The LLM's characterization of the debt strategy is fundamentally flawed. The ground truth describes a 'stable long-term debt strategy' with Apple 'preserving a mix of older, lower-yield debt instruments,' whereas the LLM incorrectly frames this as short-term debt that is 'retired' and replaced. This represents a significant misunderstanding of Apple's actual debt management approach. The LLM's conclusion about 'layered, low-cost long-term debt-structuring strategy' is partially correct in concept but is built on the false premise that these notes were retired. MULTI-HOP REASONING: The LLM failed to properly synthesize the information across the three years - it should have recognized that consistent disclosure across all three years indicates ongoing maintenance of the debt, not historical/retired status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 526,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM’s 10‑K filings show a steady, reinforced focus on “client relationships and trust” as a core competitive differentiator – it appears in the Competition section of each year’s filing (2022 Item 1, p. 3‑4; 2023 Item 1, p. 3; 2024 Item 1, p. 3). While the phrasing is unchanged, the surrounding narrative evolves: the 2022 filing first links client value to “leveraging the power of hybrid cloud and artificial intelligence (AI)” (2022 p. 3); the 2023 filing reiterates that the hybrid‑cloud/AI strategy is central to delivering business outcomes (2023 p. 3); and the 2024 filing explicitly ties trust to the secure, scalable delivery of its hybrid‑cloud and AI platforms, positioning IBM as a trusted partner for enterprise digital transformation (2024 p. 3). This multi‑year progression signals that IBM is moving from a broad competitive claim to a strategic positioning that leverages deep client relationships and trust as the foundation for expanding its hybrid‑cloud and AI business and differentiating itself from pure‑play cloud rivals.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of IBM's evolution from 2022-2024 regarding client relationships and trust as a competitive differentiator. STRENGTHS: (1) Correctly identifies the consistent emphasis on 'client relationships and trust' across all three years (2022, 2023, 2024); (2) Accurately captures the evolution from broad competitive claim to strategic positioning tied to hybrid cloud and AI; (3) Properly synthesizes the multi-hop progression showing how trust became increasingly integrated with business outcomes and digital transformation; (4) Correctly cites the Competition section (Item 1) and approximate page numbers for each year; (5) Accurately reflects the linkage between trust and hybrid cloud/AI platforms across the three-year period. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer emphasizes 'unchanged phrasing' while ground truth notes the framing 'evolved' - this is a subtle semantic difference but the LLM does acknowledge evolution in the surrounding narrative, so the distinction is minor; (2) The LLM answer focuses heavily on hybrid cloud/AI linkage, while ground truth also mentions consulting services and strategic partnerships as evolving elements - the LLM somewhat underemphasizes the consulting services angle and the explicit mention of strategic partnerships as enablers of trust in 2024; (3) Ground truth specifically notes 'mission-critical infrastructure' as part of 2023 positioning, which the LLM doesn't explicitly mention. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative strategic question, so quantitative accuracy is not a primary concern. The years (2022, 2023, 2024) and document references are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the progression of strategic positioning. The reasoning connecting trust → hybrid cloud/AI → enterprise digital transformation is sound and matches the ground truth narrative. OVERALL ASSESSMENT: The answer is substantially correct and captures the essential evolution of IBM's strategic positioning. The main limitation is incomplete coverage of consulting services and strategic partnerships as evolving differentiators, which prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 628,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx first disclosed that the 4.250 % Note due 2030 is backed by a dedicated pass‑through trust and a Liquidity Provider Revolving Credit Agreement with BNP Paribas (the “Liquidity Provider” credit line) 【page_119】. In its 2023 filing the company amended that revolving‑credit facility (Amendment No. 1, dated May 22 2023) and the 2024 filing still references the same trust and credit arrangement, indicating FedEx is actively refining and maintaining a dedicated liquidity source to support the note.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant omissions and incomplete synthesis compared to the ground truth. CORRECT ELEMENTS: (1) The 4.250% Note due 2030 is correctly identified; (2) The Liquidity Provider Revolving Credit Agreement with BNP Paribas is correctly mentioned; (3) Amendment No. 1 dated May 22, 2023 is correctly cited; (4) The general characterization of FedEx maintaining and refining the arrangement is directionally accurate. SIGNIFICANT OMISSIONS: (1) The LLM fails to mention Wilmington Trust Company as a key party to the Revolving Credit Agreement (2020-1AA), which is a material omission; (2) The LLM does not reference the Intercreditor Agreement, which is part of the foundational framework established in 2022; (3) The LLM does not explicitly mention the 2020 date of the original Revolving Credit Agreement (August 13, 2020), which provides important context for the evolution; (4) The LLM mentions a 'dedicated pass-through trust' but the ground truth does not emphasize this as a primary element of the liquidity arrangement. MULTI-HOP REASONING: The LLM attempts to synthesize the 2022-2024 evolution but does so incompletely. It correctly identifies the 2023 amendment as a key adjustment but fails to establish the full baseline of foundational agreements from 2022 and does not adequately explain the consistency maintained through 2024. The ground truth provides a more complete narrative of the evolution: foundational setup (2022) → proactive adjustment (2023) → maintained consistency (2024). The LLM's answer jumps to the amendment without fully establishing the baseline framework. QUANTITATIVE ACCURACY: Dates are correct (May 22, 2023; 2023 and 2024 filings referenced). The note percentage (4.250%) is correct. No calculation errors present. QUALITATIVE ACCURACY: The reasoning about 'actively refining and maintaining' is reasonable but lacks the depth of the ground truth's explanation about the strategic approach to credit support. The answer is somewhat superficial in its analysis of what the evolution indicates about FedEx's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 566,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s long‑term debt consistently includes the 4.45 % Notes due 2044 in each of its recent Form 10‑K filings – the notes are listed in the securities exhibit for 2022 (page 58) and appear again in the 2023 (page 56) and 2024 (page 56) filings. The fact that this low‑coupon, 20‑plus‑year bond remains on the balance sheet unchanged over three years indicates Apple’s strategy of locking in cheap, long‑dated financing to diversify its debt‑maturity profile and secure inexpensive capital for the long term.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as a consistent component across 2022, 2023, and 2024 filings; (2) Accurately notes the notes were issued in 2014 (implied by the 30-year maturity from 2014 to 2044); (3) Correctly characterizes the multi-year pattern as showing consistency and stability; (4) Provides specific page references (58, 56, 56) that add credibility; (5) The interpretation that this reflects a long-term financing strategy is sound and aligns with the ground truth conclusion. MINOR ISSUES: (1) The LLM adds interpretive details about 'cheap, long-dated financing' and 'diversify its debt-maturity profile' that, while reasonable and likely accurate, go slightly beyond what the ground truth explicitly states. The ground truth focuses on consistency and retention without early redemption, while the LLM adds strategic rationale about cost optimization and maturity diversification; (2) The phrase 'low-coupon' (4.45%) is reasonable characterization but represents interpretation rather than explicit ground truth statement. QUANTITATIVE ACCURACY: All numbers are correct - 4.45%, 2044 maturity date, three-year period (2022-2023-2024), and the 2014 issuance date are all accurate. Page numbers provided add specificity. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and draws appropriate conclusions about financing strategy consistency. The logic is sound: unchanged presence across three years → stable financing strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth (consistency suggests stable strategy) while providing additional strategic context that is reasonable but slightly beyond the ground truth's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 490,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In 2022 FedEx International Connect Plus was available from “nearly 50 origin countries to over 130 destination countries” (FDX 2022 10‑K, p. 14). By the 2023 filing the service had grown to “nearly 60 origin countries to over 190 destination countries,” and the 2024 filing still lists the same near‑60 origins and >190 destinations (FDX 2023 10‑K, p. 8; FDX 2024 10‑K, p. 8). This rapid expansion of the service’s geographic footprint—adding roughly ten new origin markets and dozens of destination markets before stabilizing at a broad global coverage—shows FedEx’s strategic emphasis on building a worldwide e‑commerce logistics platform to capture cross‑border online‑shopping demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022: nearly 50 origin countries to over 130 destination countries; 2023: nearly 60 origin countries to over 190 destination countries; 2024: same as 2023 (near 60 origins, >190 destinations). The LLM correctly identifies the expansion magnitude (roughly 10 new origin markets, dozens of destination markets) and accurately notes the stabilization pattern. ENTITY ACCURACY: Correctly identifies FedEx International Connect Plus service, proper fiscal years (2022, 2023, 2024), and appropriate filing references (10-K documents). MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to establish the expansion trajectory and then interprets the strategic implications. The logic is sound: rapid expansion 2022-2023, stabilization 2023-2024, indicating a deliberate market capture strategy followed by consolidation. SEMANTIC EQUIVALENCE: The LLM's interpretation that this shows 'strategic emphasis on building a worldwide e-commerce logistics platform to capture cross-border online-shopping demand' aligns well with the ground truth's assessment of 'strategic push to capture global e-commerce logistics demand through enhanced international connectivity.' Minor differences in wording ('consolidation and optimization' vs 'stabilizing at broad global coverage') are semantically equivalent. COMPLETENESS: The answer addresses both parts of the question - the evolution of geographic reach AND what it suggests about strategic focus. The only minor observation is that the LLM could have slightly more explicitly stated the 'consolidation/optimization' phase interpretation, though this is implied in the stabilization discussion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 500,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 are listed only in the “Officer’s Certificate” exhibit (Exhibit 4.4) of each Form 10‑K – FY 2022, FY 2023 and FY 2024 – and do not appear on the consolidated balance sheets for those years, indicating that the notes had fully matured and been retired before the 2022 reporting period【page_56】. Apple’s practice of still referencing the notes in the exhibit list shows that it keeps a complete historical record of all debt issuances, even after they have been repaid, underscoring a disciplined, transparent approach to managing maturing debt instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that the 1.05% Notes due 2017 appear only in Exhibit 4.4 across FY 2022, 2023, and 2024; (2) Accurately notes the notes do not appear on consolidated balance sheets, indicating they had matured and been retired before 2022; (3) Correctly identifies the exhibit location and filing years; (4) Provides sound reasoning about Apple's disclosure approach - maintaining historical records of debt issuances even after repayment as a transparent practice. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer infers that notes were 'fully matured and been retired before the 2022 reporting period' with confidence, while the ground truth is more cautious, stating 'no explicit updates were provided' and suggesting Apple 'may have retained historical references'; (2) The LLM characterizes this as a 'disciplined, transparent approach' while ground truth suggests it 'may have retained historical references as part of a standardized disclosure framework, possibly to maintain continuity...or to reflect refinancing activities'; (3) The LLM is more definitive about the reason (keeping complete historical record) while ground truth presents multiple possible explanations. QUANTITATIVE ACCURACY: All dates (2017 maturity, 2022-2024 fiscal years) and the percentage (1.05%) are correct. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and connects the exhibit location to balance sheet absence to draw conclusions about debt status. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - the notes continued to be referenced despite maturity, reflecting Apple's disclosure practices. The LLM's interpretation is reasonable though slightly more definitive than the ground truth's more measured approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 514,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From FY 2022 Qualcomm already positioned 5G as a core growth engine, with most QTL licensing revenue coming from OFDMA‑based 3G/4G/5G multimode devices (page 6) and early investments in new 5G‑enabled markets such as automotive, IoT and XR (page 8). By FY 2024 the company had deepened that commitment – the bulk of QTL royalties now stem from 5G modem‑RF products and it holds more than 200 active 5G license agreements (page 12), while QSI’s strategic‑investment portfolio expanded into 5G‑related startups across AI, automotive, IoT and XR (page 13) and R&D on 5G RF components and Snapdragon 5G platforms intensified (page 11). At the same time, Qualcomm’s geopolitical exposure sharpened, with explicit warnings that U.S. export‑license revocations for Huawei and broader U.S./China trade‑and‑national‑security restrictions could curtail licensing and product revenues (page 20).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Qualcomm's 5G strategy across FY 2022-2024, appropriately emphasizes the deepening commitment to 5G, and accurately captures the geopolitical risks (Huawei export license revocations, U.S./China trade restrictions). The answer correctly identifies key strategic areas (automotive, IoT, AI, XR) and mentions QTL licensing revenue, QSI venture investments, and R&D intensification. The multi-hop synthesis across years and business segments is sound.\n\nCRITICAL ERRORS: (1) The LLM states Huawei contributed $560 million in fiscal 2024 'prior to the ban,' but the ground truth explicitly states this $560 million was 'in fiscal 2024 prior to the ban' - the LLM's phrasing is ambiguous and could be misinterpreted as the contribution occurring before FY 2024, when it actually occurred during FY 2024. This is a significant quantitative detail that should be precisely stated. (2) The LLM mentions '200 active 5G license agreements' but the ground truth does not provide this specific number - this appears to be either fabricated or from a different source not in the ground truth. (3) The LLM omits the specific projection of '27 billion IoT devices by 2026' mentioned in the ground truth for FY 2022, which is a concrete forward-looking metric that demonstrates strategic commitment.\n\nMINOR ISSUES: (1) The LLM references specific page numbers (6, 8, 12, 13, 11, 20) which add specificity but cannot be verified against the ground truth. (2) The mention of 'OFDMA-based 3G/4G/5G multimode devices' in FY 2022 is accurate but the ground truth emphasizes 'OFDMA-based (including 5G)' more broadly without explicitly breaking down 3G/4G components for that year.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple business segments (QTL licensing, QSI ventures, R&D), showing proper understanding of how these elements interconnect to demonstrate deepening 5G commitment despite geopolitical headwinds.\n\nQUANTITATIVE ACCURACY PENALTY: The $560 million Huawei figure is mentioned in ground truth but not clearly attributed to FY 2024 in the LLM answer, and the '200 active 5G license agreements' number cannot be verified against ground truth, suggesting potential hallucination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 615,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "In 2022 the domestic pension plan held $89 million in U.S.‑equity funds, $91 million in international‑equity funds and $739 million in fixed‑income funds (see TMO 2023 10‑K, p. 57). By 2024 those balances were $91 million in U.S.‑equity, $89 million in international‑equity and $692 million in fixed‑income (see TMO 2024 10‑K, p. 70). Over the three‑year span equity allocations remained essentially flat (a slight net rise in U.S. equity and a modest dip in international equity) while fixed‑income exposure fell by about $47 million, indicating the company is gradually shifting a small portion of assets away from its historically 80% fixed‑income focus toward a more balanced, return‑seeking mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth across all three asset categories and years. Specific issues: (1) 2022 ALLOCATION ERRORS: LLM states $89M U.S. equity, $91M international equity, $739M fixed income. Ground truth shows $125M U.S. equity, $126M international equity, $1,001M fixed income. These are dramatically different figures (off by ~$36M, ~$35M, and ~$262M respectively). (2) 2024 ALLOCATION ERRORS: LLM states $91M U.S. equity, $89M international equity, $692M fixed income. Ground truth shows $93M U.S. equity, $93M international equity, $739M fixed income. Again, significant discrepancies ($2M, $4M, and $47M differences). (3) TOTAL ASSET ERRORS: LLM's 2022 total would be $919M (not stated but implied), while ground truth is $1,267M - a $348M error. LLM's 2024 total would be $872M, while ground truth is $947M - a $75M error. (4) MISSING 2023 DATA: The LLM completely omits 2023 allocations, which are critical to understanding the three-year evolution. Ground truth shows 2023 as the inflection point with significant reductions ($937M total). (5) INCORRECT NARRATIVE: The LLM's interpretation that 'equity allocations remained essentially flat' is contradicted by the actual data showing meaningful changes from 2022 to 2024. The LLM appears to have confused or transposed 2023 data as 2022 data. (6) CALCULATION ERRORS: The claim of a $47M decline in fixed income is incorrect - ground truth shows $1,001M (2022) to $739M (2024), a $262M decline. The LLM's analysis of 'gradually shifting away from 80% fixed-income focus' lacks supporting evidence in the provided numbers. The answer demonstrates a fundamental failure in multi-hop synthesis and contains pervasive quantitative inaccuracies that make it unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 498,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "In its 2022 filing Qualcomm framed edge networking as a core growth engine, describing new 5G‑based mobile‑broadband and Wi‑Fi 6/6E/7 access‑point products and reporting that its IoT segment – which includes edge‑networking sales – generated $7.353 billion (p. 8‑9; p. 73). By 2023 the same IoT segment fell to $5.94 billion and to $5.423 billion in 2024, but Qualcomm continued to stress integrated 5G, Wi‑Fi and on‑device‑AI solutions for edge devices, shifting its positioning from a broad market‑expansion narrative to a more technology‑focused, revenue‑driven role within the edge‑networking ecosystem (p. 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific revenue figures and attempts multi-hop synthesis across 2022-2024, but contains significant quantitative issues that undermine credibility. STRENGTHS: (1) Correctly identifies edge networking as a strategic focus area across all three years; (2) Appropriately notes the shift from market-expansion narrative to technology-focused positioning; (3) Mentions relevant product categories (5G mobile broadband, Wi-Fi 6/6E/7, on-device AI); (4) Attempts to synthesize revenue trends across the period; (5) Contextually relevant to the question about strategic evolution. CRITICAL ISSUES: (1) The revenue figures cited ($7.353B, $5.94B, $5.423B) cannot be verified against the ground truth, which does not provide specific IoT segment revenue numbers. The LLM appears to have fabricated or misattributed these figures with page citations (p. 8-9, p. 73) that suggest SEC filing references but lack verification; (2) The ground truth explicitly states edge networking was 'explicitly listed as a key revenue contributor within Qualcomm's broader industrial and consumer product segment' in 2023, not the 'IoT segment' - this is a potential entity/segment misidentification; (3) The ground truth does not mention revenue decline from 2022-2024, only consistent strategic emphasis. The LLM's narrative of declining IoT revenues contradicts or extends beyond the ground truth without clear support. REASONING ASSESSMENT: The multi-hop synthesis attempting to connect product development with revenue contributions is logically sound in structure, but the specific numbers and segment attribution appear unreliable. The qualitative assessment of strategic positioning evolution is reasonable and aligns with ground truth themes, but the quantitative claims significantly weaken the answer's credibility. The answer reads as plausible but contains unverified financial data that could mislead.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 517,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings for 2022‑2024 each include Exhibit 4.3, which lists the “0.45 % Notes due 2016” among its global notes (see the exhibit tables in the 2024 filing pages 56‑58) – the same disclosure appears in the earlier reports. By repeatedly highlighting this ultra‑low‑coupon, fixed‑rate issuance, Apple signals a disciplined strategy of locking in cheap financing and smoothing debt‑maturity timing, which helps preserve a stable capital‑structure profile over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM claims the 0.45% Notes due 2016 appear in 2022-2024 filings as current debt instruments, but the ground truth explicitly states these notes 'are no longer outstanding' and their inclusion reflects 'historical tracking' rather than active debt management. The LLM misinterprets their presence as evidence of 'locking in cheap financing' and 'smoothing debt-maturity timing,' which is fundamentally incorrect for matured/retired debt. (2) MISCHARACTERIZATION OF INTENT: The ground truth emphasizes these notes are included for 'comprehensive debt disclosure and historical tracking of capital structure evolution' - a transparency/documentation purpose. The LLM incorrectly frames this as an active capital management strategy ('disciplined strategy of locking in cheap financing'), which contradicts the fact that 2016-maturity debt would have already matured by 2022. (3) EXHIBIT REFERENCE ERROR: The LLM cites 'Exhibit 4.3' and 'pages 56-58' of the 2024 filing without verification. While the general reference to exhibits may be accurate, the specific page numbers and exhibit designation cannot be confirmed and appear speculative. (4) SEMANTIC MISALIGNMENT: The LLM's interpretation that repeated inclusion signals 'active' debt management strategy directly contradicts the ground truth's explanation that it reflects historical documentation of already-matured obligations. The LLM fundamentally misunderstands why these notes appear in filings - not because they're being actively managed, but because they're being historically tracked. (5) MISSING KEY INSIGHT: The LLM fails to acknowledge the core point that these notes are no longer outstanding, which is essential context for understanding Apple's disclosure approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 487,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "In 2022 Caterpillar’s EMD‑brand (reciprocating‑engine) sales were routed through its dealer network that reached **193 countries**【page_76】. By 2024 the same dealer network covered **187 countries**【page_66】, meaning the EMD brand’s geographic reach contracted by **six countries**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth states: 2022: 130 countries, 2023: 130 countries, 2024: 109 countries (21-country decline, ~16% reduction). LLM claims: 2022: 193 countries, 2024: 187 countries (6-country decline). All three numeric values are wrong - the LLM reports 193 vs. actual 130 for 2022 (63-country overstatement), 187 vs. actual 109 for 2024 (78-country overstatement), and 6-country decline vs. actual 21-country decline (15-country understatement of the contraction). The LLM also fails to address the 2023 data point mentioned in the ground truth. The calculation of the decline (193-187=6) is arithmetically correct but based on entirely wrong source numbers. The LLM appears to have cited different metrics or misread the source documents (page references provided don't validate the numbers). This represents a complete failure to synthesize the correct multi-hop information across the required time periods, with massive quantitative errors that fundamentally misrepresent Caterpillar's EMD distribution network changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 309,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s “1.750 % 7‑Year Senior Notes” grew from **$642 million at 12/31/2022** to **$662 million at 12/31/2023** (2023 10‑K, p. 61) and then to **$700 million at 12/31/2024** (2024 10‑K, p. 47). This steady increase in a low‑coupon, euro‑denominated tranche shows the company is deliberately expanding a modest pool of inexpensive medium‑term debt to fund its healthcare‑focused growth and acquisition plans while keeping overall leverage under control.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports $642M (2022), $662M (2023), and $700M (2024), showing an increasing trend. However, the ground truth clearly states the outstanding value was $700M in all three years (2022, 2023, and 2024) - a completely stable pattern, not a growth trajectory. The LLM's numbers are factually wrong. (2) MISCHARACTERIZATION OF TREND: The LLM describes this as a 'steady increase' and 'deliberately expanding' debt, when the ground truth indicates the opposite - a 'consistent level' and 'steady approach' with 'no retiring or increasing' of principal. This is a fundamental misinterpretation of the company's debt strategy. (3) UNSUPPORTED CLAIMS: The LLM adds details not in the ground truth (euro-denominated, page references to 10-Ks, specific acquisition funding claims) that cannot be verified and appear to be fabricated. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year progression across the 2022-2024 period. Instead of recognizing stability, it invented a growth narrative. (5) ENTITY ACCURACY: While TMO/Thermo Fisher identification is correct, the financial metrics are entirely wrong. The answer demonstrates a complete failure in quantitative accuracy on the primary metric being evaluated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 387,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In its 2022 filing, Caterpillar (via Cat Financial) warned that many variable‑rate loans and derivatives were tied to LIBOR, outlined the phase‑out schedule (one‑week and two‑month tenors ending 2021 and all other tenors by June 2023), and created a cross‑functional team to assess and hedge that exposure through match‑funding, selective derivatives and diversified funding (see 2022 p. 22). By the 2023 report, the company disclosed that new financing was being priced off the Secured Overnight Financing Rate (SOFR) and that the same team was now evaluating risk and hedging for SOFR‑linked instruments (see 2023 p. 19). The 2024 filing confirms the transition is complete, with SOFR as the primary benchmark and continued use of the team‑driven hedging framework, showing Caterpillar’s proactive shift away from LIBOR and strategic alignment with global benchmark reforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of Caterpillar's currency hedging and LIBOR-to-SOFR transition across 2022-2024. STRENGTHS: (1) All key dates are correct: FCA announcement to stop LIBOR after 2021, IBA's plan to cease USD LIBOR on June 30, 2023 for most tenors, and the phase-out timeline for one-week and two-month tenors ending 2021. (2) The three-year progression is accurately captured: 2022 (LIBOR exposure acknowledged, cross-functional team formed), 2023 (transition to SOFR-based pricing), 2024 (complete transition with SOFR as primary benchmark). (3) The multi-hop reasoning correctly synthesizes information across three fiscal years and identifies the strategic adaptation pattern. (4) Specific hedging mechanisms mentioned (match-funding, selective derivatives, diversified funding) align with ground truth. (5) Page references (2022 p. 22, 2023 p. 19) add credibility though cannot be independently verified. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual detail about 'uncertainty around derivative valuations and borrowing costs' and the explicit statement that 'the company no longer referenced LIBOR at all' in 2024. (2) The phrase 'one-week and two-month tenors ending 2021' in the LLM answer could be clearer (ground truth says these ended in 2021, while 'all other tenors' ended June 30, 2023). (3) The answer doesn't explicitly state that currency hedging instruments were 'consistently used' throughout the period, though this is implied. QUANTITATIVE VERIFICATION: All dates and timelines are accurate. No calculations required. QUALITATIVE ASSESSMENT: The reasoning is sound and demonstrates proper multi-hop synthesis across three years of filings. The strategic narrative (proactive adaptation to regulatory changes) is well-supported. OVERALL: The answer is substantially correct with minor omissions that don't materially affect the core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 541,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In the 2022 filing Thermo Fisher disclosed the original Executive Change‑in‑Control Retention Agreement for its CEO, Marc N. Casper (dated 2009) together with its 2010 and 2018 amendments, and also a separate “form of Executive Change‑in‑Control Retention Agreement for officers (other than Marc N. Casper)” that was first filed in 2018 【page_46†L10-L18】. By the 2023 10‑K the company had issued a new version of that officer form (filed as Exhibit 10.7 for the quarter ended April 1 2023) while still referencing the legacy CEO agreement and its amendments 【page_77†L10-L18】. The 2024 filing continues to reference the same updated officer form, showing that Thermo Fisher has standardized the retention agreement for all non‑CEO officers, retaining only the historic CEO‑specific agreement 【page_76†L10-L18】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Thermo Fisher's Executive Change in Control Retention Agreements from 2022-2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the CEO-specific agreement for Marc N. Casper with accurate amendment dates (2009, 2010, 2018); (2) Accurately captures the introduction of a standardized form for officers other than the CEO; (3) Properly synthesizes the three-year evolution showing progression from CEO-only to standardized officer agreements; (4) Correctly identifies the key exhibit numbers (10.12, 10.17) and their evolution across years; (5) Demonstrates proper multi-hop reasoning by connecting information across 2022, 2023, and 2024 filings. MINOR ISSUES: (1) The LLM provides additional detail about specific filing dates (e.g., 'quarter ended April 1 2023' for Exhibit 10.7) that goes slightly beyond the ground truth but appears consistent with SEC filing practices; (2) The ground truth mentions 'amendments dated through March 16, 2018' while the LLM lists '2009, 2010, and 2018 amendments' - this is semantically equivalent and accurate; (3) The LLM adds contextual detail about the officer form being 'first filed in 2018' which aligns with the ground truth's reference to Exhibit 10.17 appearing in 2023 as a new standardized form. QUANTITATIVE VERIFICATION: All dates mentioned (2009, 2010, 2018, 2022, 2023, 2024) are accurate. The exhibit numbers (10.12, 10.17, 10.7) are correctly referenced. No calculation errors present. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the evolution from CEO-specific to standardized agreements across the three-year period, properly identifying the key transition point in 2023. The conclusion that Thermo Fisher 'standardized the retention agreement for all non-CEO officers' while retaining the historic CEO agreement is logically sound and matches the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 535,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a future “back‑side power delivery” innovation slated for its upcoming Intel 20A node 【page_7】.  \n- The 2023 filing then positioned PowerVia as one of the two breakthrough features of Intel 20A, promising up to a 15 % performance‑per‑watt gain over Intel 3 【page_14】.  \n- By the 2024 filing PowerVia had moved from a planned 20A feature to the first high‑volume commercial implementation in the newer Intel 18A node, indicating that Intel has accelerated its integration and now treats PowerVia as a core element of its advanced‑process roadmap to drive power‑efficiency and signal‑performance advantages 【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of PowerVia across 2022-2024 and correctly identifies it as a core technology in Intel's advanced process roadmap. However, there are several factual discrepancies with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims a \"15% performance-per-watt gain over Intel 3\" in 2023, but this specific metric is not mentioned in the ground truth answer. This appears to be an unsupported claim that cannot be verified against the provided ground truth.\n   - The ground truth does not provide specific performance metrics, making this claim potentially fabricated or from an unreliable source.\n\n2. ENTITY AND TIMELINE ACCURACY:\n   - The LLM correctly identifies PowerVia as introduced in 2022 as a back-side power delivery innovation for Intel 20A.\n   - The LLM correctly notes the 2023 positioning of PowerVia as a breakthrough feature.\n   - However, the LLM states PowerVia moved to \"Intel 18A\" as the \"first high-volume commercial implementation,\" which aligns with ground truth that Intel 20A was canceled in favor of Intel 18A with PowerVia retained.\n\n3. MULTI-HOP REASONING:\n   - The LLM successfully synthesizes the 3-year progression and correctly identifies the strategic shift from Intel 20A to Intel 18A.\n   - The reasoning that PowerVia remained central despite roadmap adjustments is sound and matches the ground truth conclusion.\n   - However, the LLM characterizes the move as an \"acceleration\" of integration, while the ground truth frames it as a \"strategic shift to prioritize a more refined version\" - these are subtly different interpretations.\n\n4. MISSING CONTEXT:\n   - The ground truth emphasizes that PowerVia was positioned \"alongside RibbonFET\" as a breakthrough innovation in 2022, which the LLM omits.\n   - The ground truth mentions the 2025 timeline for high-volume manufacturing, which the LLM does not explicitly state.\n   - The ground truth's framing of \"greater efficiency and execution focus\" as the rationale for the 20A-to-18A shift is not captured in the LLM answer.\n\n5. SEMANTIC EQUIVALENCE:\n   - The LLM's description of PowerVia as \"back-side power delivery\" is semantically equivalent to the ground truth's \"eliminating front-side power routing.\"\n   - The characterization of PowerVia as a \"core element\" matches the ground truth's \"central pillar.\"\n\nThe answer demonstrates reasonable understanding of the overall narrative but introduces an unverified performance metric and misses some key contextual details about RibbonFET and the specific 2025 timeline. The core multi-hop synthesis is largely correct, but the unsupported quantitative claim and omitted details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 723,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 are listed in the “Officer’s Certificate” (Exhibit 4.4) that describes the company’s global notes in each filing – they appear in the 2022 Form 10‑K (see the exhibit table on page 58) and are again shown in the 2024 Form 10‑K (see the same exhibit table on page 56). The 2023 Form 10‑K repeats this description, so the note has been disclosed in the same manner for three consecutive years. This consistent, unchanged disclosure indicates that Apple has retained the low‑coupon 1.05 % Notes on its balance sheet and continues to report them transparently, reflecting a deliberate strategy of maintaining legacy, low‑cost debt as part of its overall debt‑management practice.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 1.05% Notes due 2017 appear in the Officer's Certificate (Exhibit 4.4), (2) they are disclosed in 2022, 2023, and 2024 10-K filings, and (3) the repeated inclusion suggests deliberate debt management practices. The percentage (1.05%) and exhibit reference (4.4) are accurate. The page number citations (58 for 2022, 56 for 2024) appear reasonable though cannot be independently verified from the ground truth. The LLM correctly synthesizes the multi-hop information across three years of filings. However, there are some notable differences from the ground truth: (1) The ground truth specifically mentions the Officer's Certificate was 'dated May 6, 2014' - the LLM omits this specific date detail. (2) The ground truth explicitly states the notes were 'due 2017' and discusses the significance of their appearance 'post-maturity,' implying they may have been rolled over or maintained after maturity. The LLM frames this as 'retained...on its balance sheet' but doesn't explicitly address the post-maturity aspect or the rollover possibility mentioned in the ground truth. (3) The ground truth uses the phrase 'rolled over the debt into a new instrument or maintained it in some form,' suggesting uncertainty about the mechanism, while the LLM states more definitively that Apple 'retained the low-coupon 1.05% Notes on its balance sheet.' This is a subtle but meaningful difference in how the debt management practice is characterized. The LLM's interpretation that Apple deliberately maintains legacy, low-cost debt is reasonable and aligns with the ground truth's conclusion about deliberate reporting practices, but it's slightly more assertive than the ground truth's more cautious language about the mechanism. Overall, the answer is substantially correct with good multi-hop synthesis, but lacks some specific details and nuance from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 519,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was only identified in the 2022 filing as the “2006 Plan” (a definition of the 2006 Equity Incentive Plan) 【page_113】. In the 2023 filing the plan was filed as Exhibit 10.1 and the accompanying grant agreements showed that Intel was using the plan to issue restricted‑stock units (RSUs) with three distinct vesting structures – RSUs that vest upon an executive’s retirement, standard RSUs without retirement‑vesting terms, and performance‑based RSUs that vest only if specified performance metrics are met 【page_107】. By the 2024 filing the plan’s use had broadened to also cover RSU grants to non‑employee directors (Exhibit 10.1.7) while continuing to grant the same mix of retirement‑vested, time‑vested, and performance‑vested RSUs 【page_108】【page_107】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Intel's 2006 Equity Incentive Plan from 2022-2024 and correctly identifies key developments. STRENGTHS: (1) Accurately identifies that the plan was referenced in 2022 for stock options and RSUs; (2) Correctly notes the May 11, 2023 amendment and restatement date; (3) Properly identifies the three distinct RSU vesting structures introduced in 2023 (retirement-vested, time-vested, and performance-vested); (4) Correctly notes expansion to non-employee directors in 2024; (5) Appropriately cites exhibit numbers and page references. WEAKNESSES: (1) The LLM answer is more granular/specific about exhibit citations than the ground truth, which may indicate over-specification but doesn't contradict the core facts; (2) The ground truth mentions 'grandfathered' and 'non-grandfathered' executives as a distinction in 2023-2024, which the LLM answer does not explicitly address - this is a notable omission of a nuanced detail; (3) The ground truth emphasizes 'strategic growth performance-based RSUs' in 2022, while the LLM only mentions the plan was 'identified' in 2022 without detailing the specific types as thoroughly; (4) The ground truth's characterization of 2024 as showing 'consolidation in documentation structure' and 'streamlined format' is not captured in the LLM answer, which instead emphasizes broadening to directors. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly traces the evolution of award types and vesting conditions. The logic connecting the 2023 amendment to the introduction of new vesting structures is sound. SEMANTIC EQUIVALENCE: The core message about evolution toward more nuanced performance alignment is present but less explicitly stated than in the ground truth. The LLM's focus on broadening to directors in 2024 is accurate but represents a different emphasis than the ground truth's focus on documentation consolidation. QUANTITATIVE ACCURACY: The date (May 11, 2023) is correct. No calculations are required. OVERALL: The answer is substantially correct on major facts but misses some nuanced details about grandfathered/non-grandfathered distinctions and the documentation consolidation trend noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 608,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s Share‑Capital note in each of its 10‑K filings for FY 2022, FY 2023 and FY 2024 states that the company is authorized to issue 40 000 Euro Deferred Shares with a €1.00 par value, and that at the respective reporting dates – April 29 2022, April 28 2023 and April 26 2024 – none of these shares had been issued or were outstanding【page_81】. The unchanged “no‑issuance” position over three years shows that Medtronic has deliberately not tapped this equity class for financing, relying instead on other sources (e.g., ordinary‑share repurchases, debt or other equity awards) and keeping the Euro Deferred Shares as a dormant, non‑dilutive reserve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 40,000 Euro Deferred Shares authorized, €1.00 par value, zero shares issued/outstanding across all three fiscal years (FY 2022, FY 2023, FY 2024). The specific reporting dates (April 29, 2022; April 28, 2023; April 26, 2024) are accurate. ENTITY ACCURACY: Medtronic correctly identified, fiscal years properly specified, Share-Capital note correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to establish the pattern of non-issuance and correctly interprets this as a deliberate strategic choice. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth - that Medtronic maintained authorized but unused Euro Deferred Shares while relying on alternative financing mechanisms. The characterization of these shares as a 'dormant, non-dilutive reserve' adds helpful interpretive context that aligns with the ground truth's suggestion about financing strategy preferences. MINOR CONSIDERATIONS: The LLM answer provides slightly more detailed interpretation (mentioning 'ordinary-share repurchases, debt or other equity awards') compared to the ground truth's more general reference to 'other capital structure tools,' but this represents appropriate elaboration rather than deviation. The answer fully addresses both parts of the multi-part question: (1) how disclosures evolved (consistently unchanged), and (2) what the absence suggests about financing strategy (preference for alternatives). No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 456,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "From 2022 – Intel flagged advanced‑packaging as a high‑risk, high‑investment bet, spending $17.5 billion on R&D and warning that the novel, limited‑history packaging technologies added cost, design‑manufacturing complexity and could force asset impairments or restructuring charges. In 2023 the company pushed the strategy forward, posting higher packaging revenue but a $482 million operating loss as the disaggregated‑design approach amplified logistical and manufacturing challenges; R&D fell to $16.0 billion. By 2024 Intel kept R&D at $16‑$16.5 billion and made advanced packaging a cornerstone of its IDM 2.0/Open System Foundry model, yet execution risks materialized in a $755 million penalty charge and $3.1 billion of non‑cash impairment charges, highlighting the growing financial impact of the technology’s complexity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the multi-hop question about Intel's advanced packaging evolution from 2022-2024 and captures the overall narrative arc (initial strategic bet → technical progress → financial setbacks). However, there are significant quantitative accuracy issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 as flagging advanced packaging as high-risk/high-investment\n- Correctly cites $3.1 billion non-cash impairment charges in 2024\n- Correctly references IDM 2.0 strategy and UCIe standard\n- Correctly identifies execution risks materializing by 2024\n- Appropriately synthesizes the three-year evolution narrative\n- Correctly notes R&D spending levels (~$16-17.5 billion range)\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- Claims \"$482 million operating loss\" in 2023 - this specific figure is not mentioned in the ground truth and cannot be verified\n- Claims \"$755 million penalty charge\" in 2024 - this specific figure is not in the ground truth and appears to be fabricated or confused with other charges\n- States \"packaging revenue\" increased in 2023 - ground truth does not mention packaging revenue figures\n- The specific R&D figures ($17.5B in 2022, $16.0B in 2023) are stated with precision but not verified in ground truth\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and connects R&D investment, manufacturing complexity, and financial impact. The logical flow is sound: strategic positioning → technical progress → financial strain. However, the introduction of unverified financial metrics ($482M loss, $755M penalty) undermines the credibility of the synthesis.\n\nQUANTITATIVE ACCURACY ISSUES:\nThe primary weakness is the introduction of specific dollar amounts ($482M, $755M) that are not grounded in the provided ground truth. While the $3.1B impairment is correct, the other figures appear to be either hallucinated or sourced from unreliable inference. This is a critical error in financial analysis where precision matters.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good understanding of the strategic narrative and correctly identifies key turning points, but the injection of unverified financial metrics significantly reduces confidence in the response. A score of 6 reflects that the core narrative is sound but quantitative reliability is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 634,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "Intel first announced PowerVia in its 2022 filing as a “unique industry‑first implementation of backside power delivery” that would appear in the future Intel 20A node, positioning it as a breakthrough to eliminate front‑side power routing and improve signal transmission【page_7】. In the 2023 roadmap the company said PowerVia (paired with RibbonFET) would be part of Intel 20A and was expected to deliver up to a 15% performance‑per‑watt improvement over Intel 3, emphasizing its strategic role in boosting efficiency and product leadership【page_14】. By the 2024 filing PowerVia is incorporated into the next‑generation Intel 18A process, and Intel disclosed that high‑volume manufacturing of the first 18A‑based Panther Lake products (which include PowerVia) is slated for 2025, showing the technology has moved from a roadmap concept to near‑production readiness【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 15% performance-per-watt improvement figure is accurately cited, and the timeline progression (2022 introduction, 2023 roadmap solidification, 2024 manufacturing readiness with 2025 HVM target) matches the ground truth precisely. ENTITY ACCURACY: All entities are correctly identified - Intel, PowerVia, Intel 20A, Intel 18A, RibbonFET, and Panther Lake are all properly named and contextualized. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three distinct time periods and shows the evolution from conceptual introduction → roadmap maturation → production readiness. The logical progression is clear and well-structured. The answer correctly identifies the shift from Intel 20A (2023) to Intel 18A (2024) as a refinement rather than a complete departure. COMPLETENESS: The answer addresses all three temporal phases requested in the question and explains the strategic positioning at each stage. SEMANTIC EQUIVALENCE: The LLM's phrasing of PowerVia as \"unique industry-first implementation of backside power delivery\" and its role in \"eliminating front-side power routing\" matches the ground truth's conceptual framing. The characterization of the evolution from \"roadmap concept to near-production readiness\" aligns with the ground truth's \"transition from conceptual introduction to a mature, production-ready innovation.\" MINOR OBSERVATION: The LLM includes specific page references (page_7, page_14, page_10) which add credibility but are not present in the ground truth answer. This is a positive addition that doesn't contradict the ground truth. The answer is comprehensive, factually accurate, and demonstrates sound multi-hop reasoning across the three-year evolution of PowerVia technology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 516,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s U.S.‑employee RSU agreement has not changed – the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (exhibit *10.54) appears in the FY 2022 filing【page_115】, the FY 2023 filing【page_114】 and again in FY 2024【page_115】. The unchanged language suggests the company is maintaining a stable, long‑standing equity‑compensation framework for U.S. staff rather than frequently revising its RSU terms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that the RSU agreement has NOT been updated across FY2022-FY2024, matching the ground truth; (2) Accurately references the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan; (3) Provides specific exhibit references (10.54) and page numbers for each filing year, demonstrating multi-hop synthesis across three annual filings; (4) Correctly interprets the consistency as indicating a stable equity compensation strategy; (5) Appropriately concludes that the lack of changes suggests maintenance of long-term incentive alignment without structural modifications. MINOR GAPS: (1) The LLM answer does not explicitly mention the original filing date (August 27, 2013, File No. 001-07707) that appears in the ground truth, which provides additional context about the agreement's longevity; (2) The phrase 'long-standing' is used but the specific original filing date would strengthen the temporal context. QUANTITATIVE ACCURACY: All dates (FY2022, FY2023, FY2024) are correct; exhibit number (10.54) is accurate; page numbers provided are reasonable references. REASONING QUALITY: The multi-hop synthesis is sound—the model correctly identified the same agreement across three separate filings and drew the appropriate conclusion about strategic consistency. SEMANTIC EQUIVALENCE: The LLM's interpretation of 'stable, long-standing equity-compensation framework' and 'maintaining its approach' is semantically equivalent to the ground truth's 'stable and consistent equity compensation strategy' and 'maintained its approach.' The answer fully addresses both parts of the question (whether updated AND what it suggests about strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 492,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Intel only referenced the 2006 Equity Incentive Plan (see the definition on page 113) and did not disclose any specific performance‑based RSU grant forms. By the 2024 filing the company had moved to using the 2006 Plan to issue performance‑based RSUs—first to “grandfathered” executives (exhibit 10.1.5 on page 107) and then extending the structure to “non‑grandfathered” executives with a separate grant agreement (exhibit 10.1.6 on page 108)—showing an expanded, more detailed use of the plan for executive compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CHRONOLOGICAL REVERSAL: The LLM claims that in 2022 Intel 'did not disclose any specific performance-based RSU grant forms' but by 2024 'had moved to using' performance-based RSUs. This is backwards—the ground truth shows Intel was already using performance-based RSUs in 2022 and continued through 2024, not transitioning to them. (2) MISSING 2023 DATA: The LLM completely omits 2023, which is a critical year in the three-year evolution. The ground truth explicitly states that in 2023 the company 'continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives.' (3) INCORRECT ATTRIBUTION: The LLM attributes the grandfathered/non-grandfathered distinction to 2024, when the ground truth indicates this distinction existed in 2023. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes 'consistent strategic focus' across all three years, while the LLM incorrectly portrays a transition from no performance-based RSUs to performance-based RSUs. (5) MISSING KEY DETAILS: The LLM fails to mention the May 11, 2023 amendment and restatement of the plan, or the September 26, 2023 S-8 registration filing, both of which are important to understanding the plan's evolution. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required—it needed to track the consistent use of the 2006 Plan across three years with evolving disclosure details, not a transition from non-use to use.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 442,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "- In the 2022 filing Intel described its IDM 2.0 plan to “increase our use of third‑party foundries…including modular tiles manufactured on advanced foundry process technologies” and warned that “the packaging technologies used to combine these components can increase our costs and may introduce additional complexity and quality issues” (2022 10‑K p. 56; p. 54).  \n\n- By 2023 the company said the advanced‑packaging business had “accelerated interest…especially for AI‑related designs, and we have secured five new design wins” and highlighted four Intel 18A design wins (including a high‑performance‑computing customer) plus new ecosystem agreements with ARM, Synopsys and over 40 IFS partners (2023 10‑K p. 36).  \n\n- The 2024 filing again stresses that Intel is “investing…in advanced packaging technology” as part of its disaggregated‑design approach, while noting the “novel…limited manufacturing history” and the need to manage cost and yield risks (2024 10‑K p. 35).  \n\nTogether, the narrative moves from early planning and risk‑identification (2022) to concrete AI‑driven packaging wins and ecosystem expansion (2023), and now to continued scaling with an explicit focus on mitigating execution risk (2024), showing that Intel is progressively proving its ability to execute a disaggregated design strategy and to compete in the AI‑centric semiconductor market, albeit with ongoing technical and cost challenges.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a well-structured narrative progression across 2022-2024 with good qualitative insights about Intel's advanced packaging strategy evolution. However, there are significant quantitative gaps and one critical omission that reduce overall correctness.\n\nSTRENGTHS:\n1. Correctly identifies the 2022 IDM 2.0 plan and packaging complexity/cost concerns\n2. Accurately captures 2023 progress: AI-driven packaging wins, ecosystem expansion (ARM, Synopsys, 40+ IFS partners)\n3. Properly characterizes 2024 focus on execution risk mitigation and yield management\n4. Sound multi-hop reasoning connecting strategy evolution to competitive positioning\n5. Appropriate semantic framing of progression from planning → execution → scaling\n\nCRITICAL OMISSIONS:\n1. The LLM answer completely fails to mention the $3.1 billion in non-cash impairments and accelerated depreciation charges recorded in 2024 - a key quantitative indicator of execution challenges and financial pressure that the ground truth explicitly highlights as central to understanding the trajectory\n2. Missing the $16.5 billion R&D investment figure for 2024 that contextualizes the scale of commitment\n3. Does not reference the Intel 7 process node impairments, which are specifically tied to advanced packaging manufacturing challenges\n\nQUANTITATIVE ACCURACY ISSUES:\n- No specific financial metrics provided for 2024 despite ground truth emphasizing $3.1B charges and $16.5B R&D\n- Missing quantification of the financial stakes and execution risks\n- The answer relies entirely on qualitative narrative without the concrete numbers that demonstrate \"high financial stakes\"\n\nREASONING ASSESSMENT:\n- The multi-hop synthesis across three years is logically sound\n- The conclusion about \"progressively proving ability to execute\" is reasonable but somewhat optimistic given the 2024 impairment charges\n- The answer frames challenges as \"ongoing\" but doesn't fully capture the severity indicated by the $3.1B charge\n\nSEMANTIC EQUIVALENCE:\n- The narrative arc is similar but the LLM answer presents a more positive interpretation of execution capability than the ground truth, which emphasizes \"persistent execution challenges and high financial stakes\"\n- Ground truth's tone is more cautious about execution success; LLM is more confident\n\nThe answer demonstrates good understanding of the strategic narrative but fails to incorporate critical financial data that fundamentally shapes the interpretation of Intel's execution trajectory and competitive position.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1660,
        "completion_tokens": 680,
        "total_tokens": 2341
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel’s 2022 Form 10‑K only defined the “2006 Plan” (see the “2006 Plan” entry on page 113) and did not list any amendment or new grant documents. The 2023 filing (pages 99‑103) filed the plan as an exhibit and identified it as “Intel Corporation 2006 Equity Incentive Plan, as …,” indicating that the plan had been amended or restated. By the 2024 Form 10‑K the amended plan is referenced as Exhibit 10.1 (page 107) and is used to issue a series of RSU grant agreements—including retirement‑vesting RSUs, performance‑based RSUs for non‑grandfathered executives (pages 107‑108) and a non‑employee director RSU agreement (page 108)—showing the plan’s expanded application.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Intel's 2006 Equity Incentive Plan evolution across the three-year period with mostly accurate information. STRENGTHS: (1) Correctly identifies the 2023 amendment/restatement effective May 11, 2023, matching the ground truth; (2) Accurately describes the types of grant agreements used (RSUs, stock options, performance-based RSUs, retirement-vesting RSUs, non-employee director RSUs); (3) Properly traces the progression from 2022 (plan definition and grant agreements) through 2023 (amended/restated version) to 2024 (continued reliance with standardized agreements); (4) Correctly cites exhibit references and page numbers from filings; (5) Captures the key insight about the plan's 'expanded application' and sustained reliance despite its age. WEAKNESSES: (1) The 2022 statement that the form 'did not list any amendment or new grant documents' is somewhat vague compared to the ground truth's more specific reference to 'multiple grant agreements' for executives, non-employee directors, and performance-based awards; (2) Less emphasis on the 'consistent but increasingly mature application' theme present in the ground truth; (3) The phrase 'expanded application' in 2024 could be clearer about what specifically expanded. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024, May 11, 2023) and exhibit references are correct. No calculation errors present. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the evolution pattern. The connection between the 2023 amendment and subsequent 2024 usage is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth, though with slightly less nuance about the 'formal amendments reflecting structural updates' aspect. The core narrative of evolution from definition to amendment to sustained application is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 524,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "In its 2022 filing Qualcomm described wireless‑access‑point (AP) sales as a “growth driver” for its edge‑networking market, noting that demand for mobile‑broadband and Wi‑Fi 6/6E APs was expanding the segment (see page 8). By 2024 the company’s financial tables place APs inside the QCT segment’s **IoT** revenue line and explicitly label that line “edge networking (including mobile broadband and wireless access points)” (see page 73), with IoT revenue falling from $7.35 bn in 2022 to $5.42 bn in 2024—showing a reduced share but a continued strategic focus on APs as a core part of its edge‑networking positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Qualcomm's wireless access point positioning from 2022-2024, accurately noting the shift from describing APs as a 'growth driver' in 2022 to explicit financial categorization under edge networking by 2023-2024. The answer correctly identifies that APs are included in the IoT/edge networking revenue line and maintains semantic accuracy about the strategic emphasis. The multi-hop reasoning connecting 2022 positioning to 2024 financial classification is sound.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific revenue figures ($7.35bn in 2022 declining to $5.42bn in 2024 for IoT) that are NOT present in the ground truth answer. The ground truth explicitly states 'exact revenue figures for wireless access points alone are not disclosed,' which the LLM appears to violate by providing specific IoT segment numbers. These numbers cannot be verified against the ground truth and represent a potential factual error or hallucination. The LLM also cites specific page numbers (page 8, page 73) which cannot be verified.\n\nWEAKNESSES - COMPLETENESS: The LLM answer omits the important 2022 IoT projection mentioned in ground truth (doubling of IoT devices between 2022-2026 to over 27 billion), which was explicitly highlighted as part of Qualcomm's strategic narrative. This is a material omission from the original answer's scope.\n\nWEAKNESSES - ENTITY/CLASSIFICATION: The LLM correctly identifies the categorization evolution but the specific revenue numbers provided create uncertainty about factual accuracy. The ground truth notes that in 2023 APs were 'explicitly categorized' while the LLM suggests this happened by 2024 in the financial tables, which may represent a subtle timing discrepancy.\n\nMULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound in structure, but the introduction of unverified quantitative data undermines confidence in the overall answer. The connection between strategic positioning and financial classification is correctly made.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the qualitative evolution but introduces specific numbers that cannot be verified against ground truth and omits the IoT projection narrative. The unverified revenue figures are a significant concern for a financial analysis question where accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 636,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis generated $428 million in Hospital Acute Care sales in 2022, rose to $605 million in 2023, and reached $785 million in 2024 (see the Hospital Acute Care line in the segment‑sales tables – 2022 $188 U.S. + $240 Intl., 2023 $264 U.S. + $341 Intl., 2024 $371 U.S. + $414 Intl.)【page_130】【page_141】. The steady, double‑digit growth each year signals that Prevymis is gaining market traction and becoming an increasingly important product within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the Prevymis sales figures that directly contradict the ground truth. Specifically: (1) 2022 figure: LLM states $428 million, but ground truth is $370 million - a $58 million discrepancy (15.7% error). (2) 2023 figure: LLM states $605 million, but ground truth is $428 million - a $177 million discrepancy (41.4% error). (3) 2024 figure: LLM correctly states $785 million, matching ground truth. The LLM also provides component breakdowns (U.S. and International) that sum correctly to the stated totals ($188+$240=$428 for 2022, $264+$341=$605 for 2023, $371+$414=$785 for 2024), but these component figures appear to be fabricated or misattributed since they don't align with the correct overall figures. CALCULATION ERROR: The LLM claims 'steady, double-digit growth each year' but doesn't calculate the actual growth rates. Ground truth shows: 2022-2023 growth of 15.7% ($370M to $428M), and 2023-2024 growth of 83.4% ($428M to $785M), with a 2-year CAGR of ~46%. The LLM's growth characterization is vague and doesn't capture the dramatic acceleration in 2024. MISSING ANALYSIS: The LLM fails to provide the compound growth rate calculation mentioned in the ground truth, which is a key metric for understanding the product's trajectory. ENTITY/CONTEXT: The LLM correctly identifies Prevymis, MRK/Merck, Hospital Acute Care segment, and the 2022-2024 timeframe. The reasoning about market positioning is qualitatively sound but is undermined by the incorrect underlying numbers. The reference citations appear fabricated (page numbers cited don't validate the incorrect figures provided).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 460,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel’s 2022 filing described the IDM 2.0 vision of using advanced‑packaging and modular‑tile approaches, but warned that supply‑chain constraints, the complexity of disaggregated designs and packaging could raise costs and create schedule risk (2022 p.56‑55). By 2023 the strategy began to materialize: packaging revenue jumped to $952 million (up $483 million YoY), the company secured four 18A design wins, five additional design wins, ARM and Synopsys ecosystem agreements, a Tower foundry deal, and demonstrated the Universal Chiplet Interconnect Express (UCIE) standard, indicating strong momentum in its advanced‑packaging business (2023 p.35‑37, p.36). In 2024 Intel kept investing in packaging but flagged capital constraints and delayed fab expansions—including a $755 million penalty for Ireland construction delays and postponed projects in Ohio, Germany, Poland, Malaysia and Israel—showing that while its packaging capabilities are maturing, IDM 2.0 execution now depends on overcoming financing shortfalls and manufacturing‑timeline delays (2024 p.34‑36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year trajectory of Intel's advanced packaging strategy (2022-2024), accurately captures the core narrative about IDM 2.0 evolution, mentions UCIe standard demonstration in 2023, and appropriately highlights capital constraints and manufacturing delays as execution challenges. The qualitative reasoning about the tension between strategic progress and execution challenges is sound and well-articulated.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY:\n1. PACKAGING REVENUE CLAIM: The LLM states 'packaging revenue jumped to $952 million (up $483 million YoY)' in 2023. This appears to be unsupported by the ground truth, which does not mention these specific figures. The math is internally consistent ($952M - $483M = $469M in 2022), but these numbers cannot be verified against the provided ground truth and may be fabricated.\n2. DESIGN WINS: The LLM claims 'four 18A design wins, five additional design wins' but the ground truth does not specify these exact numbers or breakdown. This is a factual claim without verification.\n3. MISSING KEY METRICS: The ground truth explicitly mentions R&D investments of $16.5 billion in 2024 and $3.1 billion in non-cash impairments in Q3 2024. The LLM answer omits these specific financial metrics entirely, which are crucial to understanding capital constraints.\n4. MISSING PROCESS NODE IMPAIRMENT: The ground truth specifically mentions the Intel 7 process node impairment, which the LLM does not reference.\n5. PRODUCT DELAY SPECIFICITY: The ground truth mentions '4th Gen Xeon Scalable processors' delays, which the LLM does not specify.\n\nPARTIAL ISSUES:\n1. The $755 million Ireland penalty is mentioned but not verified against ground truth.\n2. The specific fab locations (Ohio, Germany, Poland, Malaysia, Israel) are mentioned but not verified.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects strategic positioning to execution challenges. However, the synthesis is incomplete because it omits critical financial data ($16.5B R&D, $3.1B impairments) that are essential to understanding the 'capital constraints' narrative.\n\nSEMANTIC EQUIVALENCE: The overall narrative arc matches the ground truth (complexity/risk → strategic progress → execution challenges), but the specific supporting evidence is either missing or unverified.\n\nJUSTIFICATION: While the LLM demonstrates good understanding of the strategic narrative and multi-year trajectory, the quantitative accuracy is significantly compromised by unverified financial figures and omission of key metrics from the ground truth. The answer reads plausibly but lacks the specific R&D and impairment figures that are central to understanding Intel's capital constraints and execution challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 742,
        "total_tokens": 2301
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "Across IBM’s 2022‑2024 10‑K filings the company repeatedly lists **client relationships and trust** as a core competitive differentiator. In the 2022 filing it is paired with a “flexible, secure, and open hybrid‑cloud platform” and AI integration (2022 p.4), the 2023 filing expands the theme by noting that “embedding AI and cloud into our offerings” makes client trust a strategic asset (2023 p.3), and the 2024 filing elevates it further, stating that client relationships and trust, together with hybrid‑cloud and AI capabilities, are driving “accelerated growth now … while preparing us for the next set of business opportunities” (2024 p.3‑4). This evolution shows IBM moving client trust from a supporting differentiator to a central pillar of its hybrid‑cloud and AI strategy, positioning it as a foundational growth engine for the business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 3-year evolution (2022-2024) of IBM's emphasis on client relationships and trust; (2) Accurately captures the progression from trust paired with hybrid cloud/AI in 2022, through reinforcement in 2023, to elevation in 2024; (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Correctly identifies the strategic positioning of trust as foundational to hybrid cloud and AI strategy; (5) Appropriately characterizes the evolution as moving from 'supporting differentiator' to 'central pillar'; (6) Uses accurate page references (2022 p.4, 2023 p.3, 2024 p.3-4) that appear consistent with typical 10-K structure. MINOR GAPS: (1) The LLM answer does not explicitly mention the Palo Alto Networks strategic partnership mentioned in the ground truth as signaling 'deepening of trust-based collaboration' - this is a notable omission of a specific strategic development; (2) The ground truth emphasizes 'service and support, innovation, and talent' as broader competitive methods in 2023, which the LLM answer does not explicitly detail; (3) The ground truth's framing of 'trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market' is conceptually present but not as explicitly stated. QUANTITATIVE ACCURACY: No numerical errors detected. Page references appear reasonable for 10-K filings. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly traces the evolution across three years and connects it to strategic positioning. The logical progression (supporting → central pillar → growth engine) is well-reasoned. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically equivalent to the ground truth, with slightly different emphasis but same core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 519,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM first disclosed the 0.950 % Notes due 2025 in its 2022 Form 10‑K by incorporating the original Form 8‑K exhibit (filed May 22 2017) that defined the notes’ rights 【page_30】. The 2023 Form 10‑K repeats the same incorporation‑by‑reference to that 2017 exhibit, indicating no amendment or new issuance 【page_20】, and the 2024 Form 10‑K lists the 0.950 % Notes due 2025 among its Section 12(b) registered securities, confirming they remain outstanding and are still disclosed via the earlier exhibit 【page_1】. This evolution shows IBM’s reliance on a single, low‑coupon, long‑dated issuance and a streamlined, consistent disclosure approach—reflecting a broader debt‑management strategy focused on locking in cheap, long‑term financing while minimizing reporting burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All numeric values are correct: 0.950% coupon rate, 2025 maturity date, May 22, 2017 Form 8-K filing date. (2) Years are accurately tracked across 2022, 2023, and 2024 filings. (3) The multi-hop reasoning correctly synthesizes information across three years of 10-K filings, showing the progression from incorporation-by-reference in 2022-2023 to Section 12(b) registration listing in 2024. (4) Entity identification is precise: IBM, the specific notes instrument, Form 8-K, Form 10-K, NYSE trading symbol IBM25B. (5) The answer correctly interprets the disclosure strategy evolution and connects it to broader debt management conclusions. (6) The semantic interpretation of what the progression indicates (stable, transparent, streamlined approach focused on long-term cheap financing) aligns well with the ground truth's characterization of 'consistent disclosure framework and sustained presence.' MINOR CONSIDERATIONS: The LLM answer adds interpretive detail about 'locking in cheap, long-term financing while minimizing reporting burden' which goes slightly beyond the ground truth's more neutral characterization of 'stable and transparent debt management strategy,' but this represents reasonable inference rather than factual error. The page references (page_30, page_20, page_1) cannot be verified against the ground truth but appear plausible and don't contradict any stated facts. The answer fully addresses all components of the multi-part question regarding issuance strategy evolution, disclosure progression, and broader debt management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 457,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In the 2022 filing Intel only referenced PowerVia as a future “back‑side power” technique slated for its next‑generation Intel 20A node, indicating it was still in the research‑development stage 【page_7】. By the 2024 filing PowerVia had moved into production‑ready status: it is described as the industry‑first backside‑power implementation built into the Intel 18A node (the first high‑volume commercial use, with Panther Lake client chips slated for 2025) and remains a key feature of the forthcoming Intel 20A node 【page_10】【page_14】. This progression shows Intel’s roadmap advancing PowerVia from a roadmap concept in 2022 to an imminent high‑volume technology in 2024, underscoring backside power delivery as a cornerstone of its advanced‑node strategy for improved performance‑per‑watt and density scaling.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about PowerVia's evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the three-stage progression: 2022 (research-development/roadmap concept), 2023 (technical integration in Intel 20A - though not explicitly mentioned in LLM answer), 2024 (commercial deployment in Intel 18A). (2) Accurately states Intel 18A as the first high-volume commercial implementation with Panther Lake chips in 2025. (3) Correctly characterizes PowerVia as backside power delivery technology. (4) Properly synthesizes the strategic pivot from concept to production-ready status. (5) Dates and node names (Intel 20A, Intel 18A) are accurate. (6) The reasoning about performance-per-watt and density scaling is sound and relevant. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 2023 intermediate stage where PowerVia was positioned within Intel 20A as a key breakthrough technology - it jumps from 2022 to 2024. The ground truth emphasizes this three-stage evolution (concept → technical integration → commercial deployment), while the LLM answer presents a two-stage evolution (research-development → production-ready). (2) The statement that PowerVia 'remains a key feature of the forthcoming Intel 20A node' is somewhat ambiguous given that Intel 20A was canceled in favor of Intel 18A, though this is a minor semantic issue. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024, 2025) and node designations are correct. No calculation errors. QUALITATIVE ACCURACY: The multi-hop synthesis is sound - the answer correctly connects Intel's strategic decisions across years and nodes. The characterization of the progression is accurate, though incomplete regarding the 2023 intermediate stage. CONTEXTUAL RELEVANCE: The answer directly addresses the question about strategy evolution and what it reveals about Intel's roadmap for backside power delivery.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 529,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 10‑K filings for 2022, 2023 and 2024 all list the same “Form of Restricted Stock Unit Award Agreement” under the Amended and Restated 2013 Stock Award and Incentive Plan (exhibit *10.61 and *10.63 appear in each year’s exhibit list)【page_115†L1-L4】【page_112†L1-L4】, and the same 2021 Long‑Term Incentive Plan RSU forms (e.g., *10.80, *10.81, *10.87, *10.88) are repeated across the three years【page_116†L1-L4】【page_116†L9-L12】. The unchanged filing of these RSU agreements signals that Medtronic’s U.S. equity‑compensation framework has remained consistent and stable from 2022 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) WRONG EXHIBIT NUMBERS: The ground truth specifically identifies Exhibit 10.54 as the relevant RSU Award Agreement, but the LLM cites exhibits 10.61, 10.63, 10.80, 10.81, 10.87, 10.88 - none of which match the ground truth document. This is a fundamental factual error. (2) WRONG REFERENCE DATE: The ground truth clearly states the agreement references August 27, 2013, but the LLM mentions '2021 Long-Term Incentive Plan RSU forms' which contradicts the ground truth's focus on the 2013 plan. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that RSU agreements remained unchanged across 2022-2024, it fails to cite the specific exhibit (10.54) that demonstrates this stability. (4) CITATION ISSUES: The LLM provides page references with unclear formatting that don't correspond to standard SEC filing citations. WHAT WAS CORRECT: The LLM correctly concludes that Medtronic's equity compensation framework remained stable across the three-year period and that unchanged filings indicate strategic consistency. The semantic conclusion about stability is sound. WHAT WAS INCORRECT: The specific exhibit numbers, the reference to 2021 plans instead of the 2013 plan, and the failure to identify the correct Exhibit 10.54. The answer demonstrates partial understanding of the concept but fails on factual accuracy regarding specific document identification, which is critical for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 417,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "In 2022 Intel warned that its new disaggregated‑design approach—using advanced‑packaging to join components made on different process nodes—added logistical risk, higher cost and the potential for schedule slips, and it was already dealing with delays in its 10 nm and Intel 4 nodes and supply‑chain constraints that limited its ability to fund packaging investments【page_56】【page_55】. By 2023 the company repositioned advanced packaging as a strategic growth engine, reporting higher packaging revenue and several design wins, yet it continued to flag that the same disaggregated‑design strategy could increase costs and cause delays, contributing to an operating loss despite the revenue boost【page_38】【page_35】. In 2024, capital‑budget pressures under Intel’s “Smart Capital” approach forced delays and penalties on fab expansions, and the filing again stressed that the complexity and expense of deploying advanced‑packaging and disaggregated designs remain key execution challenges【page_34】【page_36】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's advanced packaging strategy from 2022-2024 and correctly identifies key themes: disaggregated design risks in 2022, strategic repositioning in 2023, and capital constraints in 2024. However, there are significant gaps and inaccuracies:\n\nSTRENGTHS:\n- Correctly identifies the three-year progression and main strategic shifts\n- Accurately describes 2022 concerns about disaggregated design complexity, cost, and schedule risks\n- Correctly notes 2023 repositioning of advanced packaging as strategic advantage\n- Properly identifies 2024 capital constraints under \"Smart Capital\" approach\n- Appropriately synthesizes multi-hop information across years\n- Contextually relevant to the question's focus on evolution and challenges\n\nCRITICAL GAPS:\n- MISSING KEY QUANTITATIVE DATA: The ground truth specifically mentions a \"$3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node\" in 2024. This is a major financial metric that the LLM answer completely omits. This is a significant factual gap for a financial question.\n- INCOMPLETE 2023 DETAIL: Ground truth mentions \"Universal Chiplet Interconnect Express (UCIe) standard\" as a specific 2024 differentiator, but LLM only vaguely references \"design wins\" without this technical specificity\n- MISSING INTEL 7 NODE CONTEXT: Ground truth specifically identifies Intel 7 node as the focus of the impairment charge; LLM mentions \"Intel 7 node\" only in passing context\n- VAGUE ON 2024 EXECUTION CHALLENGES: LLM mentions \"delays and penalties on fab expansions\" but doesn't quantify or specify the impairment charge\n\nQUANTITATIVE ACCURACY ISSUES:\n- The $3.1 billion impairment charge is a critical quantitative fact that is entirely absent from the LLM answer\n- No other numerical errors detected, but the omission of this key figure significantly impacts quantitative accuracy\n\nREASONING QUALITY:\n- Multi-hop synthesis is sound: correctly connects 2022 risks → 2023 repositioning → 2024 challenges\n- Logic flow is coherent and appropriate\n- However, the reasoning is incomplete without the impairment charge context\n\nSEMANTIC EQUIVALENCE:\n- The general narrative matches ground truth semantically\n- But the omission of the $3.1B impairment is not merely a wording difference—it's a material factual omission\n\nOVERALL ASSESSMENT:\nThe LLM answer demonstrates good understanding of the strategic evolution and multi-hop synthesis across years, but fails to capture a critical quantitative fact ($3.1B impairment charge) that is central to understanding 2024 execution challenges. This is a significant gap in a financial analysis context where specific numbers matter greatly. The answer would score higher (8-9) if it included this key metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 746,
        "total_tokens": 2260
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s defined‑benefit targets have moved from a near‑all‑fixed‑income mix in FY 2022 (U.S. plans ≈ 97 % debt, 3 % cash; non‑U.S. plans ≈ 50 % debt, 21 % equity) to a more diversified stance, raising non‑U.S. equity to 27 % and cutting debt to 48 % in FY 2023 and then to 23 % equity with 42 % debt (and a 5 % cash, 21 % insurance, 9 % other mix) in FY 2024, while U.S. plans added a 6 % cash allocation and reduced debt to 94 % (page 88; page 95). This gradual tilt toward higher‑return equity and modest cash, while retaining a substantial fixed‑income core, indicates a deliberate effort to boost long‑term, risk‑adjusted returns without compromising liability matching.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative data about Accenture's target asset allocation evolution across FY 2022-2024, which the original answer does not contain. Strengths: (1) The LLM correctly identifies the multi-year shift from fixed-income heavy allocations toward more diversified portfolios with increased equity exposure; (2) Specific percentages are provided (U.S. plans: 97% debt/3% cash in FY2022 → 94% debt/6% cash in FY2024; non-U.S. plans: 50% debt/21% equity in FY2022 → 48% debt/27% equity in FY2023 → 23% equity/42% debt/5% cash/21% insurance/9% other in FY2024); (3) The conclusion about deliberate effort to boost long-term risk-adjusted returns while maintaining liability matching aligns with the original answer's interpretation; (4) Page references (88, 95) suggest sourcing from actual filings. Weaknesses: (1) The original answer emphasizes flexibility and adaptability to market conditions as key strategic elements, while the LLM focuses primarily on the numerical shift itself; (2) The LLM's characterization of FY2022 as \"near-all-fixed-income\" for U.S. plans (97% debt) is accurate but somewhat hyperbolic; (3) The original answer mentions \"matching debt securities' duration to plan liabilities\" which the LLM does not explicitly address, though it's implied in \"liability matching\"; (4) Cannot independently verify the specific percentages provided without access to the actual 10-K filings, but they appear internally consistent and reasonable. The LLM answer is more concrete and data-driven than the original, providing the specific numbers that support the strategic narrative. The multi-hop reasoning is sound: it synthesizes data across three fiscal years and correctly identifies the directional trend (toward higher equity allocation and diversification). The semantic meaning aligns well with the original answer's conclusion about risk-adjusted returns and dynamic market management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 525,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K exhibits for 2023 and 2024 still list the 1.05 % Notes due 2017 in Exhibit 4.4 (e.g., “1.05 % Notes due 2017 … 3.45 % Notes due 2024 …”【page_56】), showing that the company follows a comprehensive, “all‑issued‑series” disclosure practice that retains even fully‑matured debt for historical completeness. In the same filings Apple’s recent debt program is reflected by newer series of notes spanning a wide range of maturities and rates—such as 2.85 % Notes due 2021, 3.45 % Notes due 2024, and later issuances like 4.421 % Notes due 2026, 4.000 % Notes due 2028, 4.150 % Notes due 2030, etc. 【page_58】—indicating a forward‑looking strategy of diversifying and extending its capital structure rather than merely reporting legacy obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Apple's debt disclosure practices and provides accurate information about the company's approach. STRENGTHS: (1) Correctly identifies that the 1.05% Notes due 2017 appear in 2023 and 2024 filings despite maturity, matching the ground truth observation. (2) Accurately characterizes this as a 'comprehensive, all-issued-series disclosure practice' that aligns with the ground truth's description of 'consistent and transparent approach to disclosing historical debt instruments.' (3) Correctly identifies multiple debt instruments with accurate rates and maturity dates (2.85% Notes due 2021, 3.45% Notes due 2024, 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030). (4) Properly synthesizes the multi-hop comparison between historical debt retention and broader debt issuance strategy. (5) Provides specific exhibit references (Exhibit 4.4, page citations) that add credibility. WEAKNESSES: (1) The LLM answer includes some debt instruments (2.85% Notes due 2021, 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030) that are not mentioned in the ground truth, though these appear to be accurate Apple debt instruments and don't contradict the ground truth. (2) The ground truth specifically mentions 'Floating Rate Notes due 2020' and '2.15% Notes due 2022' as examples of Apple's 2022-2024 issuance strategy, which the LLM answer does not include. This represents a minor omission of specific examples provided in the ground truth. (3) The LLM answer's characterization of the strategy as 'forward-looking' and 'diversifying and extending' is slightly more interpretive than the ground truth's more neutral description. QUANTITATIVE VERIFICATION: All debt rates and maturity dates mentioned in the LLM answer appear accurate for Apple's actual debt instruments. The years 2023 and 2024 for the filings are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple aspects: (1) historical debt retention, (2) current filing practices, and (3) broader debt strategy comparison. The reasoning is sound and logically connects these elements. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth—that Apple maintains comprehensive historical debt disclosure while actively managing a diversified debt portfolio—though with slightly different emphasis and additional examples.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 648,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.2 million Class A shares for $4.1 billion, leaving $3.13 billion of its authorized buy‑back capacity still available (page 94; page 93). The buy‑back continued in fiscal 2023, further depleting the unused portion, and by fiscal 2024 the company had bought roughly $4.5 billion of shares (including $605 million in Q4 alone) with the remaining authorization falling to $2.69 billion, after the board added $4 billion of new authority to bring total outstanding authority to $6.69 billion (page 40; page 39; page 38). This multi‑year pattern of sizable, ongoing repurchases combined with periodic increases in authorized authority signals a sustained, disciplined capital‑return strategy that relies heavily on share buybacks.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key financial figures and multi-year trends. STRENGTHS: (1) Correctly identifies fiscal 2022 available authorization of $3.13 billion and fiscal 2024 remaining authorization of $2.69 billion; (2) Accurately cites the $4.0 billion new authority approved in September 2024 and resulting $6.69 billion total outstanding authority; (3) Correctly notes $605 million in Q4 fiscal 2024 repurchases; (4) Properly synthesizes multi-hop information across fiscal years 2022-2024; (5) Provides sound reasoning about sustained, disciplined capital return strategy; (6) Appropriately references page numbers for source verification. MINOR ISSUES: (1) States fiscal 2022 repurchased 12.2 million shares for $4.1 billion - while the ground truth confirms significant repurchases in 2022, it does not explicitly verify these specific share count and dollar amount figures in the provided context; (2) Claims fiscal 2024 buybacks totaled roughly $4.5 billion (including $605M in Q4) - the ground truth only confirms $605 million in fiscal 2024 specifically, not the $4.5 billion aggregate figure for that year; (3) References fiscal 2023 buyback activity but ground truth notes 2023 filing 'mirrors' 2024 disclosures without providing specific 2023 repurchase amounts. The answer correctly captures the overall pattern and strategy but makes some specific quantitative claims about fiscal 2022 and 2024 repurchase amounts that exceed what the ground truth explicitly confirms. The multi-hop reasoning connecting authorization levels, repurchase activity, and strategic implications is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 458,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Across the three most recent filings the 4.350 % Senior Notes due 2047 are shown as an unchanged, outstanding tranche of long‑term debt. In the 2022 Form 10‑K the notes appear as Exhibit 4ff (page 137) 【page_137】, the 2023 Form 10‑K lists the same instrument again as Exhibit 4ff (page 136) 【page_136】, and the 2024 Form 10‑K includes it as Exhibit 4jj (page 134) 【page_134】—all referencing the original November 22, 2019 issuance. The consistent reporting of this 25‑year‑maturity, fixed‑rate note signals that BMS deliberately retains a long‑dated, low‑cost debt component to lock in financing, diversify its maturity schedule and limit refinancing risk as part of its long‑term capital strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.350% Senior Notes due 2047 as a consistent element across 2022-2024 filings, correctly cites the November 22, 2019 issuance date, and accurately describes the 25-year maturity. The exhibit references (4ff, 4ff, 4jj) and page numbers appear specific and plausible. The reasoning about lock-in financing, maturity diversification, and refinancing risk mitigation is sound and relevant to long-term capital strategy.\n\nWEAKNESSES: (1) The LLM answer is significantly INCOMPLETE compared to ground truth. The original answer provides crucial context about OTHER debt issuances that occurred during this period—specifically the $1.75 billion 2.950% Notes due 2032 (2023) and $2 billion 3.700% Notes due 2052 (2023), and $3.75 billion 4.250% Senior Notes due 2049 (2024). These comparative issuances are essential to demonstrating the 'multi-year pattern' and 'diversified long-term liabilities with staggered maturities' strategy. (2) The LLM characterizes the 4.350% notes as 'low-cost debt,' but the ground truth describes them as a 'high-yield component'—this is a semantic contradiction. A 4.350% coupon in the 2022-2024 period would typically be considered higher-yielding relative to the 2.950% and 3.700% notes mentioned in the ground truth, not lower-cost. (3) The LLM fails to synthesize the multi-hop aspect of the question: showing how the 2047 notes fit within a broader pattern of staggered maturities (2032, 2047, 2049, 2052) that evolved across the three years.\n\nMULTI-HOP REASONING: The question explicitly asks about evolution 'across 2022, 2023, and 2024' and what the 'multi-year pattern indicates.' The LLM identifies persistence but misses the critical comparative analysis of concurrent issuances that would demonstrate strategic intent. The ground truth shows a deliberate pattern of issuing notes with different maturities and coupons; the LLM only shows that one note persisted.\n\nNUMERIC/FACTUAL VERIFICATION: All numbers cited (4.350%, 2047 maturity, November 22, 2019 date) are correct. However, the characterization of this as 'low-cost' appears incorrect based on the comparative rates in the ground truth.\n\nCONCLUSION: The answer is partially correct on the specific instrument but fails to adequately address the multi-year pattern and comparative context that defines the company's financing strategy. It's a narrow, incomplete answer to a question requiring broader synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 653,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple first disclosed the 2.40 % Notes due 2023 in its 2022 Form 10‑K by listing them in Exhibit 4.3 (the Officer’s Certificate describing its global notes) 【page_58†L13-L20】. The 2023 Form 10‑K kept the same approach, still showing the 2.40 % Notes due 2023 in Exhibit 4.3 【page_56†L13-L20】. By the 2024 Form 10‑K, after the notes had matured, Apple continued to reference the 2.40 % Notes due 2023 in the exhibit list, but now only as a historical entry rather than an outstanding security 【page_56†L13-L20】.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer fundamentally contradicts the ground truth on the core claim about disclosure evolution. Ground truth states Apple's disclosure approach was STABLE AND UNCHANGING across 2022, 2023, and 2024, with identical descriptions and consistent exhibit placement. The LLM answer claims the approach CHANGED, stating that by 2024 the notes were 'only as a historical entry rather than an outstanding security,' implying a material shift in disclosure treatment. This is a critical factual error that misrepresents the entire premise of the answer. QUANTITATIVE ACCURACY: The numbers and dates cited (2.40%, 2023 maturity, Exhibit 4.3, Officer's Certificate dated May 3, 2013) appear correct based on the ground truth. The exhibit references and page citations seem plausible. QUALITATIVE ACCURACY: The reasoning is fundamentally flawed. The LLM correctly identifies the exhibit location and document references, but misinterprets what these consistent references mean. The ground truth explicitly states the disclosure was 'stable and unchanging' and 'identical' across all three periods, yet the LLM characterizes this as an evolution from 'outstanding security' to 'historical entry.' This represents a failure to understand that consistent disclosure of a maturing debt instrument does not constitute a change in approach. The LLM appears to have inferred a distinction between 2024 treatment and prior years that is not supported by the ground truth. CONTEXTUAL RELEVANCE: The answer addresses the right company, instrument, and time periods, but fundamentally mischaracterizes the nature of the disclosure evolution (or lack thereof). The question asks how the approach 'evolved,' and the correct answer is that it did not evolve—it remained consistent. The LLM's answer suggests evolution where none occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 498,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards in fiscal 2022 (“A maximum of 127,000,000 … authorized for awards under the Amended 2010 SIP” – page 91). By fiscal 2024 the authorized pool had been expanded to **141 million** shares (“A maximum of 141,000,000 … authorized for awards under the Amended 2010 SIP” – page 98).  \n\nThis upward shift—an increase of roughly 14 million shares—shows Accenture is deliberately enlarging its equity‑award capacity, underscoring a long‑term strategy to rely on share‑based compensation to attract, retain and motivate employees and align their interests with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key numeric values: 127 million shares in fiscal 2022 and 141 million shares in fiscal 2024, with an accurate calculation of the 14 million share increase. The answer also correctly identifies Accenture plc and the Amended 2010 SIP. However, there is a significant omission: the LLM answer fails to mention fiscal year 2023 and the fact that the authorized shares remained stable at 141 million from 2023 through 2024. The ground truth explicitly states that shares increased from 127M (2022) to 141M (2023) and remained at 141M in 2024. This is an important detail because the progression shows not just an increase, but also a stabilization pattern that is relevant to understanding the company's strategy. The LLM's interpretation of the strategic implications is reasonable and aligns with the ground truth's assessment that this represents deliberate expansion of equity-award capacity. The reasoning about share-based compensation strategy for employee attraction, retention, and motivation is sound and semantically equivalent to the ground truth. The main weakness is the incomplete temporal analysis—by not explicitly addressing the 2023 data point and the stability thereafter, the answer misses a key aspect of the 'evolution' requested in the question. The answer would have been stronger with explicit mention of all three fiscal years and the pattern of increase followed by stabilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 399,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- In the 2022 filing Intel first introduced PowerVia as a future “back‑side power” technique that would appear on the later‑generation Intel 20A node (2022 10‑K p. 7).  \n- The 2023 filing still positioned PowerVia as the unique industry‑first backside‑power delivery for Intel 20A, promising up to a 15 % performance‑per‑watt improvement (2023 10‑K p. 14).  \n- By the 2024 filing Intel had moved PowerVia forward to the Intel 18A node, calling it the first high‑volume commercial implementation of backside power and a key driver of performance‑per‑watt and density gains for that advanced process (2024 10‑K p. 10).  \n\nThis evolution—from a long‑term roadmap item to a near‑term, high‑priority feature on the next‑generation node—shows that PowerVia has become a central pillar of Intel’s advanced‑process strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PowerVia's evolution and correctly identifies the key progression from 2022-2024. Strengths: (1) Accurately captures the introduction of PowerVia in 2022 as a backside power technique for Intel 20A; (2) Correctly notes the 2023 positioning as industry-first backside power delivery with performance-per-watt benefits; (3) Properly identifies the 2024 shift to Intel 18A as the implementation node; (4) Appropriately cites specific 10-K page references; (5) Correctly synthesizes the multi-hop evolution showing progression from roadmap concept to near-term implementation. Weaknesses and discrepancies: (1) The LLM mentions a '15% performance-per-watt improvement' in the 2023 section, which is a specific quantitative claim not present in the ground truth answer - this appears to be an unsupported detail that may or may not be accurate; (2) The ground truth explicitly mentions 'Panther Lake client processor family' and '2025 high-volume manufacturing' as key 2024 details, which the LLM answer omits; (3) The ground truth emphasizes the 'cancellation of Intel 20A in favor of Intel 18A' as a strategic pivot, while the LLM frames it more as a forward movement without explicitly noting the cancellation decision; (4) The ground truth provides more nuanced context about the strategic importance (maintaining competitive parity, achieving performance-per-watt improvements), while the LLM's conclusion is somewhat more generic. The core narrative and multi-hop reasoning are sound - the answer correctly traces PowerVia from introduction through strategic repositioning. However, the omission of specific product family details (Panther Lake) and manufacturing timeline (2025) represents incomplete coverage of the 2024 developments. The unsupported '15%' figure is a minor concern but doesn't fundamentally undermine the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 512,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s defined‑benefit pension assets included roughly **$239 million of mutual‑fund equity securities in FY 2022**, which **declined to about $196 million in FY 2023**, and then **rose to approximately $274 million in FY 2024**【page 89】【page 96】. The dip in 2023 followed by a sizable rebound in 2024 indicates the company is re‑emphasizing equity‑based investments, suggesting a strategic shift toward greater equity exposure to capture long‑term market upside.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it substantially incorrect: (1) QUANTITATIVE ERRORS: The LLM states FY2022=$239M, FY2023=$196M, FY2024=$274M. The ground truth shows FY2022=$239,293M, FY2023=$196,226M, FY2024=$196,226M. The LLM has dropped three zeros from the first two years (off by factor of 1000) and completely fabricated the FY2024 figure ($274M vs actual $196,226M). (2) DIRECTIONAL ERROR: The LLM claims FY2024 saw a 'sizable rebound' to $274M, but the actual data shows FY2024 remained flat at $196,226M (same as FY2023). This is a 180-degree reversal of the actual trend. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes the company is 're-emphasizing equity-based investments' with 'greater equity exposure,' but the ground truth indicates a 'consistent reduction in exposure' and 'strategic rebalancing away from mutual fund equity securities.' The LLM's interpretation directly contradicts the actual data trend. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trajectory across all fiscal years. The correct pattern is: decline from 2022→2023, then plateau in 2024. The LLM's pattern (decline then rebound) is entirely fabricated. (5) SCALE MISUNDERSTANDING: The LLM appears to have misread the financial data by an order of magnitude, suggesting either data extraction failure or fundamental misunderstanding of the source material. The ground truth clearly shows these are large allocations in the hundreds of millions, not tens of millions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 427,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck continued to carry Dificid on its balance sheet at the $145 million net intangible‑asset value reported in the 2022 filing (see page 115) and did not record any further impairment in the 2023 or 2024 reports, indicating a stable valuation. Therapeutically, Dificid remained positioned in the Hospital‑Acute‑Care franchise as the fidaxomicin treatment for C. difficile‑associated diarrhea (see page 4). Its worldwide sales grew from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, modestly increasing its share of total pharmaceutical revenue (see page 130).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Dificid's strategic positioning and therapeutic role, with accurate qualitative information about its placement in the Hospital Acute Care franchise and its indication for C. difficile-associated diarrhea. However, there is a significant quantitative discrepancy that affects the overall score. The LLM reports 2022 sales as $263 million, but the ground truth does not provide this figure—the ground truth only mentions the $145 million intangible asset valuation in 2022 and does not cite 2022 revenue. The LLM's 2023 ($302 million) and 2024 ($340 million) figures are accurate and match the ground truth. The 2024 breakdown ($303 million U.S., $37 million international) is correctly cited in the ground truth but not mentioned in the LLM answer, representing a minor omission. The LLM correctly identifies the stable $145 million asset valuation with no impairment charges, which aligns with the ground truth's characterization of the asset. The multi-hop reasoning is sound—the LLM successfully synthesizes information about asset valuation, therapeutic positioning, and revenue contribution across the three-year period. The main weakness is the introduction of an unsourced 2022 revenue figure ($263 million) that cannot be verified against the ground truth, which creates uncertainty about data accuracy. The answer appropriately addresses all three dimensions of the question (asset valuation, therapeutic positioning, and revenue contribution) and demonstrates logical progression of Dificid's evolution. The page citations add credibility but cannot be independently verified in this evaluation context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 455,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022, Intel’s advanced‑packaging push was driven by a record‑high R&D spend of $17.5 billion and a disaggregated chip‑let strategy, but it already suffered execution setbacks such as 10 nm and Intel 4 (formerly 7 nm) delays and the postponement of its 4th‑Gen Xeon launch. In 2023 the R&D budget slipped to $16.0 billion while Intel began to reap some packaging momentum—securing design wins and expanding its IFS ecosystem—but still faced costly implementation issues, including a $922 million AI‑accelerator inventory charge and rising construction‑delay penalties. By 2024 R&D stabilized at $16.5 billion and advanced packaging remained a core differentiator for AI and systems‑of‑chips, yet Intel continued to grapple with delays in packaging roll‑outs, a $755 million Ireland‑fab penalty, and $3.1 billion of impairment charges, underscoring persistent execution challenges and heightened financial‑risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific R&D figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or from unverified sources. The ground truth does not cite specific R&D investment amounts for these years. (2) UNVERIFIED CHARGES - The LLM cites a $922 million AI-accelerator inventory charge and $755 million Ireland-fab penalty that are NOT mentioned in the ground truth. While the $3.1 billion impairment charge is correctly cited, the other financial figures lack grounding in the provided original answer. (3) MULTI-HOP SYNTHESIS - The LLM attempts to create a narrative arc across 2022-2024 with specific financial metrics, but this synthesis appears to introduce data points not supported by the ground truth. The original answer focuses on strategic positioning evolution (optimism to strain) rather than specific R&D budget figures. (4) CORRECT ELEMENTS - The LLM correctly identifies: the $3.1 billion impairment charge in 2024, the general trajectory from strategic optimism to operational strain, the focus on chiplet/disaggregated design strategy, mentions of 2D/2.5D/3D packaging, and the theme of execution challenges and delays. (5) SEMANTIC ALIGNMENT - While the LLM captures the overall narrative arc (2022 optimism → 2023 progress with challenges → 2024 financial strain), it does so by introducing unverified quantitative details that compromise factual accuracy. The ground truth emphasizes strategic positioning and execution risks; the LLM adds specific financial metrics that cannot be confirmed. This represents a significant departure from evidence-based answering in a financial context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 494,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- In the 2022 10‑K Merck said the doravirine / islatravir once‑daily regimen (MK‑8591A) was slated to enter Phase 3 in 2023, but the FDA had already placed a clinical hold on the islatravir INDs in December 2021 because of lymphocyte/CD4⁺‑cell declines (page 21).  \n- The 2023 filing reiterated that the FDA clinical hold remained in effect, noting that “no new studies may be initiated” and that the hold was still based on those same safety observations (page 24).  \n- The 2024 filing shows MK‑8591A still listed in the pipeline with a footnote indicating an FDA clinical hold (page 24) and repeats the description of the hold for the oral doravirine / islatravir regimen (page 22).  \n\nTogether, the unchanged hold status over three years while keeping the candidate in the pipeline signals Merck’s long‑term strategic intent to develop a novel, potentially long‑acting HIV‑1 treatment and to resolve the safety/regulatory issues rather than abandon the program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides useful details about the clinical hold status and regulatory challenges, but contains significant factual discrepancies with the ground truth that affect overall accuracy:\n\nKEY DISCREPANCIES:\n1. PHASE 3 ENTRY TIMING: Ground truth states MK-8591A had a Phase 3 entry date of February 2020 (already in Phase 3 by 2022). LLM claims the 2022 10-K said it was \"slated to enter Phase 3 in 2023\" - this is contradictory. The LLM appears to have misread or misinterpreted the filing, suggesting a future Phase 3 entry when it was already in Phase 3.\n\n2. CLINICAL HOLD RESOLUTION: Ground truth explicitly states \"the FDA lifted a clinical hold on December 4, 2024\" - a critical development. The LLM answer completely misses this major regulatory milestone, instead stating the hold \"remained in effect\" through 2024 and describing \"unchanged hold status over three years.\" This is a substantial factual error that contradicts the ground truth's key finding.\n\n3. PARTIAL CLINICAL HOLD: Ground truth mentions \"the compound remained under a partial clinical hold for higher doses\" in 2024. The LLM does not mention this nuance about the partial hold remaining.\n\nCORRECT ELEMENTS:\n- Correctly identifies the clinical hold was placed in December 2021\n- Correctly identifies the safety concern (lymphocyte/CD4+ cell declines)\n- Correctly notes the hold prevented new studies from being initiated\n- Correctly identifies Merck's strategic commitment to the program\n- Correctly cites page numbers from filings\n\nMULTI-HOP REASONING:\nThe LLM's synthesis across three years is partially sound in structure but fundamentally flawed in conclusion. It correctly tracks the hold status through 2023 but fails to capture the critical 2024 development (FDA lifting the hold), which is essential to understanding the \"progression\" requested in the question.\n\nSEMANTIC EQUIVALENCE:\nThe LLM's conclusion about \"long-term strategic intent\" aligns with ground truth, but the factual foundation is incomplete and partially incorrect, undermining the validity of this conclusion.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates filing familiarity and some accurate details but misses or misrepresents critical regulatory developments, particularly the December 2024 clinical hold lift. This is a significant omission for a question specifically asking about how the timeline \"evolved\" through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 645,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "Merck introduced MK‑1308A in its 2022 filing as a co‑formulation of the anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, being evaluated in a Phase 3 trial for renal‑cell carcinoma (RCC) 【page_23】 【page_25】. The 2023 report repeats that same clinical focus and combination, still listing it as a Phase 3 RCC candidate with no new disease‑area or partner added 【page_20】 【page_21】. In the 2024 filing the drug remains in the immuno‑oncology pillar as a Phase 3 RCC combination, and while Merck notes several late‑stage regulatory submissions, MK‑1308A has not yet entered FDA or EMA review, indicating continued development but no regulatory milestone achieved 【page_50】 【page_49】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies MK-1308A as a co-formulation of quavonlimab (anti-CTLA-4 antibody) with pembrolizumab, correctly identifies its Phase 3 status across all three years (2022-2024), and correctly identifies RCC as the clinical focus throughout the period. The answer appropriately notes the lack of regulatory approval through 2024. The multi-hop synthesis across three years is logically sound.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR - The LLM states MK-1308A was 'introduced in its 2022 filing as a co-formulation' with explicit details about quavonlimab. However, the ground truth indicates that in 2022, MK-1308A was 'listed as part of Merck's oncology pipeline' for RCC in Phase 3 with pembrolizumab, but the formulation details (quavonlimab specification) were NOT explicitly described until 2023. The LLM incorrectly backdates the explicit formulation identification to 2022. (2) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes 'increasing specificity in formulation and therapeutic strategy over time' and describes a progression from general listing (2022) to explicit coformulation definition (2023) to sustained emphasis (2024). The LLM flattens this progression by stating the formulation was known in 2022, missing the key narrative of how the strategy became 'more defined' over time. (3) MINOR IMPRECISION - The LLM says '2023 report repeats that same clinical focus and combination, still listing it as a Phase 3 RCC candidate with no new disease-area or partner added' - this is somewhat misleading as 2023 represents the FIRST explicit mention of the formulation details, not a repetition. (4) CITATION FORMATTING - While page citations are provided, they cannot be verified against the actual documents in this evaluation.\n\nMULTI-HOP REASONING: The synthesis across three years is present and logical, but the temporal evolution is mischaracterized. The answer should have highlighted that 2023 marked a shift to explicit formulation definition, not that 2022 already contained this information.\n\nNUMERIC/CALCULATION ACCURACY: No calculations required; dates and years are correct (2022, 2023, 2024).\n\nSEMANTIC ISSUES: The phrase 'introduced in its 2022 filing as a co-formulation' is semantically misleading about what was actually disclosed in 2022 versus 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 620,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "In fiscal 2022 Accenture repurchased roughly 12.2 million Class A shares for about $4.1 billion, leaving $3.1 billion of its $6.1 billion total repurchase authority still available. By fiscal 2024 the company was again buying back billions of dollars of stock – $4.5 billion of shares were repurchased for the year (including $605 million in Q4) – and the remaining pool of authority had fallen to about $2.7 billion after the board added a $4 billion top‑up that raised total outstanding authority to $6.7 billion. The consistent, multi‑year buy‑back volume together with periodic increases to the authorized ceiling shows a deliberate, long‑term capital‑return strategy that keeps a large, replenished buy‑back capacity for shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine its credibility. (1) FISCAL 2022 REPURCHASE VOLUME: The LLM claims 12.2 million shares repurchased for $4.1 billion in fiscal 2022, but the ground truth only specifies fiscal 2024 activity (2,000,308 shares for $605 million). The LLM appears to have fabricated or confused fiscal 2022 repurchase data not present in the ground truth. (2) FISCAL 2024 REPURCHASE AMOUNT: The LLM states $4.5 billion was repurchased in fiscal 2024, but the ground truth explicitly states only $605 million was purchased in fiscal 2024 (plus employee-related transactions). This is a massive discrepancy ($4.5B vs $605M). (3) AUTHORIZATION FIGURES: The LLM correctly identifies the $2.7 billion remaining authorization and $4 billion top-up in September 2024 bringing total to $6.7 billion, which matches ground truth. The fiscal 2022 $3.1 billion available authorization is also approximately correct. (4) MULTI-HOP REASONING: While the LLM correctly synthesizes the concept of a sustained capital return strategy with periodic replenishment, this conclusion is built on fundamentally incorrect repurchase volume data. The reasoning about strategic intent is sound in principle but undermined by the false numbers. (5) MISSING CONTEXT: The LLM fails to mention the 72,255 shares acquired through employee-related transactions in fiscal 2024, a detail in the ground truth. The reference to '2023 filing forward-looking disclosure' in the ground truth is also not addressed. VERDICT: The answer demonstrates understanding of the strategic pattern but contains critical numerical errors that make it unreliable for financial analysis. The $4.5B fiscal 2024 figure is particularly problematic as it contradicts the explicit $605M stated in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 496,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS’s $750 million 2.350 % senior notes due 2040 are listed in the capital‑structure tables of its 2022 Form 10‑K (see page 136) and again in the 2023 and 2024 Form 10‑Ks (see page 134 in each filing). The fact that this low‑coupon, long‑dated debt remains on the balance sheet across three consecutive years shows BMS is deliberately locking in inexpensive, fixed‑rate financing for the next two decades, diversifying its maturity profile and managing interest‑rate risk with stable, long‑term funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three years of SEC filings. STRENGTHS: (1) All quantitative data is correct - the $750 million principal amount, 2.350% coupon rate, and 2040 maturity date are accurately stated; (2) The multi-hop synthesis is sound - the answer correctly identifies the notes' presence across 2022, 2023, and 2024 Form 10-Ks and draws appropriate conclusions about strategic intent; (3) The reasoning about fixed-rate debt strategy, interest rate risk management, and maturity diversification is logically sound and aligns with the ground truth's core message; (4) The answer appropriately characterizes the debt as 'low-coupon' and 'inexpensive' fixed-rate financing, which is semantically equivalent to the ground truth's emphasis on 'predictable long-term liabilities' and 'fixed interest rate obligations'; (5) Page references (136 for 2022, 134 for 2023 and 2024) add specificity and credibility. MINOR WEAKNESSES: (1) The LLM uses 'BMS' as an abbreviation while the ground truth uses 'BMY' - both are acceptable ticker references but there's a slight inconsistency in notation; (2) The answer is slightly more concise than the ground truth and doesn't explicitly mention that the company 'has not refinanced or retired this instrument despite market fluctuations,' though this is implied by the statement that the debt 'remains on the balance sheet'; (3) The phrase 'diversifying its maturity profile' adds a nuance not explicitly in the ground truth, though it's a reasonable inference. CALCULATION VERIFICATION: No calculations required; all stated figures are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly connects the persistence of the notes to strategic debt management decisions. The semantic equivalence between the LLM's characterization of the strategy and the ground truth's description is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 535,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "BMS’s 4.350 % Senior Notes due 2047 are shown in each of the recent 10‑K exhibit indexes with the same 4.350 % coupon – the note appears unchanged in the 2023 filing (Exhibit 4.19 on pages 135‑136) and again in the 2024 filing (Exhibit 4.19 on page 134)【page_135†L1-L4】【page_134†L1-L4】.  The unchanged coupon across the 2022‑2024 reports indicates that the company has kept a fixed‑rate commitment for this long‑dated debt, reflecting a strategy of locking in a stable, predictable cost of capital for its long‑term financing needs.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) EXHIBIT REFERENCE DISCREPANCY: The LLM cites 'Exhibit 4.19' for both 2023 and 2024 filings, but the ground truth specifies different exhibits - 'Exhibit 4ff' for 2023 and 'Exhibit 4ff' for 2024 (with 2022 being 'Exhibit 4bbb'). This is a significant factual error in exhibit identification. (2) INDENTURE DOCUMENTATION MISSING: The ground truth provides specific supplemental indenture dates and references (Twelfth Supplemental Indenture dated November 13, 2020 for 2022; Fourteenth Supplemental Indenture dated November 13, 2023 for 2023; Form 8-K from November 22, 2019 for 2024). The LLM completely omits these important legal documentation details, which are material to understanding the company's debt structure evolution. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the consistent 4.350% coupon rate across years, it fails to synthesize the complete picture of how the debt was documented and referenced across different filing years and supplemental indentures. (4) CORRECT ELEMENTS: The LLM correctly identifies (a) the 4.350% interest rate, (b) the 2047 maturity date, (c) the consistency of the rate across 2022-2024, and (d) the strategic implication of a fixed-rate, long-term financing approach. (5) PAGE REFERENCES: The LLM provides page references (pages 135-136 for 2023, page 134 for 2024) which cannot be verified against the ground truth but appear reasonable. The core insight about stable long-term debt strategy is sound, but the execution is incomplete and contains exhibit reference errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 439,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In Nike’s FY 2022 10‑K, FlyEase was mentioned only in a broad “product‑research, design and development” paragraph that listed it alongside other innovations (Air, Zoom, Flyknit, FlyEase, etc.) 【page_6】. By FY 2024 the same phrasing still appears 【page_6】, but the filing now couples that technology reference with detailed manufacturing metrics – 96 finished‑goods footwear factories in 11 countries, 15 contract manufacturers, the largest single factory representing roughly 9 % of total footwear output, and regional splits showing factories in Vietnam (≈50 %), Indonesia (≈27 %) and China (≈18 %) together producing about 95 % of Nike footwear, with four contract makers each contributing >10 % (≈57 % total) 【page_6】. Those numbers illustrate that FlyEase‑enabled shoes are being produced at a massive, globally integrated scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about FlyEase's evolution and production scale. STRENGTHS: (1) Correctly identifies the evolution narrative from FY2022 to FY2024, noting FlyEase's consistent mention in product development sections. (2) All geographic manufacturing percentages are accurate: Vietnam ~50%, Indonesia ~27%, China ~18%, totaling ~95% - these match the ground truth exactly. (3) Provides additional quantitative detail beyond the ground truth (96 finished-goods factories in 11 countries, 15 contract manufacturers, largest factory ~9% of output, four contract makers each >10% contributing ~57% total), which enriches the answer without contradicting ground truth. (4) Correctly synthesizes the multi-hop connection between FlyEase mentions and manufacturing data to demonstrate global integration and scale. (5) Proper citation formatting with page references. MINOR WEAKNESSES: (1) The answer doesn't explicitly mention FY2023 as a transitional year where FlyEase was 'consistently mentioned alongside established technologies like Nike Air and Dri-FIT' - the ground truth emphasizes this intermediate step showing growing integration, while the LLM jumps from FY2022 to FY2024. (2) The phrasing 'the same phrasing still appears' could be clearer about whether this represents growth or stagnation in reporting emphasis. (3) The answer could more explicitly state that the manufacturing data 'includes FlyEase-integrated products' as the ground truth does, though this is reasonably implied. QUANTITATIVE VERIFICATION: All percentages (50%, 27%, 18%, 95%, 9%, 57%) are accurate. The factory counts (96, 15, 4) appear consistent with filing data. No calculation errors detected. MULTI-HOP REASONING: Successfully synthesizes information across fiscal years and connects product innovation mentions to manufacturing operations data, demonstrating the required multi-hop analysis. The logic that geographic manufacturing distribution demonstrates 'full-scale integration' is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 554,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s RedCard‑related payment products saw their share of purchases fall each year – total RedCard (Target Debit Card and related cards) penetration was 20.5 % in FY 2022, 19.8 % in FY 2023 and 18.6 % in FY 2024【page_27】. The steady decline, even though the rate remains near‑20 %, suggests the loyalty‑driven payment program is still sizable but losing momentum, indicating that its ability to generate incremental sales is weakening over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM provides an incorrect figure for FY 2024 penetration rate. Ground truth shows 17.8% for 2024, but the LLM states 18.6%. This is a material factual error of 0.8 percentage points that directly contradicts the source data. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY ASSESSMENT: The error in the 2024 figure is significant because it undermines the core trend analysis. The ground truth shows a steeper decline (20.5% → 19.8% → 17.8%, a 2.7 percentage point drop over three years), while the LLM's numbers show a smaller decline (20.5% → 19.8% → 18.6%, a 1.9 percentage point drop). This affects the interpretation of trend severity. QUALITATIVE REASONING: The LLM's interpretation of the trend is reasonable and aligns with the ground truth's conclusion about weakening effectiveness. The characterization of the program as 'losing momentum' and having 'weakening ability to generate incremental sales' is semantically equivalent to the ground truth's assessment of 'reduced customer engagement' and 'weakening effectiveness.' The reasoning about the program remaining 'sizable but losing momentum' is sound. COMPLETENESS: The LLM addresses both parts of the question - the evolution of penetration rates and what the trend suggests about strategy effectiveness. However, the incorrect 2024 figure prevents full accuracy. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information about RedCard products across three fiscal years and connects this to strategic implications, demonstrating appropriate multi-hop reasoning despite the data error. The citation reference [page_27] suggests proper sourcing, though the data itself is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 470,
        "total_tokens": 1702
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 5.99,
    "average_quantitative_accuracy": 6.32,
    "average_qualitative_accuracy": 6.24,
    "average_contextual_relevance": 7.1,
    "score_distribution": {
      "excellent": 180,
      "good": 200,
      "fair": 219,
      "poor": 201
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 29186.94,
    "timestamp": "2026-02-02T23:46:52.685092"
  }
}